1	I	PRP	O	I	_	0	SENT_1	[p1l664t83r666b200],
2	REVIEW	NNP	O	REVIEW	nn	3	SENT_1	[p1l1179t131r1352b157],
3	ARTICLE	NN	O	article	dep	1	SENT_1	[p1l1364t131r1550b157],
4	I	PRP	O	I	dep	1	SENT_1	[p1l2062t83r2064b200],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_2	[p1l1180t275r1354b298],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_2	[p1l1371t275r1548b298],

1	W.	NNP	PERSON	W.	nn	2	SENT_3	[p1l886t319r921b342],
2	Gregory	NNP	PERSON	Gregory	_	0	SENT_3	[p1l932t319r1040b350],
3	Feero	NNP	PERSON	Feero	nn	7	SENT_3	[p1l1051t319r1132b346],
4	,	,	O	,	_	0	SENT_3	[p1l1051t319r1132b346],
5	M.D.	NNP	O	M.D.	appos	7	SENT_3	[p1l1145t319r1218b346],
6	,	,	O	,	_	0	SENT_3	[p1l1145t319r1218b346],
7	Ph.D.	NNP	O	Ph.D.	dep	2	SENT_3	[p1l1231t317r1311b347],
8	,	,	O	,	_	0	SENT_3	[p1l1231t317r1311b347],
9	and	CC	O	and	_	0	SENT_3	[p1l1322t317r1370b342],
10	Alan	NNP	PERSON	Alan	nn	11	SENT_3	[p1l1381t317r1440b342],
11	E.	NNP	PERSON	E.	dep	2	SENT_3	[p1l1453t319r1474b342],
12	Guttmacher	NNP	PERSON	Guttmacher	nn	16	SENT_3	[p1l1486t317r1656b346],
13	,	,	O	,	_	0	SENT_3	[p1l1486t317r1656b346],
14	M.D.	NNP	O	M.D.	appos	16	SENT_3	[p1l1670t319r1742b346],
15	,	,	O	,	_	0	SENT_3	[p1l1670t319r1742b346],
16	Editors	NNP	O	Editors	dep	2	SENT_3	[p1l1755t317r1842b342],

1	Genomics	NNS	O	genomic	_	0	SENT_4	[p1l892t410r1197b463],
2	and	CC	O	and	_	0	SENT_4	[p1l1227t409r1337b463],
3	Drug	NN	O	drug	nn	4	SENT_4	[p1l1365t413r1520b479],
4	Response	NN	O	response	conj_and	1	SENT_4	[p1l1546t413r1836b478],

1	Liewei	NNP	PERSON	Liewei	nn	10	SENT_5	[p1l875t535r976b563],
2	Wang	NNP	PERSON	Wang	nn	10	SENT_5	[p1l989t535r1096b573],
3	,	,	O	,	_	0	SENT_5	[p1l989t535r1096b573],
4	M.D.	NNP	O	M.D.	appos	10	SENT_5	[p1l1113t535r1203b569],
5	,	,	O	,	_	0	SENT_5	[p1l1113t535r1203b569],
6	Ph.D.	NNP	O	Ph.D.	appos	10	SENT_5	[p1l1220t532r1319b569],
7	,	,	O	,	_	0	SENT_5	[p1l1220t532r1319b569],
8	Howard	NNP	PERSON	Howard	appos	10	SENT_5	[p1l1337t532r1467b563],
9	L.	NNP	PERSON	L.	nn	10	SENT_5	[p1l1485t535r1508b563],
10	McLeod	NNP	PERSON	McLeod	_	0	SENT_5	[p1l1526t532r1668b569],
11	,	,	O	,	_	0	SENT_5	[p1l1526t532r1668b569],
12	Pharm	NNP	ORGANIZATION	Pharm	appos	10	SENT_5	[p1l1686t532r1854b569],
13	.	.	O	.	_	0	SENT_5	[p1l1686t532r1854b569],

1	D.	NNP	O	D.	_	0	SENT_6	[p1l1686t532r1854b569],
2	,	,	O	,	_	0	SENT_6	[p1l1686t532r1854b569],

1	and	CC	O	and	dep	4	SENT_7	[p1l1050t582r1110b613],
2	Richard	NNP	PERSON	Richard	nn	4	SENT_7	[p1l1127t582r1251b613],
3	M.	NNP	PERSON	M.	nn	4	SENT_7	[p1l1269t585r1308b613],
4	Weinshilboum	NNP	PERSON	Weinshilboum	_	0	SENT_7	[p1l1321t582r1580b619],
5	,	,	O	,	_	0	SENT_7	[p1l1321t582r1580b619],
6	M.D.	NNP	O	M.D.	appos	4	SENT_7	[p1l1597t585r1677b613],

1	From	IN	O	from	_	0	SENT_8	[p1l92t701r156b722],
2	the	DT	O	the	det	3	SENT_8	[p1l167t699r208b722],
3	Division	NN	O	division	prep_from	11	SENT_8	[p1l221t701r324b722],
4	of	IN	O	of	_	0	SENT_8	[p1l336t698r365b722],
5	Clinical	JJ	O	clinical	amod	6	SENT_8	[p1l371t699r464b722],
6	Pharmacol	NN	O	pharmacol	prep_of	3	SENT_8	[p1l478t699r625b722],
7	-	:	O	-	_	0	SENT_8	[p1l478t699r625b722],
8	HARMACOGENOMICS	NN	PERSON	harmacogenomic	nsubj	11	SENT_8	[p1l765t700r1137b722],
9	IS	VBZ	O	be	cop	11	SENT_8	[p1l1150t701r1180b722],
10	THE	DT	O	the	det	11	SENT_8	[p1l1191t701r1263b722],
11	STUDY	NN	O	study	_	0	SENT_8	[p1l1276t701r1387b722],
12	OF	IN	O	of	_	0	SENT_8	[p1l1397t700r1441b722],
13	THE	DT	O	the	det	14	SENT_8	[p1l1452t701r1524b722],
14	ROLE	NN	O	role	prep_of	11	SENT_8	[p1l1537t701r1626b723],
15	OF	IN	O	of	prep	14	SENT_8	[p1l1639t700r1683b722],
16	INHERITED	VBN	O	inherit	dep	15	SENT_8	[p1l1695t701r1901b722],
17	AND	CC	O	and	cc	18	SENT_8	[p1l1911t701r1991b723],
18	AC	NN	O	ac	dobj	16	SENT_8	[p1l2006t701r2063b722, p1l90t744r141b767],
19	°	CD	NUMBER	°	num	20	SENT_8	[p1l2006t701r2063b722, p1l90t744r141b767],
20	g	NN	O	g	npadvmod	21	SENT_8	[p1l2006t701r2063b722, p1l90t744r141b767],
21	>	JJR	O	>	dep	16	SENT_8	[p1l2006t701r2063b722, p1l90t744r141b767],
22	’	CD	NUMBER	’	dep	21	SENT_8	[p1l2006t701r2063b722, p1l90t744r141b767],
23	v	LS	O	v	prep	22	SENT_8	[p1l2006t701r2063b722, p1l90t744r141b767],
24	D	NN	O	d	nn	26	SENT_8	[p1l159t738r317b767],
25	°	CD	NUMBER	°	num	26	SENT_8	[p1l159t738r317b767],
26	Pa	NNP	O	Pa	dep	23	SENT_8	[p1l159t738r317b767],
27	"	``	O	"	punct	35	SENT_8	[p1l159t738r317b767],
28	"	``	O	"	punct	35	SENT_8	[p1l159t738r317b767],
29	“	FW	O	“	nn	35	SENT_8	[p1l159t738r317b767],
30	°	FW	O	°	nn	35	SENT_8	[p1l159t738r317b767],
31	”	FW	O	”	nn	35	SENT_8	[p1l159t738r317b767],
32	*	FW	O	*	nn	35	SENT_8	[p1l159t738r317b767],
33	_	FW	O	_	nn	35	SENT_8	[p1l331t736r359b779],
34	°	FW	O	°	nn	35	SENT_8	[p1l331t736r359b779],
35	f	FW	O	f	dep	26	SENT_8	[p1l331t736r359b779],
36	M	NN	O	m	prep	35	SENT_8	[p1l372t736r502b760],
37	°	NN	O	°	dep	36	SENT_8	[p1l372t736r502b760],
38	'	''	O	'	_	0	SENT_8	[p1l372t736r502b760],
39	°	CD	NUMBER	°	number	40	SENT_8	[p1l372t736r502b760],
40	°	CD	NUMBER	°	dep	41	SENT_8	[p1l372t736r502b760],
41	“	NN	O	“	dep	35	SENT_8	[p1l372t736r502b760],
42	'	''	O	'	_	0	SENT_8	[p1l372t736r502b760],
43	a	DT	O	a	det	45	SENT_8	[p1l372t736r502b760],
44	’	NN	O	’	nn	45	SENT_8	[p1l372t736r502b760],
45	Pl	NN	O	pl	dep	22	SENT_8	[p1l517t736r625b779],
46	‘	CD	NUMBER	‘	nsubj	50	SENT_8	[p1l517t736r625b779],
47	a	DT	O	a	det	49	SENT_8	[p1l517t736r625b779],
48	"	``	O	"	punct	49	SENT_8	[p1l517t736r625b779],
49	T	NN	O	t	dep	46	SENT_8	[p1l517t736r625b779],
50	‘	VBD	O	‘	rcmod	45	SENT_8	[p1l517t736r625b779],
51	a	DT	O	a	dobj	50	SENT_8	[p1l517t736r625b779],
52	'	''	O	'	_	0	SENT_8	[p1l517t736r625b779],
53	quired	VBN	O	quire	partmod	51	SENT_8	[p1l764t742r871b781],
54	genetic	JJ	O	genetic	amod	55	SENT_8	[p1l888t743r1008b781],
55	variation	NN	O	variation	dobj	53	SENT_8	[p1l1022t742r1171b773],
56	in	IN	O	in	_	0	SENT_8	[p1l1187t742r1220b772],
57	drug	NN	O	drug	nn	58	SENT_8	[p1l1237t742r1316b781],
58	response	NN	O	response	prep_in	55	SENT_8	[p1l1331t744r1504b781],
59	}	CD	NUMBER	}	npadvmod	60	SENT_8	[p1l1331t744r1504b781],
60	Clinically	RB	O	clinically	advmod	55	SENT_8	[p1l1521t742r1680b781],
61	relevant	JJ	O	relevant	amod	62	SENT_8	[p1l1695t742r1827b773],
62	pharmacogecology	NN	O	pharmacogecology	dep	55	SENT_8	[p1l1841t742r2063b781, p1l90t774r174b805],
63	and	CC	O	and	_	0	SENT_8	[p1l191t774r237b797],
64	Experimental	JJ	O	experimental	amod	65	SENT_8	[p1l258t774r427b804],
65	Therapeutics	NNS	O	therapeutics	dep	55	SENT_8	[p1l445t774r624b804],
66	,	,	O	,	_	0	SENT_8	[p1l445t774r624b804],
67	.	.	O	.	_	0	SENT_8	[p1l820t792r825b798],

1	1	LS	NUMBER	1	_	0	SENT_9	[p1l976t792r985b822],
2	.	.	O	.	_	0	SENT_9	[p1l1108t793r1113b798],

1	1	LS	NUMBER	1	_	0	SENT_10	[p1l1140t792r1149b822],
2	.	.	O	.	_	0	SENT_10	[p1l1189t792r1194b798],

1	1	LS	NUMBER	1	_	0	SENT_11	[p1l1257t792r1267b822],
2	.	.	O	.	_	0	SENT_11	[p1l1288t792r1293b798],

1	d	NN	O	d	nn	2	SENT_12	[p1l1359t792r1379b823],
2	b	NN	O	b	_	0	SENT_12	[p1l1542t792r1561b823],
3	1	CD	NUMBER	1	dep	2	SENT_12	[p1l1584t792r1603b822],
4	.	.	O	.	_	0	SENT_12	[p1l1584t792r1603b822],

1	h	NN	O	h	nsubj	58	SENT_13	[p1l1687t792r1708b822],
2	b	NN	O	b	dep	1	SENT_13	[p1l1782t792r1801b823],
3	1	CD	NUMBER	1	dobj	2	SENT_13	[p1l1880t792r1889b822],
4	1	CD	NUMBER	1	rcmod	3	SENT_13	[p1l2016t792r2035b822],
5	:	:	O	:	_	0	SENT_13	[p1l2016t792r2035b822],
6	Mayo	NNP	PERSON	Mayo	nn	8	SENT_13	[p1l92t813r160b842],
7	Medicalschoolyhﬂayo	NNP	PERSON	Medicalschoolyhﬂayo	nn	8	SENT_13	[p1l170t811r454b842],
8	C	NNP	O	C	dep	4	SENT_13	[p1l463t811r625b839],
9	,	,	O	,	_	0	SENT_13	[p1l463t811r625b839],
10	,	,	O	,	_	0	SENT_13	[p1l463t811r625b839],
11	,	,	O	,	_	0	SENT_13	[p1l463t811r625b839],
12	,	,	O	,	_	0	SENT_13	[p1l463t811r625b839],
13	,	,	O	,	_	0	SENT_13	[p1l463t811r625b839],
14	,	,	O	,	_	0	SENT_13	[p1l463t811r625b839],
15	c	NN	O	c	nn	17	SENT_13	[p1l463t811r625b839],
16	’	CD	NUMBER	’	num	17	SENT_13	[p1l463t811r625b839],
17	RoCh	NNP	O	RoCh	dep	24	SENT_13	[p1l463t811r625b839],
18	_	CD	NUMBER	_	num	21	SENT_13	[p1l463t811r625b839],
19	netic	JJ	O	netic	amod	21	SENT_13	[p1l764t799r844b822],
20	examp	NN	O	examp	nn	21	SENT_13	[p1l865t802r974b831],
21	es	NNS	O	e	dep	17	SENT_13	[p1l987t802r1029b829],
22	,	,	O	,	_	0	SENT_13	[p1l987t802r1029b829],
23	mainy	JJ	O	mainy	amod	24	SENT_13	[p1l1051t802r1168b831],
24	invo	NN	O	invo	dep	1	SENT_13	[p1l1186t802r1255b823],
25	ving	NN	O	ving	nn	29	SENT_13	[p1l1267t802r1340b831],
26	rug	NN	O	rug	nn	29	SENT_13	[p1l1381t802r1439b831],
27	meta	NN	O	meta	nn	29	SENT_13	[p1l1458t798r1540b822],
28	o	NN	O	o	nn	29	SENT_13	[p1l1564t802r1582b823],
29	ism	NN	O	ism	dep	24	SENT_13	[p1l1596t802r1665b829],
30	,	,	O	,	_	0	SENT_13	[p1l1596t802r1665b829],
31	ave	NN	O	ave	nn	32	SENT_13	[p1l1710t802r1761b823],
32	een	NN	O	een	dep	33	SENT_13	[p1l1804t802r1860b822],
33	<	JJR	O	<	dep	1	SENT_13	[p1l1887t802r1996b823],
34	nown	CD	NUMBER	nown	dep	33	SENT_13	[p1l1887t802r1996b823],
35	or	CC	O	or	_	0	SENT_13	[p1l2030t802r2064b823],
36	ester	NN	O	ester	dep	1	SENT_13	[p1l90t853r159b876],
37	,	,	O	,	_	0	SENT_13	[p1l90t853r159b876],
38	MN	NN	O	mn	nn	40	SENT_13	[p1l175t851r220b872],
39	(	CD	NUMBER	(	num	40	SENT_13	[p1l239t851r309b880],
40	L.W.	NNP	LOCATION	L.W.	dep	1	SENT_13	[p1l239t851r309b880],
41	,	,	O	,	_	0	SENT_13	[p1l239t851r309b880],
42	R.M.W.	NNP	O	R.M.W.	nsubj	58	SENT_13	[p1l326t851r434b880],
43	)	CD	NUMBER	)	dep	42	SENT_13	[p1l326t851r434b880],
44	;	:	O	;	_	0	SENT_13	[p1l326t851r434b880],
45	and	CC	O	and	_	0	SENT_13	[p1l449t849r494b872],
46	the	DT	O	the	det	48	SENT_13	[p1l508t849r549b872],
47	UNC	NNP	O	UNC	nn	48	SENT_13	[p1l564t850r625b872],
48	decades	NNS	DURATION	decade	nsubj	58	SENT_13	[p1l665t842r804b879],
49	,	,	O	,	_	0	SENT_13	[p1l665t842r804b879],
50	but	CC	O	but	cc	51	SENT_13	[p1l818t842r873b873],
51	recently	RB	DATE	recently	advmod	58	SENT_13	[p1l882t842r1019b881],
52	,	,	O	,	_	0	SENT_13	[p1l882t842r1019b881],
53	the	DT	O	the	det	54	SENT_13	[p1l1033t842r1085b872],
54	field	NN	O	field	nsubj	58	SENT_13	[p1l1096t842r1171b873],
55	of	IN	O	of	_	0	SENT_13	[p1l1183t842r1222b873],
56	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	54	SENT_13	[p1l1226t842r1533b881],
57	has	VBZ	O	have	aux	58	SENT_13	[p1l1545t842r1601b872],
58	evolved	VBN	O	evolve	_	0	SENT_13	[p1l1614t842r1735b873],
59	into	IN	O	into	_	0	SENT_13	[p1l1746t842r1812b873],
60	“	NN	O	“	prep_into	58	SENT_13	[p1l1825t842r2063b881],
61	pharmacoge	NN	O	pharmacoge	nn	63	SENT_13	[p1l1825t842r2063b881],
62	—	CD	NUMBER	—	num	63	SENT_13	[p1l1825t842r2063b881],
63	Iristitute	NNP	O	Iristitute	tmod	58	SENT_13	[p1l92t888r199b929],
64	for	IN	O	for	_	0	SENT_13	[p1l211t886r247b910],
65	Pharmacogenorriics	NNPS	O	Pharmacogenorriics	prep_for	63	SENT_13	[p1l260t886r518b929],
66	and	CC	O	and	_	0	SENT_13	[p1l532t886r578b910],
67	l	NN	O	l	conj_and	65	SENT_13	[p1l593t888r625b909],
68	"	''	O	"	punct	65	SENT_13	[p1l593t888r625b909],
69	-	:	O	-	_	0	SENT_13	[p1l593t888r625b909],
70	nomics	NNS	O	nomic	nn	72	SENT_13	[p1l665t892r810b929],
71	,	,	O	,	_	0	SENT_13	[p1l665t892r810b929],
72	”	NN	O	”	dep	63	SENT_13	[p1l665t892r810b929],
73	involving	VBG	O	involve	xcomp	58	SENT_13	[p1l826t892r980b931],
74	a	DT	O	a	det	75	SENT_13	[p1l993t902r1011b922],
75	shift	NN	O	shift	dobj	73	SENT_13	[p1l1025t892r1103b922],
76	from	IN	O	from	_	0	SENT_13	[p1l1115t892r1197b923],
77	a	DT	O	a	det	78	SENT_13	[p1l1211t902r1229b922],
78	focus	NN	O	focus	prep_from	73	SENT_13	[p1l1243t892r1331b923],
79	on	IN	O	on	_	0	SENT_13	[p1l1347t902r1388b923],
80	individual	JJ	O	individual	amod	82	SENT_13	[p1l1403t892r1570b923],
81	candidate	NN	O	candidate	nn	82	SENT_13	[p1l1585t892r1747b923],
82	genes	NNS	O	gene	prep_on	78	SENT_13	[p1l1761t902r1855b931],
83	to	TO	O	to	aux	84	SENT_13	[p1l1871t898r1902b923],
84	genomedividualized	VBN	O	genomedividualize	xcomp	73	SENT_13	[p1l1918t902r2063b931, p1l90t924r245b947],
85	Therapy	NN	O	therapy	dobj	84	SENT_13	[p1l254t924r365b954],
86	,	,	O	,	_	0	SENT_13	[p1l254t924r365b954],
87	University	NNP	O	University	nn	89	SENT_13	[p1l376t926r507b954],
88	ofNorth	NNP	O	ofNorth	nn	89	SENT_13	[p1l515t923r624b947],
89	. . . . .	NNP	O	. . . . .	appos	85	SENT_13	[p1l1267t942r1272b948],[p1l697t942r702b948],
90	.	.	O	.	_	0	SENT_13	[p1l1635t942r1640b948],

1	Carolina	NNP	PERSON	Carolina	nn	3	SENT_14	[p1l90t961r197b985],
2	Chapel	NN	PERSON	chapel	nn	3	SENT_14	[p1l223t961r311b992],
3	H	NN	PERSON	h	_	0	SENT_14	[p1l331t961r373b984],
4	,	,	O	,	_	0	SENT_14	[p1l331t961r373b984],
5	“	CD	NUMBER	“	number	6	SENT_14	[p1l331t961r373b984],
6	(	CD	NUMBER	(	appos	3	SENT_14	[p1l393t963r502b992],
7	HLM	NN	O	hlm	nn	8	SENT_14	[p1l393t963r502b992],
8	)	NN	O	)	dep	6	SENT_14	[p1l393t963r502b992],
9	.	.	O	.	_	0	SENT_14	[p1l393t963r502b992],

1	Address	NN	O	address	_	0	SENT_15	[p1l519t961r625b985],
2	wide	JJ	O	wide	amod	4	SENT_15	[p1l663t942r742b973],
3	association	NN	O	association	nn	4	SENT_15	[p1l755t949r943b973],
4	studies	NNS	O	study	dep	1	SENT_15	[p1l957t942r1083b973],
5	.	.	O	.	_	0	SENT_15	[p1l957t942r1083b973],

1	Such	JJ	O	such	amod	2	SENT_16	[p1l1099t942r1177b973],
2	studies	NNS	O	study	nsubjpass	4	SENT_16	[p1l1191t942r1308b973],
3	are	VBP	O	be	auxpass	4	SENT_16	[p1l1321t952r1372b972],
4	based	VBN	O	base	_	0	SENT_16	[p1l1385t942r1480b973],
5	on	IN	O	on	_	0	SENT_16	[p1l1494t952r1535b973],
6	a	DT	O	a	det	7	SENT_16	[p1l1548t952r1565b972],
7	rapid	JJ	O	rapid	prep_on	4	SENT_16	[p1l1578t942r1662b981],
8	scan	VB	O	scan	csubj	12	SENT_16	[p1l1676t952r1751b972],
9	of	IN	O	of	_	0	SENT_16	[p1l1764t942r1803b973],
10	markers	NNS	O	marker	prep_of	8	SENT_16	[p1l1809t942r1945b973],
11	across	IN	O	across	advmod	12	SENT_16	[p1l1959t952r2062b973],
12	reprint	VBP	O	reprint	ccomp	7	SENT_16	[p1l91t1001r178b1029],
13	requests	NNS	O	request	dobj	12	SENT_16	[p1l191t1003r301b1029],
14	to	TO	O	to	_	0	SENT_16	[p1l313t1003r338b1022],
15	Dr.	NNP	O	Dr.	nn	16	SENT_16	[p1l353t1001r388b1022],
16	Weinshilboum	NNP	PERSON	Weinshilboum	prep_to	12	SENT_16	[p1l400t999r589b1022],
17	at	IN	O	at	_	0	SENT_16	[p1l603t1003r626b1022],
18	the	DT	O	the	det	19	SENT_16	[p1l665t992r717b1022],
19	genome	NN	O	genome	prep_at	16	SENT_16	[p1l732t1002r864b1031],
20	of	IN	O	of	_	0	SENT_16	[p1l880t992r919b1023],
21	persons	NNS	O	person	prep_of	19	SENT_16	[p1l927t1002r1057b1031],
22	affected	VBN	O	affect	partmod	21	SENT_16	[p1l1074t992r1208b1023],
23	by	IN	O	by	_	0	SENT_16	[p1l1223t992r1261b1031],
24	a	DT	O	a	det	26	SENT_16	[p1l1275t1002r1292b1022],
25	particular	JJ	O	particular	amod	26	SENT_16	[p1l1307t992r1474b1031],
26	disorder	NN	O	disorder	agent	22	SENT_16	[p1l1488t992r1627b1023],
27	or	CC	O	or	_	0	SENT_16	[p1l1642t1002r1676b1023],
28	drug	NN	O	drug	nn	32	SENT_16	[p1l1691t992r1931b1031],
29	—	NN	O	—	nn	32	SENT_16	[p1l1691t992r1931b1031],
30	response	NN	O	response	nn	32	SENT_16	[p1l1691t992r1931b1031],
31	phenothe	NN	O	phenothe	nn	32	SENT_16	[p1l1946t992r2063b1031, p1l89t1036r130b1060],
32	Dl	NN	MISC	dl	agent	22	SENT_16	[p1l151t1038r254b1060],
33	"	''	O	"	punct	32	SENT_16	[p1l151t1038r254b1060],
34	'	''	O	'	_	0	SENT_16	[p1l151t1038r254b1060],
35	5	CD	NUMBER	5	dobj	22	SENT_16	[p1l151t1038r254b1060],
36	'	''	O	'	_	0	SENT_16	[p1l151t1038r254b1060],
37	°	FW	O	°	nn	40	SENT_16	[p1l151t1038r254b1060],
38	”	FW	O	”	nn	40	SENT_16	[p1l151t1038r254b1060],
39	°	FW	O	°	nn	40	SENT_16	[p1l275t1036r303b1060],
40	f	FW	O	f	nsubj	48	SENT_16	[p1l275t1036r303b1060],
41	C	NN	O	c	dep	40	SENT_16	[p1l317t1036r411b1060],
42	"	''	O	"	punct	41	SENT_16	[p1l317t1036r411b1060],
43	“‘	CD	NUMBER	“‘	number	44	SENT_16	[p1l317t1036r411b1060],
44	“‘	CD	NUMBER	“‘	dep	40	SENT_16	[p1l317t1036r411b1060],
45	*	NN	O	*	nn	47	SENT_16	[p1l317t1036r411b1060],
46	'	''	O	'	_	0	SENT_16	[p1l317t1036r411b1060],
47	Pl	NN	O	pl	dep	44	SENT_16	[p1l433t1036r624b1067],
48	‘	VBD	O	‘	rcmod	35	SENT_16	[p1l433t1036r624b1067],
49	a	DT	O	a	det	51	SENT_16	[p1l433t1036r624b1067],
50	"	``	O	"	punct	51	SENT_16	[p1l433t1036r624b1067],
51	“‘	NN	O	“‘	dobj	48	SENT_16	[p1l433t1036r624b1067],
52	*	CD	NUMBER	*	number	53	SENT_16	[p1l433t1036r624b1067],
53	°	CD	NUMBER	°	num	54	SENT_16	[p1l433t1036r624b1067],
54	°	NN	O	°	dep	48	SENT_16	[p1l433t1036r624b1067],
55	'	''	O	'	_	0	SENT_16	[p1l433t1036r624b1067],
56	°	CD	NUMBER	°	num	58	SENT_16	[p1l433t1036r624b1067],
57	gYv	NN	O	gyv	nn	58	SENT_16	[p1l433t1036r624b1067],
58	type	NN	O	type	dep	19	SENT_16	[p1l665t1049r734b1081],
59	and	CC	O	and	_	0	SENT_16	[p1l749t1042r810b1073],
60	persons	NNS	O	person	dep	19	SENT_16	[p1l824t1052r952b1081],
61	who	WP	O	who	nsubjpass	64	SENT_16	[p1l966t1042r1036b1073],
62	are	VBP	O	be	auxpass	64	SENT_16	[p1l1052t1052r1101b1073],
63	not	RB	O	not	neg	64	SENT_16	[p1l1116t1048r1171b1073],
64	affected	VBN	O	affect	rcmod	60	SENT_16	[p1l1184t1042r1323b1079],
65	,	,	O	,	_	0	SENT_16	[p1l1184t1042r1323b1079],
66	with	IN	O	with	_	0	SENT_16	[p1l1339t1042r1413b1073],
67	tests	NNS	O	test	prep_with	64	SENT_16	[p1l1429t1048r1502b1073],
68	for	IN	O	for	_	0	SENT_16	[p1l1518t1042r1565b1073],
69	association	NN	O	association	prep_for	67	SENT_16	[p1l1579t1042r1762b1073],
70	that	WDT	O	that	nsubj	71	SENT_16	[p1l1778t1042r1843b1073],
71	compare	VBP	O	compare	rcmod	67	SENT_16	[p1l1857t1052r1998b1081],
72	geDepartment	NN	O	gedepartment	dobj	71	SENT_16	[p1l2013t1052r2063b1081, p1l92t1076r250b1105],
73	of	IN	O	of	_	0	SENT_16	[p1l261t1073r289b1097],
74	Molecular	JJ	O	molecular	amod	76	SENT_16	[p1l298t1074r428b1098],
75	Pharmacology	NN	O	pharmacology	nn	76	SENT_16	[p1l441t1074r626b1105],
76	. . . .	NN	O	. . . .	prep_of	72	SENT_16	[p1l914t1093r919b1098],[p1l720t1093r725b1098],
77	1	CD	NUMBER	1	num	7	SENT_16	[p1l1187t1092r1196b1122],
78	.	.	O	.	_	0	SENT_16	[p1l1272t1093r1277b1098],

1	ZA	NN	O	za	_	0	SENT_17	[p1l1334t1095r1382b1123],
2	1	CD	NUMBER	1	dobj	1	SENT_17	[p1l1527t1092r1537b1122],
3	.	.	O	.	_	0	SENT_17	[p1l1567t1093r1572b1098],
4	'	''	O	'	_	0	SENT_17	[p1l1680t1092r1708b1123],

1	}	NN	O	}	_	0	SENT_18	[p1l1680t1092r1708b1123],
2	A	NN	O	a	dep	1	SENT_18	[p1l1680t1092r1708b1123],
3	+	CC	O	+	_	0	SENT_18	[p1l1680t1092r1708b1123],
4	P	NN	O	p	nn	6	SENT_18	[p1l1728t1092r1765b1123],
5	}	NN	O	}	nn	6	SENT_18	[p1l1728t1092r1765b1123],
6	A	NN	O	a	dep	1	SENT_18	[p1l1728t1092r1765b1123],
7	+	CC	O	+	_	0	SENT_18	[p1l1728t1092r1765b1123],
8	h.	NN	O	h.	conj_+	6	SENT_18	[p1l1815t1092r1845b1122],
9	.	.	O	.	_	0	SENT_18	[p1l1878t1093r1883b1098],

1	f	LS	O	f	dep	2	SENT_19	[p1l1989t1092r2008b1123],
2	h	NN	O	h	_	0	SENT_19	[p1l2025t1092r2046b1123],
3	and	CC	O	and	prep	2	SENT_19	[p1l90t1111r134b1135],
4	ExperimentalTherapeutics	NNS	O	experimentaltherapeutic	dep	3	SENT_19	[p1l145t1111r486b1141],
5	’	CD	NUMBER	’	num	9	SENT_19	[p1l145t1111r486b1141],
6	Mayo	NNP	O	Mayo	nn	9	SENT_19	[p1l496t1114r562b1141],
7	C	NNP	O	C	nn	9	SENT_19	[p1l569t1111r625b1135],
8	“	NN	O	“	nn	9	SENT_19	[p1l569t1111r625b1135],
9	n	NN	O	n	dep	4	SENT_19	[p1l569t1111r625b1135],
10	_	VBG	O	_	partmod	2	SENT_19	[p1l569t1111r625b1135],
11	HCUC	NN	O	hcuc	nn	12	SENT_19	[p1l665t1099r744b1123],
12	V2lI	NN	O	v2lus	dobj	10	SENT_19	[p1l753t1099r901b1123],
13	'	''	O	'	_	0	SENT_19	[p1l753t1099r901b1123],
14	l	NN	O	l	prep	12	SENT_19	[p1l753t1099r901b1123],
15	£	CD	NUMBER	£	num	16	SENT_19	[p1l753t1099r901b1123],
16	ltlOI1	NN	O	ltloi1	dep	14	SENT_19	[p1l753t1099r901b1123],
17	In	IN	O	in	_	0	SENT_19	[p1l912t1102r944b1122],
18	21	CD	NUMBER	21	num	19	SENT_19	[p1l955t1102r972b1123],
19	case	NN	O	case	prep_in	10	SENT_19	[p1l983t1099r1185b1123],
20	—	CD	NUMBER	—	num	22	SENT_19	[p1l983t1099r1185b1123],
21	contro	NN	O	contro	nn	22	SENT_19	[p1l983t1099r1185b1123],
22	setting	NN	O	setting	dep	19	SENT_19	[p1l1208t1099r1331b1132],
23	.	.	O	.	_	0	SENT_19	[p1l1208t1099r1331b1132],

1	11	CD	NUMBER	11	num	2	SENT_20	[p1l1384t1102r1405b1122],
2	CXZIIIP	NN	ORGANIZATION	cxziiip	nsubj	9	SENT_20	[p1l1416t1102r1525b1131],
3	6	CD	NUMBER	6	nsubj	6	SENT_20	[p1l1538t1103r1554b1123],
4	IS	VBZ	O	be	cop	6	SENT_20	[p1l1565t1103r1590b1123],
5	pI'OVl	NN	O	pi'ovl	nn	6	SENT_20	[p1l1602t1102r1687b1131],
6	C	NN	O	c	rcmod	2	SENT_20	[p1l1710t1103r1725b1123],
7	In	IN	O	in	_	0	SENT_20	[p1l1758t1102r1790b1123],
8	I	PRP	O	I	prep_in	9	SENT_20	[p1l1802t1099r1814b1123],
9	’	VBP	O	’	_	0	SENT_20	[p1l1802t1099r1814b1123],
10	.	.	O	.	_	0	SENT_20	[p1l1802t1099r1814b1123],

1	IS	VBZ	O	be	_	0	SENT_21	[p1l1838t1103r1864b1123],
2	ISSUE	NNP	O	ISSUE	nn	3	SENT_21	[p1l1875t1102r1957b1123],
3	o	NN	O	o	nsubj	1	SENT_21	[p1l1969t1102r1987b1123],
4	C	NN	O	c	dep	5	SENT_21	[p1l2012t1099r2024b1123],
5	C	NN	O	c	amod	3	SENT_21	[p1l2048t1103r2063b1123],

1	ic	NN	O	ic	nsubj	22	SENT_22	[p1l91t1213r116b1239],
2	,	,	O	,	_	0	SENT_22	[p1l91t1213r116b1239],
3	2007First	NNP	O	2007First	nn	5	SENT_22	[p1l126t1203r237b1235],
4	St.	NNP	O	St.	nn	5	SENT_22	[p1l246t1213r276b1235],
5	sw	NN	O	sw	appos	1	SENT_22	[p1l287t1213r334b1239],
6	,	,	O	,	_	0	SENT_22	[p1l287t1213r334b1239],
7	Rochester	NNP	LOCATION	Rochester	appos	1	SENT_22	[p1l347t1203r475b1239],
8	,	,	O	,	_	0	SENT_22	[p1l347t1203r475b1239],
9	MN55905	NN	O	mn55905	appos	1	SENT_22	[p1l488t1203r624b1239],
10	,	,	O	,	_	0	SENT_22	[p1l488t1203r624b1239],
11	journal	NN	O	journal	appos	1	SENT_22	[p1l659t1204r780b1244],
12	:	:	O	:	_	0	SENT_22	[p1l659t1204r780b1244],
13	McCormack	NNP	PERSON	McCormack	dep	11	SENT_22	[p1l793t1205r998b1236],
14	and	CC	O	and	_	0	SENT_22	[p1l1009t1205r1070b1235],
15	colleagues	NNS	O	colleague	dep	11	SENT_22	[p1l1083t1205r1266b1244],
16	,	,	O	,	_	0	SENT_22	[p1l1083t1205r1266b1244],
17	testing	NN	O	testing	appos	1	SENT_22	[p1l1281t1205r1396b1244],
18	for	IN	O	for	_	0	SENT_22	[p1l1407t1204r1455b1235],
19	genomewide	JJ	O	genomewide	amod	20	SENT_22	[p1l1466t1205r1678b1244],
20	association	NN	O	association	prep_for	17	SENT_22	[p1l1690t1205r1887b1242],
21	,	,	O	,	_	0	SENT_22	[p1l1690t1205r1887b1242],
22	identified	VBD	O	identify	_	0	SENT_22	[p1l1902t1204r2063b1235],
23	°	NN	O	°	dobj	22	SENT_22	[p1l90t1257r116b1273],
24	'	''	O	'	_	0	SENT_22	[p1l90t1257r116b1273],
25	3	CD	NUMBER	3	number	26	SENT_22	[p1l125t1253r148b1273],
26	*	CD	NUMBER	*	dep	23	SENT_22	[p1l125t1253r148b1273],
27	Wei	NNP	O	Wei	dep	26	SENT_22	[p1l156t1249r609b1280],
28	“	CD	NUMBER	“	num	27	SENT_22	[p1l156t1249r609b1280],
29	5	CD	NUMBER	5	number	30	SENT_22	[p1l156t1249r609b1280],
30	“	CD	NUMBER	“	num	34	SENT_22	[p1l156t1249r609b1280],
31	l'	NN	O	l'	nn	34	SENT_22	[p1l156t1249r609b1280],
32	b	NN	O	b	nn	34	SENT_22	[p1l156t1249r609b1280],
33	°	CD	NUMBER	°	num	34	SENT_22	[p1l156t1249r609b1280],
34	“	NN	O	“	dep	26	SENT_22	[p1l156t1249r609b1280],
35	m	NN	O	m	nn	37	SENT_22	[p1l156t1249r609b1280],
36	"	''	O	"	punct	37	SENT_22	[p1l156t1249r609b1280],
37	l°“a’d@maY°-ed“-	NN	O	l°“a’d@may°-ed“-_NN	dep	34	SENT_22	[p1l156t1249r609b1280],
38	an	DT	O	a	det	40	SENT_22	[p1l665t1265r704b1285],
39	HLA	NN	O	hlum	nn	40	SENT_22	[p1l717t1258r793b1285],
40	allele	NN	O	allele	tmod	22	SENT_22	[p1l804t1255r888b1285],
41	that	WDT	O	that	nsubjpass	43	SENT_22	[p1l901t1255r967b1285],
42	is	VBZ	O	be	auxpass	43	SENT_22	[p1l978t1255r1003b1285],
43	associated	VBN	O	associate	rcmod	40	SENT_22	[p1l1016t1255r1185b1286],
44	with	IN	O	with	_	0	SENT_22	[p1l1196t1255r1271b1286],
45	hypersensitivity	NN	O	hypersensitivity	nn	46	SENT_22	[p1l1283t1255r1541b1294],
46	reactions	NNS	O	reaction	prep_with	43	SENT_22	[p1l1552t1255r1700b1286],
47	to	TO	O	to	_	0	SENT_22	[p1l1714t1261r1745b1286],
48	the	DT	O	the	det	50	SENT_22	[p1l1758t1255r1809b1285],
49	anticonvulsant	JJ	O	anticonvulsant	amod	50	SENT_22	[p1l1822t1255r2065b1286],
50	N	NN	O	n	prep_to	43	SENT_22	[p1l92t1326r109b1348],
51	Engl	NNP	O	Engl	nn	52	SENT_22	[p1l123t1324r175b1355],
52	J	NNP	O	J	nsubj	53	SENT_22	[p1l182t1326r191b1354],
53	Med	VBD	O	med	rcmod	50	SENT_22	[p1l204t1324r259b1348],
54	2o11	CD	NUMBER	2o11	dobj	53	SENT_22	[p1l270t1326r502b1352],
55	;	:	O	;	_	0	SENT_22	[p1l270t1326r502b1352],
56	354	CD	NUMBER	354	num	58	SENT_22	[p1l270t1326r502b1352],
57	;	:	O	;	_	0	SENT_22	[p1l270t1326r502b1352],
58	1144.53	CD	NUMBER	1144.53	dobj	53	SENT_22	[p1l270t1326r502b1352],
59	,	,	O	,	_	0	SENT_22	[p1l270t1326r502b1352],
60	and	CC	O	and	_	0	SENT_22	[p1l665t1305r726b1336],
61	mood	NN	O	mood	dobj	53	SENT_22	[p1l740t1305r1028b1344],
62	—	CD	NUMBER	—	num	61	SENT_22	[p1l740t1305r1028b1344],
63	stabilizing	VBG	O	stabilize	partmod	61	SENT_22	[p1l740t1305r1028b1344],
64	drug	NN	O	drug	nn	65	SENT_22	[p1l1041t1305r1120b1344],
65	carbamazepine	NN	O	carbamazepine	dobj	63	SENT_22	[p1l1133t1305r1388b1344],
66	in	IN	O	in	_	0	SENT_22	[p1l1401t1305r1434b1335],
67	persons	NNS	O	person	prep_in	63	SENT_22	[p1l1447t1315r1577b1344],
68	of	IN	O	of	_	0	SENT_22	[p1l1592t1305r1631b1336],
69	European	JJ	MISC	european	amod	71	SENT_22	[p1l1637t1308r1797b1344],
70	descent	NN	O	descent	nn	71	SENT_22	[p1l1811t1305r1960b1336],
71	.3	NN	NUMBER	.3	prep_of	67	SENT_22	[p1l1811t1305r1960b1336],
72	PharCopyright	NN	O	pharcopyright	nn	77	SENT_22	[p1l1975t1305r2063b1335, p1l90t1366r184b1391],
73	©	CD	NUMBER	©	num	77	SENT_22	[p1l193t1368r214b1389],
74	2011	CD	DATE	2011	num	77	SENT_22	[p1l224t1367r271b1385],
75	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	77	SENT_22	[p1l282t1366r422b1385],
76	Medical	NNP	ORGANIZATION	Medical	nn	77	SENT_22	[p1l431t1366r508b1385],
77	Society	NNP	ORGANIZATION	Society	dep	40	SENT_22	[p1l516t1367r588b1391],
78	.	.	O	.	_	0	SENT_22	[p1l516t1367r588b1391],

1	macogenomics	NNS	O	macogenomic	nsubj	2	SENT_23	[p1l665t1356r916b1394],
2	facilitates	VBZ	O	facilitate	_	0	SENT_23	[p1l930t1355r1090b1385],
3	the	DT	O	the	det	4	SENT_23	[p1l1105t1355r1156b1385],
4	identification	NN	O	identification	dobj	2	SENT_23	[p1l1169t1355r1396b1386],
5	of	IN	O	of	_	0	SENT_23	[p1l1409t1355r1448b1386],
6	biomarkers	NNS	O	biomarker	prep_of	4	SENT_23	[p1l1454t1355r1642b1386],
7	that	WDT	O	that	nsubj	9	SENT_23	[p1l1656t1355r1723b1385],
8	can	MD	O	can	aux	9	SENT_23	[p1l1735t1365r1793b1385],
9	help	VB	O	help	rcmod	6	SENT_23	[p1l1806t1355r1876b1394],
10	physicians	NNS	O	physician	nsubj	21	SENT_23	[p1l1889t1355r2062b1394],
11	optimize	VB	O	optimize	ccomp	9	SENT_23	[p1l665t1404r814b1443],
12	drug	NN	O	drug	nn	13	SENT_23	[p1l827t1404r907b1443],
13	selection	NN	O	selection	dobj	11	SENT_23	[p1l918t1404r1074b1441],
14	,	,	O	,	_	0	SENT_23	[p1l918t1404r1074b1441],
15	dose	NN	O	dose	conj_and	13	SENT_23	[p1l1089t1404r1174b1441],
16	,	,	O	,	_	0	SENT_23	[p1l1089t1404r1174b1441],
17	and	CC	O	and	_	0	SENT_23	[p1l1188t1404r1250b1435],
18	treatment	NN	O	treatment	nn	19	SENT_23	[p1l1262t1410r1427b1434],
19	duration	NN	O	duration	conj_and	13	SENT_23	[p1l1438t1404r1580b1435],
20	and	CC	O	and	_	0	SENT_23	[p1l1592t1404r1654b1435],
21	avert	VB	O	avert	conj_and	11	SENT_23	[p1l1666t1410r1747b1435],
22	adverse	JJ	O	adverse	amod	24	SENT_23	[p1l1757t1404r1879b1435],
23	drug	NN	O	drug	nn	24	SENT_23	[p1l1893t1404r1972b1443],
24	reactions	NNS	O	reaction	dobj	21	SENT_23	[p1l1983t1414r2063b1434, p1l665t1453r757b1484],
25	.	.	O	.	_	0	SENT_23	[p1l1983t1414r2063b1434, p1l665t1453r757b1484],

1	In	IN	O	in	_	0	SENT_24	[p1l773t1456r807b1483],
2	addition	NN	O	addition	prep_in	6	SENT_24	[p1l822t1453r969b1490],
3	,	,	O	,	_	0	SENT_24	[p1l822t1453r969b1490],
4	pharmacogenomics	NNS	O	pharmacogenomic	nsubj	6	SENT_24	[p1l985t1453r1316b1492],
5	can	MD	O	can	aux	6	SENT_24	[p1l1332t1463r1390b1483],
6	provide	VB	O	provide	_	0	SENT_24	[p1l1403t1453r1527b1492],
7	new	JJ	O	new	amod	8	SENT_24	[p1l1541t1463r1611b1484],
8	insights	NNS	O	insight	dobj	6	SENT_24	[p1l1623t1453r1756b1492],
9	into	IN	O	into	_	0	SENT_24	[p1l1771t1454r1837b1484],
10	mechanisms	NNS	O	mechanism	prep_into	6	SENT_24	[p1l1852t1453r2062b1483],
11	of	IN	O	of	_	0	SENT_24	[p1l665t1502r704b1533],
12	drug	NN	O	drug	nn	13	SENT_24	[p1l709t1502r789b1541],
13	action	NN	O	action	prep_of	10	SENT_24	[p1l799t1502r901b1533],
14	and	CC	O	and	_	0	SENT_24	[p1l913t1502r974b1533],
15	as	IN	O	as	mark	19	SENT_24	[p1l986t1512r1019b1532],
16	a	DT	O	a	det	17	SENT_24	[p1l1032t1512r1049b1532],
17	result	NN	O	result	nsubj	19	SENT_24	[p1l1061t1502r1155b1533],
18	can	MD	O	can	aux	19	SENT_24	[p1l1166t1512r1224b1532],
19	contribute	VB	O	contribute	conj_and	10	SENT_24	[p1l1236t1502r1407b1533],
20	to	TO	O	to	_	0	SENT_24	[p1l1420t1508r1451b1533],
21	the	DT	O	the	det	22	SENT_24	[p1l1464t1502r1516b1532],
22	development	NN	O	development	prep_to	19	SENT_24	[p1l1528t1502r1741b1541],
23	of	IN	O	of	_	0	SENT_24	[p1l1752t1502r1791b1533],
24	new	JJ	O	new	amod	26	SENT_24	[p1l1796t1512r1865b1533],
25	therapeutic	JJ	O	therapeutic	amod	26	SENT_24	[p1l1875t1502r2064b1541],
26	agents	NNS	O	agent	prep_of	22	SENT_24	[p1l665t1558r781b1591],
27	.	.	O	.	_	0	SENT_24	[p1l665t1558r781b1591],

1	In	IN	O	in	_	0	SENT_25	[p1l714t1604r749b1631],
2	2003	CD	DATE	2003	prep_in	9	SENT_25	[p1l764t1603r853b1638],
3	,	,	O	,	_	0	SENT_25	[p1l764t1603r853b1638],
4	two	CD	NUMBER	two	num	5	SENT_25	[p1l870t1608r932b1632],
5	reviews	NNS	O	review	nsubjpass	9	SENT_25	[p1l947t1601r1073b1632],
6	of	IN	O	of	_	0	SENT_25	[p1l1088t1601r1128b1632],
7	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	5	SENT_25	[p1l1134t1601r1448b1640],
8	were	VBD	O	be	auxpass	9	SENT_25	[p1l1461t1611r1541b1632],
9	published	VBN	O	publish	_	0	SENT_25	[p1l1555t1601r1722b1640],
10	the	DT	O	the	det	16	SENT_25	[p1l1736t1601r1959b1640],
11	]	NN	O	]	nn	16	SENT_25	[p1l1736t1601r1959b1640],
12	0l11	NN	O	0l11	nn	16	SENT_25	[p1l1736t1601r1959b1640],
13	‘	CD	NUMBER	‘	num	16	SENT_25	[p1l1736t1601r1959b1640],
14	l1al	JJ	O	l1al	amod	16	SENT_25	[p1l1736t1601r1959b1640],
15	.4	NN	NUMBER	.4	nn	16	SENT_25	[p1l1736t1601r1959b1640],
16	’	NN	O	’	dobj	9	SENT_25	[p1l1736t1601r1959b1640],
17	5	CD	NUMBER	5	nsubj	31	SENT_25	[p1l1736t1601r1959b1640],
18	Since	IN	O	since	prep	17	SENT_25	[p1l1975t1601r2063b1632],
19	then	RB	O	then	pobj	18	SENT_25	[p1l665t1650r750b1687],
20	,	,	O	,	_	0	SENT_25	[p1l665t1650r750b1687],
21	both	DT	O	both	det	23	SENT_25	[p1l766t1650r844b1681],
22	genomic	JJ	O	genomic	amod	23	SENT_25	[p1l858t1651r1004b1689],
23	science	NN	O	science	conj_and	19	SENT_25	[p1l1018t1651r1139b1680],
24	and	CC	O	and	_	0	SENT_25	[p1l1153t1650r1216b1681],
25	its	PRP$	O	its	poss	26	SENT_25	[p1l1229t1650r1268b1680],
26	application	NN	O	application	conj_and	19	SENT_25	[p1l1283t1650r1473b1689],
27	to	TO	O	to	_	0	SENT_25	[p1l1487t1657r1519b1681],
28	drug	NN	O	drug	nn	29	SENT_25	[p1l1534t1650r1615b1689],
29	response	NN	O	response	prep_to	26	SENT_25	[p1l1627t1660r1778b1689],
30	have	VBP	O	have	aux	31	SENT_25	[p1l1792t1650r1867b1681],
31	undergone	VBN	O	undergo	rcmod	16	SENT_25	[p1l1881t1650r2063b1689],
32	major	JJ	O	major	amod	33	SENT_25	[p1l665t1699r764b1738],
33	advances	NNS	O	advance	dobj	31	SENT_25	[p1l779t1699r956b1730],
34	.6	CD	NUMBER	.6	npadvmod	35	SENT_25	[p1l779t1699r956b1730],
35	Here	RB	O	here	advmod	33	SENT_25	[p1l973t1702r1052b1729],
36	we	PRP	O	we	nsubj	37	SENT_25	[p1l1067t1709r1113b1730],
37	review	VBP	O	review	rcmod	33	SENT_25	[p1l1129t1699r1240b1730],
38	some	DT	O	some	dobj	37	SENT_25	[p1l1256t1709r1344b1730],
39	of	IN	O	of	_	0	SENT_25	[p1l1361t1699r1400b1730],
40	those	DT	O	those	det	41	SENT_25	[p1l1409t1699r1501b1730],
41	advances	NNS	O	advance	prep_of	38	SENT_25	[p1l1517t1699r1678b1736],
42	,	,	O	,	_	0	SENT_25	[p1l1517t1699r1678b1736],
43	with	IN	O	with	_	0	SENT_25	[p1l1695t1699r1772b1730],
44	an	DT	O	a	det	45	SENT_25	[p1l1788t1709r1829b1729],
45	emphasis	NN	O	emphasis	prep_with	31	SENT_25	[p1l1845t1699r2004b1738],
46	on	IN	O	on	_	0	SENT_25	[p1l2021t1709r2063b1730],
47	discovery	NN	O	discovery	prep_on	45	SENT_25	[p1l665t1748r825b1787],
48	through	IN	O	through	_	0	SENT_25	[p1l842t1748r980b1787],
49	genomewide	JJ	O	genomewide	amod	51	SENT_25	[p1l998t1748r1213b1787],
50	association	NN	O	association	nn	51	SENT_25	[p1l1232t1748r1424b1779],
51	studies	NNS	O	study	prep_through	9	SENT_25	[p1l1442t1748r1571b1779],
52	.	.	O	.	_	0	SENT_25	[p1l1442t1748r1571b1779],

1	We	PRP	O	we	nsubj	2	SENT_26	[p1l1590t1751r1642b1778],
2	describe	VBP	O	describe	_	0	SENT_26	[p1l1661t1748r1802b1779],
3	examples	NNS	O	example	dobj	2	SENT_26	[p1l1820t1748r1978b1787],
4	that	WDT	O	that	nsubj	5	SENT_26	[p1l1997t1748r2065b1778],
5	highlight	VBP	O	highlight	rcmod	3	SENT_26	[p1l665t1797r816b1836],
6	principles	NNS	O	principle	dobj	5	SENT_26	[p1l825t1797r983b1836],
7	of	IN	O	of	_	0	SENT_26	[p1l996t1797r1034b1828],
8	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	6	SENT_26	[p1l1037t1797r1359b1836],
9	that	WDT	O	that	nsubj	11	SENT_26	[p1l1371t1797r1436b1827],
10	are	VBP	O	be	cop	11	SENT_26	[p1l1445t1807r1494b1827],
11	relevant	JJ	O	relevant	rcmod	8	SENT_26	[p1l1506t1797r1634b1828],
12	to	TO	O	to	_	0	SENT_26	[p1l1643t1804r1674b1828],
13	a	DT	O	a	det	15	SENT_26	[p1l1686t1807r1703b1827],
14	wide	JJ	O	wide	amod	15	SENT_26	[p1l1712t1797r1789b1828],
15	variety	NN	O	variety	prep_to	11	SENT_26	[p1l1798t1797r1908b1836],
16	of	IN	O	of	_	0	SENT_26	[p1l1917t1797r1955b1828],
17	drugs	NNS	O	drug	prep_of	15	SENT_26	[p1l1960t1797r2061b1836],
18	.	.	O	.	_	0	SENT_26	[p1l1960t1797r2061b1836],

1	The	DT	ORGANIZATION	the	det	5	SENT_27	[p1l664t1846r726b1876],
2	Food	NNP	ORGANIZATION	Food	nn	5	SENT_27	[p1l738t1846r821b1877],
3	and	CC	ORGANIZATION	and	_	0	SENT_27	[p1l834t1846r895b1877],
4	Drug	NNP	ORGANIZATION	Drug	conj_and	2	SENT_27	[p1l907t1849r993b1885],
5	Administration	NNP	ORGANIZATION	Administration	nsubj	31	SENT_27	[p1l1003t1846r1261b1877],
6	(	CD	NUMBER	(	num	8	SENT_27	[p1l1275t1849r1367b1881],
7	FDA	NNP	ORGANIZATION	FDA	nn	8	SENT_27	[p1l1275t1849r1367b1881],
8	)	NN	O	)	nsubj	10	SENT_27	[p1l1275t1849r1367b1881],
9	has	VBZ	O	have	aux	10	SENT_27	[p1l1382t1846r1438b1876],
10	altered	VBN	O	alter	rcmod	5	SENT_27	[p1l1451t1846r1565b1877],
11	drug	NN	O	drug	nn	12	SENT_27	[p1l1578t1846r1657b1885],
12	labels	NNS	O	label	dobj	10	SENT_27	[p1l1668t1846r1763b1877],
13	and	CC	O	and	_	0	SENT_27	[p1l1777t1846r1838b1877],
14	issued	VBN	O	issue	conj_and	10	SENT_27	[p1l1850t1846r1954b1877],
15	warnings	NNS	O	warning	dobj	14	SENT_27	[p1l1965t1856r2063b1877, p1l665t1895r734b1934],
16	about	IN	O	about	_	0	SENT_27	[p1l750t1895r845b1926],
17	pharmacogenomic	JJ	O	pharmacogenomic	amod	18	SENT_27	[p1l858t1895r1173b1934],
18	variation	NN	O	variation	prep_about	15	SENT_27	[p1l1186t1895r1335b1926],
19	affecting	VBG	O	affect	partmod	18	SENT_27	[p1l1350t1895r1501b1934],
20	drug	NN	O	drug	nn	21	SENT_27	[p1l1516t1895r1595b1934],
21	response	NN	O	response	dobj	19	SENT_27	[p1l1609t1905r1766b1934],
22	,	,	O	,	_	0	SENT_27	[p1l1609t1905r1766b1934],
23	raising	VBG	O	raise	partmod	14	SENT_27	[p1l1783t1895r1900b1934],
24	the	DT	O	the	det	25	SENT_27	[p1l1914t1895r1965b1925],
25	issue	NN	O	issue	dobj	23	SENT_27	[p1l1981t1895r2063b1926],
26	of	IN	O	of	_	0	SENT_27	[p1l665t1944r704b1975],
27	the	DT	O	the	det	28	SENT_27	[p1l712t1944r762b1974],
28	level	NN	O	level	prep_of	25	SENT_27	[p1l777t1944r849b1975],
29	of	IN	O	of	_	0	SENT_27	[p1l864t1944r903b1975],
30	evidence	NN	O	evidence	prep_of	28	SENT_27	[p1l911t1944r1049b1975],
31	required	VBN	O	require	_	0	SENT_27	[p1l1065t1944r1201b1983],
32	to	TO	O	to	aux	33	SENT_27	[p1l1217t1950r1248b1975],
33	show	VB	O	show	xcomp	31	SENT_27	[p1l1264t1944r1350b1975],
34	clinical	JJ	O	clinical	amod	35	SENT_27	[p1l1364t1944r1482b1974],
35	utility7	NN	O	utility7	dobj	33	SENT_27	[p1l1497t1944r1607b1983],
36	and	CC	O	and	_	0	SENT_27	[p1l1622t1944r1682b1975],
37	the	DT	O	the	det	39	SENT_27	[p1l1698t1944r1748b1974],
38	respective	JJ	O	respective	amod	39	SENT_27	[p1l1763t1945r1924b1983],
39	roles	NNS	O	role	conj_and	35	SENT_27	[p1l1939t1944r2016b1975],
40	of	IN	O	of	_	0	SENT_27	[p1l2032t1944r2070b1975],
41	regulatory	JJ	O	regulatory	amod	42	SENT_27	[p1l665t1993r843b2032],
42	agencies	NNS	O	agency	prep_of	39	SENT_27	[p1l857t1993r1000b2032],
43	such	JJ	O	such	_	0	SENT_27	[p1l1017t1993r1094b2024],
44	as	IN	O	as	_	0	SENT_27	[p1l1109t2003r1143b2023],
45	the	DT	O	the	det	46	SENT_27	[p1l1160t1993r1212b2023],
46	FDA	NNP	ORGANIZATION	FDA	prep_such_as	42	SENT_27	[p1l1227t1996r1300b2023],
47	and	CC	O	and	_	0	SENT_27	[p1l1314t1993r1377b2024],
48	of	IN	O	of	conj_and	31	SENT_27	[p1l1393t1993r1432b2024],
49	academic	JJ	O	academic	amod	52	SENT_27	[p1l1440t1993r1599b2024],
50	and	CC	O	and	_	0	SENT_27	[p1l1614t1993r1676b2024],
51	professional	JJ	O	professional	amod	52	SENT_27	[p1l1691t1993r1902b2032],
52	societies	NNS	O	society	pobj	48	SENT_27	[p1l1918t1993r2062b2024],
53	in	IN	O	in	_	0	SENT_27	[p1l665t2042r698b2072],
54	the	DT	O	the	det	55	SENT_27	[p1l714t2042r766b2072],
55	evaluation	NN	O	evaluation	prep_in	48	SENT_27	[p1l782t2042r953b2073],
56	of	IN	O	of	_	0	SENT_27	[p1l969t2042r1008b2073],
57	pharmacogenetic	JJ	O	pharmacogenetic	amod	58	SENT_27	[p1l1015t2042r1306b2081],
58	analyses	NNS	O	analysis	prep_of	55	SENT_27	[p1l1320t2042r1460b2081],
59	for	IN	O	for	_	0	SENT_27	[p1l1476t2042r1524b2073],
60	the	DT	O	the	det	61	SENT_27	[p1l1538t2042r1589b2072],
61	clinic	NN	O	clinic	prep_for	48	SENT_27	[p1l1605t2042r1704b2073],
62	.	.	O	.	_	0	SENT_27	[p1l1605t2042r1704b2073],

1	CARDIOVASCULAR	JJ	O	cardiovascular	amod	2	SENT_28	[p1l1086t2158r1481b2181],
2	DRUGS	NNS	O	drug	_	0	SENT_28	[p1l1500t2158r1642b2181],

1	Many	JJ	O	many	amod	2	SENT_29	[p1l664t2246r757b2282],
2	drugs	NNS	O	drug	nsubj	4	SENT_29	[p1l768t2243r863b2282],
3	have	VBP	O	have	aux	4	SENT_29	[p1l876t2243r950b2274],
4	proven	VBN	O	prove	_	0	SENT_29	[p1l962t2253r1075b2282],
5	efficacy	NN	O	efficacy	dobj	4	SENT_29	[p1l1088t2243r1218b2282],
6	in	IN	O	in	_	0	SENT_29	[p1l1229t2243r1261b2273],
7	the	DT	O	the	det	8	SENT_29	[p1l1274t2243r1325b2273],
8	treatment	NN	O	treatment	prep_in	4	SENT_29	[p1l1338t2249r1503b2273],
9	and	CC	O	and	_	0	SENT_29	[p1l1513t2243r1574b2274],
10	prevention	NN	O	prevention	prep_in	4	SENT_29	[p1l1586t2243r1764b2282],
11	of	IN	O	of	_	0	SENT_29	[p1l1777t2243r1815b2274],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_29	[p1l1821t2243r2064b2274],
13	disease	NN	O	disease	prep_of	8	SENT_29	[p1l665t2292r795b2323],
14	.	.	O	.	_	0	SENT_29	[p1l665t2292r795b2323],

1	Not	RB	O	not	neg	6	SENT_30	[p1l813t2295r876b2323],
2	uncommonly	RB	O	uncommonly	advmod	6	SENT_30	[p1l891t2292r1119b2331],
3	,	,	O	,	_	0	SENT_30	[p1l891t2292r1119b2331],
4	these	DT	O	these	det	5	SENT_30	[p1l1138t2292r1225b2322],
5	drugs	NNS	O	drug	nsubj	6	SENT_30	[p1l1243t2292r1337b2331],
6	have	VBP	O	have	_	0	SENT_30	[p1l1355t2292r1429b2323],
7	narrow	JJ	O	narrow	amod	9	SENT_30	[p1l1446t2302r1568b2323],
8	therapeutic	JJ	O	therapeutic	amod	9	SENT_30	[p1l1584t2292r1772b2331],
9	indexes	NNS	O	index	dobj	6	SENT_30	[p1l1789t2292r1913b2323],
10	that	WDT	O	that	nsubjpass	12	SENT_30	[p1l1931t2292r1998b2322],
11	are	VBP	O	be	auxpass	12	SENT_30	[p1l2013t2302r2063b2322],
12	influenced	VBN	O	influence	rcmod	9	SENT_30	[p1l665t2341r843b2372],
13	by	IN	O	by	_	0	SENT_30	[p1l863t2341r901b2380],
14	genetic	JJ	O	genetic	amod	16	SENT_30	[p1l918t2341r1038b2380],
15	variation	NN	O	variation	nn	16	SENT_30	[p1l1055t2341r1204b2372],
16	—	NN	O	—	agent	12	SENT_30	[p1l1222t2358r1264b2362],
17	a	DT	O	a	det	18	SENT_30	[p1l1281t2351r1299b2371],
18	hallmark	NN	O	hallmark	dobj	12	SENT_30	[p1l1317t2341r1472b2372],
19	of	IN	O	of	_	0	SENT_30	[p1l1490t2341r1529b2372],
20	drugs	NNS	O	drug	prep_of	18	SENT_30	[p1l1541t2341r1636b2380],
21	for	IN	O	for	_	0	SENT_30	[p1l1656t2341r1704b2372],
22	which	WDT	O	which	rel	26	SENT_30	[p1l1720t2341r1823b2372],
23	pharmacogenomic	JJ	O	pharmacogenomic	amod	24	SENT_30	[p1l1841t2341r2063b2380, p1l665t2390r769b2421],
24	approaches	NNS	O	approach	nsubj	26	SENT_30	[p1l783t2390r970b2429],
25	are	VBP	O	be	cop	26	SENT_30	[p1l984t2400r1034b2420],
26	likely	JJ	O	likely	rcmod	20	SENT_30	[p1l1048t2390r1138b2429],
27	to	TO	O	to	aux	28	SENT_30	[p1l1150t2396r1182b2421],
28	provide	VB	O	provide	xcomp	26	SENT_30	[p1l1196t2390r1319b2429],
29	substantial	JJ	O	substantial	amod	31	SENT_30	[p1l1334t2390r1519b2421],
30	clinical	JJ	O	clinical	amod	31	SENT_30	[p1l1532t2390r1654b2420],
31	benefit	NN	O	benefit	dobj	28	SENT_30	[p1l1668t2390r1794b2421],
32	.	.	O	.	_	0	SENT_30	[p1l1668t2390r1794b2421],

1	The	DT	O	the	det	4	SENT_31	[p1l1809t2390r1871b2420],
2	anticoagulant	JJ	O	anticoagulant	amod	4	SENT_31	[p1l1885t2390r2063b2429, p1l664t2439r730b2469],
3	agents	NNS	O	agent	nn	4	SENT_31	[p1l742t2446r850b2478],
4	warfarin	NN	O	warfarin	nsubj	8	SENT_31	[p1l863t2439r1009b2470],
5	and	CC	O	and	_	0	SENT_31	[p1l1023t2439r1084b2470],
6	clopidogrel	NN	O	clopidogrel	conj_and	4	SENT_31	[p1l1099t2439r1287b2478],
7	are	VBP	O	be	cop	8	SENT_31	[p1l1301t2449r1351b2469],
8	high	JJ	O	high	_	0	SENT_31	[p1l1366t2439r1442b2478],
9	on	IN	O	on	_	0	SENT_31	[p1l1457t2449r1498b2470],
10	the	DT	O	the	det	11	SENT_31	[p1l1513t2439r1564b2469],
11	list	NN	O	list	prep_on	8	SENT_31	[p1l1579t2439r1631b2469],
12	of	IN	O	of	_	0	SENT_31	[p1l1644t2439r1683b2470],
13	widely	RB	O	widely	advmod	14	SENT_31	[p1l1689t2439r1797b2478],
14	prescribed	VBN	O	prescribe	amod	16	SENT_31	[p1l1810t2439r1985b2478],
15	cardiovascular	JJ	O	cardiovascular	amod	16	SENT_31	[p1l2000t2449r2063b2469, p1l665t2488r856b2519],
16	drugs	NNS	O	drug	prep_of	11	SENT_31	[p1l866t2488r961b2527],
17	with	IN	O	with	_	0	SENT_31	[p1l971t2488r1047b2519],
18	narrow	JJ	O	narrow	amod	20	SENT_31	[p1l1057t2498r1179b2519],
19	therapeutic	JJ	O	therapeutic	amod	20	SENT_31	[p1l1188t2488r1377b2527],
20	indexes	NNS	O	index	prep_with	16	SENT_31	[p1l1387t2488r1521b2519],
21	.	.	O	.	_	0	SENT_31	[p1l1387t2488r1521b2519],

1	The	DT	O	the	det	3	SENT_32	[p1l1532t2488r1594b2518],
2	pharmacogenomic	JJ	O	pharmacogenomic	amod	3	SENT_32	[p1l1605t2488r1919b2527],
3	features	NNS	O	feature	nsubj	7	SENT_32	[p1l1930t2488r2062b2519],
4	of	IN	O	of	_	0	SENT_32	[p1l665t2537r704b2568],
5	these	DT	O	these	det	6	SENT_32	[p1l711t2537r797b2567],
6	drugs	NNS	O	drug	prep_of	3	SENT_32	[p1l811t2537r906b2576],
7	illustrate	VBP	O	illustrate	_	0	SENT_32	[p1l920t2537r1068b2568],
8	the	DT	O	the	det	10	SENT_32	[p1l1082t2537r1134b2567],
9	rapid	JJ	O	rapid	amod	10	SENT_32	[p1l1147t2537r1232b2576],
10	evolution	NN	O	evolution	dobj	7	SENT_32	[p1l1246t2537r1399b2568],
11	of	IN	O	of	_	0	SENT_32	[p1l1413t2537r1452b2568],
12	our	PRP$	O	we	poss	13	SENT_32	[p1l1458t2547r1515b2568],
13	understanding	NN	O	understanding	prep_of	10	SENT_32	[p1l1527t2537r1774b2576],
14	of	IN	O	of	_	0	SENT_32	[p1l1787t2537r1825b2568],
15	the	DT	O	the	det	16	SENT_32	[p1l1832t2537r1884b2567],
16	role	NN	O	role	prep_of	13	SENT_32	[p1l1897t2537r1959b2568],
17	of	IN	O	of	_	0	SENT_32	[p1l1973t2537r2012b2568],
18	inheritance	NN	O	inheritance	prep_of	16	SENT_32	[p1l2018t2537r2063b2567, p1l665t2586r820b2616],
19	in	IN	O	in	_	0	SENT_32	[p1l832t2586r864b2616],
20	the	DT	O	the	det	21	SENT_32	[p1l876t2586r928b2616],
21	variation	NN	O	variation	prep_in	7	SENT_32	[p1l938t2586r1087b2617],
22	in	IN	O	in	_	0	SENT_32	[p1l1099t2586r1131b2616],
23	drug	NN	O	drug	nn	24	SENT_32	[p1l1144t2586r1223b2625],
24	efficacy	NN	O	efficacy	prep_in	21	SENT_32	[p1l1234t2586r1364b2625],
25	and	CC	O	and	_	0	SENT_32	[p1l1374t2586r1436b2617],
26	the	DT	O	the	det	27	SENT_32	[p1l1448t2586r1499b2616],
27	risk	NN	O	risk	conj_and	21	SENT_32	[p1l1512t2586r1575b2617],
28	of	IN	O	of	_	0	SENT_32	[p1l1586t2586r1625b2617],
29	adverse	JJ	O	adverse	amod	31	SENT_32	[p1l1629t2586r1752b2617],
30	drug	NN	O	drug	nn	31	SENT_32	[p1l1764t2586r1843b2625],
31	reactions	NNS	O	reaction	prep_of	27	SENT_32	[p1l1854t2586r2015b2617],
32	.	.	O	.	_	0	SENT_32	[p1l1854t2586r2015b2617],

1	In	IN	O	in	_	0	SENT_33	[p1l2029t2589r2063b2616],
2	the	DT	O	the	det	3	SENT_33	[p1l665t2635r717b2665],
3	case	NN	O	case	pobj	1	SENT_33	[p1l728t2645r798b2665],
4	of	IN	O	of	_	0	SENT_33	[p1l809t2635r848b2666],
5	both	DT	O	both	det	6	SENT_33	[p1l852t2635r929b2666],
6	agents	NNS	O	agent	prep_of	3	SENT_33	[p1l940t2641r1056b2674],
7	,	,	O	,	_	0	SENT_33	[p1l940t2641r1056b2674],
8	the	DT	O	the	det	9	SENT_33	[p1l1070t2635r1121b2665],
9	application	NN	O	application	appos	6	SENT_33	[p1l1132t2635r1318b2674],
10	of	IN	O	of	_	0	SENT_33	[p1l1329t2635r1368b2666],
11	classic	JJ	O	classic	amod	13	SENT_33	[p1l1372t2635r1480b2665],
12	candidate-gene	JJ	O	candidate-gene	amod	13	SENT_33	[p1l1491t2635r1745b2674],
13	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	9	SENT_33	[p1l1756t2635r2063b2674],

1	1144	CD	DATE	1144	num	4	SENT_34	[p1l89t2749r165b2770],
2	N	NN	O	n	nn	4	SENT_34	[p1l1031t2762r1044b2778],
3	ENGLJ	NN	O	englj	nn	4	SENT_34	[p1l1059t2762r1137b2784],
4	MED	NN	O	med	_	0	SENT_34	[p1l1152t2762r1204b2777],
5	364	CD	NUMBER	364	dep	4	SENT_34	[p1l1214t2757r1293b2784],
6	;	:	O	;	_	0	SENT_34	[p1l1214t2757r1293b2784],
7	12	CD	NUMBER	12	num	9	SENT_34	[p1l1214t2757r1293b2784],
8	NEJM.ORG	NN	O	nejm.org	nn	9	SENT_34	[p1l1328t2762r1452b2784],
9	MARCH	NN	DATE	march	dep	5	SENT_34	[p1l1489t2762r1574b2778],
10	24	CD	DATE	24	dep	9	SENT_34	[p1l1587t2762r1623b2784],
11	,	,	DATE	,	_	0	SENT_34	[p1l1587t2762r1623b2784],
12	2011	CD	DATE	2011	appos	10	SENT_34	[p1l1634t2762r1686b2778],

1	The	DT	O	the	det	4	SENT_35	[p1l877t2795r928b2819],
2	New	NNP	O	New	nn	4	SENT_35	[p1l937t2796r999b2819],
3	England	NNP	O	England	nn	4	SENT_35	[p1l1009t2795r1119b2826],
4	Journal	NNP	O	Journal	_	0	SENT_35	[p1l1128t2795r1226b2819],
5	of	IN	O	of	_	0	SENT_35	[p1l1235t2795r1264b2819],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_35	[p1l1271t2795r1396b2819],

1	Downloaded	VBN	O	download	_	0	SENT_36	[p1l319t2836r489b2859],
2	from	IN	O	from	_	0	SENT_36	[p1l498t2836r563b2859],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_36	[p1l571t2836r690b2866],
4	at	IN	O	at	_	0	SENT_36	[p1l700t2840r723b2859],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_36	[p1l732t2836r914b2859],
6	on	IN	O	on	_	0	SENT_36	[p1l924t2843r956b2859],
7	J	NN	O	j	nn	8	SENT_36	[p1l965t2836r977b2859],
8	anuaiy	NN	O	anuaiy	prep_on	5	SENT_36	[p1l979t2843r1067b2866],
9	5	CD	NUMBER	5	num	8	SENT_36	[p1l1077t2836r1100b2863],
10	,	,	O	,	_	0	SENT_36	[p1l1077t2836r1100b2863],
11	2014	CD	DATE	2014	dobj	1	SENT_36	[p1l1111t2836r1183b2859],
12	.	.	O	.	_	0	SENT_36	[p1l1111t2836r1183b2859],

1	For	IN	O	for	_	0	SENT_37	[p1l1193t2836r1240b2859],
2	personal	JJ	O	personal	amod	3	SENT_37	[p1l1248t2836r1360b2866],
3	use	NN	O	use	pobj	1	SENT_37	[p1l1370t2843r1413b2859],
4	only	RB	O	only	advmod	3	SENT_37	[p1l1423t2836r1487b2866],
5	.	.	O	.	_	0	SENT_37	[p1l1423t2836r1487b2866],

1	No	DT	O	no	det	3	SENT_38	[p1l1498t2836r1538b2859],
2	other	JJ	O	other	amod	3	SENT_38	[p1l1548t2836r1616b2859],
3	uses	NNS	O	use	_	0	SENT_38	[p1l1624t2843r1680b2859],
4	without	IN	O	without	_	0	SENT_38	[p1l1690t2836r1792b2859],
5	permission	NN	O	permission	prep_without	3	SENT_38	[p1l1800t2836r1952b2866],
6	.	.	O	.	_	0	SENT_38	[p1l1800t2836r1952b2866],

1	Copyright	NN	O	copyright	_	0	SENT_39	[p1l670t2877r804b2908],
2	©	CD	NUMBER	©	num	6	SENT_39	[p1l814t2877r837b2901],
3	2011	CD	DATE	2011	num	6	SENT_39	[p1l847t2877r909b2901],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_39	[p1l921t2877r1113b2901],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_39	[p1l1122t2877r1231b2901],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_39	[p1l1241t2877r1346b2908],
7	.	.	O	.	_	0	SENT_39	[p1l1241t2877r1346b2908],

1	All	DT	O	all	det	2	SENT_40	[p1l1357t2877r1398b2901],
2	rights	NNS	O	rights	nsubj	3	SENT_40	[p1l1408t2877r1482b2908],
3	reserved	VBN	O	reserve	_	0	SENT_40	[p1l1492t2877r1611b2901],
4	.	.	O	.	_	0	SENT_40	[p1l1492t2877r1611b2901],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_41	[p1l909t2983r1067b3002],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_41	[p1l1081t2983r1251b3002],

1	has	VBZ	O	have	aux	2	SENT_42	[p1l11t3197r155b3275],
2	identified	VBN	O	identify	_	0	SENT_42	[p1l221t3196r638b3276],
3	important	JJ	O	important	amod	5	SENT_42	[p1l701t3198r1142b3297],
4	genomic	JJ	O	genomic	amod	5	SENT_42	[p1l1201t3198r1571b3298],
5	markers	NNS	O	marker	dobj	2	SENT_42	[p1l1635t3197r1985b3276],
6	of	IN	O	of	_	0	SENT_42	[p1l2052t3196r2152b3276],
7	variation	NN	O	variation	prep_of	5	SENT_42	[p1l7t3325r389b3403],
8	in	IN	O	in	_	0	SENT_42	[p1l439t3325r522b3402],
9	efficacy	NN	O	efficacy	nn	12	SENT_42	[p1l572t3323r909b3424],
10	and	CC	O	and	_	0	SENT_42	[p1l953t3324r1110b3403],
11	adverse	JJ	O	adverse	nn	12	SENT_42	[p1l1160t3324r1474b3404],
12	reactions	NNS	O	reaction	prep_in	2	SENT_42	[p1l1524t3325r1938b3420],
13	,	,	O	,	_	0	SENT_42	[p1l1524t3325r1938b3420],
14	observations	NNS	O	observation	appos	12	SENT_42	[p1l1995t3324r2132b3403, p1l12t3453r445b3532],
15	that	WDT	O	that	nsubjpass	18	SENT_42	[p1l493t3452r665b3530],
16	were	VBD	O	be	auxpass	18	SENT_42	[p1l701t3478r902b3532],
17	subsequently	RB	O	subsequently	advmod	18	SENT_42	[p1l950t3452r1511b3552],
18	confirmed	VBN	O	confirm	rcmod	14	SENT_42	[p1l1552t3451r2005b3531],
19	in	IN	O	in	_	0	SENT_42	[p1l2050t3453r2133b3530],
20	genomewide	JJ	O	genomewide	amod	22	SENT_42	[p1l11t3581r557b3682],
21	association	NN	O	association	nn	22	SENT_42	[p1l597t3582r1080b3660],
22	studies	NNS	O	study	prep_in	18	SENT_42	[p1l1122t3581r1447b3660],
23	.	.	O	.	_	0	SENT_42	[p1l1122t3581r1447b3660],

1	The	DT	O	the	det	2	SENT_43	[p1l1489t3581r1649b3659],
2	FDA	NNP	ORGANIZATION	FDA	nsubj	3	SENT_43	[p1l1689t3587r1873b3659],
3	acted	VBD	O	act	_	0	SENT_43	[p1l1909t3581r2133b3660],
4	quickly	RB	O	quickly	advmod	3	SENT_43	[p1l12t3709r323b3809],
5	on	IN	O	on	_	0	SENT_43	[p1l355t3735r461b3788],
6	these	DT	O	these	det	7	SENT_43	[p1l497t3709r721b3788],
7	data	NNS	O	datum	prep_on	3	SENT_43	[p1l758t3709r941b3788],
8	by	IN	O	by	_	0	SENT_43	[p1l975t3709r1073b3809],
9	relabeling	VBG	O	relabel	prepc_by	3	SENT_43	[p1l1104t3709r1538b3810],
10	warfarin	NN	O	warfarin	dobj	9	SENT_43	[p1l1566t3708r1940b3788],
11	and	CC	O	and	_	0	SENT_43	[p1l1975t3709r2133b3788],
12	adding	VBG	O	add	conj_and	9	SENT_43	[p2l11t22r309b123],
13	a	DT	O	a	det	15	SENT_43	[p2l346t48r391b100],
14	warning	NN	O	warning	nn	15	SENT_43	[p2l426t23r792b123],
15	box	NN	O	box	dobj	12	SENT_43	[p2l831t22r985b101],
16	on	IN	O	on	_	0	SENT_43	[p2l1025t48r1131b101],
17	the	DT	O	the	det	18	SENT_43	[p2l1173t22r1305b100],
18	labeling	NN	O	labeling	prep_on	12	SENT_43	[p2l1346t22r1696b123],
19	for	IN	O	for	_	0	SENT_43	[p2l1734t21r1857b101],
20	clopi	NNS	O	clopus	prep_for	18	SENT_43	[p2l1896t22r2132b122],
21	—	CD	NUMBER	—	num	22	SENT_43	[p2l1896t22r2132b122],
22	dogrel	NN	O	dogrel	dobj	9	SENT_43	[p2l12t150r308b251],
23	.	.	O	.	_	0	SENT_43	[p2l12t150r308b251],

1	Data	NNS	O	datum	nsubj	17	SENT_44	[p2l373t157r574b228],
2	supporting	VBG	O	support	partmod	1	SENT_44	[p2l635t151r1111b251],
3	the	DT	O	the	det	5	SENT_44	[p2l1169t150r1302b228],
4	clinical	JJ	O	clinical	amod	5	SENT_44	[p2l1364t150r1676b228],
5	utility	NN	O	utility	dobj	2	SENT_44	[p2l1738t150r1995b250],
6	of	IN	O	of	_	0	SENT_44	[p2l2052t149r2152b229],
7	routine	JJ	O	routine	amod	8	SENT_44	[p2l11t279r321b357],
8	use	NN	O	use	prep_of	5	SENT_44	[p2l359t304r499b357],
9	of	IN	O	of	_	0	SENT_44	[p2l538t277r638b357],
10	pharmacogenetic	JJ	O	pharmacogenetic	amod	11	SENT_44	[p2l657t278r1406b379],
11	testing	NN	O	testing	prep_of	8	SENT_44	[p2l1444t279r1742b379],
12	for	IN	O	for	_	0	SENT_44	[p2l1777t277r1900b357],
13	both	DT	O	both	predet	15	SENT_44	[p2l1935t278r2133b357],
14	these	DT	O	these	det	15	SENT_44	[p2l12t406r234b485],
15	drugs	NNS	O	drug	prep_for	11	SENT_44	[p2l270t406r514b507],
16	are	VBP	O	be	aux	17	SENT_44	[p2l550t432r679b484],
17	evolving	VBG	O	evolve	_	0	SENT_44	[p2l715t406r1231b507],
18	.8	CD	NUMBER	.8	dobj	17	SENT_44	[p2l715t406r1231b507],
19	'	''	O	'	_	0	SENT_44	[p2l715t406r1231b507],
20	1	CD	NUMBER	1	num	21	SENT_44	[p2l715t406r1231b507],
21	°	CD	NUMBER	°	dobj	17	SENT_44	[p2l715t406r1231b507],

1	Warfarin	NNP	O	Warfarin	nsubj	8	SENT_45	[p2l136t532r525b611],
2	is	VBZ	O	be	cop	8	SENT_45	[p2l576t534r642b611],
3	the	DT	O	the	det	8	SENT_45	[p2l696t533r829b611],
4	most	RBS	O	most	advmod	6	SENT_45	[p2l880t550r1097b612],
5	widely	RB	O	widely	advmod	6	SENT_45	[p2l1138t533r1418b633],
6	prescribed	VBN	O	prescribe	amod	8	SENT_45	[p2l1464t533r1916b633],
7	oral	JJ	O	oral	amod	8	SENT_45	[p2l1968t533r2134b612],
8	anticoagulant	NN	O	anticoagulant	_	0	SENT_45	[p2l11t662r593b763],
9	in	IN	O	in	_	0	SENT_45	[p2l625t663r706b740],
10	North	NNP	LOCATION	North	nn	11	SENT_45	[p2l742t662r994b741],
11	America	NNP	LOCATION	America	prep_in	8	SENT_45	[p2l1028t663r1381b740],
12	and	CC	O	and	_	0	SENT_45	[p2l1416t662r1571b741],
13	much	JJ	O	much	conj_and	11	SENT_45	[p2l1609t662r1842b741],
14	of	IN	O	of	_	0	SENT_45	[p2l1880t661r1978b741],
15	Europe	NNP	LOCATION	Europe	prep_of	13	SENT_45	[p2l1996t670r2132b741, p2l11t794r292b889],
16	.	.	O	.	_	0	SENT_45	[p2l1996t670r2132b741, p2l11t794r292b889],

1	“	NN	O	“	nsubj	8	SENT_46	[p2l1996t670r2132b741, p2l11t794r292b889],
2	Despite	IN	O	despite	_	0	SENT_46	[p2l324t790r636b889],
3	the	DT	O	the	det	4	SENT_46	[p2l670t789r799b867],
4	availability	NN	O	availability	prep_despite	8	SENT_46	[p2l831t789r1285b889],
5	of	IN	O	of	_	0	SENT_46	[p2l1315t788r1413b868],
6	the	DT	O	the	det	7	SENT_46	[p2l1427t789r1557b867],
7	international	JJ	O	international	prep_of	4	SENT_46	[p2l1589t789r2134b868],
8	normalized	VBD	O	normalize	ccomp	67	SENT_46	[p2l11t918r508b996],
9	ratio	NN	O	ratio	nn	12	SENT_46	[p2l549t919r746b996],
10	(	CD	NUMBER	(	num	12	SENT_46	[p2l793t924r1056b1013],
11	INR	NN	O	inr	nn	12	SENT_46	[p2l793t924r1056b1013],
12	)	NN	O	)	nsubj	40	SENT_46	[p2l793t924r1056b1013],
13	,	,	O	,	_	0	SENT_46	[p2l793t924r1056b1013],
14	a	DT	O	a	det	16	SENT_46	[p2l1101t944r1146b995],
15	laboratory	NN	O	laboratory	nn	16	SENT_46	[p2l1183t918r1631b1017],
16	test	NN	O	test	appos	12	SENT_46	[p2l1667t934r1822b996],
17	that	WDT	O	that	nsubjpass	20	SENT_46	[p2l1858t918r2030b996],
18	is	VBZ	O	be	auxpass	20	SENT_46	[p2l2065t919r2131b995],
19	universally	RB	O	universally	advmod	20	SENT_46	[p2l11t1046r469b1146],
20	used	VBN	O	use	rcmod	16	SENT_46	[p2l501t1046r695b1125],
21	to	TO	O	to	aux	22	SENT_46	[p2l732t1063r812b1125],
22	measure	VB	O	measure	xcomp	20	SENT_46	[p2l851t1072r1206b1125],
23	the	DT	O	the	det	26	SENT_46	[p2l1244t1046r1374b1124],
24	anticoagulant	JJ	O	anticoagulant	amod	26	SENT_46	[p2l1410t1046r1998b1147],
25	ef	NN	O	ef	nn	26	SENT_46	[p2l2031t1045r2132b1124],
26	fect	NN	O	fect	dobj	22	SENT_46	[p2l11t1172r165b1251],
27	of	IN	O	of	_	0	SENT_46	[p2l190t1172r288b1252],
28	warfarin	NN	O	warfarin	prep_of	26	SENT_46	[p2l295t1172r680b1269],
29	,	,	O	,	_	0	SENT_46	[p2l295t1172r680b1269],
30	serious	JJ	O	serious	amod	32	SENT_46	[p2l717t1174r1009b1253],
31	adverse	JJ	O	adverse	amod	32	SENT_46	[p2l1040t1173r1346b1253],
32	responses	NNS	O	response	appos	28	SENT_46	[p2l1375t1199r1810b1273],
33	,	,	O	,	_	0	SENT_46	[p2l1375t1199r1810b1273],
34	including	VBG	O	include	_	0	SENT_46	[p2l1845t1173r2132b1253, p2l11t1303r147b1403],
35	hemorrhage	NN	O	hemorrhage	prep_including	22	SENT_46	[p2l175t1302r697b1403],
36	and	CC	O	and	_	0	SENT_46	[p2l730t1302r888b1381],
37	undesired	JJ	O	undesired	amod	38	SENT_46	[p2l920t1302r1345b1381],
38	coagulation	NN	O	coagulation	prep_including	22	SENT_46	[p2l1378t1302r1910b1403],
39	,	,	O	,	_	0	SENT_46	[p2l1378t1302r1910b1403],
40	continue	VBP	O	continue	ccomp	8	SENT_46	[p2l1949t1328r2132b1381, p2l12t1431r224b1509],
41	to	TO	O	to	aux	42	SENT_46	[p2l257t1447r338b1509],
42	complicate	VB	O	complicate	xcomp	40	SENT_46	[p2l373t1430r830b1530],
43	therapy	NN	O	therapy	dobj	42	SENT_46	[p2l864t1430r1191b1530],
44	,	,	O	,	_	0	SENT_46	[p2l864t1430r1191b1530],
45	making	VBG	O	make	xcomp	8	SENT_46	[p2l1230t1430r1559b1531],
46	warfarin	NN	O	warfarin	nsubj	53	SENT_46	[p2l1584t1429r1950b1509],
47	one	CD	NUMBER	one	num	46	SENT_46	[p2l1984t1456r2133b1509],
48	of	IN	O	of	_	0	SENT_46	[p2l12t1557r110b1637],
49	the	DT	O	the	det	50	SENT_46	[p2l122t1558r251b1636],
50	drugs	NNS	O	drug	prep_of	46	SENT_46	[p2l282t1558r519b1659],
51	most	RBS	O	most	advmod	53	SENT_46	[p2l551t1575r763b1637],
52	often	RB	O	often	advmod	53	SENT_46	[p2l788t1557r1004b1637],
53	responsible	JJ	O	responsible	xcomp	45	SENT_46	[p2l1034t1558r1508b1658],
54	for	IN	O	for	_	0	SENT_46	[p2l1538t1557r1658b1637],
55	emergency	NN	O	emergency	nn	57	SENT_46	[p2l1685t1584r2138b1659],
56	room	NN	O	room	nn	57	SENT_46	[p2l11t1711r237b1764],
57	visits	NNS	O	visit	prep_for	53	SENT_46	[p2l266t1686r673b1765],
58	.12	CD	NUMBER	.12	num	59	SENT_46	[p2l266t1686r673b1765],
59	’13	CD	NUMBER	’13	tmod	45	SENT_46	[p2l266t1686r673b1765],
60	Chemically	RB	O	chemically	advmod	59	SENT_46	[p2l709t1685r1194b1785],
61	,	,	O	,	_	0	SENT_46	[p2l709t1685r1194b1785],
62	warfarin	NN	O	warfarin	nsubj	67	SENT_46	[p2l1228t1684r1595b1765],
63	is	VBZ	O	be	cop	67	SENT_46	[p2l1628t1686r1693b1763],
64	a	DT	O	a	det	67	SENT_46	[p2l1729t1711r1773b1763],
65	racemic	JJ	O	racemic	amod	67	SENT_46	[p2l1805t1686r2134b1763],
66	mixture	NN	O	mixture	nn	67	SENT_46	[p2l11t1814r339b1893],
67	(	NN	O	(	_	0	SENT_46	[p2l374t1814r536b1909],
68	i.e.	FW	O	i.e.	dep	67	SENT_46	[p2l374t1814r536b1909],
69	,	,	O	,	_	0	SENT_46	[p2l374t1814r536b1909],
70	one	CD	NUMBER	one	appos	67	SENT_46	[p2l573t1839r720b1892],
71	that	WDT	O	that	nsubjpass	73	SENT_46	[p2l751t1813r917b1891],
72	is	VBZ	O	be	auxpass	73	SENT_46	[p2l942t1814r1005b1891],
73	composed	VBN	O	compose	rcmod	70	SENT_46	[p2l1039t1813r1462b1913],
74	of	IN	O	of	_	0	SENT_46	[p2l1493t1812r1590b1892],
75	two	CD	NUMBER	two	num	77	SENT_46	[p2l1603t1830r1756b1893],
76	enantio	NN	O	enantio	nn	77	SENT_46	[p2l1789t1814r2132b1892],
77	—	NN	O	—	prep_of	73	SENT_46	[p2l1789t1814r2132b1892],
78	morphic	JJ	O	morphic	amod	79	SENT_46	[p2l11t1941r366b2041],
79	isomers	NNS	O	isomer	nsubj	80	SENT_46	[p2l394t1942r768b2032],
80	)	VBP	O	)	rcmod	77	SENT_46	[p2l394t1942r768b2032],
81	.	.	O	.	_	0	SENT_46	[p2l394t1942r768b2032],

1	S	NN	O	s	nsubj	8	SENT_47	[p2l805t1940r1244b2021],
2	—	CD	NUMBER	—	num	3	SENT_47	[p2l805t1940r1244b2021],
3	warfarin	NN	O	warfarin	dep	1	SENT_47	[p2l805t1940r1244b2021],
4	is	VBZ	O	be	cop	8	SENT_47	[p2l1273t1942r1337b2019],
5	three	CD	NUMBER	three	number	8	SENT_47	[p2l1369t1941r1583b2019],
6	to	TO	O	to	dep	8	SENT_47	[p2l1613t1958r1693b2020],
7	five	CD	NUMBER	five	number	8	SENT_47	[p2l1724t1940r1872b2021],
8	times	NNS	O	time	ccomp	19	SENT_47	[p2l1902t1942r2130b2019],
9	as	IN	O	as	_	0	SENT_47	[p2l11t2096r96b2148],
10	potent	JJ	O	potent	amod	14	SENT_47	[p2l132t2087r412b2170],
11	as	IN	O	as	_	0	SENT_47	[p2l443t2096r528b2148],
12	R	NN	O	r	prep_as	10	SENT_47	[p2l565t2069r1028b2153],
13	—	CD	NUMBER	—	num	12	SENT_47	[p2l565t2069r1028b2153],
14	warfarin	NN	O	warfarin	prep_as	8	SENT_47	[p2l565t2069r1028b2153],
15	as	IN	O	as	_	0	SENT_47	[p2l1063t2096r1149b2148],
16	an	DT	O	a	det	17	SENT_47	[p2l1186t2096r1289b2148],
17	anticoagulant	JJ	O	anticoagulant	prep_as	14	SENT_47	[p2l1324t2070r1945b2171],
18	,	,	O	,	_	0	SENT_47	[p2l1324t2070r1945b2171],
19	has	VBZ	O	have	_	0	SENT_47	[p2l1987t2070r2130b2148],
20	a	DT	O	a	det	22	SENT_47	[p2l10t2223r55b2275],
21	shorter	JJR	O	shorter	amod	22	SENT_47	[p2l97t2197r405b2276],
22	halflife	NN	O	halflife	dobj	19	SENT_47	[p2l445t2196r803b2293],
23	,	,	O	,	_	0	SENT_47	[p2l445t2196r803b2293],
24	and	CC	O	and	_	0	SENT_47	[p2l852t2197r1009b2276],
25	is	VBZ	O	be	auxpass	26	SENT_47	[p2l1052t2198r1117b2275],
26	metabolized	VBN	O	metabolize	conj_and	19	SENT_47	[p2l1163t2197r1696b2276],
27	predominantly	RB	O	predominantly	advmod	26	SENT_47	[p2l1738t2197r2132b2297, p2l11t2326r283b2425],
28	by	IN	O	by	_	0	SENT_47	[p2l309t2326r406b2425],
29	a	DT	O	a	det	31	SENT_47	[p2l431t2352r475b2403],
30	cytochrome	NN	O	cytochrome	nn	31	SENT_47	[p2l505t2326r1011b2425],
31	P	NN	O	p	agent	26	SENT_47	[p2l1040t2332r1278b2404],
32	—	CD	NUMBER	—	number	33	SENT_47	[p2l1040t2332r1278b2404],
33	450	CD	NUMBER	450	num	34	SENT_47	[p2l1040t2332r1278b2404],
34	enzyme	NN	O	enzyme	nsubj	19	SENT_47	[p2l1310t2352r1662b2425],
35	,	,	O	,	_	0	SENT_47	[p2l1310t2352r1662b2425],
36	CYPZC9	NN	O	cypzc9	appos	34	SENT_47	[p2l1698t2331r2134b2404],
37	.	.	O	.	_	0	SENT_47	[p2l1698t2331r2134b2404],

1	“	NN	O	“	dep	99	SENT_48	[p2l1698t2331r2134b2404],
2	Two	CD	NUMBER	two	dep	99	SENT_48	[p2l8t2460r184b2533],
3	common	JJ	O	common	dep	99	SENT_48	[p2l231t2480r613b2532],
4	CYPZC9	NN	O	cypzc9	dep	99	SENT_48	[p2l658t2460r995b2532],
5	allozymes	NNS	O	allozyme	dep	99	SENT_48	[p2l1041t2454r1471b2553],
6	(	VBP	O	(	dep	99	SENT_48	[p2l1524t2460r1680b2544],
7	see	VB	O	see	dep	99	SENT_48	[p2l1524t2460r1680b2544],
8	Glossary	JJ	O	glossary	dep	99	SENT_48	[p2l1726t2454r2128b2553],
9	)	NN	O	)	dep	99	SENT_48	[p2l1726t2454r2128b2553],
10	have	VBP	O	have	dep	99	SENT_48	[p2l11t2581r201b2660],
11	only	RB	O	only	dep	99	SENT_48	[p2l238t2581r422b2681],
12	a	DT	O	a	dep	99	SENT_48	[p2l453t2607r498b2659],
13	fraction	NN	O	fraction	dep	99	SENT_48	[p2l533t2580r870b2660],
14	of	IN	O	of	dep	99	SENT_48	[p2l907t2580r1008b2660],
15	the	DT	O	the	dep	99	SENT_48	[p2l1026t2581r1159b2659],
16	level	NN	O	level	dep	99	SENT_48	[p2l1195t2581r1383b2661],
17	of	IN	O	of	dep	99	SENT_48	[p2l1421t2580r1520b2660],
18	enzyme	NN	O	enzyme	dep	99	SENT_48	[p2l1539t2607r1869b2681],
19	activity	NN	O	activity	dep	99	SENT_48	[p2l1905t2582r2132b2660, p2l11t2710r118b2809],
20	of	IN	O	of	dep	99	SENT_48	[p2l149t2708r248b2788],
21	the	DT	O	the	dep	99	SENT_48	[p2l265t2709r397b2787],
22	wild	JJ	O	wild	dep	99	SENT_48	[p2l427t2709r833b2809],
23	—	NN	O	—	dep	99	SENT_48	[p2l427t2709r833b2809],
24	type	NN	O	type	dep	99	SENT_48	[p2l427t2709r833b2809],
25	allozyme	JJ	O	allozyme	dep	99	SENT_48	[p2l867t2709r1255b2809],
26	CYP2C9	NN	O	cyp2c9	dep	99	SENT_48	[p2l1289t2709r1753b2788],
27	*	NN	O	*	dep	99	SENT_48	[p2l1289t2709r1753b2788],
28	1	CD	NUMBER	1	dep	99	SENT_48	[p2l1289t2709r1753b2788],
29	:	:	O	:	_	0	SENT_48	[p2l1289t2709r1753b2788],
30	12	CD	PERCENT	12	dep	99	SENT_48	[p2l1795t2714r1980b2789],
31	%	NN	PERCENT	%	dep	99	SENT_48	[p2l1795t2714r1980b2789],
32	for	IN	O	for	dep	99	SENT_48	[p2l2014t2708r2137b2788],
33	CYP2C9	NN	O	cyp2c9	dep	99	SENT_48	[p2l11t2838r451b2917],
34	*	NN	O	*	dep	99	SENT_48	[p2l11t2838r451b2917],
35	2	CD	NUMBER	2	dep	99	SENT_48	[p2l11t2838r451b2917],
36	and	CC	O	and	dep	99	SENT_48	[p2l488t2838r646b2917],
37	5	CD	PERCENT	5	dep	99	SENT_48	[p2l684t2843r815b2917],
38	%	NN	PERCENT	%	dep	99	SENT_48	[p2l684t2843r815b2917],
39	for	IN	O	for	dep	99	SENT_48	[p2l851t2837r974b2917],
40	CYP2C9	NN	O	cyp2c9	dep	99	SENT_48	[p2l1008t2838r1644b2917],
41	*	CD	NUMBER	*	dep	99	SENT_48	[p2l1008t2838r1644b2917],
42	3.11	CD	NUMBER	3.11	dep	99	SENT_48	[p2l1008t2838r1644b2917],
43	’14	CD	NUMBER	’14	dep	99	SENT_48	[p2l1008t2838r1644b2917],
44	More	JJR	DATE	more	dep	99	SENT_48	[p2l1678t2846r1899b2917],
45	than	IN	DATE	than	dep	99	SENT_48	[p2l1937t2838r2133b2916],
46	a	DT	DATE	a	dep	99	SENT_48	[p2l11t2992r55b3044],
47	decade	NN	DATE	decade	dep	99	SENT_48	[p2l101t2966r386b3045],
48	ago	RB	DATE	ago	dep	99	SENT_48	[p2l433t2992r602b3067],
49	,	,	O	,	_	0	SENT_48	[p2l433t2992r602b3067],
50	it	PRP	O	it	dep	99	SENT_48	[p2l654t2967r712b3044],
51	was	VBD	O	be	dep	99	SENT_48	[p2l749t2992r910b3045],
52	reported	VBN	O	report	dep	99	SENT_48	[p2l959t2966r1317b3066],
53	that	IN	O	that	dep	99	SENT_48	[p2l1364t2966r1533b3044],
54	patients	NNS	O	patient	dep	99	SENT_48	[p2l1573t2967r1907b3066],
55	who	WP	O	who	dep	99	SENT_48	[p2l1952t2966r2132b3045],
56	required	VBD	O	require	dep	99	SENT_48	[p2l11t3093r365b3193],
57	a	DT	O	a	dep	99	SENT_48	[p2l398t3119r442b3171],
58	low	JJ	O	low	dep	99	SENT_48	[p2l472t3093r626b3173],
59	final	JJ	O	final	dep	99	SENT_48	[p2l655t3092r854b3171],
60	dose	NN	O	dose	dep	99	SENT_48	[p2l888t3093r1078b3172],
61	of	IN	O	of	dep	99	SENT_48	[p2l1112t3092r1211b3172],
62	warfarin	NN	O	warfarin	dep	99	SENT_48	[p2l1221t3092r1587b3173],
63	on	IN	O	on	dep	99	SENT_48	[p2l1621t3119r1725b3172],
64	the	DT	O	the	dep	99	SENT_48	[p2l1759t3093r1890b3171],
65	basis	NN	O	basis	dep	99	SENT_48	[p2l1923t3093r2130b3172],
66	of	IN	O	of	dep	99	SENT_48	[p2l12t3221r112b3301],
67	INR	NN	O	inr	dep	99	SENT_48	[p2l134t3229r320b3305],
68	values	NNS	O	value	dep	99	SENT_48	[p2l347t3222r608b3301],
69	often	RB	O	often	dep	99	SENT_48	[p2l654t3221r876b3301],
70	carried	VBD	O	carry	dep	99	SENT_48	[p2l919t3222r1220b3301],
71	one	CD	NUMBER	one	dep	99	SENT_48	[p2l1262t3248r1413b3301],
72	or	CC	O	or	dep	99	SENT_48	[p2l1456t3248r1545b3301],
73	two	CD	NUMBER	two	dep	99	SENT_48	[p2l1584t3239r1742b3301],
74	of	IN	O	of	dep	99	SENT_48	[p2l1786t3221r1886b3301],
75	these	DT	O	these	dep	99	SENT_48	[p2l1910t3222r2133b3300],
76	two	CD	NUMBER	two	dep	99	SENT_48	[p2l12t3368r169b3430],
77	common	JJ	O	common	dep	99	SENT_48	[p2l213t3377r595b3430],
78	CYPZC9	NN	O	cypzc9	dep	99	SENT_48	[p2l638t3357r932b3429],
79	variant	JJ	O	variant	dep	99	SENT_48	[p2l970t3352r1274b3430],
80	alleles	NNS	O	allele	dep	99	SENT_48	[p2l1311t3351r1577b3430],
81	and	CC	O	and	dep	99	SENT_48	[p2l1620t3351r1778b3430],
82	were	VBD	O	be	dep	99	SENT_48	[p2l1816t3377r2017b3430],
83	at	IN	O	at	dep	99	SENT_48	[p2l2059t3368r2138b3429],
84	increased	VBN	O	increase	dep	99	SENT_48	[p2l11t3479r419b3558],
85	risk	NN	O	risk	dep	99	SENT_48	[p2l470t3479r634b3558],
86	for	IN	O	for	dep	99	SENT_48	[p2l680t3478r804b3558],
87	hemorrhage	NN	O	hemorrhage	dep	99	SENT_48	[p2l852t3479r1374b3580],
88	during	IN	O	during	dep	99	SENT_48	[p2l1427t3479r1716b3580],
89	warfarin	NN	O	warfarin	dep	99	SENT_48	[p2l1759t3478r2133b3558],
90	therapy	NN	O	therapy	dep	99	SENT_48	[p2l12t3607r337b3706],
91	,	,	O	,	_	0	SENT_48	[p2l12t3607r337b3706],
92	presumably	RB	O	presumably	dep	99	SENT_48	[p2l371t3607r863b3706],
93	because	IN	O	because	dep	99	SENT_48	[p2l889t3607r1217b3686],
94	they	PRP	O	they	dep	99	SENT_48	[p2l1248t3607r1427b3706],
95	metabolized	VBD	O	metabolize	dep	99	SENT_48	[p2l1453t3607r1973b3685],
96	the	DT	O	the	dep	99	SENT_48	[p2l2003t3607r2133b3685],
97	drug	NN	O	drug	dep	99	SENT_48	[p3l12t21r212b122],
98	more	RBR	O	more	dep	99	SENT_48	[p3l242t47r457b100],
99	slowly	RB	O	slowly	_	0	SENT_48	[p3l492t21r842b121],
100	.	.	O	.	_	0	SENT_48	[p3l492t21r842b121],

1	“	NN	O	“	nsubjpass	5	SENT_49	[p3l492t21r842b121],
2	Those	DT	O	those	det	3	SENT_49	[p3l870t21r1125b100],
3	observations	NNS	O	observation	dep	1	SENT_49	[p3l1159t21r1689b100],
4	were	VBD	O	be	auxpass	5	SENT_49	[p3l1720t47r1918b100],
5	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_49	[p3l1952t47r2132b100, p3l11t147r322b244],
6	,	,	O	,	_	0	SENT_49	[p3l1952t47r2132b100, p3l11t147r322b244],
7	but	CC	O	but	_	0	SENT_49	[p3l362t148r501b228],
8	it	PRP	O	it	nsubj	11	SENT_49	[p3l529t149r588b226],
9	quickly	RB	O	quickly	advmod	11	SENT_49	[p3l617t148r928b248],
10	became	VBD	O	become	cop	11	SENT_49	[p3l958t148r1285b227],
11	clear	JJ	O	clear	conj_but	5	SENT_49	[p3l1319t148r1524b226],
12	that	IN	O	that	complm	20	SENT_49	[p3l1555t148r1727b226],
13	the	DT	O	the	det	14	SENT_49	[p3l1756t148r1888b226],
14	presence	NN	O	presence	nsubj	20	SENT_49	[p3l1920t174r2132b248, p3l12t302r201b354],
15	of	IN	O	of	_	0	SENT_49	[p3l250t275r350b355],
16	CYPZC9	NN	O	cypzc9	nn	17	SENT_49	[p3l380t283r675b354],
17	polymorphisms	NNS	O	polymorphism	prep_of	14	SENT_49	[p3l722t276r1400b376],
18	did	VBD	O	do	aux	20	SENT_49	[p3l1451t276r1586b355],
19	not	RB	O	not	neg	20	SENT_49	[p3l1633t293r1776b355],
20	explain	VB	O	explain	ccomp	11	SENT_49	[p3l1820t276r2133b376],
21	most	JJS	O	most	dobj	20	SENT_49	[p3l11t422r228b484],
22	of	IN	O	of	_	0	SENT_49	[p3l261t404r361b484],
23	the	DT	O	the	det	24	SENT_49	[p3l381t405r514b484],
24	variation	NN	O	variation	prep_of	21	SENT_49	[p3l547t406r930b484],
25	in	IN	O	in	_	0	SENT_49	[p3l968t406r1051b483],
26	the	DT	O	the	det	29	SENT_49	[p3l1089t405r1222b483],
27	ﬁnal	JJ	O	ﬁnal	amod	29	SENT_49	[p3l1261t404r1465b483],
28	warfarin	NN	O	warfarin	nn	29	SENT_49	[p3l1498t404r1871b484],
29	dose	NN	O	dose	prep_in	24	SENT_49	[p3l1911t405r2128b484],
30	.	.	O	.	_	0	SENT_49	[p3l1911t405r2128b484],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_50	[p3l138t533r886b634],
2	studies	NNS	O	study	nsubj	5	SENT_50	[p3l919t533r1219b612],
3	of	IN	O	of	_	0	SENT_50	[p3l1254t532r1354b612],
4	warfarin	NN	O	warfarin	prep_of	2	SENT_50	[p3l1364t532r1738b612],
5	changed	VBD	O	change	_	0	SENT_50	[p3l1772t533r2133b634],
6	dramatically	RB	O	dramatically	advmod	5	SENT_50	[p3l12t661r540b761],
7	in	IN	O	in	_	0	SENT_50	[p3l564t662r646b739],
8	2004	CD	DATE	2004	prep_in	5	SENT_50	[p3l674t667r880b740],
9	when	WRB	O	when	advmod	45	SENT_50	[p3l904t661r1133b740],
10	the	DT	O	the	det	11	SENT_50	[p3l1163t661r1293b739],
11	target	NN	O	target	nsubjpass	45	SENT_50	[p3l1322t678r1571b762],
12	for	IN	O	for	_	0	SENT_50	[p3l1595t660r1715b740],
13	warfarin	NN	O	warfarin	nn	14	SENT_50	[p3l1737t660r2132b740],
14	—	NN	O	—	prep_for	11	SENT_50	[p3l1737t660r2132b740],
15	based	VBN	O	base	partmod	14	SENT_50	[p3l12t789r250b868],
16	anticoagulants	NNS	O	anticoagulant	nsubjpass	30	SENT_50	[p3l277t789r917b890],
17	,	,	O	,	_	0	SENT_50	[p3l277t789r917b890],
18	vitamin	NN	O	vitamin	nn	23	SENT_50	[p3l947t790r1270b868],
19	K	NN	O	k	nn	23	SENT_50	[p3l1298t797r1365b870],
20	epoxide	NN	O	epoxide	nn	23	SENT_50	[p3l1391t789r1710b889],
21	reductase	NN	O	reductase	nn	23	SENT_50	[p3l1739t789r2133b868],
22	complex	NN	O	complex	nn	23	SENT_50	[p3l12t916r372b1016],
23	subunit	NN	O	subunit	appos	16	SENT_50	[p3l402t916r728b996],
24	1	CD	NUMBER	1	number	25	SENT_50	[p3l759t922r803b994],
25	(	CD	NUMBER	(	num	27	SENT_50	[p3l840t922r1291b1012],
26	VKORC1	NN	O	vkorc1	nn	27	SENT_50	[p3l840t922r1291b1012],
27	)	NN	O	)	dep	23	SENT_50	[p3l840t922r1291b1012],
28	,	,	O	,	_	0	SENT_50	[p3l840t922r1291b1012],
29	was	VBD	O	be	auxpass	30	SENT_50	[p3l1324t942r1487b996],
30	identified	VBN	O	identify	dep	15	SENT_50	[p3l1520t915r2133b1012],
31	,15	CD	NUMBER	,15	number	32	SENT_50	[p3l1520t915r2133b1012],
32	»	CD	NUMBER	»	num	33	SENT_50	[p3l1520t915r2133b1012],
33	16	CD	NUMBER	16	dobj	30	SENT_50	[p3l1520t915r2133b1012],
34	and	CC	O	and	_	0	SENT_50	[p3l11t1045r168b1124],
35	single	JJ	O	single	amod	38	SENT_50	[p3l217t1045r950b1146],
36	—	NN	O	—	nn	38	SENT_50	[p3l217t1045r950b1146],
37	nucleotide	NN	O	nucleotide	nn	38	SENT_50	[p3l217t1045r950b1146],
38	polymorphisms	NNS	O	polymorphism	nsubj	39	SENT_50	[p3l996t1045r1673b1145],
39	(	VBP	O	(	dep	15	SENT_50	[p3l1727t1051r1998b1136],
40	SNPs	NNS	O	snp	dobj	39	SENT_50	[p3l1727t1051r1998b1136],
41	)	CD	NUMBER	)	num	40	SENT_50	[p3l1727t1051r1998b1136],
42	in	IN	O	in	_	0	SENT_50	[p3l2050t1046r2133b1123],
43	VKORCI	NNP	O	VKORCI	prep_in	40	SENT_50	[p3l10t1179r324b1253],
44	were	VBD	O	be	auxpass	45	SENT_50	[p3l351t1199r548b1252],
45	shown	VBN	O	show	advcl	5	SENT_50	[p3l577t1173r852b1252],
46	to	TO	O	to	aux	48	SENT_50	[p3l881t1190r961b1252],
47	be	VB	O	be	auxpass	48	SENT_50	[p3l991t1173r1086b1252],
48	associated	VBN	O	associate	xcomp	45	SENT_50	[p3l1114t1173r1543b1252],
49	with	IN	O	with	_	0	SENT_50	[p3l1567t1173r1756b1252],
50	the	DT	O	the	det	51	SENT_50	[p3l1786t1173r1915b1251],
51	dose	NN	O	dose	prep_with	48	SENT_50	[p3l1944t1173r2133b1252],
52	of	IN	O	of	_	0	SENT_50	[p3l12t1300r110b1380],
53	warfarin	NN	O	warfarin	prep_of	51	SENT_50	[p3l129t1300r496b1380],
54	required	VBN	O	require	partmod	53	SENT_50	[p3l537t1301r892b1401],
55	to	TO	O	to	aux	56	SENT_50	[p3l933t1318r1013b1380],
56	achieve	VB	O	achieve	xcomp	54	SENT_50	[p3l1057t1301r1361b1380],
57	a	DT	O	a	det	60	SENT_50	[p3l1402t1327r1447b1379],
58	target	NN	O	target	nn	60	SENT_50	[p3l1487t1318r1738b1402],
59	INR	NN	O	inr	nn	60	SENT_50	[p3l1773t1308r1956b1384],
60	value	NN	O	value	dobj	56	SENT_50	[p3l1983t1301r2132b1380, p3l11t1434r204b1508],
61	.17	CD	NUMBER	.17	tmod	56	SENT_50	[p3l1983t1301r2132b1380, p3l11t1434r204b1508],
62	In	IN	O	in	_	0	SENT_50	[p3l255t1437r344b1507],
63	2009	CD	DATE	2009	prep_in	69	SENT_50	[p3l396t1435r623b1525],
64	,	,	O	,	_	0	SENT_50	[p3l396t1435r623b1525],
65	a	DT	O	a	det	68	SENT_50	[p3l680t1455r724b1507],
66	genomewide	JJ	O	genomewide	amod	68	SENT_50	[p3l774t1429r1320b1530],
67	association	NN	O	association	nn	68	SENT_50	[p3l1371t1430r1855b1508],
68	study	NN	O	study	nsubj	69	SENT_50	[p3l1908t1429r2138b1529],
69	looked	VBD	O	look	rcmod	61	SENT_50	[p3l10t1557r298b1636],
70	for	IN	O	for	_	0	SENT_50	[p3l333t1556r456b1636],
71	associations	NNS	O	association	prep_for	69	SENT_50	[p3l488t1558r1013b1636],
72	between	IN	O	between	_	0	SENT_50	[p3l1051t1557r1408b1636],
73	several	JJ	O	several	quantmod	75	SENT_50	[p3l1445t1557r1737b1636],
74	hundred	CD	NUMBER	hundred	number	75	SENT_50	[p3l1771t1557r2133b1636],
75	thousand	CD	NUMBER	thousand	num	76	SENT_50	[p3l12t1685r415b1764],
76	SNPs	NNS	O	snp	prep_between	71	SENT_50	[p3l452t1691r669b1764],
77	and	CC	O	and	_	0	SENT_50	[p3l706t1685r864b1764],
78	warfarin	NN	O	warfarin	nn	79	SENT_50	[p3l894t1684r1269b1764],
79	dose	NN	O	dose	prep_between	71	SENT_50	[p3l1305t1685r1499b1764],
80	in	IN	O	in	prep	69	SENT_50	[p3l1534t1686r1617b1763],
81	about	IN	DATE	about	pcomp	80	SENT_50	[p3l1652t1685r1896b1764],
82	1000	CD	DATE	1000	pobj	81	SENT_50	[p3l1930t1691r2133b1764],

1	Swedish	JJ	MISC	swedish	amod	2	SENT_51	[p3l13t1813r364b1892],
2	patients	NNS	O	patient	_	0	SENT_51	[p3l399t1814r740b1913],
3	who	WP	O	who	nsubj	5	SENT_51	[p3l774t1813r957b1892],
4	were	VBD	O	be	aux	5	SENT_51	[p3l990t1839r1191b1892],
5	taking	VBG	O	take	rcmod	2	SENT_51	[p3l1228t1813r1509b1914],
6	warfarin	NN	O	warfarin	dobj	5	SENT_51	[p3l1537t1812r1934b1892],
7	.	.	O	.	_	0	SENT_51	[p3l1537t1812r1934b1892],

1	The	DT	O	the	det	2	SENT_52	[p3l1973t1813r2133b1892],
2	results	NNS	O	result	nsubj	3	SENT_52	[p3l11t1941r294b2020],
3	showed	VBD	O	show	conj_and	3	SENT_52	[p3l334t1941r657b2020],
4	two	CD	NUMBER	two	num	6	SENT_52	[p3l694t1958r852b2020],
5	major	JJ	O	major	amod	6	SENT_52	[p3l890t1942r1140b2041],
6	signals	NNS	O	signal	dobj	3	SENT_52	[p3l1175t1941r1475b2042],
7	in	IN	O	in	_	0	SENT_52	[p3l1513t1942r1596b2019],
8	and	CC	O	and	_	0	SENT_52	[p3l1632t1941r1791b2020],
9	around	IN	O	around	_	0	SENT_52	[p3l1827t1941r2133b2020],
10	CYPZC9	NN	O	cypzc9	prep_around	3	SENT_52	[p3l11t2075r301b2147],
11	and	CC	O	and	_	0	SENT_52	[p3l334t2069r490b2148],
12	VKORCI	NN	O	vkorcus	prep_around	3	SENT_52	[p3l523t2075r840b2149],
13	(	CD	NUMBER	(	num	14	SENT_52	[p3l881t2070r1057b2170],
14	Fig	NN	O	fig	prep_in	3	SENT_52	[p3l881t2070r1057b2170],
15	.	.	O	.	_	0	SENT_52	[p3l881t2070r1057b2170],

1	1A	NN	O	1a	_	0	SENT_53	[p3l1099t2074r1334b2160],
2	)	CD	NUMBER	)	number	3	SENT_53	[p3l1099t2074r1334b2160],
3	.13	CD	NUMBER	.13	num	1	SENT_53	[p3l1099t2074r1334b2160],
4	When	WRB	O	when	advmod	7	SENT_53	[p3l1366t2069r1617b2147],
5	the	DT	O	the	det	6	SENT_53	[p3l1651t2069r1782b2147],
6	authors	NNS	O	author	nsubj	7	SENT_53	[p3l1815t2069r2132b2148],
7	removed	VBD	O	remove	dep	1	SENT_53	[p3l11t2197r376b2276],
8	the	DT	O	the	det	9	SENT_53	[p3l439t2197r571b2276],
9	effects	NNS	O	effect	dobj	7	SENT_53	[p3l635t2196r915b2276],
10	of	IN	O	of	_	0	SENT_53	[p3l981t2196r1081b2276],
11	those	DT	O	those	det	12	SENT_53	[p3l1125t2197r1356b2276],
12	signals	NNS	O	signal	prep_of	9	SENT_53	[p3l1420t2197r1720b2298],
13	through	IN	O	through	prep	7	SENT_53	[p3l1784t2197r2133b2298],

1	Allozymez	NNP	O	Allozymez	nn	3	SENT_54	[p3l60t2639r314b2703],
2	Alternate	JJ	O	alternate	amod	3	SENT_54	[p3l332t2639r571b2688],
3	versions	NNS	O	version	_	0	SENT_54	[p3l588t2644r807b2688],
4	of	IN	O	of	_	0	SENT_54	[p3l828t2639r885b2688],
5	an	DT	O	a	det	6	SENT_54	[p3l896t2657r953b2688],
6	enzyme	NN	O	enzyme	prep_of	3	SENT_54	[p3l975t2657r1176b2703],
7	determined	VBN	O	determine	partmod	6	SENT_54	[p3l1195t2639r1494b2688],
8	by	IN	O	by	_	0	SENT_54	[p3l1519t2639r1573b2703],
9	genetic	JJ	O	genetic	amod	10	SENT_54	[p3l1592t2644r1780b2703],
10	variants	NNS	O	variant	agent	7	SENT_54	[p3l1797t2644r2003b2688],

1	(	NN	O	(	nn	2	SENT_55	[p3l164t2712r361b2775],
2	alleles	NNS	O	allele	nsubj	3	SENT_55	[p3l164t2712r361b2775],
3	)	VBP	O	)	_	0	SENT_55	[p3l164t2712r361b2775],
4	present	JJ	DATE	present	acomp	3	SENT_55	[p3l388t2721r582b2775],
5	at	IN	O	at	_	0	SENT_55	[p3l601t2721r648b2760],
6	a	DT	O	a	det	8	SENT_55	[p3l667t2729r691b2760],
7	genetic	JJ	O	genetic	amod	8	SENT_55	[p3l712t2716r900b2776],
8	locus	NN	O	locus	prep_at	3	SENT_55	[p3l921t2712r1069b2760],
9	.	.	O	.	_	0	SENT_55	[p3l921t2712r1069b2760],

1	Gene	NNP	O	Gene	nn	2	SENT_56	[p3l62t2826r200b2871],
2	cluster	NN	O	cluster	_	0	SENT_56	[p3l217t2823r408b2871],
3	:	:	O	:	_	0	SENT_56	[p3l217t2823r408b2871],
4	Two	CD	NUMBER	two	num	7	SENT_56	[p3l426t2827r535b2871],
5	or	CC	O	or	_	0	SENT_56	[p3l555t2840r608b2871],
6	more	JJR	O	more	num	7	SENT_56	[p3l628t2840r761b2871],
7	genes	NNS	O	gene	dep	2	SENT_56	[p3l781t2840r931b2886],
8	in	IN	O	in	_	0	SENT_56	[p3l954t2827r995b2870],
9	close	JJ	O	close	amod	11	SENT_56	[p3l1017t2823r1150b2871],
10	physical	JJ	O	physical	amod	11	SENT_56	[p3l1172t2823r1376b2886],
11	proximity	NN	O	proximity	prep_in	7	SENT_56	[p3l1401t2827r1644b2886],
12	in	IN	O	in	_	0	SENT_56	[p3l1664t2827r1705b2870],
13	the	DT	O	the	det	14	SENT_56	[p3l1726t2823r1807b2871],
14	genome	NN	O	genome	prep_in	11	SENT_56	[p3l1827t2840r2039b2886],
15	that	WDT	O	that	nsubj	16	SENT_56	[p3l157t2895r260b2943],
16	encode	VBP	O	encode	rcmod	14	SENT_56	[p3l278t2895r466b2943],
17	similar	JJ	O	similar	amod	19	SENT_56	[p3l487t2895r665b2943],
18	gene	NN	O	gene	nn	19	SENT_56	[p3l683t2912r806b2959],
19	products	NNS	O	product	dobj	16	SENT_56	[p3l828t2895r1072b2958],
20	.	.	O	.	_	0	SENT_56	[p3l828t2895r1072b2958],

1	Genomewide	JJ	O	genomewide	amod	3	SENT_57	[p3l62t3006r411b3054],
2	association	NN	O	association	nn	3	SENT_57	[p3l429t3007r723b3054],
3	study	NN	O	study	_	0	SENT_57	[p3l743t3006r900b3069],
4	:	:	O	:	_	0	SENT_57	[p3l743t3006r900b3069],
5	An	DT	O	a	det	6	SENT_57	[p3l918t3009r986b3054],
6	approach	NN	O	approach	dep	3	SENT_57	[p3l1009t3006r1251b3069],
7	used	VBN	O	use	partmod	6	SENT_57	[p3l1275t3006r1394b3054],
8	in	IN	O	in	_	0	SENT_57	[p3l1418t3010r1460b3054],
9	genetics	NNS	O	genetics	nn	10	SENT_57	[p3l1482t3011r1697b3070],
10	research	NN	O	research	prep_in	7	SENT_57	[p3l1720t3006r1936b3054],
11	to	TO	O	to	aux	12	SENT_57	[p3l1956t3015r2007b3054],
12	look	VB	O	look	xcomp	7	SENT_57	[p3l161t3078r268b3127],
13	for	IN	O	for	mark	18	SENT_57	[p3l285t3078r358b3127],
14	associations	NNS	O	association	nsubj	18	SENT_57	[p3l376t3083r700b3127],
15	between	IN	O	between	_	0	SENT_57	[p3l723t3078r935b3127],
16	large	JJ	O	large	amod	17	SENT_57	[p3l960t3078r1083b3142],
17	numbers	NNS	O	number	prep_between	14	SENT_57	[p3l1106t3078r1335b3127],
18	(	VBP	O	(	advcl	12	SENT_57	[p3l1362t3078r1589b3142],
19	typically	RB	O	typically	advmod	22	SENT_57	[p3l1362t3078r1589b3142],
20	hundreds	NNS	O	hundred	nn	21	SENT_57	[p3l1609t3078r1854b3127],
21	ofthousands	NNS	O	ofthousand	nsubj	22	SENT_57	[p3l1875t3078r2079b3127, p3l160t3151r330b3214],
22	)	VBP	O	)	ccomp	18	SENT_57	[p3l1875t3078r2079b3127, p3l160t3151r330b3214],
23	ofspecific	JJ	O	ofspecific	amod	25	SENT_57	[p3l354t3150r619b3213],
24	genetic	JJ	O	genetic	amod	25	SENT_57	[p3l637t3155r826b3214],
25	variations	NNS	O	variation	nsubj	26	SENT_57	[p3l842t3155r1099b3199],
26	(	VBP	O	(	ccomp	22	SENT_57	[p3l1125t3155r1277b3214],
27	most	RBS	O	most	advmod	28	SENT_57	[p3l1125t3155r1277b3214],
28	commonly	RB	O	commonly	advmod	31	SENT_57	[p3l1295t3151r1574b3214],
29	single-nucleotide	JJ	O	single-nucleotide	amod	31	SENT_57	[p3l1593t3151r2041b3214],
30	polymorphisms	NNS	O	polymorphism	nn	31	SENT_57	[p3l161t3223r590b3286],
31	)	NN	O	)	dobj	26	SENT_57	[p3l161t3223r590b3286],
32	and	CC	O	and	_	0	SENT_57	[p3l615t3223r707b3271],
33	particular	JJ	O	particular	amod	34	SENT_57	[p3l732t3223r981b3286],
34	diseases	NNS	O	disease	dobj	26	SENT_57	[p3l998t3223r1235b3271],
35	.	.	O	.	_	0	SENT_57	[p3l998t3223r1235b3271],

1	Single-nucleotide	JJ	O	single-nucleotide	amod	2	SENT_58	[p3l61t3334r517b3397],
2	polymorphism	NN	O	polymorphism	_	0	SENT_58	[p3l536t3334r932b3397],
3	:	:	O	:	_	0	SENT_58	[p3l536t3334r932b3397],
4	A	DT	O	a	det	6	SENT_58	[p3l951t3337r988b3382],
5	single-nucleotide	JJ	O	single-nucleotide	amod	6	SENT_58	[p3l1007t3334r1455b3398],
6	variation	NN	O	variation	dep	2	SENT_58	[p3l1473t3339r1699b3383],
7	in	IN	O	in	_	0	SENT_58	[p3l1723t3339r1765b3382],
8	a	DT	O	a	det	10	SENT_58	[p3l1788t3351r1812b3382],
9	genetic	JJ	O	genetic	amod	10	SENT_58	[p3l1833t3339r2021b3398],
10	sequence	NN	O	sequence	prep_in	6	SENT_58	[p3l160t3424r419b3469],
11	;	:	O	;	_	0	SENT_58	[p3l160t3424r419b3469],
12	a	DT	O	a	det	15	SENT_58	[p3l441t3424r465b3455],
13	common	JJ	O	common	amod	15	SENT_58	[p3l486t3424r719b3455],
14	form	NN	O	form	nn	15	SENT_58	[p3l740t3406r862b3455],
15	ofvariation	NN	O	ofvariation	dep	2	SENT_58	[p3l884t3406r1176b3455],
16	in	IN	O	in	_	0	SENT_58	[p3l1201t3411r1242b3454],
17	the	DT	O	the	det	19	SENT_58	[p3l1263t3406r1344b3455],
18	human	JJ	O	human	amod	19	SENT_58	[p3l1366t3406r1545b3455],
19	genome	NN	O	genome	prep_in	15	SENT_58	[p3l1568t3424r1794b3470],
20	.	.	O	.	_	0	SENT_58	[p3l1568t3424r1794b3470],

1	multiple	JJ	O	multiple	amod	3	SENT_59	[p4l11t78r271b152],
2	regression	NN	O	regression	nn	3	SENT_59	[p4l300t78r626b152],
3	adjustment	NN	O	adjustment	nsubj	6	SENT_59	[p4l654t77r1020b152],
4	,	,	O	,	_	0	SENT_59	[p4l654t77r1020b152],
5	they	PRP	O	they	nsubj	6	SENT_59	[p4l1053t78r1187b152],
6	observed	VBD	O	observe	_	0	SENT_59	[p4l1213t77r1491b136],
7	an	DT	O	a	det	9	SENT_59	[p4l1519t97r1595b136],
8	additional	JJ	O	additional	amod	9	SENT_59	[p4l11t172r330b231],
9	signal	NN	O	signal	dobj	6	SENT_59	[p4l351t173r555b247],
10	,	,	O	,	_	0	SENT_59	[p4l351t173r555b247],
11	implicating	VBG	O	implicate	partmod	6	SENT_59	[p4l579t173r943b247],
12	another	DT	O	another	det	15	SENT_59	[p4l961t173r1206b231],
13	cytochrome	NN	O	cytochrome	nn	15	SENT_59	[p4l1225t173r1596b247],
14	P450	NN	O	p450	nn	15	SENT_59	[p4l10t272r160b326],
15	gene	NN	O	gene	dobj	11	SENT_59	[p4l187t286r336b342],
16	(	CD	NUMBER	(	num	17	SENT_59	[p4l366t272r622b335],
17	CYP4F2	NN	O	cyp4f2	dep	15	SENT_59	[p4l366t272r622b335],
18	)	CD	NUMBER	)	number	19	SENT_59	[p4l366t272r622b335],
19	(	CD	NUMBER	(	num	20	SENT_59	[p4l656t268r792b342],
20	Fig	NN	O	fig	dep	17	SENT_59	[p4l656t268r792b342],
21	.	.	O	.	_	0	SENT_59	[p4l656t268r792b342],

1	1B	NN	O	1b	_	0	SENT_60	[p4l827t272r946b335],
2	)	NN	O	)	dep	1	SENT_60	[p4l827t272r946b335],
3	.	.	O	.	_	0	SENT_60	[p4l827t272r946b335],

1	CYP4F2	NN	O	cyp4f2	nsubjpass	4	SENT_61	[p4l977t272r1218b326],
2	was	VBD	O	be	auxpass	4	SENT_61	[p4l1242t287r1363b327],
3	subsequently	RB	O	subsequently	advmod	4	SENT_61	[p4l1393t268r1595b326, p4l12t363r249b437],
4	shown	VBN	O	show	_	0	SENT_61	[p4l272t363r482b422],
5	to	TO	O	to	aux	6	SENT_61	[p4l508t375r569b421],
6	catalyze	VB	O	catalyze	xcomp	4	SENT_61	[p4l596t362r852b437],
7	vitamin	NN	O	vitamin	nn	9	SENT_61	[p4l874t363r1124b421],
8	K	NN	O	k	nn	9	SENT_61	[p4l1148t368r1198b423],
9	oxidation	NN	O	oxidation	dobj	6	SENT_61	[p4l1222t363r1596b421],
10	.	.	O	.	_	0	SENT_61	[p4l1222t363r1596b421],

1	”	NN	O	”	nsubj	6	SENT_62	[p4l1222t363r1596b421],
2	The	DT	O	the	det	5	SENT_62	[p4l9t458r128b516],
3	variant	JJ	O	variant	amod	5	SENT_62	[p4l166t458r392b516],
4	CYP4F2	NN	O	cyp4f2	nn	5	SENT_62	[p4l429t462r670b516],
5	allozyme	NN	O	allozyme	dep	1	SENT_62	[p4l710t457r1000b532],
6	shows	VBZ	O	show	_	0	SENT_62	[p4l1042t458r1238b516],
7	decreased	VBN	O	decrease	amod	8	SENT_62	[p4l1281t458r1596b516],
8	ability	NN	O	ability	nsubj	10	SENT_62	[p4l11t553r212b627],
9	to	TO	O	to	aux	10	SENT_62	[p4l246t565r307b611],
10	catalyze	VB	O	catalyze	dep	6	SENT_62	[p4l345t553r601b627],
11	the	DT	O	the	det	12	SENT_62	[p4l639t553r738b611],
12	reaction	NN	O	reaction	dobj	10	SENT_62	[p4l775t553r1052b623],
13	,	,	O	,	_	0	SENT_62	[p4l775t553r1052b623],
14	and	CC	O	and	_	0	SENT_62	[p4l1092t552r1210b611],
15	as	IN	O	as	mark	28	SENT_62	[p4l1247t572r1310b611],
16	a	DT	O	a	det	18	SENT_62	[p4l1349t572r1382b611],
17	result	NN	O	result	nn	18	SENT_62	[p4l1418t553r1599b611],
18	persons	NNS	O	person	nsubj	28	SENT_62	[p4l10t666r260b722],
19	who	WP	O	who	nsubj	20	SENT_62	[p4l284t648r420b707],
20	carry	VBP	O	carry	rcmod	18	SENT_62	[p4l447t667r612b722],
21	the	DT	O	the	det	24	SENT_62	[p4l635t648r733b706],
22	relevant	JJ	O	relevant	amod	24	SENT_62	[p4l759t648r1013b706],
23	genetic	JJ	O	genetic	amod	24	SENT_62	[p4l1034t648r1265b722],
24	variant	NN	O	variant	dobj	20	SENT_62	[p4l1286t648r1513b706],
25	in	IN	O	in	_	0	SENT_62	[p4l1534t648r1596b705],
26	CYP4F2	NN	O	cyp4f2	prep_in	24	SENT_62	[p4l11t747r225b800],
27	might	MD	O	might	aux	28	SENT_62	[p4l251t743r445b817],
28	require	VB	O	require	dep	6	SENT_62	[p4l466t743r694b817],
29	an	DT	O	a	det	30	SENT_62	[p4l719t761r796b801],
30	increase	NN	O	increase	dobj	28	SENT_62	[p4l820t743r1083b801],
31	in	IN	O	in	_	0	SENT_62	[p4l1108t743r1170b800],
32	the	DT	O	the	det	36	SENT_62	[p4l1195t743r1294b801],
33	Warfarin	NNP	MISC	Warfarin	nn	36	SENT_62	[p4l1316t742r1596b801],
34	dose	NN	O	dose	nn	36	SENT_62	[p4l12t837r156b896],
35	(	NN	O	(	nn	36	SENT_62	[p4l190t838r324b912],
36	Fig	NN	O	fig	prep_in	30	SENT_62	[p4l190t838r324b912],
37	.	.	O	.	_	0	SENT_62	[p4l190t838r324b912],

1	1C	NN	O	1c	_	0	SENT_63	[p4l361t842r478b905],
2	)	NN	O	)	dep	1	SENT_63	[p4l361t842r478b905],
3	.	.	O	.	_	0	SENT_63	[p4l361t842r478b905],

1	CYPZC9	NN	O	cypzc9	_	0	SENT_64	[p4l513t842r746b908],
2	,	,	O	,	_	0	SENT_64	[p4l513t842r746b908],
3	VKORC1	NN	O	vkorc1	conj_and	1	SENT_64	[p4l770t842r1028b908],
4	,	,	O	,	_	0	SENT_64	[p4l770t842r1028b908],
5	and	CC	O	and	_	0	SENT_64	[p4l1061t838r1179b896],
6	CYP4F2	NN	O	cyp4f2	conj_and	1	SENT_64	[p4l1209t842r1423b896],
7	have	VBP	O	have	aux	10	SENT_64	[p4l1454t837r1596b896],
8	also	RB	O	also	advmod	10	SENT_64	[p4l11t932r136b991],
9	been	VBN	O	be	auxpass	10	SENT_64	[p4l160t933r308b991],
10	implicated	VBN	O	implicate	rcmod	1	SENT_64	[p4l329t932r661b1007],
11	in	IN	O	in	_	0	SENT_64	[p4l683t933r745b990],
12	a	DT	O	a	det	15	SENT_64	[p4l766t952r799b991],
13	genomewide	JJ	O	genomewide	amod	15	SENT_64	[p4l820t932r1221b1007],
14	association	NN	O	association	nn	15	SENT_64	[p4l1243t933r1596b991],
15	study	NN	O	study	prep_in	10	SENT_64	[p4l12t1027r184b1102],
16	of	IN	O	of	_	0	SENT_64	[p4l220t1027r295b1086],
17	the	DT	O	the	det	18	SENT_64	[p4l321t1028r420b1086],
18	administration	NN	O	administration	prep_of	15	SENT_64	[p4l459t1028r941b1086],
19	of	IN	O	of	_	0	SENT_64	[p4l981t1027r1056b1086],
20	acenocoumarol	NN	O	acenocoumarol	prep_of	18	SENT_64	[p4l1081t1028r1592b1099],
21	,	,	O	,	_	0	SENT_64	[p4l1081t1028r1592b1099],
22	an	DT	O	a	det	28	SENT_64	[p4l11t1141r87b1181],
23	anticoagulant	JJ	O	anticoagulant	amod	28	SENT_64	[p4l117t1123r565b1197],
24	related	JJ	O	related	amod	28	SENT_64	[p4l591t1123r808b1181],
25	to	TO	O	to	_	0	SENT_64	[p4l838t1135r899b1181],
26	Warfarin	NNP	O	Warfarin	prep_to	24	SENT_64	[p4l926t1122r1282b1181],
27	.2	NN	NUMBER	.2	nn	28	SENT_64	[p4l926t1122r1282b1181],
28	°	NN	O	°	appos	20	SENT_64	[p4l926t1122r1282b1181],

1	Taken	VBN	O	take	partmod	8	SENT_65	[p4l105t1218r297b1277],
2	together	RB	O	together	advmod	1	SENT_65	[p4l322t1218r600b1292],
3	,	,	O	,	_	0	SENT_65	[p4l322t1218r600b1292],
4	CYPZC9	NN	O	cypzc9	nn	7	SENT_65	[p4l629t1222r846b1276],
5	and	CC	O	and	_	0	SENT_65	[p4l870t1218r987b1276],
6	VKORC1	NN	O	vkorc1	nn	7	SENT_65	[p4l1011t1222r1248b1277],
7	genotypes	NNS	O	genotype	nsubj	8	SENT_65	[p4l1275t1230r1594b1292],
8	explain	VBP	O	explain	_	0	SENT_65	[p4l12t1312r245b1387],
9	about	IN	O	about	_	0	SENT_65	[p4l272t1313r454b1371],
10	30	CD	NUMBER	30	number	12	SENT_65	[p4l478t1317r551b1371],
11	to	TO	O	to	dep	12	SENT_65	[p4l579t1325r640b1371],
12	40	CD	PERCENT	40	num	13	SENT_65	[p4l667t1317r809b1371],
13	%	NN	PERCENT	%	prep_about	8	SENT_65	[p4l667t1317r809b1371],
14	of	IN	O	of	_	0	SENT_65	[p4l836t1312r911b1371],
15	the	DT	O	the	det	17	SENT_65	[p4l925t1313r1023b1371],
16	total	JJ	O	total	amod	17	SENT_65	[p4l1051t1313r1198b1371],
17	variation	NN	O	variation	prep_of	13	SENT_65	[p4l1221t1313r1507b1371],
18	in	IN	O	in	_	0	SENT_65	[p4l1533t1313r1596b1370],
19	the	DT	O	the	det	22	SENT_65	[p4l12t1409r108b1467],
20	final	JJ	O	final	amod	22	SENT_65	[p4l131t1408r278b1467],
21	Warfarin	NNP	O	Warfarin	nn	22	SENT_65	[p4l297t1408r569b1468],
22	dose	NN	O	dose	prep_in	17	SENT_65	[p4l591t1408r806b1467],
23	.21	CD	NUMBER	.21	dobj	8	SENT_65	[p4l591t1408r806b1467],
24	These	DT	O	these	det	25	SENT_65	[p4l826t1409r1009b1467],
25	observations	NNS	O	observation	nsubj	26	SENT_65	[p4l1033t1408r1425b1468],
26	raise	VBP	O	raise	rcmod	23	SENT_65	[p4l1449t1409r1595b1467],
27	the	DT	O	the	det	28	SENT_65	[p4l12t1504r110b1562],
28	possibility	NN	O	possibility	dobj	26	SENT_65	[p4l134t1504r470b1578],
29	that	IN	O	that	complm	39	SENT_65	[p4l491t1504r620b1562],
30	testing	NN	O	testing	nn	31	SENT_65	[p4l642t1504r864b1578],
31	patients	NNS	O	patient	nsubj	39	SENT_65	[p4l885t1504r1140b1578],
32	for	IN	O	for	_	0	SENT_65	[p4l1166t1503r1258b1562],
33	variations	NNS	O	variation	prep_for	31	SENT_65	[p4l1277t1504r1594b1562],
34	in	IN	O	in	_	0	SENT_65	[p4l11t1599r72b1656],
35	CYPZC9	NN	O	cypzc9	prep_in	33	SENT_65	[p4l97t1603r314b1657],
36	and	CC	O	and	_	0	SENT_65	[p4l338t1599r455b1657],
37	VKORC1	NN	O	vkorc1	conj_and	35	SENT_65	[p4l480t1603r716b1658],
38	might	MD	O	might	aux	39	SENT_65	[p4l744t1599r935b1673],
39	provide	VB	O	provide	ccomp	26	SENT_65	[p4l955t1599r1188b1673],
40	information	NN	O	information	dobj	39	SENT_65	[p4l1213t1598r1596b1657],
41	that	WDT	O	that	nsubj	43	SENT_65	[p4l12t1694r140b1752],
42	could	MD	O	could	aux	43	SENT_65	[p4l165t1694r340b1752],
43	enhance	VB	O	enhance	rcmod	40	SENT_65	[p4l369t1694r635b1752],
44	clinical	JJ	O	clinical	amod	45	SENT_65	[p4l665t1694r898b1752],
45	algorithms	NNS	O	algorithm	dobj	43	SENT_65	[p4l926t1694r1278b1768],
46	currently	RB	DATE	currently	advmod	47	SENT_65	[p4l1308t1694r1599b1768],
47	used	VBN	O	use	partmod	45	SENT_65	[p4l11t1789r158b1847],
48	to	TO	O	to	aux	49	SENT_65	[p4l184t1801r245b1847],
49	guide	VB	O	guide	xcomp	47	SENT_65	[p4l272t1789r449b1863],
50	the	DT	O	the	det	51	SENT_65	[p4l476t1789r575b1847],
51	administration	NN	O	administration	dobj	49	SENT_65	[p4l600t1788r1082b1847],
52	of	IN	O	of	_	0	SENT_65	[p4l1109t1788r1183b1847],
53	Warfarin	NNP	O	Warfarin	prep_of	51	SENT_65	[p4l1192t1788r1489b1847],
54	.	.	O	.	_	0	SENT_65	[p4l1192t1788r1489b1847],

1	To	TO	O	to	aux	2	SENT_66	[p4l1516t1793r1594b1847],
2	examine	VB	O	examine	purpcl	34	SENT_66	[p4l12t1884r283b1942],
3	the	DT	O	the	det	6	SENT_66	[p4l320t1884r419b1942],
4	potential	JJ	O	potential	amod	6	SENT_66	[p4l455t1883r745b1958],
5	clinical	JJ	O	clinical	amod	6	SENT_66	[p4l781t1884r1016b1942],
6	utility	NN	O	utility	dobj	2	SENT_66	[p4l1052t1884r1244b1958],
7	of	IN	O	of	_	0	SENT_66	[p4l1278t1883r1353b1942],
8	testing	NN	O	testing	conj_in	8	SENT_66	[p4l1376t1884r1598b1958],
9	for	IN	O	for	_	0	SENT_66	[p4l11t1978r103b2037],
10	CYPZC9	NN	O	cypzc9	nn	13	SENT_66	[p4l126t1983r347b2037],
11	and	CC	O	and	_	0	SENT_66	[p4l371t1978r489b2037],
12	VKORC1	NN	O	vkorc1	conj_and	10	SENT_66	[p4l514t1983r754b2038],
13	genotypes	NNS	O	genotype	prep_for	8	SENT_66	[p4l782t1990r1126b2053],
14	,	,	O	,	_	0	SENT_66	[p4l782t1990r1126b2053],
15	in	IN	O	in	_	0	SENT_66	[p4l1155t1979r1217b2036],
16	addition	NN	O	addition	_	0	SENT_66	[p4l1242t1978r1509b2037],
17	to	TO	O	to	_	0	SENT_66	[p4l1534t1991r1595b2037],
18	IN	IN	O	in	_	0	SENT_66	[p4l10t2079r92b2132],
19	R	NN	O	r	nn	20	SENT_66	[p4l94t2078r149b2136],
20	monitoring	NN	O	monitoring	prep_in	8	SENT_66	[p4l166t2074r535b2148],
21	and	CC	O	and	_	0	SENT_66	[p4l557t2074r675b2132],
22	routine	JJ	O	routine	amod	23	SENT_66	[p4l700t2074r932b2132],
23	use	NN	O	use	conj_and	8	SENT_66	[p4l957t2093r1062b2132],
24	of	IN	O	of	_	0	SENT_66	[p4l1088t2073r1163b2132],
25	clinical	JJ	O	clinical	amod	26	SENT_66	[p4l1175t2074r1409b2132],
26	algorithms	NNS	O	algorithm	prep_of	23	SENT_66	[p4l1433t2074r1595b2148, p4l11t2169r242b2239],
27	,	,	O	,	_	0	SENT_66	[p4l1433t2074r1595b2148, p4l11t2169r242b2239],
28	the	DT	O	the	det	32	SENT_66	[p4l276t2169r375b2227],
29	International	NNP	ORGANIZATION	International	nn	32	SENT_66	[p4l403t2169r827b2227],
30	Warfarin	NNP	ORGANIZATION	Warfarin	nn	32	SENT_66	[p4l853t2168r1143b2227],
31	Pharmacogenetics	NNP	ORGANIZATION	Pharmacogenetics	nn	32	SENT_66	[p4l1170t2169r1595b2243, p4l11t2264r197b2322],
32	Consortium	NNP	ORGANIZATION	Consortium	nsubj	34	SENT_66	[p4l225t2264r610b2322],
33	recently	RB	DATE	recently	advmod	34	SENT_66	[p4l636t2263r890b2338],
34	investigated	VBD	O	investigate	_	0	SENT_66	[p4l912t2263r1297b2338],
35	the	DT	O	the	det	37	SENT_66	[p4l1323t2263r1422b2322],
36	anticoagulant	JJ	O	anticoagulant	amod	37	SENT_66	[p4l1448t2264r1595b2322, p4l12t2358r326b2433],
37	response	NN	O	response	dobj	34	SENT_66	[p4l347t2377r625b2433],
38	to	TO	O	to	_	0	SENT_66	[p4l650t2371r710b2417],
39	Warfarin	NNP	MISC	Warfarin	prep_to	34	SENT_66	[p4l732t2358r1022b2429],
40	,	,	O	,	_	0	SENT_66	[p4l732t2358r1022b2429],
41	as	IN	O	as	mark	42	SENT_66	[p4l1050t2378r1114b2417],
42	Well	UH	O	well	dep	39	SENT_66	[p4l1136t2358r1266b2417],
43	as	IN	O	as	_	0	SENT_66	[p4l1290t2378r1353b2417],
44	CYPZC9	NN	O	cypzc9	nn	48	SENT_66	[p4l1379t2363r1596b2417],
45	and	CC	O	and	_	0	SENT_66	[p4l11t2454r128b2512],
46	VKORC1	NN	O	vkorc1	nn	48	SENT_66	[p4l159t2458r400b2513],
47	genotype	NN	O	genotype	nn	48	SENT_66	[p4l434t2466r728b2528],
48	data	NNS	O	datum	prep_as	34	SENT_66	[p4l761t2453r914b2524],
49	,	,	O	,	_	0	SENT_66	[p4l761t2453r914b2524],
50	for	IN	O	for	dep	34	SENT_66	[p4l950t2453r1042b2512],
51	about	IN	O	about	_	0	SENT_66	[p4l1070t2454r1253b2512],
52	4000	CD	NUMBER	4000	num	53	SENT_66	[p4l1279t2458r1438b2512],
53	persons	NNS	O	person	prep_about	34	SENT_66	[p4l1469t2473r1595b2528, p4l12t2567r151b2607],
54	of	IN	O	of	_	0	SENT_66	[p4l175t2548r248b2607],
55	various	JJ	O	various	amod	57	SENT_66	[p4l253t2549r477b2607],
56	ancestral	JJ	O	ancestral	amod	57	SENT_66	[p4l500t2549r782b2607],
57	origins	NNS	O	origin	prep_of	53	SENT_66	[p4l804t2549r1038b2623],
58	.	.	O	.	_	0	SENT_66	[p4l804t2549r1038b2623],

1	The	DT	O	the	det	2	SENT_67	[p4l1062t2549r1179b2607],
2	investigators	NNS	O	investigator	nsubj	3	SENT_67	[p4l1200t2549r1594b2623],
3	compared	VBN	O	compare	_	0	SENT_67	[p4l12t2643r324b2718],
4	therapeutic	JJ	O	therapeutic	amod	5	SENT_67	[p4l351t2644r705b2718],
5	outcomes	NNS	O	outcome	dobj	3	SENT_67	[p4l731t2656r1032b2702],
6	with	IN	O	with	_	0	SENT_67	[p4l1057t2644r1200b2702],
7	the	DT	O	the	det	8	SENT_67	[p4l1226t2644r1324b2702],
8	application	NN	O	application	prep_with	3	SENT_67	[p4l1350t2643r1595b2718, p4l11t2739r135b2797],
9	of	IN	O	of	_	0	SENT_67	[p4l162t2738r236b2797],
10	standard	JJ	O	standard	amod	12	SENT_67	[p4l249t2738r526b2797],
11	clinical	JJ	O	clinical	amod	12	SENT_67	[p4l553t2739r782b2797],
12	algorithms	NNS	O	algorithm	prep_of	8	SENT_67	[p4l807t2738r1151b2813],
13	that	WDT	O	that	nsubj	14	SENT_67	[p4l1179t2739r1306b2797],
14	included	VBD	O	include	rcmod	12	SENT_67	[p4l1327t2738r1596b2797],
15	age	NN	O	age	dobj	14	SENT_67	[p4l11t2853r135b2908],
16	,	,	O	,	_	0	SENT_67	[p4l11t2853r135b2908],
17	sex	NN	O	sex	appos	15	SENT_67	[p4l168t2853r285b2904],
18	,	,	O	,	_	0	SENT_67	[p4l168t2853r285b2904],
19	and	CC	O	and	_	0	SENT_67	[p4l316t2833r434b2892],
20	IN	IN	O	in	dep	21	SENT_67	[p4l461t2839r543b2892],
21	R	NN	O	r	amod	22	SENT_67	[p4l546t2838r600b2896],
22	values	NNS	O	value	conj_and	15	SENT_67	[p4l617t2834r813b2892],
23	and	CC	O	and	_	0	SENT_67	[p4l842t2833r960b2892],
24	outcomes	NNS	O	outcome	conj_and	15	SENT_67	[p4l989t2846r1296b2892],
25	with	IN	O	with	_	0	SENT_67	[p4l1322t2834r1468b2893],
26	the	DT	O	the	det	27	SENT_67	[p4l1496t2834r1595b2892],
27	use	NN	O	use	prep_with	15	SENT_67	[p4l11t2948r116b2987],
28	of	IN	O	of	_	0	SENT_67	[p4l157t2928r232b2987],
29	an	DT	O	a	det	30	SENT_67	[p4l259t2948r336b2987],
30	algorithm	NN	O	algorithm	prep_of	27	SENT_67	[p4l376t2929r697b3003],
31	that	WDT	O	that	nsubj	32	SENT_67	[p4l738t2929r866b2987],
32	included	VBD	O	include	rcmod	15	SENT_67	[p4l903t2928r1177b2987],
33	CYPZC9	NN	O	cypzc9	nn	37	SENT_67	[p4l1217t2933r1438b2987],
34	and	CC	O	and	_	0	SENT_67	[p4l1478t2929r1596b2987],
35	VKORC1	NN	O	vkorc1	conj_and	33	SENT_67	[p4l11t3028r247b3083],
36	genotype	NN	O	genotype	nn	37	SENT_67	[p4l273t3036r561b3098],
37	information	NN	O	information	dobj	32	SENT_67	[p4l585t3023r967b3082],
38	and	CC	O	and	_	0	SENT_67	[p4l990t3023r1107b3082],
39	concluded	VBD	O	conclude	conj_and	32	SENT_67	[p4l1131t3023r1449b3082],
40	that	IN	O	that	complm	46	SENT_67	[p4l1473t3024r1600b3082],
41	the	DT	O	the	det	42	SENT_67	[p4l11t3119r110b3177],
42	addition	NN	O	addition	nsubj	46	SENT_67	[p4l143t3118r409b3177],
43	of	IN	O	of	_	0	SENT_67	[p4l443t3118r518b3177],
44	genotype	NN	O	genotype	nn	45	SENT_67	[p4l536t3131r830b3193],
45	information	NN	O	information	prep_of	42	SENT_67	[p4l863t3118r1254b3177],
46	enhanced	VBD	O	enhance	ccomp	39	SENT_67	[p4l1287t3119r1596b3177],
47	outcomes	NNS	O	outcome	dobj	46	SENT_67	[p4l12t3226r337b3284],
48	,	,	O	,	_	0	SENT_67	[p4l12t3226r337b3284],
49	especially	RB	O	especially	advmod	46	SENT_67	[p4l381t3214r694b3288],
50	for	IN	O	for	_	0	SENT_67	[p4l729t3213r821b3272],
51	patients	NNS	O	patient	prep_for	46	SENT_67	[p4l857t3214r1112b3288],
52	who	WP	O	who	nsubj	53	SENT_67	[p4l1149t3214r1286b3273],
53	required	VBD	O	require	rcmod	51	SENT_67	[p4l1326t3214r1596b3288],
54	unusually	RB	O	unusually	advmod	55	SENT_67	[p4l11t3309r324b3383],
55	high	JJ	O	high	amod	59	SENT_67	[p4l355t3309r501b3383],
56	or	CC	O	or	_	0	SENT_67	[p4l535t3327r601b3367],
57	low	JJ	O	low	conj_or	55	SENT_67	[p4l632t3309r749b3367],
58	warfarin	NN	O	warfarin	nn	59	SENT_67	[p4l776t3308r1056b3368],
59	doses	NNS	O	dose	dobj	53	SENT_67	[p4l1090t3308r1346b3367],
60	.	.	O	.	_	0	SENT_67	[p4l1090t3308r1346b3367],

1	”	NN	O	”	nn	2	SENT_68	[p4l1090t3308r1346b3367],
2	CYP4F2	NN	O	cyp4f2	nsubjpass	12	SENT_68	[p4l1381t3313r1595b3366],
3	was	VBD	O	be	auxpass	5	SENT_68	[p4l8t3423r129b3462],
4	not	RB	O	not	neg	5	SENT_68	[p4l159t3416r265b3462],
5	included	VBN	O	include	dep	16	SENT_68	[p4l289t3403r563b3462],
6	in	IN	O	in	_	0	SENT_68	[p4l591t3404r653b3461],
7	this	DT	O	this	det	8	SENT_68	[p4l681t3404r801b3462],
8	algorithm	NN	O	algorithm	prep_in	5	SENT_68	[p4l830t3403r1151b3478],
9	but	CC	O	but	_	0	SENT_68	[p4l1179t3404r1283b3462],
10	has	VBZ	O	have	aux	12	SENT_68	[p4l1308t3404r1415b3462],
11	been	VBN	O	be	auxpass	12	SENT_68	[p4l1446t3404r1596b3462],
12	included	VBN	O	include	dep	16	SENT_68	[p4l11t3499r284b3557],
13	in	IN	O	in	_	0	SENT_68	[p4l323t3499r385b3556],
14	several	JJ	O	several	amod	15	SENT_68	[p4l425t3498r643b3558],
15	algorithms	NNS	O	algorithm	prep_in	12	SENT_68	[p4l681t3499r1033b3573],
16	developed	VBD	O	develop	_	0	SENT_68	[p4l1074t3498r1393b3573],
17	more	RBR	O	more	advmod	18	SENT_68	[p4l1431t3517r1595b3557],
18	recently	RB	DATE	recently	advmod	16	SENT_68	[p4l11t3594r408b3668],
19	.23	CD	NUMBER	.23	num	20	SENT_68	[p4l11t3594r408b3668],
20	v24	NN	O	v24	dobj	16	SENT_68	[p4l11t3594r408b3668],
21	Consistent	JJ	O	consistent	nsubj	27	SENT_68	[p4l437t3594r780b3652],
22	With	IN	O	with	_	0	SENT_68	[p4l801t3593r947b3653],
23	this	DT	O	this	det	24	SENT_68	[p4l977t3594r1096b3652],
24	conclusion	NN	O	conclusion	prep_with	21	SENT_68	[p4l1127t3593r1471b3652],
25	are	VBP	O	be	cop	27	SENT_68	[p4l1499t3613r1595b3652],
26	the	DT	O	the	det	27	SENT_68	[p4l11t3689r110b3747],
27	results	NNS	O	result	rcmod	20	SENT_68	[p4l142t3688r353b3747],
28	of	IN	O	of	_	0	SENT_68	[p4l387t3688r462b3747],
29	a	DT	O	a	det	30	SENT_68	[p4l479t3708r512b3747],
30	study	NN	O	study	prep_of	27	SENT_68	[p4l544t3688r715b3763],
31	comparing	VBG	O	compare	partmod	30	SENT_68	[p4l745t3689r1095b3763],
32	nearly	RB	O	nearly	advmod	31	SENT_68	[p4l1124t3689r1321b3763],
33	900	CD	NUMBER	900	num	34	SENT_68	[p4l1349t3693r1465b3747],
34	paN	NN	O	pan	nsubj	16	SENT_68	[p4l1497t3708r1595b3763, p5l558t56r572b71],

1	ENGLJ	NNP	MISC	ENGLJ	nn	2	SENT_69	[p5l587t56r665b78],
2	MED	NNP	MISC	MED	_	0	SENT_69	[p5l679t56r731b71],
3	364	CD	NUMBER	364	num	2	SENT_69	[p5l741t50r821b78],
4	;	:	O	;	_	0	SENT_69	[p5l741t50r821b78],
5	12	CD	NUMBER	12	num	7	SENT_69	[p5l741t50r821b78],
6	NEJM.oRG	NN	O	nejm.org	nn	7	SENT_69	[p5l856t56r980b78],
7	MARCH	NN	DATE	march	dep	2	SENT_69	[p5l1017t56r1102b71],
8	24	CD	DATE	24	dep	7	SENT_69	[p5l1115t56r1150b78],
9	,	,	DATE	,	_	0	SENT_69	[p5l1115t56r1150b78],
10	2011	CD	DATE	2011	num	11	SENT_69	[p5l1162t56r1213b72],
11	1145	CD	DATE	1145	appos	8	SENT_69	[p5l1940t46r2015b69],

1	The	DT	O	the	det	4	SENT_70	[p5l702t89r753b113],
2	New	NNP	O	New	nn	4	SENT_70	[p5l762t90r824b113],
3	England	NNP	O	England	nn	4	SENT_70	[p5l833t89r944b120],
4	Journal	NNP	O	Journal	_	0	SENT_70	[p5l953t89r1050b113],
5	of	IN	O	of	_	0	SENT_70	[p5l1060t89r1089b113],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_70	[p5l1095t89r1220b113],

1	Downloaded	VBN	O	download	_	0	SENT_71	[p5l144t130r314b153],
2	from	IN	O	from	_	0	SENT_71	[p5l323t130r387b153],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_71	[p5l396t130r514b160],
4	at	IN	O	at	_	0	SENT_71	[p5l524t134r547b153],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_71	[p5l556t130r739b153],
6	on	IN	O	on	_	0	SENT_71	[p5l748t137r780b153],
7	January	NNP	DATE	January	prep_on	1	SENT_71	[p5l789t130r892b160],
8	5	CD	DATE	5	num	7	SENT_71	[p5l902t130r924b158],
9	,	,	DATE	,	_	0	SENT_71	[p5l902t130r924b158],
10	2014	CD	DATE	2014	num	7	SENT_71	[p5l935t130r1007b153],
11	.	.	O	.	_	0	SENT_71	[p5l935t130r1007b153],

1	For	IN	O	for	_	0	SENT_72	[p5l1018t130r1064b153],
2	personal	JJ	O	personal	amod	3	SENT_72	[p5l1072t130r1185b160],
3	use	NN	O	use	pobj	1	SENT_72	[p5l1194t137r1237b153],
4	only	RB	O	only	advmod	3	SENT_72	[p5l1247t130r1312b160],
5	.	.	O	.	_	0	SENT_72	[p5l1247t130r1312b160],

1	No	DT	O	no	det	3	SENT_73	[p5l1323t130r1362b153],
2	other	JJ	O	other	amod	3	SENT_73	[p5l1372t130r1440b153],
3	uses	NNS	O	use	_	0	SENT_73	[p5l1449t137r1505b153],
4	without	IN	O	without	_	0	SENT_73	[p5l1515t130r1616b153],
5	permission	NN	O	permission	prep_without	3	SENT_73	[p5l1624t130r1777b160],
6	.	.	O	.	_	0	SENT_73	[p5l1624t130r1777b160],

1	Copyright	NN	O	copyright	_	0	SENT_74	[p5l494t171r629b202],
2	©	CD	NUMBER	©	num	6	SENT_74	[p5l638t171r661b195],
3	2011	CD	DATE	2011	num	6	SENT_74	[p5l672t171r734b195],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_74	[p5l746t171r937b195],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_74	[p5l947t171r1055b195],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_74	[p5l1065t171r1170b202],
7	.	.	O	.	_	0	SENT_74	[p5l1065t171r1170b202],

1	All	DT	O	all	det	2	SENT_75	[p5l1181t171r1223b195],
2	rights	NNS	O	rights	nsubj	3	SENT_75	[p5l1232t171r1307b202],
3	reserved	VBN	O	reserve	_	0	SENT_75	[p5l1316t171r1435b195],
4	.	.	O	.	_	0	SENT_75	[p5l1316t171r1435b195],

1	The	DT	O	the	det	4	SENT_76	[p5l673t213r718b234],
2	NEW	NNP	O	NEW	nn	4	SENT_76	[p5l737t215r822b234],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_76	[p5l841t215r1029b234],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_76	[p5l1048t215r1228b241],
5	of	IN	O	of	_	0	SENT_76	[p5l1247t213r1276b240],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_76	[p5l1288t215r1487b234],

1	A	DT	O	a	det	2	SENT_77	[p5l260t350r282b375],
2	Association	NNP	O	Association	_	0	SENT_77	[p5l304t353r452b376],
3	with	IN	O	with	_	0	SENT_77	[p5l461t352r516b376],
4	CYPZC9	NN	O	cypzc9	prep_with	2	SENT_77	[p5l526t354r629b376],
5	and	CC	O	and	_	0	SENT_77	[p5l638t352r683b376],
6	VKORC1	NN	O	vkorc1	prep_with	2	SENT_77	[p5l695t354r803b376],

1	CYPZC9	NN	O	cypzc9	nn	2	SENT_78	[p5l1202t399r1305b420],
2	VKORC1	NN	O	vkorc1	_	0	SENT_78	[p5l1517t399r1624b420],

1	:	:	O	:	_	0	SENT_79	[p5l1249t482r1257b495],
2	=	JJ	O	=	_	0	SENT_79	[p5l1265t475r1314b495],
3	'	''	O	'	_	0	SENT_79	[p5l1265t475r1314b495],
4	~	NN	O	~	npadvmod	7	SENT_79	[p5l1265t475r1314b495],
5	'	''	O	'	_	0	SENT_79	[p5l1265t475r1314b495],
6	2	CD	NUMBER	2	amod	4	SENT_79	[p5l1265t475r1314b495],
7	=	JJ	O	=	prep	2	SENT_79	[p5l1265t475r1314b495],
8	‘	NN	O	‘	dep	7	SENT_79	[p5l1265t475r1314b495],
9	=	JJ	O	=	amod	2	SENT_79	[p5l1265t475r1314b495],
10	3	CD	NUMBER	3	num	13	SENT_79	[p5l1265t475r1314b495],
11	composite	JJ	O	composite	amod	13	SENT_79	[p5l1324t474r1450b501],
12	p	NN	O	p	nn	13	SENT_79	[p5l1069t744r1152b782],
13	X	NN	O	x	dep	2	SENT_79	[p5l1069t744r1152b782],
14	+	CC	O	+	_	0	SENT_79	[p5l1069t744r1152b782],
15	10	CD	NUMBER	10	num	16	SENT_79	[p5l1191t762r1217b782],
16	QY	NN	O	qy	conj_+	2	SENT_79	[p5l1247t744r1283b782],
17	+	CC	O	+	_	0	SENT_79	[p5l1247t744r1283b782],
18	͈	NN	O	͈	conj_+	2	SENT_79	[p5l1322t744r1384b782],
19	+	CC	O	+	_	0	SENT_79	[p5l1322t744r1384b782],
20	13	CD	NUMBER	13	num	22	SENT_79	[p5l1397t743r1421b782],
21	P	NN	O	p	nn	22	SENT_79	[p5l1450t743r1526b782],
22	Y	NN	O	y	conj_+	18	SENT_79	[p5l1450t743r1526b782],
23	+	CC	O	+	_	0	SENT_79	[p5l1450t743r1526b782],
24	16Wl7	NN	O	16wl7	conj_+	16	SENT_79	[p5l1541t744r1613b782],
25	18	CD	NUMBER	18	num	26	SENT_79	[p5l1622t762r1647b782],
26	19	CD	NUMBER	19	rcmod	24	SENT_79	[p5l1661t744r1686b782],
27	'	''	O	'	_	0	SENT_79	[p5l1727t744r1790b782],
28	2l	NN	O	2l	dep	26	SENT_79	[p5l1727t744r1790b782],
29	'	''	O	'	_	0	SENT_79	[p5l1727t744r1790b782],
30	X	NN	O	x	dep	26	SENT_79	[p5l1727t744r1790b782],
31	20	CD	NUMBER	20	num	32	SENT_79	[p5l1688t789r1715b810],
32	22	CD	NUMBER	22	dep	2	SENT_79	[p5l1757t790r1784b809],

1	Chromosome	NN	O	chromosome	_	0	SENT_80	[p5l1054t811r1229b834],

1	C	NN	O	c	nn	2	SENT_81	[p5l1711t941r1730b963],
2	YP4F2	NN	O	yp4f2	_	0	SENT_81	[p5l1731t942r1810b963],

1	9	CD	NUMBER	9	number	2	SENT_82	[p5l1128t1179r1141b1199],
2	10	CD	NUMBER	10	_	0	SENT_82	[p5l1188t1178r1214b1199],
3	11	CD	NUMBER	11	num	4	SENT_82	[p5l1258t1179r1282b1199],
4	12	CD	NUMBER	12	dep	2	SENT_82	[p5l1320t1179r1345b1199],
5	13	CD	NUMBER	13	number	6	SENT_82	[p5l1393t1179r1417b1199],
6	14 15 16171819	CD	NUMBER	14 15 16171819	num	8	SENT_82	[p5l1544t1178r1684b1199],[p5l1448t1179r1474b1199],
7	21	CD	NUMBER	21	num	8	SENT_82	[p5l1722t1179r1748b1199],
8	X	NN	O	x	dep	2	SENT_82	[p5l1767t1179r1782b1199],
9	20	CD	NUMBER	20	number	10	SENT_82	[p5l1683t1206r1710b1226],
10	22	CD	NUMBER	22	amod	8	SENT_82	[p5l1740t1206r1767b1226],

1	Chromosome	NN	O	chromosome	_	0	SENT_83	[p5l1054t1227r1229b1251],

1	C	NN	O	c	nn	2	SENT_84	[p5l259t1312r280b1338],
2	Warfarin	NN	O	warfarin	_	0	SENT_84	[p5l302t1314r412b1338],
3	and	CC	O	and	_	0	SENT_84	[p5l422t1314r468b1338],
4	the	DT	O	the	det	7	SENT_84	[p5l478t1314r519b1338],
5	Vitamin	NN	O	vitamin	nn	7	SENT_84	[p5l527t1315r626b1338],
6	K	NN	O	k	nn	7	SENT_84	[p5l638t1317r654b1338],
7	Cycle	NN	O	cycle	conj_and	2	SENT_84	[p5l662t1314r730b1345],

1	Vitamin	NN	O	vitamin	nn	2	SENT_85	[p5l1138t1387r1238b1410],
2	K	NN	O	k	_	0	SENT_85	[p5l1250t1389r1265b1410],

1	70H	NN	O	70h	_	0	SENT_86	[p5l360t1449r422b1470],
2	f	SYM	O	f	dep	1	SENT_86	[p5l477t1447r488b1469],
3	_	CD	NUMBER	_	num	4	SENT_86	[p5l510t1450r513b1453],
4	CYPZC9	NN	O	cypzc9	rcmod	2	SENT_86	[p5l583t1427r685b1448],
5	W	NN	O	w	prep	4	SENT_86	[p5l730t1450r755b1470],
6	f	FW	O	f	nn	7	SENT_86	[p5l780t1447r791b1469],
7	_	FW	O	_	dep	5	SENT_86	[p5l813t1450r816b1453],
8	dihydroquinone	NN	O	dihydroquinone	nn	10	SENT_86	[p5l1100t1422r1303b1453],
9	Clotting	NN	O	clotting	nn	10	SENT_86	[p5l1647t1426r1742b1455],
10	protein	NN	O	protein	dep	4	SENT_86	[p5l1751t1428r1834b1455],
11	-	:	O	-	_	0	SENT_86	[p5l373t1461r379b1464],
12	-	:	O	-	_	0	SENT_86	[p5l426t1455r476b1470],
13	war	NN	O	war	nn	14	SENT_86	[p5l426t1455r476b1470],
14	arm	NN	O	arm	dep	2	SENT_86	[p5l486t1455r529b1470],
15	«	CD	NUMBER	«	num	18	SENT_86	[p5l545t1455r705b1466],
16	T	NN	O	t	nn	18	SENT_86	[p5l545t1455r705b1466],
17	ar	NN	O	ar	nn	18	SENT_86	[p5l757t1455r779b1470],
18	arm	NN	O	arm	dep	14	SENT_86	[p5l789t1455r832b1470],

1	VKORC1	NN	O	vkorc1	nn	3	SENT_87	[p5l890t1463r1000b1485],
2	C	NN	O	c	nn	3	SENT_87	[p5l1647t1473r1663b1493],
3	b	NN	O	b	_	0	SENT_87	[p5l1689t1471r1701b1493],
4	d	SYM	O	d	dep	3	SENT_87	[p5l1742t1471r1762b1493],
5	-	:	O	-	_	0	SENT_87	[p5l1742t1471r1762b1493],
6	~	NN	O	~	nn	7	SENT_87	[p5l1793t1471r1812b1493],
7	d	NN	O	d	dep	3	SENT_87	[p5l1793t1471r1812b1493],
8	and	CC	O	and	_	0	SENT_87	[p5l891t1496r933b1518],
9	quinone	NN	O	quinone	nn	10	SENT_87	[p5l944t1498r1041b1525],
10	reductase	NN	O	reductase	dep	3	SENT_87	[p5l1051t1496r1166b1518],
11	all	DT	O	all	dep	7	SENT_87	[p5l1665t1479r1687b1493],
12	on	IN	O	on	_	0	SENT_87	[p5l1704t1479r1732b1493],
13	loxl	NN	O	loxl	prep_on	11	SENT_87	[p5l1759t1479r1796b1493],
14	e	SYM	O	e	dep	11	SENT_87	[p5l1815t1479r1827b1493],

1	_	RB	O	_	dep	3	SENT_88	[p5l785t1549r789b1554],
2	_	CD	NUMBER	_	num	3	SENT_88	[p5l843t1549r848b1554],
3	Vitamin	NN	O	vitamin	dep	4	SENT_88	[p5l1418t1528r1511b1548],
4	KHydroxy	NN	O	khydroxy	_	0	SENT_88	[p5l1523t1528r1552b1548, p5l417t1548r531b1579],
5	-	:	O	-	_	0	SENT_88	[p5l1523t1528r1552b1548, p5l417t1548r531b1579],
6	CYP4F2	NN	O	cyp4f2	nn	8	SENT_88	[p5l608t1546r707b1568],
7	Vitamin	NN	O	vitamin	nn	8	SENT_88	[p5l765t1550r864b1572],
8	K	NN	O	k	dep	14	SENT_88	[p5l876t1550r892b1571],
9	dependent	JJ	O	dependent	amod	10	SENT_88	[p5l1421t1559r1549b1588],
10	vitamin	NN	O	vitamin	dep	8	SENT_88	[p5l411t1584r507b1607],
11	K	NN	O	k	nn	12	SENT_88	[p5l519t1586r534b1607],
12	quinone	NN	O	quinone	dep	14	SENT_88	[p5l776t1584r881b1614],
13	Carboxyiation	NN	O	carboxyiation	nn	14	SENT_88	[p5l1406t1593r1562b1622],
14	y_CarboXy	NN	O	y_carboxy	dep	20	SENT_88	[p5l1664t1600r1790b1629],
15	_	CD	NUMBER	_	num	16	SENT_88	[p5l1664t1600r1790b1629],
16	Y	NN	O	y	dep	14	SENT_88	[p5l840t1635r1056b1728],
17	gllutamyl	NN	O	gllutamyl	nn	20	SENT_88	[p5l1676t1633r1776b1688],
18	VKORC1	NN	O	vkorc1	nn	20	SENT_88	[p5l923t1676r1034b1697],
19	C	NN	O	c	nn	20	SENT_88	[p5l1682t1674r1693b1689],
20	otting	NN	O	otting	dep	4	SENT_88	[p5l1702t1669r1772b1696],

1	CYPZC9	NN	O	cypzc9	_	0	SENT_89	[p5l638t1691r740b1712],
2	. . .	CD	NUMBER	. . .	num	1	SENT_89	[p5l1282t1706r1287b1712],[p5l1104t1706r1108b1712],

1	7-OH-warfarin	JJ	O	7-oh-warfarin	amod	6	SENT_90	[p5l415t1711r584b1734],
2	«	NN	O	«	nn	6	SENT_90	[p5l600t1718r760b1730],
3	T	NN	O	t	nn	6	SENT_90	[p5l600t1718r760b1730],
4	Warfarin	NNP	O	Warfarin	nn	6	SENT_90	[p5l785t1711r887b1734],
5	Vltamm	NNP	PERSON	Vltamm	nn	6	SENT_90	[p5l1084t1708r1183b1730],
6	Kepoxlde	NNP	PERSON	Kepoxlde	_	0	SENT_90	[p5l1195t1706r1319b1736],
7	f	FW	O	f	nn	8	SENT_90	[p5l1686t1700r1766b1722],
8	‘	FW	O	‘	amod	6	SENT_90	[p5l1686t1700r1766b1722],
9	=	JJ	O	=	amod	13	SENT_90	[p5l1686t1700r1766b1722],
10	‘	NN	O	‘	nn	13	SENT_90	[p5l1686t1700r1766b1722],
11	C	NN	O	c	nn	13	SENT_90	[p5l1686t1700r1766b1722],
12	"	''	O	"	punct	13	SENT_90	[p5l1686t1700r1766b1722],
13	°	NN	O	°	dep	6	SENT_90	[p5l1686t1700r1766b1722],
14	'	''	O	'	_	0	SENT_90	[p5l1686t1700r1766b1722],
15	5	CD	NUMBER	5	dep	13	SENT_90	[p5l1686t1700r1766b1722],

1	Figure	NNP	O	Figure	_	0	SENT_91	[p5l266t1846r350b1878],
2	1	CD	NUMBER	1	dep	1	SENT_91	[p5l362t1848r384b1870],
3	.	.	O	.	_	0	SENT_91	[p5l362t1848r384b1870],

1	Warfarin	NNP	O	Warfarin	nn	2	SENT_92	[p5l394t1845r513b1871],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	_	0	SENT_92	[p5l527t1845r808b1878],
3	.	.	O	.	_	0	SENT_92	[p5l527t1845r808b1878],

1	Panels	NNS	O	panel	nsubj	5	SENT_93	[p5l266t1895r353b1921],
2	A	DT	O	a	dep	1	SENT_93	[p5l364t1897r384b1920],
3	and	CC	O	and	_	0	SENT_93	[p5l395t1895r443b1921],
4	B	NN	O	b	conj_and	2	SENT_93	[p5l458t1898r473b1920],
5	show	VBP	O	show	dep	11	SENT_93	[p5l486t1895r557b1921],
6	Manhattan	NNP	LOCATION	Manhattan	nn	7	SENT_93	[p5l570t1895r718b1921],
7	plots	NNS	O	plot	dobj	5	SENT_93	[p5l733t1895r799b1928],
8	of	IN	O	of	_	0	SENT_93	[p5l811t1895r841b1921],
9	P	NN	O	p	nn	10	SENT_93	[p5l850t1898r864b1920],
10	values	NNS	O	value	prep_of	7	SENT_93	[p5l875t1895r961b1921],
11	(	VBP	O	(	_	0	SENT_93	[p5l976t1898r1100b1929],
12	negative	JJ	O	negative	amod	14	SENT_93	[p5l976t1898r1100b1929],
13	logm	NN	O	logm	nn	14	SENT_93	[p5l1115t1895r1190b1929],
14	)	NN	O	)	dobj	11	SENT_93	[p5l1115t1895r1190b1929],
15	for	IN	O	for	_	0	SENT_93	[p5l1203t1895r1242b1921],
16	the	DT	O	the	det	17	SENT_93	[p5l1251t1895r1294b1921],
17	association	NN	O	association	prep_for	11	SENT_93	[p5l1306t1898r1461b1921],
18	between	IN	O	between	_	0	SENT_93	[p5l1475t1895r1590b1921],
19	singlenucleotidepolymorphisms	NNS	O	singlenucleotidepolymorphism	prep_between	17	SENT_93	[p5l1603t1895r1852b1929, p5l265t1937r481b1970],
20	(	CD	NUMBER	(	num	21	SENT_93	[p5l496t1939r588b1970],
21	SNPs	NNS	O	snp	nsubj	11	SENT_93	[p5l496t1939r588b1970],
22	)	CD	NUMBER	)	dep	21	SENT_93	[p5l496t1939r588b1970],
23	across	IN	O	across	_	0	SENT_93	[p5l603t1946r689b1962],
24	the	DT	O	the	det	25	SENT_93	[p5l701t1937r744b1962],
25	genome	NN	O	genome	prep_across	22	SENT_93	[p5l756t1946r867b1970],
26	and	CC	O	and	_	0	SENT_93	[p5l879t1937r928b1962],
27	the	DT	O	the	det	30	SENT_93	[p5l939t1937r983b1962],
28	final	JJ	O	final	amod	30	SENT_93	[p5l994t1937r1052b1962],
29	warfarin	NN	O	warfarin	nn	30	SENT_93	[p5l1064t1937r1177b1962],
30	dose	NN	O	dose	prep_across	22	SENT_93	[p5l1190t1937r1262b1962],
31	.	.	O	.	_	0	SENT_93	[p5l1190t1937r1262b1962],

1	The	DT	O	the	det	3	SENT_94	[p5l1273t1937r1325b1962],
2	horizontal	JJ	O	horizontal	amod	3	SENT_94	[p5l1337t1937r1476b1962],
3	line	NN	O	line	nsubj	4	SENT_94	[p5l1490t1937r1537b1962],
4	indicates	VBZ	O	indicate	_	0	SENT_94	[p5l1549t1937r1671b1962],
5	a	DT	O	a	det	7	SENT_94	[p5l1684t1946r1697b1962],
6	P	NN	O	p	nn	7	SENT_94	[p5l1711t1939r1725b1962],
7	value	NN	O	value	nsubj	14	SENT_94	[p5l1736t1937r1807b1962],
8	of	IN	O	of	_	0	SENT_94	[p5l1819t1937r1849b1962],
9	1.5	CD	NUMBER	1.5	num	10	SENT_94	[p5l266t1979r386b2008],
10	>	JJR	O	>	npadvmod	11	SENT_94	[p5l266t1979r386b2008],
11	<	JJR	O	<	prep_of	7	SENT_94	[p5l266t1979r386b2008],
12	10	CD	NUMBER	10	dep	7	SENT_94	[p5l266t1979r386b2008],
13	'	''	O	'	_	0	SENT_94	[p5l266t1979r386b2008],
14	7	CD	NUMBER	7	xcomp	4	SENT_94	[p5l266t1979r386b2008],
15	,	,	O	,	_	0	SENT_94	[p5l266t1979r386b2008],
16	which	WDT	O	which	nsubj	19	SENT_94	[p5l398t1979r478b2004],
17	is	VBZ	O	be	cop	19	SENT_94	[p5l492t1981r511b2004],
18	the	DT	O	the	det	19	SENT_94	[p5l522t1979r565b2004],
19	level	NN	O	level	rcmod	14	SENT_94	[p5l578t1979r636b2004],
20	of	IN	O	of	_	0	SENT_94	[p5l649t1979r679b2004],
21	genomewide	JJ	O	genomewide	amod	23	SENT_94	[p5l686t1979r864b2012],
22	statistical	JJ	O	statistical	amod	23	SENT_94	[p5l876t1979r1007b2004],
23	significance	NN	O	significance	prep_of	19	SENT_94	[p5l1020t1979r1192b2012],
24	.	.	O	.	_	0	SENT_94	[p5l1020t1979r1192b2012],

1	In	IN	O	in	_	0	SENT_95	[p5l1207t1981r1229b2004],
2	Panel	NN	O	panel	nn	3	SENT_95	[p5l1244t1979r1316b2004],
3	A	NN	O	a	prep_in	7	SENT_95	[p5l1328t1981r1355b2009],
4	,	,	O	,	_	0	SENT_95	[p5l1328t1981r1355b2009],
5	the	DT	O	the	det	6	SENT_95	[p5l1366t1979r1410b2004],
6	results	NNS	O	result	nsubj	7	SENT_95	[p5l1423t1979r1513b2004],
7	ofunivariate	VBP	O	ofunivariate	conj_or	7	SENT_95	[p5l1525t1979r1697b2004],
8	regression	NN	O	regression	nn	12	SENT_95	[p5l1710t1981r1852b2012],
9	analysis	NN	O	analysis	nn	12	SENT_95	[p5l264t2020r371b2053],
10	highlight	NN	O	highlight	nn	12	SENT_95	[p5l385t2020r506b2054],
11	SNP	NN	O	snp	nn	12	SENT_95	[p5l517t2022r576b2046],
12	signals	NNS	O	signal	dobj	7	SENT_95	[p5l588t2020r682b2054],
13	in	IN	O	in	_	0	SENT_95	[p5l695t2023r717b2045],
14	or	CC	O	or	_	0	SENT_95	[p5l730t2029r758b2046],
15	near	IN	O	near	_	0	SENT_95	[p5l769t2029r829b2046],
16	CYPZC9	NN	O	cypzc9	prep_near	7	SENT_95	[p5l840t2022r950b2046],
17	and	CC	O	and	_	0	SENT_95	[p5l960t2020r1009b2046],
18	VKORC1	NN	O	vkorc1	prep_in	7	SENT_95	[p5l1023t2022r1147b2046],
19	.	.	O	.	_	0	SENT_95	[p5l1023t2022r1147b2046],

1	In	IN	O	in	_	0	SENT_96	[p5l1161t2023r1184b2045],
2	Panel	NN	O	panel	nn	3	SENT_96	[p5l1199t2020r1270b2046],
3	B	NN	O	b	prep_in	20	SENT_96	[p5l1285t2023r1308b2050],
4	,	,	O	,	_	0	SENT_96	[p5l1285t2023r1308b2050],
5	the	DT	O	the	det	6	SENT_96	[p5l1320t2020r1363b2046],
6	results	NNS	O	result	nsubj	20	SENT_96	[p5l1376t2020r1466b2046],
7	of	IN	O	of	_	0	SENT_96	[p5l1479t2020r1509b2046],
8	multivariate	JJ	O	multivariate	amod	10	SENT_96	[p5l1516t2020r1680b2046],
9	regression	NN	O	regression	nn	10	SENT_96	[p5l1693t2023r1834b2054],
10	analysis	NN	O	analysis	prep_of	6	SENT_96	[p5l264t2062r371b2095],
11	with	IN	O	with	_	0	SENT_96	[p5l383t2062r440b2087],
12	adjustment	NN	O	adjustment	prep_with	10	SENT_96	[p5l453t2062r611b2095],
13	for	IN	O	for	_	0	SENT_96	[p5l621t2062r660b2087],
14	the	DT	O	the	det	15	SENT_96	[p5l669t2062r713b2087],
15	contributions	NNS	O	contribution	prep_for	12	SENT_96	[p5l724t2062r910b2087],
16	of	IN	O	of	_	0	SENT_96	[p5l922t2062r952b2087],
17	CYPZC9	NN	O	cypzc9	prep_of	15	SENT_96	[p5l959t2064r1070b2087],
18	and	CC	O	and	_	0	SENT_96	[p5l1079t2062r1128b2087],
19	VKORC1	NN	O	vkorc1	conj_and	17	SENT_96	[p5l1142t2064r1257b2088],
20	show	VBP	O	show	_	0	SENT_96	[p5l1271t2062r1343b2087],
21	the	DT	O	the	det	23	SENT_96	[p5l1352t2062r1396b2087],
22	CYP4F2	NN	O	cyp4f2	nn	23	SENT_96	[p5l1408t2064r1515b2087],
23	signal	NN	O	signal	dobj	20	SENT_96	[p5l1526t2062r1604b2095],
24	on	IN	O	on	_	0	SENT_96	[p5l1617t2071r1649b2087],
25	chromosome	NN	O	chromosome	prep_on	23	SENT_96	[p5l1662t2062r1847b2087],
26	19	CD	NUMBER	19	num	25	SENT_96	[p5l1860t2064r1895b2087],
27	.	.	O	.	_	0	SENT_96	[p5l1860t2064r1895b2087],

1	(	NNP	O	(	nn	2	SENT_97	[p5l267t2106r340b2137],
2	Data	NNP	O	Data	nsubj	7	SENT_97	[p5l267t2106r340b2137],
3	are	VBP	O	be	cop	7	SENT_97	[p5l353t2113r393b2129],
4	from	IN	O	from	_	0	SENT_97	[p5l404t2104r468b2129],
5	Takeuchi	NNP	PERSON	Takeuchi	prep_from	7	SENT_97	[p5l480t2104r601b2129],
6	et	FW	O	et	nn	7	SENT_97	[p5l614t2109r638b2129],
7	al.	FW	O	al.	_	0	SENT_97	[p5l650t2103r714b2137],
8	13	CD	NUMBER	13	number	9	SENT_97	[p5l650t2103r714b2137],
9	)	CD	NUMBER	)	num	12	SENT_97	[p5l650t2103r714b2137],
10	The	DT	O	the	det	12	SENT_97	[p5l728t2104r779b2129],
11	label	NN	O	label	nn	12	SENT_97	[p5l792t2104r853b2129],
12	*	NN	O	*	nsubj	14	SENT_97	[p5l866t2106r897b2129],
13	2	CD	NUMBER	2	amod	12	SENT_97	[p5l866t2106r897b2129],
14	indicates	VBZ	O	indicate	rcmod	7	SENT_97	[p5l910t2104r1033b2129],
15	the	DT	O	the	det	18	SENT_97	[p5l1044t2104r1087b2129],
16	nonsynonymous	JJ	O	nonsynonymous	amod	18	SENT_97	[p5l1100t2113r1328b2137],
17	SNP	NN	O	snp	nn	18	SENT_97	[p5l1341t2106r1400b2129],
18	rs1799853	NN	O	rs1799853	dobj	14	SENT_97	[p5l1412t2105r1558b2134],
19	,	,	O	,	_	0	SENT_97	[p5l1412t2105r1558b2134],
20	*	CD	NUMBER	*	number	21	SENT_97	[p5l1570t2106r1600b2129],
21	3	CD	NUMBER	3	nsubj	22	SENT_97	[p5l1570t2106r1600b2129],
22	indicates	VBZ	O	indicate	ccomp	7	SENT_97	[p5l1614t2104r1736b2129],
23	the	DT	O	the	det	26	SENT_97	[p5l1748t2104r1791b2129],
24	nonsynonymous	JJ	O	nonsynonymous	amod	26	SENT_97	[p5l1804t2113r1865b2129, p5l265t2154r439b2178],
25	SNP	NN	O	snp	nn	26	SENT_97	[p5l452t2147r510b2171],
26	rs1057910	NN	O	rs1057910	dobj	22	SENT_97	[p5l523t2147r667b2175],
27	,	,	O	,	_	0	SENT_97	[p5l523t2147r667b2175],
28	and	CC	O	and	_	0	SENT_97	[p5l680t2145r728b2171],
29	the	DT	O	the	det	30	SENT_97	[p5l740t2145r783b2171],
30	*	NN	O	*	nsubj	35	SENT_97	[p5l794t2148r858b2171],
31	2	CD	NUMBER	2	number	32	SENT_97	[p5l794t2148r858b2171],
32	*	CD	NUMBER	*	num	30	SENT_97	[p5l794t2148r858b2171],
33	3	CD	NUMBER	3	number	34	SENT_97	[p5l794t2148r858b2171],
34	composite	JJ	O	composite	amod	30	SENT_97	[p5l872t2148r1017b2178],
35	indicates	VBZ	O	indicate	conj_and	7	SENT_97	[p5l1029t2145r1151b2171],
36	the	DT	O	the	det	38	SENT_97	[p5l1162t2145r1206b2171],
37	SNP	NN	O	snp	nn	38	SENT_97	[p5l1218t2147r1277b2171],
38	rs4917639	NN	O	rs4917639	dobj	35	SENT_97	[p5l1289t2148r1433b2171],
39	.	.	O	.	_	0	SENT_97	[p5l1289t2148r1433b2171],

1	M	NN	O	m	nsubj	2	SENT_98	[p5l1448t2148r1470b2170],
2	denotes	VBZ	O	denote	_	0	SENT_98	[p5l1484t2145r1594b2171],
3	mitochondrial	JJ	O	mitochondrial	amod	5	SENT_98	[p5l1607t2145r1800b2171],
4	SN	NNP	O	SN	nn	5	SENT_98	[p5l1813t2147r1851b2171],
5	Ps	NNPS	O	Ps	dobj	2	SENT_98	[p5l1858t2148r1895b2171],
6	.	.	O	.	_	0	SENT_98	[p5l1858t2148r1895b2171],

1	Panel	NN	O	panel	nn	2	SENT_99	[p5l266t2187r338b2212],
2	C	NN	O	c	nsubj	3	SENT_99	[p5l351t2189r369b2212],
3	shows	VBZ	O	show	_	0	SENT_99	[p5l380t2187r466b2212],
4	the	DT	O	the	det	7	SENT_99	[p5l477t2187r520b2212],
5	sites	NNS	O	site	nn	7	SENT_99	[p5l532t2190r592b2212],
6	ofaction	NN	O	ofaction	nn	7	SENT_99	[p5l604t2187r721b2212],
7	ofwarfarin	NN	O	ofwarfarin	dobj	3	SENT_99	[p5l733t2187r878b2212],
8	in	IN	O	in	_	0	SENT_99	[p5l892t2189r913b2212],
9	the	DT	O	the	det	12	SENT_99	[p5l924t2187r967b2212],
10	vitamin	NN	O	vitamin	nn	12	SENT_99	[p5l977t2189r1077b2212],
11	K	NN	O	k	nn	12	SENT_99	[p5l1091t2189r1107b2212],
12	cycle	NN	O	cycle	prep_in	7	SENT_99	[p5l1117t2187r1189b2220],
13	,	,	O	,	_	0	SENT_99	[p5l1117t2187r1189b2220],
14	as	RB	O	as	_	0	SENT_99	[p5l1202t2196r1229b2212],
15	well	RB	O	well	_	0	SENT_99	[p5l1240t2187r1291b2212],
16	as	IN	O	as	_	0	SENT_99	[p5l1303t2196r1331b2212],
17	the	DT	O	the	det	18	SENT_99	[p5l1341t2187r1384b2212],
18	roles	NNS	O	role	conj_and	7	SENT_99	[p5l1396t2187r1459b2212],
19	ofCYP2C9	NN	O	ofcyp2c9	dep	18	SENT_99	[p5l1471t2187r1622b2217],
20	,	,	O	,	_	0	SENT_99	[p5l1471t2187r1622b2217],
21	CYP4F2	NN	O	cyp4f2	dep	18	SENT_99	[p5l1634t2189r1747b2217],
22	,	,	O	,	_	0	SENT_99	[p5l1634t2189r1747b2217],
23	and	CC	O	and	_	0	SENT_99	[p5l1759t2187r1807b2212],
24	VKORC1	NN	O	vkorc1	dep	18	SENT_99	[p5l263t2231r379b2254],
25	in	IN	O	in	_	0	SENT_99	[p5l392t2231r413b2254],
26	this	DT	O	this	det	27	SENT_99	[p5l425t2229r473b2254],
27	process	NN	O	process	prep_in	3	SENT_99	[p5l486t2238r597b2262],
28	.	.	O	.	_	0	SENT_99	[p5l486t2238r597b2262],

1	tients	NNS	O	tient	_	0	SENT_100	[p5l11t2473r249b2551],
2	for	IN	O	for	_	0	SENT_100	[p5l296t2472r420b2551],
3	whom	WP	O	whom	dobj	11	SENT_100	[p5l457t2472r730b2551],
4	genetic	JJ	O	genetic	amod	5	SENT_100	[p5l774t2473r1086b2573],
5	information	NN	O	information	nsubjpass	11	SENT_100	[p5l1129t2472r1656b2551],
6	on	IN	O	on	_	0	SENT_100	[p5l1701t2498r1808b2551],
7	CYPZC9	NN	O	cypzc9	prep_on	5	SENT_100	[p5l1853t2479r2150b2551],
8	and	CC	O	and	_	0	SENT_100	[p5l10t2600r169b2679],
9	VKORC1	NN	O	vkorc1	prep_on	5	SENT_100	[p5l220t2607r545b2680],
10	was	VBD	O	be	auxpass	11	SENT_100	[p5l595t2627r759b2679],
11	made	VBN	O	make	prepc_for	1	SENT_100	[p5l813t2600r1046b2679],
12	available	JJ	O	available	acomp	11	SENT_100	[p5l1098t2600r1472b2679],
13	to	TO	O	to	_	0	SENT_100	[p5l1525t2617r1607b2679],
14	prescribing	VBG	O	prescribe	prepc_to	12	SENT_100	[p5l1658t2600r2154b2701],
15	physicians	NNS	O	physician	dobj	14	SENT_100	[p5l10t2728r447b2829],
16	with	IN	O	with	_	0	SENT_100	[p5l472t2728r664b2807],
17	a	DT	O	a	det	21	SENT_100	[p5l691t2755r736b2807],
18	matched	VBN	O	match	amod	21	SENT_100	[p5l761t2728r1124b2807],
19	historical	JJ	O	historical	amod	21	SENT_100	[p5l1151t2728r1547b2807],
20	control	NN	O	control	nn	21	SENT_100	[p5l1575t2728r1875b2807],
21	group	NN	O	group	prep_with	14	SENT_100	[p5l1900t2754r2149b2829],
22	of	IN	O	of	_	0	SENT_100	[p5l12t2856r113b2935],
23	patients	NNS	O	patient	prep_of	21	SENT_100	[p5l125t2857r469b2957],
24	who	WP	O	who	nsubjpass	26	SENT_100	[p5l500t2856r684b2935],
25	were	VBD	O	be	auxpass	26	SENT_100	[p5l714t2882r917b2935],
26	started	VBN	O	start	rcmod	23	SENT_100	[p5l951t2856r1252b2935],
27	on	IN	O	on	_	0	SENT_100	[p5l1285t2882r1392b2935],
28	warfarin	NN	O	warfarin	nn	29	SENT_100	[p5l1420t2856r1798b2936],
29	therapy	NN	O	therapy	prep_on	26	SENT_100	[p5l1830t2856r2154b2957],
30	without	IN	O	without	_	0	SENT_100	[p5l6t2984r348b3063],
31	genetic	JJ	O	genetic	amod	32	SENT_100	[p5l385t2985r696b3085],
32	information	NN	O	information	prep_without	26	SENT_100	[p5l737t2984r1364b3063],
33	.	.	O	.	_	0	SENT_100	[p5l737t2984r1364b3063],

1	”	NN	O	”	_	0	SENT_101	[p5l737t2984r1364b3063],
2	Six	CD	DURATION	six	num	3	SENT_101	[p5l1412t2985r1538b3063],
3	months	NNS	NUMBER	month	dep	18	SENT_101	[p5l1577t2984r1906b3063],
4	after	IN	O	after	dep	18	SENT_101	[p5l1950t2984r2154b3063],
5	the	DT	O	the	det	6	SENT_101	[p5l11t3112r143b3191],
6	initiation	NN	O	initiation	nsubj	18	SENT_101	[p5l172t3113r565b3191],
7	of	IN	O	of	_	0	SENT_101	[p5l596t3112r695b3191],
8	warfarin	NN	O	warfarin	nn	9	SENT_101	[p5l703t3112r1072b3191],
9	therapy	NN	O	therapy	prep_of	6	SENT_101	[p5l1102t3112r1432b3213],
10	,	,	O	,	_	0	SENT_101	[p5l1102t3112r1432b3213],
11	hospitalizations	NNS	O	hospitalization	appos	9	SENT_101	[p5l1467t3112r2148b3213],
12	for	IN	O	for	_	0	SENT_101	[p5l11t3240r135b3319],
13	hemorrhage	NN	O	hemorrhage	prep_for	11	SENT_101	[p5l181t3240r708b3341],
14	were	VBD	O	be	cop	18	SENT_101	[p5l753t3266r956b3319],
15	28	CD	PERCENT	28	num	16	SENT_101	[p5l1006t3246r1194b3319],
16	%	NN	PERCENT	%	npadvmod	17	SENT_101	[p5l1006t3246r1194b3319],
17	less	JJR	O	less	advmod	18	SENT_101	[p5l1241t3240r1398b3319],
18	common	JJ	O	common	dep	1	SENT_101	[p5l1450t3266r1834b3319],
19	in	IN	O	in	_	0	SENT_101	[p5l1883t3241r1967b3318],
20	the	DT	O	the	det	21	SENT_101	[p5l2016t3240r2150b3319],
21	group	NN	O	group	prep_in	18	SENT_101	[p5l11t3394r265b3469],
22	of	IN	O	of	_	0	SENT_101	[p5l305t3368r406b3447],
23	patients	NNS	O	patient	prep_of	21	SENT_101	[p5l425t3369r768b3469],
24	for	IN	O	for	_	0	SENT_101	[p5l809t3368r933b3447],
25	whom	WP	O	whom	dobj	34	SENT_101	[p5l964t3368r1237b3447],
26	genetic	JJ	O	genetic	amod	27	SENT_101	[p5l1275t3369r1586b3469],
27	information	NN	O	information	nsubjpass	34	SENT_101	[p5l1623t3368r2151b3447],
28	on	IN	O	on	_	0	SENT_101	[p5l12t3522r118b3575],
29	CYPZC9	NN	O	cypzc9	prep_on	27	SENT_101	[p5l181t3503r478b3575],
30	and	CC	O	and	_	0	SENT_101	[p5l541t3496r700b3575],
31	VKORC1	NN	O	vkorc1	prep_on	27	SENT_101	[p5l761t3503r1087b3576],
32	had	VBD	O	have	aux	34	SENT_101	[p5l1153t3496r1310b3575],
33	been	VBN	O	be	auxpass	34	SENT_101	[p5l1374t3496r1576b3575],
34	supplied	VBN	O	supply	prepc_for	23	SENT_101	[p5l1640t3496r2004b3597],
35	to	TO	O	to	_	0	SENT_101	[p5l2067t3513r2149b3575],
36	prescribing	VBG	O	prescribe	prepc_to	34	SENT_101	[p5l10t3624r504b3725],
37	physicians	NNS	O	physician	dobj	36	SENT_101	[p5l536t3624r988b3725],
38	than	IN	O	than	prep	36	SENT_101	[p5l1026t3624r1224b3703],
39	in	IN	O	in	pcomp	38	SENT_101	[p5l1259t3625r1344b3702],
40	the	DT	O	the	det	42	SENT_101	[p5l1380t3624r1513b3703],
41	control	NN	O	control	nn	42	SENT_101	[p5l1551t3624r1859b3703],
42	group	NN	O	group	pobj	39	SENT_101	[p5l1895t3650r2149b3725],

1	(	NN	O	(	_	0	SENT_102	[p6l16t21r196b121],
2	Fig	NN	O	fig	dep	1	SENT_102	[p6l16t21r196b121],
3	.	.	O	.	_	0	SENT_102	[p6l16t21r196b121],

1	2	CD	NUMBER	2	num	2	SENT_103	[p6l242t26r343b111],
2	)	CD	NUMBER	)	_	0	SENT_103	[p6l242t26r343b111],
3	.	.	O	.	_	0	SENT_103	[p6l242t26r343b111],

1	The	DT	O	the	det	2	SENT_104	[p6l137t149r297b227],
2	FDA	NNP	ORGANIZATION	FDA	nsubj	3	SENT_104	[p6l332t156r516b227],
3	revised	VBD	O	revise	_	0	SENT_104	[p6l547t149r848b228],
4	the	DT	O	the	det	5	SENT_104	[p6l884t149r1016b227],
5	label	NN	O	label	dobj	3	SENT_104	[p6l1050t149r1254b228],
6	on	IN	O	on	_	0	SENT_104	[p6l1289t175r1395b228],
7	Warfarin	NNP	MISC	Warfarin	prep_on	3	SENT_104	[p6l1425t148r1799b228],
8	in	IN	O	in	_	0	SENT_104	[p6l1833t150r1916b226],
9	February	NNP	DATE	February	prep_in	3	SENT_104	[p6l1949t149r2133b228, p6l12t303r240b377],
10	2010	CD	DATE	2010	num	9	SENT_104	[p6l269t283r486b373],
11	,	,	O	,	_	0	SENT_104	[p6l269t283r486b373],
12	providing	VBG	O	provide	dep	3	SENT_104	[p6l523t277r932b378],
13	genotype	NN	O	genotype	iobj	12	SENT_104	[p6l961t276r1709b378],
14	—	CD	NUMBER	—	num	16	SENT_104	[p6l961t276r1709b378],
15	specif1c	NN	O	specif1c	nn	16	SENT_104	[p6l961t276r1709b378],
16	ranges	NNS	O	range	dobj	12	SENT_104	[p6l1740t303r2018b378],
17	of	IN	O	of	_	0	SENT_104	[p6l2054t276r2152b356],
18	doses	NNS	O	dose	prep_of	16	SENT_104	[p6l12t405r242b484],
19	and	CC	O	and	_	0	SENT_104	[p6l273t405r428b483],
20	suggesting	VBG	O	suggest	conj_and	12	SENT_104	[p6l458t406r913b506],
21	that	IN	O	that	complm	24	SENT_104	[p6l939t405r1106b483],
22	genotypes	NNS	O	genotype	nsubjpass	24	SENT_104	[p6l1131t422r1554b506],
23	be	VB	O	be	auxpass	24	SENT_104	[p6l1586t405r1680b484],
24	taken	VBN	O	take	ccomp	20	SENT_104	[p6l1711t405r1941b484],
25	into	IN	O	into	_	0	SENT_104	[p6l1969t406r2133b484],
26	consideration	NN	O	consideration	prep_into	24	SENT_104	[p6l12t533r596b612],
27	when	WRB	O	when	advmod	31	SENT_104	[p6l637t533r870b612],
28	the	DT	O	the	det	29	SENT_104	[p6l916t533r1048b611],
29	drug	NN	O	drug	nsubjpass	31	SENT_104	[p6l1094t533r1298b634],
30	is	VBZ	O	be	auxpass	31	SENT_104	[p6l1339t534r1405b611],
31	prescribed	VBN	O	prescribe	advcl	24	SENT_104	[p6l1451t533r1926b633],
32	.	.	O	.	_	0	SENT_104	[p6l1451t533r1926b633],

1	The	DT	O	the	det	3	SENT_105	[p6l1973t533r2134b611],
2	Wide	NN	MISC	wide	nn	3	SENT_105	[p6l7t661r211b740],
3	availability	NN	O	availability	nsubj	16	SENT_105	[p6l247t661r717b761],
4	of	IN	O	of	_	0	SENT_105	[p6l750t660r849b739],
5	CYPZC9	NN	O	cypzc9	nn	8	SENT_105	[p6l867t668r1162b739],
6	and	CC	O	and	_	0	SENT_105	[p6l1197t661r1355b740],
7	VKORC1	NN	O	vkorc1	nn	8	SENT_105	[p6l1391t668r1713b740],
8	genotyping	NN	O	genotyping	prep_of	3	SENT_105	[p6l1752t678r2133b762, p6l11t790r150b890],
9	and	CC	O	and	_	0	SENT_105	[p6l188t789r345b868],
10	the	DT	O	the	det	11	SENT_105	[p6l387t789r520b867],
11	release	NN	O	release	conj_and	3	SENT_105	[p6l561t789r854b867],
12	of	IN	O	of	_	0	SENT_105	[p6l896t788r996b867],
13	both	DT	O	both	det	15	SENT_105	[p6l1019t789r1217b868],
14	Web	NN	O	web	nn	15	SENT_105	[p6l1254t789r1726b868],
15	—	NN	O	—	prep_of	11	SENT_105	[p6l1254t789r1726b868],
16	based	VBN	O	base	_	0	SENT_105	[p6l1254t789r1726b868],
17	and	CC	O	and	_	0	SENT_105	[p6l1766t789r1925b867],
18	personal	JJ	O	personal	amod	22	SENT_105	[p6l1965t815r2133b889, p6l13t917r242b995],
19	decision	NN	O	decision	nn	22	SENT_105	[p6l285t917r1008b1017],
20	—	NN	O	—	nn	22	SENT_105	[p6l285t917r1008b1017],
21	support	NN	O	support	nn	22	SENT_105	[p6l285t917r1008b1017],
22	tools	NNS	O	tool	nsubj	24	SENT_105	[p6l1046t917r1253b995],
23	have	VBP	O	have	aux	24	SENT_105	[p6l1298t917r1488b996],
24	facilitated	VBN	O	facilitate	conj_and	16	SENT_105	[p6l1531t916r1959b995],
25	the	DT	O	the	det	27	SENT_105	[p6l2002t917r2134b995],
26	clinical	JJ	O	clinical	amod	27	SENT_105	[p6l12t1045r318b1123],
27	use	NN	O	use	dobj	24	SENT_105	[p6l352t1071r490b1124],
28	of	IN	O	of	_	0	SENT_105	[p6l525t1044r624b1124],
29	this	DT	O	this	det	30	SENT_105	[p6l640t1045r797b1123],
30	information	NN	O	information	prep_of	27	SENT_105	[p6l832t1044r1367b1124],
31	.	.	O	.	_	0	SENT_105	[p6l832t1044r1367b1124],

1	Nevertheless	RB	O	nevertheless	advmod	9	SENT_106	[p6l1405t1045r1963b1141],
2	,	,	O	,	_	0	SENT_106	[p6l1405t1045r1963b1141],
3	the	DT	O	the	det	5	SENT_106	[p6l2003t1045r2134b1123],
4	clinical	JJ	O	clinical	amod	5	SENT_106	[p6l12t1173r318b1251],
5	adoption	NN	O	adoption	nsubj	9	SENT_106	[p6l356t1173r731b1273],
6	of	IN	O	of	_	0	SENT_106	[p6l770t1172r869b1251],
7	genotype	NN	O	genotype	nn	8	SENT_106	[p6l889t1173r1603b1274],
8	—	NN	O	—	prep_of	5	SENT_106	[p6l889t1173r1603b1274],
9	guided	VBD	O	guide	_	0	SENT_106	[p6l889t1173r1603b1274],
10	administration	NN	O	administration	nsubj	15	SENT_106	[p6l1641t1173r2133b1251, p6l12t1302r178b1380],
11	of	IN	O	of	_	0	SENT_106	[p6l217t1300r317b1380],
12	Warfarin	NNP	MISC	Warfarin	prep_of	10	SENT_106	[p6l332t1300r706b1380],
13	has	VBZ	O	have	aux	15	SENT_106	[p6l745t1301r889b1379],
14	been	VBN	O	be	cop	15	SENT_106	[p6l930t1301r1132b1380],
15	slow	JJ	O	slow	ccomp	9	SENT_106	[p6l1172t1301r1381b1397],
16	,	,	O	,	_	0	SENT_106	[p6l1172t1301r1381b1397],
17	even	RB	O	even	advmod	25	SENT_106	[p6l1426t1327r1615b1380],
18	though	IN	O	though	dep	25	SENT_106	[p6l1654t1301r1962b1402],
19	the	DT	O	the	det	20	SENT_106	[p6l2001t1301r2134b1379],
20	evidence	NN	O	evidence	nsubj	25	SENT_106	[p6l12t1429r377b1508],
21	supporting	VBG	O	support	partmod	20	SENT_106	[p6l422t1430r897b1530],
22	such	JJ	O	such	amod	23	SENT_106	[p6l937t1429r1131b1508],
23	adoption	NN	O	adoption	dobj	21	SENT_106	[p6l1173t1429r1554b1529],
24	is	VBZ	O	be	cop	25	SENT_106	[p6l1595t1430r1661b1507],
25	similar	JJ	O	similar	ccomp	15	SENT_106	[p6l1707t1429r2013b1507],
26	to	TO	O	to	prep	25	SENT_106	[p6l2052t1445r2133b1508],

1	1146	CD	DATE	1146	num	4	SENT_107	[p6l149t1605r225b1628],
2	N	NN	O	n	nn	4	SENT_107	[p6l950t1616r964b1631],
3	ENGLJ	NN	O	englj	nn	4	SENT_107	[p6l978t1616r1056b1638],
4	MED	NN	O	med	_	0	SENT_107	[p6l1071t1616r1123b1631],
5	364	CD	NUMBER	364	num	7	SENT_107	[p6l1133t1610r1212b1638],
6	;	:	O	;	_	0	SENT_107	[p6l1133t1610r1212b1638],
7	12	CD	NUMBER	12	dep	4	SENT_107	[p6l1133t1610r1212b1638],
8	NEjM	NNP	O	NEjM	dep	4	SENT_107	[p6l1248t1616r1372b1638],
9	,	,	O	,	_	0	SENT_107	[p6l1248t1616r1372b1638],
10	ORG	NNP	O	ORG	nn	11	SENT_107	[p6l1248t1616r1372b1638],
11	MARCH	NNP	DATE	MARCH	appos	8	SENT_107	[p6l1409t1616r1494b1632],
12	24	CD	DATE	24	num	11	SENT_107	[p6l1506t1616r1542b1638],
13	,	,	DATE	,	_	0	SENT_107	[p6l1506t1616r1542b1638],
14	2011	CD	DATE	2011	num	11	SENT_107	[p6l1553t1616r1605b1632],

1	The	DT	O	the	det	4	SENT_108	[p6l935t1649r986b1673],
2	New	NNP	O	New	nn	4	SENT_108	[p6l995t1650r1057b1673],
3	England	NNP	O	England	nn	4	SENT_108	[p6l1066t1649r1177b1680],
4	Journal	NNP	O	Journal	_	0	SENT_108	[p6l1186t1649r1283b1673],
5	of	IN	O	of	_	0	SENT_108	[p6l1293t1649r1322b1673],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_108	[p6l1329t1649r1454b1673],

1	Downloaded	VBN	O	download	_	0	SENT_109	[p6l377t1690r547b1713],
2	from	IN	O	from	_	0	SENT_109	[p6l556t1690r621b1713],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_109	[p6l629t1690r748b1720],
4	at	IN	O	at	_	0	SENT_109	[p6l758t1694r781b1713],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_109	[p6l789t1690r972b1713],
6	on	IN	O	on	_	0	SENT_109	[p6l981t1697r1014b1713],
7	January	NNP	DATE	January	prep_on	1	SENT_109	[p6l1022t1690r1125b1720],
8	5	CD	DATE	5	num	7	SENT_109	[p6l1135t1690r1158b1717],
9	,	,	DATE	,	_	0	SENT_109	[p6l1135t1690r1158b1717],
10	2014	CD	DATE	2014	num	7	SENT_109	[p6l1168t1690r1241b1713],
11	.	.	O	.	_	0	SENT_109	[p6l1168t1690r1241b1713],

1	For	IN	O	for	_	0	SENT_110	[p6l1251t1690r1298b1713],
2	personal	JJ	O	personal	amod	3	SENT_110	[p6l1306t1690r1418b1720],
3	use	NN	O	use	pobj	1	SENT_110	[p6l1427t1697r1471b1713],
4	only	RB	O	only	advmod	3	SENT_110	[p6l1480t1690r1545b1720],
5	.	.	O	.	_	0	SENT_110	[p6l1480t1690r1545b1720],

1	No	DT	O	no	det	3	SENT_111	[p6l1556t1690r1595b1713],
2	other	JJ	O	other	amod	3	SENT_111	[p6l1605t1690r1673b1713],
3	uses	NNS	O	use	_	0	SENT_111	[p6l1682t1697r1738b1713],
4	without	IN	O	without	_	0	SENT_111	[p6l1748t1690r1849b1713],
5	permission	NN	O	permission	prep_without	3	SENT_111	[p6l1857t1690r2010b1720],
6	.	.	O	.	_	0	SENT_111	[p6l1857t1690r2010b1720],

1	Copyright	NN	O	copyright	_	0	SENT_112	[p6l728t1731r862b1762],
2	©	CD	NUMBER	©	num	6	SENT_112	[p6l871t1731r895b1755],
3	2011	CD	DATE	2011	num	6	SENT_112	[p6l905t1731r967b1755],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_112	[p6l979t1731r1170b1755],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_112	[p6l1180t1731r1288b1755],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_112	[p6l1299t1731r1404b1762],
7	.	.	O	.	_	0	SENT_112	[p6l1299t1731r1404b1762],

1	All	DT	O	all	det	2	SENT_113	[p6l1415t1731r1456b1755],
2	rights	NNS	O	rights	nsubj	3	SENT_113	[p6l1465t1731r1540b1762],
3	reserved	VBN	O	reserve	_	0	SENT_113	[p6l1550t1731r1668b1755],
4	.	.	O	.	_	0	SENT_113	[p6l1550t1731r1668b1755],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_114	[p6l909t1837r1067b1856],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_114	[p6l1081t1837r1251b1856],

1	the	DT	O	the	det	2	SENT_115	[p6l12t2050r144b2128],
2	evidence	NN	O	evidence	nsubj	5	SENT_115	[p6l196t2050r561b2129],
3	supporting	VBG	O	support	partmod	2	SENT_115	[p6l613t2051r1089b2151],
4	currently	RB	DATE	currently	advmod	3	SENT_115	[p6l1137t2050r1527b2150],
5	used	VBN	O	use	_	0	SENT_115	[p6l1573t2050r1769b2129],
6	clinical	JJ	O	clinical	amod	7	SENT_115	[p6l1820t2050r2134b2128],
7	variables	NNS	O	variable	dobj	5	SENT_115	[p6l7t2178r400b2274],
8	,	,	O	,	_	0	SENT_115	[p6l7t2178r400b2274],
9	such	JJ	O	such	_	0	SENT_115	[p6l446t2178r637b2257],
10	as	IN	O	as	_	0	SENT_115	[p6l674t2204r758b2256],
11	age	NN	O	age	prep_such_as	7	SENT_115	[p6l799t2204r962b2279],
12	,	,	O	,	_	0	SENT_115	[p6l799t2204r962b2279],
13	drug	NN	O	drug	nn	14	SENT_115	[p6l1006t2178r1207b2279],
14	interactions	NNS	O	interaction	prep_such_as	7	SENT_115	[p6l1241t2179r1763b2274],
15	,	,	O	,	_	0	SENT_115	[p6l1241t2179r1763b2274],
16	and	CC	O	and	_	0	SENT_115	[p6l1806t2178r1962b2257],
17	ancestral	JJ	O	ancestral	amod	18	SENT_115	[p6l2000t2204r2132b2256, p6l12t2306r288b2384],
18	origin	NN	O	origin	prep_such_as	7	SENT_115	[p6l332t2307r613b2407],
19	.	.	O	.	_	0	SENT_115	[p6l332t2307r613b2407],

1	Some	DT	O	some	det	2	SENT_116	[p6l665t2312r896b2385],
2	observers	NNS	O	observer	nsubj	4	SENT_116	[p6l941t2306r1346b2385],
3	have	VBP	O	have	aux	4	SENT_116	[p6l1392t2306r1581b2385],
4	expressed	VBN	O	express	_	0	SENT_116	[p6l1627t2306r2047b2406],
5	a	DT	O	a	det	6	SENT_116	[p6l2090t2332r2135b2384],
6	need	NN	O	need	dobj	4	SENT_116	[p6l11t2433r212b2512],
7	for	IN	O	for	_	0	SENT_116	[p6l257t2432r380b2512],
8	prospective	JJ	O	prospective	amod	9	SENT_116	[p6l421t2434r910b2533],
9	assessment	NN	O	assessment	prep_for	6	SENT_116	[p6l955t2450r1445b2511],
10	of	IN	O	of	_	0	SENT_116	[p6l1486t2432r1586b2512],
11	the	DT	O	the	det	12	SENT_116	[p6l1613t2433r1746b2511],
12	value	NN	O	value	prep_of	9	SENT_116	[p6l1787t2433r2006b2513],
13	of	IN	O	of	_	0	SENT_116	[p6l2052t2432r2152b2512],
14	this	DT	O	this	det	16	SENT_116	[p6l12t2562r167b2640],
15	genetic	JJ	O	genetic	amod	16	SENT_116	[p6l206t2563r508b2663],
16	information	NN	O	information	prep_of	12	SENT_116	[p6l543t2561r1056b2641],
17	in	IN	O	in	_	0	SENT_116	[p6l1092t2563r1173b2640],
18	Warfarin	NNP	MISC	Warfarin	nn	19	SENT_116	[p6l1205t2561r1572b2641],
19	therapy	NN	O	therapy	prep_in	4	SENT_116	[p6l1609t2562r1936b2662],
20	,	,	O	,	_	0	SENT_116	[p6l1609t2562r1936b2662],
21	and	CC	O	and	_	0	SENT_116	[p6l1978t2562r2133b2641],
22	several	JJ	O	several	amod	25	SENT_116	[p6l12t2690r304b2769],
23	prospective	JJ	O	prospective	amod	25	SENT_116	[p6l346t2691r836b2790],
24	clinical	JJ	O	clinical	amod	25	SENT_116	[p6l881t2690r1195b2768],
25	trials	NNS	O	trial	nsubj	27	SENT_116	[p6l1239t2690r1458b2768],
26	are	VBP	O	be	cop	27	SENT_116	[p6l1504t2716r1633b2768],
27	ongoing	JJ	O	ongoing	conj_and	4	SENT_116	[p6l1678t2691r2133b2791],
28	.	.	O	.	_	0	SENT_116	[p6l1678t2691r2133b2791],

1	”	NN	O	”	nsubjpass	8	SENT_117	[p6l1678t2691r2133b2791],
2	Alternative	JJ	O	alternative	amod	4	SENT_117	[p6l7t2818r478b2897],
3	anticoagulant	JJ	O	anticoagulant	amod	4	SENT_117	[p6l525t2818r1125b2919],
4	therapies	NNS	O	therapy	dep	1	SENT_117	[p6l1168t2818r1557b2918],
5	are	VBP	O	be	aux	8	SENT_117	[p6l1606t2844r1734b2896],
6	also	RB	O	also	advmod	8	SENT_117	[p6l1782t2818r1952b2897],
7	being	VBG	O	be	auxpass	8	SENT_117	[p6l2002t2818r2132b2897, p6l11t2947r150b3047],
8	developed	VBN	O	develop	_	0	SENT_117	[p6l192t2946r619b3046],
9	that	IN	O	that	complm	11	SENT_117	[p6l663t2946r836b3024],
10	might	MD	O	might	aux	11	SENT_117	[p6l875t2946r1135b3047],
11	replace	VB	O	replace	ccomp	8	SENT_117	[p6l1174t2946r1477b3046],
12	Warfarin	NNP	O	Warfarin	dobj	11	SENT_117	[p6l1517t2945r1915b3042],
13	,	,	O	,	_	0	SENT_117	[p6l1517t2945r1915b3042],
14	perhaps	RB	O	perhaps	advmod	11	SENT_117	[p6l1963t2972r2132b3046, p6l11t3074r210b3174],
15	in	IN	O	in	_	0	SENT_117	[p6l250t3075r333b3152],
16	patients	NNS	O	patient	prep_in	11	SENT_117	[p6l371t3075r712b3174],
17	with	IN	O	with	_	0	SENT_117	[p6l749t3074r944b3153],
18	genotypes	NNS	O	genotype	prep_with	16	SENT_117	[p6l982t3091r1418b3175],
19	associated	VBN	O	associate	partmod	18	SENT_117	[p6l1459t3074r1903b3153],
20	with	IN	O	with	_	0	SENT_117	[p6l1938t3074r2133b3153],
21	extreme	JJ	O	extreme	amod	22	SENT_117	[p6l12t3218r354b3279],
22	variation	NN	O	variation	prep_with	19	SENT_117	[p6l390t3202r772b3280],
23	in	IN	O	in	_	0	SENT_117	[p6l811t3202r894b3279],
24	Warfarin	NNP	O	Warfarin	nn	25	SENT_117	[p6l929t3200r1303b3281],
25	response	NN	O	response	prep_in	22	SENT_117	[p6l1343t3207r1826b3301],
26	.	.	O	.	_	0	SENT_117	[p6l1343t3207r1826b3301],

1	”	NN	O	”	_	0	SENT_118	[p6l1343t3207r1826b3301],

1	Clopidogrel	NN	O	clopidogrel	nsubj	2	SENT_119	[p6l140t3330r652b3431],
2	inhibits	VBZ	O	inhibit	_	0	SENT_119	[p6l706t3330r1043b3409],
3	adenosine	NN	O	adenosine	nn	4	SENT_119	[p6l1098t3330r1538b3409],
4	diphosphate	NN	O	diphosphate	nsubj	7	SENT_119	[p6l1593t3330r2133b3430],
5	(	CD	NUMBER	(	num	7	SENT_119	[p6l16t3458r798b3549],
6	ADP	NN	O	adp	nn	7	SENT_119	[p6l16t3458r798b3549],
7	)	NN	O	)	xcomp	2	SENT_119	[p6l16t3458r798b3549],
8	.	.	O	.	_	0	SENT_119	[p6l16t3458r798b3549],

1	—	NN	O	—	_	0	SENT_120	[p6l16t3458r798b3549],
2	.	.	O	.	_	0	SENT_120	[p6l16t3458r798b3549],

1	stimulated	VBN	O	stimulate	_	0	SENT_121	[p6l16t3458r798b3549],
2	platelet	NN	O	platelet	nn	3	SENT_121	[p6l835t3458r1161b3558],
3	activation	NN	O	activation	dobj	1	SENT_121	[p6l1194t3459r1621b3537],
4	by	IN	O	by	_	0	SENT_121	[p6l1660t3458r1758b3558],
5	binding	VBG	O	bind	prepc_by	1	SENT_121	[p6l1793t3458r2137b3559],
6	irreversibly	RB	O	irreversibly	advmod	5	SENT_121	[p6l11t3585r490b3685],
7	to	TO	O	to	_	0	SENT_121	[p6l520t3602r601b3664],
8	a	DT	O	a	det	11	SENT_121	[p6l636t3611r680b3663],
9	specific	JJ	O	specific	amod	11	SENT_121	[p6l715t3584r1044b3685],
10	platelet	NN	O	platelet	nn	11	SENT_121	[p6l1076t3585r1395b3685],
11	receptor	NN	O	receptor	prep_to	5	SENT_121	[p6l1423t3602r1779b3685],
12	of	IN	O	of	_	0	SENT_121	[p6l1811t3584r1911b3664],
13	ADP	NN	O	adp	prep_of	11	SENT_121	[p6l1922t3592r2129b3681],
14	,	,	O	,	_	0	SENT_121	[p6l1922t3592r2129b3681],

1	P2Y12	NN	O	p2y12	nsubj	37	SENT_122	[p7l9t27r261b124],
2	,	,	O	,	_	0	SENT_122	[p7l9t27r261b124],
3	thus	RB	O	thus	advmod	4	SENT_122	[p7l323t21r506b100],
4	inhibiting	VBG	O	inhibit	dep	37	SENT_122	[p7l563t21r997b122],
5	platelet	NN	O	platelet	nn	6	SENT_122	[p7l1048t21r1366b121],
6	aggregation	NN	O	aggregation	dobj	4	SENT_122	[p7l1416t22r2133b122],
7	.28	CD	NUMBER	.28	number	8	SENT_122	[p7l1416t22r2133b122],
8	’29	CD	NUMBER	’29	num	13	SENT_122	[p7l1416t22r2133b122],
9	Dual	JJ	O	dual	amod	13	SENT_122	[p7l9t149r215b228],
10	antiplatelet	JJ	O	antiplatelet	amod	13	SENT_122	[p7l257t149r744b249],
11	therapy	NN	O	therapy	nn	13	SENT_122	[p7l782t149r1104b249],
12	—	NN	O	—	nn	13	SENT_122	[p7l1139t194r1247b202],
13	clopidogrel	NN	O	clopidogrel	nsubjpass	19	SENT_122	[p7l1287t149r1769b250],
14	and	CC	O	and	_	0	SENT_122	[p7l1812t149r1970b228],
15	aspirin	NN	O	aspirin	nn	16	SENT_122	[p7l2013t175r2132b227, p7l9t277r218b376],
16	—	NN	O	—	conj_and	13	SENT_122	[p7l254t321r362b329],
17	has	VBZ	O	have	aux	19	SENT_122	[p7l398t276r541b354],
18	been	VBN	O	be	auxpass	19	SENT_122	[p7l585t276r786b355],
19	shown	VBN	O	show	rcmod	6	SENT_122	[p7l827t276r1109b356],
20	to	TO	O	to	aux	21	SENT_122	[p7l1149t293r1231b355],
21	decrease	VB	O	decrease	xcomp	19	SENT_122	[p7l1273t276r1638b355],
22	the	DT	O	the	det	23	SENT_122	[p7l1679t276r1812b354],
23	risk	NN	O	risk	dobj	21	SENT_122	[p7l1851t276r2015b356],
24	of	IN	O	of	_	0	SENT_122	[p7l2051t275r2151b355],
25	subsequent	JJ	O	subsequent	amod	29	SENT_122	[p7l13t405r499b504],
26	ischemic	JJ	O	ischemic	amod	29	SENT_122	[p7l545t405r924b483],
27	vascular	JJ	O	vascular	amod	29	SENT_122	[p7l972t405r1329b484],
28	events	NNS	O	event	nn	29	SENT_122	[p7l1380t411r1848b484],
29	.3	NN	NUMBER	.3	prep_of	23	SENT_122	[p7l1380t411r1848b484],
30	°	CD	NUMBER	°	number	31	SENT_122	[p7l1380t411r1848b484],
31	'32	CD	NUMBER	'32	num	29	SENT_122	[p7l1380t411r1848b484],
32	However	RB	O	however	advmod	21	SENT_122	[p7l1900t412r2132b484, p7l12t559r197b629],
33	,	,	O	,	_	0	SENT_122	[p7l1900t412r2132b484, p7l12t559r197b629],
34	clopidogrel	NN	O	clopidogrel	nsubj	37	SENT_122	[p7l240t533r712b634],
35	is	VBZ	O	be	cop	37	SENT_122	[p7l748t534r813b611],
36	a	DT	O	a	det	37	SENT_122	[p7l852t559r896b611],
37	prodrug	NN	O	prodrug	_	0	SENT_122	[p7l930t533r1279b634],
38	that	WDT	O	that	nsubj	39	SENT_122	[p7l1312t533r1482b611],
39	requires	VBZ	O	require	rcmod	37	SENT_122	[p7l1514t534r1854b633],
40	metabolic	JJ	O	metabolic	amod	41	SENT_122	[p7l1894t550r2132b611, p7l12t661r215b739],
41	activation	NN	O	activation	dobj	39	SENT_122	[p7l248t662r656b740],
42	in	IN	O	in	_	0	SENT_122	[p7l689t662r771b738],
43	a	DT	O	a	det	44	SENT_122	[p7l805t687r849b738],
44	reaction	NN	O	reaction	prep_in	39	SENT_122	[p7l881t662r1222b739],
45	catalyzed	VBN	O	catalyze	partmod	44	SENT_122	[p7l1257t661r1648b760],
46	by	IN	O	by	_	0	SENT_122	[p7l1682t661r1778b760],
47	another	DT	O	another	det	52	SENT_122	[p7l1808t661r2137b739],
48	cytochrome	NN	O	cytochrome	nn	52	SENT_122	[p7l12t789r506b888],
49	P	NN	O	p	nn	52	SENT_122	[p7l536t795r768b867],
50	—	CD	NUMBER	—	num	52	SENT_122	[p7l536t795r768b867],
51	45O	NN	O	45o	nn	52	SENT_122	[p7l536t795r768b867],
52	enzyme	NN	O	enzyme	agent	45	SENT_122	[p7l800t815r1146b888],
53	,	,	O	,	_	0	SENT_122	[p7l800t815r1146b888],
54	CYPZC19	NN	O	cypzc19	appos	52	SENT_122	[p7l1182t795r1580b867],
55	.	.	O	.	_	0	SENT_122	[p7l1182t795r1580b867],

1	Like	IN	O	like	_	0	SENT_123	[p7l1615t789r1791b868],
2	CYPZC9	NN	O	cypzc9	prep_like	7	SENT_123	[p7l1822t795r2128b884],
3	,	,	O	,	_	0	SENT_123	[p7l1822t795r2128b884],
4	CYPZCI9	NN	O	cypzci9	nsubj	7	SENT_123	[p7l11t923r356b995],
5	is	VBZ	O	be	cop	7	SENT_123	[p7l397t918r463b995],
6	genetically	RB	O	genetically	advmod	7	SENT_123	[p7l507t917r973b1018],
7	polymorphic	JJ	O	polymorphic	_	0	SENT_123	[p7l1009t917r1560b1017],
8	with	IN	O	with	_	0	SENT_123	[p7l1597t917r1792b996],
9	a	DT	O	a	det	12	SENT_123	[p7l1833t943r1878b995],
10	common	JJ	O	common	amod	12	SENT_123	[p7l1919t943r2132b996, p7l11t1071r202b1123],
11	SN	NN	O	sn	nn	12	SENT_123	[p7l236t1051r356b1124],
12	P	NN	O	p	prep_with	7	SENT_123	[p7l359t1051r410b1122],
13	that	WDT	O	that	nsubj	14	SENT_123	[p7l441t1045r610b1122],
14	results	VBZ	O	result	rcmod	12	SENT_123	[p7l636t1045r913b1124],
15	in	IN	O	in	_	0	SENT_123	[p7l946t1046r1028b1122],
16	a	DT	O	a	prep_in	14	SENT_123	[p7l1059t1071r1104b1122],
17	truncated	VBN	O	truncate	partmod	16	SENT_123	[p7l1134t1045r1540b1124],
18	protein	NN	O	protein	nn	19	SENT_123	[p7l1570t1046r1875b1144],
19	product	NN	O	product	nsubj	62	SENT_123	[p7l1904t1045r2132b1144, p7l11t1190r141b1252],
20	With	IN	O	with	_	0	SENT_123	[p7l166t1173r358b1252],
21	little	JJ	O	little	amod	23	SENT_123	[p7l391t1173r582b1251],
22	enzymatic	JJ	O	enzymatic	amod	23	SENT_123	[p7l618t1174r1051b1272],
23	activity	NN	O	activity	prep_with	28	SENT_123	[p7l1084t1174r1471b1272],
24	.33	CD	NUMBER	.33	num	26	SENT_123	[p7l1084t1174r1471b1272],
25	Several	JJ	O	several	amod	26	SENT_123	[p7l1510t1173r1803b1252],
26	studies	NNS	O	study	nsubj	28	SENT_123	[p7l1838t1173r2131b1252],
27	have	VBP	O	have	aux	28	SENT_123	[p7l11t1301r197b1380],
28	shown	VBN	O	show	rcmod	19	SENT_123	[p7l240t1301r518b1380],
29	that	IN	O	that	complm	41	SENT_123	[p7l560t1301r729b1379],
30	genetic	JJ	O	genetic	amod	31	SENT_123	[p7l765t1302r1067b1402],
31	variation	NN	O	variation	nsubjpass	41	SENT_123	[p7l1103t1302r1478b1380],
32	in	IN	O	in	_	0	SENT_123	[p7l1518t1302r1600b1379],
33	CYPZCI9	NN	O	cypzci9	prep_in	31	SENT_123	[p7l1642t1307r1980b1379],
34	resulting	VBG	O	result	partmod	33	SENT_123	[p7l2022t1327r2132b1379, p7l12t1429r306b1530],
35	in	IN	O	in	_	0	SENT_123	[p7l341t1430r425b1507],
36	a	DT	O	a	det	37	SENT_123	[p7l465t1455r509b1507],
37	paucity	NN	O	paucity	prep_in	34	SENT_123	[p7l546t1430r857b1529],
38	of	IN	O	of	_	0	SENT_123	[p7l893t1428r993b1508],
39	activity	NN	O	activity	prep_of	37	SENT_123	[p7l1014t1430r1324b1529],
40	is	VBZ	O	be	auxpass	41	SENT_123	[p7l1359t1430r1425b1507],
41	associated	VBN	O	associate	ccomp	28	SENT_123	[p7l1467t1429r1908b1508],
42	with	IN	O	with	_	0	SENT_123	[p7l1942t1429r2134b1508],
43	decreased	VBN	O	decrease	amod	46	SENT_123	[p7l12t1557r425b1636],
44	clopidogrel	NN	O	clopidogrel	nn	46	SENT_123	[p7l469t1557r941b1658],
45	metabolic	JJ	O	metabolic	amod	46	SENT_123	[p7l983t1557r1399b1636],
46	activation	NN	O	activation	prep_with	41	SENT_123	[p7l1441t1558r1871b1653],
47	,	,	O	,	_	0	SENT_123	[p7l1441t1558r1871b1653],
48	a	DT	O	a	det	51	SENT_123	[p7l1918t1583r1963b1635],
49	decreased	VBN	O	decrease	amod	51	SENT_123	[p7l2005t1557r2132b1636, p7l12t1684r325b1763],
50	antiplatelet	JJ	O	antiplatelet	amod	51	SENT_123	[p7l364t1684r838b1784],
51	effect	NN	O	effect	conj_and	46	SENT_123	[p7l874t1683r1129b1780],
52	,	,	O	,	_	0	SENT_123	[p7l874t1683r1129b1780],
53	and	CC	O	and	_	0	SENT_123	[p7l1174t1684r1329b1763],
54	an	DT	O	a	det	56	SENT_123	[p7l1368t1710r1470b1762],
55	increased	VBN	O	increase	amod	56	SENT_123	[p7l1508t1684r1908b1763],
56	likelihood	NN	O	likelihood	conj_and	46	SENT_123	[p7l1947t1684r2132b1764, p7l10t1813r284b1892],
57	of	IN	O	of	_	0	SENT_123	[p7l332t1812r432b1892],
58	a	DT	O	a	det	60	SENT_123	[p7l462t1839r506b1891],
59	cardiovascular	JJ	O	cardiovascular	amod	60	SENT_123	[p7l554t1813r1181b1892],
60	event	NN	O	event	prep_of	19	SENT_123	[p7l1227t1818r1645b1892],
61	.34	CD	NUMBER	.34	npadvmod	62	SENT_123	[p7l1227t1818r1645b1892],
62	>	JJR	O	>	xcomp	17	SENT_123	[p7l1227t1818r1645b1892],
63	35	CD	NUMBER	35	dobj	14	SENT_123	[p7l1227t1818r1645b1892],
64	These	DT	O	these	det	65	SENT_123	[p7l1693t1813r1945b1891],
65	observations	NNS	O	observation	dep	63	SENT_123	[p7l1994t1813r2132b1892, p7l12t1942r444b2020],

1	have	VBP	O	have	aux	3	SENT_124	[p7l475t1941r665b2020],
2	been	VBN	O	be	auxpass	3	SENT_124	[p7l694t1941r896b2020],
3	confirmed	VBN	O	confirm	_	0	SENT_124	[p7l924t1940r1378b2020],
4	in	IN	O	in	_	0	SENT_124	[p7l1405t1942r1488b2019],
5	a	DT	O	a	det	8	SENT_124	[p7l1516t1967r1560b2019],
6	genomewide	JJ	O	genomewide	amod	8	SENT_124	[p7l1587t1941r2133b2042],
7	association	NN	O	association	nn	8	SENT_124	[p7l11t2070r494b2147],
8	study	NN	O	study	prep_in	3	SENT_124	[p7l535t2069r858b2168],
9	.34	CD	NUMBER	.34	nsubjpass	3	SENT_124	[p7l535t2069r858b2168],

1	Early	RB	O	early	advmod	7	SENT_125	[p7l138t2197r355b2297],
2	in	IN	O	in	_	0	SENT_125	[p7l382t2198r465b2275],
3	2010	CD	DATE	2010	prep_in	1	SENT_125	[p7l497t2203r718b2293],
4	,	,	O	,	_	0	SENT_125	[p7l497t2203r718b2293],
5	the	DT	O	the	det	6	SENT_125	[p7l755t2197r888b2275],
6	FDA	NNP	ORGANIZATION	FDA	nsubj	7	SENT_125	[p7l919t2203r1103b2275],
7	added	VBD	O	add	_	0	SENT_125	[p7l1131t2197r1386b2276],
8	a	DT	O	a	det	10	SENT_125	[p7l1416t2223r1461b2275],
9	boxed	JJ	O	boxed	amod	10	SENT_125	[p7l1491t2197r1744b2276],
10	warning	NN	O	warning	dobj	7	SENT_125	[p7l1771t2198r2137b2298],
11	to	TO	O	to	_	0	SENT_125	[p7l12t2342r92b2404],
12	prescribing	VBG	O	prescribe	amod	13	SENT_125	[p7l136t2325r628b2426],
13	information	NN	O	information	prep_to	7	SENT_125	[p7l667t2324r1190b2404],
14	for	IN	O	for	_	0	SENT_125	[p7l1233t2324r1356b2404],
15	clopidogrel	NN	O	clopidogrel	prep_for	13	SENT_125	[p7l1397t2325r1902b2426],
16	,	,	O	,	_	0	SENT_125	[p7l1397t2325r1902b2426],
17	stating	VBG	O	state	partmod	7	SENT_125	[p7l1953t2342r2132b2403, p7l11t2454r150b2554],
18	that	IN	O	that	complm	38	SENT_125	[p7l193t2453r366b2531],
19	persons	NNS	O	person	nsubj	38	SENT_125	[p7l405t2479r741b2553],
20	with	IN	O	with	_	0	SENT_125	[p7l785t2453r980b2532],
21	a	DT	O	a	det	22	SENT_125	[p7l1026t2479r1070b2531],
22	CYPZCI9	NN	O	cypzci9	prep_with	19	SENT_125	[p7l1114t2459r1459b2531],
23	variant	JJ	O	variant	amod	22	SENT_125	[p7l1501t2454r1804b2532],
24	encoding	VBG	O	encode	partmod	22	SENT_125	[p7l1846t2453r2132b2532, p7l11t2582r150b2682],
25	a	DT	O	a	det	26	SENT_125	[p7l186t2607r230b2659],
26	form	NN	O	form	dobj	24	SENT_125	[p7l269t2580r479b2660],
27	of	IN	O	of	_	0	SENT_125	[p7l520t2580r620b2660],
28	the	DT	O	the	det	29	SENT_125	[p7l642t2581r775b2659],
29	enzyme	NN	O	enzyme	prep_of	26	SENT_125	[p7l816t2607r1145b2681],
30	associated	VBN	O	associate	partmod	29	SENT_125	[p7l1185t2581r1630b2660],
31	with	IN	O	with	_	0	SENT_125	[p7l1665t2581r1861b2660],
32	a	DT	O	a	det	34	SENT_125	[p7l1900t2607r1944b2659],
33	low	JJ	O	low	amod	34	SENT_125	[p7l1982t2581r2138b2660],
34	rate	NN	O	rate	prep_with	30	SENT_125	[p7l11t2726r171b2787],
35	of	IN	O	of	_	0	SENT_125	[p7l227t2708r327b2788],
36	metabolism	NN	O	metabolism	prep_of	34	SENT_125	[p7l364t2709r875b2788],
37	might	MD	O	might	aux	38	SENT_125	[p7l930t2709r1190b2810],
38	require	VB	O	require	ccomp	17	SENT_125	[p7l1241t2710r1546b2809],
39	dose	NN	O	dose	nn	40	SENT_125	[p7l1602t2709r1796b2788],
40	adjustment	NN	O	adjustment	dobj	38	SENT_125	[p7l1852t2709r2132b2809, p7l11t2854r232b2915],
41	or	CC	O	or	_	0	SENT_125	[p7l269t2863r357b2916],
42	the	DT	O	the	det	43	SENT_125	[p7l395t2837r528b2915],
43	use	NN	O	use	conj_or	40	SENT_125	[p7l569t2863r709b2916],
44	of	IN	O	of	_	0	SENT_125	[p7l751t2836r851b2916],
45	a	DT	O	a	det	47	SENT_125	[p7l873t2863r918b2915],
46	different	JJ	O	different	amod	47	SENT_125	[p7l957t2836r1334b2916],
47	drug	NN	O	drug	prep_of	43	SENT_125	[p7l1370t2837r1672b2938],
48	.36	CD	NUMBER	.36	nsubj	64	SENT_125	[p7l1370t2837r1672b2938],
49	After	IN	O	after	_	0	SENT_125	[p7l1711t2836r1933b2915],
50	this	DT	O	this	det	52	SENT_125	[p7l1971t2837r2131b2915],
51	FDA	NNP	O	FDA	nn	52	SENT_125	[p7l10t2970r194b3041],
52	action	NN	O	action	prep_after	48	SENT_125	[p7l225t2965r510b3059],
53	,	,	O	,	_	0	SENT_125	[p7l225t2965r510b3059],
54	the	DT	O	the	det	57	SENT_125	[p7l550t2964r683b3041],
55	American	JJ	O	american	amod	57	SENT_125	[p7l714t2965r1133b3041],
56	Heart	NNP	ORGANIZATION	Heart	nn	57	SENT_125	[p7l1167t2971r1413b3041],
57	Association	NNP	ORGANIZATION	Association	conj_and	52	SENT_125	[p7l1439t2965r1943b3042],
58	and	CC	O	and	_	0	SENT_125	[p7l1976t2964r2134b3042],
59	the	DT	O	the	det	61	SENT_125	[p7l12t3092r142b3170],
60	American	NNP	ORGANIZATION	American	nn	61	SENT_125	[p7l172t3093r585b3170],
61	College	NNP	ORGANIZATION	College	conj_and	52	SENT_125	[p7l620t3092r931b3193],
62	of	IN	ORGANIZATION	of	_	0	SENT_125	[p7l966t3091r1065b3171],
63	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	61	SENT_125	[p7l1080t3092r1546b3193],
64	issued	VBD	O	issue	rcmod	47	SENT_125	[p7l1574t3092r1837b3171],
65	a	DT	O	a	det	67	SENT_125	[p7l1870t3118r1915b3170],
66	joint	JJ	O	joint	amod	67	SENT_125	[p7l1933t3093r2138b3192],
67	endorsement	NN	O	endorsement	dobj	64	SENT_125	[p7l12t3220r572b3299],
68	of	IN	O	of	_	0	SENT_125	[p7l607t3219r706b3299],
69	CYPZCI9	NN	O	cypzci9	nn	70	SENT_125	[p7l726t3227r1071b3298],
70	genotyping	NN	O	genotyping	prep_of	67	SENT_125	[p7l1108t3221r1599b3321],
71	for	IN	O	for	_	0	SENT_125	[p7l1633t3219r1756b3299],
72	patients	NNS	O	patient	prep_for	64	SENT_125	[p7l1790t3221r2131b3320],
73	at	IN	O	at	_	0	SENT_125	[p7l11t3365r88b3426],
74	moderate	JJ	O	moderate	amod	77	SENT_125	[p7l116t3348r512b3427],
75	or	CC	O	or	_	0	SENT_125	[p7l546t3374r634b3427],
76	high	JJ	O	high	amod	77	SENT_125	[p7l663t3348r855b3449],
77	risk	NN	O	risk	prep_at	72	SENT_125	[p7l888t3348r1048b3427],
78	for	IN	O	for	_	0	SENT_125	[p7l1077t3347r1198b3427],
79	cardiovascular	JJ	O	cardiovascular	amod	80	SENT_125	[p7l1229t3348r1842b3427],
80	events	NNS	O	event	prep_for	77	SENT_125	[p7l1873t3365r2130b3427],
81	who	WP	O	who	nsubjpass	83	SENT_125	[p7l7t3476r189b3555],
82	are	VBP	O	be	auxpass	83	SENT_125	[p7l231t3502r360b3554],
83	treated	VBN	O	treat	rcmod	72	SENT_125	[p7l402t3476r700b3555],
84	with	IN	O	with	_	0	SENT_125	[p7l737t3476r932b3555],
85	clopidogrel	NN	O	clopidogrel	prep_with	83	SENT_125	[p7l973t3476r1556b3577],
86	.37	CD	NUMBER	.37	num	85	SENT_125	[p7l973t3476r1556b3577],
87	This	DT	O	this	det	89	SENT_125	[p7l1595t3476r1782b3554],
88	genetic	JJ	O	genetic	amod	89	SENT_125	[p7l1825t3477r2134b3577],
89	test	NN	O	test	nsubj	92	SENT_125	[p7l12t3621r166b3682],
90	is	VBZ	O	be	cop	92	SENT_125	[p7l193t3605r258b3681],
91	Widely	RB	O	widely	advmod	92	SENT_125	[p7l288t3604r568b3703],
92	available	JJ	O	available	rcmod	85	SENT_125	[p7l595t3604r967b3683],
93	in	IN	O	in	_	0	SENT_125	[p7l999t3605r1082b3681],
94	the	DT	O	the	det	96	SENT_125	[p7l1115t3604r1248b3682],
95	United	NNP	LOCATION	United	nn	96	SENT_125	[p7l1280t3604r1567b3682],
96	States	NNPS	LOCATION	States	prep_in	92	SENT_125	[p7l1601t3610r1868b3682],
97	.	.	O	.	_	0	SENT_125	[p7l1601t3610r1868b3682],

1	However	RB	O	however	_	0	SENT_126	[p7l1903t3611r2132b3683, p8l12t47r197b117],
2	,	,	O	,	_	0	SENT_126	[p7l1903t3611r2132b3683, p8l12t47r197b117],

1	enthusiasm	NN	O	enthusiasm	nsubjpass	7	SENT_127	[p8l240t21r726b100],
2	for	IN	O	for	_	0	SENT_127	[p8l763t20r884b100],
3	its	PRP$	O	its	poss	4	SENT_127	[p8l917t22r1013b99],
4	use	NN	O	use	prep_for	1	SENT_127	[p8l1053t47r1191b100],
5	has	VBZ	O	have	aux	7	SENT_127	[p8l1228t21r1370b99],
6	been	VBN	O	be	auxpass	7	SENT_127	[p8l1410t21r1608b100],
7	muted	VBN	O	mute	_	0	SENT_127	[p8l1645t21r1934b117],
8	,	,	O	,	_	0	SENT_127	[p8l1645t21r1934b117],
9	owing	VBG	O	owe	xcomp	7	SENT_127	[p8l1979t47r2132b100, p8l11t151r148b251],
10	to	TO	O	to	_	0	SENT_127	[p8l180t167r260b229],
11	a	DT	O	a	det	12	SENT_127	[p8l297t176r341b228],
12	lack	NN	O	lack	prep_to	9	SENT_127	[p8l373t150r546b229],
13	of	IN	O	of	_	0	SENT_127	[p8l577t149r676b229],
14	clarity	NN	O	clarity	prep_of	12	SENT_127	[p8l694t150r958b250],
15	with	IN	O	with	_	0	SENT_127	[p8l984t150r1176b229],
16	regard	NN	O	regard	prep_with	9	SENT_127	[p8l1212t150r1484b251],
17	to	TO	O	to	_	0	SENT_127	[p8l1519t167r1599b229],
18	the	DT	O	the	det	20	SENT_127	[p8l1636t150r1767b228],
19	optimal	JJ	O	optimal	amod	20	SENT_127	[p8l1804t150r2134b250],
20	treatment	NN	O	treatment	prep_to	9	SENT_127	[p8l12t294r435b355],
21	of	IN	O	of	_	0	SENT_127	[p8l475t276r575b356],
22	patients	NNS	O	patient	prep_of	20	SENT_127	[p8l599t278r940b377],
23	who	WP	O	who	nsubj	24	SENT_127	[p8l982t277r1164b357],
24	carry	VBP	O	carry	rcmod	22	SENT_127	[p8l1210t303r1431b377],
25	a	DT	O	a	det	27	SENT_127	[p8l1471t303r1515b355],
26	CYPZCI9	NN	O	cypzci9	nn	27	SENT_127	[p8l1557t284r1902b355],
27	variant	NN	O	variant	dobj	24	SENT_127	[p8l1941t278r2132b356, p8l11t423r169b502],
28	,	,	O	,	_	0	SENT_127	[p8l1941t278r2132b356, p8l11t423r169b502],
29	as	IN	O	as	mark	30	SENT_127	[p8l216t432r301b484],
30	shown	VBN	O	show	advcl	7	SENT_127	[p8l346t406r628b485],
31	by	IN	O	by	_	0	SENT_127	[p8l670t406r767b506],
32	data	NNS	O	datum	prep_by	30	SENT_127	[p8l805t406r987b485],
33	from	IN	O	from	_	0	SENT_127	[p8l1027t405r1238b485],
34	two	CD	NUMBER	two	num	38	SENT_127	[p8l1280t423r1438b485],
35	large	JJ	O	large	amod	38	SENT_127	[p8l1479t406r1716b507],
36	,	,	O	,	_	0	SENT_127	[p8l1479t406r1716b507],
37	randomized	JJ	O	randomized	amod	38	SENT_127	[p8l1764t406r2132b485, p8l11t534r188b613],
38	trials	NNS	O	trial	prep_from	30	SENT_127	[p8l229t534r447b612],
39	in	IN	O	in	_	0	SENT_127	[p8l489t535r572b612],
40	which	WDT	O	which	rel	45	SENT_127	[p8l608t534r870b613],
41	CYPZCI9	NN	O	cypzci9	nn	42	SENT_127	[p8l910t540r1255b612],
42	genotyping	NN	O	genotyping	nsubj	45	SENT_127	[p8l1294t535r1785b635],
43	did	VBD	O	do	aux	45	SENT_127	[p8l1822t534r1956b613],
44	not	RB	O	not	neg	45	SENT_127	[p8l1996t551r2138b613],
45	have	VB	O	have	rcmod	38	SENT_127	[p8l11t662r201b741],
46	a	DT	O	a	det	48	SENT_127	[p8l238t688r282b740],
47	signiﬁcant	JJ	O	signiﬁcant	amod	48	SENT_127	[p8l319t661r787b763],
48	effect	NN	O	effect	dobj	45	SENT_127	[p8l821t661r1062b741],
49	on	IN	O	on	_	0	SENT_127	[p8l1095t688r1201b741],
50	the	DT	O	the	det	51	SENT_127	[p8l1239t662r1372b740],
51	incidence	NN	O	incidence	prep_on	45	SENT_127	[p8l1409t662r1813b741],
52	of	IN	O	of	_	0	SENT_127	[p8l1852t661r1952b741],
53	cardiovascular	JJ	O	cardiovascular	amod	54	SENT_127	[p8l1971t688r2132b740, p8l12t790r504b869],
54	events	NNS	O	event	prep_of	51	SENT_127	[p8l565t807r829b869],
55	among	IN	O	among	_	0	SENT_127	[p8l893t816r1193b891],
56	patients	NNS	O	patient	prep_among	45	SENT_127	[p8l1251t791r1592b890],
57	With	IN	O	with	dep	66	SENT_127	[p8l1653t790r1848b869],
58	acute	JJ	O	acute	amod	60	SENT_127	[p8l1911t807r2133b869],
59	coronary	JJ	O	coronary	amod	60	SENT_127	[p8l12t943r397b1017],
60	syndromes	NNS	O	syndrome	pobj	57	SENT_127	[p8l427t917r892b1017],
61	or	CC	O	or	_	0	SENT_127	[p8l929t943r1017b996],
62	atrial	JJ	O	atrial	amod	63	SENT_127	[p8l1048t917r1274b995],
63	fibrillation	NN	O	fibrillation	pobj	57	SENT_127	[p8l1307t916r1973b996],
64	.38	CD	NUMBER	.38	num	65	SENT_127	[p8l1307t916r1973b996],
65	>	JJR	O	>	dep	63	SENT_127	[p8l1307t916r1973b996],
66	39	CD	NUMBER	39	rcmod	56	SENT_127	[p8l1307t916r1973b996],
67	On	IN	O	on	dep	66	SENT_127	[p8l2007t923r2133b996],
68	the	DT	O	the	det	70	SENT_127	[p8l12t1045r142b1123],
69	other	JJ	O	other	amod	70	SENT_127	[p8l182t1045r406b1124],
70	hand	NN	O	hand	pobj	67	SENT_127	[p8l442t1045r677b1141],
71	,	,	O	,	_	0	SENT_127	[p8l442t1045r677b1141],
72	in	IN	O	in	dep	66	SENT_127	[p8l721t1046r803b1123],
73	a	DT	O	a	det	77	SENT_127	[p8l843t1071r887b1123],
74	recent	JJ	O	recent	amod	77	SENT_127	[p8l925t1062r1184b1123],
75	meta	NN	O	meta	nn	77	SENT_127	[p8l1219t1045r1793b1145],
76	—	NN	O	—	nn	77	SENT_127	[p8l1219t1045r1793b1145],
77	analysis	NN	O	analysis	pobj	72	SENT_127	[p8l1219t1045r1793b1145],
78	of	IN	O	of	_	0	SENT_127	[p8l1835t1044r1934b1124],
79	data	NNS	O	datum	prep_of	77	SENT_127	[p8l1956t1045r2135b1124],
80	from	IN	O	from	_	0	SENT_127	[p8l11t1173r221b1253],
81	nine	CD	NUMBER	nine	num	83	SENT_127	[p8l270t1175r457b1252],
82	pharmacogenetic	JJ	O	pharmacogenetic	amod	83	SENT_127	[p8l505t1174r1253b1275],
83	studies	NNS	O	study	prep_from	45	SENT_127	[p8l1303t1174r1603b1253],
84	of	IN	O	of	_	0	SENT_127	[p8l1654t1173r1754b1253],
85	clopido	NN	O	clopido	nn	86	SENT_127	[p8l1784t1174r2132b1274],
86	—	NN	O	—	prep_of	83	SENT_127	[p8l1784t1174r2132b1274],

1	A	DT	O	a	det	2	SENT_128	[p9l57t60r100b108],
2	Hospitalization	NN	O	hospitalization	_	0	SENT_128	[p9l146t64r517b122],
3	for	IN	O	for	_	0	SENT_128	[p9l536t63r605b109],
4	Any	DT	O	any	det	5	SENT_128	[p9l620t68r714b123],
5	Cause	NN	O	cause	prep_for	2	SENT_128	[p9l731t67r882b109],

1	3	CD	NUMBER	3	num	4	SENT_129	[p9l204t158r257b197],
2	°	NN	O	°	nn	4	SENT_129	[p9l204t158r257b197],
3	Hazard	NN	O	hazard	nn	4	SENT_129	[p9l335t185r497b228],
4	ratio	NN	O	ratio	_	0	SENT_129	[p9l519t189r632b235],
5	,	,	O	,	_	0	SENT_129	[p9l519t189r632b235],
6	0.69	CD	PERCENT	0.69	number	7	SENT_129	[p9l652t188r746b228],
7	(	CD	PERCENT	(	appos	4	SENT_129	[p9l770t188r885b241],
8	95	CD	PERCENT	95	number	9	SENT_129	[p9l770t188r885b241],
9	%	NN	PERCENT	%	amod	10	SENT_129	[p9l770t188r885b241],
10	CI	NN	O	ci	dep	4	SENT_129	[p9l904t189r962b235],
11	,	,	O	,	_	0	SENT_129	[p9l904t189r962b235],
12	0.58-0	CD	NUMBER	0.58-0	num	14	SENT_129	[p9l982t188r1224b241],
13	.82	CD	NUMBER	.82	num	14	SENT_129	[p9l982t188r1224b241],
14	)	NN	O	)	appos	10	SENT_129	[p9l982t188r1224b241],

1	P	NN	O	p	_	0	SENT_130	[p9l335t257r522b296],
2	<	JJR	O	<	dep	1	SENT_130	[p9l335t257r522b296],
3	0.001	CD	NUMBER	0.001	dep	1	SENT_130	[p9l335t257r522b296],

1	Ix	NN	O	ix	_	0	SENT_131	[p9l203t284r227b322],
2	)	CD	NUMBER	)	num	3	SENT_131	[p9l203t284r227b322],
3	5	CD	NUMBER	5	dep	1	SENT_131	[p9l232t284r253b323],

1	Historical	JJ	O	historical	amod	3	SENT_132	[p9l1202t323r1420b365],
2	control	NN	O	control	nn	3	SENT_132	[p9l1440t323r1599b365],
3	ix	NN	O	ix	_	0	SENT_132	[p9l203t409r227b447],
4	)	NN	O	)	nn	5	SENT_132	[p9l203t409r227b447],
5	o	NN	O	o	dep	3	SENT_132	[p9l231t408r257b448],

1	Intervention	NN	O	intervention	nn	2	SENT_133	[p9l1621t598r1895b637],
2	group	NN	O	group	_	0	SENT_133	[p9l1916t609r2050b650],

1	I-1	NN	O	i-1	nn	2	SENT_134	[p9l207t659r225b697],
2	o	NN	O	o	_	0	SENT_134	[p9l231t658r257b698],

1	Risk	NN	O	risk	_	0	SENT_135	[p9l87t785r132b884],
2	of	IN	O	of	_	0	SENT_135	[p9l86t712r132b768],
3	Hospitalization	NN	O	hospitalization	prep_of	1	SENT_135	[p9l87t330r146b701],
4	(	CD	PERCENT	(	num	5	SENT_135	[p9l90t227r147b306],
5	%	NN	PERCENT	%	dep	1	SENT_135	[p9l90t227r147b306],
6	)	CD	NUMBER	)	dep	5	SENT_135	[p9l90t227r147b306],

1	U1	NN	O	u1	_	0	SENT_136	[p9l232t785r253b823],
2	5	CD	NUMBER	5	num	1	SENT_136	[p9l207t534r253b573],

1	I	PRP	O	I	_	0	SENT_137	[p9l408t815r478b852],

1	o	NN	O	o	nn	2	SENT_138	[p9l231t909r257b949],
2	o	NN	O	o	_	0	SENT_138	[p9l278t972r303b1012],
3	10	CD	NUMBER	10	number	4	SENT_138	[p9l365t972r415b1012],
4	20	CD	NUMBER	20	num	6	SENT_138	[p9l459t972r512b1012],
5	30	CD	NUMBER	30	number	6	SENT_138	[p9l558t972r610b1012],
6	40	CD	NUMBER	40	dep	2	SENT_138	[p9l653t972r708b1012],
7	50	CD	NUMBER	50	number	8	SENT_138	[p9l752t972r805b1012],
8	60	CD	NUMBER	60	dep	2	SENT_138	[p9l851t972r903b1012],
9	70	CD	NUMBER	70	num	11	SENT_138	[p9l950t972r1000b1012],
10	80 90 100110120	CD	NUMBER	80 90 100110120	num	11	SENT_138	[p9l1230t972r2088b1012],[p9l1045t972r1098b1012],
11	130140l5016017018O	NN	O	130140l5016017018o	dep	8	SENT_138	[p9l1230t972r2088b1012],

1	Days	NNS	DURATION	day	_	0	SENT_139	[p9l795t1071r913b1126],
2	after	IN	O	after	_	0	SENT_139	[p9l932t1066r1044b1112],
3	Onset	NN	O	onset	prep_after	1	SENT_139	[p9l1060t1070r1211b1112],
4	of	IN	O	of	_	0	SENT_139	[p9l1226t1066r1283b1112],
5	Treatment	NN	O	treatment	prep_of	1	SENT_139	[p9l1289t1071r1547b1112],

1	B	NN	O	b	nn	2	SENT_140	[p9l62t1238r97b1286],
2	Hospitalization	NN	O	hospitalization	_	0	SENT_140	[p9l145t1242r517b1300],
3	for	IN	O	for	_	0	SENT_140	[p9l536t1241r604b1287],
4	Bleeding	NN	O	bleeding	prep_for	2	SENT_140	[p9l624t1242r836b1301],
5	or	CC	O	or	_	0	SENT_140	[p9l852t1257r903b1287],
6	Thromboembolism	NN	O	thromboembolism	prep_for	2	SENT_140	[p9l917t1242r1389b1287],

1	1	CD	NUMBER	1	number	2	SENT_141	[p9l207t1339r257b1379],
2	°	CD	NUMBER	°	num	10	SENT_141	[p9l207t1339r257b1379],
3	Hazard	NN	O	hazard	nn	10	SENT_141	[p9l335t1367r497b1409],
4	ratio	NN	O	ratio	nn	10	SENT_141	[p9l519t1371r632b1417],
5	,	,	O	,	_	0	SENT_141	[p9l519t1371r632b1417],
6	0.72	CD	PERCENT	0.72	number	7	SENT_141	[p9l652t1370r746b1410],
7	(	CD	PERCENT	(	amod	10	SENT_141	[p9l770t1369r885b1423],
8	95	CD	PERCENT	95	num	9	SENT_141	[p9l770t1369r885b1423],
9	%	NN	PERCENT	%	dep	7	SENT_141	[p9l770t1369r885b1423],
10	CI	NN	O	ci	_	0	SENT_141	[p9l904t1370r962b1417],
11	,	,	O	,	_	0	SENT_141	[p9l904t1370r962b1417],
12	0.53-0	CD	NUMBER	0.53-0	appos	10	SENT_141	[p9l982t1370r1224b1423],
13	.97	CD	NUMBER	.97	num	14	SENT_141	[p9l982t1370r1224b1423],
14	)	NN	O	)	dep	10	SENT_141	[p9l982t1370r1224b1423],

1	P	NN	O	p	_	0	SENT_142	[p9l335t1438r493b1478],
2	=	JJ	O	=	amod	1	SENT_142	[p9l335t1438r493b1478],
3	0.03	CD	NUMBER	0.03	tmod	2	SENT_142	[p9l335t1438r493b1478],

1	Historical	JJ	O	historical	amod	2	SENT_143	[p9l1197t1571r1415b1613],
2	control	NN	O	control	_	0	SENT_143	[p9l1435t1571r1594b1613],

1	Intervention	NN	O	intervention	nn	2	SENT_144	[p9l1621t1810r1895b1848],
2	group	NN	O	group	nsubj	13	SENT_144	[p9l1916t1821r2050b1862],
3	i	FW	O	i	nn	5	SENT_144	[p9l90t1427r147b1491],
4	E.	FW	O	e.	nn	5	SENT_144	[p9l102t1514r132b1539],
5	o	NN	O	o	dep	2	SENT_144	[p9l102t1544r132b1573],
6	°	CD	NUMBER	°	dep	2	SENT_144	[p9l88t1577r132b1608, p9l102t1610r132b1635],
7	:	:	O	:	_	0	SENT_144	[p9l88t1577r132b1608, p9l102t1610r132b1635],
8	N	NNP	O	N	dep	2	SENT_144	[p9l88t1577r132b1608, p9l102t1610r132b1635],
9	.5	CD	NUMBER	.5	num	8	SENT_144	[p9l88t1638r131b1674],
10	Ta	NNP	O	Ta	dep	8	SENT_144	[p9l87t1680r132b1718],
11	.4	CD	NUMBER	.4	num	10	SENT_144	[p9l88t1720r132b1751],
12	:	:	O	:	_	0	SENT_144	[p9l88t1720r132b1751],
13	ca	MD	O	can	_	0	SENT_144	[p9l102t1755r146b1783],
14	.	.	O	.	_	0	SENT_144	[p9l102t1755r146b1783],

1	In	IN	O	in	dep	3	SENT_145	[p9l102t1788r132b1812],
2	o	NN	O	o	pobj	1	SENT_145	[p9l102t1814r132b1843],
3	I	PRP	O	I	_	0	SENT_145	[p9l91t1849r132b1886],
4	Ho	NNP	O	Ho	nn	5	SENT_145	[p9l86t1897r131b1923, p9l102t1924r132b1953],
5	A	NNP	O	A	dep	3	SENT_145	[p9l87t1969r131b1994],
6	:	:	O	:	_	0	SENT_145	[p9l87t1969r131b1994],
7	J2	NN	O	j2	dep	5	SENT_145	[p9l88t1999r132b2036],
8	n	NN	O	n	dep	7	SENT_145	[p9l91t2040r131b2069],
9	:	:	O	:	_	0	SENT_145	[p9l91t2040r131b2069],

1	Days	NNS	DURATION	day	_	0	SENT_146	[p9l795t2258r913b2314],
2	after	IN	O	after	_	0	SENT_146	[p9l932t2254r1044b2300],
3	Onset	NN	O	onset	prep_after	1	SENT_146	[p9l1060t2258r1211b2300],
4	of	IN	O	of	_	0	SENT_146	[p9l1226t2254r1283b2300],
5	Treatment	NN	O	treatment	prep_of	1	SENT_146	[p9l1289t2258r1547b2300],

1	Figure	NN	O	figure	_	0	SENT_147	[p9l65t2416r228b2478],
2	2	CD	NUMBER	2	dep	1	SENT_147	[p9l248t2419r294b2463],
3	.	.	O	.	_	0	SENT_147	[p9l248t2419r294b2463],

1	Risk	NN	O	risk	_	0	SENT_148	[p9l320t2415r427b2464],
2	of	IN	O	of	_	0	SENT_148	[p9l446t2414r507b2463],
3	Hospitalization	NN	O	hospitalization	prep_of	1	SENT_148	[p9l520t2415r921b2477],
4	among	IN	O	among	_	0	SENT_148	[p9l945t2431r1128b2478],
5	Patients	NNS	O	patient	prep_among	3	SENT_148	[p9l1152t2416r1364b2464],
6	Who	WP	O	who	nsubj	7	SENT_148	[p9l1384t2415r1507b2464],
7	Underwent	VBD	O	undergo	rcmod	5	SENT_148	[p9l1530t2415r1828b2464],
8	VKORC1	NN	O	vkorc1	nn	11	SENT_148	[p9l1849t2419r2072b2464],
9	and	CC	O	and	_	0	SENT_148	[p9l62t2495r156b2544],
10	CYP2C9	NN	O	cyp2c9	nn	11	SENT_148	[p9l179t2499r394b2544],
11	Genotyping	NN	O	genotyping	dobj	7	SENT_148	[p9l412t2496r737b2559],
12	,	,	O	,	_	0	SENT_148	[p9l412t2496r737b2559],
13	as	IN	O	as	_	0	SENT_148	[p9l760t2511r815b2544],
14	Compared	VBN	O	compare	prepc_as	7	SENT_148	[p9l837t2495r1110b2558],
15	with	IN	O	with	pcomp	14	SENT_148	[p9l1132t2495r1244b2544],
16	a	DT	O	a	det	19	SENT_148	[p9l1268t2512r1295b2544],
17	Historical	JJ	ORGANIZATION	historical	amod	19	SENT_148	[p9l1320t2495r1574b2544],
18	Control	NNP	ORGANIZATION	Control	nn	19	SENT_148	[p9l1596t2495r1791b2544],
19	Group	NNP	ORGANIZATION	Group	pobj	15	SENT_148	[p9l1813t2499r1995b2558],
20	,	,	O	,	_	0	SENT_148	[p9l1813t2499r1995b2558],
21	6	CD	DURATION	6	num	22	SENT_148	[p9l62t2580r91b2624],
22	Months	NNS	DURATION	month	appos	19	SENT_148	[p9l115t2576r316b2624],
23	after	IN	O	after	_	0	SENT_148	[p9l338t2575r462b2624],
24	the	DT	O	the	det	25	SENT_148	[p9l479t2576r564b2624],
25	Initiation	NN	O	initiation	prep_after	22	SENT_148	[p9l588t2577r821b2624],
26	of	IN	O	of	_	0	SENT_148	[p9l844t2575r1141b2624],
27	'	''	O	'	_	0	SENT_148	[p9l844t2575r1141b2624],
28	Warfarin	NNP	O	Warfarin	nn	29	SENT_148	[p9l844t2575r1141b2624],
29	Therapy	NN	O	therapy	prep_of	25	SENT_148	[p9l1163t2576r1390b2639],
30	.	.	O	.	_	0	SENT_148	[p9l1163t2576r1390b2639],

1	Shown	VBN	O	show	csubj	4	SENT_149	[p9l63t2672r236b2720],
2	are	VBP	O	be	cop	4	SENT_149	[p9l260t2689r337b2720],
3	the	DT	O	the	det	4	SENT_149	[p9l355t2672r438b2720],
4	rates	NNS	O	rate	_	0	SENT_149	[p9l461t2681r583b2720],
5	of	IN	O	of	_	0	SENT_149	[p9l605t2671r662b2720],
6	hospitalization	NN	O	hospitalization	prep_of	4	SENT_149	[p9l676t2672r1059b2735],
7	for	IN	O	for	_	0	SENT_149	[p9l1081t2671r1154b2720],
8	any	DT	O	any	det	11	SENT_149	[p9l1173t2689r1261b2735],
9	cause	NN	O	cause	nn	11	SENT_149	[p9l1280t2689r1427b2720],
10	(	CD	NUMBER	(	num	11	SENT_149	[p9l1454t2672r1610b2735],
11	Panel	NN	O	panel	prep_for	6	SENT_149	[p9l1454t2672r1610b2735],
12	A	DT	O	a	det	13	SENT_149	[p9l1632t2675r1685b2735],
13	)	NN	O	)	dep	6	SENT_149	[p9l1632t2675r1685b2735],
14	and	CC	O	and	_	0	SENT_149	[p9l1712t2672r1804b2720],
15	for	IN	O	for	dep	6	SENT_149	[p9l1826t2671r1899b2720],
16	bleeding	VBG	O	bleed	pobj	15	SENT_149	[p9l1920t2672r2078b2720, p9l64t2757r143b2816],
17	or	CC	O	or	_	0	SENT_149	[p9l164t2769r218b2801],
18	thromboembolism	NN	O	thromboembolism	nn	21	SENT_149	[p9l236t2752r737b2801],
19	(	CD	NUMBER	(	num	21	SENT_149	[p9l768t2752r928b2815],
20	Panel	NN	O	panel	nn	21	SENT_149	[p9l768t2752r928b2815],
21	B	NN	O	b	conj_or	6	SENT_149	[p9l957t2756r1022b2815],
22	)	NN	O	)	dep	21	SENT_149	[p9l957t2756r1022b2815],
23	.	.	O	.	_	0	SENT_149	[p9l957t2756r1022b2815],

1	There	EX	O	there	expl	2	SENT_150	[p9l1044t2752r1196b2801],
2	was	VBD	O	be	_	0	SENT_150	[p9l1216t2769r1315b2801],
3	a	DT	O	a	det	5	SENT_150	[p9l1339t2769r1364b2801],
4	significant	JJ	O	significant	amod	5	SENT_150	[p9l1388t2751r1667b2816],
5	benefit	NN	O	benefit	nsubj	2	SENT_150	[p9l1690t2751r1876b2801],
6	for	IN	O	for	_	0	SENT_150	[p9l1895t2751r1969b2801],
7	patients	NNS	O	patient	prep_for	5	SENT_150	[p9l1992t2769r2070b2815, p9l60t2837r210b2881],
8	who	WP	O	who	nsubj	10	SENT_150	[p9l231t2832r342b2881],
9	had	VBD	O	have	aux	10	SENT_150	[p9l366t2832r458b2881],
10	undergone	VBN	O	undergo	rcmod	7	SENT_150	[p9l485t2832r771b2896],
11	genotyping	VBG	O	genotype	xcomp	10	SENT_150	[p9l793t2837r1093b2896],
12	for	IN	O	for	_	0	SENT_150	[p9l1112t2832r1187b2881],
13	the	DT	O	the	det	14	SENT_150	[p9l1205t2832r1288b2881],
14	presence	NN	O	presence	prep_for	11	SENT_150	[p9l1313t2850r1549b2895],
15	of	IN	O	of	_	0	SENT_150	[p9l1571t2832r1629b2881],
16	VKORC1	NN	O	vkorc1	nn	19	SENT_150	[p9l1644t2836r1866b2881],
17	and	CC	O	and	_	0	SENT_150	[p9l1892t2832r1985b2881],
18	CYP2C9	NN	O	cyp2c9	nn	19	SENT_150	[p9l64t2916r277b2961],
19	variants	NNS	O	variant	prep_of	14	SENT_150	[p9l293t2917r503b2961],
20	that	WDT	O	that	nsubjpass	24	SENT_150	[p9l525t2913r630b2961],
21	have	VBP	O	have	aux	24	SENT_150	[p9l653t2913r771b2961],
22	been	VBN	O	be	auxpass	24	SENT_150	[p9l795t2913r918b2961],
23	significantly	RB	O	significantly	advmod	24	SENT_150	[p9l944t2912r1266b2976],
24	associated	VBN	O	associate	rcmod	14	SENT_150	[p9l1287t2913r1565b2961],
25	with	IN	O	with	_	0	SENT_150	[p9l1588t2913r1698b2961],
26	the	DT	O	the	det	27	SENT_150	[p9l1721t2913r1805b2961],
27	risk	NN	O	risk	prep_with	24	SENT_150	[p9l1829t2913r1920b2961],
28	of	IN	O	of	_	0	SENT_150	[p9l1941t2912r1998b2961],
29	over-anticoagulation	NN	O	over-anticoagulation	prep_of	27	SENT_150	[p9l62t2993r624b3057],
30	.	.	O	.	_	0	SENT_150	[p9l62t2993r624b3057],

1	Data	NNS	O	datum	nsubj	2	SENT_151	[p9l652t2997r772b3041],
2	are	VBP	O	be	_	0	SENT_151	[p9l796t3010r873b3041],
3	from	IN	O	from	_	0	SENT_151	[p9l894t2992r1018b3041],
4	Epstein	NN	PERSON	epstein	prep_from	2	SENT_151	[p9l1047t2997r1237b3056],
5	et	FW	O	et	nn	6	SENT_151	[p9l1262t3002r1310b3041],
6	al.	FW	O	al.	dep	4	SENT_151	[p9l1332t2992r1438b3041],
7	25	CD	NUMBER	25	dep	6	SENT_151	[p9l1332t2992r1438b3041],

1	grel	NN	O	grel	nsubj	2	SENT_152	[p9l11t3266r134b3341],
2	involving	VBG	O	involve	partmod	21	SENT_152	[p9l172t3266r468b3341],
3	9685	CD	DATE	9685	num	4	SENT_152	[p9l504t3270r654b3325],
4	patients	NNS	O	patient	dobj	2	SENT_152	[p9l693t3267r948b3340],
5	who	WP	O	who	nsubj	6	SENT_152	[p9l985t3266r1122b3325],
6	had	VBD	O	have	rcmod	4	SENT_152	[p9l1161t3266r1278b3325],
7	an	DT	O	a	det	10	SENT_152	[p9l1315t3285r1392b3324],
8	acute	JJ	O	acute	amod	10	SENT_152	[p9l1430t3278r1596b3325],
9	coronary	JJ	O	coronary	amod	10	SENT_152	[p9l12t3380r299b3435],
10	syndrome	NN	O	syndrome	dobj	6	SENT_152	[p9l324t3361r640b3435],
11	or	CC	O	or	_	0	SENT_152	[p9l668t3380r734b3420],
12	were	VBD	O	be	aux	13	SENT_152	[p9l756t3380r907b3420],
13	undergoing	VBG	O	undergo	rcmod	4	SENT_152	[p9l934t3361r1308b3436],
14	percuta	JJ	O	percuta	amod	15	SENT_152	[p9l1332t3373r1595b3435],
15	—	NN	O	—	dobj	13	SENT_152	[p9l1332t3373r1595b3435],
16	neous	JJ	O	neous	amod	18	SENT_152	[p9l11t3475r194b3515],
17	coronary	JJ	O	coronary	amod	18	SENT_152	[p9l227t3475r509b3530],
18	intervention	NN	O	intervention	dobj	6	SENT_152	[p9l535t3457r934b3527],
19	,	,	O	,	_	0	SENT_152	[p9l535t3457r934b3527],
20	there	EX	O	there	expl	21	SENT_152	[p9l969t3456r1127b3514],
21	was	VBD	O	be	_	0	SENT_152	[p9l1154t3475r1274b3515],
22	a	DT	O	a	det	24	SENT_152	[p9l1305t3475r1339b3514],
23	significant	JJ	O	significant	amod	24	SENT_152	[p9l1369t3455r1595b3531, p9l12t3563r147b3609],
24	association	NN	O	association	nsubj	21	SENT_152	[p9l165t3552r518b3610],
25	between	IN	O	between	_	0	SENT_152	[p9l540t3551r803b3610],
26	homozygosity	NN	O	homozygosity	prep_between	24	SENT_152	[p9l825t3551r1268b3626],
27	or	CC	O	or	_	0	SENT_152	[p9l1287t3570r1353b3610],
28	heterozygosity	NN	O	heterozygosity	conj_or	26	SENT_152	[p9l1372t3551r1595b3610, p9l11t3647r269b3721],
29	for	IN	O	for	_	0	SENT_152	[p9l293t3645r384b3705],
30	CYPZCI9	NN	O	cypzci9	nn	32	SENT_152	[p9l409t3651r662b3704],
31	reduced-function	NN	O	reduced-function	nn	32	SENT_152	[p9l690t3645r1230b3705],
32	alleles	NNS	O	allele	prep_for	26	SENT_152	[p9l1257t3646r1450b3704],
33	and	CC	O	and	_	0	SENT_152	[p9l1479t3646r1596b3705],
34	an	DT	O	a	det	36	SENT_152	[p9l11t3761r87b3800],
35	increased	VBN	O	increase	amod	36	SENT_152	[p9l124t3742r429b3801],
36	risk	NN	O	risk	prep_between	24	SENT_152	[p9l466t3742r588b3801],
37	of	IN	O	of	_	0	SENT_152	[p9l622t3741r697b3801],
38	death	NN	O	death	prep_of	36	SENT_152	[p9l721t3742r898b3801],
39	from	IN	O	from	_	0	SENT_152	[p9l935t3741r1092b3801],
40	cardiovascular	JJ	O	cardiovascular	amod	41	SENT_152	[p9l1129t3742r1598b3801],
41	causes	NNS	O	cause	prep_from	36	SENT_152	[p10l12t45r231b97],
42	,	,	O	,	_	0	SENT_152	[p10l12t45r231b97],
43	myocardial	JJ	O	myocardial	amod	44	SENT_152	[p10l261t26r612b100],
44	infarction	NN	O	infarction	conj_or	36	SENT_152	[p10l637t25r965b97],
45	,	,	O	,	_	0	SENT_152	[p10l637t25r965b97],
46	or	CC	O	or	_	0	SENT_152	[p10l996t45r1061b85],
47	strol	NN	O	strol	conj_or	36	SENT_152	[p10l1086t26r1322b85],
48	<	JJR	O	<	rel	56	SENT_152	[p10l1086t26r1322b85],
49	e.	CD	NUMBER	e.	number	50	SENT_152	[p10l1086t26r1322b85],
50	9	CD	NUMBER	9	num	48	SENT_152	[p10l1086t26r1322b85],
51	At	IN	O	at	_	0	SENT_152	[p10l1345t32r1419b84],
52	present	JJ	DATE	present	prep_at	48	SENT_152	[p10l1439t45r1595b100, p10l12t133r124b192],
53	,	,	O	,	_	0	SENT_152	[p10l1439t45r1595b100, p10l12t133r124b192],
54	it	PRP	O	it	nsubj	56	SENT_152	[p10l161t122r206b179],
55	is	VBZ	O	be	cop	56	SENT_152	[p10l234t122r284b179],
56	unclear	JJ	O	unclear	rcmod	47	SENT_152	[p10l318t121r557b180],
57	whether	IN	O	whether	complm	67	SENT_152	[p10l585t121r851b180],
58	genotyping	VBG	O	genotype	csubj	67	SENT_152	[p10l881t122r1248b196],
59	to	TO	O	to	aux	60	SENT_152	[p10l1279t133r1339b180],
60	predict	VB	O	predict	xcomp	58	SENT_152	[p10l1373t121r1600b195],
61	the	DT	O	the	det	62	SENT_152	[p10l12t216r110b274],
62	response	NN	O	response	dobj	60	SENT_152	[p10l147t235r432b290],
63	to	TO	O	to	_	0	SENT_152	[p10l469t228r529b275],
64	clopidogrel	NN	O	clopidogrel	prep_to	60	SENT_152	[p10l568t216r928b291],
65	is	VBZ	O	be	cop	67	SENT_152	[p10l964t217r1013b274],
66	clinically	RB	O	clinically	advmod	67	SENT_152	[p10l1052t216r1344b290],
67	useful	JJ	O	useful	ccomp	56	SENT_152	[p10l1377t215r1591b275],
68	.	.	O	.	_	0	SENT_152	[p10l1377t215r1591b275],

1	Several	JJ	O	several	amod	2	SENT_153	[p10l13t311r236b370],
2	studies	NNS	O	study	nsubj	3	SENT_153	[p10l261t311r485b370],
3	are	VBP	O	be	_	0	SENT_153	[p10l511t330r607b369],
4	under	IN	O	under	_	0	SENT_153	[p10l632t311r819b370],
5	way	NN	O	way	prep_under	3	SENT_153	[p10l838t330r963b385],
6	to	TO	O	to	aux	7	SENT_153	[p10l985t323r1045b370],
7	assess	VB	O	assess	xcomp	3	SENT_153	[p10l1070t330r1268b369],
8	the	DT	O	the	det	9	SENT_153	[p10l1294t311r1393b369],
9	effect	NN	O	effect	dobj	7	SENT_153	[p10l1419t310r1599b369],
10	of	IN	O	of	_	0	SENT_153	[p10l12t405r85b465],
11	dose	NN	O	dose	nn	12	SENT_153	[p10l94t406r236b465],
12	adjustment	NN	O	adjustment	prep_of	9	SENT_153	[p10l258t406r608b480],
13	for	IN	O	for	_	0	SENT_153	[p10l627t405r717b465],
14	clopidogrel	NN	O	clopidogrel	prep_for	12	SENT_153	[p10l737t406r1088b481],
15	in	IN	O	in	_	0	SENT_153	[p10l1109t407r1171b463],
16	patients	NNS	O	patient	prep_in	7	SENT_153	[p10l1191t407r1439b480],
17	who	WP	O	who	nsubj	18	SENT_153	[p10l1460t406r1595b465],
18	carry	VBP	O	carry	rcmod	16	SENT_153	[p10l12t520r177b575],
19	CYPZCI9	NN	O	cypzci9	nn	21	SENT_153	[p10l203t506r461b559],
20	variant	JJ	O	variant	amod	21	SENT_153	[p10l486t502r713b560],
21	alleles	NNS	O	allele	dobj	18	SENT_153	[p10l738t501r987b560],
22	.8	CD	NUMBER	.8	tmod	18	SENT_153	[p10l738t501r987b560],

1	AGENTS	NNS	O	agent	nsubj	2	SENT_154	[p10l514t749r839b793],
2	USED	VBD	O	use	_	0	SENT_154	[p10l879t750r1089b793],

1	FOR	IN	O	for	_	0	SENT_155	[p10l235t828r396b872],
2	INFECTIOUS	JJ	O	infectious	amod	3	SENT_155	[p10l432t828r944b872],
3	DISEASES	NNS	O	disease	pobj	1	SENT_155	[p10l986t828r1372b872],

1	Genomewide	JJ	O	genomewide	amod	3	SENT_156	[p10l11t994r435b1053],
2	association	NN	O	association	nn	3	SENT_156	[p10l458t995r819b1053],
3	studies	NNS	O	study	nsubj	5	SENT_156	[p10l843t994r1067b1053],
4	have	VBP	O	have	aux	5	SENT_156	[p10l1092t994r1233b1053],
5	confirmed	VBN	O	confirm	_	0	SENT_156	[p10l1257t993r1596b1053],
6	the	DT	O	the	det	7	SENT_156	[p10l12t1081r110b1139],
7	identity	NN	O	identity	dobj	5	SENT_156	[p10l140t1081r385b1155],
8	of	IN	O	of	_	0	SENT_156	[p10l411t1080r485b1140],
9	genetic	JJ	O	genetic	amod	10	SENT_156	[p10l500t1082r731b1156],
10	variants	NNS	O	variant	prep_of	7	SENT_156	[p10l756t1082r1013b1140],
11	in	IN	O	in	_	0	SENT_156	[p10l1043t1082r1105b1138],
12	previously	RB	DATE	previously	advmod	13	SENT_156	[p10l1133t1081r1462b1155],
13	imENGLJ	NN	O	imenglj	prep_in	5	SENT_156	[p10l1487t1082r1595b1139, p10l587t1241r665b1263],

1	MED	NNP	O	MED	_	0	SENT_157	[p10l679t1241r731b1256],
2	64	CD	NUMBER	64	num	1	SENT_157	[p10l756t1235r820b1263],
3	;	:	O	;	_	0	SENT_157	[p10l756t1235r820b1263],
4	12	CD	NUMBER	12	num	7	SENT_157	[p10l756t1235r820b1263],
5	NEjM	NNP	O	NEjM	nn	7	SENT_157	[p10l856t1241r980b1263],
6	,	,	O	,	_	0	SENT_157	[p10l856t1241r980b1263],
7	ORG	NNP	O	ORG	dep	1	SENT_157	[p10l856t1241r980b1263],
8	MARCH2	NN	O	march2	dep	7	SENT_157	[p10l1017t1241r1127b1256],
9	,2	CD	NUMBER	,2	num	8	SENT_157	[p10l1146t1241r1213b1261],
10	o11	NN	O	o11	dep	7	SENT_157	[p10l1146t1241r1213b1261],
11	1147	CD	DATE	1147	num	10	SENT_157	[p10l1940t1231r2016b1253],

1	e	LS	O	e	dep	4	SENT_158	[p10l739t1282r753b1298],
2	New	NNP	O	New	nn	4	SENT_158	[p10l762t1275r824b1298],
3	England	NNP	O	England	nn	4	SENT_158	[p10l833t1274r944b1305],
4	Journal	NNP	O	Journal	_	0	SENT_158	[p10l952t1274r1050b1298],
5	of	IN	O	of	prep	4	SENT_158	[p10l1059t1274r1088b1298],
6	e	SYM	O	e	dep	5	SENT_158	[p10l1125t1282r1139b1298],
7	icine	FW	O	icine	dep	4	SENT_158	[p10l1156t1274r1220b1298],

1	Downloaded	VBN	O	download	_	0	SENT_159	[p10l144t1315r314b1338],
2	from	IN	O	from	_	0	SENT_159	[p10l323t1315r387b1338],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_159	[p10l396t1315r514b1345],
4	at	IN	O	at	_	0	SENT_159	[p10l524t1319r547b1338],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_159	[p10l556t1315r738b1338],
6	on	IN	O	on	_	0	SENT_159	[p10l748t1322r780b1338],
7	January	NNP	DATE	January	prep_on	1	SENT_159	[p10l789t1315r892b1345],
8	5	CD	DATE	5	num	7	SENT_159	[p10l902t1315r924b1343],
9	,	,	DATE	,	_	0	SENT_159	[p10l902t1315r924b1343],
10	2014	CD	DATE	2014	num	7	SENT_159	[p10l935t1315r1007b1338],
11	.	.	O	.	_	0	SENT_159	[p10l935t1315r1007b1338],

1	For	IN	O	for	_	0	SENT_160	[p10l1018t1315r1064b1338],
2	personal	JJ	O	personal	amod	3	SENT_160	[p10l1072t1315r1185b1345],
3	use	NN	O	use	pobj	1	SENT_160	[p10l1194t1322r1237b1338],
4	only	RB	O	only	advmod	3	SENT_160	[p10l1247t1315r1312b1345],
5	.	.	O	.	_	0	SENT_160	[p10l1247t1315r1312b1345],

1	No	DT	O	no	det	3	SENT_161	[p10l1322t1315r1362b1338],
2	other	JJ	O	other	amod	3	SENT_161	[p10l1372t1315r1440b1338],
3	uses	NNS	O	use	_	0	SENT_161	[p10l1448t1322r1504b1338],
4	without	IN	O	without	_	0	SENT_161	[p10l1514t1315r1616b1338],
5	permission	NN	O	permission	prep_without	3	SENT_161	[p10l1624t1315r1776b1345],
6	.	.	O	.	_	0	SENT_161	[p10l1624t1315r1776b1345],

1	Copyright	NN	O	copyright	_	0	SENT_162	[p10l494t1356r629b1387],
2	©	CD	NUMBER	©	num	6	SENT_162	[p10l638t1356r661b1380],
3	2011	CD	DATE	2011	num	6	SENT_162	[p10l671t1356r734b1380],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_162	[p10l746t1356r937b1380],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_162	[p10l947t1356r1055b1380],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_162	[p10l1065t1356r1170b1387],
7	.	.	O	.	_	0	SENT_162	[p10l1065t1356r1170b1387],

1	All	DT	O	all	det	2	SENT_163	[p10l1181t1356r1223b1380],
2	rights	NNS	O	rights	nsubj	3	SENT_163	[p10l1232t1356r1306b1387],
3	reserved	VBN	O	reserve	_	0	SENT_163	[p10l1316t1356r1435b1380],
4	.	.	O	.	_	0	SENT_163	[p10l1316t1356r1435b1380],

1	The	DT	O	the	det	4	SENT_164	[p10l673t1462r718b1483],
2	NEW	NNP	O	NEW	nn	4	SENT_164	[p10l737t1464r822b1483],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_164	[p10l841t1464r1029b1483],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_164	[p10l1048t1464r1227b1490],
5	of	IN	O	of	_	0	SENT_164	[p10l1247t1462r1275b1489],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_164	[p10l1287t1464r1486b1483],

1	plicated	JJ	O	plicated	amod	3	SENT_165	[p10l15t1683r354b1783],
2	candidate	NN	O	candidate	nn	3	SENT_165	[p10l389t1683r805b1762],
3	genes	NNS	O	gene	_	0	SENT_165	[p10l840t1709r1081b1784],
4	that	WDT	O	that	nsubj	5	SENT_165	[p10l1118t1683r1291b1761],
5	contribute	VBP	O	contribute	rcmod	3	SENT_165	[p10l1321t1683r1761b1762],
6	to	TO	O	to	_	0	SENT_165	[p10l1797t1700r1878b1762],
7	clinically	RB	O	clinically	advmod	8	SENT_165	[p10l1916t1683r2135b1761, p10l17t1811r215b1911],
8	important	JJ	O	important	amod	9	SENT_165	[p10l247t1812r688b1911],
9	outcomes	NNS	O	outcome	prep_to	3	SENT_165	[p10l721t1828r1156b1907],
10	,	,	O	,	_	0	SENT_165	[p10l721t1828r1156b1907],
11	including	VBG	O	include	_	0	SENT_165	[p10l1198t1811r1609b1912],
12	severe	JJ	O	severe	amod	13	SENT_165	[p10l1645t1837r1902b1890],
13	idiosyncratic	JJ	O	idiosyncratic	amod	15	SENT_165	[p10l1939t1811r2135b1890, p10l17t1940r398b2039],
14	adverse	JJ	O	adverse	amod	15	SENT_165	[p10l432t1939r747b2018],
15	reactions	NNS	O	reaction	prep_including	9	SENT_165	[p10l783t1940r1172b2018],
16	and	CC	O	and	_	0	SENT_165	[p10l1210t1939r1368b2018],
17	variation	NN	O	variation	prep_including	9	SENT_165	[p10l1399t1940r1781b2018],
18	in	IN	O	in	_	0	SENT_165	[p10l1816t1940r1899b2017],
19	drug	NN	O	drug	nn	20	SENT_165	[p10l1936t1939r2140b2040],
20	efﬁcacy	NN	O	efﬁcacy	prep_in	17	SENT_165	[p10l17t2065r357b2166],
21	.	.	O	.	_	0	SENT_165	[p10l17t2065r357b2166],

1	In	IN	O	in	_	0	SENT_166	[p10l391t2074r479b2144],
2	the	DT	O	the	det	4	SENT_166	[p10l511t2066r641b2144],
3	next	JJ	O	next	amod	4	SENT_166	[p10l672t2083r853b2145],
4	set	NN	O	set	prep_in	14	SENT_166	[p10l880t2083r998b2144],
5	of	IN	O	of	_	0	SENT_166	[p10l1024t2065r1122b2145],
6	examples	NNS	O	example	prep_of	4	SENT_166	[p10l1136t2066r1549b2166],
7	,	,	O	,	_	0	SENT_166	[p10l1136t2066r1549b2166],
8	the	DT	O	the	det	9	SENT_166	[p10l1586t2066r1716b2144],
9	results	NNS	O	result	nsubj	14	SENT_166	[p10l1747t2066r2023b2146],
10	of	IN	O	of	_	0	SENT_166	[p10l2056t2065r2154b2145],
11	pharmacogenomic	JJ	O	pharmacogenomic	amod	12	SENT_166	[p10l15t2195r824b2296],
12	studies	NNS	O	study	prep_of	9	SENT_166	[p10l860t2195r1159b2274],
13	were	VBD	O	be	cop	14	SENT_166	[p10l1191t2221r1393b2274],
14	unanticipated	JJ	O	unanticipated	_	0	SENT_166	[p10l1428t2195r2042b2295],
15	.	.	O	.	_	0	SENT_166	[p10l1428t2195r2042b2295],

1	Hepatotoxicity	NN	O	hepatotoxicity	nsubj	6	SENT_167	[p10l144t2323r762b2422],
2	is	VBZ	O	be	cop	6	SENT_167	[p10l790t2323r854b2400],
3	the	DT	O	the	det	6	SENT_167	[p10l891t2322r1021b2400],
4	most	RBS	O	most	advmod	5	SENT_167	[p10l1055t2339r1268b2401],
5	common	JJ	O	common	amod	6	SENT_167	[p10l1297t2348r1672b2401],
6	reason	NN	O	reason	_	0	SENT_167	[p10l1707t2348r1985b2401],
7	for	IN	O	for	_	0	SENT_167	[p10l2019t2321r2140b2401],
8	the	DT	O	the	det	9	SENT_167	[p10l16t2451r147b2530],
9	termination	NN	O	termination	prep_for	6	SENT_167	[p10l182t2452r685b2530],
10	of	IN	O	of	_	0	SENT_167	[p10l721t2450r819b2530],
11	clinical	JJ	O	clinical	amod	12	SENT_167	[p10l837t2451r1143b2529],
12	trials	NNS	O	trial	prep_of	9	SENT_167	[p10l1177t2451r1391b2529],
13	investigating	VBG	O	investigate	partmod	12	SENT_167	[p10l1427t2452r1974b2552],
14	the	DT	O	the	det	15	SENT_167	[p10l2006t2451r2136b2530],
15	efficacy	NN	O	efficacy	dobj	13	SENT_167	[p10l17t2578r353b2679],
16	of	IN	O	of	_	0	SENT_167	[p10l400t2578r500b2658],
17	new	JJ	O	new	amod	18	SENT_167	[p10l533t2605r710b2658],
18	drugs	NNS	O	drug	prep_of	15	SENT_167	[p10l758t2579r1026b2680],
19	,	,	O	,	_	0	SENT_167	[p10l758t2579r1026b2680],
20	accounting	VBG	O	account	prep	13	SENT_167	[p10l1083t2580r1563b2680],
21	for	IN	O	for	pcomp	20	SENT_167	[p10l1610t2578r1734b2658],
22	approximately	RB	O	approximately	quantmod	24	SENT_167	[p10l1781t2580r2135b2679, p10l16t2706r303b2806],
23	33	CD	NUMBER	33	number	24	SENT_167	[p10l334t2712r515b2786],
24	°	CD	NUMBER	°	pobj	21	SENT_167	[p10l334t2712r515b2786],
25	/	:	O	/	punct	26	SENT_167	[p10l334t2712r515b2786],
26	o	NN	O	o	dep	24	SENT_167	[p10l334t2712r515b2786],
27	of	IN	O	of	_	0	SENT_167	[p10l551t2705r650b2785],
28	such	JJ	O	such	amod	29	SENT_167	[p10l668t2706r862b2786],
29	terminations	NNS	O	termination	prep_of	26	SENT_167	[p10l898t2707r1478b2802],
30	,	,	O	,	_	0	SENT_167	[p10l898t2707r1478b2802],
31	and	CC	O	and	_	0	SENT_167	[p10l1517t2706r1675b2785],
32	is	VBZ	O	be	cop	35	SENT_167	[p10l1709t2707r1775b2784],
33	a	DT	O	a	det	35	SENT_167	[p10l1811t2732r1856b2784],
34	major	JJ	O	major	amod	35	SENT_167	[p10l1890t2707r2139b2806],
35	reason	NN	O	reason	conj_and	6	SENT_167	[p10l16t2861r300b2914],
36	for	IN	O	for	_	0	SENT_167	[p10l372t2834r496b2914],
37	postmarketing	VBG	O	postmarket	prepc_for	35	SENT_167	[p10l563t2835r1205b2936],
38	drug	NN	O	drug	nn	39	SENT_167	[p10l1274t2835r1478b2936],
39	Withdrawal	NNP	O	Withdrawal	dobj	37	SENT_167	[p10l1542t2835r2136b2914],
40	.	.	O	.	_	0	SENT_167	[p10l1542t2835r2136b2914],

1	“	NN	O	“	nn	2	SENT_168	[p10l1542t2835r2136b2914],
2	Floxacillin	NN	O	floxacillin	nsubjpass	18	SENT_168	[p10l15t2963r474b3058],
3	,	,	O	,	_	0	SENT_168	[p10l15t2963r474b3058],
4	an	DT	O	a	det	5	SENT_168	[p10l514t2989r616b3041],
5	antibiotic	JJ	O	antibiotic	appos	2	SENT_168	[p10l650t2963r1050b3041],
6	used	VBN	O	use	partmod	5	SENT_168	[p10l1084t2963r1278b3042],
7	in	IN	O	in	_	0	SENT_168	[p10l1311t2964r1394b3040],
8	Europe	NNP	LOCATION	Europe	prep_in	6	SENT_168	[p10l1427t2970r1724b3062],
9	and	CC	O	and	_	0	SENT_168	[p10l1758t2963r1914b3041],
10	Australia	NNP	LOCATION	Australia	prep_in	6	SENT_168	[p10l1945t2970r2135b3042, p10l16t3090r238b3168],
11	to	TO	O	to	aux	12	SENT_168	[p10l274t3107r354b3169],
12	treat	VB	O	treat	xcomp	6	SENT_168	[p10l393t3107r587b3168],
13	staphylococcal	JJ	O	staphylococcal	amod	14	SENT_168	[p10l621t3090r1237b3190],
14	infections	NNS	O	infection	dobj	12	SENT_168	[p10l1273t3089r1715b3186],
15	,	,	O	,	_	0	SENT_168	[p10l1273t3089r1715b3186],
16	has	VBZ	O	have	aux	18	SENT_168	[p10l1757t3090r1899b3168],
17	been	VBN	O	be	auxpass	18	SENT_168	[p10l1939t3090r2136b3169],
18	associated	VBN	O	associate	_	0	SENT_168	[p10l15t3219r460b3298],
19	with	IN	O	with	_	0	SENT_168	[p10l503t3219r699b3298],
20	an	DT	O	a	det	22	SENT_168	[p10l747t3245r850b3297],
21	unusual	JJ	O	unusual	amod	22	SENT_168	[p10l899t3219r1240b3298],
22	form	NN	O	form	prep_with	18	SENT_168	[p10l1288t3218r1498b3298],
23	of	IN	O	of	_	0	SENT_168	[p10l1547t3218r1647b3298],
24	cholestatic	JJ	O	cholestatic	amod	25	SENT_168	[p10l1678t3219r2136b3298],
25	hepatitis	NN	O	hepatitis	prep_of	22	SENT_168	[p10l16t3346r401b3446],
26	,	,	O	,	_	0	SENT_168	[p10l16t3346r401b3446],
27	with	IN	O	with	_	0	SENT_168	[p10l436t3346r628b3426],
28	an	DT	O	a	det	30	SENT_168	[p10l662t3372r764b3424],
29	estimated	VBN	O	estimate	amod	30	SENT_168	[p10l798t3346r1211b3425],
30	incidence	NN	O	incidence	prep_with	18	SENT_168	[p10l1244t3346r1640b3425],
31	of	IN	O	of	_	0	SENT_168	[p10l1676t3345r1774b3425],
32	approximately	RB	O	approximately	quantmod	33	SENT_168	[p10l1789t3347r2135b3446, p10l16t3475r297b3574],
33	85	CD	NUMBER	85	num	34	SENT_168	[p10l329t3481r450b3553],
34	cases	NNS	O	case	prep_of	30	SENT_168	[p10l489t3501r707b3553],
35	per	IN	O	per	_	0	SENT_168	[p10l743t3501r881b3574],
36	100,000	CD	NUMBER	100,000	num	37	SENT_168	[p10l917t3481r1244b3570],
37	patients	NNS	O	patient	prep_per	34	SENT_168	[p10l1279t3476r1810b3574],
38	.41	CD	NUMBER	.41	number	39	SENT_168	[p10l1279t3476r1810b3574],
39	'44	CD	NUMBER	'44	num	37	SENT_168	[p10l1279t3476r1810b3574],
40	A	DT	O	a	det	44	SENT_168	[p10l1842t3482r1908b3552],
41	multicenter	NN	O	multicenter	nn	44	SENT_168	[p10l1941t3475r2135b3554, p10l16t3604r342b3682],
42	genomewide	JJ	O	genomewide	amod	44	SENT_168	[p10l377t3603r923b3704],
43	association	NN	O	association	nn	44	SENT_168	[p10l961t3604r1444b3682],
44	study	NN	O	study	nsubj	50	SENT_168	[p10l1484t3603r1726b3703],
45	,	,	O	,	_	0	SENT_168	[p10l1484t3603r1726b3703],
46	reported	VBN	O	report	partmod	44	SENT_168	[p10l1770t3603r2136b3703],
47	in	IN	O	in	_	0	SENT_168	[p11l15t22r99b99],
48	2009	CD	DATE	2009	prep_in	46	SENT_168	[p11l147t27r374b117],
49	,	,	O	,	_	0	SENT_168	[p11l147t27r374b117],
50	analyzed	VBD	O	analyze	rcmod	34	SENT_168	[p11l427t21r806b121],
51	the	DT	O	the	det	52	SENT_168	[p11l855t21r988b99],
52	genotypes	NNS	O	genotype	nsubj	59	SENT_168	[p11l1037t38r1473b122],
53	of	IN	O	of	_	0	SENT_168	[p11l1524t20r1624b100],
54	51	CD	NUMBER	51	num	55	SENT_168	[p11l1656t27r1751b100],
55	persons	NNS	O	person	prep_of	52	SENT_168	[p11l1799t47r2134b121],
56	with	IN	O	with	_	0	SENT_168	[p11l11t148r207b227],
57	ﬂoxacillin	NN	O	ﬂoxacillin	nn	58	SENT_168	[p11l257t147r1069b228],
58	—	NN	O	—	prep_with	55	SENT_168	[p11l257t147r1069b228],
59	induced	VBD	O	induce	ccomp	50	SENT_168	[p11l257t147r1069b228],
60	hepatic	JJ	O	hepatic	amod	61	SENT_168	[p11l1119t148r1430b248],
61	injury	NN	O	injury	dobj	59	SENT_168	[p11l1479t149r1733b248],
62	and	CC	O	and	_	0	SENT_168	[p11l1777t148r1935b227],
63	282	CD	NUMBER	282	num	65	SENT_168	[p11l1985t154r2135b227],
64	matched	VBN	O	match	amod	65	SENT_168	[p11l16t277r385b355],
65	controls	NNS	O	control	conj_and	61	SENT_168	[p11l435t277r883b355],
66	.45	CD	NUMBER	.45	dep	61	SENT_168	[p11l435t277r883b355],
67	A	DT	O	a	det	68	SENT_168	[p11l933t284r999b354],
68	SNP	NN	ORGANIZATION	snp	dep	66	SENT_168	[p11l1048t283r1225b356],
69	in	IN	O	in	_	0	SENT_168	[p11l1272t278r1355b354],
70	the	DT	O	the	det	73	SENT_168	[p11l1406t277r1538b355],
71	major	JJ	O	major	amod	73	SENT_168	[p11l1589t278r1839b376],
72	histocompatibility	NN	O	histocompatibility	nn	73	SENT_168	[p11l1886t277r2135b355, p11l17t405r590b504],
73	complex	NN	O	complex	prep_in	68	SENT_168	[p11l645t405r1004b504],
74	and	CC	O	and	_	0	SENT_168	[p11l1059t405r1216b483],
75	closely	RB	O	closely	advmod	76	SENT_168	[p11l1275t405r1564b504],
76	linked	VBN	O	link	conj_and	18	SENT_168	[p11l1617t405r1888b484],
77	with	IN	O	with	_	0	SENT_168	[p11l1941t405r2136b484],
78	HLA	NN	O	hlum	prep_with	76	SENT_168	[p11l15t533r542b612],
79	.	.	O	.	_	0	SENT_168	[p11l15t533r542b612],

1	—	NN	O	—	_	0	SENT_169	[p11l15t533r542b612],
2	.	.	O	.	_	0	SENT_169	[p11l15t533r542b612],

1	B	NN	O	b	nsubj	4	SENT_170	[p11l15t533r542b612],
2	*	CD	NUMBER	*	num	3	SENT_170	[p11l15t533r542b612],
3	5701	CD	NUMBER	5701	dep	1	SENT_170	[p11l15t533r542b612],
4	showed	VBD	O	show	_	0	SENT_170	[p11l580t533r898b612],
5	very	RB	O	very	advmod	6	SENT_170	[p11l929t559r1103b633],
6	strong	JJ	O	strong	amod	7	SENT_170	[p11l1136t550r1408b634],
7	association	NN	O	association	dobj	4	SENT_170	[p11l1440t534r1912b612],
8	with	IN	O	with	_	0	SENT_170	[p11l1944t533r2136b612],
9	hepatic	JJ	O	hepatic	amod	10	SENT_170	[p11l16t661r327b760],
10	injury	NN	O	injury	prep_with	4	SENT_170	[p11l358t662r625b760],
11	.	.	O	.	_	0	SENT_170	[p11l358t662r625b760],

1	The	DT	O	the	det	2	SENT_171	[p11l659t661r819b739],
2	association	NN	O	association	_	0	SENT_171	[p11l852t662r1335b739],
3	between	IN	O	between	_	0	SENT_171	[p11l1368t661r1726b740],
4	the	DT	O	the	det	5	SENT_171	[p11l1759t661r1891b739],
5	presence	NN	O	presence	prep_between	2	SENT_171	[p11l1923t687r2135b760, p11l17t814r201b866],
6	of	IN	O	of	_	0	SENT_171	[p11l231t787r330b867],
7	HLA	NN	O	hlum	prep_of	2	SENT_171	[p11l340t788r863b867],
8	.	.	O	.	_	0	SENT_171	[p11l340t788r863b867],

1	—	NN	O	—	_	0	SENT_172	[p11l340t788r863b867],
2	.	.	O	.	_	0	SENT_172	[p11l340t788r863b867],

1	B	NN	O	b	nsubjpass	26	SENT_173	[p11l340t788r863b867],
2	*	CD	NUMBER	*	number	3	SENT_173	[p11l340t788r863b867],
3	5701	CD	DATE	5701	dep	1	SENT_173	[p11l340t788r863b867],
4	and	CC	O	and	_	0	SENT_173	[p11l891t788r1046b867],
5	hypersensitivity	NN	O	hypersensitivity	nn	6	SENT_173	[p11l1075t788r1732b888],
6	reactions	NNS	O	reaction	nsubjpass	26	SENT_173	[p11l1757t789r2134b867],
7	to	TO	O	to	_	0	SENT_173	[p11l16t934r98b996],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_173	[p11l141t917r515b1013],
9	,	,	O	,	_	0	SENT_173	[p11l141t917r515b1013],
10	a	DT	O	a	det	12	SENT_173	[p11l562t943r607b995],
11	nucleoside	JJ	O	nucleoside	amod	12	SENT_173	[p11l648t917r1098b996],
12	analogue	NN	O	analogue	appos	1	SENT_173	[p11l1140t917r1534b1018],
13	used	VBN	O	use	partmod	12	SENT_173	[p11l1577t917r1774b996],
14	to	TO	O	to	aux	15	SENT_173	[p11l1816t934r1898b996],
15	treat	VB	O	treat	xcomp	13	SENT_173	[p11l1942t934r2141b995],
16	human	JJ	O	human	amod	19	SENT_173	[p11l16t1044r315b1123],
17	immunodeficiency	NN	O	immunodeficiency	nn	19	SENT_173	[p11l354t1043r1149b1144],
18	virus	NN	O	virus	nn	19	SENT_173	[p11l1178t1045r1386b1124],
19	type	NN	O	type	dobj	15	SENT_173	[p11l1428t1061r1605b1144],
20	1	CD	NUMBER	1	num	21	SENT_173	[p11l1649t1050r1693b1122],
21	infection	NN	O	infection	dep	19	SENT_173	[p11l1731t1043r2131b1140],
22	,	,	O	,	_	0	SENT_173	[p11l1731t1043r2131b1140],
23	had	VBD	O	have	aux	26	SENT_173	[p11l16t1173r172b1251],
24	already	RB	O	already	advmod	26	SENT_173	[p11l204t1173r515b1272],
25	been	VBN	O	be	auxpass	26	SENT_173	[p11l544t1173r746b1251],
26	reported	VBN	O	report	_	0	SENT_173	[p11l778t1173r1353b1272],
27	,46	CD	NUMBER	,46	number	28	SENT_173	[p11l778t1173r1353b1272],
28	'48	CD	NUMBER	'48	dobj	26	SENT_173	[p11l778t1173r1353b1272],
29	which	WDT	O	which	nsubj	30	SENT_173	[p11l1383t1173r1645b1252],
30	resulted	VBD	O	result	rcmod	28	SENT_173	[p11l1678t1173r2020b1252],
31	in	IN	O	in	_	0	SENT_173	[p11l2053t1174r2136b1250],
32	the	DT	O	the	det	34	SENT_173	[p11l16t1301r149b1379],
33	FDA	NNP	ORGANIZATION	FDA	nn	34	SENT_173	[p11l204t1308r388b1379],
34	modification	NN	O	modification	prep_in	30	SENT_173	[p11l441t1300r1002b1380],
35	of	IN	O	of	_	0	SENT_173	[p11l1060t1300r1159b1380],
36	the	DT	O	the	det	38	SENT_173	[p11l1198t1301r1330b1380],
37	abacavir	NN	O	abacavir	nn	38	SENT_173	[p11l1386t1301r1741b1380],
38	label	NN	O	label	prep_of	34	SENT_173	[p11l1793t1301r1997b1380],
39	to	TO	O	to	aux	40	SENT_173	[p11l2053t1318r2135b1380],
40	include	VB	O	include	xcomp	30	SENT_173	[p11l15t1429r326b1508],
41	a	DT	O	a	det	42	SENT_173	[p11l358t1455r403b1507],
42	recommendation	NN	O	recommendation	dobj	40	SENT_173	[p11l434t1429r1171b1508],
43	that	WDT	O	that	dobj	45	SENT_173	[p11l1204t1429r1377b1507],
44	patients	NNS	O	patient	nsubj	45	SENT_173	[p11l1404t1430r1744b1529],
45	undergo	VBP	O	undergo	rcmod	42	SENT_173	[p11l1780t1429r2135b1530],
46	genotyping	VBG	O	genotype	xcomp	45	SENT_173	[p11l16t1558r505b1658],
47	for	IN	O	for	_	0	SENT_173	[p11l538t1556r661b1636],
48	HLA	NN	O	hlum	prep_for	46	SENT_173	[p11l693t1557r1229b1636],
49	.	.	O	.	_	0	SENT_173	[p11l693t1557r1229b1636],

1	—	NN	O	—	_	0	SENT_174	[p11l693t1557r1229b1636],
2	.	.	O	.	_	0	SENT_174	[p11l693t1557r1229b1636],

1	B	NN	O	b	nsubj	15	SENT_175	[p11l693t1557r1229b1636],
2	*	CD	NUMBER	*	number	3	SENT_175	[p11l693t1557r1229b1636],
3	5701	CD	NUMBER	5701	npadvmod	1	SENT_175	[p11l693t1557r1229b1636],
4	before	IN	O	before	_	0	SENT_175	[p11l1266t1556r1533b1636],
5	the	DT	O	the	det	6	SENT_175	[p11l1570t1557r1702b1635],
6	initiation	NN	O	initiation	prep_before	1	SENT_175	[p11l1738t1558r2136b1636],
7	of	IN	O	of	_	0	SENT_175	[p11l17t1683r117b1763],
8	therapy	NN	O	therapy	npadvmod	10	SENT_175	[p11l139t1684r553b1784],
9	.49	CD	NUMBER	.49	num	8	SENT_175	[p11l139t1684r553b1784],
10	Rare	JJ	O	rare	amod	14	SENT_175	[p11l593t1691r792b1768],
11	but	CC	O	but	_	0	SENT_175	[p11l832t1684r972b1764],
12	severe	JJ	O	severe	amod	14	SENT_175	[p11l1008t1710r1266b1764],
13	adverse	JJ	O	adverse	amod	14	SENT_175	[p11l1305t1684r1620b1763],
14	events	NNS	O	event	prep_of	6	SENT_175	[p11l1660t1701r1924b1764],
15	represent	VBP	O	represent	_	0	SENT_175	[p11l1966t1710r2135b1784, p11l16t1830r278b1891],
16	a	DT	O	a	det	18	SENT_175	[p11l313t1839r357b1891],
17	major	JJ	O	major	amod	18	SENT_175	[p11l395t1814r645b1913],
18	reason	NN	O	reason	dobj	15	SENT_175	[p11l682t1839r966b1892],
19	why	WRB	O	why	advmod	22	SENT_175	[p11l1002t1813r1179b1913],
20	drugs	NNS	O	drug	nsubjpass	22	SENT_175	[p11l1215t1813r1458b1914],
21	are	VBP	O	be	auxpass	22	SENT_175	[p11l1499t1839r1628b1891],
22	withdrawn	VBN	O	withdraw	advcl	15	SENT_175	[p11l1664t1813r2136b1892],
23	after	IN	O	after	_	0	SENT_175	[p11l15t1940r217b2019],
24	FDA	NNP	ORGANIZATION	FDA	nn	25	SENT_175	[p11l256t1948r440b2019],
25	approval	NN	O	approval	prep_after	22	SENT_175	[p11l479t1941r868b2041],
26	.	.	O	.	_	0	SENT_175	[p11l479t1941r868b2041],

1	Although	IN	O	although	mark	4	SENT_176	[p11l913t1941r1319b2042],
2	it	PRP	O	it	nsubj	4	SENT_176	[p11l1362t1942r1421b2019],
3	was	VBD	O	be	cop	4	SENT_176	[p11l1454t1967r1617b2020],
4	possible	JJ	O	possible	_	0	SENT_176	[p11l1660t1941r2010b2041],
5	to	TO	O	to	aux	6	SENT_176	[p11l2053t1958r2135b2020],
6	attempt	VB	O	attempt	xcomp	4	SENT_176	[p11l15t2085r350b2168],
7	a	DT	O	a	det	8	SENT_176	[p11l383t2094r427b2146],
8	replication	NN	O	replication	dobj	6	SENT_176	[p11l465t2068r925b2168],
9	of	IN	O	of	_	0	SENT_176	[p11l965t2067r1065b2147],
10	the	DT	O	the	det	11	SENT_176	[p11l1086t2068r1218b2146],
11	association	NN	O	association	prep_of	8	SENT_176	[p11l1257t2069r1739b2147],
12	between	IN	O	between	_	0	SENT_176	[p11l1779t2068r2136b2148],
13	the	DT	O	the	det	14	SENT_176	[p11l16t2197r147b2275],
14	variant	NN	O	variant	prep_between	11	SENT_176	[p11l173t2198r469b2276],
15	in	IN	O	in	_	0	SENT_176	[p11l493t2198r576b2275],
16	HLA	NN	O	hlum	prep_in	14	SENT_176	[p11l605t2197r1130b2276],
17	.	.	O	.	_	0	SENT_176	[p11l605t2197r1130b2276],

1	—	NN	O	—	_	0	SENT_177	[p11l605t2197r1130b2276],
2	.	.	O	.	_	0	SENT_177	[p11l605t2197r1130b2276],

1	B	NN	O	b	nsubj	7	SENT_178	[p11l605t2197r1130b2276],
2	*	CD	NUMBER	*	number	3	SENT_178	[p11l605t2197r1130b2276],
3	5701	CD	DATE	5701	dep	1	SENT_178	[p11l605t2197r1130b2276],
4	and	CC	O	and	_	0	SENT_178	[p11l1160t2197r1316b2276],
5	ﬂoXacillin	NN	O	ﬂoxacillin	nn	6	SENT_178	[p11l1346t2196r2136b2276],
6	—	NN	O	—	conj_and	1	SENT_178	[p11l1346t2196r2136b2276],
7	induced	VBD	O	induce	_	0	SENT_178	[p11l1346t2196r2136b2276],
8	hepatitis	NN	O	hepatitis	dobj	7	SENT_178	[p11l16t2325r486b2425],
9	,45	CD	NUMBER	,45	num	8	SENT_178	[p11l16t2325r486b2425],
10	it	PRP	O	it	nsubj	13	SENT_178	[p11l529t2326r587b2403],
11	is	VBZ	O	be	cop	13	SENT_178	[p11l622t2326r687b2403],
12	often	RB	O	often	advmod	13	SENT_178	[p11l730t2324r952b2404],
13	difficult	JJ	O	difficult	rcmod	8	SENT_178	[p11l992t2324r1346b2404],
14	to	TO	O	to	aux	15	SENT_178	[p11l1382t2342r1463b2404],
15	gather	VB	O	gather	xcomp	13	SENT_178	[p11l1503t2325r1780b2426],
16	enough	JJ	O	enough	amod	17	SENT_178	[p11l1817t2325r2136b2426],
17	cases	NNS	O	case	dobj	15	SENT_178	[p11l17t2479r234b2531],
18	of	IN	O	of	_	0	SENT_178	[p11l279t2452r378b2532],
19	rare	JJ	O	rare	amod	22	SENT_178	[p11l402t2479r565b2531],
20	adverse	JJ	O	adverse	amod	22	SENT_178	[p11l607t2453r915b2532],
21	drug	NN	O	drug	nn	22	SENT_178	[p11l958t2453r1158b2554],
22	reactions	NNS	O	reaction	prep_of	17	SENT_178	[p11l1197t2454r1578b2532],
23	to	TO	O	to	aux	24	SENT_178	[p11l1623t2470r1703b2532],
24	apply	VB	O	apply	xcomp	15	SENT_178	[p11l1745t2453r1970b2553],
25	genomewide	JJ	O	genomewide	amod	26	SENT_178	[p11l2007t2479r2135b2554, p11l16t2581r453b2660],
26	techniques	NNS	O	technique	dobj	24	SENT_178	[p11l493t2581r980b2680],
27	.	.	O	.	_	0	SENT_178	[p11l493t2581r980b2680],

1	This	DT	O	this	det	2	SENT_179	[p11l141t2709r328b2787],
2	situation	NN	O	situation	nsubj	3	SENT_179	[p11l364t2710r741b2788],
3	presents	VBZ	O	present	_	0	SENT_179	[p11l772t2726r1130b2809],
4	a	DT	O	a	det	5	SENT_179	[p11l1164t2735r1208b2787],
5	challenge	NN	O	challenge	dobj	3	SENT_179	[p11l1239t2709r1648b2810],
6	for	IN	O	for	_	0	SENT_179	[p11l1681t2708r1804b2788],
7	regulators	NNS	O	regulator	prep_for	5	SENT_179	[p11l1833t2709r2135b2810, p11l16t2854r199b2916],
8	.	.	O	.	_	0	SENT_179	[p11l1833t2709r2135b2810, p11l16t2854r199b2916],

1	To	TO	O	to	_	0	SENT_180	[p11l253t2843r357b2916],
2	date	NN	O	date	prep_to	8	SENT_180	[p11l412t2837r608b2933],
3	,	,	O	,	_	0	SENT_180	[p11l412t2837r608b2933],
4	the	DT	O	the	det	5	SENT_180	[p11l666t2837r796b2915],
5	FDA	NNP	ORGANIZATION	FDA	nsubj	8	SENT_180	[p11l847t2843r1029b2915],
6	has	VBZ	O	have	aux	8	SENT_180	[p11l1079t2837r1220b2915],
7	generally	RB	O	generally	advmod	8	SENT_180	[p11l1275t2837r1660b2938],
8	chosen	VBN	O	choose	_	0	SENT_180	[p11l1708t2837r2002b2916],
9	to	TO	O	to	aux	10	SENT_180	[p11l2055t2854r2135b2916],
10	include	VB	O	include	xcomp	8	SENT_180	[p11l15t2965r319b3044],
11	pharmacogenetic	JJ	O	pharmacogenetic	amod	12	SENT_180	[p11l350t2965r1098b3066],
12	information	NN	O	information	dobj	10	SENT_180	[p11l1129t2964r1653b3044],
13	relevant	JJ	O	relevant	amod	15	SENT_180	[p11l1685t2965r2025b3044],
14	to	TO	O	to	dep	15	SENT_180	[p11l2054t2982r2135b3044],
15	rare	JJ	O	rare	amod	18	SENT_180	[p11l16t3119r183b3172],
16	severe	JJ	O	severe	amod	18	SENT_180	[p11l218t3119r476b3172],
17	adverse	JJ	O	adverse	amod	18	SENT_180	[p11l510t3093r824b3172],
18	events	NNS	O	event	nsubj	22	SENT_180	[p11l859t3110r1122b3172],
19	on	IN	O	on	_	0	SENT_180	[p11l1158t3119r1264b3172],
20	drug	NN	O	drug	nn	21	SENT_180	[p11l1298t3093r1502b3194],
21	labels	NNS	O	label	prep_on	18	SENT_180	[p11l1532t3093r1778b3172],
22	—	VBP	O	—	rcmod	12	SENT_180	[p11l1810t3138r1917b3146],
23	even	RB	O	even	advmod	36	SENT_180	[p11l1948t3119r2136b3172],
24	when	WRB	O	when	advmod	36	SENT_180	[p11l11t3222r245b3301],
25	the	DT	O	the	det	26	SENT_180	[p11l301t3222r433b3301],
26	association	NN	O	association	nsubjpass	36	SENT_180	[p11l489t3223r972b3301],
27	between	IN	O	between	_	0	SENT_180	[p11l1028t3222r1386b3301],
28	the	DT	O	the	det	32	SENT_180	[p11l1442t3222r1574b3300],
29	variant	JJ	O	variant	amod	32	SENT_180	[p11l1626t3223r1929b3301],
30	and	CC	O	and	_	0	SENT_180	[p11l1979t3222r2136b3301],
31	drug	NN	O	drug	conj_and	29	SENT_180	[p11l17t3350r220b3451],
32	response	NN	O	response	prep_between	26	SENT_180	[p11l261t3376r641b3450],
33	has	VBZ	O	have	aux	36	SENT_180	[p11l685t3350r829b3428],
34	not	RB	O	not	neg	36	SENT_180	[p11l876t3367r1018b3429],
35	been	VBN	O	be	auxpass	36	SENT_180	[p11l1057t3350r1259b3429],
36	replicated	VBN	O	replicate	ccomp	22	SENT_180	[p11l1302t3350r1724b3450],
37	—	RB	O	—	advmod	36	SENT_180	[p11l1765t3395r1872b3403],
38	so	RB	O	so	advmod	41	SENT_180	[p11l1913t3376r2003b3429],
39	as	IN	O	as	dep	41	SENT_180	[p11l2048t3376r2134b3428],
40	to	TO	O	to	aux	41	SENT_180	[p11l16t3494r98b3556],
41	warn	VB	O	warn	ccomp	36	SENT_180	[p11l137t3503r357b3557],
42	prescribers	NNS	O	prescriber	dobj	41	SENT_180	[p11l398t3477r873b3577],
43	of	IN	O	of	_	0	SENT_180	[p11l919t3476r1019b3556],
44	potential	JJ	O	potential	amod	45	SENT_180	[p11l1042t3477r1429b3577],
45	risk	NN	O	risk	prep_of	42	SENT_180	[p11l1471t3477r1731b3557],
46	.	.	O	.	_	0	SENT_180	[p11l1471t3477r1731b3557],

1	”	NN	O	”	nsubj	4	SENT_181	[p11l1471t3477r1731b3557],
2	This	DT	O	this	det	3	SENT_181	[p11l1771t3477r1958b3555],
3	approach	NN	O	approach	dep	1	SENT_181	[p11l2003t3503r2135b3577, p11l15t3606r308b3705],
4	places	VBZ	O	place	_	0	SENT_181	[p11l341t3606r603b3705],
5	a	DT	O	a	det	6	SENT_181	[p11l640t3632r684b3683],
6	burden	NN	O	burden	nsubj	10	SENT_181	[p11l717t3606r1019b3685],
7	on	IN	O	on	_	0	SENT_181	[p11l1055t3632r1160b3684],
8	clinicians	NNS	O	clinician	prep_on	6	SENT_181	[p11l1195t3606r1606b3684],
9	to	TO	O	to	aux	10	SENT_181	[p11l1644t3623r1725b3684],
10	use	VB	O	use	xcomp	4	SENT_181	[p11l1761t3632r1901b3685],
11	their	PRP$	O	they	poss	13	SENT_181	[p11l1936t3606r2139b3684],
12	own	JJ	O	own	amod	13	SENT_181	[p12l17t48r200b101],
13	judgment	NN	O	judgment	dobj	10	SENT_181	[p12l217t22r641b123],
14	regarding	VBG	O	regard	_	0	SENT_181	[p12l667t22r1090b123],
15	the	DT	O	the	det	16	SENT_181	[p12l1118t22r1251b100],
16	need	NN	O	need	prep_regarding	13	SENT_181	[p12l1283t22r1484b101],
17	for	IN	O	for	_	0	SENT_181	[p12l1515t21r1638b101],
18	pharmacogenetic	JJ	O	pharmacogenetic	amod	19	SENT_181	[p12l1665t22r2135b122, p12l16t151r318b251],
19	testing	NN	O	testing	prep_for	16	SENT_181	[p12l354t151r645b251],
20	before	IN	O	before	_	0	SENT_181	[p12l679t149r942b229],
21	prescribing	VBG	O	prescribe	prepc_before	10	SENT_181	[p12l977t150r1457b251],
22	a	DT	O	a	det	23	SENT_181	[p12l1490t176r1534b228],
23	drug	NN	O	drug	dobj	21	SENT_181	[p12l1570t150r1788b251],
24	.	.	O	.	_	0	SENT_181	[p12l1570t150r1788b251],

1	In	IN	O	in	_	0	SENT_182	[p12l1829t158r1917b228],
2	contrast	NN	O	contrast	prep_in	8	SENT_182	[p12l1955t176r2135b229, p12l16t294r208b355],
3	with	IN	O	with	_	0	SENT_182	[p12l244t277r439b357],
4	unreplicated	JJ	O	unreplicated	amod	5	SENT_182	[p12l485t277r1023b377],
5	tests	NNS	O	test	prep_with	2	SENT_182	[p12l1070t294r1264b355],
6	for	IN	O	for	_	0	SENT_182	[p12l1312t276r1435b356],
7	association	NN	O	association	prep_for	5	SENT_182	[p12l1477t278r1961b356],
8	are	VBP	O	be	_	0	SENT_182	[p12l2007t303r2135b355],
9	prospective	JJ	O	prospective	amod	10	SENT_182	[p12l15t407r504b506],
10	trials	NNS	O	trial	nsubj	8	SENT_182	[p12l542t406r760b484],
11	of	IN	O	of	_	0	SENT_182	[p12l801t405r900b485],
12	genotyping	VBG	O	genotype	prepc_of	10	SENT_182	[p12l919t407r1409b507],
13	to	TO	O	to	aux	14	SENT_182	[p12l1444t423r1525b485],
14	avoid	VB	O	avoid	xcomp	12	SENT_182	[p12l1563t406r1785b485],
15	adverse	JJ	O	adverse	amod	17	SENT_182	[p12l1821t406r2136b485],
16	pharmacogenetic	JJ	O	pharmacogenetic	amod	17	SENT_182	[p12l15t534r764b635],
17	effects	NNS	O	effect	dobj	14	SENT_182	[p12l811t533r1117b613],
18	.	.	O	.	_	0	SENT_182	[p12l811t533r1117b613],

1	One	CD	NUMBER	one	num	3	SENT_183	[p12l1171t540r1342b613],
2	such	JJ	O	such	amod	3	SENT_183	[p12l1391t534r1585b613],
3	study	NN	O	study	nsubjpass	5	SENT_183	[p12l1635t534r1864b634],
4	is	VBZ	O	be	auxpass	5	SENT_183	[p12l1906t535r1972b612],
5	reported	VBN	O	report	_	0	SENT_183	[p12l2022t560r2135b612, p12l15t662r292b762],
6	in	IN	O	in	_	0	SENT_183	[p12l333t663r415b740],
7	this	DT	O	this	det	8	SENT_183	[p12l457t662r613b740],
8	issue	NN	O	issue	prep_in	5	SENT_183	[p12l657t663r863b741],
9	of	IN	O	of	_	0	SENT_183	[p12l906t661r1005b741],
10	the	DT	O	the	det	11	SENT_183	[p12l1029t662r1158b740],
11	journal	NN	O	journal	prep_of	8	SENT_183	[p12l1185t662r1563b763],
12	,	,	O	,	_	0	SENT_183	[p12l1185t662r1563b763],
13	“	NN	O	“	appos	11	SENT_183	[p12l1185t662r1563b763],
14	in	IN	O	in	_	0	SENT_183	[p12l1604t663r1686b740],
15	which	WDT	O	which	rel	17	SENT_183	[p12l1723t662r1981b741],
16	investigators	NNS	O	investigator	nsubj	17	SENT_183	[p12l2022t663r2135b740, p12l11t791r464b891],
17	observed	VBN	O	observe	rcmod	13	SENT_183	[p12l499t790r880b869],
18	no	DT	O	no	det	19	SENT_183	[p12l913t816r1018b869],
19	instances	NNS	O	instance	dobj	17	SENT_183	[p12l1052t791r1455b869],
20	of	IN	O	of	_	0	SENT_183	[p12l1491t789r1591b869],
21	the	DT	O	the	det	23	SENT_183	[p12l1606t790r1738b868],
22	StevensJohnson	NN	O	stevensjohnson	nn	23	SENT_183	[p12l1775t796r2139b869, p12l6t918r355b1008],
23	syndrome	NN	O	syndrome	prep_of	19	SENT_183	[p12l386t918r796b1017],
24	or	CC	O	or	_	0	SENT_183	[p12l827t944r913b996],
25	toxic	JJ	O	toxic	amod	27	SENT_183	[p12l940t919r1139b996],
26	epidermal	JJ	O	epidermal	amod	27	SENT_183	[p12l1169t918r1586b1017],
27	necrolysis	NN	O	necrolysis	prep_of	19	SENT_183	[p12l1615t918r2020b1017],
28	in	IN	O	in	_	0	SENT_183	[p12l2053t919r2136b995],
29	a	DT	O	a	det	30	SENT_183	[p12l11t1071r56b1123],
30	sample	NN	O	sample	prep_in	17	SENT_183	[p12l90t1045r388b1145],
31	of	IN	O	of	_	0	SENT_183	[p12l422t1044r521b1124],
32	nearly	RB	O	nearly	quantmod	33	SENT_183	[p12l537t1045r796b1145],
33	5000	CD	NUMBER	5000	num	35	SENT_183	[p12l827t1051r1031b1124],
34	Taiwanese	JJ	MISC	taiwanese	amod	35	SENT_183	[p12l1062t1046r1507b1125],
35	candidates	NNS	O	candidate	prep_of	30	SENT_183	[p12l1541t1045r1993b1124],
36	for	IN	O	for	_	0	SENT_183	[p12l2029t1044r2151b1124],
37	carbamazepine	NN	O	carbamazepine	nn	38	SENT_183	[p12l12t1174r674b1274],
38	therapy	NN	O	therapy	prep_for	35	SENT_183	[p12l726t1174r1063b1274],
39	,	,	O	,	_	0	SENT_183	[p12l726t1174r1063b1274],
40	among	IN	O	among	_	0	SENT_183	[p12l1120t1200r1422b1275],
41	Whom	WP	O	whom	dobj	47	SENT_183	[p12l1466t1174r1738b1253],
42	carbam	FW	O	carbam	nn	44	SENT_183	[p12l1791t1174r2147b1253],
43	—	FW	O	—	nn	44	SENT_183	[p12l1791t1174r2147b1253],
44	azepine	NN	O	azepine	nsubjpass	47	SENT_183	[p12l11t1302r343b1401],
45	had	VBD	O	have	aux	47	SENT_183	[p12l386t1301r544b1380],
46	been	VBN	O	be	auxpass	47	SENT_183	[p12l588t1301r791b1380],
47	withheld	VBN	O	withhold	prepc_among	17	SENT_183	[p12l830t1301r1216b1381],
48	from	IN	O	from	_	0	SENT_183	[p12l1259t1300r1471b1380],
49	carriers	NNS	O	carrier	prep_from	47	SENT_183	[p12l1515t1302r1842b1379],
50	of	IN	O	of	_	0	SENT_183	[p12l1888t1300r1989b1380],
51	the	DT	O	the	det	52	SENT_183	[p12l2014t1301r2148b1379],
52	HLA	NN	O	hlum	prep_of	49	SENT_183	[p12l11t1430r545b1509],
53	.	.	O	.	_	0	SENT_183	[p12l11t1430r545b1509],

1	—	NN	O	—	_	0	SENT_184	[p12l11t1430r545b1509],
2	.	.	O	.	_	0	SENT_184	[p12l11t1430r545b1509],

1	B	NN	O	b	_	0	SENT_185	[p12l11t1430r545b1509],
2	*	CD	NUMBER	*	number	3	SENT_185	[p12l11t1430r545b1509],
3	1502	CD	DATE	1502	num	4	SENT_185	[p12l11t1430r545b1509],
4	allele	NN	O	allele	dobj	1	SENT_185	[p12l577t1430r817b1526],
5	,	,	O	,	_	0	SENT_185	[p12l577t1430r817b1526],
6	which	WDT	O	which	nsubjpass	9	SENT_185	[p12l849t1430r1109b1510],
7	has	VBZ	O	have	aux	9	SENT_185	[p12l1140t1430r1282b1508],
8	been	VBN	O	be	auxpass	9	SENT_185	[p12l1316t1430r1516b1509],
9	reported	VBN	O	report	rcmod	4	SENT_185	[p12l1546t1430r1907b1530],
10	to	TO	O	to	aux	12	SENT_185	[p12l1938t1447r2019b1509],
11	be	VB	O	be	auxpass	12	SENT_185	[p12l2052t1430r2148b1509],
12	associated	VBN	O	associate	xcomp	9	SENT_185	[p12l11t1559r459b1638],
13	with	IN	O	with	_	0	SENT_185	[p12l505t1559r702b1639],
14	the	DT	O	the	det	15	SENT_185	[p12l753t1559r887b1637],
15	Stevens	NNP	PERSON	Stevens	prep_with	12	SENT_185	[p12l941t1559r1670b1650],
16	.	.	O	.	_	0	SENT_185	[p12l941t1559r1670b1650],

1	—	NN	O	—	_	0	SENT_186	[p12l941t1559r1670b1650],
2	.	.	O	.	_	0	SENT_186	[p12l941t1559r1670b1650],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_187	[p12l941t1559r1670b1650],
2	syndrome	NN	O	syndrome	_	0	SENT_187	[p12l1722t1559r2148b1659],
3	in	IN	O	in	_	0	SENT_187	[p12l11t1690r95b1767],
4	Han	NNP	LOCATION	Han	nn	5	SENT_187	[p12l134t1697r317b1767],
5	Chinese	NNP	LOCATION	Chinese	prep_in	2	SENT_187	[p12l356t1689r800b1768],
6	.	.	O	.	_	0	SENT_187	[p12l356t1689r800b1768],

1	”	NN	O	”	_	0	SENT_188	[p12l356t1689r800b1768],

1	Another	DT	O	another	det	3	SENT_189	[p12l138t1817r490b1896],
2	pharmacogenomic	JJ	O	pharmacogenomic	amod	3	SENT_189	[p12l527t1817r1327b1918],
3	example	NN	O	example	nsubj	11	SENT_189	[p12l1369t1817r1720b1917],
4	involving	VBG	O	involve	_	0	SENT_189	[p12l1761t1817r2152b1918],
5	agents	NNS	O	agent	prep_involving	3	SENT_189	[p12l11t1962r289b2047],
6	used	VBN	O	use	partmod	5	SENT_189	[p12l325t1945r523b2025],
7	to	TO	O	to	aux	8	SENT_189	[p12l557t1962r639b2025],
8	treat	VB	O	treat	xcomp	6	SENT_189	[p12l675t1962r876b2024],
9	infectious	JJ	O	infectious	amod	10	SENT_189	[p12l904t1944r1333b2025],
10	diseases	NNS	O	disease	dobj	8	SENT_189	[p12l1369t1945r1724b2025],
11	concerns	VBZ	O	concern	dep	54	SENT_189	[p12l1761t1971r2146b2025],
12	the	DT	O	the	det	13	SENT_189	[p12l12t2073r146b2151],
13	treatment	NN	O	treatment	dobj	11	SENT_189	[p12l182t2090r609b2151],
14	of	IN	O	of	_	0	SENT_189	[p12l641t2072r742b2152],
15	chronic	JJ	O	chronic	amod	16	SENT_189	[p12l760t2073r1085b2152],
16	infection	NN	O	infection	prep_of	13	SENT_189	[p12l1120t2072r1509b2152],
17	with	IN	O	with	_	0	SENT_189	[p12l1540t2073r1737b2153],
18	hepatitis	NN	O	hepatitis	nn	23	SENT_189	[p12l1774t2073r2146b2173],
19	C	NN	O	c	nn	23	SENT_189	[p12l12t2208r70b2281],
20	virus	NN	O	virus	nn	23	SENT_189	[p12l108t2203r321b2281],
21	(	CD	NUMBER	(	num	23	SENT_189	[p12l368t2208r654b2298],
22	HCV	NN	MISC	hcv	nn	23	SENT_189	[p12l368t2208r654b2298],
23	)	NN	O	)	prep_with	11	SENT_189	[p12l368t2208r654b2298],
24	,	,	O	,	_	0	SENT_189	[p12l368t2208r654b2298],
25	which	WDT	O	which	nsubj	26	SENT_189	[p12l695t2202r959b2281],
26	develops	VBZ	O	develop	rcmod	23	SENT_189	[p12l1000t2202r1368b2302],
27	in	IN	O	in	_	0	SENT_189	[p12l1409t2203r1493b2280],
28	approximately	RB	O	approximately	quantmod	29	SENT_189	[p12l1532t2202r2152b2302],
29	80	CD	PERCENT	80	num	30	SENT_189	[p12l12t2335r202b2409],
30	%	NN	PERCENT	%	prep_in	26	SENT_189	[p12l12t2335r202b2409],
31	of	IN	O	of	_	0	SENT_189	[p12l242t2329r342b2409],
32	patients	NNS	O	patient	prep_of	30	SENT_189	[p12l363t2331r707b2430],
33	who	WP	O	who	nsubjpass	35	SENT_189	[p12l744t2330r929b2410],
34	are	VBP	O	be	auxpass	35	SENT_189	[p12l970t2356r1100b2408],
35	infected	VBN	O	infect	rcmod	32	SENT_189	[p12l1140t2329r1489b2409],
36	with	IN	O	with	_	0	SENT_189	[p12l1525t2330r1721b2410],
37	the	DT	O	the	det	38	SENT_189	[p12l1762t2330r1896b2408],
38	virus	NN	O	virus	prep_with	35	SENT_189	[p12l1932t2331r2145b2410],
39	and	CC	O	and	_	0	SENT_189	[p12l11t2458r170b2537],
40	is	VBZ	O	be	cop	43	SENT_189	[p12l204t2459r271b2536],
41	a	DT	O	a	det	43	SENT_189	[p12l307t2484r351b2536],
42	major	JJ	O	major	amod	43	SENT_189	[p12l385t2459r637b2558],
43	cause	NN	O	cause	rcmod	32	SENT_189	[p12l669t2484r904b2538],
44	of	IN	O	of	_	0	SENT_189	[p12l940t2457r1040b2537],
45	liver	NN	O	liver	nn	46	SENT_189	[p12l1056t2458r1241b2537],
46	failure	NN	O	failure	prep_of	43	SENT_189	[p12l1273t2457r1751b2538],
47	.5354	CD	NUMBER	.5354	num	49	SENT_189	[p12l1273t2457r1751b2538],
48	Successful	JJ	O	successful	amod	49	SENT_189	[p12l1788t2464r2147b2538, p12l12t2586r131b2666],
49	treatment	NN	O	treatment	dobj	35	SENT_189	[p12l174t2604r601b2666],
50	of	IN	O	of	_	0	SENT_189	[p12l639t2586r740b2666],
51	chronic	JJ	O	chronic	amod	53	SENT_189	[p12l765t2587r1091b2666],
52	HCV	NN	O	hcv	nn	53	SENT_189	[p12l1133t2593r1335b2666],
53	infection	NN	O	infection	prep_of	49	SENT_189	[p12l1374t2586r1763b2666],
54	involves	VBZ	O	involve	_	0	SENT_189	[p12l1806t2587r2145b2666],
55	a	DT	O	a	det	58	SENT_189	[p12l11t2742r56b2794],
56	sustained	JJ	O	sustained	amod	58	SENT_189	[p12l95t2715r508b2795],
57	Virologic	NNP	ORGANIZATION	Virologic	nn	58	SENT_189	[p12l543t2715r923b2817],
58	response	NN	O	response	nsubj	54	SENT_189	[p12l961t2741r1368b2816],
59	,	,	O	,	_	0	SENT_189	[p12l961t2741r1368b2816],
60	which	WDT	O	which	nsubjpass	62	SENT_189	[p12l1408t2715r1673b2795],
61	is	VBZ	O	be	auxpass	62	SENT_189	[p12l1711t2716r1778b2794],
62	defined	VBN	O	define	rcmod	58	SENT_189	[p12l1820t2714r2148b2795],
63	by	IN	O	by	_	0	SENT_189	[p12l12t2843r110b2943],
64	an	DT	O	a	det	66	SENT_189	[p12l142t2869r245b2921],
65	undetectable	JJ	O	undetectable	amod	66	SENT_189	[p12l281t2843r833b2922],
66	level	NN	O	level	agent	62	SENT_189	[p12l869t2843r1059b2923],
67	of	IN	O	of	_	0	SENT_189	[p12l1095t2842r1195b2922],
68	HCV	NN	O	hcv	nn	69	SENT_189	[p12l1213t2849r1415b2922],
69	RNA	NN	O	rna	prep_of	66	SENT_189	[p12l1446t2850r1657b2927],
70	in	IN	O	in	_	0	SENT_189	[p12l1689t2844r1773b2921],
71	plasma	NN	O	plasma	prep_in	62	SENT_189	[p12l1808t2843r2143b2943],
72	.	.	O	.	_	0	SENT_189	[p12l1808t2843r2143b2943],

1	Unfortunately	RB	O	unfortunately	advmod	17	SENT_190	[p12l11t2970r620b3071],
2	,	,	O	,	_	0	SENT_190	[p12l11t2970r620b3071],
3	only	RB	O	only	quantmod	6	SENT_190	[p12l658t2971r840b3071],
4	40	CD	NUMBER	40	number	6	SENT_190	[p12l865t2977r967b3050],
5	to	TO	O	to	dep	6	SENT_190	[p12l1000t2988r1081b3050],
6	50	CD	PERCENT	50	num	7	SENT_190	[p12l1115t2976r1299b3051],
7	%	NN	PERCENT	%	nsubj	17	SENT_190	[p12l1115t2976r1299b3051],
8	of	IN	O	of	_	0	SENT_190	[p12l1331t2970r1430b3050],
9	patients	NNS	O	patient	prep_of	7	SENT_190	[p12l1441t2972r1777b3071],
10	who	WP	O	who	nsubjpass	12	SENT_190	[p12l1806t2971r1988b3051],
11	are	VBP	O	be	auxpass	12	SENT_190	[p12l2020t2997r2148b3049],
12	infected	VBN	O	infect	rcmod	9	SENT_190	[p12l11t3099r361b3180],
13	with	IN	O	with	_	0	SENT_190	[p12l400t3100r597b3180],
14	HCV	NN	O	hcv	nn	15	SENT_190	[p12l639t3106r841b3180],
15	genotype	NN	O	genotype	prep_with	12	SENT_190	[p12l881t3117r1277b3202],
16	1	CD	NUMBER	1	num	15	SENT_190	[p12l1324t3106r1369b3178],
17	have	VBP	O	have	_	0	SENT_190	[p12l1413t3100r1604b3180],
18	a	DT	O	a	det	21	SENT_190	[p12l1647t3127r1692b3179],
19	sustained	JJ	O	sustained	amod	21	SENT_190	[p12l1735t3100r2148b3180],
20	virologic	JJ	O	virologic	amod	21	SENT_190	[p12l7t3229r379b3330],
21	response	NN	O	response	dobj	17	SENT_190	[p12l448t3255r824b3329],
22	when	WRB	O	when	advmod	23	SENT_190	[p12l889t3229r1121b3308],
23	receiving	VBG	O	receive	dep	21	SENT_190	[p12l1190t3230r1574b3330],
24	the	DT	O	the	det	26	SENT_190	[p12l1641t3229r1773b3307],
25	current	JJ	DATE	current	amod	26	SENT_190	[p12l1843t3246r2153b3308],
26	standard	NN	O	standard	dobj	23	SENT_190	[p12l13t3357r385b3436],
27	of	IN	O	of	_	0	SENT_190	[p12l418t3356r517b3436],
28	care	NN	O	care	prep_of	26	SENT_190	[p12l531t3383r703b3435],
29	for	IN	O	for	_	0	SENT_190	[p12l735t3356r856b3436],
30	the	DT	O	the	det	31	SENT_190	[p12l885t3357r1016b3435],
31	treatment	NN	O	treatment	prep_for	23	SENT_190	[p12l1048t3374r1465b3436],
32	of	IN	O	of	_	0	SENT_190	[p12l1492t3356r1591b3436],
33	chronic	JJ	O	chronic	amod	34	SENT_190	[p12l1605t3357r1922b3436],
34	HCV	NN	O	hcv	prep_of	31	SENT_190	[p12l1953t3363r2152b3436],

1	infection	NN	O	infection	nn	3	SENT_191	[p12l11t3484r400b3565],
2	—	NN	O	—	nn	3	SENT_191	[p12l456t3531r564b3539],
3	injections	NNS	O	injection	_	0	SENT_191	[p12l618t3486r1037b3586],
4	of	IN	O	of	advmod	5	SENT_191	[p12l1099t3484r1199b3565],
5	pegylated	VBN	O	pegylate	partmod	3	SENT_191	[p12l1238t3485r1656b3587],
6	interferon	NN	O	interferon	nn	7	SENT_191	[p12l1714t3484r2148b3565],
7	alfa	NN	O	alfa	dobj	5	SENT_191	[p12l11t3613r172b3693],
8	together	RB	O	together	_	0	SENT_191	[p12l199t3614r564b3716],
9	with	IN	O	with	_	0	SENT_191	[p12l586t3614r783b3694],
10	oral	JJ	O	oral	amod	11	SENT_191	[p12l813t3614r980b3694],
11	ribavirin	NNP	O	ribavirin	prep_together_with	5	SENT_191	[p12l1008t3614r1378b3694],
12	for	IN	O	for	_	0	SENT_191	[p12l1408t3613r1532b3694],
13	48	CD	NUMBER	48	prep_for	5	SENT_191	[p12l1557t3621r1658b3694],
14	W	NN	O	w	dep	19	SENT_191	[p12l1685t3614r2149b3694],
15	€	CD	MONEY	€	num	16	SENT_191	[p12l1685t3614r2149b3694],
16	€	NN	MONEY	€	dep	14	SENT_191	[p12l1685t3614r2149b3694],
17	l	NN	O	l	dep	19	SENT_191	[p12l1685t3614r2149b3694],
18	(	CD	NUMBER	(	num	17	SENT_191	[p12l1685t3614r2149b3694],
19	S.	NNP	O	S.	dep	3	SENT_191	[p12l1685t3614r2149b3694],
20	53	CD	NUMBER	53	num	19	SENT_191	[p12l1685t3614r2149b3694],
21	’54	CD	NUMBER	’54	dep	19	SENT_191	[p12l1685t3614r2149b3694],

1	The	DT	O	the	det	2	SENT_192	[p13l138t20r300b98],
2	ability	NN	O	ability	nsubj	15	SENT_192	[p13l344t20r616b120],
3	to	TO	O	to	aux	4	SENT_192	[p13l657t37r739b99],
4	identify	VB	O	identify	infmod	2	SENT_192	[p13l786t19r1121b120],
5	patients	NNS	O	patient	dobj	4	SENT_192	[p13l1160t21r1503b120],
6	with	IN	O	with	_	0	SENT_192	[p13l1546t20r1743b100],
7	a	DT	O	a	det	9	SENT_192	[p13l1787t46r1832b98],
8	differential	JJ	O	differential	amod	9	SENT_192	[p13l1876t19r2147b99, p13l12t149r255b228],
9	response	NN	O	response	prep_with	5	SENT_192	[p13l313t175r697b250],
10	to	TO	O	to	aux	11	SENT_192	[p13l756t166r838b229],
11	pegylated	VBN	O	pegylate	xcomp	4	SENT_192	[p13l896t149r1313b251],
12	interferon	NN	O	interferon	nn	13	SENT_192	[p13l1371t148r1805b229],
13	alfa	NN	O	alfa	dobj	11	SENT_192	[p13l1863t148r2023b228],
14	is	VBZ	O	be	cop	15	SENT_192	[p13l2079t150r2145b228],
15	important	JJ	O	important	_	0	SENT_192	[p13l11t278r455b377],
16	in	IN	O	in	_	0	SENT_192	[p13l504t278r588b355],
17	the	DT	O	the	det	19	SENT_192	[p13l643t277r777b355],
18	current	JJ	DATE	current	amod	19	SENT_192	[p13l833t294r1149b357],
19	era	NN	O	era	prep_in	15	SENT_192	[p13l1200t303r1329b355],
20	of	IN	O	of	_	0	SENT_192	[p13l1383t276r1483b356],
21	new	JJ	O	new	amod	22	SENT_192	[p13l1519t303r1699b357],
22	anti	JJ	O	anti	prep_of	19	SENT_192	[p13l1749t278r2152b356],
23	.	.	O	.	_	0	SENT_192	[p13l1749t278r2152b356],

1	—	NN	O	—	_	0	SENT_193	[p13l1749t278r2152b356],
2	.	.	O	.	_	0	SENT_193	[p13l1749t278r2152b356],

1	HCV	NN	O	hcv	nn	2	SENT_194	[p13l1749t278r2152b356],
2	drugs	NNS	O	drug	nsubj	9	SENT_194	[p13l12t406r258b508],
3	because	IN	O	because	mark	4	SENT_194	[p13l299t406r637b486],
4	pegylated	VBN	O	pegylate	dep	2	SENT_194	[p13l674t406r1091b508],
5	interferon	NN	O	interferon	nn	6	SENT_194	[p13l1128t405r1562b486],
6	alfa	NN	O	alfa	dobj	4	SENT_194	[p13l1600t405r1760b485],
7	remains	VBZ	O	remain	cop	9	SENT_194	[p13l1796t407r2145b485],
8	the	DT	O	the	det	9	SENT_194	[p13l12t534r146b612],
9	backbone	NN	O	backbone	_	0	SENT_194	[p13l181t534r594b614],
10	of	IN	O	of	_	0	SENT_194	[p13l629t533r729b613],
11	therapy	NN	O	therapy	prep_of	9	SENT_194	[p13l746t534r1082b634],
12	,	,	O	,	_	0	SENT_194	[p13l746t534r1082b634],
13	to	TO	O	to	_	0	SENT_194	[p13l1123t551r1205b613],
14	which	WDT	O	which	rel	21	SENT_194	[p13l1236t534r1500b614],
15	many	JJ	O	many	nsubjpass	21	SENT_194	[p13l1535t560r1775b634],
16	of	IN	O	of	_	0	SENT_194	[p13l1806t533r1906b613],
17	these	DT	O	these	det	19	SENT_194	[p13l1923t534r2148b613],
18	new	JJ	O	new	amod	19	SENT_194	[p13l12t689r190b742],
19	agents	NNS	O	agent	prep_of	15	SENT_194	[p13l237t680r515b764],
20	are	VBP	O	be	auxpass	21	SENT_194	[p13l566t689r696b741],
21	added	VBN	O	add	rcmod	11	SENT_194	[p13l747t663r1026b742],
22	.	.	O	.	_	0	SENT_194	[p13l747t663r1026b742],

1	Recently	RB	DATE	recently	advmod	27	SENT_195	[p13l1081t663r1466b763],
2	,	,	O	,	_	0	SENT_195	[p13l1081t663r1466b763],
3	in	IN	O	in	_	0	SENT_195	[p13l1522t664r1605b741],
4	three	CD	NUMBER	three	num	8	SENT_195	[p13l1656t663r1877b742],
5	independent	JJ	O	independent	amod	8	SENT_195	[p13l1927t663r2147b742, p13l11t791r363b891],
6	genomewide	JJ	O	genomewide	amod	8	SENT_195	[p13l398t791r947b892],
7	association	NN	O	association	nn	8	SENT_195	[p13l987t792r1474b870],
8	studies55	NN	O	studies55	nsubj	10	SENT_195	[p13l1514t791r1992b870],
9	'57	CD	NUMBER	'57	dep	8	SENT_195	[p13l1514t791r1992b870],
10	involving	VBG	O	involve	prepc_in	27	SENT_195	[p13l2031t792r2147b869, p13l7t919r322b1021],
11	patients	NNS	O	patient	dobj	10	SENT_195	[p13l351t920r694b1020],
12	with	IN	O	with	_	0	SENT_195	[p13l726t919r922b999],
13	chronic	JJ	O	chronic	amod	15	SENT_195	[p13l956t919r1282b999],
14	HCV	NN	O	hcv	nn	15	SENT_195	[p13l1313t925r1516b999],
15	infection	NN	O	infection	prep_with	10	SENT_195	[p13l1544t918r1934b999],
16	who	WP	O	who	nsubjpass	18	SENT_195	[p13l1962t919r2147b999],
17	were	VBD	O	be	auxpass	18	SENT_195	[p13l7t1074r211b1128],
18	treated	VBN	O	treat	rcmod	15	SENT_195	[p13l258t1048r558b1128],
19	with	IN	O	with	_	0	SENT_195	[p13l600t1048r796b1128],
20	pegylated	VBN	O	pegylate	prepc_with	18	SENT_195	[p13l842t1048r1259b1150],
21	interferon	NN	O	interferon	nn	22	SENT_195	[p13l1305t1047r1739b1128],
22	alfa	NN	O	alfa	dobj	20	SENT_195	[p13l1785t1047r1945b1127],
23	and	CC	O	and	_	0	SENT_195	[p13l1989t1048r2148b1128],
24	ribavirin	NNP	O	ribavirin	dobj	20	SENT_195	[p13l12t1177r406b1273],
25	,	,	O	,	_	0	SENT_195	[p13l12t1177r406b1273],
26	there	EX	O	there	expl	27	SENT_195	[p13l473t1177r690b1255],
27	was	VBD	O	be	_	0	SENT_195	[p13l747t1203r911b1256],
28	an	DT	O	a	det	29	SENT_195	[p13l973t1203r1077b1255],
29	association	NN	O	association	nsubj	27	SENT_195	[p13l1136t1178r1623b1256],
30	between	IN	O	between	_	0	SENT_195	[p13l1684t1177r2045b1256],
31	a	DT	O	a	det	32	SENT_195	[p13l2105t1203r2149b1255],
32	variant	NN	O	variant	prep_between	29	SENT_195	[p13l7t1307r313b1385],
33	in	IN	O	in	_	0	SENT_195	[p13l351t1307r434b1384],
34	ILZ8B	NN	O	ilz8b	prep_in	32	SENT_195	[p13l477t1313r725b1402],
35	,	,	O	,	_	0	SENT_195	[p13l477t1313r725b1402],
36	the	DT	O	the	det	39	SENT_195	[p13l774t1306r908b1384],
37	gene	NN	O	gene	nn	39	SENT_195	[p13l951t1332r1151b1407],
38	encoding	VBG	O	encode	amod	39	SENT_195	[p13l1196t1306r1599b1407],
39	interleukin28B	NN	O	interleukin28b	conj_and	29	SENT_195	[p13l1637t1306r2147b1385, p13l12t1440r196b1531],
40	,	,	O	,	_	0	SENT_195	[p13l1637t1306r2147b1385, p13l12t1440r196b1531],
41	and	CC	O	and	_	0	SENT_195	[p13l263t1434r421b1514],
42	the	DT	O	the	det	44	SENT_195	[p13l483t1434r616b1513],
43	drug	NN	O	drug	nn	44	SENT_195	[p13l678t1434r884b1536],
44	response	NN	O	response	nsubj	27	SENT_195	[p13l942t1460r1348b1535],
45	.	.	O	.	_	0	SENT_195	[p13l942t1460r1348b1535],

1	In	IN	O	in	_	0	SENT_196	[p13l1413t1442r1503b1512],
2	one	CD	NUMBER	one	prep_in	27	SENT_196	[p13l1565t1460r1717b1514],
3	of	IN	O	of	_	0	SENT_196	[p13l1779t1433r1880b1514],
4	these	DT	O	these	det	5	SENT_196	[p13l1923t1434r2148b1513],
5	studies	NNS	O	study	prep_of	2	SENT_196	[p13l13t1562r332b1658],
6	,	,	O	,	_	0	SENT_196	[p13l13t1562r332b1658],
7	peripheral	JJ	O	peripheral	amod	11	SENT_196	[p13l374t1562r1082b1662],
8	—	NN	O	—	nn	11	SENT_196	[p13l374t1562r1082b1662],
9	blood	NN	O	blood	nn	11	SENT_196	[p13l374t1562r1082b1662],
10	mononuclear	JJ	O	mononuclear	amod	11	SENT_196	[p13l1120t1562r1681b1642],
11	cells	NNS	O	cell	nsubj	27	SENT_196	[p13l1717t1562r1900b1640],
12	from	IN	O	from	_	0	SENT_196	[p13l1940t1561r2148b1641],
13	patients	NNS	O	patient	prep_from	11	SENT_196	[p13l11t1692r354b1791],
14	carrying	VBG	O	carry	partmod	13	SENT_196	[p13l403t1692r769b1792],
15	the	DT	O	the	det	17	SENT_196	[p13l812t1691r946b1769],
16	variant	JJ	O	variant	amod	17	SENT_196	[p13l987t1692r1293b1770],
17	allele	NN	O	allele	dobj	14	SENT_196	[p13l1334t1691r1558b1769],
18	that	WDT	O	that	nsubj	19	SENT_196	[p13l1605t1691r1778b1769],
19	was	VBD	O	be	rcmod	17	SENT_196	[p13l1815t1717r1978b1770],
20	as	IN	O	as	_	0	SENT_196	[p13l2026t1717r2147b1769],
21	—	NN	O	—	prep_as	19	SENT_196	[p13l2026t1717r2147b1769],
22	sociated	VBN	O	sociate	partmod	21	SENT_196	[p13l13t1819r367b1898],
23	with	IN	O	with	_	0	SENT_196	[p13l396t1819r593b1899],
24	a	DT	O	a	det	26	SENT_196	[p13l626t1845r671b1897],
25	poor	JJ	O	poor	amod	26	SENT_196	[p13l702t1845r907b1919],
26	response	NN	O	response	prep_with	22	SENT_196	[p13l938t1845r1321b1919],
27	had	VBD	O	have	_	0	SENT_196	[p13l1356t1819r1513b1898],
28	comparatively	RB	O	comparatively	advmod	29	SENT_196	[p13l1548t1819r2153b1919],
29	low	JJ	O	low	amod	30	SENT_196	[p13l11t1947r168b2027],
30	levels	NNS	O	level	dobj	27	SENT_196	[p13l197t1947r429b2027],
31	of	IN	O	of	_	0	SENT_196	[p13l466t1946r567b2026],
32	IL28B	NN	O	il28b	nn	33	SENT_196	[p13l582t1953r832b2026],
33	expression	NN	O	expression	prep_of	30	SENT_196	[p13l869t1948r1429b2047],
34	.	.	O	.	_	0	SENT_196	[p13l869t1948r1429b2047],

1	“	NN	O	“	nn	2	SENT_197	[p13l869t1948r1429b2047],
2	IL28B	NN	O	il28b	nsubj	3	SENT_197	[p13l1463t1954r1690b2025],
3	encodes	VBZ	O	encode	dep	13	SENT_197	[p13l1725t1947r2069b2026],
4	a	DT	O	a	det	5	SENT_197	[p13l2105t1973r2149b2025],
5	protein	NN	O	protein	dobj	3	SENT_197	[p13l11t2077r317b2176],
6	that	WDT	O	that	nsubjpass	8	SENT_197	[p13l350t2076r520b2154],
7	is	VBZ	O	be	auxpass	8	SENT_197	[p13l546t2077r611b2154],
8	thought	VBN	O	think	rcmod	5	SENT_197	[p13l646t2076r985b2177],
9	to	TO	O	to	aux	11	SENT_197	[p13l1012t2093r1093b2155],
10	be	VB	O	be	auxpass	11	SENT_197	[p13l1127t2076r1223b2155],
11	involved	VBN	O	involve	xcomp	8	SENT_197	[p13l1254t2076r1601b2155],
12	in	IN	O	in	prep	11	SENT_197	[p13l1632t2077r1714b2154],
13	suppress	VBP	O	suppress	_	0	SENT_197	[p13l1748t2102r2147b2176],
14	—	CD	NUMBER	—	dobj	13	SENT_197	[p13l1748t2102r2147b2176],
15	ing	VBG	O	ing	xcomp	13	SENT_197	[p13l11t2205r150b2306],
16	the	DT	O	the	det	17	SENT_197	[p13l198t2204r331b2283],
17	replication	NN	O	replication	dobj	15	SENT_197	[p13l382t2204r846b2305],
18	of	IN	O	of	_	0	SENT_197	[p13l899t2203r999b2284],
19	a	DT	O	a	det	20	SENT_197	[p13l1031t2231r1077b2283],
20	number	NN	O	number	prep_of	17	SENT_197	[p13l1126t2204r1466b2284],
21	of	IN	O	of	_	0	SENT_197	[p13l1515t2203r1616b2284],
22	viruses	NNS	O	virus	prep_of	20	SENT_197	[p13l1644t2205r1974b2301],
23	,	,	O	,	_	0	SENT_197	[p13l1644t2205r1974b2301],
24	including	VBG	O	include	_	0	SENT_197	[p13l2031t2205r2147b2282, p13l12t2333r337b2434],
25	HCV	NNP	O	HCV	prep_including	17	SENT_197	[p13l366t2338r755b2412],
26	.55	CD	NUMBER	.55	number	27	SENT_197	[p13l366t2338r755b2412],
27	'53	CD	NUMBER	'53	nsubj	13	SENT_197	[p13l366t2338r755b2412],
28	This	DT	O	this	det	29	SENT_197	[p13l786t2333r975b2411],
29	example	NN	O	example	nsubj	30	SENT_197	[p13l1011t2333r1368b2433],
30	shows	VBZ	O	show	rcmod	27	SENT_197	[p13l1403t2333r1668b2412],
31	how	WRB	O	how	advmod	39	SENT_197	[p13l1702t2333r1888b2412],
32	pharmacogenomic	JJ	O	pharmacogenomic	amod	35	SENT_197	[p13l1916t2333r2147b2433, p13l12t2462r602b2562],
33	genomewide	JJ	O	genomewide	amod	35	SENT_197	[p13l631t2461r1163b2562],
34	association	NN	O	association	nn	35	SENT_197	[p13l1192t2462r1660b2540],
35	studies	NNS	O	study	nsubj	50	SENT_197	[p13l1692t2461r1982b2540],
36	not	RB	O	not	neg	37	SENT_197	[p13l2014t2478r2153b2540],
37	only	RB	O	only	preconj	39	SENT_197	[p13l13t2588r198b2688],
38	have	VBP	O	have	aux	39	SENT_197	[p13l244t2588r434b2668],
39	identified	VBN	O	identify	ccomp	30	SENT_197	[p13l485t2587r904b2667],
40	biomarkers	NNS	O	biomarker	dobj	39	SENT_197	[p13l956t2588r1444b2668],
41	of	IN	O	of	_	0	SENT_197	[p13l1498t2587r1599b2667],
42	response	NN	O	response	prep_of	40	SENT_197	[p13l1630t2614r2013b2688],
43	to	TO	O	to	aux	44	SENT_197	[p13l2065t2605r2147b2667],
44	pegylated	VBN	O	pegylate	xcomp	39	SENT_197	[p13l11t2717r420b2819],
45	interferon	NN	O	interferon	nn	46	SENT_197	[p13l467t2716r891b2797],
46	alfa	NN	O	alfa	dobj	44	SENT_197	[p13l939t2716r1096b2796],
47	but	CC	O	but	_	0	SENT_197	[p13l1144t2717r1282b2797],
48	also	RB	O	also	advmod	50	SENT_197	[p13l1325t2717r1494b2797],
49	have	VBP	O	have	aux	50	SENT_197	[p13l1544t2717r1731b2797],
50	provided	VBN	O	provide	conj_but	39	SENT_197	[p13l1779t2717r2148b2818],
51	insights	NNS	O	insight	dobj	50	SENT_197	[p13l12t2846r339b2947],
52	that	WDT	O	that	nsubjpass	55	SENT_197	[p13l372t2846r538b2924],
53	might	MD	O	might	aux	55	SENT_197	[p13l563t2846r816b2947],
54	be	VB	O	be	auxpass	55	SENT_197	[p13l842t2846r936b2925],
55	used	VBN	O	use	rcmod	51	SENT_197	[p13l966t2846r1157b2925],
56	to	TO	O	to	aux	57	SENT_197	[p13l1187t2863r1267b2925],
57	determine	VB	O	determine	ccomp	55	SENT_197	[p13l1299t2846r1722b2925],
58	therapeutic	JJ	O	therapeutic	amod	59	SENT_197	[p13l1753t2846r2147b2946, p13l12t2974r112b3051],
59	approaches	NNS	O	approach	dobj	57	SENT_197	[p13l147t2973r615b3073],
60	to	TO	O	to	_	0	SENT_197	[p13l654t2990r734b3052],
61	this	DT	O	this	det	63	SENT_197	[p13l772t2973r926b3051],
62	chronic	JJ	O	chronic	amod	63	SENT_197	[p13l965t2973r1279b3052],
63	infection	NN	O	infection	prep_to	57	SENT_197	[p13l1314t2972r1687b3052],
64	and	CC	O	and	_	0	SENT_197	[p13l1723t2973r1878b3052],
65	to	TO	O	to	aux	66	SENT_197	[p13l1914t2990r1994b3052],
66	select	VB	O	select	ccomp	55	SENT_197	[p13l2032t2999r2147b3051, p13l11t3102r159b3181],
67	a	DT	O	a	det	69	SENT_197	[p13l190t3129r235b3181],
68	drug	NN	O	drug	nn	69	SENT_197	[p13l274t3102r480b3204],
69	target	NN	O	target	dobj	66	SENT_197	[p13l516t3119r773b3204],
70	for	IN	O	for	_	0	SENT_197	[p13l808t3101r932b3182],
71	therapeutic	JJ	O	therapeutic	amod	72	SENT_197	[p13l969t3102r1457b3203],
72	development	NN	O	development	prep_for	66	SENT_197	[p13l1497t3102r2070b3203],
73	.	.	O	.	_	0	SENT_197	[p13l1497t3102r2070b3203],

1	ANTINEOPLASTIC	JJ	O	antineoplastic	amod	2	SENT_198	[p13l364t3400r1365b3460],
2	DRUGS	NNS	O	drug	_	0	SENT_198	[p13l1421t3400r1790b3460],

1	The	DT	O	the	det	2	SENT_199	[p13l8t3619r168b3698],
2	field	NN	O	field	nsubjpass	7	SENT_199	[p13l202t3618r391b3699],
3	of	IN	O	of	_	0	SENT_199	[p13l426t3618r525b3699],
4	cancer	NN	O	cancer	nn	5	SENT_199	[p13l542t3645r819b3698],
5	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	2	SENT_199	[p13l848t3619r1690b3721],
6	is	VBZ	O	be	auxpass	7	SENT_199	[p13l1724t3620r1790b3698],
7	complicated	VBN	O	complicate	_	0	SENT_199	[p13l1826t3619r2147b3720, p14l12t21r234b101],

1	by	IN	O	by	_	0	SENT_200	[p14l272t21r369b122],
2	the	DT	O	the	det	3	SENT_200	[p14l404t21r537b100],
3	fact	NN	O	fact	pobj	1	SENT_200	[p14l575t20r735b100],
4	that	IN	O	that	complm	8	SENT_200	[p14l769t21r942b100],
5	two	CD	NUMBER	two	num	6	SENT_200	[p14l976t38r1134b101],
6	genomes	NNS	O	genome	nsubjpass	8	SENT_200	[p14l1174t47r1558b123],
7	are	VBP	O	be	auxpass	8	SENT_200	[p14l1598t47r1728b100],
8	involved	VBN	O	involve	dep	3	SENT_200	[p14l1766t21r2144b101],
9	:	:	O	:	_	0	SENT_200	[p14l1766t21r2144b101],
10	the	DT	O	the	det	12	SENT_200	[p14l12t150r146b229],
11	germline	NN	O	germline	nn	12	SENT_200	[p14l187t150r578b252],
12	genome	NN	O	genome	dep	3	SENT_200	[p14l620t176r962b252],
13	of	IN	O	of	_	0	SENT_200	[p14l1004t149r1105b230],
14	the	DT	O	the	det	15	SENT_200	[p14l1129t150r1262b229],
15	patient	NN	O	patient	prep_of	12	SENT_200	[p14l1302t151r1607b251],
16	and	CC	O	and	_	0	SENT_200	[p14l1643t150r1801b230],
17	the	DT	O	the	det	19	SENT_200	[p14l1843t150r1977b229],
18	somatic	JJ	O	somatic	amod	19	SENT_200	[p14l2020t176r2147b230, p14l12t280r249b358],
19	genome	NN	O	genome	conj_and	3	SENT_200	[p14l281t305r617b381],
20	of	IN	O	of	_	0	SENT_200	[p14l651t278r751b359],
21	the	DT	O	the	det	22	SENT_200	[p14l765t279r897b358],
22	tumor	NN	O	tumor	prep_of	19	SENT_200	[p14l930t296r1212b359],
23	.	.	O	.	_	0	SENT_200	[p14l930t296r1212b359],

1	Obviously	RB	O	obviously	_	0	SENT_201	[p14l1251t279r1682b380],
2	,	,	O	,	_	0	SENT_201	[p14l1251t279r1682b380],
3	the	DT	O	the	det	4	SENT_201	[p14l1722t279r1853b358],
4	tumor	NN	O	tumor	appos	1	SENT_201	[p14l1887t296r2152b359],

1	1143	CD	DATE	1143	num	4	SENT_202	[p14l149t439r224b461],
2	N	NN	O	n	nn	4	SENT_202	[p14l950t449r964b464],
3	ENGLJ	NN	O	englj	nn	4	SENT_202	[p14l978t449r1056b471],
4	MED	NN	O	med	_	0	SENT_202	[p14l1071t449r1123b464],
5	364	CD	NUMBER	364	dep	4	SENT_202	[p14l1133t443r1212b471],
6	;	:	O	;	_	0	SENT_202	[p14l1133t443r1212b471],
7	12	CD	NUMBER	12	num	9	SENT_202	[p14l1133t443r1212b471],
8	NEJM.ORG	NN	O	nejm.org	nn	9	SENT_202	[p14l1248t449r1372b471],
9	MARCH	NN	DATE	march	dep	5	SENT_202	[p14l1409t449r1494b464],
10	24	CD	DATE	24	dep	9	SENT_202	[p14l1506t449r1542b471],
11	,	,	DATE	,	_	0	SENT_202	[p14l1506t449r1542b471],
12	2011	CD	DATE	2011	appos	10	SENT_202	[p14l1553t449r1605b465],

1	The	DT	O	the	det	4	SENT_203	[p14l935t482r986b506],
2	New	NNP	O	New	nn	4	SENT_203	[p14l995t483r1057b506],
3	England	NNP	O	England	nn	4	SENT_203	[p14l1066t482r1177b513],
4	Journal	NNP	O	Journal	_	0	SENT_203	[p14l1186t482r1283b506],
5	of	IN	O	of	_	0	SENT_203	[p14l1293t482r1322b506],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_203	[p14l1329t482r1454b506],

1	Downloaded	VBN	O	download	_	0	SENT_204	[p14l377t523r547b546],
2	from	IN	O	from	_	0	SENT_204	[p14l556t523r621b546],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_204	[p14l629t523r748b553],
4	at	IN	O	at	_	0	SENT_204	[p14l758t527r781b546],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_204	[p14l789t523r972b546],
6	on	IN	O	on	_	0	SENT_204	[p14l981t530r1014b546],
7	January	NNP	DATE	January	prep_on	1	SENT_204	[p14l1022t523r1125b553],
8	5	CD	DATE	5	num	7	SENT_204	[p14l1135t523r1158b550],
9	,	,	DATE	,	_	0	SENT_204	[p14l1135t523r1158b550],
10	2014	CD	DATE	2014	num	7	SENT_204	[p14l1168t523r1240b546],
11	.	.	O	.	_	0	SENT_204	[p14l1168t523r1240b546],

1	For	IN	O	for	_	0	SENT_205	[p14l1251t523r1298b546],
2	personal	JJ	O	personal	amod	3	SENT_205	[p14l1306t523r1418b553],
3	use	NN	O	use	pobj	1	SENT_205	[p14l1427t530r1471b546],
4	only	RB	O	only	advmod	3	SENT_205	[p14l1480t523r1545b553],
5	.	.	O	.	_	0	SENT_205	[p14l1480t523r1545b553],

1	No	DT	O	no	det	3	SENT_206	[p14l1556t523r1595b546],
2	other	JJ	O	other	amod	3	SENT_206	[p14l1605t523r1673b546],
3	uses	NNS	O	use	_	0	SENT_206	[p14l1682t530r1738b546],
4	without	IN	O	without	_	0	SENT_206	[p14l1748t523r1849b546],
5	permission	NN	O	permission	prep_without	3	SENT_206	[p14l1857t523r2010b553],
6	.	.	O	.	_	0	SENT_206	[p14l1857t523r2010b553],

1	Copyright	NN	O	copyright	_	0	SENT_207	[p14l728t564r862b595],
2	©	CD	NUMBER	©	num	6	SENT_207	[p14l871t564r895b588],
3	2011	CD	DATE	2011	num	6	SENT_207	[p14l905t564r967b588],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_207	[p14l979t564r1170b588],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_207	[p14l1180t564r1288b588],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_207	[p14l1299t564r1404b595],
7	.	.	O	.	_	0	SENT_207	[p14l1299t564r1404b595],

1	All	DT	O	all	det	2	SENT_208	[p14l1415t564r1456b588],
2	rights	NNS	O	rights	nsubj	3	SENT_208	[p14l1465t564r1540b595],
3	reserved	VBN	O	reserve	_	0	SENT_208	[p14l1550t564r1668b588],
4	.	.	O	.	_	0	SENT_208	[p14l1550t564r1668b588],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_209	[p14l909t670r1067b689],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_209	[p14l1081t670r1251b689],

1	genome	NN	O	genome	nsubj	2	SENT_210	[p14l11t909r350b984],
2	plays	VBZ	O	play	_	0	SENT_210	[p14l399t883r612b983],
3	a	DT	O	a	det	5	SENT_210	[p14l663t909r708b961],
4	critical	JJ	O	critical	amod	5	SENT_210	[p14l756t883r1052b961],
5	role	NN	O	role	dobj	2	SENT_210	[p14l1100t883r1260b962],
6	in	IN	O	in	_	0	SENT_210	[p14l1308t884r1391b961],
7	the	DT	O	the	det	8	SENT_210	[p14l1441t883r1574b961],
8	variation	NN	O	variation	prep_in	5	SENT_210	[p14l1619t884r2001b962],
9	in	IN	O	in	_	0	SENT_210	[p14l2050t884r2133b961],
10	response	NN	O	response	prep_in	8	SENT_210	[p14l11t1037r384b1110],
11	to	TO	O	to	_	0	SENT_210	[p14l421t1028r501b1089],
12	antineoplastic	JJ	O	antineoplastic	amod	13	SENT_210	[p14l537t1011r1133b1110],
13	therapy	NN	O	therapy	prep_to	2	SENT_210	[p14l1169t1011r1496b1110],
14	.	.	O	.	_	0	SENT_210	[p14l1169t1011r1496b1110],

1	Prominent	JJ	O	prominent	amod	2	SENT_211	[p14l1535t1012r1986b1089],
2	examples	NNS	O	example	nsubj	25	SENT_211	[p14l2017t1037r2132b1089, p14l11t1138r307b1238],
3	include	VBP	O	include	dep	62	SENT_211	[p14l350t1138r661b1218],
4	HER2	NN	O	her2	nn	5	SENT_211	[p14l702t1145r931b1218],
5	overexpression	NN	O	overexpression	dobj	3	SENT_211	[p14l976t1139r1613b1238],
6	or	CC	O	or	_	0	SENT_211	[p14l1657t1164r1746b1217],
7	amplification	NN	O	amplification	conj_or	5	SENT_211	[p14l1785t1137r2132b1238, p14l12t1268r275b1345],
8	in	IN	O	in	_	0	SENT_211	[p14l312t1268r395b1344],
9	patients	NNS	O	patient	prep_in	5	SENT_211	[p14l431t1268r773b1366],
10	with	IN	O	with	_	0	SENT_211	[p14l809t1267r1004b1346],
11	breast	NN	O	breast	nn	12	SENT_211	[p14l1042t1267r1305b1345],
12	cancer	NN	O	cancer	prep_with	9	SENT_211	[p14l1338t1293r1619b1345],
13	and	CC	O	and	_	0	SENT_211	[p14l1653t1267r1811b1345],
14	the	DT	O	the	det	15	SENT_211	[p14l1849t1267r1982b1345],
15	response	NN	O	response	prep_in	5	SENT_211	[p14l2019t1293r2132b1345, p14l12t1420r307b1494],
16	of	IN	O	of	_	0	SENT_211	[p14l349t1393r449b1473],
17	these	DT	O	these	det	18	SENT_211	[p14l472t1394r696b1472],
18	tumors	NNS	O	tumor	prep_of	15	SENT_211	[p14l737t1411r1044b1474],
19	to	TO	O	to	_	0	SENT_211	[p14l1089t1411r1170b1473],
20	trastuzumab59	CD	NUMBER	trastuzumab59	num	21	SENT_211	[p14l1213t1394r1934b1474],
21	’	CD	NUMBER	’	prep_to	18	SENT_211	[p14l1213t1394r1934b1474],
22	5	CD	NUMBER	5	num	23	SENT_211	[p14l1213t1394r1934b1474],
23	°	NN	O	°	dep	15	SENT_211	[p14l1213t1394r1934b1474],
24	and	CC	O	and	_	0	SENT_211	[p14l1975t1394r2133b1473],
25	increased	VBD	O	increase	dep	62	SENT_211	[p14l11t1523r410b1602],
26	sensitivity	NN	O	sensitivity	dobj	25	SENT_211	[p14l446t1524r868b1623],
27	to	TO	O	to	_	0	SENT_211	[p14l898t1540r978b1602],
28	the	DT	O	the	det	34	SENT_211	[p14l1015t1523r1145b1602],
29	epidermal	JJ	O	epidermal	amod	34	SENT_211	[p14l1181t1523r1604b1623],
30	growth	NN	O	growth	nn	34	SENT_211	[p14l1638t1523r1947b1624],
31	factor	NN	O	factor	nn	34	SENT_211	[p14l1982t1522r2132b1601, p14l12t1668r132b1730],
32	receptor	NN	O	receptor	nn	34	SENT_211	[p14l170t1668r526b1751],
33	(	CD	NUMBER	(	num	34	SENT_211	[p14l570t1657r877b1742],
34	EGFR	NN	ORGANIZATION	egfr	prep_to	25	SENT_211	[p14l570t1657r877b1742],
35	)	CD	NUMBER	)	num	37	SENT_211	[p14l570t1657r877b1742],
36	antagonist	NN	O	antagonist	nn	37	SENT_211	[p14l924t1652r1385b1752],
37	geﬁtinib	NN	O	geﬁtinib	dobj	3	SENT_211	[p14l1422t1650r1794b1752],
38	among	IN	O	among	_	0	SENT_211	[p14l1837t1677r2137b1752],
39	patients	NNS	O	patient	prep_among	3	SENT_211	[p14l10t1780r351b1879],
40	with	IN	O	with	_	0	SENT_211	[p14l409t1779r604b1858],
41	non	JJ	O	non	amod	47	SENT_211	[p14l664t1779r1306b1858],
42	—	JJ	O	—	amod	47	SENT_211	[p14l664t1779r1306b1858],
43	small	JJ	O	small	amod	47	SENT_211	[p14l664t1779r1306b1858],
44	—	NN	O	—	nn	47	SENT_211	[p14l664t1779r1306b1858],
45	cell	NN	O	cell	nn	47	SENT_211	[p14l664t1779r1306b1858],
46	lung	NN	O	lung	nn	47	SENT_211	[p14l1365t1779r1558b1880],
47	cancer	NN	O	cancer	prep_with	3	SENT_211	[p14l1615t1805r1897b1857],
48	who	WP	O	who	nsubj	49	SENT_211	[p14l1949t1779r2132b1858],
49	have	VBP	O	have	rcmod	47	SENT_211	[p14l11t1907r201b1986],
50	activating	VBG	O	activate	amod	51	SENT_211	[p14l244t1908r666b2008],
51	mutations	NNS	O	mutation	dobj	49	SENT_211	[p14l707t1908r1142b1986],
52	in	IN	O	in	_	0	SENT_211	[p14l1188t1908r1271b1985],
53	the	DT	O	the	det	56	SENT_211	[p14l1316t1907r1448b1985],
54	gene	NN	O	gene	nn	56	SENT_211	[p14l1493t1933r1692b2008],
55	encoding	VBG	O	encode	amod	56	SENT_211	[p14l1737t1907r2137b2008],
56	EGFR	NN	ORGANIZATION	egfr	prep_in	51	SENT_211	[p14l9t2039r451b2118],
57	.61	CD	NUMBER	.61	number	58	SENT_211	[p14l9t2039r451b2118],
58	’62	CD	NUMBER	’62	dep	51	SENT_211	[p14l9t2039r451b2118],
59	A	DT	O	a	det	61	SENT_211	[p14l490t2042r557b2112],
60	recent	JJ	O	recent	amod	61	SENT_211	[p14l596t2052r861b2113],
61	example	NN	O	example	dep	58	SENT_211	[p14l898t2035r1254b2134],
62	involves	VBZ	O	involve	_	0	SENT_211	[p14l1296t2035r1634b2114],
63	melanoma	NN	O	melanoma	dobj	62	SENT_211	[p14l1678t2035r2135b2113],
64	and	CC	O	and	_	0	SENT_211	[p14l11t2163r168b2242],
65	a	DT	O	a	det	66	SENT_211	[p14l198t2189r242b2241],
66	mutation	NN	O	mutation	conj_and	63	SENT_211	[p14l270t2164r662b2242],
67	in	IN	O	in	_	0	SENT_211	[p14l692t2164r775b2241],
68	BRAF	NN	O	braf	prep_in	66	SENT_211	[p14l803t2169r1027b2243],
69	encoding	VBG	O	encode	xcomp	62	SENT_211	[p14l1052t2163r1452b2264],
70	a	DT	O	a	det	73	SENT_211	[p14l1477t2189r1522b2241],
71	serine	NN	O	serine	nn	73	SENT_211	[p14l1552t2163r2132b2242],
72	—	NN	O	—	nn	73	SENT_211	[p14l1552t2163r2132b2242],
73	threo	NN	O	threo	dobj	69	SENT_211	[p14l1552t2163r2132b2242],
74	—	CD	NUMBER	—	num	73	SENT_211	[p14l1552t2163r2132b2242],
75	nine	CD	NUMBER	nine	num	77	SENT_211	[p14l11t2291r199b2368],
76	protein	NN	O	protein	nn	77	SENT_211	[p14l250t2291r562b2390],
77	kinase	NN	O	kinase	nsubj	62	SENT_211	[p14l613t2290r915b2370],
78	.	.	O	.	_	0	SENT_211	[p14l613t2290r915b2370],

1	Since	IN	O	since	mark	8	SENT_212	[p14l976t2291r1198b2369],
2	a	DT	O	a	det	4	SENT_212	[p14l1250t2316r1294b2368],
3	specific	JJ	O	specific	amod	4	SENT_212	[p14l1347t2289r1676b2390],
4	inhibitor	NN	O	inhibitor	nsubj	8	SENT_212	[p14l1728t2290r2128b2386],
5	,	,	O	,	_	0	SENT_212	[p14l1728t2290r2128b2386],
6	PLX4032	NN	O	plx4032	appos	4	SENT_212	[p14l9t2425r386b2515],
7	,	,	O	,	_	0	SENT_212	[p14l9t2425r386b2515],
8	targets	VBZ	O	target	advcl	15	SENT_212	[p14l418t2436r702b2520],
9	the	DT	O	the	det	12	SENT_212	[p14l731t2419r860b2498],
10	mutant	JJ	O	mutant	amod	12	SENT_212	[p14l886t2436r1191b2498],
11	activated	VBN	O	activate	amod	12	SENT_212	[p14l1210t2419r1575b2498],
12	kinase	NN	O	kinase	dobj	8	SENT_212	[p14l1600t2419r1892b2515],
13	,	,	O	,	_	0	SENT_212	[p14l1600t2419r1892b2515],
14	there	EX	O	there	expl	15	SENT_212	[p14l1923t2419r2133b2497],
15	is	VBZ	O	be	_	0	SENT_212	[p14l11t2548r77b2625],
16	a	DT	O	a	det	18	SENT_212	[p14l111t2573r156b2625],
17	pharmacogenetic	JJ	O	pharmacogenetic	amod	18	SENT_212	[p14l186t2547r936b2648],
18	effect	NN	O	effect	nsubj	15	SENT_212	[p14l969t2546r1211b2626],
19	in	IN	O	in	_	0	SENT_212	[p14l1239t2548r1323b2625],
20	that	DT	O	that	det	21	SENT_212	[p14l1356t2547r1529b2625],
21	PLX4032	NN	O	plx4032	prep_in	18	SENT_212	[p14l1556t2553r1920b2626],
22	prolongs	VBZ	O	prolong	rcmod	21	SENT_212	[p14l1953t2573r2132b2647, p14l10t2675r241b2776],
23	survival	NN	O	survival	dobj	22	SENT_212	[p14l281t2675r612b2754],
24	in	IN	O	in	_	0	SENT_212	[p14l648t2676r731b2753],
25	patients	NNS	O	patient	prep_in	22	SENT_212	[p14l766t2676r1107b2775],
26	carrying	VBG	O	carry	partmod	25	SENT_212	[p14l1146t2676r1510b2776],
27	the	DT	O	the	det	28	SENT_212	[p14l1543t2675r1676b2753],
28	mutation	NN	O	mutation	dobj	26	SENT_212	[p14l1712t2676r2128b2754],
29	.	.	O	.	_	0	SENT_212	[p14l1712t2676r2128b2754],

1	This	DT	O	this	det	3	SENT_213	[p14l7t2803r192b2881],
2	clinical	JJ	O	clinical	amod	3	SENT_213	[p14l221t2803r527b2881],
3	finding	NN	O	finding	nsubjpass	5	SENT_213	[p14l553t2802r870b2904],
4	was	VBD	O	be	auxpass	5	SENT_213	[p14l889t2829r1049b2882],
5	based	VBN	O	base	_	0	SENT_213	[p14l1079t2803r1319b2882],
6	on	IN	O	on	_	0	SENT_213	[p14l1346t2829r1451b2882],
7	the	DT	O	the	det	8	SENT_213	[p14l1477t2803r1608b2881],
8	discovery	NN	O	discovery	prep_on	5	SENT_213	[p14l1636t2803r2030b2903],
9	of	IN	O	of	_	0	SENT_213	[p14l2053t2802r2152b2882],
10	a	DT	O	a	det	12	SENT_213	[p14l11t2957r55b3009],
11	BRAF	NN	O	braf	nn	12	SENT_213	[p14l106t2937r330b3011],
12	mutation	NN	O	mutation	prep_of	8	SENT_213	[p14l378t2932r771b3010],
13	through	IN	O	through	_	0	SENT_213	[p14l826t2931r1174b3032],
14	the	DT	O	the	det	15	SENT_213	[p14l1229t2931r1362b3009],
15	sequencing	NN	O	sequencing	prep_through	5	SENT_213	[p14l1418t2932r1903b3032],
16	of	IN	O	of	_	0	SENT_213	[p14l1956t2930r2055b3010],
17	a	DT	O	a	det	19	SENT_213	[p14l2091t2957r2135b3009],
18	large	JJ	O	large	amod	19	SENT_213	[p14l10t3059r224b3160],
19	number	NN	O	number	prep_of	15	SENT_213	[p14l261t3059r598b3138],
20	of	IN	O	of	_	0	SENT_213	[p14l632t3058r732b3138],
21	kinase	NN	O	kinase	nn	22	SENT_213	[p14l750t3059r1029b3138],
22	genes	NNS	O	gene	prep_of	19	SENT_213	[p14l1065t3085r1306b3160],
23	in	IN	O	in	_	0	SENT_213	[p14l1344t3060r1427b3137],
24	tumors	NNS	O	tumor	prep_in	22	SENT_213	[p14l1464t3063r1972b3138],
25	.	.	O	.	_	0	SENT_213	[p14l1464t3063r1972b3138],

1	°	NN	O	°	dep	102	SENT_214	[p14l1464t3063r1972b3138],
2	3	CD	NUMBER	3	dep	102	SENT_214	[p14l1464t3063r1972b3138],
3	»	NN	O	»	dep	102	SENT_214	[p14l1464t3063r1972b3138],
4	54	CD	NUMBER	54	dep	102	SENT_214	[p14l1464t3063r1972b3138],
5	On	IN	O	on	dep	102	SENT_214	[p14l2007t3065r2133b3138],
6	the	DT	O	the	dep	102	SENT_214	[p14l12t3187r142b3265],
7	other	JJ	O	other	dep	102	SENT_214	[p14l173t3187r396b3266],
8	hand	NN	O	hand	dep	102	SENT_214	[p14l423t3187r658b3283],
9	,	,	O	,	_	0	SENT_214	[p14l423t3187r658b3283],
10	germline	NN	O	germline	dep	102	SENT_214	[p14l693t3187r1074b3288],
11	SN	NNP	O	SN	dep	102	SENT_214	[p14l1107t3193r1227b3266],
12	Ps	NNP	O	Ps	dep	102	SENT_214	[p14l1229t3193r1320b3265],
13	in	IN	O	in	dep	102	SENT_214	[p14l1352t3188r1434b3265],
14	the	DT	O	the	dep	102	SENT_214	[p14l1464t3187r1595b3266],
15	gene	NN	O	gene	dep	102	SENT_214	[p14l1625t3213r1821b3288],
16	encod	NN	O	encod	dep	102	SENT_214	[p14l1852t3187r2132b3266],
17	—	CD	NUMBER	—	dep	102	SENT_214	[p14l1852t3187r2132b3266],
18	ing	VBG	O	ing	dep	102	SENT_214	[p14l11t3316r148b3416],
19	the	DT	O	the	dep	102	SENT_214	[p14l197t3315r330b3393],
20	enzyme	NN	O	enzyme	dep	102	SENT_214	[p14l384t3341r714b3415],
21	thiopurine	NN	O	thiopurine	dep	102	SENT_214	[p14l768t3315r1223b3415],
22	S	NN	O	s	dep	102	SENT_214	[p14l1279t3314r2133b3415],
23	—	CD	NUMBER	—	dep	102	SENT_214	[p14l1279t3314r2133b3415],
24	methyltransferase	NN	O	methyltransferase	dep	102	SENT_214	[p14l1279t3314r2133b3415],
25	(	CD	NUMBER	(	dep	102	SENT_214	[p14l16t3449r319b3533],
26	TPMT	NN	O	tpmt	dep	102	SENT_214	[p14l16t3449r319b3533],
27	)	NN	O	)	dep	102	SENT_214	[p14l16t3449r319b3533],
28	can	MD	O	can	dep	102	SENT_214	[p14l356t3469r505b3520],
29	result	VB	O	result	dep	102	SENT_214	[p14l537t3443r780b3522],
30	in	IN	O	in	dep	102	SENT_214	[p14l805t3444r889b3520],
31	increased	VBN	O	increase	dep	102	SENT_214	[p14l919t3443r1328b3521],
32	sensitivity	NN	O	sensitivity	dep	102	SENT_214	[p14l1361t3444r1793b3542],
33	to	TO	O	to	dep	102	SENT_214	[p14l1820t3459r1902b3521],
34	mercaptopurine	NN	O	mercaptopurine	dep	102	SENT_214	[p14l1935t3469r2132b3521, p14l12t3571r528b3670],
35	as	IN	O	as	dep	102	SENT_214	[p14l590t3596r675b3648],
36	a	DT	O	a	dep	102	SENT_214	[p14l739t3596r784b3648],
37	result	NN	O	result	dep	102	SENT_214	[p14l844t3570r1088b3650],
38	of	IN	O	of	dep	102	SENT_214	[p14l1146t3569r1246b3649],
39	decreased	VBN	O	decrease	dep	102	SENT_214	[p14l1291t3570r1713b3649],
40	metabolism	NN	O	metabolism	dep	102	SENT_214	[p14l1775t3570r2132b3649, p14l10t3698r370b3794],
41	,1	CD	NUMBER	,1	dep	102	SENT_214	[p14l1775t3570r2132b3649, p14l10t3698r370b3794],
42	’	CD	NUMBER	’	dep	102	SENT_214	[p14l1775t3570r2132b3649, p14l10t3698r370b3794],
43	4	CD	NUMBER	4	dep	102	SENT_214	[p14l1775t3570r2132b3649, p14l10t3698r370b3794],
44	»	NN	O	»	dep	102	SENT_214	[p14l1775t3570r2132b3649, p14l10t3698r370b3794],
45	5	CD	NUMBER	5	dep	102	SENT_214	[p14l1775t3570r2132b3649, p14l10t3698r370b3794],
46	whereas	IN	O	whereas	dep	102	SENT_214	[p14l403t3698r755b3777],
47	the	DT	O	the	dep	102	SENT_214	[p14l793t3698r926b3776],
48	number	NN	O	number	dep	102	SENT_214	[p14l961t3698r1300b3777],
49	of	IN	O	of	dep	102	SENT_214	[p14l1333t3697r1432b3777],
50	TA	NNP	O	TA	dep	102	SENT_214	[p14l1446t3705r1570b3776],
51	dinucleotide	NN	O	dinucleotide	dep	102	SENT_214	[p14l1603t3698r2133b3777],
52	repeats	NNS	O	repeat	dep	102	SENT_214	[p15l11t41r318b124],
53	in	IN	O	in	dep	102	SENT_214	[p15l364t25r447b102],
54	the	DT	O	the	dep	102	SENT_214	[p15l492t24r625b102],
55	promoter	NN	O	promoter	dep	102	SENT_214	[p15l668t41r1073b124],
56	of	IN	O	of	dep	102	SENT_214	[p15l1115t23r1215b103],
57	UGT1A1	NN	O	ugt1a1	dep	102	SENT_214	[p15l1245t30r1570b102],
58	in	IN	O	in	dep	102	SENT_214	[p15l1617t25r1700b102],
59	germline	NN	O	germline	dep	102	SENT_214	[p15l1744t24r2133b125],
60	DNA	NN	MISC	dna	dep	102	SENT_214	[p15l10t158r218b230],
61	can	MD	O	can	dep	102	SENT_214	[p15l251t177r399b229],
62	increase	VB	O	increase	dep	102	SENT_214	[p15l434t152r785b229],
63	the	DT	O	the	dep	102	SENT_214	[p15l821t151r953b229],
64	toxic	JJ	O	toxic	dep	102	SENT_214	[p15l989t152r1195b230],
65	effects	NNS	O	effect	dep	102	SENT_214	[p15l1230t150r1510b229],
66	of	IN	O	of	dep	102	SENT_214	[p15l1548t150r1648b230],
67	irinotecan	NN	O	irinotecan	dep	102	SENT_214	[p15l1664t152r2128b247],
68	,	,	O	,	_	0	SENT_214	[p15l1664t152r2128b247],
69	also	RB	O	also	dep	102	SENT_214	[p15l11t280r179b359],
70	as	IN	O	as	dep	102	SENT_214	[p15l209t306r293b358],
71	a	DT	O	a	dep	102	SENT_214	[p15l324t306r368b358],
72	result	NN	O	result	dep	102	SENT_214	[p15l396t280r634b359],
73	of	IN	O	of	dep	102	SENT_214	[p15l660t279r759b359],
74	decreased	VBN	O	decrease	dep	102	SENT_214	[p15l770t280r1184b359],
75	metabolism	NN	O	metabolism	dep	102	SENT_214	[p15l1213t280r1863b359],
76	.1	CD	NUMBER	.1	dep	102	SENT_214	[p15l1213t280r1863b359],
77	>	JJR	O	>	dep	102	SENT_214	[p15l1213t280r1863b359],
78	65	CD	NUMBER	65	dep	102	SENT_214	[p15l1213t280r1863b359],
79	There	EX	O	there	dep	102	SENT_214	[p15l1893t280r2133b358],
80	are	VBP	O	be	dep	102	SENT_214	[p15l11t434r137b486],
81	now	RB	DATE	now	dep	102	SENT_214	[p15l169t434r351b487],
82	many	JJ	O	many	dep	102	SENT_214	[p15l378t434r614b508],
83	examples	NNS	O	example	dep	102	SENT_214	[p15l641t408r1032b508],
84	of	IN	O	of	dep	102	SENT_214	[p15l1066t407r1165b487],
85	pharmacogenetic	JJ	O	pharmacogenetic	dep	102	SENT_214	[p15l1177t408r1911b509],
86	tests	NNS	O	test	dep	102	SENT_214	[p15l1942t425r2131b486],
87	paired	VBN	O	pair	dep	102	SENT_214	[p15l9t536r283b636],
88	with	IN	O	with	dep	102	SENT_214	[p15l312t536r508b615],
89	anticancer	JJ	O	anticancer	dep	102	SENT_214	[p15l541t537r993b615],
90	drugs	NNS	O	drug	dep	102	SENT_214	[p15l1024t536r1268b637],
91	that	WDT	O	that	dep	102	SENT_214	[p15l1305t536r1477b614],
92	are	VBP	O	be	dep	102	SENT_214	[p15l1506t562r1634b615],
93	considered	VBN	O	consider	dep	102	SENT_214	[p15l1670t536r2133b615],
94	part	NN	O	part	dep	102	SENT_214	[p15l9t681r189b764],
95	of	IN	O	of	dep	102	SENT_214	[p15l221t663r321b743],
96	routine	JJ	O	routine	dep	102	SENT_214	[p15l338t665r647b743],
97	oncologic	JJ	O	oncologic	dep	102	SENT_214	[p15l684t664r1101b765],
98	care	NN	O	care	dep	102	SENT_214	[p15l1137t690r1311b742],
99	(	RB	O	(	dep	102	SENT_214	[p15l1352t664r1610b755],
100	Table	NNP	O	Table	dep	102	SENT_214	[p15l1352t664r1610b755],
101	1	CD	NUMBER	1	dep	102	SENT_214	[p15l1650t670r1745b755],
102	)	CD	NUMBER	)	_	0	SENT_214	[p15l1650t670r1745b755],
103	.	.	O	.	_	0	SENT_214	[p15l1650t670r1745b755],

1	The	DT	O	the	det	2	SENT_215	[p15l1783t664r1943b742],
2	fact	NN	O	fact	nsubjpass	27	SENT_215	[p15l1979t663r2138b742],
3	that	IN	O	that	complm	20	SENT_215	[p15l12t792r184b870],
4	clinically	RB	O	clinically	advmod	5	SENT_215	[p15l226t792r617b892],
5	relevant	JJ	O	relevant	amod	7	SENT_215	[p15l659t792r1000b871],
6	pharmacogenomic	JJ	O	pharmacogenomic	amod	7	SENT_215	[p15l1040t792r1851b893],
7	variation	NN	O	variation	nsubj	20	SENT_215	[p15l1893t793r2132b871, p15l12t921r181b999],
8	in	IN	O	in	_	0	SENT_215	[p15l215t921r299b998],
9	both	CC	O	both	preconj	12	SENT_215	[p15l334t920r532b999],
10	the	DT	O	the	det	12	SENT_215	[p15l567t920r700b998],
11	tumor	NN	O	tumor	nn	12	SENT_215	[p15l736t937r1003b999],
12	genome	NN	O	genome	prep_in	7	SENT_215	[p15l1035t946r1374b1021],
13	and	CC	O	and	_	0	SENT_215	[p15l1409t920r1567b999],
14	the	DT	O	the	det	15	SENT_215	[p15l1602t920r1734b998],
15	patient	NN	O	patient	poss	18	SENT_215	[p15l1769t921r2132b1020],
16	’s	POS	O	’s	_	0	SENT_215	[p15l1769t921r2132b1020],
17	germline	NN	O	germline	nn	18	SENT_215	[p15l11t1048r399b1149],
18	genome	NN	O	genome	prep_in	7	SENT_215	[p15l440t1074r780b1149],
19	can	MD	O	can	aux	20	SENT_215	[p15l821t1074r970b1126],
20	influence	VB	O	influence	dep	2	SENT_215	[p15l1010t1047r1413b1127],
21	the	DT	O	the	det	22	SENT_215	[p15l1455t1048r1587b1126],
22	response	NN	O	response	dobj	20	SENT_215	[p15l1628t1074r2009b1148],
23	to	TO	O	to	_	0	SENT_215	[p15l2050t1065r2132b1127],
24	antineoplastic	JJ	O	antineoplastic	amod	25	SENT_215	[p15l11t1176r621b1276],
25	therapy	NN	O	therapy	prep_to	20	SENT_215	[p15l664t1176r985b1276],
26	is	VBZ	O	be	auxpass	27	SENT_215	[p15l1024t1177r1089b1254],
27	illustrated	VBN	O	illustrate	_	0	SENT_215	[p15l1134t1176r1573b1255],
28	in	IN	O	in	_	0	SENT_215	[p15l1615t1177r1699b1254],
29	Figure	NNP	O	Figure	prep_in	27	SENT_215	[p15l1741t1177r2014b1277],
30	3	CD	NUMBER	3	num	29	SENT_215	[p15l2058t1182r2128b1272],
31	,	,	O	,	_	0	SENT_215	[p15l2058t1182r2128b1272],
32	with	IN	O	with	_	0	SENT_215	[p15l7t1304r202b1383],
33	gefitinib	NN	O	gefitinib	prep_with	27	SENT_215	[p15l236t1303r608b1405],
34	and	CC	O	and	_	0	SENT_215	[p15l643t1304r801b1383],
35	irinotecan	NN	O	irinotecan	prep_with	27	SENT_215	[p15l835t1305r1276b1383],
36	as	IN	O	as	_	0	SENT_215	[p15l1311t1330r1395b1382],
37	examples	NNS	O	example	prep_as	33	SENT_215	[p15l1433t1304r1856b1404],
38	.	.	O	.	_	0	SENT_215	[p15l1433t1304r1856b1404],

1	AROMATASE	NNP	O	AROMATASE	nn	2	SENT_216	[p15l361t1600r1030b1661],
2	INHIBITORS	NNS	O	inhibitor	_	0	SENT_216	[p15l1085t1600r1777b1660],

1	Genetic	JJ	O	genetic	amod	2	SENT_217	[p15l11t1820r341b1898],
2	polymorphisms	NNS	O	polymorphism	nsubj	11	SENT_217	[p15l386t1819r1064b1919],
3	in	IN	O	in	_	0	SENT_217	[p15l1113t1820r1196b1897],
4	a	DT	O	a	det	5	SENT_217	[p15l1244t1845r1288b1897],
5	patient	NN	O	patient	poss	8	SENT_217	[p15l1333t1820r1695b1919],
6	’s	POS	O	’s	_	0	SENT_217	[p15l1333t1820r1695b1919],
7	germline	NN	O	germline	nn	8	SENT_217	[p15l1744t1819r2133b1920],
8	genome	NN	O	genome	prep_in	2	SENT_217	[p15l11t1973r350b2048],
9	can	MD	O	can	aux	11	SENT_217	[p15l386t1973r535b2025],
10	also	RB	O	also	advmod	11	SENT_217	[p15l568t1947r740b2026],
11	play	VB	O	play	_	0	SENT_217	[p15l773t1947r950b2047],
12	an	DT	O	a	det	14	SENT_217	[p15l979t1973r1082b2025],
13	important	JJ	O	important	amod	14	SENT_217	[p15l1115t1948r1556b2047],
14	role	NN	O	role	dobj	11	SENT_217	[p15l1586t1947r1746b2026],
15	in	IN	O	in	_	0	SENT_217	[p15l1779t1948r1862b2025],
16	variation	NN	O	variation	prep_in	14	SENT_217	[p15l1893t1948r2132b2026, p15l12t2076r181b2153],
17	in	IN	O	in	_	0	SENT_217	[p15l211t2076r295b2152],
18	the	DT	O	the	det	19	SENT_217	[p15l326t2075r459b2153],
19	response	NN	O	response	prep_in	11	SENT_217	[p15l489t2101r870b2174],
20	to	TO	O	to	_	0	SENT_217	[p15l902t2092r983b2153],
21	cancer	NN	O	cancer	nn	22	SENT_217	[p15l1017t2101r1297b2153],
22	therapy	NN	O	therapy	prep_to	11	SENT_217	[p15l1326t2075r1660b2174],
23	.	.	O	.	_	0	SENT_217	[p15l1326t2075r1660b2174],

1	Endocrine	JJ	MISC	endocrine	amod	2	SENT_218	[p15l1695t2075r2133b2153],
2	therapy	NN	O	therapy	nsubj	6	SENT_218	[p15l12t2203r333b2303],
3	of	IN	O	of	_	0	SENT_218	[p15l367t2202r466b2282],
4	breast	NN	O	breast	nn	5	SENT_218	[p15l487t2203r749b2282],
5	cancer6657	NN	O	cancer6657	prep_of	2	SENT_218	[p15l782t2207r1233b2281],
6	offers	VBZ	O	offer	_	0	SENT_218	[p15l1272t2202r1518b2282],
7	a	DT	O	a	det	9	SENT_218	[p15l1556t2229r1601b2281],
8	striking	JJ	O	striking	amod	9	SENT_218	[p15l1638t2203r1979b2304],
9	example	NN	O	example	dobj	6	SENT_218	[p15l2015t2229r2132b2281, p15l11t2331r270b2431],
10	of	IN	O	of	_	0	SENT_218	[p15l322t2330r421b2410],
11	how	WRB	O	how	advmod	17	SENT_218	[p15l453t2331r638b2410],
12	a	DT	O	a	det	15	SENT_218	[p15l684t2357r728b2409],
13	genomewide	JJ	O	genomewide	amod	15	SENT_218	[p15l777t2331r1323b2432],
14	association	NN	O	association	nn	15	SENT_218	[p15l1373t2332r1857b2410],
15	study	NN	O	study	nsubj	17	SENT_218	[p15l1908t2331r2138b2431],
16	has	VBZ	O	have	aux	17	SENT_218	[p15l11t2459r155b2537],
17	lead	VBN	O	lead	prepc_of	9	SENT_218	[p15l210t2459r384b2538],
18	to	TO	O	to	_	0	SENT_218	[p15l438t2476r519b2538],
19	the	DT	O	the	det	20	SENT_218	[p15l576t2459r708b2538],
20	identification	NN	O	identification	prep_to	17	SENT_218	[p15l762t2458r1346b2538],
21	of	IN	O	of	_	0	SENT_218	[p15l1400t2458r1501b2538],
22	a	DT	O	a	det	23	SENT_218	[p15l1535t2485r1580b2537],
23	mechanism	NN	O	mechanism	prep_of	20	SENT_218	[p15l1632t2459r2133b2538],
24	that	WDT	O	that	nsubj	26	SENT_218	[p15l12t2586r184b2664],
25	would	MD	O	would	aux	26	SENT_218	[p15l216t2586r482b2666],
26	seem	VB	O	seem	rcmod	23	SENT_218	[p15l525t2612r744b2664],
27	to	TO	O	to	aux	29	SENT_218	[p15l786t2603r867b2665],
28	be	VB	O	be	cop	29	SENT_218	[p15l911t2586r1008b2665],
29	responsible	JJ	O	responsible	xcomp	26	SENT_218	[p15l1050t2586r1540b2686],
30	for	IN	O	for	mark	35	SENT_218	[p15l1582t2585r1705b2665],
31	a	DT	O	a	det	34	SENT_218	[p15l1744t2612r1788b2664],
32	serious	JJ	O	serious	amod	34	SENT_218	[p15l1830t2587r2132b2666],
33	drug	NN	O	drug	nn	34	SENT_218	[p15l12t2715r588b2816],
34	—	NN	O	—	nsubj	35	SENT_218	[p15l12t2715r588b2816],
35	induced	VBD	O	induce	advcl	29	SENT_218	[p15l12t2715r588b2816],
36	adverse	JJ	O	adverse	amod	37	SENT_218	[p15l630t2715r945b2794],
37	reaction	NN	O	reaction	dobj	35	SENT_218	[p15l987t2716r1336b2794],
38	that	WDT	O	that	nsubj	39	SENT_218	[p15l1379t2715r1551b2793],
39	limits	VBZ	O	limit	rcmod	37	SENT_218	[p15l1588t2715r1836b2793],
40	therapeutic	JJ	O	therapeutic	amod	41	SENT_218	[p15l1882t2715r2132b2793, p15l9t2843r273b2942],
41	options	NNS	O	option	dobj	39	SENT_218	[p15l308t2843r628b2942],
42	for	IN	O	for	_	0	SENT_218	[p15l665t2841r788b2921],
43	some	DT	O	some	det	44	SENT_218	[p15l821t2868r1045b2921],
44	patients	NNS	O	patient	prep_for	41	SENT_218	[p15l1079t2843r1444b2942],
45	.	.	O	.	_	0	SENT_218	[p15l1079t2843r1444b2942],

1	The	DT	O	the	det	2	SENT_219	[p15l136t2970r297b3048],
2	tumors	NNS	O	tumor	nsubj	13	SENT_219	[p15l357t2987r664b3050],
3	of	IN	O	of	_	0	SENT_219	[p15l727t2969r826b3049],
4	approximately	RB	O	approximately	quantmod	5	SENT_219	[p15l866t2970r1483b3070],
5	70	CD	PERCENT	70	num	6	SENT_219	[p15l1538t2976r1722b3050],
6	%	NN	PERCENT	%	prep_of	2	SENT_219	[p15l1538t2976r1722b3050],
7	of	IN	O	of	_	0	SENT_219	[p15l1781t2969r1881b3049],
8	postmenopausal	JJ	O	postmenopausal	amod	9	SENT_219	[p15l1920t2987r2132b3070, p15l11t3099r515b3198],
9	women	NNS	O	woman	prep_of	6	SENT_219	[p15l539t3125r848b3178],
10	with	IN	O	with	_	0	SENT_219	[p15l872t3099r1062b3178],
11	breast	NN	O	breast	nn	12	SENT_219	[p15l1092t3099r1345b3177],
12	cancer	NN	O	cancer	prep_with	9	SENT_219	[p15l1369t3125r1641b3177],
13	express	VBP	O	express	_	0	SENT_219	[p15l1667t3125r1973b3198],
14	the	DT	O	the	det	16	SENT_219	[p15l2004t3099r2133b3177],
15	estrogen	NN	O	estrogen	nn	16	SENT_219	[p15l12t3244r382b3328],
16	receptor	NN	O	receptor	dobj	13	SENT_219	[p15l421t3244r795b3327],
17	.	.	O	.	_	0	SENT_219	[p15l421t3244r795b3327],

1	The	DT	O	the	det	2	SENT_220	[p15l837t3227r998b3305],
2	blockade	NN	O	blockade	nsubj	25	SENT_220	[p15l1038t3227r1417b3306],
3	of	IN	O	of	_	0	SENT_220	[p15l1458t3226r1558b3306],
4	this	DT	O	this	det	5	SENT_220	[p15l1579t3227r1739b3305],
5	receptor	NN	O	receptor	prep_of	2	SENT_220	[p15l1781t3244r2137b3327],
6	with	IN	O	with	_	0	SENT_220	[p15l7t3355r202b3434],
7	tamoxifen	NN	O	tamoxifen	prep_with	5	SENT_220	[p15l240t3354r679b3434],
8	or	CC	O	or	_	0	SENT_220	[p15l717t3381r806b3434],
9	the	DT	O	the	det	10	SENT_220	[p15l841t3355r973b3433],
10	blockade	NN	O	blockade	conj_or	5	SENT_220	[p15l1012t3355r1391b3434],
11	of	IN	O	of	_	0	SENT_220	[p15l1430t3354r1530b3434],
12	estrogen	NN	O	estrogen	nn	13	SENT_220	[p15l1550t3372r1920b3456],
13	synthesis	NN	O	synthesis	prep_of	10	SENT_220	[p15l1959t3381r2132b3455, p15l12t3483r252b3561],
14	through	IN	O	through	_	0	SENT_220	[p15l286t3483r628b3584],
15	the	DT	O	the	det	16	SENT_220	[p15l659t3483r789b3562],
16	inhibition	NN	O	inhibition	prep_through	13	SENT_220	[p15l820t3483r1239b3562],
17	of	IN	O	of	_	0	SENT_220	[p15l1270t3482r1369b3562],
18	aromatase	NN	O	aromatase	prep_of	16	SENT_220	[p15l1381t3500r1818b3562],
19	(	CD	NUMBER	(	num	18	SENT_220	[p15l1854t3483r2134b3574],
20	Which	WDT	O	which	nsubj	21	SENT_220	[p15l1854t3483r2134b3574],
21	catalyzes	VBZ	O	catalyze	rcmod	10	SENT_220	[p15l12t3611r397b3711],
22	estrogen	NN	O	estrogen	nn	23	SENT_220	[p15l457t3628r827b3712],
23	synthesis	NN	O	synthesis	dobj	21	SENT_220	[p15l885t3611r1305b3711],
24	)	CD	NUMBER	)	num	23	SENT_220	[p15l885t3611r1305b3711],
25	halves	VBZ	O	halve	_	0	SENT_220	[p15l1367t3611r1630b3690],
26	the	DT	O	the	det	27	SENT_220	[p15l1690t3611r1822b3689],
27	recurTable	JJ	O	recurtable	dobj	25	SENT_220	[p15l1880t3637r2132b3690, p16l77t209r269b274],

1	1	LS	NUMBER	1	_	0	SENT_221	[p16l296t215r350b273],
2	.	.	O	.	_	0	SENT_221	[p16l296t215r350b273],

1	Anticancer	JJ	O	anticancer	amod	2	SENT_222	[p16l374t210r756b274],
2	Drugs	NNS	O	drug	nsubj	3	SENT_222	[p16l781t215r992b293],
3	Approved	VBN	O	approve	_	0	SENT_222	[p16l1014t209r1354b293],
4	by	IN	O	by	_	0	SENT_222	[p16l1384t208r1461b294],
5	the	DT	O	the	det	6	SENT_222	[p16l1481t209r1594b274],
6	Food	NNP	ORGANIZATION	Food	prep_by	3	SENT_222	[p16l1623t209r1791b274],
7	and	CC	ORGANIZATION	and	_	0	SENT_222	[p16l1818t209r1945b274],
8	Drug	NNP	ORGANIZATION	Drug	nn	11	SENT_222	[p16l83t322r257b401],
9	Administration	NNP	ORGANIZATION	Administration	nn	11	SENT_222	[p16l278t316r806b381],
10	(	CD	NUMBER	(	num	11	SENT_222	[p16l838t322r1037b402],
11	FDA	NNP	ORGANIZATION	FDA	conj_and	3	SENT_222	[p16l838t322r1037b402],
12	)	CD	NUMBER	)	npadvmod	13	SENT_222	[p16l838t322r1037b402],
13	with	IN	O	with	dep	11	SENT_222	[p16l1063t316r1213b381],
14	Labeling	VBG	O	label	pcomp	13	SENT_222	[p16l1246t316r1540b401],
15	Regarding	VBG	O	regard	xcomp	14	SENT_222	[p16l1567t316r1923b402],
16	Pharmacogenomic	JJ	O	pharmacogenomic	amod	17	SENT_222	[p16l83t425r744b509],
17	Biomarkers	NNS	O	biomarker	dobj	15	SENT_222	[p16l772t425r1235b490],
18	.	.	O	.	_	0	SENT_222	[p16l772t425r1235b490],
19	"	''	O	"	punct	3	SENT_222	[p16l772t425r1235b490],
20	"	''	O	"	punct	3	SENT_222	[p16l772t425r1235b490],

1	Type	NN	O	type	nn	2	SENT_223	[p16l210t623r376b702],
2	ofBiomarker	NN	O	ofbiomarker	_	0	SENT_223	[p16l402t616r860b682],
3	and	CC	O	and	_	0	SENT_223	[p16l884t617r1008b682],
4	Associated	NNP	O	Associated	nn	5	SENT_223	[p16l1035t617r1417b682],
5	Drug	NNP	O	Drug	conj_and	2	SENT_223	[p16l1453t623r1623b702],

1	Biomarker	NN	O	biomarker	_	0	SENT_224	[p16l346t750r709b815],
2	with	IN	O	with	_	0	SENT_224	[p16l728t750r879b815],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_224	[p16l909t750r1498b834],
4	effect	NN	O	effect	nn	5	SENT_224	[p16l1521t749r1714b815],
5	TPMT	NN	O	tpmt	prep_with	1	SENT_224	[p16l340t873r556b931],

1	Mercaptopurine	NNP	O	Mercaptopurine	nn	2	SENT_225	[p16l478t990r1042b1068],
2	Thioguanine	NNP	O	Thioguanine	_	0	SENT_225	[p16l469t1101r914b1187],

1	UGT1A1	NN	O	ugt1a1	_	0	SENT_226	[p16l347t1222r639b1283],

1	Irinotecan	NNP	MISC	Irinotecan	nn	2	SENT_227	[p16l478t1341r826b1399],
2	Nilotinib	NNP	MISC	Nilotinib	_	0	SENT_227	[p16l478t1452r781b1517],

1	Biomarker	NN	O	biomarker	_	0	SENT_228	[p16l346t1568r709b1634],
2	with	IN	O	with	_	0	SENT_228	[p16l728t1569r879b1633],
3	pharmacodynamic	JJ	O	pharmacodynamic	amod	5	SENT_228	[p16l909t1568r1565b1653],
4	effect	NN	O	effect	nn	5	SENT_228	[p16l1588t1567r1783b1634],
5	EGFR	NN	ORGANIZATION	egfr	prep_with	1	SENT_228	[p16l346t1691r542b1751],

1	Cetuximab	NNP	O	Cetuximab	nn	4	SENT_229	[p16l473t1803r848b1868],
2	Erlotinib	NNP	O	Erlotinib	nn	4	SENT_229	[p16l478t1920r770b1985],
3	Geﬁtinib	NNP	O	Geﬁtinib	nn	4	SENT_229	[p16l473t2036r775b2101],
4	Panitumumab	NNP	LOCATION	Panitumumab	_	0	SENT_229	[p16l478t2154r976b2219],

1	KRAS	NNS	ORGANIZATION	kra	_	0	SENT_230	[p16l349t2275r532b2336],

1	Cetuximab	NNP	PERSON	Cetuximab	nn	2	SENT_231	[p16l473t2387r848b2452],
2	Panitumumab	NNP	PERSON	Panitumumab	_	0	SENT_231	[p16l478t2505r976b2569],

1	ABL	NN	O	abl	_	0	SENT_232	[p16l340t2625r484b2685],

1	Imatinib	NNP	MISC	Imatinib	nn	3	SENT_233	[p16l478t2738r767b2803],
2	Dasatinib	NNP	MISC	Dasatinib	nn	3	SENT_233	[p16l478t2855r810b2920],
3	Nilotinib	NNP	MISC	Nilotinib	_	0	SENT_233	[p16l478t2972r781b3037],

1	C-Kit	NN	O	c-kit	_	0	SENT_234	[p16l345t3092r511b3154],
2	(	CD	NUMBER	(	num	4	SENT_234	[p16l543t3095r707b3175],
3	KIT	NN	O	kit	nn	4	SENT_234	[p16l543t3095r707b3175],
4	)	NN	O	)	dep	1	SENT_234	[p16l543t3095r707b3175],

1	Imatinib	NN	O	imatinib	_	0	SENT_235	[p16l478t3207r767b3271],

1	HER2/neu	NN	O	her2/neu	_	0	SENT_236	[p16l346t3330r704b3409],
2	(	CD	NUMBER	(	num	4	SENT_236	[p16l738t3330r1021b3409],
3	ERBB2	NN	O	erbb2	nn	4	SENT_236	[p16l738t3330r1021b3409],
4	)	NN	O	)	dep	1	SENT_236	[p16l738t3330r1021b3409],

1	Lapatinib	NNP	MISC	Lapatinib	nn	4	SENT_237	[p16l478t3441r800b3525],
2	Trastuzumab	NNP	MISC	Trastuzumab	nn	4	SENT_237	[p16l469t3558r941b3623],
3	Estrogen	NN	MISC	estrogen	nn	4	SENT_237	[p16l349t3681r651b3760],
4	receptor	NN	O	receptor	_	0	SENT_237	[p16l685t3687r975b3759],

1	To	TO	O	to	_	0	SENT_238	[p16l469t3798r550b3834],
2	rnnvi-Fan	JJ	O	rnnvi-fan	pobj	1	SENT_238	[p16l564t3791r837b3834],

1	‘	NN	O	‘	_	0	SENT_239	[p17l8t6r16b129],
2	IGIIIKIAIICII	CD	NUMBER	igiiikiaiicii	num	3	SENT_239	[p17l489t6r837b28],
3	|	NNS	O	|	dep	1	SENT_239	[p17l2145t6r2153b129],

1	7	CD	NUMBER	7	num	3	SENT_240	[p17l10t190r49b227],
2	"	``	O	"	punct	3	SENT_240	[p17l10t190r49b227],
3	Data	NNS	O	datum	_	0	SENT_240	[p17l82t190r238b248],
4	are	VBP	O	be	rcmod	3	SENT_240	[p17l271t207r375b248],
5	from	IN	O	from	_	0	SENT_240	[p17l403t183r567b248],
6	the	DT	O	the	det	7	SENT_240	[p17l598t183r708b248],
7	FDA	NNP	ORGANIZATION	FDA	poss	11	SENT_240	[p17l744t188r948b248],
8	’s	POS	O	’s	_	0	SENT_240	[p17l744t188r948b248],
9	pharmacogenetics	NNS	O	pharmacogenetic	nn	11	SENT_240	[p17l983t183r1630b269],
10	Web	NN	O	web	nn	11	SENT_240	[p17l1659t183r1816b248],
11	site	NN	O	site	prep_from	4	SENT_240	[p17l1848t190r1968b248],

1	(	NN	O	(	_	0	SENT_241	[p17l83t281r2040b366],
2	www.fda.gov/Drugs/ScienceResearch/ResearchAreas/	NN	O	www.fda.gov/drugs/scienceresearch/researchareas/	nn	3	SENT_241	[p17l83t281r2040b366],
3	Pharmacogenetics/ucm083378	NN	O	pharmacogenetics/ucm083378	dep	1	SENT_241	[p17l82t377r1400b462],
4	.	.	O	.	_	0	SENT_241	[p17l82t377r1400b462],

1	htm	NN	O	htm	_	0	SENT_242	[p17l82t377r1400b462],
2	)	NN	O	)	dep	1	SENT_242	[p17l82t377r1400b462],
3	.	.	O	.	_	0	SENT_242	[p17l82t377r1400b462],

1	The	DT	O	the	det	2	SENT_243	[p17l1429t377r1560b442],
2	biomarkers	NNS	O	biomarker	nsubjpass	5	SENT_243	[p17l1593t377r1985b442],
3	have	VBP	O	have	aux	5	SENT_243	[p17l79t473r236b538],
4	been	VBN	O	be	auxpass	5	SENT_243	[p17l270t473r429b538],
5	separated	VBN	O	separate	_	0	SENT_243	[p17l465t473r805b557],
6	into	IN	O	into	_	0	SENT_243	[p17l841t479r972b538],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	8	SENT_243	[p17l1007t473r1595b557],
8	effect	NN	O	effect	prep_into	5	SENT_243	[p17l1623t473r1813b538],
9	(	CD	NUMBER	(	num	12	SENT_243	[p17l1849t473r2034b558],
10	drug	NN	O	drug	nn	12	SENT_243	[p17l1849t473r2034b558],
11	metabolism	NN	O	metabolism	nn	12	SENT_243	[p17l79t569r520b654],
12	)	NN	O	)	dep	8	SENT_243	[p17l79t569r520b654],
13	and	CC	O	and	_	0	SENT_243	[p17l559t569r682b634],
14	pharmacodynamic	JJ	O	pharmacodynamic	amod	15	SENT_243	[p17l719t569r1376b654],
15	effect	NN	O	effect	prep_into	5	SENT_243	[p17l1404t569r1594b634],
16	(	CD	NUMBER	(	num	18	SENT_243	[p17l1630t569r1815b654],
17	drug	NN	O	drug	nn	18	SENT_243	[p17l1630t569r1815b654],
18	target	NN	O	target	dep	15	SENT_243	[p17l1841t574r2095b654],
19	)	CD	NUMBER	)	dep	15	SENT_243	[p17l1841t574r2095b654],
20	.	.	O	.	_	0	SENT_243	[p17l1841t574r2095b654],

1	Biomarkers	NNS	O	biomarker	nsubjpass	7	SENT_244	[p17l82t665r469b730],
2	for	IN	O	for	_	0	SENT_244	[p17l498t665r594b730],
3	cytogenetic	JJ	O	cytogenetic	amod	4	SENT_244	[p17l619t671r1010b750],
4	alterations	NNS	O	alteration	prep_for	1	SENT_244	[p17l1038t665r1398b730],
5	have	VBP	O	have	aux	7	SENT_244	[p17l1431t665r1586b730],
6	been	VBN	O	be	auxpass	7	SENT_244	[p17l1618t665r1775b730],
7	excluded	VBN	O	exclude	_	0	SENT_244	[p17l1807t665r2127b730],
8	.	.	O	.	_	0	SENT_244	[p17l1807t665r2127b730],

1	rence	NN	O	rence	nn	2	SENT_245	[p17l11t996r235b1048],
2	rate	NN	O	rate	nsubj	15	SENT_245	[p17l270t974r629b1049],
3	.66	CD	NUMBER	.66	num	4	SENT_245	[p17l270t974r629b1049],
4	'68	CD	NUMBER	'68	dep	2	SENT_245	[p17l270t974r629b1049],
5	However	RB	O	however	advmod	4	SENT_245	[p17l664t978r1052b1066],
6	,	,	O	,	_	0	SENT_245	[p17l664t978r1052b1066],
7	the	DT	O	the	det	8	SENT_245	[p17l1092t970r1223b1048],
8	administration	NN	O	administration	nsubj	15	SENT_245	[p17l1257t970r1891b1049],
9	of	IN	O	of	_	0	SENT_245	[p17l1926t969r2025b1049],
10	an	DT	O	a	det	12	SENT_245	[p17l2040t996r2142b1048],
11	aromatase	NN	O	aromatase	nn	12	SENT_245	[p17l11t1117r450b1179],
12	inhibitor	NN	O	inhibitor	prep_of	8	SENT_245	[p17l481t1100r856b1179],
13	can	MD	O	can	aux	15	SENT_245	[p17l885t1126r1033b1178],
14	also	RB	O	also	advmod	15	SENT_245	[p17l1064t1100r1232b1179],
15	result	VB	O	result	_	0	SENT_245	[p17l1266t1100r1504b1179],
16	in	IN	O	in	_	0	SENT_245	[p17l1530t1101r1613b1178],
17	severe	JJ	O	severe	amod	18	SENT_245	[p17l1646t1126r1899b1179],
18	musculoskeletal	JJ	O	musculoskeletal	prep_in	15	SENT_245	[p17l1930t1126r2140b1179, p17l12t1228r513b1308],

1	pain	NN	O	pain	_	0	SENT_246	[p17l542t1229r734b1328],
2	that	WDT	O	that	nsubj	3	SENT_246	[p17l767t1228r940b1306],
3	leads	VBZ	O	lead	rcmod	1	SENT_246	[p17l966t1228r1182b1307],
4	women	NNS	O	woman	nsubj	5	SENT_246	[p17l1212t1254r1530b1308],
5	(	VBP	O	(	ccomp	3	SENT_246	[p17l1567t1234r1690b1319],
6	10	CD	NUMBER	10	dobj	5	SENT_246	[p17l1567t1234r1690b1319],
7	to	TO	O	to	_	0	SENT_246	[p17l1724t1245r1805b1307],
8	20	CD	NUMBER	20	number	9	SENT_246	[p17l1839t1233r2027b1307],
9	°	CD	NUMBER	°	prep_to	5	SENT_246	[p17l1839t1233r2027b1307],
10	/	:	O	/	punct	1	SENT_246	[p17l1839t1233r2027b1307],
11	o	NN	O	o	nsubj	15	SENT_246	[p17l1839t1233r2027b1307],
12	in	IN	O	in	_	0	SENT_246	[p17l2058t1229r2142b1306],
13	some	DT	O	some	det	14	SENT_246	[p17l12t1383r232b1436],
14	studies	NNS	O	study	prep_in	11	SENT_246	[p17l263t1357r578b1448],
15	)	VBP	O	)	dep	1	SENT_246	[p17l263t1357r578b1448],
16	to	TO	O	to	aux	17	SENT_246	[p17l613t1374r694b1436],
17	terminate	VB	O	terminate	xcomp	15	SENT_246	[p17l725t1358r1131b1435],
18	therapy	NN	O	therapy	dobj	17	SENT_246	[p17l1162t1357r1559b1457],
19	.67	CD	NUMBER	.67	num	18	SENT_246	[p17l1162t1357r1559b1457],
20	In	IN	O	in	_	0	SENT_246	[p17l1587t1365r1675b1435],
21	a	DT	O	a	det	24	SENT_246	[p17l1704t1383r1748b1435],
22	genomewide	JJ	O	genomewide	amod	24	SENT_246	[p17l1776t1383r2140b1458, p17l7t1485r211b1564],
23	association	NN	O	association	nn	24	SENT_246	[p17l260t1486r746b1564],
24	study	NN	O	study	prep_in	17	SENT_246	[p17l797t1485r1028b1585],
25	that	WDT	O	that	nsubj	26	SENT_246	[p17l1074t1485r1247b1563],
26	used	VBD	O	use	rcmod	24	SENT_246	[p17l1291t1485r1489b1564],
27	DNA	NN	O	dna	nn	28	SENT_246	[p17l1537t1491r1746b1564],
28	samples	NNS	O	sample	dobj	26	SENT_246	[p17l1794t1485r2140b1585],
29	from	IN	O	from	_	0	SENT_246	[p17l11t1613r219b1693],
30	a	DT	O	a	det	33	SENT_246	[p17l254t1640r299b1692],
31	large	JJ	O	large	amod	33	SENT_246	[p17l333t1614r543b1715],
32	clinical	JJ	O	clinical	amod	33	SENT_246	[p17l581t1614r888b1692],
33	trial	NN	O	trial	prep_from	26	SENT_246	[p17l924t1614r1098b1692],
34	of	IN	O	of	_	0	SENT_246	[p17l1135t1613r1234b1693],
35	aromatase	NN	O	aromatase	nn	36	SENT_246	[p17l1251t1631r1691b1693],
36	inhibitors	NNS	O	inhibitor	prep_of	33	SENT_246	[p17l1727t1614r2140b1693],
37	to	TO	O	to	aux	38	SENT_246	[p17l12t1759r93b1821],
38	treat	VB	O	treat	xcomp	26	SENT_246	[p17l125t1759r324b1820],
39	women	NNS	O	woman	dobj	38	SENT_246	[p17l345t1768r661b1822],
40	with	IN	O	with	_	0	SENT_246	[p17l687t1742r883b1822],
41	breast	NN	O	breast	nn	43	SENT_246	[p17l913t1742r1177b1821],
42	cancer	NN	O	cancer	nn	43	SENT_246	[p17l1202t1768r1484b1820],
43	(	NN	O	(	prep_with	38	SENT_246	[p17l1515t1742r1793b1833],
44	called	VBN	O	call	partmod	43	SENT_246	[p17l1515t1742r1793b1833],
45	MA	NNP	O	MA	nsubj	49	SENT_246	[p17l1820t1748r2136b1833],
46	.27	CD	NUMBER	.27	num	45	SENT_246	[p17l1820t1748r2136b1833],
47	)	CD	NUMBER	)	number	48	SENT_246	[p17l1820t1748r2136b1833],
48	(	CD	NUMBER	(	num	49	SENT_246	[p17l16t1871r787b1972],
49	ClinicalTrials	NNS	O	clinicaltrial	xcomp	44	SENT_246	[p17l16t1871r787b1972],
50	.	.	O	.	_	0	SENT_246	[p17l16t1871r787b1972],

1	gov	NN	O	gov	nn	2	SENT_247	[p17l16t1871r787b1972],
2	number	NN	O	number	_	0	SENT_247	[p17l826t1871r1177b1967],
3	,	,	O	,	_	0	SENT_247	[p17l826t1871r1177b1967],
4	NCTOO968214	NN	O	nctoo968214	nn	5	SENT_247	[p17l1223t1877r1879b1967],
5	)	NN	O	)	appos	2	SENT_247	[p17l1223t1877r1879b1967],
6	,	,	O	,	_	0	SENT_247	[p17l1223t1877r1879b1967],
7	there	EX	O	there	expl	8	SENT_247	[p17l1928t1871r2141b1950],
8	was	VBD	O	be	dep	2	SENT_247	[p17l7t2025r168b2078],
9	an	DT	O	a	det	10	SENT_247	[p17l204t2025r306b2077],
10	association	NN	O	association	nsubj	8	SENT_247	[p17l340t2000r814b2078],
11	between	IN	O	between	_	0	SENT_247	[p17l850t1999r1202b2078],
12	musculoskeletal	JJ	O	musculoskeletal	amod	13	SENT_247	[p17l1236t1999r1921b2079],
13	pain	NN	O	pain	prep_between	10	SENT_247	[p17l1953t2000r2142b2099],
14	and	CC	O	and	_	0	SENT_247	[p17l11t2128r169b2207],
15	variants	NNS	O	variant	prep_between	10	SENT_247	[p17l207t2129r551b2207],
16	in	IN	O	in	_	0	SENT_247	[p17l595t2129r679b2206],
17	the	DT	O	the	det	19	SENT_247	[p17l722t2128r855b2206],
18	gene	NN	O	gene	nn	19	SENT_247	[p17l898t2154r1098b2229],
19	cluster	NN	O	cluster	prep_in	10	SENT_247	[p17l1141t2128r1428b2207],
20	encoding	VBG	O	encode	partmod	19	SENT_247	[p17l1468t2128r1870b2229],
21	T	NN	O	t	nn	24	SENT_247	[p17l1905t2128r2143b2207],
22	—	NN	O	—	nn	24	SENT_247	[p17l1905t2128r2143b2207],
23	cell	NN	O	cell	nn	24	SENT_247	[p17l1905t2128r2143b2207],
24	leul	NN	O	leul	dep	25	SENT_247	[p17l10t2256r923b2356],
25	<	JJR	O	<	dobj	20	SENT_247	[p17l10t2256r923b2356],
26	emia	CD	NUMBER	emia	num	28	SENT_247	[p17l10t2256r923b2356],
27	—	NN	O	—	nn	28	SENT_247	[p17l10t2256r923b2356],
28	lymphoma	NN	O	lymphoma	dep	20	SENT_247	[p17l10t2256r923b2356],
29	(	CD	NUMBER	(	num	32	SENT_247	[p17l959t2262r1188b2347],
30	TCL	NNP	ORGANIZATION	TCL	nn	32	SENT_247	[p17l959t2262r1188b2347],
31	)	NN	O	)	nn	32	SENT_247	[p17l959t2262r1188b2347],
32	proteins	NNS	O	protein	dep	28	SENT_247	[p17l1224t2257r1604b2356],
33	.	.	O	.	_	0	SENT_247	[p17l1224t2257r1604b2356],

1	The	DT	O	the	det	2	SENT_248	[p17l1639t2256r1800b2334],
2	marker	NN	O	marker	nsubj	25	SENT_248	[p17l1833t2256r2145b2336],
3	showing	VBG	O	show	partmod	2	SENT_248	[p17l12t2385r381b2486],
4	the	DT	O	the	det	6	SENT_248	[p17l414t2385r547b2463],
5	strongest	JJS	O	strongest	amod	6	SENT_248	[p17l584t2402r986b2486],
6	(	CD	NUMBER	(	dobj	3	SENT_248	[p17l1022t2385r1434b2486],
7	although	IN	O	although	mark	12	SENT_248	[p17l1022t2385r1434b2486],
8	not	RB	O	not	neg	12	SENT_248	[p17l1469t2402r1613b2464],
9	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_248	[p17l1644t2384r2136b2486],
10	)	NN	O	)	nn	11	SENT_248	[p17l1644t2384r2136b2486],
11	association	NN	O	association	nsubj	12	SENT_248	[p17l11t2515r497b2593],
12	created	VBD	O	create	dep	6	SENT_248	[p17l533t2514r841b2593],
13	a	DT	O	a	det	18	SENT_248	[p17l877t2540r921b2592],
14	new	JJ	O	new	amod	18	SENT_248	[p17l955t2540r1134b2593],
15	estrogen	NN	O	estrogen	nn	18	SENT_248	[p17l1166t2531r1955b2615],
16	—	NN	O	—	nn	18	SENT_248	[p17l1166t2531r1955b2615],
17	response	NN	O	response	nn	18	SENT_248	[p17l1166t2531r1955b2615],
18	element	NN	O	element	nsubj	19	SENT_248	[p17l1992t2514r2140b2593, p17l11t2660r230b2721],
19	close	JJ	O	close	xcomp	12	SENT_248	[p17l258t2643r467b2722],
20	to	TO	O	to	aux	21	SENT_248	[p17l501t2660r582b2722],
21	TCLlA	VB	O	tclla	xcomp	19	SENT_248	[p17l616t2647r969b2722],
22	.69	CD	NUMBER	.69	num	24	SENT_248	[p17l616t2647r969b2722],
23	Functional	JJ	O	functional	amod	24	SENT_248	[p17l1002t2643r1458b2722],
24	studies	NNS	O	study	dobj	21	SENT_248	[p17l1492t2643r1787b2722],
25	showed	VBD	O	show	_	0	SENT_248	[p17l1824t2643r2142b2722],
26	that	IN	O	that	complm	28	SENT_248	[p17l12t2772r185b2850],
27	the	DT	O	the	det	28	SENT_248	[p17l223t2772r356b2851],
28	markers	NNS	O	marker	dep	25	SENT_248	[p17l399t2772r751b2851],
29	that	WDT	O	that	nsubjpass	31	SENT_248	[p17l796t2772r969b2850],
30	were	VBD	O	be	auxpass	31	SENT_248	[p17l1003t2798r1205b2851],
31	associated	VBN	O	associate	rcmod	28	SENT_248	[p17l1247t2772r1694b2851],
32	with	IN	O	with	_	0	SENT_248	[p17l1732t2772r1928b2851],
33	susceptibility	NN	O	susceptibility	prep_with	31	SENT_248	[p17l1973t2798r2140b2851, p17l12t2900r436b3000],

1	to	TO	O	to	_	0	SENT_249	[p17l477t2917r558b2979],
2	musculoskeletal	JJ	O	musculoskeletal	amod	3	SENT_249	[p17l605t2900r1289b2980],
3	pain	NN	O	pain	prep_to	4	SENT_249	[p17l1333t2901r1521b3000],
4	were	VBD	O	be	_	0	SENT_249	[p17l1563t2926r1762b2980],
5	also	RB	O	also	advmod	4	SENT_249	[p17l1808t2900r1977b2979],
6	asENGLJ	NN	O	asenglj	nsubj	4	SENT_249	[p17l2023t2926r2140b2978, p17l587t3085r665b3107],

1	MED	NNP	O	MED	_	0	SENT_250	[p17l679t3085r731b3100],
2	64	CD	NUMBER	64	num	1	SENT_250	[p17l756t3079r820b3107],
3	;	:	O	;	_	0	SENT_250	[p17l756t3079r820b3107],
4	12	CD	NUMBER	12	num	6	SENT_250	[p17l756t3079r820b3107],
5	NEjM.ORG	NN	O	nejm.org	nn	6	SENT_250	[p17l856t3085r980b3107],
6	MARCH2	NN	O	march2	dep	1	SENT_250	[p17l1017t3085r1127b3100],
7	,2	CD	NUMBER	,2	num	8	SENT_250	[p17l1146t3085r1213b3105],
8	o11	NN	O	o11	dep	6	SENT_250	[p17l1146t3085r1213b3105],
9	1149	CD	DATE	1149	dep	6	SENT_250	[p17l1940t3075r2016b3098],

1	e	LS	O	e	dep	4	SENT_251	[p17l739t3126r753b3142],
2	New	NNP	O	New	nn	4	SENT_251	[p17l762t3119r824b3142],
3	England	NNP	O	England	nn	4	SENT_251	[p17l833t3118r944b3149],
4	Journal	NNP	O	Journal	_	0	SENT_251	[p17l952t3118r1050b3142],
5	of	IN	O	of	prep	4	SENT_251	[p17l1059t3118r1088b3142],
6	e	SYM	O	e	dep	5	SENT_251	[p17l1125t3126r1139b3142],
7	icine	FW	O	icine	dep	4	SENT_251	[p17l1156t3118r1220b3142],

1	Downloaded	VBN	O	download	_	0	SENT_252	[p17l144t3159r314b3182],
2	from	IN	O	from	_	0	SENT_252	[p17l323t3159r387b3182],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_252	[p17l396t3159r514b3189],
4	at	IN	O	at	_	0	SENT_252	[p17l524t3163r547b3182],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_252	[p17l556t3159r738b3182],
6	on	IN	O	on	_	0	SENT_252	[p17l748t3166r780b3182],
7	January	NNP	DATE	January	prep_on	1	SENT_252	[p17l789t3159r892b3189],
8	5	CD	DATE	5	num	7	SENT_252	[p17l902t3159r924b3187],
9	,	,	DATE	,	_	0	SENT_252	[p17l902t3159r924b3187],
10	2014	CD	DATE	2014	num	7	SENT_252	[p17l935t3159r1007b3182],
11	.	.	O	.	_	0	SENT_252	[p17l935t3159r1007b3182],

1	For	IN	O	for	_	0	SENT_253	[p17l1018t3159r1064b3182],
2	personal	JJ	O	personal	amod	3	SENT_253	[p17l1072t3159r1185b3189],
3	use	NN	O	use	pobj	1	SENT_253	[p17l1194t3166r1237b3182],
4	only	RB	O	only	advmod	3	SENT_253	[p17l1247t3159r1312b3189],
5	.	.	O	.	_	0	SENT_253	[p17l1247t3159r1312b3189],

1	No	DT	O	no	det	3	SENT_254	[p17l1322t3159r1362b3182],
2	other	JJ	O	other	amod	3	SENT_254	[p17l1372t3159r1440b3182],
3	uses	NNS	O	use	_	0	SENT_254	[p17l1448t3166r1504b3182],
4	without	IN	O	without	_	0	SENT_254	[p17l1514t3159r1616b3182],
5	permission	NN	O	permission	prep_without	3	SENT_254	[p17l1624t3159r1776b3189],
6	.	.	O	.	_	0	SENT_254	[p17l1624t3159r1776b3189],

1	Copyright	NN	O	copyright	_	0	SENT_255	[p17l494t3200r629b3231],
2	©	CD	NUMBER	©	num	6	SENT_255	[p17l638t3200r661b3224],
3	2011	CD	DATE	2011	num	6	SENT_255	[p17l671t3200r734b3224],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_255	[p17l746t3200r937b3224],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_255	[p17l947t3200r1055b3224],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_255	[p17l1065t3200r1170b3231],
7	.	.	O	.	_	0	SENT_255	[p17l1065t3200r1170b3231],

1	All	DT	O	all	det	2	SENT_256	[p17l1181t3200r1223b3224],
2	rights	NNS	O	rights	nsubj	3	SENT_256	[p17l1232t3200r1306b3231],
3	reserved	VBN	O	reserve	_	0	SENT_256	[p17l1316t3200r1435b3224],
4	.	.	O	.	_	0	SENT_256	[p17l1316t3200r1435b3224],

1	The	DT	O	the	det	4	SENT_257	[p17l815t3242r860b3263],
2	NEW	NNP	O	NEW	nn	4	SENT_257	[p17l879t3244r964b3263],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_257	[p17l983t3244r1171b3263],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_257	[p17l1191t3244r1370b3270],
5	of	IN	O	of	_	0	SENT_257	[p17l1390t3242r1418b3269],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_257	[p17l1430t3244r1629b3263],

1	A	DT	O	a	det	3	SENT_258	[p18l399t72r424b100],
2	Tumor	NN	O	tumor	nn	3	SENT_258	[p18l444t77r537b100],
3	genome	NN	O	genome	_	0	SENT_258	[p18l546t83r656b108],

1	EG	NN	O	eg	_	0	SENT_259	[p18l1249t162r1280b183],
2	F	NN	O	f	nn	3	SENT_259	[p18l1285t162r1297b182],
3	receptor	NN	O	receptor	dep	1	SENT_259	[p18l1307t164r1405b189],

1	Tumor	NN	O	tumor	nn	2	SENT_260	[p18l1791t225r1873b245],
2	genome	NN	O	genome	_	0	SENT_260	[p18l1880t230r1977b252],

1	Lung	NN	O	lung	nn	2	SENT_261	[p18l936t316r994b344],
2	cancer	NN	O	cancer	_	0	SENT_261	[p18l1002t322r1080b337],

1	Gefitinib	NNP	O	Gefitinib	_	0	SENT_262	[p18l1177t468r1279b491],
2	.	.	O	.	_	0	SENT_262	[p18l1379t452r1393b475],

1	‘	NN	O	‘	_	0	SENT_263	[p18l1379t452r1393b475],
2	I	CD	NUMBER	i	num	1	SENT_263	[p18l1414t494r1417b499],
3	‘	NN	O	‘	dep	1	SENT_263	[p18l1414t494r1417b499],
4	'	''	O	'	_	0	SENT_263	[p18l1557t470r1559b472],
5	’	CD	NUMBER	’	num	6	SENT_263	[p18l1655t475r1657b477],
6	_	NN	O	_	dep	3	SENT_263	[p18l1680t491r1687b494],
7	.	.	O	.	_	0	SENT_263	[p18l1712t455r1715b458],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_264	[p18l1791t470r1856b491],
2	activating	VBG	O	activate	dep	1	SENT_264	[p18l1865t471r1980b498],
3	(	NN	O	(	nn	7	SENT_264	[p18l1127t504r1210b533],
4	kinase	NN	O	kinase	nn	7	SENT_264	[p18l1127t504r1210b533],
5	inhibitor	NN	O	inhibitor	nn	7	SENT_264	[p18l1220t504r1329b533],
6	)	NN	O	)	nn	7	SENT_264	[p18l1220t504r1329b533],
7	o	NN	O	o	dobj	2	SENT_264	[p18l1415t508r1425b519],
8	_	CD	NUMBER	_	num	9	SENT_264	[p18l1415t508r1425b519],
9	*	NN	O	*	dep	7	SENT_264	[p18l1415t508r1425b519],
10	;	:	O	;	_	0	SENT_264	[p18l1442t518r1456b534],
11	,	,	O	,	_	0	SENT_264	[p18l1442t518r1456b534],
12	mutations	NNS	O	mutation	dep	7	SENT_264	[p18l1824t506r1945b526],

1	Increased	VBN	O	increase	amod	3	SENT_265	[p18l1445t681r1558b704],
2	tumor	NN	O	tumor	nn	3	SENT_265	[p18l1567t685r1642b704],
3	sensitivity	NN	O	sensitivity	_	0	SENT_265	[p18l1415t719r1533b745],
4	to	TO	O	to	_	0	SENT_265	[p18l1541t721r1564b739],
5	gefitinib	NN	O	gefitinib	prep_to	3	SENT_265	[p18l1574t716r1670b746],

1	B	NN	O	b	_	0	SENT_266	[p18l402t849r422b877],
2	Germline	NN	O	germline	nn	3	SENT_266	[p18l445t852r572b878],
3	genome	NN	O	genome	dep	1	SENT_266	[p18l581t861r692b885],

1	Low	JJ	O	low	amod	2	SENT_267	[p18l1620t891r1667b911],
2	expression	NN	O	expression	_	0	SENT_267	[p18l1675t891r1802b918],
3	of	IN	O	of	_	0	SENT_267	[p18l1812t888r1838b911],
4	UGT1A1	NN	O	ugt1a1	nn	8	SENT_267	[p18l1845t890r1943b911],
5	and	CC	O	and	_	0	SENT_267	[p18l1954t889r1996b911],
6	low	JJ	O	low	nn	8	SENT_267	[p18l1643t924r1683b946],
7	level	NN	O	level	nn	8	SENT_267	[p18l1692t924r1742b946],
8	ofglucuronidation	NN	O	ofglucuronidation	prep_of	2	SENT_267	[p18l1753t923r1973b953],

1	Germline	NN	O	germline	nn	2	SENT_268	[p18l1088t963r1199b985],
2	genome	NN	O	genome	_	0	SENT_268	[p18l1207t970r1304b992],

1	SN-38	NN	O	sn-38	_	0	SENT_269	[p18l1547t1015r1620b1036],
2	(	CD	NUMBER	(	num	5	SENT_269	[p18l1510t1050r1586b1077],
3	active	JJ	O	active	amod	5	SENT_269	[p18l1510t1050r1586b1077],
4	drug	NN	O	drug	nn	5	SENT_269	[p18l1595t1048r1657b1078],
5	)	NN	O	)	dep	1	SENT_269	[p18l1595t1048r1657b1078],

1	‘	NN	O	‘	nn	2	SENT_270	[p18l554t1107r555b1116],
2	irinotecan	NN	O	irinotecan	_	0	SENT_270	[p18l572t1088r690b1109],
3	l	NN	O	l	dep	2	SENT_270	[p18l495t1151r498b1164],
4	^	CD	NUMBER	^	num	5	SENT_270	[p18l515t1125r562b1161],
5	*	NN	O	*	dep	2	SENT_270	[p18l515t1125r562b1161],

1	UGT1A1	NN	O	ugt1a1	_	0	SENT_271	[p18l1502t1185r1646b1206],
2	*	CD	NUMBER	*	dep	1	SENT_271	[p18l1502t1185r1646b1206],
3	28	CD	NUMBER	28	number	4	SENT_271	[p18l1502t1185r1646b1206],
4	(	CD	NUMBER	(	num	7	SENT_271	[p18l1518t1220r1566b1248],
5	TA	NNP	O	TA	nn	7	SENT_271	[p18l1518t1220r1566b1248],
6	)	CD	NUMBER	)	num	7	SENT_271	[p18l1518t1220r1566b1248],
7	7TAA	NN	O	7taa	dep	2	SENT_271	[p18l1571t1220r1630b1249],

1	Healthy	JJ	O	healthy	amod	2	SENT_272	[p18l760t1277r850b1307],
2	liver	NN	O	liver	_	0	SENT_272	[p18l860t1277r909b1300],
3	sN_38	NN	O	sn_38	nn	4	SENT_272	[p18l1883t1296r1956b1317],
4	glucuronide	NN	O	glucuronide	dep	2	SENT_272	[p18l1849t1329r1991b1359],

1	|	NN	O	|	dep	10	SENT_273	[p18l1112t1342r1230b1362],
2	r	NN	O	r	dep	1	SENT_273	[p18l1112t1342r1230b1362],
3	'	''	O	'	_	0	SENT_273	[p18l1112t1342r1230b1362],
4	notecan	JJ	O	notecan	amod	6	SENT_273	[p18l1112t1342r1230b1362],
5	SN-38	NN	O	sn-38	nn	6	SENT_273	[p18l1334t1340r1406b1361],
6	l	NN	O	l	dep	2	SENT_273	[p18l1130t1348r1133b1362],
7	UGTIAI	NNP	O	UGTIAI	dep	10	SENT_273	[p18l1519t1347r1617b1368],
8	(	CD	NUMBER	(	num	10	SENT_273	[p18l1798t1366r1897b1393],
9	inactive	JJ	O	inactive	amod	10	SENT_273	[p18l1798t1366r1897b1393],
10	metabolite	NN	O	metabolite	dep	15	SENT_273	[p18l1907t1364r2042b1393],
11	)	CD	NUMBER	)	num	13	SENT_273	[p18l1907t1364r2042b1393],
12	(	NN	O	(	nn	13	SENT_273	[p18l1113t1375r1225b1404],
13	prodrug	NN	O	prodrug	dep	10	SENT_273	[p18l1113t1375r1225b1404],
14	)	CD	NUMBER	)	num	15	SENT_273	[p18l1113t1375r1225b1404],
15	(	NN	O	(	dep	18	SENT_273	[p18l1296t1376r1373b1403],
16	active	JJ	O	active	amod	18	SENT_273	[p18l1296t1376r1373b1403],
17	drug	NN	O	drug	nn	18	SENT_273	[p18l1382t1374r1444b1403],
18	)	NN	O	)	dep	22	SENT_273	[p18l1382t1374r1444b1403],
19	(	CD	NUMBER	(	num	20	SENT_273	[p18l1513t1382r1625b1411],
20	1-A	NN	O	1-a	dep	18	SENT_273	[p18l1513t1382r1625b1411],
21	)	CD	NUMBER	)	num	22	SENT_273	[p18l1513t1382r1625b1411],
22	61-AA	NN	O	61-aa	_	0	SENT_273	[p18l1513t1382r1625b1411],

1	Colon	NN	O	colon	nn	2	SENT_274	[p18l1009t1493r1077b1515],
2	cancer	NN	O	cancer	_	0	SENT_274	[p18l1009t1536r1087b1550],

1	Germline	NN	O	germline	nn	2	SENT_275	[p18l1146t1616r1258b1638],
2	genome	NN	O	genome	_	0	SENT_275	[p18l1265t1623r1362b1645],

1	High	JJ	O	high	amod	2	SENT_276	[p18l1615t1655r1670b1685],
2	expression	NN	O	expression	_	0	SENT_276	[p18l1681t1658r1807b1685],
3	of	IN	O	of	_	0	SENT_276	[p18l1817t1655r1844b1678],
4	UGT1A1	NN	O	ugt1a1	nn	8	SENT_276	[p18l1850t1657r1948b1678],
5	and	CC	O	and	_	0	SENT_276	[p18l1959t1655r2002b1678],
6	high	JJ	O	high	nn	8	SENT_276	[p18l1637t1691r1686b1720],
7	level	NN	O	level	nn	8	SENT_276	[p18l1698t1691r1748b1713],
8	ofglucuronidation	NN	O	ofglucuronidation	prep_of	2	SENT_276	[p18l1758t1690r1978b1720],

1	Figure	NNP	O	Figure	_	0	SENT_277	[p18l408t1776r492b1808],
2	3	CD	NUMBER	3	dep	1	SENT_277	[p18l503t1778r525b1800],
3	.	.	O	.	_	0	SENT_277	[p18l503t1778r525b1800],

1	Cancer	NN	O	cancer	_	0	SENT_278	[p18l536t1777r633b1801],
2	Pharmacogenomics	NNS	O	pharmacogenomic	dep	1	SENT_278	[p18l644t1775r917b1808],
3	and	CC	O	and	_	0	SENT_278	[p18l928t1775r977b1801],
4	Tumor	NN	O	tumor	nn	7	SENT_278	[p18l988t1778r1079b1801],
5	and	CC	O	and	_	0	SENT_278	[p18l1089t1775r1138b1801],
6	Germline	NN	O	germline	conj_and	4	SENT_278	[p18l1150t1775r1279b1801],
7	Genomes	NNS	O	genome	conj_and	2	SENT_278	[p18l1289t1777r1430b1801],
8	.	.	O	.	_	0	SENT_278	[p18l1289t1777r1430b1801],

1	Both	CC	O	both	dep	4	SENT_279	[p18l408t1826r469b1851],
2	the	DT	O	the	det	4	SENT_279	[p18l481t1826r524b1851],
3	tumor	NN	O	tumor	nn	4	SENT_279	[p18l535t1830r621b1851],
4	genome	NN	O	genome	nsubj	31	SENT_279	[p18l632t1834r744b1859],
5	(	CD	NUMBER	(	dep	4	SENT_279	[p18l758t1828r822b1859],
6	e.g.	FW	O	e.g.	dep	5	SENT_279	[p18l758t1828r822b1859],
7	,	,	O	,	_	0	SENT_279	[p18l758t1828r822b1859],
8	in	IN	O	in	_	0	SENT_279	[p18l835t1828r857b1850],
9	the	DT	O	the	det	10	SENT_279	[p18l869t1826r912b1851],
10	case	NN	O	case	prep_in	5	SENT_279	[p18l924t1834r984b1851],
11	of	IN	O	of	_	0	SENT_279	[p18l995t1825r1025b1851],
12	gefitinib	NN	O	gefitinib	nn	14	SENT_279	[p18l1032t1825r1145b1859],
13	therapy	NN	O	therapy	nn	14	SENT_279	[p18l1156t1826r1269b1859],
14	)	NN	O	)	prep_of	10	SENT_279	[p18l1156t1826r1269b1859],
15	and	CC	O	and	_	0	SENT_279	[p18l1283t1826r1332b1851],
16	the	DT	O	the	det	17	SENT_279	[p18l1343t1826r1387b1851],
17	patient	NN	O	patient	poss	20	SENT_279	[p18l1400t1827r1518b1858],
18	’s	POS	O	’s	_	0	SENT_279	[p18l1400t1827r1518b1858],
19	germline	NN	O	germline	nn	20	SENT_279	[p18l1530t1826r1652b1859],
20	genome	NN	O	genome	conj_and	10	SENT_279	[p18l1663t1834r1775b1859],
21	(	CD	NUMBER	(	dep	20	SENT_279	[p18l1789t1828r1853b1859],
22	e.g.	FW	O	e.g.	dep	20	SENT_279	[p18l1789t1828r1853b1859],
23	,	,	O	,	_	0	SENT_279	[p18l1789t1828r1853b1859],
24	in	IN	O	in	_	0	SENT_279	[p18l1867t1828r1888b1850],
25	the	DT	O	the	det	29	SENT_279	[p18l1900t1826r1944b1851],
26	case	NN	O	case	nn	29	SENT_279	[p18l1955t1834r2015b1851],
27	ofirinotecan	NN	O	ofirinotecan	nn	29	SENT_279	[p18l406t1867r580b1893],
28	therapy	NN	O	therapy	nn	29	SENT_279	[p18l592t1867r704b1900],
29	)	NN	O	)	prep_in	5	SENT_279	[p18l592t1867r704b1900],
30	can	MD	O	can	aux	31	SENT_279	[p18l718t1876r764b1893],
31	contribute	VB	O	contribute	_	0	SENT_279	[p18l777t1867r920b1893],
32	to	TO	O	to	_	0	SENT_279	[p18l930t1872r957b1893],
33	pharmacogenomic	JJ	O	pharmacogenomic	amod	34	SENT_279	[p18l970t1867r1230b1901],
34	variation	NN	O	variation	prep_to	31	SENT_279	[p18l1240t1870r1360b1893],
35	in	IN	O	in	_	0	SENT_279	[p18l1374t1870r1395b1892],
36	response	NN	O	response	prep_in	34	SENT_279	[p18l1409t1876r1534b1900],
37	to	TO	O	to	_	0	SENT_279	[p18l1544t1872r1571b1893],
38	antineoplastic	JJ	O	antineoplastic	amod	39	SENT_279	[p18l1583t1867r1779b1900],
39	drugs	NNS	O	drug	prep_to	31	SENT_279	[p18l1790t1867r1876b1901],
40	.	.	O	.	_	0	SENT_279	[p18l1790t1867r1876b1901],

1	The	DT	O	the	det	3	SENT_280	[p18l1887t1867r1939b1892],
2	tumor	NN	O	tumor	nn	3	SENT_280	[p18l1949t1872r2036b1893],
3	genome	NN	O	genome	nsubj	4	SENT_280	[p18l406t1918r518b1942],
4	plays	VBZ	O	play	_	0	SENT_280	[p18l531t1909r598b1942],
5	a	DT	O	a	det	7	SENT_280	[p18l610t1918r623b1934],
6	critical	JJ	O	critical	amod	7	SENT_280	[p18l635t1909r725b1934],
7	role	NN	O	role	iobj	4	SENT_280	[p18l739t1909r789b1934],
8	in	IN	O	in	_	0	SENT_280	[p18l802t1911r823b1934],
9	the	DT	O	the	det	10	SENT_280	[p18l835t1909r879b1934],
10	response	NN	O	response	prep_in	7	SENT_280	[p18l891t1918r1016b1942],
11	to	TO	O	to	_	0	SENT_280	[p18l1026t1914r1053b1934],
12	gefitinib	NN	O	gefitinib	nn	14	SENT_280	[p18l1065t1909r1179b1942],
13	(	CD	NUMBER	(	num	14	SENT_280	[p18l1193t1909r1276b1942],
14	Panel	NN	O	panel	prep_to	10	SENT_280	[p18l1193t1909r1276b1942],
15	A	DT	O	a	det	16	SENT_280	[p18l1288t1911r1325b1942],
16	)	NN	O	)	dobj	4	SENT_280	[p18l1288t1911r1325b1942],
17	,	,	O	,	_	0	SENT_280	[p18l1288t1911r1325b1942],
18	since	IN	O	since	mark	31	SENT_280	[p18l1338t1911r1408b1934],
19	the	DT	O	the	det	20	SENT_280	[p18l1418t1909r1462b1934],
20	sensitivity	NN	O	sensitivity	nsubjpass	31	SENT_280	[p18l1473t1911r1612b1942],
21	of	IN	O	of	_	0	SENT_280	[p18l1623t1909r1653b1934],
22	non	JJ	O	non	amod	26	SENT_280	[p18l1661t1909r1863b1934],
23	—	JJ	O	—	amod	26	SENT_280	[p18l1661t1909r1863b1934],
24	small-cell	NN	O	small-cell	nn	26	SENT_280	[p18l1661t1909r1863b1934],
25	lung	NN	O	lung	nn	26	SENT_280	[p18l1877t1909r1936b1942],
26	cancer	NN	O	cancer	prep_of	20	SENT_280	[p18l1947t1918r2038b1934],
27	to	TO	O	to	_	0	SENT_280	[p18l405t1955r432b1976],
28	this	DT	O	this	det	29	SENT_280	[p18l442t1951r492b1976],
29	drug	NN	O	drug	prep_to	20	SENT_280	[p18l504t1951r568b1984],
30	is	VBZ	O	be	auxpass	31	SENT_280	[p18l579t1953r598b1976],
31	enhanced	VBN	O	enhance	dep	16	SENT_280	[p18l611t1951r743b1976],
32	by	IN	O	by	_	0	SENT_280	[p18l757t1951r786b1984],
33	activating	VBG	O	activate	agent	31	SENT_280	[p18l797t1953r932b1984],
34	mutations	NNS	O	mutation	dobj	33	SENT_280	[p18l944t1953r1084b1976],
35	in	IN	O	in	_	0	SENT_280	[p18l1097t1953r1119b1975],
36	the	DT	O	the	det	40	SENT_280	[p18l1130t1951r1174b1976],
37	kinase	NN	O	kinase	nn	40	SENT_280	[p18l1186t1951r1272b1976],
38	domain	NN	O	domain	nn	40	SENT_280	[p18l1283t1951r1387b1976],
39	ofthe	NN	O	ofthe	nn	40	SENT_280	[p18l1400t1950r1479b1976],
40	gene	NN	O	gene	prep_in	33	SENT_280	[p18l1490t1959r1555b1984],
41	encoding	VBG	O	encode	partmod	40	SENT_280	[p18l1567t1951r1695b1984],
42	epidermal	JJ	O	epidermal	amod	45	SENT_280	[p18l1705t1951r1843b1983],
43	growth	NN	O	growth	nn	45	SENT_280	[p18l1857t1951r1952b1984],
44	factor	NN	O	factor	nn	45	SENT_280	[p18l1964t1950r2045b1976],
45	receptor	NN	O	receptor	dobj	41	SENT_280	[p18l407t1997r522b2025],
46	(	CD	NUMBER	(	num	47	SENT_280	[p18l535t1992r697b2025],
47	EGFR	NN	ORGANIZATION	egfr	tmod	41	SENT_280	[p18l535t1992r697b2025],
48	)	CD	NUMBER	)	number	49	SENT_280	[p18l535t1992r697b2025],
49	.58	CD	NUMBER	.58	nsubj	60	SENT_280	[p18l535t1992r697b2025],
50	'59	CD	NUMBER	'59	num	52	SENT_280	[p18l535t1992r697b2025],
51	Tumor	NN	O	tumor	nn	52	SENT_280	[p18l707t1995r800b2018],
52	EGFR	NN	ORGANIZATION	egfr	dep	49	SENT_280	[p18l811t1994r886b2018],
53	encoding	VBG	O	encode	partmod	49	SENT_280	[p18l896t1992r1025b2026],
54	activating	VBG	O	activate	xcomp	53	SENT_280	[p18l1036t1995r1170b2026],
55	mutations	NNS	O	mutation	dobj	54	SENT_280	[p18l1182t1995r1322b2018],
56	within	IN	O	within	_	0	SENT_280	[p18l1333t1992r1417b2018],
57	the	DT	O	the	det	59	SENT_280	[p18l1429t1992r1472b2018],
58	kinase	NN	O	kinase	nn	59	SENT_280	[p18l1485t1992r1570b2018],
59	domain	NN	O	domain	prep_within	54	SENT_280	[p18l1582t1992r1685b2018],
60	results	VBZ	O	result	rcmod	47	SENT_280	[p18l1699t1992r1790b2018],
61	in	IN	O	in	_	0	SENT_280	[p18l1803t1995r1825b2017],
62	enhanced	VBN	O	enhance	amod	64	SENT_280	[p18l1837t1992r1970b2018],
63	tumor	NN	O	tumor	nn	64	SENT_280	[p18l1982t1997r2019b2018, p18l407t2043r463b2059],
64	sensitivity	NN	O	sensitivity	prep_in	60	SENT_280	[p18l474t2036r612b2067],
65	to	TO	O	to	_	0	SENT_280	[p18l622t2039r649b2059],
66	gefitinib	NN	O	gefitinib	prep_to	64	SENT_280	[p18l660t2034r781b2067],
67	.	.	O	.	_	0	SENT_280	[p18l660t2034r781b2067],

1	The	DT	O	the	det	4	SENT_281	[p18l792t2034r844b2059],
2	rate	NN	O	rate	nn	4	SENT_281	[p18l857t2039r907b2059],
3	oftoxic	JJ	O	oftoxic	amod	4	SENT_281	[p18l918t2034r1019b2059],
4	effects	NNS	O	effect	nsubjpass	14	SENT_281	[p18l1030t2034r1122b2059],
5	associated	VBN	O	associate	partmod	4	SENT_281	[p18l1135t2034r1279b2059],
6	with	IN	O	with	_	0	SENT_281	[p18l1291t2034r1348b2059],
7	irinotecan	NN	O	irinotecan	nn	9	SENT_281	[p18l1362t2036r1498b2059],
8	(	CD	NUMBER	(	num	9	SENT_281	[p18l1514t2034r1636b2067],
9	diarrhea	NN	O	diarrhea	prep_with	5	SENT_281	[p18l1514t2034r1636b2067],
10	and	CC	O	and	_	0	SENT_281	[p18l1649t2034r1697b2059],
11	myelosuppression	NN	O	myelosuppression	nn	12	SENT_281	[p18l1711t2034r1972b2067],
12	)	NN	O	)	conj_and	9	SENT_281	[p18l1711t2034r1972b2067],
13	is	VBZ	O	be	auxpass	14	SENT_281	[p18l1988t2036r2007b2059],
14	increased	VBN	O	increase	_	0	SENT_281	[p18l407t2076r537b2101],
15	in	IN	O	in	_	0	SENT_281	[p18l551t2078r573b2100],
16	patients	NNS	O	patient	prep_in	14	SENT_281	[p18l587t2078r697b2108],
17	with	IN	O	with	_	0	SENT_281	[p18l708t2076r765b2101],
18	seven	CD	NUMBER	seven	num	21	SENT_281	[p18l778t2084r855b2101],
19	TA	NNP	O	TA	nn	21	SENT_281	[p18l866t2077r902b2100],
20	dinucleotide	NN	O	dinucleotide	nn	21	SENT_281	[p18l913t2076r1085b2101],
21	repeats	NNS	O	repeat	prep_with	16	SENT_281	[p18l1098t2080r1198b2108],
22	rather	RB	O	rather	_	0	SENT_281	[p18l1211t2076r1293b2101],
23	than	IN	O	than	_	0	SENT_281	[p18l1302t2076r1363b2101],
24	the	DT	O	the	det	32	SENT_281	[p18l1374t2076r1418b2101],
25	more	JJR	O	more	amod	32	SENT_281	[p18l1430t2084r1501b2101],
26	common	JJ	O	common	amod	32	SENT_281	[p18l1512t2084r1635b2101],
27	six	CD	NUMBER	six	num	28	SENT_281	[p18l1648t2078r1683b2101],
28	repeats	NNS	O	repeat	dep	26	SENT_281	[p18l1695t2080r1795b2108],
29	in	IN	O	in	_	0	SENT_281	[p18l1808t2078r1830b2100],
30	the	DT	O	the	det	31	SENT_281	[p18l1842t2076r1885b2101],
31	promoter	NN	O	promoter	prep_in	28	SENT_281	[p18l1898t2080r2028b2108],
32	region	NN	O	region	conj_negcc	16	SENT_281	[p18l407t2120r492b2151],
33	of	IN	O	of	_	0	SENT_281	[p18l505t2117r535b2143],
34	UGT1A1	NN	O	ugt1a1	prep_of	32	SENT_281	[p18l543t2119r657b2143],
35	encoding	VBG	O	encode	partmod	34	SENT_281	[p18l670t2117r798b2151],
36	a	DT	O	a	det	37	SENT_281	[p18l809t2126r822b2143],
37	UDP-glucuronosyltransferase	NN	O	udp-glucuronosyltransferase	dobj	35	SENT_281	[p18l836t2117r1245b2151],
38	in	IN	O	in	_	0	SENT_281	[p18l1257t2120r1279b2142],
39	germline	NN	O	germline	nn	40	SENT_281	[p18l1292t2117r1414b2151],
40	DNA	NN	MISC	dna	prep_in	37	SENT_281	[p18l1427t2119r1501b2147],
41	,	,	O	,	_	0	SENT_281	[p18l1427t2119r1501b2147],
42	resulting	VBG	O	result	partmod	37	SENT_281	[p18l1515t2117r1635b2151],
43	in	IN	O	in	_	0	SENT_281	[p18l1647t2120r1668b2142],
44	lower	JJR	O	lower	amod	46	SENT_281	[p18l1682t2117r1756b2143],
45	enzyme	NN	O	enzyme	nn	46	SENT_281	[p18l1767t2126r1874b2150],
46	activity	NN	O	activity	prep_in	42	SENT_281	[p18l1885t2120r1984b2150],
47	and	CC	O	and	_	0	SENT_281	[p18l1995t2117r2043b2143],
48	a	DT	O	a	det	51	SENT_281	[p18l406t2168r419b2184],
49	decreased	VBN	O	decrease	amod	51	SENT_281	[p18l431t2159r570b2184],
50	rate	NN	O	rate	nn	51	SENT_281	[p18l584t2164r635b2184],
51	ofdrug	NN	O	ofdrug	conj_and	46	SENT_281	[p18l646t2159r746b2192],
52	metabolism	NN	O	metabolism	nn	55	SENT_281	[p18l758t2159r921b2184],
53	(	CD	NUMBER	(	num	55	SENT_281	[p18l936t2159r1020b2192],
54	Panel	NN	O	panel	nn	55	SENT_281	[p18l936t2159r1020b2192],
55	B	NN	O	b	dep	37	SENT_281	[p18l1035t2158r1115b2192],
56	)	CD	NUMBER	)	number	57	SENT_281	[p18l1035t2158r1115b2192],
57	.1	CD	NUMBER	.1	num	58	SENT_281	[p18l1035t2158r1115b2192],
58	'52	CD	NUMBER	'52	dep	55	SENT_281	[p18l1035t2158r1115b2192],

1	sociated	VBN	O	sociate	_	0	SENT_282	[p18l380t2293r511b2324],
2	with	IN	O	with	_	0	SENT_282	[p18l523t2293r596b2325],
3	increased	VBN	O	increase	amod	5	SENT_282	[p18l610t2293r762b2324],
4	TCL1A	NN	O	tcl1a	nn	5	SENT_282	[p18l776t2296r873b2324],
5	expression	NN	O	expression	prep_with	1	SENT_282	[p18l885t2294r1056b2333],
6	after	IN	O	after	_	0	SENT_282	[p18l1069t2293r1145b2324],
7	estrogen	NN	O	estrogen	nn	8	SENT_282	[p18l1158t2304r1202b2324, p18l379t2349r484b2382],
8	exposure	NN	O	exposure	prep_after	5	SENT_282	[p18l496t2353r655b2382],
9	.	.	O	.	_	0	SENT_282	[p18l496t2353r655b2382],

1	TCL1A	NN	O	tcl1a	nsubj	2	SENT_283	[p18l669t2345r784b2373],
2	regulates	VBZ	O	regulate	_	0	SENT_283	[p18l795t2343r947b2382],
3	the	DT	O	the	det	4	SENT_283	[p18l961t2343r1012b2373],
4	expression	NN	O	expression	npadvmod	7	SENT_283	[p18l1025t2343r1202b2382],
5	of	IN	O	of	_	0	SENT_283	[p18l380t2392r418b2423],
6	interleul	NN	O	interleul	prep_of	4	SENT_283	[p18l436t2392r669b2423],
7	<	JJR	O	<	acomp	2	SENT_283	[p18l436t2392r669b2423],
8	in	IN	O	in	_	0	SENT_283	[p18l436t2392r669b2423],
9	—	CD	NUMBER	—	number	10	SENT_283	[p18l436t2392r669b2423],
10	17	CD	NUMBER	17	num	12	SENT_283	[p18l436t2392r669b2423],
11	receptor	NN	O	receptor	nn	12	SENT_283	[p18l695t2399r833b2431],
12	A	NN	O	a	prep_in	7	SENT_283	[p18l856t2395r890b2429],
13	,	,	O	,	_	0	SENT_283	[p18l856t2395r890b2429],
14	an	DT	O	a	det	16	SENT_283	[p18l917t2402r957b2423],
15	experimental	JJ	O	experimental	amod	16	SENT_283	[p18l982t2392r1203b2431],
16	target	NN	O	target	appos	12	SENT_283	[p18l380t2448r479b2481],
17	for	IN	O	for	_	0	SENT_283	[p18l489t2441r537b2472],
18	the	DT	O	the	det	19	SENT_283	[p18l548t2441r600b2472],
19	treatment	NN	O	treatment	prep_for	16	SENT_283	[p18l612t2448r777b2472],
20	of	IN	O	of	_	0	SENT_283	[p18l787t2441r826b2472],
21	patients	NNS	O	patient	prep_of	19	SENT_283	[p18l831t2442r963b2481],
22	with	IN	O	with	_	0	SENT_283	[p18l974t2441r1050b2473],
23	rheumatoid	JJ	O	rheumatoid	amod	24	SENT_283	[p18l1062t2441r1202b2473, p18l380t2491r444b2522],
24	arthritis	NN	O	arthritis	prep_with	21	SENT_283	[p18l454t2491r630b2522],
25	.	.	O	.	_	0	SENT_283	[p18l454t2491r630b2522],

1	”	NN	O	”	nsubj	9	SENT_284	[p18l454t2491r630b2522],
2	These	DT	O	these	det	3	SENT_284	[p18l639t2491r737b2522],
3	observations	NNS	O	observation	dep	1	SENT_284	[p18l748t2491r968b2528],
4	,	,	O	,	_	0	SENT_284	[p18l748t2491r968b2528],
5	if	IN	O	if	mark	6	SENT_284	[p18l981t2491r1011b2521],
6	conﬁrmed	VBN	O	conﬁrmed	dep	1	SENT_284	[p18l1015t2491r1200b2528],
7	,	,	O	,	_	0	SENT_284	[p18l1015t2491r1200b2528],
8	may	MD	O	may	aux	9	SENT_284	[p18l379t2551r449b2580],
9	provide	VB	O	provide	_	0	SENT_284	[p18l469t2541r592b2580],
10	new	JJ	O	new	amod	11	SENT_284	[p18l614t2551r683b2572],
11	insight	NN	O	insight	dobj	9	SENT_284	[p18l703t2541r820b2580],
12	into	IN	O	into	_	0	SENT_284	[p18l840t2541r906b2571],
13	the	DT	O	the	det	14	SENT_284	[p18l928t2541r980b2571],
14	relationship	NN	O	relationship	prep_into	9	SENT_284	[p18l1002t2541r1202b2580],
15	between	IN	O	between	_	0	SENT_284	[p18l380t2590r518b2622],
16	estrogens	NNS	O	estrogen	prep_between	14	SENT_284	[p18l534t2597r694b2630],
17	and	CC	O	and	_	0	SENT_284	[p18l709t2590r771b2621],
18	joint	JJ	O	joint	amod	19	SENT_284	[p18l781t2591r862b2630],
19	pain	NN	O	pain	prep_between	14	SENT_284	[p18l875t2591r958b2630],
20	.	.	O	.	_	0	SENT_284	[p18l875t2591r958b2630],

1	This	DT	O	this	det	2	SENT_285	[p18l1291t2293r1362b2324],
2	example	NN	O	example	nsubj	3	SENT_285	[p18l1376t2293r1511b2333],
3	illustrates	VBZ	O	illustrate	_	0	SENT_285	[p18l1523t2293r1684b2325],
4	several	JJ	O	several	amod	5	SENT_285	[p18l1697t2293r1808b2325],
5	challenges	NNS	O	challenge	dobj	3	SENT_285	[p18l1820t2293r1992b2333],
6	and	CC	O	and	_	0	SENT_285	[p18l2005t2293r2065b2324],
7	opportunities	NNS	O	opportunity	dobj	3	SENT_285	[p18l1242t2343r1464b2382],
8	associated	VBN	O	associate	partmod	5	SENT_285	[p18l1482t2343r1651b2373],
9	with	IN	O	with	_	0	SENT_285	[p18l1666t2343r1740b2374],
10	pharmacogenomic	JJ	O	pharmacogenomic	amod	11	SENT_285	[p18l1757t2343r2065b2382],
11	studies	NNS	O	study	prep_with	8	SENT_285	[p18l1243t2392r1359b2423],
12	and	CC	O	and	_	0	SENT_285	[p18l1374t2392r1435b2423],
13	their	PRP$	O	they	poss	14	SENT_285	[p18l1449t2392r1528b2423],
14	application	NN	O	application	prep_with	8	SENT_285	[p18l1541t2392r1727b2431],
15	to	TO	O	to	_	0	SENT_285	[p18l1741t2399r1773b2423],
16	clinical	JJ	O	clinical	amod	17	SENT_285	[p18l1788t2392r1909b2423],
17	practice	NN	O	practice	prep_to	8	SENT_285	[p18l1923t2393r2063b2431],
18	.	.	O	.	_	0	SENT_285	[p18l1923t2393r2063b2431],

1	First	RB	ORDINAL	first	advmod	11	SENT_286	[p18l1242t2442r1323b2479],
2	,	,	O	,	_	0	SENT_286	[p18l1242t2442r1323b2479],
3	associations	NNS	O	association	nsubj	11	SENT_286	[p18l1339t2442r1538b2472],
4	that	WDT	O	that	nsubjpass	6	SENT_286	[p18l1553t2441r1618b2472],
5	are	VBP	O	be	auxpass	6	SENT_286	[p18l1630t2451r1679b2472],
6	uncovered	VBN	O	uncover	rcmod	3	SENT_286	[p18l1692t2441r1859b2473],
7	by	IN	O	by	_	0	SENT_286	[p18l1873t2441r1910b2481],
8	genomewide	JJ	O	genomewide	amod	10	SENT_286	[p18l1922t2451r2064b2481, p18l1240t2491r1317b2522],
9	association	NN	O	association	nn	10	SENT_286	[p18l1328t2492r1508b2522],
10	studies	NNS	O	study	agent	6	SENT_286	[p18l1520t2491r1632b2522],
11	require	VBP	O	require	_	0	SENT_286	[p18l1643t2492r1757b2530],
12	replication	NN	O	replication	dobj	11	SENT_286	[p18l1768t2491r1940b2530],
13	if	IN	O	if	mark	15	SENT_286	[p18l1950t2491r1980b2521],
14	there	EX	O	there	expl	15	SENT_286	[p18l1984t2491r2065b2522],
15	are	VBP	O	be	advcl	11	SENT_286	[p18l1242t2551r1291b2571],
16	appropriate	JJ	O	appropriate	amod	18	SENT_286	[p18l1305t2541r1493b2580],
17	sample	NN	O	sample	nn	18	SENT_286	[p18l1507t2541r1622b2580],
18	sets	NNS	O	set	nsubj	15	SENT_286	[p18l1636t2547r1706b2571],
19	.	.	O	.	_	0	SENT_286	[p18l1636t2547r1706b2571],

1	However	RB	O	however	advmod	9	SENT_287	[p18l1722t2544r1872b2578],
2	,	,	O	,	_	0	SENT_287	[p18l1722t2544r1872b2578],
3	MA	NNP	LOCATION	MA	nsubj	9	SENT_287	[p18l1886t2543r1995b2571],
4	.27	CD	NUMBER	.27	num	3	SENT_287	[p18l1886t2543r1995b2571],
5	is	VBZ	O	be	cop	9	SENT_287	[p18l2009t2541r2034b2571],
6	a	DT	O	a	det	9	SENT_287	[p18l2048t2551r2066b2571],
7	large	JJ	O	large	amod	9	SENT_287	[p18l1242t2590r1325b2630],
8	clinical	JJ	O	clinical	amod	9	SENT_287	[p18l1338t2590r1460b2621],
9	trial	NN	O	trial	_	0	SENT_287	[p18l1473t2590r1542b2621],
10	of	IN	O	of	_	0	SENT_287	[p18l1555t2590r1594b2621],
11	aromatase	NN	O	aromatase	nn	12	SENT_287	[p18l1600t2597r1773b2621],
12	inhibitors	NNS	O	inhibitor	prep_of	9	SENT_287	[p18l1786t2590r1959b2628],
13	,	,	O	,	_	0	SENT_287	[p18l1786t2590r1959b2628],
14	spanN	NNP	O	spanN	appos	12	SENT_287	[p18l1975t2600r2064b2630, p18l894t2715r908b2730],

1	ENGL	NN	ORGANIZATION	engl	_	0	SENT_288	[p18l923t2715r1001b2737],
2	)	CD	NUMBER	)	num	1	SENT_288	[p18l923t2715r1001b2737],
3	MED	NN	O	med	dep	1	SENT_288	[p18l1015t2715r1067b2730],
4	364	CD	NUMBER	364	num	3	SENT_288	[p18l1077t2709r1157b2737],
5	;	:	O	;	_	0	SENT_288	[p18l1077t2709r1157b2737],
6	12	CD	NUMBER	12	num	7	SENT_288	[p18l1077t2709r1157b2737],
7	NE	NNS	O	ne	dep	1	SENT_288	[p18l1192t2715r1316b2737],
8	)	VBP	O	)	dep	7	SENT_288	[p18l1192t2715r1316b2737],
9	M.ORG	NN	O	m.org	nn	10	SENT_288	[p18l1192t2715r1316b2737],
10	MARCH	NN	DATE	march	tmod	8	SENT_288	[p18l1353t2715r1438b2731],
11	24	CD	DATE	24	num	10	SENT_288	[p18l1451t2715r1486b2737],
12	,	,	DATE	,	_	0	SENT_288	[p18l1451t2715r1486b2737],
13	2011	CD	DATE	2011	appos	1	SENT_288	[p18l1498t2715r1549b2731],

1	The	DT	O	the	det	4	SENT_289	[p18l879t2773r930b2796],
2	New	NNP	O	New	nn	4	SENT_289	[p18l940t2773r1001b2796],
3	England	NNP	O	England	nn	4	SENT_289	[p18l1011t2773r1121b2803],
4	Journal	NNP	O	Journal	_	0	SENT_289	[p18l1130t2773r1228b2796],
5	of	IN	O	of	_	0	SENT_289	[p18l1237t2773r1266b2796],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_289	[p18l1273t2773r1398b2796],

1	Downloaded	VBN	O	download	_	0	SENT_290	[p18l321t2813r491b2836],
2	from	IN	O	from	_	0	SENT_290	[p18l500t2813r565b2836],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_290	[p18l573t2813r692b2843],
4	at	IN	O	at	_	0	SENT_290	[p18l702t2816r725b2836],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_290	[p18l734t2813r916b2836],
6	on	IN	O	on	_	0	SENT_290	[p18l925t2820r958b2836],
7	January	NNP	DATE	January	prep_on	1	SENT_290	[p18l967t2813r1069b2843],
8	5	CD	DATE	5	num	7	SENT_290	[p18l1079t2813r1102b2840],
9	,	,	DATE	,	_	0	SENT_290	[p18l1079t2813r1102b2840],
10	2014	CD	DATE	2014	num	7	SENT_290	[p18l1113t2813r1185b2836],
11	.	.	O	.	_	0	SENT_290	[p18l1113t2813r1185b2836],

1	For	IN	O	for	_	0	SENT_291	[p18l1195t2813r1242b2836],
2	personal	JJ	O	personal	amod	3	SENT_291	[p18l1250t2813r1362b2843],
3	use	NN	O	use	pobj	1	SENT_291	[p18l1372t2820r1415b2836],
4	only	RB	O	only	advmod	3	SENT_291	[p18l1425t2813r1490b2843],
5	.	.	O	.	_	0	SENT_291	[p18l1425t2813r1490b2843],

1	No	DT	O	no	det	3	SENT_292	[p18l1500t2813r1540b2836],
2	other	JJ	O	other	amod	3	SENT_292	[p18l1550t2813r1618b2836],
3	uses	NNS	O	use	_	0	SENT_292	[p18l1626t2820r1682b2836],
4	without	IN	O	without	_	0	SENT_292	[p18l1692t2813r1794b2836],
5	permission	NN	O	permission	prep_without	3	SENT_292	[p18l1802t2813r1954b2843],
6	.	.	O	.	_	0	SENT_292	[p18l1802t2813r1954b2843],

1	Copyright	NN	O	copyright	_	0	SENT_293	[p18l672t2854r806b2885],
2	©	CD	NUMBER	©	num	6	SENT_293	[p18l816t2854r839b2878],
3	2011	CD	DATE	2011	num	6	SENT_293	[p18l849t2854r911b2878],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_293	[p18l924t2854r1115b2878],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_293	[p18l1125t2854r1233b2878],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_293	[p18l1243t2854r1348b2885],
7	.	.	O	.	_	0	SENT_293	[p18l1243t2854r1348b2885],

1	All	DT	O	all	det	2	SENT_294	[p18l1359t2854r1400b2878],
2	rights	NNS	O	rights	nsubj	3	SENT_294	[p18l1410t2854r1484b2885],
3	reserved	VBN	O	reserve	_	0	SENT_294	[p18l1494t2854r1613b2878],
4	.	.	O	.	_	0	SENT_294	[p18l1494t2854r1613b2878],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_295	[p18l909t2960r1067b2979],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_295	[p18l1081t2960r1251b2979],

1	ning	VBG	O	ning	_	0	SENT_296	[p18l11t3177r210b3276],
2	8	CD	DURATION	8	num	3	SENT_296	[p18l245t3182r291b3254],
3	years	NNS	NUMBER	year	tmod	1	SENT_296	[p18l327t3201r547b3275],
4	at	IN	O	at	_	0	SENT_296	[p18l587t3192r666b3253],
5	a	DT	O	a	det	6	SENT_296	[p18l699t3201r744b3253],
6	cost	NN	O	cost	prep_at	1	SENT_296	[p18l781t3192r956b3254],
7	of	IN	O	of	_	0	SENT_296	[p18l990t3174r1090b3254],
8	more	JJR	O	more	quantmod	10	SENT_296	[p18l1111t3201r1329b3254],
9	than	IN	O	than	quantmod	10	SENT_296	[p18l1369t3175r1565b3253],
10	$	$	MONEY	$	prep_of	6	SENT_296	[p18l1607t3173r1748b3263],
11	35	CD	MONEY	35	number	10	SENT_296	[p18l1607t3173r1748b3263],
12	million	CD	MONEY	million	number	10	SENT_296	[p18l1790t3175r2128b3254],
13	.	.	O	.	_	0	SENT_296	[p18l1790t3175r2128b3254],

1	Therefore	RB	O	therefore	advmod	3	SENT_297	[p18l7t3303r447b3400],
2	,	,	O	,	_	0	SENT_297	[p18l7t3303r447b3400],
3	identifying	VBG	O	identify	_	0	SENT_297	[p18l513t3303r988b3405],
4	a	DT	O	a	det	8	SENT_297	[p18l1044t3330r1089b3382],
5	large	JJ	O	large	amod	8	SENT_297	[p18l1147t3304r1360b3405],
6	and	CC	O	and	_	0	SENT_297	[p18l1421t3304r1578b3383],
7	appropriate	JJ	O	appropriate	conj_and	5	SENT_297	[p18l1638t3305r2133b3404],
8	sample	NN	O	sample	dobj	3	SENT_297	[p18l12t3431r314b3531],
9	to	TO	O	to	aux	10	SENT_297	[p18l350t3448r431b3510],
10	test	VB	O	test	xcomp	3	SENT_297	[p18l468t3448r622b3509],
11	for	IN	O	for	_	0	SENT_297	[p18l652t3430r775b3510],
12	replication	NN	O	replication	prep_for	10	SENT_297	[p18l807t3431r1268b3531],
13	will	MD	O	will	aux	15	SENT_297	[p18l1298t3431r1462b3511],
14	be	VB	O	be	cop	15	SENT_297	[p18l1498t3431r1594b3510],
15	difficult	JJ	O	difficult	dep	3	SENT_297	[p18l1630t3430r2005b3511],
16	.	.	O	.	_	0	SENT_297	[p18l1630t3430r2005b3511],

1	In	IN	O	in	_	0	SENT_298	[p18l2044t3439r2133b3509],
2	cases	NNS	O	case	prep_in	19	SENT_298	[p18l12t3586r234b3638],
3	in	IN	O	in	_	0	SENT_298	[p18l271t3561r355b3637],
4	which	WDT	O	which	rel	9	SENT_298	[p18l387t3560r650b3639],
5	replication	NN	O	replication	nn	6	SENT_298	[p18l686t3560r1147b3659],
6	samples	NNS	O	sample	nsubj	12	SENT_298	[p18l1185t3560r1529b3659],
7	are	VBP	O	be	cop	9	SENT_298	[p18l1567t3586r1697b3638],
8	not	RB	O	not	neg	9	SENT_298	[p18l1733t3577r1876b3638],
9	available	JJ	O	available	rcmod	2	SENT_298	[p18l1906t3560r2132b3639, p18l11t3688r178b3767],
10	or	CC	O	or	_	0	SENT_298	[p18l217t3714r304b3767],
11	are	VBP	O	be	cop	12	SENT_298	[p18l338t3714r465b3767],
12	difficult	JJ	O	difficult	rcmod	2	SENT_298	[p18l504t3687r850b3767],
13	to	TO	O	to	aux	14	SENT_298	[p18l883t3705r964b3767],
14	obtain	VB	O	obtain	xcomp	12	SENT_298	[p18l1004t3688r1297b3784],
15	,	,	O	,	_	0	SENT_298	[p18l1004t3688r1297b3784],
16	pharmacogenomic	JJ	O	pharmacogenomic	amod	17	SENT_298	[p18l1338t3688r2134b3789],
17	studies	NNS	O	study	nsubj	19	SENT_298	[p19l12t20r312b100],
18	may	MD	O	may	aux	19	SENT_298	[p19l362t46r541b120],
19	beneﬁt	VB	O	beneﬁt	_	0	SENT_298	[p19l584t19r889b99],
20	from	IN	O	from	_	0	SENT_298	[p19l931t19r1141b99],
21	the	DT	O	the	det	22	SENT_298	[p19l1189t20r1322b98],
22	use	NN	O	use	prep_from	19	SENT_298	[p19l1369t46r1510b99],
23	of	IN	O	of	_	0	SENT_298	[p19l1558t19r1658b99],
24	functional	JJ	O	functional	amod	25	SENT_298	[p19l1687t19r2134b100],
25	validation	NN	O	validation	prep_of	22	SENT_298	[p19l7t149r421b228],
26	to	TO	O	to	aux	27	SENT_298	[p19l452t166r531b228],
27	help	VB	O	help	xcomp	19	SENT_298	[p19l562t149r737b249],
28	verify	VB	O	verify	xcomp	27	SENT_298	[p19l764t148r1000b249],
29	the	DT	O	the	det	30	SENT_298	[p19l1026t149r1155b227],
30	results	NNS	O	result	dobj	28	SENT_298	[p19l1185t149r1458b228],
31	of	IN	O	of	_	0	SENT_298	[p19l1491t148r1590b228],
32	genomewide	JJ	O	genomewide	amod	33	SENT_298	[p19l1600t149r2133b250],
33	studies	NNS	O	study	prep_of	30	SENT_298	[p19l12t277r330b356],
34	.	.	O	.	_	0	SENT_298	[p19l12t277r330b356],

1	For	IN	O	for	_	0	SENT_299	[p19l366t284r506b356],
2	example	NN	O	example	prep_for	14	SENT_299	[p19l536t277r907b377],
3	,	,	O	,	_	0	SENT_299	[p19l536t277r907b377],
4	the	DT	O	the	det	6	SENT_299	[p19l945t277r1075b355],
5	biologic	JJ	O	biologic	amod	6	SENT_299	[p19l1109t277r1443b378],
6	plausibility	NN	O	plausibility	nsubj	14	SENT_299	[p19l1473t277r1942b377],
7	that	WDT	O	that	nsubjpass	9	SENT_299	[p19l1970t277r2139b355],
8	is	VBZ	O	be	auxpass	9	SENT_299	[p19l11t405r75b482],
9	provided	VBN	O	provide	rcmod	6	SENT_299	[p19l116t404r483b504],
10	by	IN	O	by	_	0	SENT_299	[p19l524t404r621b504],
11	the	DT	O	the	det	13	SENT_299	[p19l657t404r788b482],
12	functional	JJ	O	functional	amod	13	SENT_299	[p19l829t403r1266b484],
13	data	NNS	O	datum	agent	9	SENT_299	[p19l1307t404r1486b483],
14	(	VBP	O	(	_	0	SENT_299	[p19l1530t405r1698b500],
15	i.e.	FW	O	i.e.	dobj	14	SENT_299	[p19l1530t405r1698b500],
16	,	,	O	,	_	0	SENT_299	[p19l1530t405r1698b500],
17	the	DT	O	the	det	18	SENT_299	[p19l1744t404r1875b482],
18	association	NN	O	association	appos	15	SENT_299	[p19l1916t430r2132b483, p19l12t534r309b611],
19	between	IN	O	between	_	0	SENT_299	[p19l359t533r723b612],
20	phenotype	NN	O	phenotype	nn	21	SENT_299	[p19l769t533r1726b632],
21	—	NN	O	—	prep_between	18	SENT_299	[p19l769t533r1726b632],
22	associated	VBN	O	associate	partmod	21	SENT_299	[p19l769t533r1726b632],
23	markers	NNS	O	marker	nsubj	28	SENT_299	[p19l1774t533r2132b612],
24	and	CC	O	and	_	0	SENT_299	[p19l11t660r168b739],
25	TCLIA	NN	O	tclium	nn	27	SENT_299	[p19l205t666r464b738],
26	expression	NN	O	expression	nn	27	SENT_299	[p19l498t661r980b760],
27	)	NN	O	)	conj_and	23	SENT_299	[p19l498t661r980b760],
28	increases	VBZ	O	increase	ccomp	22	SENT_299	[p19l1022t661r1416b738],
29	confidence	NN	O	confidence	dobj	28	SENT_299	[p19l1457t659r1928b739],
30	that	IN	O	that	complm	35	SENT_299	[p19l1966t660r2138b738],
31	the	DT	O	the	det	33	SENT_299	[p19l12t789r142b867],
32	genetic	JJ	O	genetic	amod	33	SENT_299	[p19l176t790r478b890],
33	association	NN	O	association	nsubjpass	35	SENT_299	[p19l511t790r984b868],
34	is	VBZ	O	be	auxpass	35	SENT_299	[p19l1017t790r1082b867],
35	driven	VBN	O	drive	ccomp	28	SENT_299	[p19l1119t789r1380b868],
36	by	IN	O	by	_	0	SENT_299	[p19l1414t789r1510b889],
37	biology	NN	O	biology	agent	35	SENT_299	[p19l1540t789r1853b890],
38	rather	RB	O	rather	_	0	SENT_299	[p19l1882t789r2137b868],
39	than	IN	O	than	_	0	SENT_299	[p19l12t917r208b995],
40	chance	NN	O	chance	agent	35	SENT_299	[p19l243t917r563b996],
41	.	.	O	.	_	0	SENT_299	[p19l243t917r563b996],

1	A	DT	O	a	det	3	SENT_300	[p19l599t925r665b995],
2	final	JJ	O	final	amod	3	SENT_300	[p19l696t916r900b995],
3	consideration	NN	O	consideration	nsubj	7	SENT_300	[p19l934t917r1518b996],
4	is	VBZ	O	be	cop	7	SENT_300	[p19l1551t918r1617b995],
5	the	DT	O	the	det	7	SENT_300	[p19l1653t917r1786b995],
6	clinical	JJ	O	clinical	amod	7	SENT_300	[p19l1821t917r2134b995],
7	context	NN	O	context	_	0	SENT_300	[p19l12t1061r349b1123],
8	.	.	O	.	_	0	SENT_300	[p19l12t1061r349b1123],

1	Because	IN	O	because	mark	4	SENT_301	[p19l392t1051r736b1124],
2	aromatase	NN	O	aromatase	nn	3	SENT_301	[p19l775t1061r1221b1123],
3	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_301	[p19l1261t1045r1682b1123],
4	have	VBP	O	have	advcl	33	SENT_301	[p19l1724t1045r1914b1124],
5	only	RB	O	only	advmod	8	SENT_301	[p19l1954t1045r2138b1144],
6	a	DT	O	a	det	8	SENT_301	[p19l11t1199r55b1251],
7	slight	JJ	O	slight	amod	8	SENT_301	[p19l86t1173r322b1274],
8	beneﬁt	NN	O	beneﬁt	dobj	4	SENT_301	[p19l349t1172r647b1252],
9	over	IN	O	over	_	0	SENT_301	[p19l674t1199r848b1252],
10	tamoxifen	NN	O	tamoxifen	prep_over	8	SENT_301	[p19l876t1172r1306b1252],
11	in	IN	O	in	_	0	SENT_301	[p19l1337t1174r1418b1251],
12	the	DT	O	the	det	13	SENT_301	[p19l1450t1173r1580b1252],
13	treatment	NN	O	treatment	prep_in	10	SENT_301	[p19l1611t1190r2027b1252],
14	of	IN	O	of	_	0	SENT_301	[p19l2053t1172r2152b1252],
15	breast	NN	O	breast	nn	16	SENT_301	[p19l12t1300r274b1379],
16	cancer	NN	O	cancer	prep_of	13	SENT_301	[p19l324t1326r623b1396],
17	,	,	O	,	_	0	SENT_301	[p19l324t1326r623b1396],
18	and	CC	O	and	_	0	SENT_301	[p19l683t1300r840b1379],
19	tamoxifen	NN	O	tamoxifen	nsubj	23	SENT_301	[p19l895t1299r1334b1379],
20	is	VBZ	O	be	cop	23	SENT_301	[p19l1388t1301r1453b1378],
21	much	RB	O	much	advmod	23	SENT_301	[p19l1510t1300r1748b1379],
22	less	RBR	O	less	advmod	23	SENT_301	[p19l1802t1300r1957b1378],
23	expensive	JJ	O	expensive	conj_and	4	SENT_301	[p19l2015t1326r2132b1378, p19l9t1430r327b1528],
24	than	IN	O	than	_	0	SENT_301	[p19l363t1429r559b1507],
25	aromatase	NN	O	aromatase	nn	26	SENT_301	[p19l595t1446r1042b1507],
26	inhibitors	NNS	O	inhibitor	prep_than	23	SENT_301	[p19l1077t1429r1523b1524],
27	,	,	O	,	_	0	SENT_301	[p19l1077t1429r1523b1524],
28	a	DT	O	a	det	31	SENT_301	[p19l1564t1455r1608b1506],
29	clear	JJ	O	clear	amod	31	SENT_301	[p19l1644t1429r1849b1507],
30	therapeutic	JJ	O	therapeutic	amod	31	SENT_301	[p19l1882t1429r2132b1507, p19l9t1557r273b1656],
31	alternative	NN	O	alternative	nsubj	33	SENT_301	[p19l318t1556r768b1636],
32	is	VBZ	O	be	cop	33	SENT_301	[p19l814t1557r879b1634],
33	available	JJ	O	available	_	0	SENT_301	[p19l927t1556r1298b1636],
34	for	IN	O	for	_	0	SENT_301	[p19l1345t1555r1468b1635],
35	patients	NNS	O	patient	prep_for	33	SENT_301	[p19l1510t1557r1851b1656],
36	at	IN	O	at	_	0	SENT_301	[p19l1899t1573r1978b1634],
37	increased	VBN	O	increase	amod	38	SENT_301	[p19l2018t1557r2132b1634, p19l12t1684r332b1763],
38	risk	NN	O	risk	prep_at	35	SENT_301	[p19l365t1684r528b1764],
39	for	IN	O	for	_	0	SENT_301	[p19l557t1683r680b1763],
40	musculoskeletal	JJ	O	musculoskeletal	amod	41	SENT_301	[p19l710t1684r1408b1764],
41	pain	NN	O	pain	prep_for	38	SENT_301	[p19l1439t1685r1652b1784],
42	.	.	O	.	_	0	SENT_301	[p19l1439t1685r1652b1784],

1	Therefore	RB	O	therefore	advmod	17	SENT_302	[p19l1687t1683r2128b1780],
2	,	,	O	,	_	0	SENT_302	[p19l1687t1683r2128b1780],
3	a	DT	O	a	det	5	SENT_302	[p19l11t1839r55b1891],
4	genetic	JJ	O	genetic	amod	5	SENT_302	[p19l90t1814r398b1914],
5	test	NN	O	test	nsubj	17	SENT_302	[p19l435t1830r590b1891],
6	with	IN	O	with	_	0	SENT_302	[p19l617t1813r812b1892],
7	sufficient	JJ	O	sufficient	amod	9	SENT_302	[p19l850t1812r1262b1892],
8	predictive	JJ	O	predictive	amod	9	SENT_302	[p19l1293t1813r1712b1913],
9	power	NN	O	power	prep_with	5	SENT_302	[p19l1748t1839r2016b1913],
10	to	TO	O	to	aux	11	SENT_302	[p19l2050t1830r2132b1892],
11	identify	VB	O	identify	infmod	5	SENT_302	[p19l11t1940r343b2041],
12	such	JJ	O	such	amod	13	SENT_302	[p19l378t1941r571b2020],
13	patients	NNS	O	patient	dobj	11	SENT_302	[p19l608t1942r949b2041],
14	might	MD	O	might	aux	17	SENT_302	[p19l989t1941r1249b2042],
15	be	VB	O	be	cop	17	SENT_302	[p19l1281t1941r1378b2020],
16	clinically	RB	O	clinically	advmod	17	SENT_302	[p19l1417t1941r1808b2041],
17	useful	JJ	O	useful	_	0	SENT_302	[p19l1841t1940r2128b2020],
18	.	.	O	.	_	0	SENT_302	[p19l1841t1940r2128b2020],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_303	[p19l377t2238r916b2296],
2	TRANSLATION	NN	O	translation	_	0	SENT_303	[p19l962t2237r1765b2296],

1	The	DT	O	the	det	2	SENT_304	[p19l7t2454r166b2533],
2	use	NN	O	use	nsubjpass	15	SENT_304	[p19l195t2480r333b2533],
3	of	IN	O	of	_	0	SENT_304	[p19l363t2453r461b2533],
4	genotyping	VBG	O	genotype	prepc_of	2	SENT_304	[p19l471t2455r951b2555],
5	to	TO	O	to	aux	6	SENT_304	[p19l977t2471r1057b2533],
6	inform	VB	O	inform	xcomp	4	SENT_304	[p19l1087t2453r1381b2533],
7	clinical	JJ	O	clinical	amod	8	SENT_304	[p19l1411t2454r1716b2532],
8	decisions	NNS	O	decision	dobj	6	SENT_304	[p19l1746t2454r2130b2533],
9	about	IN	O	about	_	0	SENT_304	[p19l11t2582r254b2661],
10	drug	NN	O	drug	nn	11	SENT_304	[p19l287t2582r491b2683],
11	use	NN	O	use	prep_about	6	SENT_304	[p19l524t2608r664b2661],
12	is	VBZ	O	be	auxpass	15	SENT_304	[p19l701t2583r766b2660],
13	not	RB	O	not	neg	15	SENT_304	[p19l805t2599r948b2661],
14	Widely	RB	O	widely	advmod	15	SENT_304	[p19l975t2582r1255b2682],
15	practiced	VBN	O	practice	_	0	SENT_304	[p19l1285t2582r1703b2682],
16	.	.	O	.	_	0	SENT_304	[p19l1285t2582r1703b2682],

1	The	DT	O	the	det	3	SENT_305	[p19l1742t2582r1903b2660],
2	slow	JJ	O	slow	amod	3	SENT_305	[p19l1942t2582r2137b2661],
3	pace	NN	O	pace	nsubj	12	SENT_305	[p19l9t2736r201b2810],
4	of	IN	O	of	_	0	SENT_305	[p19l247t2709r347b2789],
5	the	DT	O	the	det	7	SENT_305	[p19l374t2710r507b2788],
6	clinical	JJ	O	clinical	amod	7	SENT_305	[p19l554t2710r866b2788],
7	application	NN	O	application	prep_of	3	SENT_305	[p19l911t2710r1390b2810],
8	of	IN	O	of	_	0	SENT_305	[p19l1436t2709r1536b2789],
9	pharmacoge	NN	O	pharmacoge	nn	11	SENT_305	[p19l1561t2710r2132b2811],
10	—	NN	O	—	nn	11	SENT_305	[p19l1561t2710r2132b2811],
11	nomics	NNS	O	nomic	prep_of	7	SENT_305	[p19l11t2839r316b2916],
12	has	VBZ	O	have	_	0	SENT_305	[p19l350t2838r492b2916],
13	many	JJ	O	many	amod	14	SENT_305	[p19l526t2864r762b2937],
14	causes	NNS	O	cause	dobj	12	SENT_305	[p19l790t2864r1083b2917],
15	.	.	O	.	_	0	SENT_305	[p19l790t2864r1083b2917],

1	Obviously	RB	O	obviously	advmod	9	SENT_306	[p19l1121t2838r1550b2937],
2	,	,	O	,	_	0	SENT_306	[p19l1121t2838r1550b2937],
3	the	DT	O	the	det	6	SENT_306	[p19l1587t2838r1718b2916],
4	most	RBS	O	most	advmod	5	SENT_306	[p19l1750t2855r1964b2916],
5	important	JJ	O	important	amod	6	SENT_306	[p19l1989t2839r2132b2915, p19l9t2983r336b3065],
6	issue	NN	O	issue	nsubj	9	SENT_306	[p19l359t2967r571b3045],
7	is	VBZ	O	be	cop	9	SENT_306	[p19l600t2967r665b3044],
8	the	DT	O	the	det	9	SENT_306	[p19l698t2966r830b3044],
9	need	NN	O	need	_	0	SENT_306	[p19l860t2966r1061b3044],
10	to	TO	O	to	aux	11	SENT_306	[p19l1091t2983r1173b3044],
11	establish	VB	O	establish	infmod	9	SENT_306	[p19l1204t2966r1585b3044],
12	clinical	JJ	O	clinical	amod	13	SENT_306	[p19l1615t2966r1929b3044],
13	utility	NN	O	utility	dobj	11	SENT_306	[p19l1957t2966r2132b3045, p19l11t3095r118b3194],
14	in	IN	O	in	mark	17	SENT_306	[p19l142t3095r225b3172],
15	order	NN	O	order	dep	17	SENT_306	[p19l256t3094r484b3173],
16	to	TO	O	to	aux	17	SENT_306	[p19l511t3111r592b3173],
17	support	VB	O	support	purpcl	11	SENT_306	[p19l625t3111r958b3194],
18	the	DT	O	the	det	19	SENT_306	[p19l983t3094r1115b3172],
19	value	NN	O	value	dobj	17	SENT_306	[p19l1141t3094r1360b3173],
20	of	IN	O	of	_	0	SENT_306	[p19l1391t3093r1491b3173],
21	genotyping	NN	O	genotyping	prep_of	19	SENT_306	[p19l1502t3095r2011b3195],
22	.	.	O	.	_	0	SENT_306	[p19l1502t3095r2011b3195],

1	In	IN	O	in	_	0	SENT_307	[p19l2045t3102r2134b3172],
2	the	DT	O	the	det	3	SENT_307	[p19l12t3221r144b3299],
3	absence	NN	O	absence	prep_in	11	SENT_307	[p19l182t3221r520b3300],
4	of	IN	O	of	_	0	SENT_307	[p19l560t3220r660b3300],
5	such	JJ	O	such	amod	6	SENT_307	[p19l681t3221r875b3301],
6	evidence	NN	O	evidence	prep_of	3	SENT_307	[p19l915t3221r1303b3317],
7	,	,	O	,	_	0	SENT_307	[p19l915t3221r1303b3317],
8	payers	NNS	O	payer	nsubj	11	SENT_307	[p19l1346t3247r1615b3321],
9	will	MD	O	will	aux	11	SENT_307	[p19l1651t3221r1816b3301],
10	be	VB	O	be	cop	11	SENT_307	[p19l1855t3221r1952b3300],
11	unlikely	JJ	O	unlikely	_	0	SENT_307	[p19l1991t3247r2132b3301, p19l10t3349r237b3449],
12	to	TO	O	to	aux	13	SENT_307	[p19l265t3366r345b3428],
13	provide	VB	O	provide	xcomp	11	SENT_307	[p19l377t3349r688b3449],
14	reimbursement	NN	O	reimbursement	dobj	13	SENT_307	[p19l720t3349r1369b3429],
15	for	IN	O	for	_	0	SENT_307	[p19l1396t3348r1518b3428],
16	routine	JJ	O	routine	amod	17	SENT_307	[p19l1547t3350r1849b3428],
17	use	NN	O	use	prep_for	13	SENT_307	[p19l1881t3375r2020b3428],
18	of	IN	O	of	_	0	SENT_307	[p19l2053t3348r2152b3428],
19	pharmacogenetic	JJ	O	pharmacogenetic	amod	20	SENT_307	[p19l9t3478r759b3579],
20	testing	NN	O	testing	prep_of	17	SENT_307	[p19l806t3479r1122b3579],
21	,	,	O	,	_	0	SENT_307	[p19l806t3479r1122b3579],
22	and	CC	O	and	_	0	SENT_307	[p19l1174t3478r1332b3557],
23	tests	NNS	O	test	nsubj	26	SENT_307	[p19l1378t3495r1572b3557],
24	will	MD	O	will	aux	26	SENT_307	[p19l1617t3478r1781b3557],
25	remain	VB	O	remain	cop	26	SENT_307	[p19l1828t3479r2133b3557],
26	inaccessible	JJ	O	inaccessible	conj_and	11	SENT_307	[p19l11t3605r510b3684],
27	to	TO	O	to	_	0	SENT_307	[p19l574t3622r655b3684],
28	the	DT	O	the	det	29	SENT_307	[p19l720t3605r851b3683],
29	majority	NN	O	majority	prep_to	26	SENT_307	[p19l915t3606r1268b3705],
30	of	IN	O	of	_	0	SENT_307	[p19l1328t3604r1426b3684],
31	patients	NNS	O	patient	prep_of	29	SENT_307	[p19l1470t3606r1827b3705],
32	.	.	O	.	_	0	SENT_307	[p19l1470t3606r1827b3705],

1	There	EX	O	there	expl	2	SENT_308	[p19l1893t3605r2133b3683],
2	seems	VBZ	O	seem	_	0	SENT_308	[p20l12t48r268b101],
3	to	TO	O	to	aux	6	SENT_308	[p20l297t39r379b101],
4	be	VB	O	be	cop	6	SENT_308	[p20l409t22r505b101],
5	little	JJ	O	little	amod	6	SENT_308	[p20l533t22r730b101],
6	consensus	NN	O	consensus	xcomp	2	SENT_308	[p20l759t48r1199b101],
7	on	IN	O	on	_	0	SENT_308	[p20l1230t48r1336b101],
8	the	DT	O	the	det	9	SENT_308	[p20l1365t22r1497b100],
9	level	NN	O	level	prep_on	6	SENT_308	[p20l1525t22r1714b101],
10	or	CC	O	or	_	0	SENT_308	[p20l1742t48r1831b101],
11	nature	NN	O	nature	prep_on	6	SENT_308	[p20l1856t39r2133b101],
12	of	IN	O	of	_	0	SENT_308	[p20l12t148r112b228],
13	data	NNS	O	datum	prep_of	9	SENT_308	[p20l129t149r312b228],
14	required	VBN	O	require	partmod	13	SENT_308	[p20l345t149r706b249],
15	to	TO	O	to	aux	16	SENT_308	[p20l741t166r822b228],
16	establish	VB	O	establish	xcomp	14	SENT_308	[p20l859t149r1240b228],
17	clinical	JJ	O	clinical	amod	18	SENT_308	[p20l1276t149r1589b227],
18	utility	NN	O	utility	dobj	16	SENT_308	[p20l1623t149r1932b249],
19	.7	CD	NUMBER	.7	tmod	16	SENT_308	[p20l1623t149r1932b249],

1	No	DT	O	no	det	2	SENT_309	[p20l138t285r262b356],
2	matter	NN	O	matter	advmod	16	SENT_309	[p20l309t294r595b355],
3	What	WDT	O	what	dobj	8	SENT_309	[p20l632t277r848b357],
4	level	NN	O	level	nsubjpass	8	SENT_309	[p20l887t277r1075b356],
5	of	IN	O	of	_	0	SENT_309	[p20l1121t276r1221b356],
6	evidence	NN	O	evidence	prep_of	4	SENT_309	[p20l1248t277r1613b357],
7	is	VBZ	O	be	auxpass	8	SENT_309	[p20l1658t278r1724b355],
8	required	VBN	O	require	dep	2	SENT_309	[p20l1771t277r2133b377],
9	for	IN	O	for	_	0	SENT_309	[p20l11t404r134b484],
10	each	DT	O	each	det	11	SENT_309	[p20l166t405r358b483],
11	situation	NN	O	situation	prep_for	8	SENT_309	[p20l392t406r793b501],
12	,	,	O	,	_	0	SENT_309	[p20l392t406r793b501],
13	it	PRP	O	it	nsubj	16	SENT_309	[p20l831t406r891b483],
14	Will	MD	O	will	aux	16	SENT_309	[p20l915t405r1079b485],
15	be	VB	O	be	cop	16	SENT_309	[p20l1113t405r1209b484],
16	necessary	JJ	O	necessary	_	0	SENT_309	[p20l1243t431r1663b505],
17	to	TO	O	to	aux	18	SENT_309	[p20l1693t422r1774b484],
18	develop	VB	O	develop	xcomp	16	SENT_309	[p20l1810t405r2132b505],
19	simple	JJ	O	simple	amod	21	SENT_309	[p20l12t534r293b634],
20	clinical	JJ	O	clinical	amod	21	SENT_309	[p20l346t534r659b612],
21	algorithms	NNS	O	algorithm	dobj	18	SENT_309	[p20l710t534r1181b635],
22	to	TO	O	to	aux	23	SENT_309	[p20l1236t551r1317b613],
23	aid	VB	O	aid	xcomp	18	SENT_309	[p20l1370t534r1498b613],
24	physicians	NNS	O	physician	dobj	23	SENT_309	[p20l1549t534r1996b634],
25	in	IN	O	in	_	0	SENT_309	[p20l2050t535r2133b612],
26	their	PRP$	O	they	poss	27	SENT_309	[p20l12t662r215b741],
27	interpretation	NN	O	interpretation	prep_in	23	SENT_309	[p20l245t663r844b762],
28	and	CC	O	and	_	0	SENT_309	[p20l878t662r1035b741],
29	use	NN	O	use	prep_in	23	SENT_309	[p20l1070t688r1210b741],
30	of	IN	O	of	_	0	SENT_309	[p20l1245t661r1345b741],
31	genetic	JJ	O	genetic	amod	32	SENT_309	[p20l1360t663r1668b763],
32	data	NNS	O	datum	prep_of	27	SENT_309	[p20l1703t662r1907b741],
33	.	.	O	.	_	0	SENT_309	[p20l1703t662r1907b741],

1	This	DT	O	this	det	2	SENT_310	[p20l1944t662r2131b740],
2	goal	NN	O	goal	nsubjpass	6	SENT_310	[p20l11t790r194b891],
3	may	MD	O	may	aux	6	SENT_310	[p20l234t816r413b890],
4	be	VB	O	be	auxpass	6	SENT_310	[p20l451t790r546b869],
5	best	RB	O	best	advmod	6	SENT_310	[p20l589t790r766b869],
6	achieved	VBN	O	achieve	_	0	SENT_310	[p20l800t790r1168b869],
7	through	IN	O	through	_	0	SENT_310	[p20l1209t790r1558b891],
8	the	DT	O	the	det	9	SENT_310	[p20l1599t790r1732b868],
9	development	NN	O	development	prep_through	6	SENT_310	[p20l1774t790r2132b890, p20l11t934r232b995],
10	of	IN	O	of	_	0	SENT_310	[p20l284t916r384b996],
11	point	NN	O	point	nn	12	SENT_310	[p20l421t916r976b1017],
12	—	NN	O	—	prep_of	9	SENT_310	[p20l421t916r976b1017],
13	of	IN	O	of	_	0	SENT_310	[p20l421t916r976b1017],
14	—	CD	NUMBER	—	num	16	SENT_310	[p20l421t916r976b1017],
15	care	NN	O	care	nn	16	SENT_310	[p20l421t916r976b1017],
16	tools	NNS	O	tool	prep_of	12	SENT_310	[p20l1033t917r1240b996],
17	embedded	VBN	O	embed	partmod	16	SENT_310	[p20l1300t917r1743b996],
18	in	IN	O	in	_	0	SENT_310	[p20l1799t918r1882b995],
19	electronic	JJ	O	electronic	amod	22	SENT_310	[p20l1939t917r2132b995, p20l12t1047r265b1124],
20	medical	JJ	O	medical	amod	22	SENT_310	[p20l316t1046r656b1124],
21	record	NN	O	record	nn	22	SENT_310	[p20l707t1046r980b1124],
22	systems	NNS	O	system	prep_in	17	SENT_310	[p20l1032t1063r1391b1145],
23	.	.	O	.	_	0	SENT_310	[p20l1032t1063r1391b1145],

1	Even	RB	O	even	advmod	2	SENT_311	[p20l1446t1053r1645b1125],
2	With	IN	O	with	advcl	12	SENT_311	[p20l1692t1046r1887b1125],
3	such	JJ	O	such	amod	4	SENT_311	[p20l1939t1046r2133b1125],
4	tools	NNS	O	tool	pobj	2	SENT_311	[p20l12t1174r243b1269],
5	,	,	O	,	_	0	SENT_311	[p20l12t1174r243b1269],
6	physicians	NNS	O	physician	nsubj	12	SENT_311	[p20l282t1174r730b1273],
7	and	CC	O	and	_	0	SENT_311	[p20l766t1174r924b1252],
8	other	JJ	O	other	amod	11	SENT_311	[p20l959t1174r1186b1252],
9	health	NN	O	health	nn	11	SENT_311	[p20l1218t1174r1488b1252],
10	care	NN	O	care	nn	11	SENT_311	[p20l1524t1200r1699b1252],
11	providers	NNS	O	provider	conj_and	6	SENT_311	[p20l1733t1174r2131b1273],
12	need	VBP	O	need	_	0	SENT_311	[p20l11t1302r212b1381],
13	to	TO	O	to	aux	15	SENT_311	[p20l253t1319r335b1381],
14	be	VB	O	be	cop	15	SENT_311	[p20l378t1302r474b1381],
15	aware	JJ	O	aware	xcomp	12	SENT_311	[p20l515t1328r764b1381],
16	of	IN	O	of	_	0	SENT_311	[p20l806t1301r906b1381],
17	this	DT	O	this	det	18	SENT_311	[p20l929t1302r1088b1380],
18	area	NN	O	area	prep_of	15	SENT_311	[p20l1130t1328r1311b1381],
19	of	IN	O	of	_	0	SENT_311	[p20l1351t1301r1450b1381],
20	biomedical	JJ	O	biomedical	amod	21	SENT_311	[p20l1473t1302r1948b1381],
21	science	NN	O	science	prep_of	18	SENT_311	[p20l1990t1303r2132b1380, p20l12t1455r201b1507],
22	in	IN	O	in	mark	25	SENT_311	[p20l236t1430r320b1507],
23	order	NN	O	order	dep	25	SENT_311	[p20l356t1429r584b1508],
24	to	TO	O	to	aux	25	SENT_311	[p20l617t1446r699b1508],
25	apply	VB	O	apply	purpcl	15	SENT_311	[p20l736t1429r964b1529],
26	the	DT	O	the	det	27	SENT_311	[p20l996t1429r1129b1507],
27	information	NN	O	information	dobj	25	SENT_311	[p20l1164t1428r1688b1508],
28	clinically	RB	O	clinically	advmod	25	SENT_311	[p20l1724t1429r2128b1529],
29	.	.	O	.	_	0	SENT_311	[p20l1724t1429r2128b1529],

1	A	DT	O	a	det	3	SENT_312	[p20l7t1565r73b1635],
2	major	JJ	O	major	amod	3	SENT_312	[p20l127t1558r376b1657],
3	effort	NN	O	effort	nsubjpass	6	SENT_312	[p20l430t1556r673b1636],
4	Will	MD	O	will	aux	6	SENT_312	[p20l719t1557r884b1637],
5	be	VB	O	be	auxpass	6	SENT_312	[p20l940t1557r1036b1636],
6	required	VBN	O	require	_	0	SENT_312	[p20l1093t1557r1454b1657],
7	to	TO	O	to	aux	8	SENT_312	[p20l1511t1574r1592b1636],
8	educate	VB	O	educate	xcomp	6	SENT_312	[p20l1650t1557r1973b1637],
9	all	DT	O	all	det	10	SENT_312	[p20l2029t1557r2133b1635],
10	members	NNS	O	member	dobj	8	SENT_312	[p20l11t1686r408b1765],
11	of	IN	O	of	_	0	SENT_312	[p20l453t1685r553b1765],
12	the	DT	O	the	det	15	SENT_312	[p20l578t1686r710b1764],
13	health	NN	O	health	nn	15	SENT_312	[p20l753t1686r1023b1764],
14	care	NN	O	care	nn	15	SENT_312	[p20l1066t1712r1241b1764],
15	team	NN	O	team	prep_of	10	SENT_312	[p20l1284t1703r1497b1765],
16	about	IN	O	about	_	0	SENT_312	[p20l1539t1686r1783b1765],
17	clinical	JJ	O	clinical	amod	18	SENT_312	[p20l1820t1686r2134b1764],
18	genomics	NNS	O	genomic	prep_about	8	SENT_312	[p20l11t1815r447b1914],
19	.	.	O	.	_	0	SENT_312	[p20l11t1815r447b1914],

1	In	IN	O	in	_	0	SENT_313	[p20l138t1950r228b2020],
2	recent	JJ	DURATION	recent	amod	3	SENT_313	[p20l263t1959r528b2020],
3	years	NNS	DURATION	year	prep_in	9	SENT_313	[p20l554t1968r798b2042],
4	,	,	O	,	_	0	SENT_313	[p20l554t1968r798b2042],
5	the	DT	O	the	det	6	SENT_313	[p20l839t1942r972b2020],
6	FDA	NNP	ORGANIZATION	FDA	nsubj	9	SENT_313	[p20l1006t1948r1191b2020],
7	has	VBZ	O	have	aux	9	SENT_313	[p20l1223t1942r1367b2020],
8	aggressively	RB	O	aggressively	advmod	9	SENT_313	[p20l1404t1942r1924b2043],
9	pursued	VBN	O	pursue	_	0	SENT_313	[p20l1954t1968r2132b2042, p20l12t2070r199b2149],
10	drug	NN	O	drug	nn	13	SENT_313	[p20l233t2070r654b2171],
11	—	NN	O	—	nn	13	SENT_313	[p20l233t2070r654b2171],
12	label	NN	O	label	nn	13	SENT_313	[p20l233t2070r654b2171],
13	modification	NN	O	modification	dobj	9	SENT_313	[p20l686t2069r1224b2149],
14	When	WRB	O	when	advmod	20	SENT_313	[p20l1252t2070r1479b2149],
15	excess	JJ	O	excess	amod	16	SENT_313	[p20l1512t2096r1768b2148],
16	risk	NN	O	risk	nsubjpass	20	SENT_313	[p20l1802t2070r1960b2149],
17	can	MD	O	can	aux	20	SENT_313	[p20l1988t2096r2133b2148],
18	be	VB	O	be	auxpass	20	SENT_313	[p20l12t2198r106b2277],
19	convincingly	RB	O	convincingly	advmod	20	SENT_313	[p20l137t2198r664b2299],
20	linked	VBN	O	link	advcl	9	SENT_313	[p20l689t2198r950b2277],
21	to	TO	O	to	_	0	SENT_313	[p20l981t2215r1060b2277],
22	a	DT	O	a	det	24	SENT_313	[p20l1092t2224r1136b2276],
23	genetic	JJ	O	genetic	amod	24	SENT_313	[p20l1164t2199r1461b2299],
24	marker	NN	O	marker	prep_to	20	SENT_313	[p20l1491t2198r1808b2277],
25	.	.	O	.	_	0	SENT_313	[p20l1491t2198r1808b2277],

1	Several	JJ	O	several	nsubjpass	7	SENT_314	[p20l1846t2198r2134b2277],
2	of	IN	O	of	_	0	SENT_314	[p20l12t2324r112b2404],
3	the	DT	O	the	det	4	SENT_314	[p20l131t2325r263b2403],
4	examples	NNS	O	example	prep_of	1	SENT_314	[p20l301t2325r699b2425],
5	have	VBP	O	have	aux	7	SENT_314	[p20l738t2325r928b2405],
6	been	VBN	O	be	auxpass	7	SENT_314	[p20l965t2325r1167b2404],
7	described	VBN	O	describe	_	0	SENT_314	[p20l1204t2325r1616b2404],
8	here	RB	O	here	advmod	7	SENT_314	[p20l1653t2325r1858b2421],
9	;	:	O	;	_	0	SENT_314	[p20l1653t2325r1858b2421],
10	many	JJ	O	many	nsubjpass	13	SENT_314	[p20l1899t2351r2138b2425],
11	more	JJR	O	more	advmod	13	SENT_314	[p20l11t2480r230b2533],
12	are	VBP	O	be	auxpass	13	SENT_314	[p20l282t2480r411b2533],
13	listed	VBN	O	list	parataxis	7	SENT_314	[p20l461t2454r695b2533],
14	in	IN	O	in	_	0	SENT_314	[p20l746t2455r829b2532],
15	the	DT	O	the	det	16	SENT_314	[p20l881t2454r1013b2533],
16	FDA	NNP	ORGANIZATION	FDA	poss	18	SENT_314	[p20l1064t2460r1302b2532],
17	’s	POS	O	’s	_	0	SENT_314	[p20l1064t2460r1302b2532],
18	Table	NNP	O	Table	prep_in	13	SENT_314	[p20l1352t2454r1582b2533],
19	of	IN	O	of	_	0	SENT_314	[p20l1635t2453r1735b2533],
20	Pharmacogenomic	NNP	O	Pharmacogenomic	nn	21	SENT_314	[p20l1766t2454r2132b2532, p20l12t2583r481b2683],
21	Biomarkers	NNS	O	biomarker	nn	26	SENT_314	[p20l545t2582r1038b2661],
22	in	IN	O	in	_	0	SENT_314	[p20l1105t2583r1188b2660],
23	Drug	NN	O	drug	nn	24	SENT_314	[p20l1253t2588r1474b2683],
24	Labels	NNP	O	Labels	prep_in	21	SENT_314	[p20l1535t2582r1808b2661],
25	(	CD	NUMBER	(	num	24	SENT_314	[p20l1880t2588r2137b2673],
26	WWW	NNP	O	WWW	prep_of	18	SENT_314	[p20l1880t2588r2137b2673],
27	.	.	O	.	_	0	SENT_314	[p20l15t2709r2130b2811],

1	fda	NN	O	fda	_	0	SENT_315	[p20l15t2709r2130b2811],
2	.	.	O	.	_	0	SENT_315	[p20l15t2709r2130b2811],

1	gov/Drugs/ScienceResearch	NN	O	gov/drugs/scienceresearch	_	0	SENT_316	[p20l15t2709r2130b2811],
2	/	:	O	/	punct	3	SENT_316	[p20l15t2709r2130b2811],
3	ResearchAreas	NNP	O	ResearchAreas	dep	1	SENT_316	[p20l15t2709r2130b2811],
4	/	:	O	/	punct	3	SENT_316	[p20l15t2709r2130b2811],
5	Pharmacogeneticslucm083378	NN	O	pharmacogeneticslucm083378	dep	3	SENT_316	[p20l9t2838r1507b2939],
6	.	.	O	.	_	0	SENT_316	[p20l9t2838r1507b2939],

1	htm	NN	O	htm	_	0	SENT_317	[p20l9t2838r1507b2939],
2	)	NN	O	)	dep	1	SENT_317	[p20l9t2838r1507b2939],
3	.	.	O	.	_	0	SENT_317	[p20l9t2838r1507b2939],

1	Warnings	NNS	O	warning	nsubj	21	SENT_318	[p20l1538t2839r1941b2939],
2	that	IN	O	that	complm	6	SENT_318	[p20l1973t2838r2138b2916],
3	the	DT	O	the	det	4	SENT_318	[p20l12t2965r144b3043],
4	FDA	NNP	ORGANIZATION	FDA	nsubj	6	SENT_318	[p20l203t2972r388b3043],
5	has	VBZ	O	have	aux	6	SENT_318	[p20l445t2965r589b3043],
6	issued	VBN	O	issue	dep	1	SENT_318	[p20l650t2965r918b3045],
7	about	IN	O	about	_	0	SENT_318	[p20l978t2965r1222b3045],
8	the	DT	O	the	det	9	SENT_318	[p20l1277t2965r1409b3043],
9	prescription	NN	O	prescription	prep_about	6	SENT_318	[p20l1468t2966r1991b3065],
10	of	IN	O	of	_	0	SENT_318	[p20l2052t2964r2152b3044],
11	clopidogrel	NN	O	clopidogrel	prep_of	9	SENT_318	[p20l12t3094r494b3195],
12	and	CC	O	and	_	0	SENT_318	[p20l542t3094r700b3173],
13	abacavir	NN	O	abacavir	conj_and	11	SENT_318	[p20l747t3094r1104b3173],
14	Without	IN	O	without	_	0	SENT_318	[p20l1144t3094r1484b3173],
15	testing	NN	O	testing	prep_without	6	SENT_318	[p20l1527t3095r1825b3195],
16	of	IN	O	of	_	0	SENT_318	[p20l1871t3093r1970b3173],
17	the	DT	O	the	det	19	SENT_318	[p20l2001t3094r2133b3172],
18	relevant	JJ	O	relevant	amod	19	SENT_318	[p20l11t3222r352b3301],
19	genotype	NN	O	genotype	prep_of	15	SENT_318	[p20l395t3239r789b3323],
20	are	VBP	O	be	cop	21	SENT_318	[p20l836t3248r966b3301],
21	examples	NNS	O	example	_	0	SENT_318	[p20l1015t3222r1413b3322],
22	of	IN	O	of	_	0	SENT_318	[p20l1464t3221r1564b3301],
23	the	DT	O	the	det	24	SENT_318	[p20l1595t3222r1728b3300],
24	agency	NN	O	agency	poss	28	SENT_318	[p20l1775t3228r2131b3323],
25	’s	POS	O	’s	_	0	SENT_318	[p20l1775t3228r2131b3323],
26	increasingly	RB	O	increasingly	advmod	27	SENT_318	[p20l11t3350r533b3451],
27	activist	JJ	O	activist	amod	28	SENT_318	[p20l568t3351r874b3429],
28	stance	NN	O	stance	prep_of	21	SENT_318	[p20l910t3367r1204b3429],
29	.	.	O	.	_	0	SENT_318	[p20l910t3367r1204b3429],

1	CONCLUSIONS	NNS	O	conclusion	_	0	SENT_319	[p20l675t3646r1467b3705],

1	There	EX	O	there	expl	6	SENT_320	[p21l7t66r252b144],
2	has	VBZ	O	have	aux	6	SENT_320	[p21l296t66r440b144],
3	been	VBN	O	be	cop	6	SENT_320	[p21l487t66r688b145],
4	a	DT	O	a	det	6	SENT_320	[p21l732t92r776b144],
5	good	JJ	O	good	amod	6	SENT_320	[p21l818t66r1034b167],
6	deal	NN	O	deal	_	0	SENT_320	[p21l1079t66r1255b145],
7	of	IN	O	of	_	0	SENT_320	[p21l1299t65r1399b145],
8	comment	NN	O	comment	prep_of	6	SENT_320	[p21l1425t83r1834b145],
9	in	IN	O	in	_	0	SENT_320	[p21l1872t67r1956b144],
10	the	DT	O	the	det	12	SENT_320	[p21l2000t66r2133b144],
11	scientific	JJ	O	scientific	amod	12	SENT_320	[p21l12t192r406b271],
12	literature71	NN	O	literature71	prep_in	8	SENT_320	[p21l458t193r1019b273],
13	‘	CD	NUMBER	‘	number	14	SENT_320	[p21l458t193r1019b273],
14	74	CD	NUMBER	74	num	12	SENT_320	[p21l458t193r1019b273],
15	and	CC	O	and	_	0	SENT_320	[p21l1048t193r1205b272],
16	the	DT	O	the	det	18	SENT_320	[p21l1260t193r1393b271],
17	popular	JJ	O	popular	amod	18	SENT_320	[p21l1446t193r1786b293],
18	press75	NN	O	press75	prep_of	6	SENT_320	[p21l1836t199r2130b293],
19	about	IN	O	about	_	0	SENT_320	[p21l11t322r255b401],
20	the	DT	O	the	det	22	SENT_320	[p21l283t322r415b401],
21	slow	JJ	O	slow	amod	22	SENT_320	[p21l450t322r646b401],
22	pace	NN	O	pace	prep_about	18	SENT_320	[p21l674t348r865b422],
23	of	IN	O	of	_	0	SENT_320	[p21l899t321r999b401],
24	the	DT	O	the	det	25	SENT_320	[p21l1014t322r1146b400],
25	application	NN	O	application	prep_of	22	SENT_320	[p21l1179t322r1658b422],
26	of	IN	O	of	_	0	SENT_320	[p21l1693t321r1792b401],
27	genomics	NNS	O	genomic	prep_of	25	SENT_320	[p21l1807t348r2132b423, p21l11t451r121b528],
28	to	TO	O	to	_	0	SENT_320	[p21l172t467r253b528],
29	clinical	JJ	O	clinical	amod	30	SENT_320	[p21l303t450r616b528],
30	medicine	NN	O	medicine	prep_to	6	SENT_320	[p21l663t450r1079b528],
31	.	.	O	.	_	0	SENT_320	[p21l663t450r1079b528],

1	We	PRP	O	we	nsubj	2	SENT_321	[p21l1129t457r1262b528],
2	hope	VBP	O	hope	_	0	SENT_321	[p21l1310t450r1519b549],
3	that	IN	O	that	complm	6	SENT_321	[p21l1567t450r1739b528],
4	We	PRP	O	we	nsubj	6	SENT_321	[p21l1778t476r1896b529],
5	have	VBP	O	have	aux	6	SENT_321	[p21l1943t450r2133b529],
6	provided	VBN	O	provide	ccomp	2	SENT_321	[p21l9t578r384b677],
7	some	DT	O	some	det	8	SENT_321	[p21l425t604r648b656],
8	reassurance	NN	O	reassurance	dobj	6	SENT_321	[p21l687t604r1197b657],
9	that	WDT	O	that	dobj	23	SENT_321	[p21l1236t578r1409b656],
10	advances	NNS	O	advance	nsubj	30	SENT_321	[p21l1441t578r1824b657],
11	resulting	VBG	O	result	partmod	10	SENT_321	[p21l1864t578r2132b657, p21l11t707r150b807],
12	from	IN	O	from	_	0	SENT_321	[p21l193t705r403b785],
13	the	DT	O	the	det	14	SENT_321	[p21l450t706r582b784],
14	application	NN	O	application	prep_from	11	SENT_321	[p21l628t706r1107b806],
15	of	IN	O	of	_	0	SENT_321	[p21l1155t705r1254b785],
16	genomic	JJ	O	genomic	amod	17	SENT_321	[p21l1282t707r1652b807],
17	science	NN	O	science	prep_of	14	SENT_321	[p21l1699t707r2004b784],
18	to	TO	O	to	_	0	SENT_321	[p21l2050t723r2132b785],
19	drug	NN	O	drug	nn	20	SENT_321	[p21l12t834r212b935],
20	therapy	NN	O	therapy	prep_to	11	SENT_321	[p21l240t834r555b934],
21	may	MD	O	may	aux	23	SENT_321	[p21l581t860r758b934],
22	be	VB	O	be	cop	23	SENT_321	[p21l784t834r879b913],
23	helpful	JJ	O	helpful	rcmod	8	SENT_321	[p21l910t833r1207b934],
24	in	IN	O	in	_	0	SENT_321	[p21l1236t835r1318b912],
25	drug	NN	O	drug	nn	26	SENT_321	[p21l1349t834r1550b935],
26	selection	NN	O	selection	prep_in	23	SENT_321	[p21l1578t834r1948b913],
27	and	CC	O	and	_	0	SENT_321	[p21l1978t834r2134b913],
28	administration	NN	O	administration	prep_in	23	SENT_321	[p21l11t962r656b1041],
29	and	CC	O	and	_	0	SENT_321	[p21l706t962r865b1041],
30	reduce	VB	O	reduce	conj_and	23	SENT_321	[p21l915t962r1195b1041],
31	the	DT	O	the	det	32	SENT_321	[p21l1246t962r1379b1040],
32	odds	NNS	O	odds	dobj	30	SENT_321	[p21l1431t962r1633b1041],
33	of	IN	O	of	_	0	SENT_321	[p21l1687t961r1787b1041],
34	adverse	JJ	O	adverse	amod	36	SENT_321	[p21l1819t962r2133b1041],
35	drug	NN	O	drug	nn	36	SENT_321	[p21l12t1090r216b1191],
36	reactions	NNS	O	reaction	prep_of	32	SENT_321	[p21l270t1091r684b1169],
37	.	.	O	.	_	0	SENT_321	[p21l270t1091r684b1169],

1	Challenges	NNS	O	challenge	nsubj	23	SENT_322	[p21l747t1090r1218b1191],
2	that	WDT	O	that	nsubjpass	4	SENT_322	[p21l1279t1090r1451b1168],
3	are	VBP	O	be	auxpass	4	SENT_322	[p21l1502t1116r1631b1168],
4	associated	VBN	O	associate	rcmod	1	SENT_322	[p21l1689t1090r2133b1169],
5	with	IN	O	with	_	0	SENT_322	[p21l7t1218r202b1297],
6	the	DT	O	the	det	7	SENT_322	[p21l256t1218r388b1297],
7	replication	NN	O	replication	prep_with	4	SENT_322	[p21l441t1218r902b1318],
8	of	IN	O	of	_	0	SENT_322	[p21l956t1217r1056b1297],
9	study	NN	O	study	nn	10	SENT_322	[p21l1093t1218r1323b1318],
10	findings	NNS	O	finding	prep_of	7	SENT_322	[p21l1371t1217r1735b1319],
11	and	CC	O	and	_	0	SENT_322	[p21l1789t1218r1947b1297],
12	the	DT	O	the	det	13	SENT_322	[p21l2001t1218r2133b1296],
13	development	NN	O	development	conj_and	7	SENT_322	[p21l12t1346r561b1446],
14	of	IN	O	of	_	0	SENT_322	[p21l591t1345r691b1425],
15	proof	NN	O	proof	prep_of	13	SENT_322	[p21l707t1345r957b1446],
16	of	IN	O	of	_	0	SENT_322	[p21l974t1345r1074b1425],
17	the	DT	O	the	det	19	SENT_322	[p21l1092t1346r1224b1425],
18	clinical	JJ	O	clinical	amod	19	SENT_322	[p21l1260t1346r1573b1424],
19	significance	NN	O	significance	prep_of	15	SENT_322	[p21l1609t1345r2133b1447],
20	of	IN	O	of	_	0	SENT_322	[p21l12t1472r112b1552],
21	implicated	VBN	O	implicate	amod	22	SENT_322	[p21l120t1473r575b1573],
22	variants	NNS	O	variant	prep_of	19	SENT_322	[p21l599t1474r941b1553],
23	underscore	VBP	O	underscore	_	0	SENT_322	[p21l972t1473r1448b1553],
24	the	DT	O	the	det	25	SENT_322	[p21l1476t1473r1609b1551],
25	importance	NN	O	importance	nsubj	30	SENT_322	[p21l1637t1474r2134b1573],
26	of	IN	O	of	_	0	SENT_322	[p21l12t1601r113b1681],
27	functional	JJ	O	functional	amod	28	SENT_322	[p21l150t1601r606b1681],
28	experiments	NNS	O	experiment	prep_of	25	SENT_322	[p21l662t1603r1201b1702],
29	to	TO	O	to	aux	30	SENT_322	[p21l1259t1619r1341b1681],
30	test	VB	O	test	ccomp	23	SENT_322	[p21l1399t1619r1556b1680],
31	for	IN	O	for	_	0	SENT_322	[p21l1606t1601r1732b1681],
32	biologic	JJ	O	biologic	amod	33	SENT_322	[p21l1784t1602r2134b1703],
33	plausibility	NN	O	plausibility	prep_for	30	SENT_322	[p21l9t1730r495b1830],
34	and	CC	O	and	_	0	SENT_322	[p21l533t1730r691b1809],
35	to	TO	O	to	aux	36	SENT_322	[p21l735t1747r816b1809],
36	extend	VB	O	extend	ccomp	23	SENT_322	[p21l862t1730r1145b1809],
37	our	PRP$	O	we	poss	38	SENT_322	[p21l1189t1756r1334b1809],
38	understanding	NN	O	understanding	dobj	36	SENT_322	[p21l1375t1730r2011b1831],
39	of	IN	O	of	_	0	SENT_322	[p21l2052t1729r2152b1809],
40	drug	NN	O	drug	nn	41	SENT_322	[p21l12t1858r216b1959],
41	mechanisms	NNS	O	mechanism	prep_of	38	SENT_322	[p21l262t1858r820b1937],
42	.	.	O	.	_	0	SENT_322	[p21l262t1858r820b1937],

1	Finally	RB	O	finally	advmod	15	SENT_323	[p21l871t1858r1170b1958],
2	,	,	O	,	_	0	SENT_323	[p21l871t1858r1170b1958],
3	a	DT	O	a	det	5	SENT_323	[p21l1223t1884r1267b1936],
4	blend	VB	O	blend	dep	5	SENT_323	[p21l1314t1858r1545b1937],
5	of	IN	O	of	nsubjpass	15	SENT_323	[p21l1593t1857r1692b1937],
6	scientific	JJ	O	scientific	amod	12	SENT_323	[p21l1723t1857r2128b1954],
7	,	,	O	,	_	0	SENT_323	[p21l1723t1857r2128b1954],
8	regulatory	JJ	O	regulatory	amod	12	SENT_323	[p21l11t1986r472b2087],
9	,	,	O	,	_	0	SENT_323	[p21l11t1986r472b2087],
10	and	CC	O	and	_	0	SENT_323	[p21l507t1986r665b2065],
11	psychological	JJ	O	psychological	amod	12	SENT_323	[p21l694t1986r1282b2087],
12	factors	NNS	O	factor	pobj	5	SENT_323	[p21l1312t1985r1601b2065],
13	must	MD	O	must	aux	15	SENT_323	[p21l1634t2003r1850b2065],
14	be	VB	O	be	auxpass	15	SENT_323	[p21l1876t1986r1973b2065],
15	addressed	VBN	O	address	_	0	SENT_323	[p21l2002t1986r2132b2065, p21l12t2114r338b2193],
16	if	IN	O	if	mark	19	SENT_323	[p21l369t2113r446b2192],
17	pharmacogenomic	JJ	O	pharmacogenomic	amod	18	SENT_323	[p21l458t2114r1269b2215],
18	tests	NNS	O	test	nsubj	19	SENT_323	[p21l1300t2131r1493b2192],
19	are	VBP	O	be	advcl	15	SENT_323	[p21l1526t2140r1656b2192],
20	to	TO	O	to	aux	24	SENT_323	[p21l1688t2131r1769b2193],
21	become	VB	O	become	cop	24	SENT_323	[p21l1803t2114r2133b2193],
22	a	DT	O	a	det	24	SENT_323	[p21l11t2267r55b2319],
23	routine	JJ	O	routine	amod	24	SENT_323	[p21l88t2242r397b2320],
24	part	NN	O	part	xcomp	19	SENT_323	[p21l430t2258r609b2341],
25	of	IN	O	of	_	0	SENT_323	[p21l639t2240r740b2320],
26	clinical	JJ	O	clinical	amod	27	SENT_323	[p21l756t2241r1069b2319],
27	practice	NN	O	practice	prep_of	24	SENT_323	[p21l1102t2242r1463b2341],
28	.	.	O	.	_	0	SENT_323	[p21l1102t2242r1463b2341],

1	The	DT	O	the	det	7	SENT_324	[p21l1499t2241r1660b2319],
2	FDA	NNP	O	FDA	nn	7	SENT_324	[p21l1693t2248r2132b2319],
3	—	CD	NUMBER	—	num	7	SENT_324	[p21l1693t2248r2132b2319],
4	man	NN	O	man	npadvmod	6	SENT_324	[p21l1693t2248r2132b2319],
5	—	CD	NUMBER	—	num	4	SENT_324	[p21l1693t2248r2132b2319],
6	dated	JJ	O	dated	amod	7	SENT_324	[p21l12t2370r246b2449],
7	incorporation	NN	O	incorporation	nsubj	18	SENT_324	[p21l285t2371r879b2470],
8	of	IN	O	of	_	0	SENT_324	[p21l920t2369r1021b2449],
9	pharmacogenomic	JJ	O	pharmacogenomic	amod	10	SENT_324	[p21l1041t2370r1852b2471],
10	information	NN	O	information	prep_of	7	SENT_324	[p21l1891t2369r2132b2449, p21l11t2499r317b2577],
11	in	IN	O	in	_	0	SENT_324	[p21l363t2499r446b2576],
12	drug	NN	O	drug	nn	13	SENT_324	[p21l493t2498r697b2599],
13	labeling	NN	O	labeling	prep_in	10	SENT_324	[p21l740t2498r1090b2599],
14	will	MD	O	will	aux	18	SENT_324	[p21l1129t2498r1293b2577],
15	remain	VB	O	remain	cop	18	SENT_324	[p21l1339t2499r1645b2576],
16	an	DT	O	a	det	18	SENT_324	[p21l1691t2524r1795b2576],
17	important	JJ	O	important	amod	18	SENT_324	[p21l1841t2499r2132b2598, p21l12t2643r184b2704],
18	step	NN	O	step	_	0	SENT_324	[p21l207t2643r379b2726],
19	in	IN	O	in	_	0	SENT_324	[p21l405t2627r489b2704],
20	the	DT	O	the	det	21	SENT_324	[p21l516t2626r648b2704],
21	acceptance	NN	O	acceptance	prep_in	18	SENT_324	[p21l675t2643r1145b2726],
22	of	IN	O	of	_	0	SENT_324	[p21l1173t2625r1272b2705],
23	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	21	SENT_324	[p21l1280t2626r2132b2727],
24	in	IN	O	in	_	0	SENT_324	[p21l11t2755r94b2831],
25	clinical	JJ	O	clinical	amod	26	SENT_324	[p21l151t2754r464b2832],
26	practice	NN	O	practice	prep_in	23	SENT_324	[p21l519t2755r880b2853],
27	.	.	O	.	_	0	SENT_324	[p21l519t2755r880b2853],

1	Perhaps	RB	O	perhaps	advmod	5	SENT_325	[p21l941t2754r1278b2853],
2	equally	RB	O	equally	advmod	3	SENT_325	[p21l1337t2754r1646b2853],
3	important	JJ	O	important	dep	5	SENT_325	[p21l1698t2755r2138b2853],
4	will	MD	O	will	aux	5	SENT_325	[p21l7t2882r171b2961],
5	be	VB	O	be	_	0	SENT_325	[p21l211t2882r307b2961],
6	the	DT	O	the	det	7	SENT_325	[p21l347t2882r479b2961],
7	willingness	NN	O	willingness	nsubj	5	SENT_325	[p21l515t2882r1013b2983],
8	of	IN	O	of	_	0	SENT_325	[p21l1056t2881r1155b2961],
9	physicians	NNS	O	physician	prep_of	7	SENT_325	[p21l1175t2882r1622b2982],
10	to	TO	O	to	aux	11	SENT_325	[p21l1664t2899r1746b2961],
11	reexamine	VB	O	reexamine	infmod	9	SENT_325	[p21l1787t2908r2132b2960, p21l11t3011r139b3088],
12	suboptimal	JJ	O	suboptimal	amod	15	SENT_325	[p21l170t3010r660b3110],
13	pharmacologic	JJ	O	pharmacologic	amod	15	SENT_325	[p21l688t3010r1335b3111],
14	management	NN	O	management	nn	15	SENT_325	[p21l1364t3027r1930b3111],
15	programs	NNS	O	program	dobj	11	SENT_325	[p21l1953t3036r2132b3110, p21l11t3137r305b3212],
16	.	.	O	.	_	0	SENT_325	[p21l1953t3036r2132b3110, p21l11t3137r305b3212],

1	Supported	VBN	O	support	csubj	6	SENT_326	[p21l98t3324r434b3399],
2	in	IN	O	in	_	0	SENT_326	[p21l462t3325r526b3382],
3	part	NN	O	part	prep_in	1	SENT_326	[p21l552t3337r689b3399],
4	by	IN	O	by	_	0	SENT_326	[p21l714t3324r788b3399],
5	grants	NNS	O	grant	prep_by	1	SENT_326	[p21l812t3336r1021b3399],
6	(	VBP	O	(	_	0	SENT_326	[p21l1054t3328r1592b3395],
7	K22	NN	O	k22	dobj	6	SENT_326	[p21l1054t3328r1592b3395],
8	.	.	O	.	_	0	SENT_326	[p21l1054t3328r1592b3395],

1	—	NN	O	—	_	0	SENT_327	[p21l1054t3328r1592b3395],
2	.	.	O	.	_	0	SENT_327	[p21l1054t3328r1592b3395],

1	CA130828	NN	O	ca130828	_	0	SENT_328	[p21l1054t3328r1592b3395],
2	,	,	O	,	_	0	SENT_328	[p21l1054t3328r1592b3395],
3	RO1	NN	O	ro1	appos	1	SENT_328	[p21l1623t3328r2130b3395],
4	.	.	O	.	_	0	SENT_328	[p21l1623t3328r2130b3395],

1	—	NN	O	—	_	0	SENT_329	[p21l1623t3328r2130b3395],
2	.	.	O	.	_	0	SENT_329	[p21l1623t3328r2130b3395],

1	CA138461	NN	O	ca138461	_	0	SENT_330	[p21l1623t3328r2130b3395],
2	,	,	O	,	_	0	SENT_330	[p21l1623t3328r2130b3395],
3	RO1	NN	O	ro1	appos	1	SENT_330	[p21l9t3424r491b3491],
4	.	.	O	.	_	0	SENT_330	[p21l9t3424r491b3491],

1	—	NN	O	—	_	0	SENT_331	[p21l9t3424r491b3491],
2	.	.	O	.	_	0	SENT_331	[p21l9t3424r491b3491],

1	GM28157	NN	O	gm28157	_	0	SENT_332	[p21l9t3424r491b3491],
2	,	,	O	,	_	0	SENT_332	[p21l9t3424r491b3491],
3	R01	NN	O	r01	appos	1	SENT_332	[p21l533t3424r1037b3491],
4	.	.	O	.	_	0	SENT_332	[p21l533t3424r1037b3491],

1	—	NN	O	—	_	0	SENT_333	[p21l533t3424r1037b3491],
2	.	.	O	.	_	0	SENT_333	[p21l533t3424r1037b3491],

1	CA132780	NNP	O	CA132780	_	0	SENT_334	[p21l533t3424r1037b3491],
2	,	,	O	,	_	0	SENT_334	[p21l533t3424r1037b3491],
3	UO1	NN	O	uo1	appos	1	SENT_334	[p21l1080t3424r1595b3491],
4	.	.	O	.	_	0	SENT_334	[p21l1080t3424r1595b3491],

1	—	NN	O	—	_	0	SENT_335	[p21l1080t3424r1595b3491],
2	.	.	O	.	_	0	SENT_335	[p21l1080t3424r1595b3491],

1	HGOO5137	NN	O	hgoo5137	_	0	SENT_336	[p21l1080t3424r1595b3491],
2	,	,	O	,	_	0	SENT_336	[p21l1080t3424r1595b3491],
3	U19	NN	O	u19	appos	1	SENT_336	[p21l1638t3424r2129b3491],
4	.	.	O	.	_	0	SENT_336	[p21l1638t3424r2129b3491],

1	—	NN	O	—	_	0	SENT_337	[p21l1638t3424r2129b3491],
2	.	.	O	.	_	0	SENT_337	[p21l1638t3424r2129b3491],

1	GM61388	NN	O	gm61388	_	0	SENT_338	[p21l1638t3424r2129b3491],
2	,	,	O	,	_	0	SENT_338	[p21l1638t3424r2129b3491],
3	U01-GM63340	NN	O	u01-gm63340	conj_and	1	SENT_338	[p21l9t3519r492b3586],
4	,	,	O	,	_	0	SENT_338	[p21l9t3519r492b3586],
5	and	CC	O	and	_	0	SENT_338	[p21l527t3515r645b3574],
6	UL1RR025747	NN	O	ul1rr025747	conj_and	1	SENT_338	[p21l675t3519r1158b3583],
7	)	CD	NUMBER	)	dep	1	SENT_338	[p21l675t3519r1158b3583],
8	from	IN	O	from	_	0	SENT_338	[p21l1192t3514r1350b3574],
9	the	DT	O	the	det	24	SENT_338	[p21l1381t3515r1480b3573],
10	National	NNP	ORGANIZATION	National	dep	24	SENT_338	[p21l1510t3515r1790b3574],
11	Institutes	NNPS	ORGANIZATION	Institutes	dep	10	SENT_338	[p21l1820t3516r2132b3574],
12	of	IN	ORGANIZATION	of	_	0	SENT_338	[p21l11t3609r87b3669],
13	Health	NNP	ORGANIZATION	Health	prep_of	10	SENT_338	[p21l97t3610r336b3681],
14	,	,	O	,	_	0	SENT_338	[p21l97t3610r336b3681],
15	a	DT	O	a	det	18	SENT_338	[p21l364t3629r398b3668],
16	PhRMA	NNP	ORGANIZATION	PhRMA	nn	18	SENT_338	[p21l421t3610r676b3672],
17	Foundation	NNP	ORGANIZATION	Foundation	nn	18	SENT_338	[p21l697t3610r1076b3670],
18	Center	NNP	ORGANIZATION	Center	appos	13	SENT_338	[p21l1101t3614r1317b3669],
19	of	IN	O	of	_	0	SENT_338	[p21l1340t3609r1416b3669],
20	Excellence	NNP	O	Excellence	prep_of	18	SENT_338	[p21l1426t3610r1767b3668],
21	in	IN	O	in	_	0	SENT_338	[p21l1792t3611r1855b3668],
22	Clinical	JJ	O	clinical	amod	23	SENT_338	[p21l1880t3610r2134b3669],
23	Pharmacology	NNP	O	Pharmacology	prep_in	20	SENT_338	[p21l9t3706r485b3781],
24	Award	NN	O	award	prep_from	7	SENT_338	[p21l507t3706r737b3777],
25	,	,	O	,	_	0	SENT_338	[p21l507t3706r737b3777],
26	and	CC	O	and	_	0	SENT_338	[p21l770t3706r891b3765],
27	an	DT	O	a	det	29	SENT_338	[p21l919t3725r998b3764],
28	American	JJ	ORGANIZATION	american	amod	29	SENT_338	[p21l1024t3707r1346b3765],
29	Society	NNP	ORGANIZATION	Society	prep_from	7	SENT_338	[p21l1377t3707r1610b3781],
30	for	IN	ORGANIZATION	for	_	0	SENT_338	[p21l1636t3705r1730b3765],
31	Pharmacology	NNP	ORGANIZATION	Pharmacology	prep_for	29	SENT_338	[p21l1756t3706r2133b3765, p22l11t36r130b92],

1	and	CC	O	and	cc	4	SENT_339	[p22l150t17r270b76],
2	Experimental	JJ	O	experimental	amod	3	SENT_339	[p22l295t17r739b92],
3	Therapeutics	NNS	O	therapeutics	nsubj	4	SENT_339	[p22l761t17r1187b92],
4	(	VBP	O	(	_	0	SENT_339	[p22l1218t17r1781b85],
5	ASPET	NNP	O	ASPET	dobj	4	SENT_339	[p22l1218t17r1781b85],
6	)	CD	NUMBER	)	num	5	SENT_339	[p22l1218t17r1781b85],
7	.	.	O	.	_	0	SENT_339	[p22l1218t17r1781b85],

1	—	NN	O	—	_	0	SENT_340	[p22l1218t17r1781b85],
2	.	.	O	.	_	0	SENT_340	[p22l1218t17r1781b85],

1	Astellas	NNP	O	Astellas	_	0	SENT_341	[p22l1218t17r1781b85],
2	Award	NN	O	award	dep	1	SENT_341	[p22l1805t17r2034b77],
3	.	.	O	.	_	0	SENT_341	[p22l1805t17r2034b77],

1	Disclosure	NN	O	disclosure	nsubj	2	SENT_342	[p22l95t113r442b173],
2	forms	VBZ	O	form	_	0	SENT_342	[p22l475t112r668b172],
3	provided	VBN	O	provide	csubj	8	SENT_342	[p22l701t113r988b188],
4	by	IN	O	by	_	0	SENT_342	[p22l1021t113r1095b188],
5	the	DT	O	the	det	6	SENT_342	[p22l1125t113r1226b171],
6	authors	NNS	O	author	prep_by	3	SENT_342	[p22l1258t113r1505b173],
7	are	VBP	O	be	cop	8	SENT_342	[p22l1539t132r1638b172],
8	available	JJ	O	available	ccomp	2	SENT_342	[p22l1671t113r1956b173],
9	With	IN	O	with	_	0	SENT_342	[p22l1985t113r2134b173],
10	the	DT	O	the	det	12	SENT_342	[p22l11t209r112b267],
11	full	JJ	O	full	amod	12	SENT_342	[p22l137t208r251b269],
12	text	NN	O	text	prep_with	8	SENT_342	[p22l276t221r399b267],
13	of	IN	O	of	_	0	SENT_342	[p22l421t208r497b268],
14	this	DT	O	this	det	15	SENT_342	[p22l509t209r631b267],
15	article	NN	O	article	prep_of	12	SENT_342	[p22l658t209r864b267],
16	at	IN	O	at	_	0	SENT_342	[p22l889t222r949b267],
17	NEJM.org	NN	O	nejm.org	prep_at	15	SENT_342	[p22l968t214r1308b284],
18	.	.	O	.	_	0	SENT_342	[p22l968t214r1308b284],

1	We	PRP	O	we	nsubj	2	SENT_343	[p22l93t310r194b363],
2	thank	VBP	O	thank	_	0	SENT_343	[p22l225t305r420b365],
3	Luanne	NNP	PERSON	Luanne	nn	4	SENT_343	[p22l446t310r689b365],
4	Wussow	NNP	PERSON	Wussow	dobj	2	SENT_343	[p22l716t310r1007b376],
5	,	,	O	,	_	0	SENT_343	[p22l716t310r1007b376],
6	Linda	NNP	PERSON	Linda	nn	7	SENT_343	[p22l1040t305r1226b364],
7	Pelleymounter	NNP	PERSON	Pelleymounter	conj_and	4	SENT_343	[p22l1254t305r1746b380],
8	,	,	O	,	_	0	SENT_343	[p22l1254t305r1746b380],
9	and	CC	O	and	_	0	SENT_343	[p22l1779t305r1899b364],
10	Katar	NNP	PERSON	Katar	conj_and	4	SENT_343	[p22l1929t310r2133b366],
11	—	CD	NUMBER	—	num	13	SENT_343	[p22l1929t310r2133b366],
12	zyna	NN	O	zyna	nn	13	SENT_343	[p22l10t420r163b476],
13	Ellsworth	NNP	PERSON	Ellsworth	tmod	2	SENT_343	[p22l200t401r519b461],
14	for	IN	O	for	_	0	SENT_343	[p22l559t400r654b460],
15	their	PRP$	O	they	poss	16	SENT_343	[p22l692t401r848b460],
16	assistance	NN	O	assistance	prep_for	13	SENT_343	[p22l885t402r1221b460],
17	in	IN	O	in	_	0	SENT_343	[p22l1260t402r1324b459],
18	the	DT	O	the	det	19	SENT_343	[p22l1364t401r1465b459],
19	preparation	NN	O	preparation	prep_in	16	SENT_343	[p22l1504t402r1890b476],
20	of	IN	O	of	_	0	SENT_343	[p22l1930t400r2006b460],
21	the	DT	O	the	det	22	SENT_343	[p22l2033t401r2134b459],
22	manuscript	NN	O	manuscript	prep_of	19	SENT_343	[p22l10t498r403b573],
23	.	.	O	.	_	0	SENT_343	[p22l10t498r403b573],

1	N	NN	O	n	nn	3	SENT_344	[p22l558t658r572b673],
2	ENGLJ	NN	O	englj	nn	3	SENT_344	[p22l587t658r665b680],
3	MED	NN	O	med	_	0	SENT_344	[p22l679t658r731b673],
4	364	CD	NUMBER	364	dep	3	SENT_344	[p22l741t652r820b680],
5	;	:	O	;	_	0	SENT_344	[p22l741t652r820b680],
6	12	CD	NUMBER	12	num	8	SENT_344	[p22l741t652r820b680],
7	NEjM.oRG	NN	O	nejm.org	nn	8	SENT_344	[p22l856t658r980b680],
8	MARCH2	NN	O	march2	dep	4	SENT_344	[p22l1017t658r1127b673],
9	,2	CD	NUMBER	,2	num	10	SENT_344	[p22l1147t658r1213b678],
10	o11	NN	O	o11	dep	8	SENT_344	[p22l1147t658r1213b678],
11	1151	CD	DATE	1151	dep	3	SENT_344	[p22l1940t648r2016b671],

1	The	DT	O	the	det	4	SENT_345	[p22l702t691r753b715],
2	New	NNP	O	New	nn	4	SENT_345	[p22l762t692r824b715],
3	England	NNP	O	England	nn	4	SENT_345	[p22l833t691r944b722],
4	Journal	NNP	O	Journal	_	0	SENT_345	[p22l952t691r1050b715],
5	of	IN	O	of	prep	4	SENT_345	[p22l1059t691r1088b715],
6	e	SYM	O	e	dep	5	SENT_345	[p22l1125t699r1139b715],
7	icine	FW	O	icine	dep	4	SENT_345	[p22l1156t691r1220b715],

1	Downloaded	VBN	O	download	_	0	SENT_346	[p22l144t732r314b755],
2	from	IN	O	from	_	0	SENT_346	[p22l323t732r387b755],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_346	[p22l396t732r514b762],
4	at	IN	O	at	_	0	SENT_346	[p22l524t736r547b755],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_346	[p22l556t732r738b755],
6	on	IN	O	on	_	0	SENT_346	[p22l748t739r780b755],
7	J	NN	O	j	nn	8	SENT_346	[p22l789t732r801b755],
8	anu	NN	O	anu	prep_on	1	SENT_346	[p22l803t739r849b755],
9	,	,	O	,	_	0	SENT_346	[p22l919t751r924b760],
10	2014	CD	DATE	2014	appos	8	SENT_346	[p22l935t732r1007b755],
11	.	.	O	.	_	0	SENT_346	[p22l935t732r1007b755],

1	For	IN	O	for	_	0	SENT_347	[p22l1018t732r1064b755],
2	personal	JJ	O	personal	amod	3	SENT_347	[p22l1072t732r1185b762],
3	use	NN	O	use	pobj	1	SENT_347	[p22l1194t739r1237b755],
4	only	RB	O	only	advmod	3	SENT_347	[p22l1247t732r1312b762],
5	.	.	O	.	_	0	SENT_347	[p22l1247t732r1312b762],

1	No	DT	O	no	det	3	SENT_348	[p22l1322t732r1362b755],
2	other	JJ	O	other	amod	3	SENT_348	[p22l1372t732r1440b755],
3	uses	NNS	O	use	_	0	SENT_348	[p22l1448t739r1504b755],
4	without	IN	O	without	_	0	SENT_348	[p22l1515t732r1616b755],
5	permission	NN	O	permission	prep_without	3	SENT_348	[p22l1624t732r1776b762],
6	.	.	O	.	_	0	SENT_348	[p22l1624t732r1776b762],

1	Copyright	NN	O	copyright	nn	5	SENT_349	[p22l494t773r629b804],
2	©	CD	NUMBER	©	num	5	SENT_349	[p22l638t773r661b797],
3	2011	CD	DATE	2011	num	5	SENT_349	[p22l671t773r734b797],
4	Massac	NNP	LOCATION	Massac	nn	5	SENT_349	[p22l746t774r844b797],
5	usetts	NNP	O	usetts	_	0	SENT_349	[p22l862t777r937b797],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_349	[p22l947t773r1055b797],
7	Society	NNP	ORGANIZATION	Society	dep	5	SENT_349	[p22l1065t773r1170b804],
8	.	.	O	.	_	0	SENT_349	[p22l1065t773r1170b804],

1	All	DT	O	all	det	2	SENT_350	[p22l1181t773r1223b797],
2	rights	NNS	O	rights	nsubj	3	SENT_350	[p22l1232t773r1306b804],
3	reserved	VBN	O	reserve	_	0	SENT_350	[p22l1316t773r1435b797],
4	.	.	O	.	_	0	SENT_350	[p22l1316t773r1435b797],

1	The	DT	O	the	det	4	SENT_351	[p22l673t879r718b900],
2	NEW	NNP	O	NEW	nn	4	SENT_351	[p22l737t881r822b900],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_351	[p22l841t881r1029b900],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_351	[p22l1048t881r1227b907],
5	of	IN	O	of	_	0	SENT_351	[p22l1247t879r1275b906],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_351	[p22l1287t881r1486b900],

1	REFERENCES	NNS	O	reference	_	0	SENT_352	[p22l20t1206r688b1270],

1	1	LS	NUMBER	1	_	0	SENT_353	[p22l16t1447r92b1527],
2	.	.	O	.	_	0	SENT_353	[p22l16t1447r92b1527],

1	Weinshilboum	NNP	O	Weinshilboum	nn	2	SENT_354	[p22l207t1437r959b1529],
2	RM	NN	O	rm	_	0	SENT_354	[p22l999t1445r1208b1547],
3	,	,	O	,	_	0	SENT_354	[p22l999t1445r1208b1547],
4	Wang	NNP	PERSON	Wang	nn	6	SENT_354	[p22l1252t1445r1547b1553],
5	L.	NNP	PERSON	L.	nn	6	SENT_354	[p22l1581t1445r1671b1527],
6	Pharmacogenetics	NNP	PERSON	Pharmacogenetics	conj_and	2	SENT_354	[p22l1716t1437r2147b1527, p22l14t1587r536b1703],
7	and	CC	O	and	_	0	SENT_354	[p22l578t1587r760b1677],
8	pharmacogenomics	NNS	O	pharmacogenomic	conj_and	2	SENT_354	[p22l798t1587r1816b1703],
9	:	:	O	:	_	0	SENT_354	[p22l798t1587r1816b1703],
10	development	NN	O	development	dep	2	SENT_354	[p22l1862t1587r2147b1679, p22l14t1755r427b1853],
11	,	,	O	,	_	0	SENT_354	[p22l1862t1587r2147b1679, p22l14t1755r427b1853],
12	science	NN	O	science	dep	2	SENT_354	[p22l502t1737r891b1847],
13	,	,	O	,	_	0	SENT_354	[p22l502t1737r891b1847],
14	and	CC	O	and	_	0	SENT_354	[p22l963t1737r1149b1827],
15	translation	NN	O	translation	dep	2	SENT_354	[p22l1216t1737r1802b1827],
16	.	.	O	.	_	0	SENT_354	[p22l1216t1737r1802b1827],

1	Annu	NNP	PERSON	Annu	nn	3	SENT_355	[p22l1870t1745r2149b1829],
2	Rev	NN	PERSON	rev	nn	3	SENT_355	[p22l10t1893r196b1983],
3	Genomics	NNS	PERSON	genomic	_	0	SENT_355	[p22l227t1887r740b1977],
4	Hum	NNP	PERSON	Hum	nn	5	SENT_355	[p22l777t1895r1031b1979],
5	Genet	NNP	PERSON	Genet	dep	3	SENT_355	[p22l1066t1893r1370b1977],
6	2006	CD	DATE	2006	num	5	SENT_355	[p22l1401t1893r2141b1997],
7	;	:	O	;	_	0	SENT_355	[p22l1401t1893r2141b1997],
8	7:223	CD	NUMBER	7:223	number	9	SENT_355	[p22l1401t1893r2141b1997],
9	—	CD	NUMBER	—	dep	3	SENT_355	[p22l1401t1893r2141b1997],
10	45	CD	NUMBER	45	dep	9	SENT_355	[p22l1401t1893r2141b1997],
11	.	.	O	.	_	0	SENT_355	[p22l1401t1893r2141b1997],

1	2	LS	NUMBER	2	_	0	SENT_356	[p22l10t2047r94b2127],
2	.	.	O	.	_	0	SENT_356	[p22l10t2047r94b2127],

1	Manolio	NNP	O	Manolio	nn	2	SENT_357	[p22l207t2037r630b2127],
2	TA	NNP	O	TA	_	0	SENT_357	[p22l661t2043r832b2127],
3	.	.	O	.	_	0	SENT_357	[p22l661t2043r832b2127],

1	Genomevvide	NN	MISC	genomevvide	nn	3	SENT_358	[p22l873t2037r1543b2129],
2	association	NN	O	association	nn	3	SENT_358	[p22l1575t2037r2149b2127],
3	studies	NNS	O	study	_	0	SENT_358	[p22l14t2187r369b2279],
4	and	CC	O	and	_	0	SENT_358	[p22l413t2187r598b2277],
5	assessment	NN	O	assessment	conj_and	3	SENT_358	[p22l640t2205r1220b2277],
6	of	IN	O	of	_	0	SENT_358	[p22l1256t2185r1374b2277],
7	the	DT	O	the	det	8	SENT_358	[p22l1395t2187r1551b2277],
8	risk	NN	O	risk	prep_of	3	SENT_358	[p22l1593t2187r1786b2279],
9	of	IN	O	of	_	0	SENT_358	[p22l1824t2185r1942b2277],
10	disease	NN	O	disease	prep_of	3	SENT_358	[p22l1962t2187r2147b2277, p22l14t2367r254b2427],
11	.	.	O	.	_	0	SENT_358	[p22l1962t2187r2147b2277, p22l14t2367r254b2427],

1	N	NN	O	n	nn	3	SENT_359	[p22l299t2345r385b2427],
2	Engll	NNP	O	Engll	nn	3	SENT_359	[p22l422t2337r722b2453],
3	Med	NNP	O	Med	_	0	SENT_359	[p22l756t2337r975b2427],
4	2010	CD	DATE	2010	num	3	SENT_359	[p22l1015t2343r1864b2447],
5	;	:	O	;	_	0	SENT_359	[p22l1015t2343r1864b2447],
6	363:166	CD	NUMBER	363:166	number	7	SENT_359	[p22l1015t2343r1864b2447],
7	—	CD	NUMBER	—	dep	3	SENT_359	[p22l1015t2343r1864b2447],
8	76	CD	NUMBER	76	dep	7	SENT_359	[p22l1015t2343r1864b2447],
9	.	.	O	.	_	0	SENT_359	[p22l1015t2343r1864b2447],

1	3	LS	NUMBER	3	_	0	SENT_360	[p22l12t2497r88b2577],
2	.	.	O	.	_	0	SENT_360	[p22l12t2497r88b2577],

1	McCormacl	NN	O	mccormacl	_	0	SENT_361	[p22l207t2487r822b2579],
2	<	JJR	O	<	amod	3	SENT_361	[p22l207t2487r822b2579],
3	M	NN	O	m	dep	1	SENT_361	[p22l855t2495r981b2597],
4	,	,	O	,	_	0	SENT_361	[p22l855t2495r981b2597],
5	Alﬁrevic	NNP	MISC	Alﬁrevic	nn	6	SENT_361	[p22l1026t2485r1457b2577],
6	A	NNP	MISC	A	appos	3	SENT_361	[p22l1495t2495r1597b2597],
7	,	,	O	,	_	0	SENT_361	[p22l1495t2495r1597b2597],
8	Bourgeois	NNP	PERSON	Bourgeois	nn	9	SENT_361	[p22l1644t2487r2145b2603],
9	S	NNP	O	S	appos	3	SENT_361	[p22l14t2643r94b2747],
10	,	,	O	,	_	0	SENT_361	[p22l14t2643r94b2747],
11	et	FW	O	et	nn	12	SENT_361	[p22l149t2655r239b2727],
12	al.	FW	O	al.	appos	3	SENT_361	[p22l281t2637r393b2727],
13	.	.	O	.	_	0	SENT_361	[p22l281t2637r393b2727],

1	HLA	NN	O	hlum	_	0	SENT_362	[p22l446t2637r1065b2729],
2	.	.	O	.	_	0	SENT_362	[p22l446t2637r1065b2729],

1	—	NN	O	—	_	0	SENT_363	[p22l446t2637r1065b2729],
2	.	.	O	.	_	0	SENT_363	[p22l446t2637r1065b2729],

1	A	DT	O	a	det	3	SENT_364	[p22l446t2637r1065b2729],
2	*	JJ	O	*	amod	3	SENT_364	[p22l446t2637r1065b2729],
3	3101	CD	NUMBER	3101	nsubj	7	SENT_364	[p22l446t2637r1065b2729],
4	and	CC	O	and	_	0	SENT_364	[p22l1112t2637r1296b2727],
5	carbamazepine	NN	O	carbamazepine	nn	6	SENT_364	[p22l1345t2637r2147b2753],
6	—	NN	O	—	conj_and	3	SENT_364	[p22l1345t2637r2147b2753],
7	induced	VBD	O	induce	_	0	SENT_364	[p22l12t2787r405b2879],
8	hypersensitivity	NN	O	hypersensitivity	nn	9	SENT_364	[p22l436t2787r1226b2903],
9	reactions	NNS	O	reaction	dobj	7	SENT_364	[p22l1252t2787r1705b2877],
10	in	IN	O	in	_	0	SENT_364	[p22l1738t2787r1836b2875],
11	Europeans	NNPS	MISC	Europeans	prep_in	7	SENT_364	[p22l1868t2795r2147b2879, p22l10t2967r337b3053],
12	.	.	O	.	_	0	SENT_364	[p22l1868t2795r2147b2879, p22l10t2967r337b3053],

1	N	NN	O	n	nn	3	SENT_365	[p22l381t2945r467b3027],
2	Engl	NNP	O	Engl	nn	3	SENT_365	[p22l504t2937r732b3053],
3	J	NNP	O	J	nsubj	4	SENT_365	[p22l760t2945r804b3041],
4	Med	VBD	O	med	_	0	SENT_365	[p22l837t2937r1057b3027],
5	2011	CD	DATE	2011	dobj	4	SENT_365	[p22l1096t2943r2029b3047],
6	;	:	O	;	_	0	SENT_365	[p22l1096t2943r2029b3047],
7	364:1134	CD	NUMBER	364:1134	number	8	SENT_365	[p22l1096t2943r2029b3047],
8	—	CD	NUMBER	—	dep	5	SENT_365	[p22l1096t2943r2029b3047],
9	43	CD	NUMBER	43	dep	8	SENT_365	[p22l1096t2943r2029b3047],
10	.	.	O	.	_	0	SENT_365	[p22l1096t2943r2029b3047],

1	4	LS	NUMBER	4	_	0	SENT_366	[p22l10t3097r92b3177],
2	.	.	O	.	_	0	SENT_366	[p22l10t3097r92b3177],

1	Weinshilboum	NNP	MISC	Weinshilboum	_	0	SENT_367	[p22l207t3087r959b3179],
2	R.	NNP	MISC	R.	nn	3	SENT_367	[p22l1062t3093r1164b3183],
3	Inheritance	NNP	MISC	Inheritance	dep	1	SENT_367	[p22l1274t3087r1860b3177],
4	and	CC	O	and	_	0	SENT_367	[p22l1963t3087r2149b3177],
5	drug	NN	O	drug	nn	6	SENT_367	[p22l14t3237r253b3353],
6	response	NN	O	response	dep	1	SENT_367	[p22l311t3265r790b3353],
7	.	.	O	.	_	0	SENT_367	[p22l311t3265r790b3353],

1	N	NN	O	n	nn	3	SENT_368	[p22l855t3245r941b3327],
2	Engl	NNP	O	Engl	nn	3	SENT_368	[p22l999t3237r1228b3353],
3	J	NNP	O	J	nsubj	4	SENT_368	[p22l1276t3245r1320b3341],
4	Med	VBD	O	med	_	0	SENT_368	[p22l1375t3237r1593b3327],
5	2003	CD	DATE	2003	dobj	4	SENT_368	[p22l1654t3243r2143b3347],
6	;	:	O	;	_	0	SENT_368	[p22l1654t3243r2143b3347],
7	348	CD	NUMBER	348	num	9	SENT_368	[p22l1654t3243r2143b3347],
8	:	:	O	:	_	0	SENT_368	[p22l1654t3243r2143b3347],
9	529-37	CD	NUMBER	529-37	dep	5	SENT_368	[p22l14t3393r365b3477],
10	.	.	O	.	_	0	SENT_368	[p22l14t3393r365b3477],

1	S.	NNP	PERSON	S.	nn	3	SENT_369	[p22l14t3547r90b3627],
2	Evans	NNP	PERSON	Evans	nn	3	SENT_369	[p22l209t3545r499b3629],
3	WE	NNP	O	WE	_	0	SENT_369	[p22l542t3545r750b3647],
4	,	,	O	,	_	0	SENT_369	[p22l542t3545r750b3647],
5	McLeod	NNP	PERSON	McLeod	nn	6	SENT_369	[p22l797t3537r1200b3627],
6	HL	NNS	O	hl	appos	3	SENT_369	[p22l1244t3545r1425b3627],
7	.	.	O	.	_	0	SENT_369	[p22l1244t3545r1425b3627],

1	Pharmacogenomics	NNP	O	Pharmacogenomics	_	0	SENT_370	[p22l1475t3537r2147b3653, p22l12t3687r379b3777],
2	—	CD	NUMBER	—	num	3	SENT_370	[p22l414t3739r539b3747],
3	drug	NN	O	drug	dep	1	SENT_370	[p22l572t3687r813b3803],
4	disposition	NN	O	disposition	dep	3	SENT_370	[p22l847t3687r1443b3803],
5	,	,	O	,	_	0	SENT_370	[p22l847t3687r1443b3803],
6	drug	NN	O	drug	nn	7	SENT_370	[p22l1487t3687r1729b3803],
7	targets	NNS	O	target	appos	4	SENT_370	[p22l1762t3705r2141b3803],
8	,	,	O	,	_	0	SENT_370	[p22l1762t3705r2141b3803],

1	and	CC	O	and	_	0	SENT_371	[p23l12t25r198b115],
2	side	JJ	O	side	amod	3	SENT_371	[p23l247t25r441b115],
3	effects	NNS	O	effect	dep	1	SENT_371	[p23l490t23r854b115],
4	.	.	O	.	_	0	SENT_371	[p23l490t23r854b115],

1	N	NN	O	n	nn	3	SENT_372	[p23l907t33r993b115],
2	Engl	NNP	O	Engl	nn	3	SENT_372	[p23l1038t25r1266b141],
3	J	NNP	O	J	nsubj	4	SENT_372	[p23l1302t33r1346b129],
4	Med	VBD	O	med	_	0	SENT_372	[p23l1388t25r1607b115],
5	2003	CD	DATE	2003	dobj	4	SENT_372	[p23l1654t31r2143b135],
6	;	:	O	;	_	0	SENT_372	[p23l1654t31r2143b135],
7	348	CD	NUMBER	348	num	9	SENT_372	[p23l1654t31r2143b135],
8	:	:	O	:	_	0	SENT_372	[p23l1654t31r2143b135],
9	538-49	CD	NUMBER	538-49	dep	5	SENT_372	[p23l14t179r379b263],
10	.	.	O	.	_	0	SENT_372	[p23l14t179r379b263],

1	6	CD	NUMBER	6	_	0	SENT_373	[p23l12t335r92b415],
2	.	.	O	.	_	0	SENT_373	[p23l12t335r92b415],

1	Feero	NNP	PERSON	Feero	nn	2	SENT_374	[p23l209t333r480b415],
2	WG	NNP	O	WG	_	0	SENT_374	[p23l512t331r728b435],
3	,	,	O	,	_	0	SENT_374	[p23l512t331r728b435],
4	Guttmacher	NNP	PERSON	Guttmacher	nn	5	SENT_374	[p23l769t325r1372b417],
5	AE	NNP	O	AE	appos	2	SENT_374	[p23l1399t333r1569b435],
6	,	,	O	,	_	0	SENT_374	[p23l1399t333r1569b435],
7	Collins	NNP	ORGANIZATION	Collins	nn	8	SENT_374	[p23l1611t325r1964b415],
8	FS	NNP	ORGANIZATION	FS	appos	5	SENT_374	[p23l1999t331r2141b415],
9	.	.	O	.	_	0	SENT_374	[p23l1999t331r2141b415],

1	Genomic	JJ	O	genomic	nsubj	2	SENT_375	[p23l12t475r474b565],
2	medicine	NN	O	medicine	_	0	SENT_375	[p23l511t475r975b565],
3	—	CD	NUMBER	—	nsubj	6	SENT_375	[p23l1010t527r1135b535],
4	an	DT	O	a	det	6	SENT_375	[p23l1168t505r1288b565],
5	updated	VBN	O	update	amod	6	SENT_375	[p23l1326t475r1735b591],
6	primer	NN	O	primer	xcomp	2	SENT_375	[p23l1772t475r2141b591],
7	.	.	O	.	_	0	SENT_375	[p23l1772t475r2141b591],

1	N	NN	O	n	nn	3	SENT_376	[p23l10t633r96b715],
2	Engl	NNP	O	Engl	nn	3	SENT_376	[p23l133t625r433b741],
3	]	NNP	O	]	nsubj	4	SENT_376	[p23l133t625r433b741],
4	Med	VBD	O	med	_	0	SENT_376	[p23l467t625r686b715],
5	2010	CD	DATE	2010	dobj	4	SENT_376	[p23l726t631r1637b735],
6	;	:	O	;	_	0	SENT_376	[p23l726t631r1637b735],
7	362:2001	CD	NUMBER	362:2001	number	8	SENT_376	[p23l726t631r1637b735],
8	—	CD	NUMBER	—	dep	5	SENT_376	[p23l726t631r1637b735],
9	11	CD	NUMBER	11	dep	8	SENT_376	[p23l726t631r1637b735],
10	.	.	O	.	_	0	SENT_376	[p23l726t631r1637b735],

1	7	CD	NUMBER	7	_	0	SENT_377	[p23l14t785r82b865],
2	.	.	O	.	_	0	SENT_377	[p23l14t785r82b865],

1	Woodcock	NNP	PERSON	Woodcock	nn	3	SENT_378	[p23l207t775r748b867],
2	J.	NNP	O	J.	nn	3	SENT_378	[p23l809t783r875b879],
3	Assessing	NNP	O	Assessing	nsubj	9	SENT_378	[p23l957t775r1465b891],
4	the	DT	O	the	det	6	SENT_378	[p23l1541t775r1697b865],
5	clinical	JJ	O	clinical	amod	6	SENT_378	[p23l1776t775r2149b865],
6	utility	NN	O	utility	dep	3	SENT_378	[p23l12t925r317b1041],
7	of	IN	O	of	_	0	SENT_378	[p23l361t923r479b1015],
8	diagnostics	NNS	O	diagnostic	prep_of	3	SENT_378	[p23l506t925r1089b1041],
9	used	VBN	O	use	_	0	SENT_378	[p23l1140t925r1372b1017],
10	in	IN	O	in	_	0	SENT_378	[p23l1419t925r1517b1013],
11	drug	NN	O	drug	nn	12	SENT_378	[p23l1565t925r1806b1041],
12	therapy	NN	O	therapy	prep_in	9	SENT_378	[p23l1850t925r2147b1015, p23l10t1105r144b1191],
13	.	.	O	.	_	0	SENT_378	[p23l1850t925r2147b1015, p23l10t1105r144b1191],

1	Clin	NNP	O	Clin	nn	3	SENT_379	[p23l191t1075r401b1165],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_379	[p23l438t1075r983b1165],
3	Ther	NNP	O	Ther	_	0	SENT_379	[p23l1019t1075r1256b1165],
4	2010	CD	DATE	2010	num	3	SENT_379	[p23l1292t1081r2075b1185],
5	;	:	O	;	_	0	SENT_379	[p23l1292t1081r2075b1185],
6	88:765	CD	NUMBER	88:765	number	7	SENT_379	[p23l1292t1081r2075b1185],
7	—	CD	NUMBER	—	dep	3	SENT_379	[p23l1292t1081r2075b1185],
8	73	CD	NUMBER	73	dep	7	SENT_379	[p23l1292t1081r2075b1185],
9	.	.	O	.	_	0	SENT_379	[p23l1292t1081r2075b1185],

1	8	CD	NUMBER	8	_	0	SENT_380	[p23l12t1233r92b1317],
2	.	.	O	.	_	0	SENT_380	[p23l12t1233r92b1317],

1	Fuster	NNP	PERSON	Fuster	nn	2	SENT_381	[p23l209t1233r526b1317],
2	V	NNP	PERSON	V	_	0	SENT_381	[p23l564t1233r650b1335],
3	,	,	O	,	_	0	SENT_381	[p23l564t1233r650b1335],
4	Sweeny	NNP	PERSON	Sweeny	nn	5	SENT_381	[p23l702t1231r1077b1341],
5	JM	NN	O	jm	appos	2	SENT_381	[p23l1102t1233r1274b1329],
6	.	.	O	.	_	0	SENT_381	[p23l1102t1233r1274b1329],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_382	[p23l1325t1225r1920b1341],
2	and	CC	O	and	_	0	SENT_382	[p23l1963t1225r2147b1315],
3	the	DT	O	the	det	7	SENT_382	[p23l12t1375r172b1465],
4	reduced	VBN	O	reduce	amod	7	SENT_382	[p23l253t1373r1148b1467],
5	—	NN	O	—	nn	7	SENT_382	[p23l253t1373r1148b1467],
6	function	NN	O	function	nn	7	SENT_382	[p23l253t1373r1148b1467],
7	CYPZC19	NN	O	cypzc19	conj_and	1	SENT_382	[p23l1230t1381r1694b1465],
8	genetic	JJ	O	genetic	npadvmod	9	SENT_382	[p23l1776t1375r2149b1491],
9	Variant	JJ	O	variant	amod	7	SENT_382	[p23l8t1525r397b1615],
10	:	:	O	:	_	0	SENT_382	[p23l8t1525r397b1615],
11	a	DT	O	a	det	13	SENT_382	[p23l435t1555r487b1615],
12	limited	JJ	O	limited	amod	13	SENT_382	[p23l518t1525r885b1615],
13	piece	NN	O	piece	dep	1	SENT_382	[p23l917t1525r1174b1641],
14	of	IN	O	of	_	0	SENT_382	[p23l1210t1523r1328b1615],
15	the	DT	O	the	det	18	SENT_382	[p23l1342t1525r1497b1615],
16	overall	JJ	O	overall	amod	18	SENT_382	[p23l1535t1525r1874b1615],
17	therapeutic	JJ	O	therapeutic	amod	18	SENT_382	[p23l1908t1525r2147b1615, p23l12t1675r377b1791],
18	puzzle	NN	O	puzzle	prep_of	13	SENT_382	[p23l415t1675r774b1791],
19	.	.	O	.	_	0	SENT_382	[p23l415t1675r774b1791],

1	JAMA	NNP	O	JAMA	_	0	SENT_383	[p23l807t1683r1111b1779],
2	2010	CD	DATE	2010	num	1	SENT_383	[p23l1148t1681r2077b1785],
3	;	:	O	;	_	0	SENT_383	[p23l1148t1681r2077b1785],
4	304:1839	CD	NUMBER	304:1839	number	5	SENT_383	[p23l1148t1681r2077b1785],
5	—	CD	NUMBER	—	dep	1	SENT_383	[p23l1148t1681r2077b1785],
6	40	CD	NUMBER	40	dep	5	SENT_383	[p23l1148t1681r2077b1785],
7	.	.	O	.	_	0	SENT_383	[p23l1148t1681r2077b1785],

1	9	CD	NUMBER	9	_	0	SENT_384	[p23l12t1835r90b1915],
2	.	.	O	.	_	0	SENT_384	[p23l12t1835r90b1915],

1	Mega	JJ	ORGANIZATION	mega	amod	2	SENT_385	[p23l207t1833r485b1941],
2	JL	NN	ORGANIZATION	jl	_	0	SENT_385	[p23l536t1833r672b1935],
3	,	,	O	,	_	0	SENT_385	[p23l536t1833r672b1935],
4	Simon	NNP	PERSON	Simon	nn	5	SENT_385	[p23l748t1825r1069b1915],
5	T	NN	PERSON	t	appos	2	SENT_385	[p23l1130t1831r1220b1935],
6	,	,	O	,	_	0	SENT_385	[p23l1130t1831r1220b1935],
7	Collet	NNP	PERSON	Collet	nn	8	SENT_385	[p23l1293t1825r1595b1915],
8	J	NNP	O	J	appos	5	SENT_385	[p23l1642t1833r1802b1935],
9	.	.	O	.	_	0	SENT_385	[p23l1642t1833r1802b1935],

1	—	NN	O	—	_	0	SENT_386	[p23l1642t1833r1802b1935],
2	.	.	O	.	_	0	SENT_386	[p23l1642t1833r1802b1935],

1	P	NN	O	p	_	0	SENT_387	[p23l1642t1833r1802b1935],
2	,	,	O	,	_	0	SENT_387	[p23l1642t1833r1802b1935],
3	et	FW	O	et	nn	4	SENT_387	[p23l1876t1843r1968b1915],
4	al.	FW	O	al.	appos	1	SENT_387	[p23l2027t1825r2141b1915],
5	.	.	O	.	_	0	SENT_387	[p23l2027t1825r2141b1915],

1	Reduced	VBN	O	reduce	amod	5	SENT_388	[p23l10t1973r921b2071],
2	—	NN	O	—	nn	5	SENT_388	[p23l10t1973r921b2071],
3	function	NN	O	function	nn	5	SENT_388	[p23l10t1973r921b2071],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_388	[p23l961t1981r1417b2065],
5	genotype	NN	O	genotype	nsubj	14	SENT_388	[p23l1457t1993r1924b2091],
6	and	CC	O	and	_	0	SENT_388	[p23l1963t1975r2149b2065],
7	risk	NN	O	risk	nsubj	14	SENT_388	[p23l12t2125r206b2217],
8	of	IN	O	of	_	0	SENT_388	[p23l255t2123r373b2215],
9	adverse	JJ	O	adverse	amod	11	SENT_388	[p23l404t2125r778b2217],
10	clinical	JJ	O	clinical	amod	11	SENT_388	[p23l833t2125r1204b2215],
11	outcomes	NNS	O	outcome	prep_of	7	SENT_388	[p23l1258t2143r1744b2217],
12	among	IN	O	among	_	0	SENT_388	[p23l1800t2153r2153b2241],
13	patients	NNS	O	patient	prep_among	11	SENT_388	[p23l10t2275r415b2391],
14	treated	VBN	O	treat	_	0	SENT_388	[p23l456t2275r809b2365],
15	With	IN	O	with	_	0	SENT_388	[p23l841t2275r1071b2367],
16	clopidogrel	NN	O	clopidogrel	prep_with	14	SENT_388	[p23l1108t2275r1681b2391],
17	predominantly	RB	O	predominantly	advmod	14	SENT_388	[p23l1716t2275r2147b2391, p23l12t2425r371b2541],
18	for	IN	O	for	_	0	SENT_388	[p23l437t2423r584b2515],
19	PCI	NNP	O	PCI	prep_for	14	SENT_388	[p23l650t2431r855b2515],
20	:	:	O	:	_	0	SENT_388	[p23l650t2431r855b2515],
21	a	DT	O	a	det	24	SENT_388	[p23l933t2455r983b2515],
22	meta	NN	O	meta	nn	24	SENT_388	[p23l1054t2425r1780b2541],
23	—	NN	O	—	nn	24	SENT_388	[p23l1054t2425r1780b2541],
24	analysis	NN	O	analysis	dep	19	SENT_388	[p23l1054t2425r1780b2541],
25	.	.	O	.	_	0	SENT_388	[p23l1054t2425r1780b2541],

1	JAMA	NNP	O	JAMA	_	0	SENT_389	[p23l1848t2433r2151b2529],
2	2010	CD	DATE	2010	num	1	SENT_389	[p23l12t2581r925b2685],
3	;	:	O	;	_	0	SENT_389	[p23l12t2581r925b2685],
4	304:1821	CD	NUMBER	304:1821	number	5	SENT_389	[p23l12t2581r925b2685],
5	—	CD	NUMBER	—	dep	1	SENT_389	[p23l12t2581r925b2685],
6	30	CD	NUMBER	30	dep	5	SENT_389	[p23l12t2581r925b2685],
7	.	.	O	.	_	0	SENT_389	[p23l12t2581r925b2685],

1	10	CD	NUMBER	10	_	0	SENT_390	[p23l16t2733r146b2815],
2	.	.	O	.	_	0	SENT_390	[p23l16t2733r146b2815],

1	Paré	NN	O	paré	nn	2	SENT_391	[p23l209t2721r427b2815],
2	G	NN	O	g	_	0	SENT_391	[p23l480t2731r588b2835],
3	,	,	O	,	_	0	SENT_391	[p23l480t2731r588b2835],
4	Mehta	NNP	ORGANIZATION	Mehta	nn	5	SENT_391	[p23l644t2725r963b2815],
5	SR	NN	ORGANIZATION	sr	appos	2	SENT_391	[p23l1016t2731r1172b2835],
6	,	,	O	,	_	0	SENT_391	[p23l1016t2731r1172b2835],
7	Yusuf	NNP	PERSON	Yusuf	nn	8	SENT_391	[p23l1228t2723r1529b2817],
8	S	NNP	PERSON	S	appos	2	SENT_391	[p23l1563t2731r1643b2835],
9	,	,	O	,	_	0	SENT_391	[p23l1563t2731r1643b2835],
10	et	FW	O	et	nn	11	SENT_391	[p23l1702t2743r1792b2815],
11	al.	FW	O	al.	appos	2	SENT_391	[p23l1838t2725r1954b2815],
12	.	.	O	.	_	0	SENT_391	[p23l1838t2725r1954b2815],

1	Effects	NNS	O	effect	nsubj	4	SENT_392	[p23l2009t2723r2147b2813, p23l12t2873r246b2965],
2	of	IN	O	of	_	0	SENT_392	[p23l303t2873r421b2965],
3	CYl	NN	O	cyl	prep_of	1	SENT_392	[p23l452t2881r909b2965],
4	>	JJR	O	>	_	0	SENT_392	[p23l452t2881r909b2965],
5	2C19	CD	NUMBER	2c19	num	6	SENT_392	[p23l452t2881r909b2965],
6	genotype	NN	O	genotype	dobj	4	SENT_392	[p23l963t2893r1428b2991],
7	on	IN	O	on	_	0	SENT_392	[p23l1483t2903r1607b2965],
8	outcomes	NNS	O	outcome	prep_on	6	SENT_392	[p23l1660t2893r2145b2967],
9	of	IN	O	of	_	0	SENT_392	[p23l14t3023r130b3115],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_392	[p23l173t3025r746b3141],
11	treatment	NN	O	treatment	prep_of	4	SENT_392	[p23l809t3043r1336b3115],
12	.	.	O	.	_	0	SENT_392	[p23l809t3043r1336b3115],

1	N	NN	O	n	nn	3	SENT_393	[p23l1403t3033r1489b3115],
2	Engl	NNP	O	Engl	nn	3	SENT_393	[p23l1549t3025r1778b3141],
3	J	NNP	O	J	nsubj	4	SENT_393	[p23l1828t3033r1872b3129],
4	Med	VBD	O	med	_	0	SENT_393	[p23l1930t3025r2149b3115],
5	2010	CD	DATE	2010	dobj	4	SENT_393	[p23l12t3181r919b3285],
6	;	:	O	;	_	0	SENT_393	[p23l12t3181r919b3285],
7	363:1704	CD	NUMBER	363:1704	number	8	SENT_393	[p23l12t3181r919b3285],
8	—	CD	NUMBER	—	dep	5	SENT_393	[p23l12t3181r919b3285],
9	14	CD	NUMBER	14	dep	8	SENT_393	[p23l12t3181r919b3285],
10	.	.	O	.	_	0	SENT_393	[p23l12t3181r919b3285],

1	11	CD	NUMBER	11	_	0	SENT_394	[p23l16t3335r146b3415],
2	.	.	O	.	_	0	SENT_394	[p23l16t3335r146b3415],

1	Daly	NNP	PERSON	Daly	nn	2	SENT_395	[p23l209t3325r441b3441],
2	AK	NNP	O	AK	_	0	SENT_395	[p23l480t3333r664b3435],
3	,	,	O	,	_	0	SENT_395	[p23l480t3333r664b3435],
4	King	NNP	O	King	nn	5	SENT_395	[p23l719t3325r967b3441],
5	BP	NNP	O	BP	appos	2	SENT_395	[p23l1011t3331r1158b3415],
6	.	.	O	.	_	0	SENT_395	[p23l1011t3331r1158b3415],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_396	[p23l1212t3325r2145b3441],
2	of	IN	O	of	_	0	SENT_396	[p23l14t3473r130b3565],
3	oral	JJ	O	oral	amod	4	SENT_396	[p23l148t3475r345b3565],
4	anticoagulants	NNS	O	anticoagulant	prep_of	1	SENT_396	[p23l381t3475r1170b3591],
5	.	.	O	.	_	0	SENT_396	[p23l381t3475r1170b3591],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_397	[p23l1212t3475r2147b3591],
2	2003	CD	DATE	2003	num	1	SENT_397	[p23l12t3631r798b3735],
3	;	:	O	;	_	0	SENT_397	[p23l12t3631r798b3735],
4	13:247	CD	NUMBER	13:247	number	5	SENT_397	[p23l12t3631r798b3735],
5	—	CD	NUMBER	—	dep	1	SENT_397	[p23l12t3631r798b3735],
6	52	CD	NUMBER	52	dep	5	SENT_397	[p23l12t3631r798b3735],
7	.	.	O	.	_	0	SENT_397	[p23l12t3631r798b3735],

1	12	CD	NUMBER	12	_	0	SENT_398	[p24l16t37r150b117],
2	.	.	O	.	_	0	SENT_398	[p24l16t37r150b117],

1	Budnitz	NNP	PERSON	Budnitz	nn	2	SENT_399	[p24l209t27r610b119],
2	DS	NN	O	d	_	0	SENT_399	[p24l686t33r855b137],
3	,	,	O	,	_	0	SENT_399	[p24l686t33r855b137],
4	Shehab	NNP	PERSON	Shehab	nn	5	SENT_399	[p24l943t27r1306b117],
5	N	NNP	PERSON	N	appos	2	SENT_399	[p24l1383t35r1493b137],
6	,	,	O	,	_	0	SENT_399	[p24l1383t35r1493b137],
7	Kegler	NNP	PERSON	Kegler	nn	8	SENT_399	[p24l1579t27r1906b143],
8	SR	NN	O	sr	appos	2	SENT_399	[p24l1985t33r2141b137],
9	,	,	O	,	_	0	SENT_399	[p24l1985t33r2141b137],
10	Richards	NNP	PERSON	Richards	nn	11	SENT_399	[p24l10t177r461b273],
11	CL	NN	O	cl	appos	2	SENT_399	[p24l526t183r688b267],
12	.	.	O	.	_	0	SENT_399	[p24l526t183r688b267],

1	Medication	NN	O	medication	nn	2	SENT_400	[p24l752t177r1326b267],
2	use	NN	O	use	_	0	SENT_400	[p24l1389t207r1553b269],
3	leading	VBG	O	lead	partmod	2	SENT_400	[p24l1615t177r1993b293],
4	to	TO	O	to	_	0	SENT_400	[p24l2051t195r2147b267],
5	emergency	NN	O	emergency	nn	7	SENT_400	[p24l14t357r562b443],
6	department	NN	O	department	nn	7	SENT_400	[p24l616t327r1210b443],
7	visits	NNS	O	visit	prep_to	3	SENT_400	[p24l1256t327r1517b417],
8	for	IN	O	for	_	0	SENT_400	[p24l1577t325r1723b417],
9	adverse	JJ	O	adverse	amod	11	SENT_400	[p24l1776t327r2149b417],
10	drug	NN	O	drug	nn	11	SENT_400	[p24l14t477r253b593],
11	events	NNS	O	event	prep_for	3	SENT_400	[p24l313t495r624b567],
12	in	IN	O	in	_	0	SENT_400	[p24l688t477r786b565],
13	older	JJR	O	older	amod	14	SENT_400	[p24l847t477r1105b567],
14	adults	NNS	O	adult	prep_in	11	SENT_400	[p24l1162t477r1497b569],
15	.	.	O	.	_	0	SENT_400	[p24l1162t477r1497b569],

1	Ann	NNP	O	Ann	nn	3	SENT_401	[p24l1561t485r1775b565],
2	Intern	NNP	O	Intern	nn	3	SENT_401	[p24l1834t485r2149b567],
3	Med	NNP	O	Med	_	0	SENT_401	[p24l8t627r228b717],
4	2007	CD	DATE	2007	num	3	SENT_401	[p24l267t633r1103b737],
5	;	:	O	;	_	0	SENT_401	[p24l267t633r1103b737],
6	147:755	CD	NUMBER	147:755	number	7	SENT_401	[p24l267t633r1103b737],
7	—	CD	NUMBER	—	dep	3	SENT_401	[p24l267t633r1103b737],
8	65	CD	NUMBER	65	dep	7	SENT_401	[p24l267t633r1103b737],
9	.	.	O	.	_	0	SENT_401	[p24l267t633r1103b737],

1	13	CD	NUMBER	13	_	0	SENT_402	[p24l16t787r146b867],
2	.	.	O	.	_	0	SENT_402	[p24l16t787r146b867],

1	Wysowski	NNP	ORGANIZATION	Wysowski	nn	2	SENT_403	[p24l207t777r722b893],
2	DK	NNP	ORGANIZATION	DK	_	0	SENT_403	[p24l779t785r965b887],
3	,	,	O	,	_	0	SENT_403	[p24l779t785r965b887],
4	Nourjah	NNP	PERSON	Nourjah	nn	5	SENT_403	[p24l1028t777r1447b893],
5	P	NN	PERSON	p	appos	2	SENT_403	[p24l1505t785r1581b887],
6	,	,	O	,	_	0	SENT_403	[p24l1505t785r1581b887],
7	Svvartz	NNP	O	Svvartz	nn	9	SENT_403	[p24l1650t783r1996b869],
8	L.	NNP	O	L.	nn	9	SENT_403	[p24l2053t785r2141b867],
9	Bleeding	NNP	O	Bleeding	appos	2	SENT_403	[p24l10t927r450b1043],
10	complications	NNS	O	complication	nsubj	11	SENT_403	[p24l485t927r1186b1043],
11	vvith	VBP	O	vvith	rcmod	9	SENT_403	[p24l1222t927r1448b1019],
12	vvarfarin	NN	O	vvarfarin	nn	13	SENT_403	[p24l1481t925r1916b1019],
13	use	NN	O	use	dobj	11	SENT_403	[p24l1953t957r2143b1019],
14	:	:	O	:	_	0	SENT_403	[p24l1953t957r2143b1019],
15	a	DT	O	a	det	18	SENT_403	[p24l12t1107r64b1167],
16	prevalent	JJ	O	prevalent	amod	17	SENT_403	[p24l136t1077r618b1193],
17	adverse	JJ	O	adverse	amod	18	SENT_403	[p24l688t1077r1068b1169],
18	effect	NN	O	effect	nsubj	19	SENT_403	[p24l1146t1075r1439b1167],
19	resulting	VBG	O	result	dep	2	SENT_403	[p24l1509t1077r1978b1193],
20	in	IN	O	in	_	0	SENT_403	[p24l2049t1077r2149b1165],
21	regulatory	JJ	O	regulatory	amod	22	SENT_403	[p24l12t1227r544b1343],
22	action	NN	O	action	prep_in	19	SENT_403	[p24l584t1227r923b1317],
23	.	.	O	.	_	0	SENT_403	[p24l584t1227r923b1317],

1	Arch	NNP	O	Arch	nn	3	SENT_404	[p24l971t1227r1214b1317],
2	Intern	NNP	O	Intern	nn	3	SENT_404	[p24l1260t1235r1573b1317],
3	Med	NNP	O	Med	_	0	SENT_404	[p24l1615t1227r1834b1317],
4	2007	CD	DATE	2007	num	3	SENT_404	[p24l1880t1233r2143b1337],
5	;	:	O	;	_	0	SENT_404	[p24l1880t1233r2143b1337],
6	167:1414	CD	NUMBER	167:1414	number	7	SENT_404	[p24l16t1383r570b1467],
7	—	CD	NUMBER	—	dep	3	SENT_404	[p24l16t1383r570b1467],
8	9	CD	NUMBER	9	dep	7	SENT_404	[p24l16t1383r570b1467],
9	.	.	O	.	_	0	SENT_404	[p24l16t1383r570b1467],

1	14	CD	NUMBER	14	_	0	SENT_405	[p24l16t1537r148b1617],
2	.	.	O	.	_	0	SENT_405	[p24l16t1537r148b1617],

1	Aithal	NNP	O	Aithal	nn	2	SENT_406	[p24l207t1527r522b1617],
2	GP	NNP	O	GP	_	0	SENT_406	[p24l574t1533r738b1637],
3	,	,	O	,	_	0	SENT_406	[p24l574t1533r738b1637],
4	Day	NNP	DURATION	Day	nn	5	SENT_406	[p24l795t1535r989b1643],
5	CP	NNP	O	CP	appos	2	SENT_406	[p24l1036t1533r1188b1637],
6	,	,	O	,	_	0	SENT_406	[p24l1036t1533r1188b1637],
7	Kesteven	NNP	PERSON	Kesteven	nn	9	SENT_406	[p24l1246t1535r1695b1619],
8	P	NN	O	p	nn	9	SENT_406	[p24l1746t1535r1866b1637],
9	]	NN	O	]	appos	2	SENT_406	[p24l1746t1535r1866b1637],
10	,	,	O	,	_	0	SENT_406	[p24l1746t1535r1866b1637],
11	Daly	NNP	PERSON	Daly	nn	12	SENT_406	[p24l1923t1527r2153b1643],
12	AK	NNP	O	AK	appos	2	SENT_406	[p24l8t1685r192b1769],
13	.	.	O	.	_	0	SENT_406	[p24l8t1685r192b1769],

1	Association	NNP	O	Association	_	0	SENT_407	[p24l235t1677r833b1767],
2	of	IN	O	of	_	0	SENT_407	[p24l875t1675r991b1767],
3	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_407	[p24l1009t1677r1810b1793],
4	in	IN	O	in	_	0	SENT_407	[p24l1852t1677r1952b1765],
5	the	DT	O	the	det	12	SENT_407	[p24l1991t1677r2147b1767],
6	cytochrome	NN	O	cytochrome	nn	12	SENT_407	[p24l14t1827r612b1943],
7	P450	NN	O	p450	nn	12	SENT_407	[p24l670t1833r907b1917],
8	CYPZC9	NN	O	cypzc9	nn	12	SENT_407	[p24l969t1833r1366b1917],
9	vvith	NN	O	vvith	nn	12	SENT_407	[p24l1421t1827r1651b1919],
10	vvarfarin	NN	O	vvarfarin	nn	12	SENT_407	[p24l1706t1825r2149b1919],
11	dose	NN	O	dose	nn	12	SENT_407	[p24l14t1977r242b2067],
12	requirement	NN	O	requirement	prep_in	3	SENT_407	[p24l317t1977r947b2093],
13	and	CC	O	and	_	0	SENT_407	[p24l1016t1977r1202b2067],
14	risk	NN	O	risk	conj_and	3	SENT_407	[p24l1276t1977r1471b2069],
15	of	IN	O	of	_	0	SENT_407	[p24l1541t1975r1659b2067],
16	bleeding	VBG	O	bleed	amod	17	SENT_407	[p24l1712t1977r2153b2093],
17	complications	NNS	O	complication	prep_of	14	SENT_407	[p24l14t2127r758b2243],
18	.	.	O	.	_	0	SENT_407	[p24l14t2127r758b2243],

1	Lancet	NNP	O	Lancet	_	0	SENT_408	[p24l803t2135r1143b2217],
2	1999	CD	DATE	1999	num	1	SENT_408	[p24l1180t2133r1958b2237],
3	;	:	O	;	_	0	SENT_408	[p24l1180t2133r1958b2237],
4	353:717	CD	NUMBER	353:717	number	5	SENT_408	[p24l1180t2133r1958b2237],
5	—	CD	NUMBER	—	dep	1	SENT_408	[p24l1180t2133r1958b2237],
6	9	CD	NUMBER	9	dep	5	SENT_408	[p24l1180t2133r1958b2237],
7	.	.	O	.	_	0	SENT_408	[p24l1180t2133r1958b2237],

1	15	CD	NUMBER	15	_	0	SENT_409	[p24l16t2287r146b2367],
2	.	.	O	.	_	0	SENT_409	[p24l16t2287r146b2367],

1	Li	NNP	PERSON	Li	nn	2	SENT_410	[p24l209t2277r303b2365],
2	T	NN	PERSON	t	_	0	SENT_410	[p24l345t2283r435b2387],
3	,	,	O	,	_	0	SENT_410	[p24l345t2283r435b2387],
4	Chang	NNP	PERSON	Chang	nn	5	SENT_410	[p24l488t2277r820b2393],
5	CY	NNP	O	CY	appos	2	SENT_410	[p24l863t2283r1021b2387],
6	,	,	O	,	_	0	SENT_410	[p24l863t2283r1021b2387],
7	Jin	NNP	PERSON	Jin	nn	8	SENT_410	[p24l1062t2277r1206b2381],
8	DY	NNP	PERSON	DY	appos	2	SENT_410	[p24l1252t2285r1415b2387],
9	,	,	O	,	_	0	SENT_410	[p24l1252t2285r1415b2387],
10	Lin	NNP	PERSON	Lin	nn	12	SENT_410	[p24l1465t2277r1629b2365],
11	P	NN	O	p	nn	12	SENT_410	[p24l1674t2285r1794b2387],
12	]	NN	O	]	appos	8	SENT_410	[p24l1674t2285r1794b2387],
13	,	,	O	,	_	0	SENT_410	[p24l1674t2285r1794b2387],
14	l	NN	O	l	tmod	8	SENT_410	[p24l1846t2277r2147b2369],
15	(	CD	NUMBER	(	num	16	SENT_410	[p24l1846t2277r2147b2369],
16	hvo	NN	O	hvo	dep	2	SENT_410	[p24l1846t2277r2147b2369],
17	—	CD	NUMBER	—	num	19	SENT_410	[p24l1846t2277r2147b2369],
18	rova	NN	O	rova	nn	19	SENT_410	[p24l12t2455r225b2519],
19	A	NN	O	a	dep	16	SENT_410	[p24l259t2435r363b2537],
20	,	,	O	,	_	0	SENT_410	[p24l259t2435r363b2537],
21	Stafford	NNP	PERSON	Stafford	nn	22	SENT_410	[p24l412t2425r824b2517],
22	DW	NNP	O	DW	appos	2	SENT_410	[p24l863t2433r1068b2517],
23	.	.	O	.	_	0	SENT_410	[p24l863t2433r1068b2517],

1	Identification	NN	O	identification	_	0	SENT_411	[p24l1114t2425r1812b2517],
2	of	IN	O	of	_	0	SENT_411	[p24l1854t2425r1972b2517],
3	the	DT	O	the	det	4	SENT_411	[p24l1991t2427r2149b2517],
4	gene	NN	O	gene	prep_of	1	SENT_411	[p24l12t2607r247b2693],
5	for	IN	O	for	_	0	SENT_411	[p24l283t2575r427b2667],
6	vitamin	NN	O	vitamin	nn	9	SENT_411	[p24l454t2577r849b2669],
7	K	NN	O	k	nn	9	SENT_411	[p24l883t2585r961b2669],
8	epoxide	NN	O	epoxide	nn	9	SENT_411	[p24l993t2577r1384b2693],
9	reductase	NN	O	reductase	prep_for	1	SENT_411	[p24l1419t2577r1930b2669],
10	.	.	O	.	_	0	SENT_411	[p24l1419t2577r1930b2669],

1	Nature	NNP	O	Nature	_	0	SENT_412	[p24l1970t2585r2147b2667, p24l12t2745r214b2819],
2	2004	CD	DATE	2004	num	1	SENT_412	[p24l253t2733r1047b2837],
3	;	:	O	;	_	0	SENT_412	[p24l253t2733r1047b2837],
4	427:541	CD	NUMBER	427:541	number	5	SENT_412	[p24l253t2733r1047b2837],
5	—	CD	NUMBER	—	dep	1	SENT_412	[p24l253t2733r1047b2837],
6	4	CD	NUMBER	4	dep	5	SENT_412	[p24l253t2733r1047b2837],
7	.	.	O	.	_	0	SENT_412	[p24l253t2733r1047b2837],

1	16	CD	NUMBER	16	_	0	SENT_413	[p24l16t2887r148b2967],
2	.	.	O	.	_	0	SENT_413	[p24l16t2887r148b2967],

1	Rost	NNP	PERSON	Rost	nn	2	SENT_414	[p24l209t2883r443b2973],
2	S	NNP	O	S	_	0	SENT_414	[p24l481t2883r562b2987],
3	,	,	O	,	_	0	SENT_414	[p24l481t2883r562b2987],
4	Fregin	NNP	MISC	Fregin	nn	5	SENT_414	[p24l608t2877r935b2993],
5	A	NNP	MISC	A	appos	2	SENT_414	[p24l973t2885r1076b2987],
6	,	,	O	,	_	0	SENT_414	[p24l973t2885r1076b2987],
7	Ivaskevicius	NNP	MISC	Ivaskevicius	nn	8	SENT_414	[p24l1122t2877r1724b2969],
8	V	NNP	O	V	appos	2	SENT_414	[p24l1764t2885r1850b2987],
9	,	,	O	,	_	0	SENT_414	[p24l1764t2885r1850b2987],
10	et	FW	O	et	nn	11	SENT_414	[p24l1900t2895r1992b2967],
11	al.	FW	O	al.	appos	2	SENT_414	[p24l2027t2877r2141b2967],
12	.	.	O	.	_	0	SENT_414	[p24l2027t2877r2141b2967],

1	Mutations	NNS	O	mutation	_	0	SENT_415	[p24l8t3027r526b3119],
2	in	IN	O	in	_	0	SENT_415	[p24l576t3027r674b3115],
3	VKORC1	NN	O	vkorc1	nn	6	SENT_415	[p24l717t3033r1156b3123],
4	cause	NN	O	cause	nn	6	SENT_415	[p24l1204t3057r1480b3119],
5	vvarfarin	NN	O	vvarfarin	nn	6	SENT_415	[p24l1523t3025r1966b3119],
6	resistance	NN	O	resistance	prep_in	1	SENT_415	[p24l2013t3057r2147b3117, p24l14t3177r419b3267],
7	and	CC	O	and	_	0	SENT_415	[p24l475t3177r660b3267],
8	multiple	JJ	O	multiple	amod	11	SENT_415	[p24l717t3177r1139b3293],
9	coagulation	NN	O	coagulation	nn	11	SENT_415	[p24l1196t3177r1798b3293],
10	factor	NN	O	factor	nn	11	SENT_415	[p24l1856t3175r2151b3267],
11	deficiency	NN	O	deficiency	conj_and	6	SENT_415	[p24l14t3325r530b3443],
12	type	NN	O	type	amod	1	SENT_415	[p24l594t3345r807b3443],
13	2	CD	NUMBER	2	number	12	SENT_415	[p24l877t3333r961b3417],
14	.	.	O	.	_	0	SENT_415	[p24l877t3333r961b3417],

1	Nature	NNP	O	Nature	_	0	SENT_416	[p24l1033t3335r1381b3419],
2	2004	CD	DATE	2004	num	1	SENT_416	[p24l1449t3333r2147b3437, p24l10t3483r153b3567],
3	;	:	O	;	_	0	SENT_416	[p24l1449t3333r2147b3437, p24l10t3483r153b3567],
4	427:53741	CD	NUMBER	427:53741	dep	1	SENT_416	[p24l1449t3333r2147b3437, p24l10t3483r153b3567],
5	.	.	O	.	_	0	SENT_416	[p24l1449t3333r2147b3437, p24l10t3483r153b3567],

1	17	CD	NUMBER	17	_	0	SENT_417	[p24l16t3637r138b3717],
2	.	.	O	.	_	0	SENT_417	[p24l16t3637r138b3717],

1	Rieder	NNP	PERSON	Rieder	nn	3	SENT_418	[p24l209t3627r542b3723],
2	M	NNP	O	M	nn	3	SENT_418	[p24l582t3635r744b3737],
3	]	NN	O	]	_	0	SENT_418	[p24l582t3635r744b3737],
4	,	,	O	,	_	0	SENT_418	[p24l582t3635r744b3737],
5	Reiner	NNP	PERSON	Reiner	nn	7	SENT_418	[p24l797t3627r1132b3723],
6	Al	NNP	PERSON	Al	nn	7	SENT_418	[p24l1172t3635r1332b3737],
7	)	NNP	O	)	appos	3	SENT_418	[p24l1172t3635r1332b3737],
8	,	,	O	,	_	0	SENT_418	[p24l1172t3635r1332b3737],
9	Gage	NNP	PERSON	Gage	nn	10	SENT_418	[p24l1385t3633r1643b3743],
10	BF	NNP	O	BF	appos	3	SENT_418	[p24l1690t3635r1838b3737],
11	,	,	O	,	_	0	SENT_418	[p24l1690t3635r1838b3737],
12	et	FW	O	et	nn	13	SENT_418	[p24l1894t3645r1986b3717],
13	al.	FW	O	al.	appos	3	SENT_418	[p24l2027t3627r2141b3717],
14	.	.	O	.	_	0	SENT_418	[p24l2027t3627r2141b3717],

1	Effect	NN	O	effect	_	0	SENT_419	[p25l10t23r311b115],
2	of	IN	O	of	dep	1	SENT_419	[p25l383t23r500b115],
3	VKORC1	NN	O	vkorc1	nn	4	SENT_419	[p25l552t31r991b121],
4	haplotypes	NNS	O	haplotype	pobj	2	SENT_419	[p25l1067t25r1621b141],
5	on	IN	O	on	dep	1	SENT_419	[p25l1700t53r1824b115],
6	transcriptional	JJ	O	transcriptional	pobj	5	SENT_419	[p25l1902t43r2147b115, p25l11t286r274b342],

1	regulation	NN	O	regulation	_	0	SENT_420	[p25l294t286r549b342],
2	and	CC	O	and	_	0	SENT_420	[p25l569t286r659b330],
3	warfarin	NN	O	warfarin	conj_and	1	SENT_420	[p25l677t285r890b330],
4	dose	NN	O	dose	dep	1	SENT_420	[p25l912t286r1036b330],
5	.	.	O	.	_	0	SENT_420	[p25l912t286r1036b330],

1	N	NN	O	n	nn	3	SENT_421	[p25l9t361r51b401],
2	Engl	NNP	O	Engl	nn	3	SENT_421	[p25l68t357r178b413],
3	J	NNP	O	J	nsubj	4	SENT_421	[p25l192t361r213b408],
4	Med	VBD	O	med	_	0	SENT_421	[p25l229t357r335b401],
5	2005	CD	DATE	2005	dobj	4	SENT_421	[p25l354t360r798b410],
6	;	:	O	;	_	0	SENT_421	[p25l354t360r798b410],
7	352:2285	CD	NUMBER	352:2285	number	8	SENT_421	[p25l354t360r798b410],
8	—	CD	NUMBER	—	dep	5	SENT_421	[p25l354t360r798b410],
9	93	CD	NUMBER	93	dep	8	SENT_421	[p25l354t360r798b410],
10	.	.	O	.	_	0	SENT_421	[p25l354t360r798b410],

1	18	CD	NUMBER	18	_	0	SENT_422	[p25l12t432r76b472],
2	.	.	O	.	_	0	SENT_422	[p25l12t432r76b472],

1	Takeuchi	NNP	PERSON	Takeuchi	nn	2	SENT_423	[p25l104t428r328b472],
2	F	NN	O	f	_	0	SENT_423	[p25l345t432r383b481],
3	,	,	O	,	_	0	SENT_423	[p25l345t432r383b481],
4	McGinnis	NNP	PERSON	McGinnis	nn	5	SENT_423	[p25l402t428r643b472],
5	R	NNP	PERSON	R	appos	2	SENT_423	[p25l661t431r710b481],
6	,	,	O	,	_	0	SENT_423	[p25l661t431r710b481],
7	Bourgeois	NNP	PERSON	Bourgeois	nn	8	SENT_423	[p25l731t428r977b484],
8	S	NNP	O	S	appos	2	SENT_423	[p25l997t431r1036b481],
9	,	,	O	,	_	0	SENT_423	[p25l997t431r1036b481],
10	et	FW	O	et	nn	11	SENT_423	[p25l10t508r53b543],
11	al.	FW	O	al.	appos	2	SENT_423	[p25l64t499r118b543],
12	.	.	O	.	_	0	SENT_423	[p25l64t499r118b543],

1	A	DT	O	a	det	4	SENT_424	[p25l134t503r170b542],
2	genome-wide	JJ	O	genome-wide	amod	4	SENT_424	[p25l183t499r502b555],
3	association	NN	O	association	nn	4	SENT_424	[p25l516t499r782b543],
4	study	NN	O	study	nsubj	5	SENT_424	[p25l798t499r924b555],
5	confirms	VBZ	O	confirm	_	0	SENT_424	[p25l937t513r1038b543, p25l10t569r144b614],
6	VKORC1	NN	O	vkorc1	dobj	5	SENT_424	[p25l171t573r395b623],
7	,	,	O	,	_	0	SENT_424	[p25l171t573r395b623],
8	CYP2C9	NN	O	cyp2c9	dobj	5	SENT_424	[p25l426t573r629b623],
9	,	,	O	,	_	0	SENT_424	[p25l426t573r629b623],
10	and	CC	O	and	_	0	SENT_424	[p25l660t570r750b614],
11	CYP4F2	NN	O	cyp4f2	conj_and	6	SENT_424	[p25l778t573r961b614],
12	as	IN	O	as	_	0	SENT_424	[p25l989t584r1037b614],
13	principal	JJ	O	principal	amod	15	SENT_424	[p25l9t641r230b697],
14	genetic	JJ	O	genetic	amod	15	SENT_424	[p25l255t641r431b697],
15	determinants	NNS	O	determinant	prep_as	5	SENT_424	[p25l456t641r785b685],
16	of	IN	O	of	_	0	SENT_424	[p25l812t640r868b685],
17	warfarin	NN	O	warfarin	nn	18	SENT_424	[p25l881t640r1038b685, p25l10t712r79b755],
18	dose	NN	O	dose	prep_of	15	SENT_424	[p25l99t712r223b756],
19	.	.	O	.	_	0	SENT_424	[p25l99t712r223b756],

1	PLoS	NNP	O	PLoS	nn	2	SENT_425	[p25l245t715r362b756],
2	Genet	NNP	O	Genet	_	0	SENT_425	[p25l383t715r529b756],
3	2009	CD	DATE	2009	num	2	SENT_425	[p25l546t715r1035b765],
4	;	:	O	;	_	0	SENT_425	[p25l546t715r1035b765],
5	5	CD	NUMBER	5	number	6	SENT_425	[p25l546t715r1035b765],
6	(	CD	NUMBER	(	dep	2	SENT_425	[p25l546t715r1035b765],
7	3	CD	NUMBER	3	num	8	SENT_425	[p25l546t715r1035b765],
8	)	NN	O	)	dep	6	SENT_425	[p25l546t715r1035b765],
9	:	:	O	:	_	0	SENT_425	[p25l546t715r1035b765],
10	e1000433	NN	O	e1000433	dep	6	SENT_425	[p25l546t715r1035b765],
11	.	.	O	.	_	0	SENT_425	[p25l546t715r1035b765],

1	19	CD	NUMBER	19	_	0	SENT_426	[p25l12t789r74b828],
2	.	.	O	.	_	0	SENT_426	[p25l12t789r74b828],

1	McDonald	NNP	ORGANIZATION	McDonald	nn	2	SENT_427	[p25l104t784r359b828],
2	MG	NN	ORGANIZATION	mg	_	0	SENT_427	[p25l375t787r477b837],
3	,	,	O	,	_	0	SENT_427	[p25l375t787r477b837],
4	Rieder	NNP	PERSON	Rieder	nn	6	SENT_427	[p25l497t784r656b830],
5	M	NNP	O	M	nn	6	SENT_427	[p25l670t788r748b837],
6	]	NN	O	]	appos	2	SENT_427	[p25l670t788r748b837],
7	,	,	O	,	_	0	SENT_427	[p25l670t788r748b837],
8	Nakano	NNP	PERSON	Nakano	nn	9	SENT_427	[p25l767t784r958b828],
9	M	NNP	PERSON	M	appos	2	SENT_427	[p25l975t788r1036b837],
10	,	,	O	,	_	0	SENT_427	[p25l975t788r1036b837],
11	Hsia	NNP	LOCATION	Hsia	nn	12	SENT_427	[p25l10t854r120b898],
12	CK	NNP	LOCATION	CK	appos	2	SENT_427	[p25l143t857r228b907],
13	,	,	O	,	_	0	SENT_427	[p25l143t857r228b907],
14	Rettie	NNP	O	Rettie	nn	15	SENT_427	[p25l255t854r399b901],
15	AE	NNP	O	AE	appos	2	SENT_427	[p25l422t858r505b898],
16	.	.	O	.	_	0	SENT_427	[p25l422t858r505b898],

1	CYP4F2	NN	O	cyp4f2	nsubj	6	SENT_428	[p25l532t857r716b898],
2	is	VBZ	O	be	cop	6	SENT_428	[p25l740t854r778b898],
3	a	DT	O	a	det	6	SENT_428	[p25l803t868r828b898],
4	vitamin	NN	O	vitamin	nn	6	SENT_428	[p25l849t854r1039b898],
5	K1	NN	O	k1	nn	6	SENT_428	[p25l10t928r75b970],
6	oxidase	NN	O	oxidase	_	0	SENT_428	[p25l112t925r309b969],
7	:	:	O	:	_	0	SENT_428	[p25l112t925r309b969],
8	an	DT	O	a	det	9	SENT_428	[p25l348t939r406b969],
9	explanation	NN	O	explanation	dep	6	SENT_428	[p25l443t925r731b981],
10	for	IN	O	for	_	0	SENT_428	[p25l767t924r837b969],
11	altered	JJ	O	altered	amod	13	SENT_428	[p25l872t925r1039b969],
12	warfarin	NN	O	warfarin	nn	13	SENT_428	[p25l8t995r221b1040],
13	dose	NN	O	dose	prep_for	9	SENT_428	[p25l253t996r363b1040],
14	in	IN	O	in	_	0	SENT_428	[p25l394t996r441b1039],
15	carriers	NNS	O	carrier	prep_in	13	SENT_428	[p25l473t996r658b1040],
16	of	IN	O	of	_	0	SENT_428	[p25l691t995r748b1040],
17	the	DT	O	the	det	19	SENT_428	[p25l769t996r845b1040],
18	V433M	NN	O	v433m	nn	19	SENT_428	[p25l874t999r1038b1040],
19	variant	NN	O	variant	prep_of	15	SENT_428	[p25l8t1067r193b1111],
20	.	.	O	.	_	0	SENT_428	[p25l8t1067r193b1111],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_429	[p25l214t1067r308b1111],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_429	[p25l326t1067r589b1111],
3	2009	CD	DATE	2009	num	2	SENT_429	[p25l608t1070r1021b1120],
4	;	:	O	;	_	0	SENT_429	[p25l608t1070r1021b1120],
5	75:1337	CD	NUMBER	75:1337	number	6	SENT_429	[p25l608t1070r1021b1120],
6	—	CD	NUMBER	—	dep	2	SENT_429	[p25l608t1070r1021b1120],
7	46	CD	NUMBER	46	dep	6	SENT_429	[p25l608t1070r1021b1120],
8	.	.	O	.	_	0	SENT_429	[p25l608t1070r1021b1120],

1	20	CD	NUMBER	20	_	0	SENT_430	[p25l9t1142r75b1182],
2	.	.	O	.	_	0	SENT_430	[p25l9t1142r75b1182],

1	Teichert	NNP	PERSON	Teichert	nn	2	SENT_431	[p25l104t1138r300b1182],
2	M	NNP	O	M	_	0	SENT_431	[p25l311t1142r371b1191],
3	,	,	O	,	_	0	SENT_431	[p25l311t1142r371b1191],
4	Eijgelsheim	NNP	O	Eijgelsheim	nn	5	SENT_431	[p25l388t1138r667b1194],
5	M	NNP	O	M	appos	2	SENT_431	[p25l680t1142r740b1191],
6	,	,	O	,	_	0	SENT_431	[p25l680t1142r740b1191],
7	Rivadeneira	NNP	PERSON	Rivadeneira	nn	8	SENT_431	[p25l757t1138r1040b1185],
8	F	NN	O	f	appos	2	SENT_431	[p25l9t1213r47b1262],
9	,	,	O	,	_	0	SENT_431	[p25l9t1213r47b1262],
10	et	FW	O	et	nn	11	SENT_431	[p25l71t1218r115b1253],
11	al.	FW	O	al.	appos	2	SENT_431	[p25l132t1209r188b1253],
12	.	.	O	.	_	0	SENT_431	[p25l132t1209r188b1253],

1	A	DT	O	a	det	4	SENT_432	[p25l209t1213r246b1252],
2	genome-wide	JJ	O	genome-wide	amod	4	SENT_432	[p25l264t1209r593b1265],
3	association	NN	O	association	nn	4	SENT_432	[p25l613t1209r890b1253],
4	study	NN	O	study	_	0	SENT_432	[p25l911t1209r1042b1265],
5	of	IN	O	of	_	0	SENT_432	[p25l10t1279r67b1324],
6	acenocoumarol	NN	O	acenocoumarol	nn	8	SENT_432	[p25l90t1280r467b1324],
7	maintenance	NN	O	maintenance	nn	8	SENT_432	[p25l501t1280r819b1324],
8	dosage	NN	O	dosage	prep_of	4	SENT_432	[p25l853t1280r1036b1336],
9	.	.	O	.	_	0	SENT_432	[p25l853t1280r1036b1336],

1	Hum	NNP	O	Hum	nn	3	SENT_433	[p25l10t1356r131b1396],
2	Mol	NNP	O	Mol	nn	3	SENT_433	[p25l149t1352r243b1396],
3	Genet	NNP	O	Genet	_	0	SENT_433	[p25l262t1355r409b1396],
4	2009	CD	DATE	2009	num	3	SENT_433	[p25l425t1355r844b1405],
5	;	:	O	;	_	0	SENT_433	[p25l425t1355r844b1405],
6	18:3758	CD	NUMBER	18:3758	number	7	SENT_433	[p25l425t1355r844b1405],
7	—	CD	NUMBER	—	dep	3	SENT_433	[p25l425t1355r844b1405],
8	68	CD	NUMBER	68	dep	7	SENT_433	[p25l425t1355r844b1405],
9	.	.	O	.	_	0	SENT_433	[p25l425t1355r844b1405],

1	21	CD	NUMBER	21	_	0	SENT_434	[p25l9t1427r75b1466],
2	.	.	O	.	_	0	SENT_434	[p25l9t1427r75b1466],

1	Manolopoulos	NNP	O	Manolopoulos	nn	2	SENT_435	[p25l104t1422r457b1478],
2	VG	NNP	O	VG	_	0	SENT_435	[p25l477t1425r564b1475],
3	,	,	O	,	_	0	SENT_435	[p25l477t1425r564b1475],
4	Ragia	NNP	O	Ragia	nn	5	SENT_435	[p25l588t1422r728b1478],
5	G	NNP	O	G	appos	2	SENT_435	[p25l748t1425r801b1475],
6	,	,	O	,	_	0	SENT_435	[p25l748t1425r801b1475],
7	Tavridou	NNP	O	Tavridou	nn	9	SENT_435	[p25l823t1422r1039b1466],
8	A.	NNP	O	A.	nn	9	SENT_435	[p25l8t1497r58b1537],
9	Pharmacogenetics	NNP	O	Pharmacogenetics	appos	2	SENT_435	[p25l87t1493r536b1549],
10	of	IN	O	of	_	0	SENT_435	[p25l565t1492r621b1537],
11	coumarinic	JJ	O	coumarinic	amod	13	SENT_435	[p25l638t1493r918b1537],
12	oral	JJ	O	oral	amod	13	SENT_435	[p25l945t1493r1039b1537],
13	anticoagulants	NNS	O	anticoagulant	prep_of	9	SENT_435	[p25l10t1564r381b1620],
14	.	.	O	.	_	0	SENT_435	[p25l10t1564r381b1620],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_436	[p25l409t1564r884b1620],
2	2010	CD	DATE	2010	num	1	SENT_436	[p25l911t1567r1037b1617],
3	;	:	O	;	_	0	SENT_436	[p25l911t1567r1037b1617],
4	11:493	CD	NUMBER	11:493	number	5	SENT_436	[p25l12t1639r236b1680],
5	-6	CD	NUMBER	-6	dep	1	SENT_436	[p25l12t1639r236b1680],
6	.	.	O	.	_	0	SENT_436	[p25l12t1639r236b1680],

1	22	CD	NUMBER	22	_	0	SENT_437	[p25l9t1712r77b1750],
2	.	.	O	.	_	0	SENT_437	[p25l9t1712r77b1750],

1	The	DT	O	the	det	3	SENT_438	[p25l104t1707r195b1750],
2	International	NNP	O	International	nn	3	SENT_438	[p25l226t1707r550b1750],
3	Warfarin	NNP	O	Warfarin	_	0	SENT_438	[p25l579t1706r800b1750],
4	Pharmacogenetics	NNP	O	Pharmacogenetics	nn	5	SENT_438	[p25l831t1707r1038b1750, p25l10t1777r267b1833],
5	Consortium	NNP	O	Consortium	dep	3	SENT_438	[p25l285t1777r593b1821],
6	.	.	O	.	_	0	SENT_438	[p25l285t1777r593b1821],

1	Estimation	NN	O	estimation	_	0	SENT_439	[p25l613t1777r882b1821],
2	of	IN	O	of	_	0	SENT_439	[p25l900t1776r957b1821],
3	the	DT	O	the	det	5	SENT_439	[p25l963t1777r1039b1821],
4	warfarin	NN	O	warfarin	nn	5	SENT_439	[p25l8t1847r221b1892],
5	dose	NN	O	dose	prep_of	1	SENT_439	[p25l245t1848r356b1892],
6	with	IN	O	with	_	0	SENT_439	[p25l378t1848r488b1892],
7	clinical	JJ	O	clinical	amod	10	SENT_439	[p25l513t1848r693b1892],
8	and	CC	O	and	_	0	SENT_439	[p25l716t1848r806b1892],
9	pharmacogenetic	JJ	O	pharmacogenetic	amod	10	SENT_439	[p25l829t1848r1038b1904, p25l10t1919r243b1975],
10	data	NNS	O	datum	prep_with	1	SENT_439	[p25l271t1919r388b1963],
11	.	.	O	.	_	0	SENT_439	[p25l271t1919r388b1963],

1	N	NN	O	n	nn	3	SENT_440	[p25l419t1923r460b1963],
2	Engl	NNP	O	Engl	nn	3	SENT_440	[p25l487t1919r597b1975],
3	J	NNP	O	J	nsubj	4	SENT_440	[p25l619t1923r640b1970],
4	Med	VBD	O	med	_	0	SENT_440	[p25l666t1919r771b1963],
5	2009	CD	DATE	2009	dobj	4	SENT_440	[p25l799t1922r1037b1972],
6	;	:	O	;	_	0	SENT_440	[p25l799t1922r1037b1972],
7	360	CD	NUMBER	360	num	9	SENT_440	[p25l799t1922r1037b1972],
8	:	:	O	:	_	0	SENT_440	[p25l799t1922r1037b1972],
9	753-64	CD	NUMBER	753-64	dep	5	SENT_440	[p25l11t1993r189b2034],
10	.	.	O	.	_	0	SENT_440	[p25l11t1993r189b2034],

1	[	NN	O	[	nn	2	SENT_441	[p25l214t1993r448b2043],
2	Erratum	NN	O	erratum	nsubj	7	SENT_441	[p25l214t1993r448b2043],
3	,	,	O	,	_	0	SENT_441	[p25l214t1993r448b2043],
4	N	NN	O	n	appos	2	SENT_441	[p25l467t1994r508b2034],
5	Engl	NNP	O	Engl	nn	6	SENT_441	[p25l524t1990r666b2046],
6	]	NNP	O	]	dep	4	SENT_441	[p25l524t1990r666b2046],
7	Med	VBD	O	med	_	0	SENT_441	[p25l680t1990r785b2034],
8	2009	CD	DATE	2009	dobj	7	SENT_441	[p25l802t1993r1036b2043],
9	;	:	O	;	_	0	SENT_441	[p25l802t1993r1036b2043],
10	361	CD	NUMBER	361	dep	8	SENT_441	[p25l802t1993r1036b2043],
11	:	:	O	:	_	0	SENT_441	[p25l802t1993r1036b2043],
12	1613	CD	DATE	1613	dep	10	SENT_441	[p25l12t2064r152b2111],
13	.	.	O	.	_	0	SENT_441	[p25l12t2064r152b2111],
14	]	SYM	O	]	dep	8	SENT_441	[p25l12t2064r152b2111],

1	23	CD	NUMBER	23	_	0	SENT_442	[p25l9t2137r75b2176],
2	.	.	O	.	_	0	SENT_442	[p25l9t2137r75b2176],

1	Sagreiya	FW	O	sagreiya	_	0	SENT_443	[p25l107t2132r309b2188],
2	H	NN	O	h	dep	1	SENT_443	[p25l336t2136r390b2185],
3	,	,	O	,	_	0	SENT_443	[p25l336t2136r390b2185],
4	Berube	NN	PERSON	berube	nn	5	SENT_443	[p25l421t2132r592b2176],
5	C	NN	O	c	appos	2	SENT_443	[p25l620t2135r667b2185],
6	,	,	O	,	_	0	SENT_443	[p25l620t2135r667b2185],
7	Wen	NNP	MISC	Wen	nn	8	SENT_443	[p25l696t2136r804b2176],
8	A	NNP	MISC	A	appos	2	SENT_443	[p25l831t2136r880b2185],
9	,	,	O	,	_	0	SENT_443	[p25l831t2136r880b2185],
10	et	FW	O	et	nn	11	SENT_443	[p25l912t2141r955b2176],
11	al.	FW	O	al.	appos	2	SENT_443	[p25l980t2132r1036b2176],
12	.	.	O	.	_	0	SENT_443	[p25l980t2132r1036b2176],

1	Extending	VBG	O	extend	_	0	SENT_444	[p25l9t2203r261b2259],
2	and	CC	O	and	_	0	SENT_444	[p25l279t2203r368b2247],
3	evaluating	VBG	O	evaluate	conj_and	1	SENT_444	[p25l388t2203r643b2259],
4	a	DT	O	a	det	7	SENT_444	[p25l661t2217r685b2247],
5	warfarin	NN	O	warfarin	nn	7	SENT_444	[p25l702t2202r915b2247],
6	dosing	NN	O	dosing	nn	7	SENT_444	[p25l936t2203r1038b2247, p25l10t2274r89b2330],
7	algorithm	NN	O	algorithm	dobj	1	SENT_444	[p25l114t2274r359b2330],
8	that	WDT	O	that	nsubj	9	SENT_444	[p25l386t2274r484b2318],
9	includes	VBZ	O	include	rcmod	7	SENT_444	[p25l508t2274r710b2318],
10	CYP4F2	NN	O	cyp4f2	dobj	9	SENT_444	[p25l738t2277r922b2318],
11	and	CC	O	and	_	0	SENT_444	[p25l950t2274r1039b2318],
12	pooled	VBD	O	pool	rcmod	7	SENT_444	[p25l9t2345r175b2401],
13	rare	JJ	O	rare	amod	14	SENT_444	[p25l198t2359r293b2389],
14	variants	NNS	O	variant	dobj	12	SENT_444	[p25l314t2345r509b2389],
15	of	IN	O	of	_	0	SENT_444	[p25l534t2344r590b2389],
16	CYP2C9	NN	O	cyp2c9	prep_of	14	SENT_444	[p25l602t2348r806b2389],
17	.	.	O	.	_	0	SENT_444	[p25l602t2348r806b2389],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_445	[p25l831t2345r1038b2389, p25l10t2425r201b2472],
2	Genomics	NNP	O	Genomics	_	0	SENT_445	[p25l218t2416r464b2460],
3	2010	CD	DATE	2010	num	2	SENT_445	[p25l485t2419r865b2469],
4	;	:	O	;	_	0	SENT_445	[p25l485t2419r865b2469],
5	20:407	CD	NUMBER	20:407	number	6	SENT_445	[p25l485t2419r865b2469],
6	—	CD	NUMBER	—	dep	2	SENT_445	[p25l485t2419r865b2469],
7	13	CD	NUMBER	13	dep	6	SENT_445	[p25l485t2419r865b2469],
8	.	.	O	.	_	0	SENT_445	[p25l485t2419r865b2469],

1	24	CD	NUMBER	24	_	0	SENT_446	[p25l9t2492r76b2531],
2	.	.	O	.	_	0	SENT_446	[p25l9t2492r76b2531],

1	Zambon	NNP	O	Zambon	nn	2	SENT_447	[p25l105t2487r309b2531],
2	C	NNP	O	C	_	0	SENT_447	[p25l326t2490r418b2540],
3	.	.	O	.	_	0	SENT_447	[p25l326t2490r418b2540],

1	—	NN	O	—	_	0	SENT_448	[p25l326t2490r418b2540],
2	.	.	O	.	_	0	SENT_448	[p25l326t2490r418b2540],

1	F	NN	O	f	_	0	SENT_449	[p25l326t2490r418b2540],
2	,	,	O	,	_	0	SENT_449	[p25l326t2490r418b2540],
3	Pengo	NNP	ORGANIZATION	Pengo	nn	4	SENT_449	[p25l437t2490r585b2543],
4	V	NNP	O	V	appos	1	SENT_449	[p25l600t2491r642b2540],
5	,	,	O	,	_	0	SENT_449	[p25l600t2491r642b2540],
6	Padrini	NNP	PERSON	Padrini	nn	7	SENT_449	[p25l661t2487r839b2531],
7	R	NNP	PERSON	R	appos	1	SENT_449	[p25l854t2490r903b2540],
8	,	,	O	,	_	0	SENT_449	[p25l854t2490r903b2540],
9	et	FW	O	et	nn	10	SENT_449	[p25l923t2496r967b2531],
10	al.	FW	O	al.	appos	1	SENT_449	[p25l980t2487r1036b2531],
11	.	.	O	.	_	0	SENT_449	[p25l980t2487r1036b2531],

1	VKORC1	NN	O	vkorc1	nn	7	SENT_450	[p25l8t2561r233b2611],
2	,	,	O	,	_	0	SENT_450	[p25l8t2561r233b2611],
3	CYP2C9	NN	O	cyp2c9	nn	7	SENT_450	[p25l272t2561r463b2602],
4	and	CC	O	and	_	0	SENT_450	[p25l499t2558r588b2602],
5	CYP4F2	NN	O	cyp4f2	nn	7	SENT_450	[p25l624t2561r808b2602],
6	geneticbased	JJ	O	geneticbased	amod	7	SENT_450	[p25l844t2558r1038b2614, p25l10t2629r149b2673],
7	algorithm	NN	O	algorithm	_	0	SENT_450	[p25l175t2629r419b2685],
8	for	IN	O	for	_	0	SENT_450	[p25l445t2628r515b2673],
9	warfarin	NN	O	warfarin	nn	10	SENT_450	[p25l537t2628r750b2673],
10	dosing	NN	O	dosing	prep_for	7	SENT_450	[p25l776t2629r953b2685],
11	:	:	O	:	_	0	SENT_450	[p25l776t2629r953b2685],
12	an	DT	O	a	det	15	SENT_450	[p25l981t2643r1039b2673],
13	Italian	JJ	MISC	italian	amod	15	SENT_450	[p25l9t2700r170b2744],
14	retrospective	NN	O	retrospective	nn	15	SENT_450	[p25l199t2700r515b2756],
15	study	NN	O	study	dep	7	SENT_450	[p25l545t2700r683b2756],
16	.	.	O	.	_	0	SENT_450	[p25l545t2700r683b2756],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_451	[p25l715t2700r1038b2756, p25l10t2772r187b2816],
2	2010	CD	DATE	2010	num	1	SENT_451	[p25l207t2775r559b2825],
3	;	:	O	;	_	0	SENT_451	[p25l207t2775r559b2825],
4	12:15	CD	TIME	12:15	dep	1	SENT_451	[p25l207t2775r559b2825],
5	—	CD	NUMBER	—	number	6	SENT_451	[p25l207t2775r559b2825],
6	25	CD	NUMBER	25	dep	4	SENT_451	[p25l207t2775r559b2825],
7	.	.	O	.	_	0	SENT_451	[p25l207t2775r559b2825],

1	25	CD	NUMBER	25	_	0	SENT_452	[p25l9t2847r74b2886],
2	.	.	O	.	_	0	SENT_452	[p25l9t2847r74b2886],

1	Epstein	NN	PERSON	epstein	nn	2	SENT_453	[p25l105t2842r284b2898],
2	RS	NN	O	r	_	0	SENT_453	[p25l299t2845r377b2895],
3	,	,	O	,	_	0	SENT_453	[p25l299t2845r377b2895],
4	Moyer	NNP	PERSON	Moyer	nn	5	SENT_453	[p25l394t2846r544b2898],
5	TP	NNP	O	TP	appos	2	SENT_453	[p25l557t2845r629b2895],
6	,	,	O	,	_	0	SENT_453	[p25l557t2845r629b2895],
7	Aubert	NNP	PERSON	Aubert	nn	8	SENT_453	[p25l646t2842r811b2886],
8	RE	NNP	O	RE	appos	2	SENT_453	[p25l824t2845r905b2895],
9	,	,	O	,	_	0	SENT_453	[p25l824t2845r905b2895],
10	et	FW	O	et	nn	11	SENT_453	[p25l925t2851r968b2886],
11	al.	FW	O	al.	appos	2	SENT_453	[p25l981t2842r1036b2886],
12	.	.	O	.	_	0	SENT_453	[p25l981t2842r1036b2886],

1	Warfarin	NNP	O	Warfarin	nsubj	3	SENT_454	[p25l8t2912r234b2957],
2	genotyping	VBG	O	genotype	partmod	1	SENT_454	[p25l271t2913r556b2969],
3	reduces	VBZ	O	reduce	_	0	SENT_454	[p25l592t2913r779b2957],
4	hospitalization	NN	O	hospitalization	nn	5	SENT_454	[p25l818t2913r1038b2969, p25l10t2985r181b3029],
5	rates	NNS	O	rate	dobj	3	SENT_454	[p25l209t2994r339b3029],
6	:	:	O	:	_	0	SENT_454	[p25l209t2994r339b3029],
7	results	NNS	O	result	dobj	3	SENT_454	[p25l369t2985r530b3029],
8	from	IN	O	from	_	0	SENT_454	[p25l559t2984r679b3029],
9	the	DT	O	the	det	10	SENT_454	[p25l707t2985r782b3029],
10	MM-WES	NN	O	mm-we	prep_from	7	SENT_454	[p25l808t2988r1037b3029],
11	(	CD	NUMBER	(	num	12	SENT_454	[p25l13t3055r346b3111],
12	Medco	NNP	ORGANIZATION	Medco	dep	10	SENT_454	[p25l13t3055r346b3111],
13	.	.	O	.	_	0	SENT_454	[p25l13t3055r346b3111],

1	—	NN	O	—	_	0	SENT_455	[p25l13t3055r346b3111],
2	.	.	O	.	_	0	SENT_455	[p25l13t3055r346b3111],

1	Mayo	NNP	O	Mayo	nn	4	SENT_456	[p25l13t3055r346b3111],
2	Warfarin	NNP	O	Warfarin	nn	4	SENT_456	[p25l415t3054r641b3099],
3	Effectiveness	NNP	O	Effectiveness	nn	4	SENT_456	[p25l711t3054r1038b3099],
4	Study	NNP	O	Study	_	0	SENT_456	[p25l11t3126r177b3182],
5	)	NN	O	)	dep	4	SENT_456	[p25l11t3126r177b3182],
6	.	.	O	.	_	0	SENT_456	[p25l11t3126r177b3182],

1	J	NNP	O	J	nn	4	SENT_457	[p25l204t3130r224b3177],
2	Am	NNP	O	Am	nn	4	SENT_457	[p25l249t3130r335b3169],
3	Coll	NNP	O	Coll	nn	4	SENT_457	[p25l362t3126r460b3170],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_457	[p25l487t3126r667b3170],
5	2010	CD	DATE	2010	num	4	SENT_457	[p25l694t3129r1038b3179],
6	;	:	O	;	_	0	SENT_457	[p25l694t3129r1038b3179],
7	55:2804	CD	NUMBER	55:2804	number	8	SENT_457	[p25l694t3129r1038b3179],
8	—	CD	NUMBER	—	dep	4	SENT_457	[p25l694t3129r1038b3179],
9	12	CD	NUMBER	12	dep	8	SENT_457	[p25l12t3200r81b3241],
10	.	.	O	.	_	0	SENT_457	[p25l12t3200r81b3241],

1	26	CD	NUMBER	26	_	0	SENT_458	[p25l9t3273r77b3312],
2	.	.	O	.	_	0	SENT_458	[p25l9t3273r77b3312],

1	Ginsburg	NNP	PERSON	Ginsburg	nn	2	SENT_459	[p25l106t3268r338b3324],
2	GS	NN	O	g	_	0	SENT_459	[p25l360t3271r441b3321],
3	,	,	O	,	_	0	SENT_459	[p25l360t3271r441b3321],
4	Voora	NNP	O	Voora	nn	6	SENT_459	[p25l466t3272r608b3312],
5	D.	NNP	O	D.	nn	6	SENT_459	[p25l630t3271r680b3312],
6	The	NNP	O	The	appos	2	SENT_459	[p25l705t3268r796b3312],
7	long	JJ	O	long	amod	6	SENT_459	[p25l820t3268r928b3324],
8	and	CC	O	and	_	0	SENT_459	[p25l950t3268r1039b3312],
9	winding	VBG	O	wind	amod	6	SENT_459	[p25l8t3339r214b3395],
10	road	NN	O	road	dobj	9	SENT_459	[p25l246t3339r354b3383],
11	to	TO	O	to	_	0	SENT_459	[p25l389t3348r435b3383],
12	warfarin	NN	O	warfarin	nn	14	SENT_459	[p25l467t3338r680b3383],
13	pharmacoge	NN	O	pharmacoge	nn	14	SENT_459	[p25l713t3339r1038b3395],
14	—	NN	O	—	prep_to	9	SENT_459	[p25l713t3339r1038b3395],
15	netic	JJ	O	netic	amod	16	SENT_459	[p25l10t3410r128b3454],
16	testing	NN	O	testing	dep	14	SENT_459	[p25l153t3410r334b3466],
17	.	.	O	.	_	0	SENT_459	[p25l153t3410r334b3466],

1	I	PRP	O	I	nsubj	4	SENT_460	[p25l356t3414r377b3461],
2	Am	VBP	O	be	cop	4	SENT_460	[p25l398t3414r484b3453],
3	Coll	NNP	O	Coll	nn	4	SENT_460	[p25l509t3410r607b3454],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_460	[p25l632t3410r811b3454],
5	2010	CD	DATE	2010	dep	4	SENT_460	[p25l836t3413r1036b3463],
6	;	:	O	;	_	0	SENT_460	[p25l836t3413r1036b3463],
7	55	CD	NUMBER	55	num	9	SENT_460	[p25l836t3413r1036b3463],
8	:	:	O	:	_	0	SENT_460	[p25l836t3413r1036b3463],
9	2813-5	CD	NUMBER	2813-5	dep	4	SENT_460	[p25l10t3484r187b3525],
10	.	.	O	.	_	0	SENT_460	[p25l10t3484r187b3525],

1	27	CD	NUMBER	27	_	0	SENT_461	[p25l9t3557r71b3596],
2	.	.	O	.	_	0	SENT_461	[p25l9t3557r71b3596],

1	Kanagasabapathy	NNP	O	Kanagasabapathy	nn	2	SENT_462	[p25l106t3552r540b3608],
2	P	NN	O	p	_	0	SENT_462	[p25l554t3555r592b3605],
3	,	,	O	,	_	0	SENT_462	[p25l554t3555r592b3605],
4	Chowdary	JJ	PERSON	chowdary	amod	5	SENT_462	[p25l612t3552r862b3608],
5	P	NN	PERSON	p	appos	2	SENT_462	[p25l876t3555r914b3605],
6	,	,	O	,	_	0	SENT_462	[p25l876t3555r914b3605],
7	Gatt	NNP	PERSON	Gatt	nn	9	SENT_462	[p25l934t3555r1042b3596],
8	A.	NNP	PERSON	A.	nn	9	SENT_462	[p25l8t3627r58b3667],
9	Alternatives	NNP	PERSON	Alternatives	appos	2	SENT_462	[p25l91t3623r385b3667],
10	to	TO	O	to	aux	11	SENT_462	[p25l418t3632r464b3667],
11	warfarin	VB	O	warfarin	infmod	9	SENT_462	[p25l495t3622r708b3667],
12	—	CD	NUMBER	—	dobj	11	SENT_462	[p25l738t3648r798b3652],
13	the	DT	O	the	det	15	SENT_462	[p25l829t3623r904b3667],
14	next	JJ	O	next	amod	15	SENT_462	[p25l936t3632r1042b3667],
15	generation	NN	O	generation	tmod	11	SENT_462	[p25l10t3694r272b3750],
16	of	IN	O	of	_	0	SENT_462	[p25l297t3693r353b3738],
17	anticoagulants	NNS	O	anticoagulant	prep_of	15	SENT_462	[p25l366t3694r746b3750],
18	.	.	O	.	_	0	SENT_462	[p25l366t3694r746b3750],

1	Cardiovasc	NNP	O	Cardiovasc	nn	2	SENT_463	[p25l772t3694r1039b3738],
2	Ther	NNP	O	Ther	_	0	SENT_463	[p25l8t3765r122b3809],
3	2010	CD	DATE	2010	num	2	SENT_463	[p25l140t3768r253b3809],
4	July	NNP	DATE	July	tmod	2	SENT_463	[p25l267t3765r362b3821],
5	8	CD	DATE	8	num	4	SENT_463	[p25l379t3768r405b3809],
6	(	CD	NUMBER	(	num	7	SENT_463	[p25l428t3765r568b3821],
7	Epub	NN	O	epub	npadvmod	2	SENT_463	[p25l428t3765r568b3821],
8	ahead	RB	O	ahead	_	0	SENT_463	[p25l588t3765r731b3809],
9	of	IN	O	of	_	0	SENT_463	[p25l750t3764r807b3809],
10	print	NN	O	print	nn	11	SENT_463	[p25l815t3765r965b3821],
11	)	NN	O	)	prep_ahead_of	2	SENT_463	[p25l815t3765r965b3821],
12	.	.	O	.	_	0	SENT_463	[p25l815t3765r965b3821],

1	farction	NN	O	farction	_	0	SENT_464	[p25l1114t285r1303b330],
2	with	IN	O	with	_	0	SENT_464	[p25l1316t286r1425b330],
3	ST-segment	NN	O	st-segment	nn	4	SENT_464	[p25l1441t289r1723b342],
4	elevation	NN	O	elevation	prep_with	1	SENT_464	[p25l1736t286r1962b330],
5	.	.	O	.	_	0	SENT_464	[p25l1736t286r1962b330],

1	N	NN	O	n	nn	3	SENT_465	[p25l1979t290r2021b330],
2	Engl	NNP	O	Engl	nn	3	SENT_465	[p25l2035t286r2143b342],
3	J	NNP	O	J	nsubj	4	SENT_465	[p25l1108t361r1130b408],
4	Med	VBD	O	med	_	0	SENT_465	[p25l1146t357r1252b401],
5	2005	CD	DATE	2005	dobj	4	SENT_465	[p25l1271t360r1712b410],
6	;	:	O	;	_	0	SENT_465	[p25l1271t360r1712b410],
7	352:1179	CD	NUMBER	352:1179	number	8	SENT_465	[p25l1271t360r1712b410],
8	—	CD	NUMBER	—	dep	5	SENT_465	[p25l1271t360r1712b410],
9	89	CD	NUMBER	89	dep	8	SENT_465	[p25l1271t360r1712b410],
10	.	.	O	.	_	0	SENT_465	[p25l1271t360r1712b410],

1	32	CD	NUMBER	32	_	0	SENT_466	[p25l1114t433r1181b472],
2	.	.	O	.	_	0	SENT_466	[p25l1114t433r1181b472],

1	King	NNP	O	King	nn	2	SENT_467	[p25l1210t428r1329b484],
2	SB	NN	O	sb	dep	17	SENT_467	[p25l1346t431r1404b472],
3	III	CD	NUMBER	iii	num	2	SENT_467	[p25l1422t432r1492b481],
4	,	,	O	,	_	0	SENT_467	[p25l1422t432r1492b481],
5	Smith	NNP	ORGANIZATION	Smith	nn	7	SENT_467	[p25l1514t428r1658b472],
6	SC	NNP	ORGANIZATION	SC	nn	7	SENT_467	[p25l1677t431r1737b472],
7	Jr	NNP	ORGANIZATION	Jr	appos	2	SENT_467	[p25l1750t432r1803b481],
8	,	,	O	,	_	0	SENT_467	[p25l1750t432r1803b481],
9	Hirshfeld	NNP	ORGANIZATION	Hirshfeld	nn	11	SENT_467	[p25l1823t427r2056b472],
10	JW	NNP	ORGANIZATION	JW	nn	11	SENT_467	[p25l2068t432r2144b479],
11	Jr	NNP	ORGANIZATION	Jr	appos	2	SENT_467	[p25l1108t503r1161b552],
12	,	,	O	,	_	0	SENT_467	[p25l1108t503r1161b552],
13	et	FW	O	et	nn	14	SENT_467	[p25l1183t508r1227b543],
14	al.	FW	O	al.	appos	2	SENT_467	[p25l1242t499r1298b543],
15	2007	CD	DATE	2007	dep	17	SENT_467	[p25l1319t502r1435b543],
16	Focused	NNP	O	Focused	nn	17	SENT_467	[p25l1453t499r1653b543],
17	Update	NNP	O	Update	dep	31	SENT_467	[p25l1671t499r1845b555],
18	of	IN	O	of	_	0	SENT_467	[p25l1864t498r1920b543],
19	the	DT	O	the	det	24	SENT_467	[p25l1928t499r2004b543],
20	ACCI	NNP	ORGANIZATION	ACCI	nn	24	SENT_467	[p25l2020t502r2142b549],
21	AHA/SCAI	NNP	O	AHA/SCAI	nn	24	SENT_467	[p25l1112t573r1371b620],
22	2005	CD	DATE	2005	num	24	SENT_467	[p25l1387t573r1502b614],
23	Guideline	NNP	O	Guideline	nn	24	SENT_467	[p25l1520t570r1759b614],
24	Update	NNP	O	Update	prep_of	17	SENT_467	[p25l1774t570r1948b626],
25	for	IN	O	for	_	0	SENT_467	[p25l1964t569r2034b614],
26	Percutaneous	NNP	O	Percutaneous	nn	28	SENT_467	[p25l2048t573r2143b614, p25l1115t650r1358b685],
27	Coronary	NNP	O	Coronary	nn	28	SENT_467	[p25l1379t644r1605b697],
28	Intervention	NN	O	intervention	prep_for	17	SENT_467	[p25l1622t641r1931b685],
29	:	:	O	:	_	0	SENT_467	[p25l1622t641r1931b685],
30	a	DT	O	a	det	31	SENT_467	[p25l1953t655r1978b685],
31	report	NN	O	report	_	0	SENT_467	[p25l1997t650r2146b697],
32	of	IN	O	of	_	0	SENT_467	[p25l1115t711r1171b756],
33	the	DT	O	the	det	35	SENT_467	[p25l1193t712r1268b756],
34	American	NNP	ORGANIZATION	American	nn	35	SENT_467	[p25l1297t712r1536b756],
35	College	NNP	ORGANIZATION	College	prep_of	31	SENT_467	[p25l1567t712r1749b768],
36	of	IN	ORGANIZATION	of	_	0	SENT_467	[p25l1781t711r1837b756],
37	Cardiology	NNP	ORGANIZATION	Cardiology	nn	43	SENT_467	[p25l1859t712r2142b768],
38	]	NNP	ORGANIZATION	]	nn	43	SENT_467	[p25l1859t712r2142b768],
39	American	NNP	ORGANIZATION	American	nn	43	SENT_467	[p25l1112t784r1351b828],
40	Heart	NNP	ORGANIZATION	Heart	nn	43	SENT_467	[p25l1383t788r1522b828],
41	Association	NNP	ORGANIZATION	Association	nn	43	SENT_467	[p25l1549t784r1837b828],
42	Task	NNP	ORGANIZATION	Task	nn	43	SENT_467	[p25l1867t784r1983b828],
43	Force	NNP	ORGANIZATION	Force	prep_of	35	SENT_467	[p25l2011t788r2143b828],
44	on	IN	O	on	_	0	SENT_467	[p25l1115t868r1173b898],
45	Practice	NNP	O	Practice	nn	46	SENT_467	[p25l1187t854r1373b898],
46	Guidelines	NNS	O	guideline	prep_on	43	SENT_467	[p25l1387t854r1654b898],
47	:	:	O	:	_	0	SENT_467	[p25l1387t854r1654b898],
48	2007	CD	DATE	2007	prep_of	31	SENT_467	[p25l1671t857r1784b898],
49	Writing	VBG	O	write	partmod	48	SENT_467	[p25l1796t854r1981b910],
50	Group	NNP	O	Group	dobj	49	SENT_467	[p25l1993t857r2142b910],
51	to	TO	O	to	_	0	SENT_467	[p25l1114t934r1160b969],
52	Review	NNP	O	Review	nn	54	SENT_467	[p25l1185t925r1361b971],
53	New	NNP	O	New	nn	54	SENT_467	[p25l1383t929r1494b969],
54	Evidence	NN	O	evidence	prep_to	49	SENT_467	[p25l1516t925r1730b969],
55	and	CC	O	and	_	0	SENT_467	[p25l1755t925r1844b969],
56	Update	NNP	O	Update	prep_of	31	SENT_467	[p25l1869t925r2042b981],
57	the	DT	O	the	det	65	SENT_467	[p25l2067t925r2143b969],
58	ACC/AHA/SCAI	NNP	O	ACC/AHA/SCAI	nn	65	SENT_467	[p25l1112t999r1493b1046],
59	2005	CD	DATE	2005	num	65	SENT_467	[p25l1533t999r1648b1040],
60	Guideline	NNP	O	Guideline	nn	61	SENT_467	[p25l1690t996r1929b1040],
61	Update	NNP	O	Update	dep	65	SENT_467	[p25l1969t996r2143b1052],
62	for	IN	O	for	_	0	SENT_467	[p25l1114t1066r1184b1111],
63	Percutaneous	NNP	O	Percutaneous	nn	64	SENT_467	[p25l1211t1070r1539b1111],
64	Coronary	NNP	O	Coronary	prep_for	61	SENT_467	[p25l1568t1070r1799b1123],
65	Intervention	NN	O	intervention	dep	56	SENT_467	[p25l1824t1067r2140b1120],
66	,	,	O	,	_	0	SENT_467	[p25l1824t1067r2140b1120],
67	writing	VBG	O	write	partmod	35	SENT_467	[p25l1112t1138r1295b1194],
68	on	IN	O	on	_	0	SENT_467	[p25l1328t1152r1388b1182],
69	behalf	NN	O	behalf	_	0	SENT_467	[p25l1423t1137r1587b1182],
70	of	IN	O	of	_	0	SENT_467	[p25l1612t1137r1669b1182],
71	the	DT	O	the	det	72	SENT_467	[p25l1694t1138r1769b1182],
72	2005	CD	DATE	2005	prep_on_behalf_of	67	SENT_467	[p25l1804t1141r1919b1182],
73	Writing	VBG	O	write	xcomp	67	SENT_467	[p25l1954t1138r2145b1194],
74	Committee	NNP	O	Committee	dobj	73	SENT_467	[p25l1114t1209r1401b1253],
75	.	.	O	.	_	0	SENT_467	[p25l1114t1209r1401b1253],

1	Circulation	NN	O	circulation	_	0	SENT_468	[p25l1431t1209r1706b1253],
2	2008	CD	DATE	2008	num	1	SENT_468	[p25l1732t1212r2140b1262],
3	;	:	O	;	_	0	SENT_468	[p25l1732t1212r2140b1262],
4	117:261	CD	NUMBER	117:261	number	5	SENT_468	[p25l1732t1212r2140b1262],
5	—	CD	NUMBER	—	dep	1	SENT_468	[p25l1732t1212r2140b1262],
6	95	CD	NUMBER	95	dep	5	SENT_468	[p25l1732t1212r2140b1262],
7	.	.	O	.	_	0	SENT_468	[p25l1732t1212r2140b1262],

1	[	NN	O	[	nn	2	SENT_469	[p25l1119t1283r1352b1333],
2	Erratum	NN	O	erratum	_	0	SENT_469	[p25l1119t1283r1352b1333],
3	,	,	O	,	_	0	SENT_469	[p25l1119t1283r1352b1333],
4	Circulation	NN	O	circulation	appos	2	SENT_469	[p25l1375t1280r1650b1324],
5	2008	CD	DATE	2008	num	4	SENT_469	[p25l1669t1283r2109b1333],
6	;	:	O	;	_	0	SENT_469	[p25l1669t1283r2109b1333],
7	117	CD	NUMBER	117	dep	2	SENT_469	[p25l1669t1283r2109b1333],
8	(	CD	NUMBER	(	number	9	SENT_469	[p25l1669t1283r2109b1333],
9	6	CD	NUMBER	6	num	10	SENT_469	[p25l1669t1283r2109b1333],
10	)	NN	O	)	rcmod	7	SENT_469	[p25l1669t1283r2109b1333],
11	:	:	O	:	_	0	SENT_469	[p25l1669t1283r2109b1333],
12	e161	NN	O	e161	dep	10	SENT_469	[p25l1669t1283r2109b1333],
13	.	.	O	.	_	0	SENT_469	[p25l1669t1283r2109b1333],
14	]	SYM	O	]	dep	10	SENT_469	[p25l1669t1283r2109b1333],

1	33	CD	NUMBER	33	_	0	SENT_470	[p25l1114t1357r1178b1396],
2	.	.	O	.	_	0	SENT_470	[p25l1114t1357r1178b1396],

1	de	IN	O	de	dep	5	SENT_471	[p25l1211t1352r1265b1396],
2	Morais	NNP	O	Morais	nn	3	SENT_471	[p25l1290t1352r1458b1396],
3	SM	NNP	O	SM	pobj	1	SENT_471	[p25l1487t1355r1574b1405],
4	,	,	O	,	_	0	SENT_471	[p25l1487t1355r1574b1405],
5	Wilkinson	NNP	PERSON	Wilkinson	_	0	SENT_471	[p25l1602t1352r1860b1396],
6	GR	NN	O	gr	dep	5	SENT_471	[p25l1886t1355r1976b1405],
7	,	,	O	,	_	0	SENT_471	[p25l1886t1355r1976b1405],
8	Blaisdell	NNP	PERSON	Blaisdell	nn	9	SENT_471	[p25l2005t1352r2143b1395, p25l1115t1422r1203b1466],
9	J	NNP	PERSON	J	dep	5	SENT_471	[p25l1219t1426r1251b1475],
10	,	,	O	,	_	0	SENT_471	[p25l1219t1426r1251b1475],
11	Nakamura	NNP	PERSON	Nakamura	nn	12	SENT_471	[p25l1274t1422r1533b1466],
12	K	NNP	PERSON	K	appos	9	SENT_471	[p25l1554t1426r1602b1475],
13	,	,	O	,	_	0	SENT_471	[p25l1554t1426r1602b1475],
14	Meyer	NNP	ORGANIZATION	Meyer	nn	15	SENT_471	[p25l1625t1426r1774b1478],
15	UA	NNP	ORGANIZATION	UA	appos	9	SENT_471	[p25l1793t1426r1880b1475],
16	,	,	O	,	_	0	SENT_471	[p25l1793t1426r1880b1475],
17	Goldstein	NNP	PERSON	Goldstein	nn	18	SENT_471	[p25l1904t1422r2143b1466],
18	IA	NNP	O	IA	appos	9	SENT_471	[p25l1108t1497r1178b1544],
19	.	.	O	.	_	0	SENT_471	[p25l1108t1497r1178b1544],

1	The	DT	O	the	det	4	SENT_472	[p25l1206t1493r1297b1537],
2	major	JJ	O	major	amod	4	SENT_472	[p25l1323t1493r1465b1549],
3	genetic	JJ	O	genetic	amod	4	SENT_472	[p25l1490t1493r1666b1549],
4	defect	NN	O	defect	dep	5	SENT_472	[p25l1692t1492r1840b1537],
5	responsible	JJ	O	responsible	_	0	SENT_472	[p25l1864t1493r2143b1549],
6	for	IN	O	for	_	0	SENT_472	[p25l1114t1563r1184b1608],
7	the	DT	O	the	det	8	SENT_472	[p25l1209t1564r1285b1608],
8	polymorphism	NN	O	polymorphism	prep_for	5	SENT_472	[p25l1311t1564r1673b1620],
9	of	IN	O	of	_	0	SENT_472	[p25l1700t1563r1756b1608],
10	S	NN	O	s	nn	13	SENT_472	[p25l1774t1564r2143b1620],
11	—	CD	NUMBER	—	num	13	SENT_472	[p25l1774t1564r2143b1620],
12	mephenytoin	NN	O	mephenytoin	nn	13	SENT_472	[p25l1774t1564r2143b1620],
13	metabolism	NN	O	metabolism	prep_of	8	SENT_472	[p25l1114t1636r1405b1680],
14	in	IN	O	in	_	0	SENT_472	[p25l1420t1636r1467b1679],
15	humans	NNS	O	human	prep_in	13	SENT_472	[p25l1484t1636r1694b1680],
16	.	.	O	.	_	0	SENT_472	[p25l1484t1636r1694b1680],

1	J	NNP	O	J	nn	3	SENT_473	[p25l1707t1640r1729b1686],
2	Biol	NNP	O	Biol	nn	3	SENT_473	[p25l1743t1636r1837b1680],
3	Chem	NNP	O	Chem	_	0	SENT_473	[p25l1853t1636r1994b1680],
4	1994	CD	DATE	1994	num	3	SENT_473	[p25l2012t1639r2141b1689],
5	;	:	O	;	_	0	SENT_473	[p25l2012t1639r2141b1689],
6	269:15419	CD	NUMBER	269:15419	number	7	SENT_473	[p25l1114t1710r1452b1750],
7	-22	CD	NUMBER	-22	dep	3	SENT_473	[p25l1114t1710r1452b1750],
8	.	.	O	.	_	0	SENT_473	[p25l1114t1710r1452b1750],

1	34	CD	NUMBER	34	_	0	SENT_474	[p25l1114t1782r1181b1821],
2	.	.	O	.	_	0	SENT_474	[p25l1114t1782r1181b1821],

1	Shuldiner	NNP	PERSON	Shuldiner	nn	2	SENT_475	[p25l1211t1777r1448b1821],
2	AR	NNS	O	ar	_	0	SENT_475	[p25l1478t1780r1567b1830],
3	,	,	O	,	_	0	SENT_475	[p25l1478t1780r1567b1830],
4	O’Connell	NN	O	o’connell	nn	5	SENT_475	[p25l1604t1777r1852b1821],
5	JR	NN	O	jr	appos	2	SENT_475	[p25l1879t1780r1952b1830],
6	,	,	O	,	_	0	SENT_475	[p25l1879t1780r1952b1830],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_475	[p25l1988t1777r2143b1821],
8	KP	NNP	O	KP	appos	2	SENT_475	[p25l1114t1851r1191b1901],
9	,	,	O	,	_	0	SENT_475	[p25l1114t1851r1191b1901],
10	et	FW	O	et	nn	11	SENT_475	[p25l1214t1857r1257b1892],
11	al.	FW	O	al.	appos	2	SENT_475	[p25l1273t1848r1328b1892],
12	.	.	O	.	_	0	SENT_475	[p25l1273t1848r1328b1892],

1	Association	NNP	O	Association	_	0	SENT_476	[p25l1349t1848r1636b1892],
2	of	IN	O	of	_	0	SENT_476	[p25l1656t1847r1712b1892],
3	cytochrome	NN	O	cytochrome	nn	6	SENT_476	[p25l1721t1848r2010b1904],
4	P450	NN	O	p450	nn	6	SENT_476	[p25l2028t1851r2143b1892],
5	2C19	NN	O	2c19	nn	6	SENT_476	[p25l1114t1922r1235b1963],
6	genotype	NN	O	genotype	prep_of	1	SENT_476	[p25l1253t1928r1477b1975],
7	with	IN	O	with	_	0	SENT_476	[p25l1493t1919r1604b1963],
8	the	DT	O	the	det	10	SENT_476	[p25l1621t1919r1697b1963],
9	antiplatelet	JJ	O	antiplatelet	amod	10	SENT_476	[p25l1714t1919r1993b1975],
10	effect	NN	O	effect	prep_with	1	SENT_476	[p25l2008t1918r2146b1963],
11	and	CC	O	and	_	0	SENT_476	[p25l1114t1990r1204b2034],
12	clinical	JJ	O	clinical	amod	13	SENT_476	[p25l1227t1990r1411b2034],
13	efficacy	NN	O	efficacy	conj_and	10	SENT_476	[p25l1434t1989r1630b2046],
14	of	IN	O	of	_	0	SENT_476	[p25l1650t1989r1708b2034],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_476	[p25l1720t1990r2002b2046],
16	therapy	NN	O	therapy	prep_of	1	SENT_476	[p25l2025t1990r2143b2034, p25l1114t2075r1205b2117],
17	.	.	O	.	_	0	SENT_476	[p25l2025t1990r2143b2034, p25l1114t2075r1205b2117],

1	JAMA	NNP	O	JAMA	_	0	SENT_477	[p25l1222t2065r1368b2112],
2	2009	CD	DATE	2009	num	1	SENT_477	[p25l1385t2064r1798b2114],
3	;	:	O	;	_	0	SENT_477	[p25l1385t2064r1798b2114],
4	302:849	CD	NUMBER	302:849	number	5	SENT_477	[p25l1385t2064r1798b2114],
5	—	CD	NUMBER	—	dep	1	SENT_477	[p25l1385t2064r1798b2114],
6	57	CD	NUMBER	57	dep	5	SENT_477	[p25l1385t2064r1798b2114],
7	.	.	O	.	_	0	SENT_477	[p25l1385t2064r1798b2114],

1	35	CD	NUMBER	35	_	0	SENT_478	[p25l1114t2137r1179b2176],
2	.	.	O	.	_	0	SENT_478	[p25l1114t2137r1179b2176],

1	Mega	JJ	O	mega	amod	2	SENT_479	[p25l1209t2136r1342b2188],
2	JL	NN	O	jl	_	0	SENT_479	[p25l1360t2136r1426b2185],
3	,	,	O	,	_	0	SENT_479	[p25l1360t2136r1426b2185],
4	Close	NNP	O	Close	nn	5	SENT_479	[p25l1454t2132r1586b2176],
5	SL	NNP	O	SL	appos	2	SENT_479	[p25l1612t2135r1681b2185],
6	,	,	O	,	_	0	SENT_479	[p25l1612t2135r1681b2185],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_479	[p25l1707t2132r1890b2176],
8	SD	NN	O	sd	appos	2	SENT_479	[p25l1913t2135r1990b2185],
9	,	,	O	,	_	0	SENT_479	[p25l1913t2135r1990b2185],
10	et	FW	O	et	nn	11	SENT_479	[p25l2019t2141r2063b2176],
11	al.	FW	O	al.	appos	2	SENT_479	[p25l2085t2132r2140b2176],
12	.	.	O	.	_	0	SENT_479	[p25l2085t2132r2140b2176],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_480	[p25l1114t2203r1408b2259],
2	P	NN	O	p	_	0	SENT_480	[p25l1425t2206r1558b2247],
3	—	CD	NUMBER	—	number	4	SENT_480	[p25l1425t2206r1558b2247],
4	450	CD	NUMBER	450	num	5	SENT_480	[p25l1425t2206r1558b2247],
5	polymorphisms	NNS	O	polymorphism	dep	2	SENT_480	[p25l1576t2203r1954b2259],
6	and	CC	O	and	_	0	SENT_480	[p25l1973t2203r2062b2247],
7	response	NN	O	response	conj_and	5	SENT_480	[p25l2079t2217r2143b2247, p25l1115t2288r1282b2330],
8	to	TO	O	to	_	0	SENT_480	[p25l1300t2283r1346b2318],
9	clopidogrel	NN	O	clopidogrel	prep_to	7	SENT_480	[p25l1364t2274r1654b2330],
10	.	.	O	.	_	0	SENT_480	[p25l1364t2274r1654b2330],

1	N	NN	O	n	nn	3	SENT_481	[p25l1673t2278r1714b2318],
2	Engl	NNP	O	Engl	nn	3	SENT_481	[p25l1730t2274r1872b2330],
3	]	NNP	O	]	nsubj	4	SENT_481	[p25l1730t2274r1872b2330],
4	Med	VBD	O	med	_	0	SENT_481	[p25l1886t2274r1992b2318],
5	2009	CD	DATE	2009	dobj	4	SENT_481	[p25l2009t2277r2141b2327],
6	;	:	O	;	_	0	SENT_481	[p25l2009t2277r2141b2327],
7	360:354	CD	NUMBER	360:354	number	8	SENT_481	[p25l1115t2348r1400b2389],
8	—	CD	NUMBER	—	dep	5	SENT_481	[p25l1115t2348r1400b2389],
9	62	CD	NUMBER	62	dep	8	SENT_481	[p25l1115t2348r1400b2389],
10	.	.	O	.	_	0	SENT_481	[p25l1115t2348r1400b2389],

1	36	CD	NUMBER	36	_	0	SENT_482	[p25l1114t2421r1181b2460],
2	.	.	O	.	_	0	SENT_482	[p25l1114t2421r1181b2460],

1	FDA	NNP	ORGANIZATION	FDA	nn	4	SENT_483	[p25l1209t2419r1314b2459],
2	drug	NN	O	drug	nn	4	SENT_483	[p25l1339t2416r1454b2472],
3	safety	NN	O	safety	nn	4	SENT_483	[p25l1479t2415r1623b2472],
4	communication	NN	O	communication	_	0	SENT_483	[p25l1648t2416r2050b2460],
5	:	:	O	:	_	0	SENT_483	[p25l1648t2416r2050b2460],
6	reduced	VBN	O	reduce	amod	7	SENT_483	[p25l2078t2430r2143b2460, p25l1115t2487r1260b2531],
7	effectiveness	NN	O	effectiveness	dep	4	SENT_483	[p25l1297t2486r1617b2531],
8	of	IN	O	of	_	0	SENT_483	[p25l1656t2486r1713b2531],
9	Plavix	NNP	O	Plavix	prep_of	7	SENT_483	[p25l1739t2487r1886b2531],
10	(	CD	NUMBER	(	num	9	SENT_483	[p25l1924t2487r2143b2543, p25l1114t2558r1227b2614],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_483	[p25l1924t2487r2143b2543, p25l1114t2558r1227b2614],
12	)	NN	O	)	dep	7	SENT_483	[p25l1924t2487r2143b2543, p25l1114t2558r1227b2614],
13	in	IN	O	in	_	0	SENT_483	[p25l1247t2558r1295b2601],
14	patients	NNS	O	patient	prep_in	12	SENT_483	[p25l1311t2558r1510b2614],
15	who	WP	O	who	nsubj	18	SENT_483	[p25l1527t2558r1631b2602],
16	are	VBP	O	be	cop	18	SENT_483	[p25l1649t2572r1724b2602],
17	poor	JJ	O	poor	amod	18	SENT_483	[p25l1741t2572r1858b2614],
18	metabolizers	NNS	O	metabolizer	rcmod	14	SENT_483	[p25l1873t2558r2143b2602, p25l1115t2643r1182b2673],
19	of	IN	O	of	_	0	SENT_483	[p25l1198t2628r1254b2673],
20	the	DT	O	the	det	21	SENT_483	[p25l1259t2629r1333b2673],
21	drug	NN	O	drug	prep_of	18	SENT_483	[p25l1349t2629r1473b2685],
22	.	.	O	.	_	0	SENT_483	[p25l1349t2629r1473b2685],

1	(	NN	O	(	nn	4	SENT_484	[p25l1494t2628r2142b2685],
2	http://www.fda.gov/drugs]	NN	O	http://www.fda.gov/drugs]	nn	4	SENT_484	[p25l1494t2628r2142b2685],
3	drugsafety/PostmarketDrugSafety	NN	O	drugsafety/postmarketdrugsafety	nn	4	SENT_484	[p25l1115t2699r1973b2756],
4	InformationforPatientsandProviders	NNS	O	informationforpatientsandprovider	_	0	SENT_484	[p25l1113t2771r2046b2822],
5	/	:	O	/	punct	6	SENT_484	[p25l1113t2771r2046b2822],
6	ucm203888	NN	O	ucm203888	dep	4	SENT_484	[p25l1114t2842r1545b2893],
7	.	.	O	.	_	0	SENT_484	[p25l1114t2842r1545b2893],

1	htm	NN	O	htm	_	0	SENT_485	[p25l1114t2842r1545b2893],
2	.	.	O	.	_	0	SENT_485	[p25l1114t2842r1545b2893],
3	)	SYM	O	)	dep	1	SENT_485	[p25l1114t2842r1545b2893],

1	37	CD	NUMBER	37	_	0	SENT_486	[p25l1114t2918r1174b2957],
2	.	.	O	.	_	0	SENT_486	[p25l1114t2918r1174b2957],

1	Holmes	NNP	PERSON	Holmes	nn	3	SENT_487	[p25l1210t2913r1398b2957],
2	DR	NN	PERSON	dr	nn	3	SENT_487	[p25l1432t2916r1512b2960],
3	Jr	NNP	PERSON	Jr	_	0	SENT_487	[p25l1534t2917r1587b2966],
4	,	,	O	,	_	0	SENT_487	[p25l1534t2917r1587b2966],
5	Dehmer	NNP	O	Dehmer	nn	7	SENT_487	[p25l1622t2913r1820b2957],
6	G	NNP	O	G	nn	7	SENT_487	[p25l1851t2916r1920b2966],
7	]	NNS	O	]	appos	3	SENT_487	[p25l1851t2916r1920b2966],
8	,	,	O	,	_	0	SENT_487	[p25l1851t2916r1920b2966],
9	Kaul	NNP	PERSON	Kaul	nn	10	SENT_487	[p25l1956t2913r2068b2958],
10	S	NNP	O	S	appos	7	SENT_487	[p25l2102t2916r2140b2966],
11	,	,	O	,	_	0	SENT_487	[p25l2102t2916r2140b2966],
12	Leifer	NNP	PERSON	Leifer	nn	13	SENT_487	[p25l1113t2984r1255b3029],
13	D	NNP	O	D	appos	7	SENT_487	[p25l1269t2988r1320b3038],
14	,	,	O	,	_	0	SENT_487	[p25l1269t2988r1320b3038],
15	O’Gara	NNP	O	O’Gara	nn	16	SENT_487	[p25l1339t2988r1513b3029],
16	PT	NN	O	pt	appos	7	SENT_487	[p25l1528t2988r1602b3038],
17	,	,	O	,	_	0	SENT_487	[p25l1528t2988r1602b3038],
18	Stein	NNP	PERSON	Stein	nn	19	SENT_487	[p25l1623t2985r1743b3029],
19	CM	NN	O	cm	appos	7	SENT_487	[p25l1760t2988r1856b3029],
20	.	.	O	.	_	0	SENT_487	[p25l1760t2988r1856b3029],

1	ACCFIAHA	NNP	O	ACCFIAHA	nn	4	SENT_488	[p25l1873t2988r2144b3035],
2	clopidogrel	NN	O	clopidogrel	nn	4	SENT_488	[p25l1115t3055r1390b3111],
3	clinical	JJ	O	clinical	amod	4	SENT_488	[p25l1422t3055r1601b3099],
4	alert	NN	O	alert	_	0	SENT_488	[p25l1631t3055r1756b3099],
5	:	:	O	:	_	0	SENT_488	[p25l1631t3055r1756b3099],
6	approaches	NNS	O	approach	dep	4	SENT_488	[p25l1788t3055r2064b3111],
7	to	TO	O	to	_	0	SENT_488	[p25l2096t3064r2142b3099],
8	the	DT	O	the	det	9	SENT_488	[p25l1115t3126r1190b3170],
9	FDA	NNP	ORGANIZATION	FDA	prep_to	6	SENT_488	[p25l1209t3129r1314b3169],
10	“	CD	NUMBER	“	num	9	SENT_488	[p25l1335t3126r1503b3170],
11	boxed	VBN	O	box	partmod	9	SENT_488	[p25l1335t3126r1503b3170],
12	warning	VBG	O	warn	xcomp	11	SENT_488	[p25l1521t3126r1764b3182],
13	”	CD	NUMBER	”	dobj	12	SENT_488	[p25l1521t3126r1764b3182],
14	:	:	O	:	_	0	SENT_488	[p25l1521t3126r1764b3182],
15	a	DT	O	a	det	16	SENT_488	[p25l1786t3140r1811b3170],
16	report	NN	O	report	conj_and	6	SENT_488	[p25l1831t3135r1983b3182],
17	of	IN	O	of	_	0	SENT_488	[p25l2001t3125r2057b3170],
18	the	DT	O	the	det	20	SENT_488	[p25l2068t3126r2143b3170],
19	American	NNP	ORGANIZATION	American	nn	20	SENT_488	[p25l1112t3197r1351b3241],
20	College	NNP	ORGANIZATION	College	prep_of	16	SENT_488	[p25l1375t3197r1557b3253],
21	of	IN	ORGANIZATION	of	_	0	SENT_488	[p25l1581t3196r1638b3241],
22	Cardiology	NNP	ORGANIZATION	Cardiology	nn	25	SENT_488	[p25l1651t3197r1922b3253],
23	Foundation	NNP	ORGANIZATION	Foundation	nn	25	SENT_488	[p25l1943t3197r2143b3241, p25l1114t3268r1211b3312],
24	Task	NNP	ORGANIZATION	Task	nn	25	SENT_488	[p25l1227t3268r1343b3312],
25	Force	NNP	ORGANIZATION	Force	prep_of	20	SENT_488	[p25l1358t3272r1490b3312],
26	on	IN	O	on	_	0	SENT_488	[p25l1508t3282r1568b3312],
27	clinical	JJ	O	clinical	amod	30	SENT_488	[p25l1586t3268r1766b3312],
28	expert	NN	O	expert	nn	30	SENT_488	[p25l1784t3277r1938b3324],
29	consensus	NN	O	consensus	nn	30	SENT_488	[p25l1953t3282r2143b3312, p25l1115t3353r1191b3383],
30	documents	NNS	O	document	prep_on	25	SENT_488	[p25l1221t3339r1490b3383],
31	and	CC	O	and	_	0	SENT_488	[p25l1519t3339r1609b3383],
32	the	DT	O	the	det	35	SENT_488	[p25l1637t3339r1712b3383],
33	American	JJ	O	american	amod	35	SENT_488	[p25l1739t3339r1978b3383],
34	Heart	NNP	ORGANIZATION	Heart	nn	35	SENT_488	[p25l2006t3343r2146b3383],
35	Association	NNP	ORGANIZATION	Association	conj_and	6	SENT_488	[p25l1112t3410r1400b3454],
36	endorsed	VBN	O	endorse	partmod	35	SENT_488	[p25l1431t3410r1653b3454],
37	by	IN	O	by	_	0	SENT_488	[p25l1684t3410r1739b3466],
38	the	DT	O	the	det	39	SENT_488	[p25l1767t3410r1842b3454],
39	Society	NNP	ORGANIZATION	Society	agent	36	SENT_488	[p25l1873t3410r2047b3466],
40	for	IN	ORGANIZATION	for	_	0	SENT_488	[p25l2075t3409r2145b3454],
41	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	42	SENT_488	[p25l1114t3481r1475b3525],
42	Angiography	NNP	ORGANIZATION	Angiography	prep_for	39	SENT_488	[p25l1490t3481r1804b3537],
43	and	CC	O	and	_	0	SENT_488	[p25l1820t3481r1908b3525],
44	Interventions	NNPS	O	Interventions	prep_for	39	SENT_488	[p25l1926t3485r2143b3525, p25l1114t3552r1235b3596],
45	and	CC	O	and	_	0	SENT_488	[p25l1271t3552r1361b3596],
46	the	DT	O	the	det	47	SENT_488	[p25l1397t3552r1472b3596],
47	Society	NNP	O	Society	conj_and	39	SENT_488	[p25l1509t3552r1683b3608],
48	of	IN	O	of	_	0	SENT_488	[p25l1716t3551r1773b3596],
49	Thoracic	NNP	O	Thoracic	nn	50	SENT_488	[p25l1797t3552r2009b3596],
50	Surgeons	NNPS	O	Surgeons	prep_of	47	SENT_488	[p25l2045t3555r2143b3596, p25l1114t3637r1271b3679],
51	.	.	O	.	_	0	SENT_488	[p25l2045t3555r2143b3596, p25l1114t3637r1271b3679],

1	J	NNP	O	J	nn	4	SENT_489	[p25l1288t3627r1309b3674],
2	Am	NNP	O	Am	nn	4	SENT_489	[p25l1325t3627r1411b3666],
3	Coll	NNP	O	Coll	nn	4	SENT_489	[p25l1430t3623r1528b3667],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_489	[p25l1547t3623r1727b3667],
5	2010	CD	DATE	2010	num	4	SENT_489	[p25l1746t3626r2127b3676],
6	;	:	O	;	_	0	SENT_489	[p25l1746t3626r2127b3676],
7	56:321	CD	NUMBER	56:321	number	8	SENT_489	[p25l1746t3626r2127b3676],
8	—	CD	NUMBER	—	dep	4	SENT_489	[p25l1746t3626r2127b3676],
9	41	CD	NUMBER	41	dep	8	SENT_489	[p25l1746t3626r2127b3676],
10	.	.	O	.	_	0	SENT_489	[p25l1746t3626r2127b3676],

1	38	CD	NUMBER	38	_	0	SENT_490	[p25l1114t3698r1180b3738],
2	.	.	O	.	_	0	SENT_490	[p25l1114t3698r1180b3738],

1	Wallentin	NNP	PERSON	Wallentin	nn	2	SENT_491	[p25l1208t3694r1448b3738],
2	L	NNP	PERSON	L	_	0	SENT_491	[p25l1467t3698r1510b3747],
3	,	,	O	,	_	0	SENT_491	[p25l1467t3698r1510b3747],
4	James	NNP	PERSON	James	nn	5	SENT_491	[p25l1526t3698r1674b3745],
5	S	NNP	PERSON	S	appos	2	SENT_491	[p25l1696t3697r1734b3747],
6	,	,	O	,	_	0	SENT_491	[p25l1696t3697r1734b3747],
7	Storey	NNP	PERSON	Storey	nn	8	SENT_491	[p25l1758t3697r1909b3750],
8	RF	NNP	O	RF	appos	2	SENT_491	[p25l1925t3697r2002b3747],
9	,	,	O	,	_	0	SENT_491	[p25l1925t3697r2002b3747],
10	et	FW	O	et	nn	11	SENT_491	[p25l2025t3703r2069b3738],
11	al.	FW	O	al.	appos	2	SENT_491	[p25l2085t3694r2140b3738],
12	.	.	O	.	_	0	SENT_491	[p25l2085t3694r2140b3738],

1	Effect	NN	O	effect	_	0	SENT_492	[p25l1113t3764r1258b3809],
2	of	IN	O	of	_	0	SENT_492	[p25l1279t3764r1336b3809],
3	CYP2C19	NN	O	cyp2c19	nn	7	SENT_492	[p25l1349t3768r1569b3809],
4	and	CC	O	and	_	0	SENT_492	[p25l1592t3765r1682b3809],
5	ABCB1	NN	O	abcb1	nn	7	SENT_492	[p25l1703t3768r1872b3809],
6	single	JJ	O	single	amod	7	SENT_492	[p25l1897t3765r2041b3821],
7	nu28	NN	O	nu28	prep_of	1	SENT_492	[p25l2064t3779r2143b3809, p26l9t19r77b59],
8	.	.	O	.	_	0	SENT_492	[p25l2064t3779r2143b3809, p26l9t19r77b59],

1	Hollopeter	NNP	PERSON	Hollopeter	nn	2	SENT_493	[p26l106t15r368b71],
2	G	NNP	PERSON	G	_	0	SENT_493	[p26l385t18r437b68],
3	,	,	O	,	_	0	SENT_493	[p26l385t18r437b68],
4	Jantzen	NNP	PERSON	Jantzen	nn	5	SENT_493	[p26l453t19r640b66],
5	HM	NNS	O	hm	appos	2	SENT_493	[p26l658t19r763b68],
6	,	,	O	,	_	0	SENT_493	[p26l658t19r763b68],
7	Vincent	NNP	PERSON	Vincent	nn	8	SENT_493	[p26l782t15r971b59],
8	D	NNP	PERSON	D	appos	2	SENT_493	[p26l985t18r1036b68],
9	,	,	O	,	_	0	SENT_493	[p26l985t18r1036b68],
10	et	FW	O	et	nn	11	SENT_493	[p26l10t95r54b130],
11	al.	FW	O	al.	appos	2	SENT_493	[p26l82t86r138b130],
12	.	.	O	.	_	0	SENT_493	[p26l82t86r138b130],

1	Identification	NN	O	identification	nsubj	7	SENT_494	[p26l171t85r508b130],
2	of	IN	O	of	_	0	SENT_494	[p26l539t85r596b130],
3	the	DT	O	the	det	6	SENT_494	[p26l617t86r692b130],
4	platelet	NN	O	platelet	nn	6	SENT_494	[p26l723t86r905b142],
5	ADP	NN	O	adp	nn	6	SENT_494	[p26l932t89r1040b129],
6	receptor	NN	O	receptor	prep_of	1	SENT_494	[p26l10t166r209b213],
7	targeted	VBN	O	target	_	0	SENT_494	[p26l223t157r421b213],
8	by	IN	O	by	_	0	SENT_494	[p26l437t157r491b213],
9	antithrombotic	JJ	O	antithrombotic	amod	10	SENT_494	[p26l503t157r871b201],
10	drugs	NNS	O	drug	prep_by	7	SENT_494	[p26l886t157r1036b213],
11	.	.	O	.	_	0	SENT_494	[p26l886t157r1036b213],

1	Nature	NNP	O	Nature	_	0	SENT_495	[p26l9t232r176b272],
2	2001	CD	DATE	2001	num	1	SENT_495	[p26l196t231r574b281],
3	;	:	O	;	_	0	SENT_495	[p26l196t231r574b281],
4	409:202	CD	NUMBER	409:202	number	5	SENT_495	[p26l196t231r574b281],
5	-7	CD	NUMBER	-7	dep	1	SENT_495	[p26l196t231r574b281],
6	.	.	O	.	_	0	SENT_495	[p26l196t231r574b281],

1	29	CD	NUMBER	29	_	0	SENT_496	[p26l9t304r75b343],
2	.	.	O	.	_	0	SENT_496	[p26l9t304r75b343],

1	Savi	NNP	PERSON	Savi	nn	2	SENT_497	[p26l107t299r202b343],
2	P	NN	O	p	_	0	SENT_497	[p26l218t302r255b352],
3	,	,	O	,	_	0	SENT_497	[p26l218t302r255b352],
4	Pereillo	NNP	O	Pereillo	nn	5	SENT_497	[p26l275t299r459b343],
5	JM	NN	O	jm	appos	2	SENT_497	[p26l471t303r553b352],
6	,	,	O	,	_	0	SENT_497	[p26l471t303r553b352],
7	Uzabiaga	NNP	O	Uzabiaga	nn	8	SENT_497	[p26l572t299r799b355],
8	MF	NN	O	mf	appos	2	SENT_497	[p26l813t303r902b352],
9	,	,	O	,	_	0	SENT_497	[p26l813t303r902b352],
10	et	FW	O	et	nn	11	SENT_497	[p26l923t308r966b343],
11	al.	FW	O	al.	appos	2	SENT_497	[p26l980t299r1036b343],
12	.	.	O	.	_	0	SENT_497	[p26l980t299r1036b343],

1	Identification	NN	O	identification	nn	4	SENT_498	[p26l9t370r339b415],
2	and	CC	O	and	_	0	SENT_498	[p26l355t371r444b415],
3	biological	JJ	O	biological	nn	4	SENT_498	[p26l461t371r697b427],
4	activity	NN	O	activity	_	0	SENT_498	[p26l714t371r887b427],
5	of	IN	O	of	_	0	SENT_498	[p26l902t370r958b415],
6	the	DT	O	the	det	8	SENT_498	[p26l965t371r1039b415],
7	active	JJ	O	active	amod	8	SENT_498	[p26l10t442r147b486],
8	metabolite	NN	O	metabolite	prep_of	4	SENT_498	[p26l171t442r432b486],
9	of	IN	O	of	_	0	SENT_498	[p26l456t441r512b486],
10	clopidogrel	NN	O	clopidogrel	prep_of	4	SENT_498	[p26l526t442r815b498],
11	.	.	O	.	_	0	SENT_498	[p26l526t442r815b498],

1	Thromb	NNP	O	Thromb	nn	2	SENT_499	[p26l840t442r1038b486],
2	Haemost	NNP	O	Haemost	_	0	SENT_499	[p26l10t517r230b557],
3	2000	CD	DATE	2000	num	2	SENT_499	[p26l247t516r608b566],
4	;	:	O	;	_	0	SENT_499	[p26l247t516r608b566],
5	84:891	CD	NUMBER	84:891	number	6	SENT_499	[p26l247t516r608b566],
6	—	CD	NUMBER	—	dep	2	SENT_499	[p26l247t516r608b566],
7	6	CD	NUMBER	6	dep	6	SENT_499	[p26l247t516r608b566],
8	.	.	O	.	_	0	SENT_499	[p26l247t516r608b566],

1	30	CD	NUMBER	30	_	0	SENT_500	[p26l10t589r76b629],
2	.	.	O	.	_	0	SENT_500	[p26l10t589r76b629],

1	Yusuf	NNP	PERSON	Yusuf	nn	2	SENT_501	[p26l104t584r250b629],
2	S	NNP	PERSON	S	_	0	SENT_501	[p26l266t588r304b638],
3	,	,	O	,	_	0	SENT_501	[p26l266t588r304b638],
4	Zhao	NNP	PERSON	Zhao	nn	5	SENT_501	[p26l331t585r452b629],
5	F	NN	PERSON	f	appos	2	SENT_501	[p26l477t589r515b638],
6	,	,	O	,	_	0	SENT_501	[p26l477t589r515b638],
7	Mehta	NNP	ORGANIZATION	Mehta	nn	8	SENT_501	[p26l541t585r695b629],
8	SR	NN	ORGANIZATION	sr	appos	2	SENT_501	[p26l720t588r796b638],
9	,	,	O	,	_	0	SENT_501	[p26l720t588r796b638],
10	et	FW	O	et	nn	11	SENT_501	[p26l824t594r868b629],
11	al.	FW	O	al.	appos	2	SENT_501	[p26l890t585r945b629],
12	.	.	O	.	_	0	SENT_501	[p26l890t585r945b629],

1	Effects	NNS	O	effect	_	0	SENT_502	[p26l972t584r1038b628, p26l10t654r123b699],
2	of	IN	O	of	_	0	SENT_502	[p26l145t654r202b699],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_502	[p26l213t655r488b711],
4	in	IN	O	in	_	0	SENT_502	[p26l509t655r556b698],
5	addition	NN	O	addition	_	0	SENT_502	[p26l576t655r780b699],
6	to	TO	O	to	_	0	SENT_502	[p26l801t664r847b699],
7	aspirin	NN	O	aspirin	prep_in_addition_to	1	SENT_502	[p26l868t655r1039b711],
8	in	IN	O	in	_	0	SENT_502	[p26l10t726r56b769],
9	patients	NNS	O	patient	prep_in	1	SENT_502	[p26l73t726r264b782],
10	with	IN	O	with	_	0	SENT_502	[p26l280t726r388b770],
11	acute	JJ	O	acute	amod	13	SENT_502	[p26l405t735r530b770],
12	coronary	JJ	O	coronary	amod	13	SENT_502	[p26l547t740r762b782],
13	syndromes	NNS	O	syndrome	prep_with	9	SENT_502	[p26l778t726r1038b782],
14	without	IN	O	without	_	0	SENT_502	[p26l8t797r201b841],
15	ST-segment	NN	O	st-segment	nn	16	SENT_502	[p26l231t800r517b853],
16	elevation	NN	O	elevation	prep_without	13	SENT_502	[p26l547t797r778b841],
17	.	.	O	.	_	0	SENT_502	[p26l547t797r778b841],

1	N	NN	O	n	nn	3	SENT_503	[p26l812t801r853b841],
2	Engl	NNP	O	Engl	nn	3	SENT_503	[p26l883t797r993b853],
3	J	NNP	O	J	nsubj	4	SENT_503	[p26l1019t801r1040b848],
4	Med	VBD	O	med	_	0	SENT_503	[p26l8t868r114b912],
5	2001	CD	DATE	2001	dobj	4	SENT_503	[p26l139t871r584b921],
6	;	:	O	;	_	0	SENT_503	[p26l139t871r584b921],
7	345:494	CD	NUMBER	345:494	num	8	SENT_503	[p26l139t871r584b921],
8	-502	CD	NUMBER	-502	dep	5	SENT_503	[p26l139t871r584b921],
9	.	.	O	.	_	0	SENT_503	[p26l139t871r584b921],

1	[	NN	O	[	nn	6	SENT_504	[p26l618t871r797b921],
2	Errata	NNP	O	Errata	nn	6	SENT_504	[p26l618t871r797b921],
3	,	,	O	,	_	0	SENT_504	[p26l618t871r797b921],
4	N	NNP	O	N	appos	6	SENT_504	[p26l824t872r866b912],
5	Engl	NNP	O	Engl	nn	6	SENT_504	[p26l889t868r1040b924],
6	]	NNP	O	]	nsubj	7	SENT_504	[p26l889t868r1040b924],
7	Med	VBD	O	med	_	0	SENT_504	[p26l8t939r114b983],
8	2001	CD	DATE	2001	dobj	7	SENT_504	[p26l133t942r502b992],
9	;	:	O	;	_	0	SENT_504	[p26l133t942r502b992],
10	345:1506	CD	NUMBER	345:1506	dep	8	SENT_504	[p26l133t942r502b992],
11	,	,	O	,	_	0	SENT_504	[p26l133t942r502b992],
12	1716	CD	DATE	1716	dep	10	SENT_504	[p26l526t942r666b989],
13	.	.	O	.	_	0	SENT_504	[p26l526t942r666b989],
14	]	SYM	O	]	dep	8	SENT_504	[p26l526t942r666b989],

1	31	CD	NUMBER	31	_	0	SENT_505	[p26l10t1015r74b1054],
2	.	.	O	.	_	0	SENT_505	[p26l10t1015r74b1054],

1	Sabatine	NNP	PERSON	Sabatine	nn	2	SENT_506	[p26l107t1010r315b1054],
2	MS	NN	O	m	_	0	SENT_506	[p26l331t1013r421b1063],
3	,	,	O	,	_	0	SENT_506	[p26l331t1013r421b1063],
4	Cannon	NNP	ORGANIZATION	Cannon	nn	5	SENT_506	[p26l442t1013r634b1054],
5	CP	NNP	ORGANIZATION	CP	appos	2	SENT_506	[p26l652t1013r725b1063],
6	,	,	O	,	_	0	SENT_506	[p26l652t1013r725b1063],
7	Gibson	NNP	PERSON	Gibson	nn	8	SENT_506	[p26l746t1010r921b1054],
8	CM	NN	O	cm	appos	2	SENT_506	[p26l939t1013r1036b1063],
9	,	,	O	,	_	0	SENT_506	[p26l939t1013r1036b1063],
10	et	FW	O	et	nn	11	SENT_506	[p26l10t1090r54b1125],
11	al.	FW	O	al.	appos	2	SENT_506	[p26l81t1081r136b1125],
12	.	.	O	.	_	0	SENT_506	[p26l81t1081r136b1125],

1	Addition	NN	O	addition	_	0	SENT_507	[p26l166t1081r381b1125],
2	of	IN	O	of	_	0	SENT_507	[p26l411t1080r468b1125],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_507	[p26l487t1081r763b1137],
4	to	TO	O	to	dep	1	SENT_507	[p26l792t1090r839b1125],
5	aspirin	NN	O	aspirin	pobj	4	SENT_507	[p26l868t1081r1039b1137],
6	and	CC	O	and	_	0	SENT_507	[p26l10t1152r98b1196],
7	fibrinolytic	JJ	O	fibrinolytic	amod	8	SENT_507	[p26l117t1151r386b1208],
8	therapy	NN	O	therapy	conj_and	5	SENT_507	[p26l405t1152r585b1208],
9	for	IN	O	for	dep	1	SENT_507	[p26l601t1151r670b1196],
10	myocardial	JJ	O	myocardial	amod	11	SENT_507	[p26l688t1152r956b1208],
11	incleotide	NN	O	incleotide	pobj	9	SENT_507	[p26l974t1152r1038b1195, p26l1115t15r1304b59],

1	polymorphisms	NNS	O	polymorphism	_	0	SENT_508	[p26l1331t15r1717b71],
2	on	IN	O	on	_	0	SENT_508	[p26l1746t29r1806b59],
3	outcomes	NNS	O	outcome	prep_on	1	SENT_508	[p26l1834t24r2068b59],
4	of	IN	O	of	_	0	SENT_508	[p26l2097t14r2153b59],
5	treatment	NN	O	treatment	prep_of	3	SENT_508	[p26l1115t95r1356b130],
6	with	IN	O	with	_	0	SENT_508	[p26l1375t86r1485b130],
7	ticagrelor	NN	O	ticagrelor	prep_with	5	SENT_508	[p26l1509t86r1747b142],
8	versus	CC	O	versus	prep	7	SENT_508	[p26l1767t100r1919b130],
9	clopidogrel	NN	O	clopidogrel	dep	8	SENT_508	[p26l1944t86r2143b142, p26l1114t157r1208b213],
10	for	IN	O	for	_	0	SENT_508	[p26l1232t156r1302b201],
11	acute	JJ	O	acute	amod	13	SENT_508	[p26l1323t166r1450b201],
12	coronary	JJ	O	coronary	amod	13	SENT_508	[p26l1475t171r1694b213],
13	syndromes	NNS	O	syndrome	prep_for	9	SENT_508	[p26l1716t157r1995b213],
14	:	:	O	:	_	0	SENT_508	[p26l1716t157r1995b213],
15	a	DT	O	a	det	17	SENT_508	[p26l2021t171r2046b201],
16	genetic	JJ	O	genetic	amod	17	SENT_508	[p26l2068t171r2143b213, p26l1114t228r1233b272],
17	substudy	NN	O	substudy	dep	1	SENT_508	[p26l1254t228r1472b284],
18	of	IN	O	of	_	0	SENT_508	[p26l1491t227r1547b272],
19	the	DT	O	the	det	21	SENT_508	[p26l1558t228r1634b272],
20	PLATO	NNP	O	PLATO	nn	21	SENT_508	[p26l1654t231r1823b272],
21	trial	NN	O	trial	prep_of	17	SENT_508	[p26l1844t228r1959b272],
22	.	.	O	.	_	0	SENT_508	[p26l1844t228r1959b272],

1	Lancet	NNP	O	Lancet	_	0	SENT_509	[p26l1982t232r2146b272],
2	2010	CD	DATE	2010	num	1	SENT_509	[p26l1114t302r1528b352],
3	;	:	O	;	_	0	SENT_509	[p26l1114t302r1528b352],
4	376:1320	CD	NUMBER	376:1320	number	5	SENT_509	[p26l1114t302r1528b352],
5	-8	CD	NUMBER	-8	dep	1	SENT_509	[p26l1114t302r1528b352],
6	.	.	O	.	_	0	SENT_509	[p26l1114t302r1528b352],

1	39	CD	NUMBER	39	_	0	SENT_510	[p26l1114t376r1178b415],
2	.	.	O	.	_	0	SENT_510	[p26l1114t376r1178b415],

1	Paré	NN	O	paré	nn	2	SENT_511	[p26l1209t369r1314b415],
2	G	NN	O	g	_	0	SENT_511	[p26l1339t374r1392b424],
3	,	,	O	,	_	0	SENT_511	[p26l1339t374r1392b424],
4	Mehta	NNP	ORGANIZATION	Mehta	nn	5	SENT_511	[p26l1418t371r1572b415],
5	SR	NN	ORGANIZATION	sr	appos	2	SENT_511	[p26l1598t374r1673b424],
6	,	,	O	,	_	0	SENT_511	[p26l1598t374r1673b424],
7	Yusuf	NNP	PERSON	Yusuf	nn	8	SENT_511	[p26l1699t370r1845b415],
8	S	NNP	PERSON	S	appos	2	SENT_511	[p26l1861t374r1900b424],
9	,	,	O	,	_	0	SENT_511	[p26l1861t374r1900b424],
10	et	FW	O	et	nn	11	SENT_511	[p26l1928t380r1972b415],
11	al.	FW	O	al.	appos	2	SENT_511	[p26l1994t371r2049b415],
12	.	.	O	.	_	0	SENT_511	[p26l1994t371r2049b415],

1	Effects	NNS	O	effect	_	0	SENT_512	[p26l2076t370r2143b414, p26l1114t441r1227b486],
2	of	IN	O	of	_	0	SENT_512	[p26l1254t441r1311b486],
3	CYP2C19	NN	O	cyp2c19	nn	4	SENT_512	[p26l1326t445r1546b486],
4	genotype	NN	O	genotype	prep_of	1	SENT_512	[p26l1572t451r1796b498],
5	on	IN	O	on	_	0	SENT_512	[p26l1822t456r1882b486],
6	outcomes	NNS	O	outcome	prep_on	1	SENT_512	[p26l1908t451r2142b486],
7	of	IN	O	of	_	0	SENT_512	[p26l1115t512r1171b557],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_512	[p26l1192t513r1467b569],
9	treatment	NN	O	treatment	prep_of	6	SENT_512	[p26l1498t522r1752b557],
10	.	.	O	.	_	0	SENT_512	[p26l1498t522r1752b557],

1	N	NN	O	n	nn	3	SENT_513	[p26l1784t517r1826b557],
2	Engl	NNP	O	Engl	nn	3	SENT_513	[p26l1854t513r1965b569],
3	J	NNP	O	J	nsubj	4	SENT_513	[p26l1989t517r2010b564],
4	Med	VBD	O	med	_	0	SENT_513	[p26l2038t513r2143b557],
5	2010	CD	DATE	2010	dobj	4	SENT_513	[p26l1114t588r1551b638],
6	;	:	O	;	_	0	SENT_513	[p26l1114t588r1551b638],
7	363:1704	CD	NUMBER	363:1704	num	8	SENT_513	[p26l1114t588r1551b638],
8	-14	CD	NUMBER	-14	dep	5	SENT_513	[p26l1114t588r1551b638],
9	.	.	O	.	_	0	SENT_513	[p26l1114t588r1551b638],

1	40	CD	NUMBER	40	_	0	SENT_514	[p26l1113t659r1181b699],
2	.	.	O	.	_	0	SENT_514	[p26l1113t659r1181b699],

1	Mann	NNP	PERSON	Mann	nn	2	SENT_515	[p26l1209t659r1351b699],
2	R	NNP	O	R	_	0	SENT_515	[p26l1374t658r1423b708],
3	,	,	O	,	_	0	SENT_515	[p26l1374t658r1423b708],
4	Andrews	NNP	PERSON	Andrews	nn	5	SENT_515	[p26l1447t655r1664b699],
5	E	NNP	PERSON	E	appos	2	SENT_515	[p26l1687t659r1731b708],
6	,	,	O	,	_	0	SENT_515	[p26l1687t659r1731b708],
7	eds	NNS	O	ed	appos	5	SENT_515	[p26l1758t655r1851b699],
8	.	.	O	.	_	0	SENT_515	[p26l1758t655r1851b699],

1	Pharmacovigilance	NNP	O	Pharmacovigilance	_	0	SENT_516	[p26l1876t655r2143b699, p26l1112t726r1346b782],
2	.	.	O	.	_	0	SENT_516	[p26l1876t655r2143b699, p26l1112t726r1346b782],

1	2nd	JJ	ORDINAL	2nd	nsubj	2	SENT_517	[p26l1384t726r1475b770],
2	ed	VBN	O	ed	_	0	SENT_517	[p26l1509t726r1578b770],
3	.	.	O	.	_	0	SENT_517	[p26l1509t726r1578b770],

1	Chichester	NNP	PERSON	Chichester	nn	3	SENT_518	[p26l1615t726r1887b779],
2	,	,	O	,	_	0	SENT_518	[p26l1615t726r1887b779],
3	England	NNP	LOCATION	England	_	0	SENT_518	[p26l1924t726r2141b782],
4	:	:	O	:	_	0	SENT_518	[p26l1924t726r2141b782],
5	John	NNP	PERSON	John	nn	6	SENT_518	[p26l1108t797r1225b848],
6	Wiley	NNP	PERSON	Wiley	dep	3	SENT_518	[p26l1242t797r1382b853],
7	and	CC	O	and	_	0	SENT_518	[p26l1398t797r1488b841],
8	Sons	NNPS	O	Sons	dep	3	SENT_518	[p26l1508t800r1635b850],
9	,	,	O	,	_	0	SENT_518	[p26l1508t800r1635b850],
10	2006	CD	DATE	2006	appos	8	SENT_518	[p26l1658t800r1790b841],
11	.	.	O	.	_	0	SENT_518	[p26l1658t800r1790b841],

1	41	CD	NUMBER	41	_	0	SENT_519	[p26l1113t873r1179b912],
2	.	.	O	.	_	0	SENT_519	[p26l1113t873r1179b912],

1	Olsson	JJ	PERSON	olsson	amod	2	SENT_520	[p26l1210t868r1379b912],
2	R	NN	PERSON	r	_	0	SENT_520	[p26l1395t871r1445b921],
3	,	,	O	,	_	0	SENT_520	[p26l1395t871r1445b921],
4	Wiholm	NNP	O	Wiholm	nsubj	5	SENT_520	[p26l1463t868r1662b912],
5	BE	VBP	O	be	dep	2	SENT_520	[p26l1679t871r1756b921],
6	,	,	O	,	_	0	SENT_520	[p26l1679t871r1756b921],
7	Sand	NNP	O	Sand	nn	8	SENT_520	[p26l1778t868r1895b912],
8	C	NNP	O	C	appos	2	SENT_520	[p26l1913t871r1960b921],
9	,	,	O	,	_	0	SENT_520	[p26l1913t871r1960b921],
10	Zettergren	NNP	O	Zettergren	nn	11	SENT_520	[p26l1979t872r2143b912, p26l1114t953r1224b995],
11	L	NNP	O	L	appos	2	SENT_520	[p26l1256t943r1299b992],
12	,	,	O	,	_	0	SENT_520	[p26l1256t943r1299b992],
13	Hultcrantz	NNP	PERSON	Hultcrantz	nn	14	SENT_520	[p26l1334t939r1598b983],
14	R	NNP	PERSON	R	appos	2	SENT_520	[p26l1630t942r1679b992],
15	,	,	O	,	_	0	SENT_520	[p26l1630t942r1679b992],
16	Myrhed	NNP	O	Myrhed	nn	19	SENT_520	[p26l1713t939r1899b995],
17	M.	NNP	O	M.	nn	19	SENT_520	[p26l1930t943r1991b983],
18	Liver	NN	O	liver	nn	19	SENT_520	[p26l2026t939r2145b983],
19	damage	NN	O	damage	appos	2	SENT_520	[p26l1115t1010r1300b1066],
20	from	IN	O	from	_	0	SENT_520	[p26l1319t1009r1435b1054],
21	flucloxacillin	NN	O	flucloxacillin	prep_from	19	SENT_520	[p26l1454t1009r1775b1063],
22	,	,	O	,	_	0	SENT_520	[p26l1454t1009r1775b1063],
23	cloxacillin	NN	O	cloxacillin	prep_from	19	SENT_520	[p26l1797t1010r2038b1054],
24	and	CC	O	and	_	0	SENT_520	[p26l2056t1010r2143b1054],
25	dicloxacillin	NN	O	dicloxacillin	prep_from	19	SENT_520	[p26l1115t1081r1429b1125],
26	.	.	O	.	_	0	SENT_520	[p26l1115t1081r1429b1125],

1	J	NNP	O	J	nn	2	SENT_521	[p26l1446t1085r1468b1132],
2	Hepatol	NNP	O	Hepatol	_	0	SENT_521	[p26l1485t1081r1677b1137],
3	1992	CD	DATE	1992	num	2	SENT_521	[p26l1698t1084r2084b1134],
4	;	:	O	;	_	0	SENT_521	[p26l1698t1084r2084b1134],
5	15:154	CD	NUMBER	15:154	number	6	SENT_521	[p26l1698t1084r2084b1134],
6	—	CD	NUMBER	—	dep	2	SENT_521	[p26l1698t1084r2084b1134],
7	61	CD	NUMBER	61	dep	6	SENT_521	[p26l1698t1084r2084b1134],
8	.	.	O	.	_	0	SENT_521	[p26l1698t1084r2084b1134],

1	42	CD	NUMBER	42	_	0	SENT_522	[p26l1113t1157r1181b1196],
2	.	.	O	.	_	0	SENT_522	[p26l1113t1157r1181b1196],

1	Fairley	NNP	LOCATION	Fairley	nn	2	SENT_523	[p26l1209t1152r1374b1208],
2	CK	NNP	LOCATION	CK	_	0	SENT_523	[p26l1396t1155r1481b1205],
3	,	,	O	,	_	0	SENT_523	[p26l1396t1155r1481b1205],
4	McNeil	NNP	PERSON	McNeil	nn	6	SENT_523	[p26l1507t1152r1682b1196],
5	J	NNP	O	J	nn	6	SENT_523	[p26l1701t1156r1752b1205],
6	]	NN	O	]	appos	2	SENT_523	[p26l1701t1156r1752b1205],
7	,	,	O	,	_	0	SENT_523	[p26l1701t1156r1752b1205],
8	Desmond	NNP	PERSON	Desmond	nn	9	SENT_523	[p26l1779t1152r2013b1196],
9	P	NN	PERSON	p	appos	2	SENT_523	[p26l2037t1155r2074b1205],
10	,	,	O	,	_	0	SENT_523	[p26l2037t1155r2074b1205],
11	et	FW	O	et	appos	2	SENT_523	[p26l2102t1161r2146b1196],

1	N	NN	O	n	nn	3	SENT_524	[p26l950t1293r964b1308],
2	ENGLJ	NN	O	englj	nn	3	SENT_524	[p26l978t1293r1056b1315],
3	MED	NN	O	med	_	0	SENT_524	[p26l1071t1293r1123b1308],
4	364	CD	NUMBER	364	dep	3	SENT_524	[p26l1133t1287r1212b1315],
5	;	:	O	;	_	0	SENT_524	[p26l1133t1287r1212b1315],
6	12	CD	NUMBER	12	num	7	SENT_524	[p26l1133t1287r1212b1315],
7	NEjM	NNP	O	NEjM	dep	3	SENT_524	[p26l1248t1293r1372b1315],
8	,	,	O	,	_	0	SENT_524	[p26l1248t1293r1372b1315],
9	ORG	NNP	O	ORG	nn	10	SENT_524	[p26l1248t1293r1372b1315],
10	MARCH	NNP	DATE	MARCH	appos	7	SENT_524	[p26l1409t1293r1494b1308],
11	24	CD	DATE	24	num	10	SENT_524	[p26l1506t1293r1542b1315],
12	,	,	DATE	,	_	0	SENT_524	[p26l1506t1293r1542b1315],
13	2011	CD	DATE	2011	num	10	SENT_524	[p26l1553t1293r1605b1309],
14	The	DT	O	the	det	17	SENT_524	[p26l935t1326r986b1350],
15	New	NNP	O	New	nn	17	SENT_524	[p26l995t1327r1057b1350],
16	England	NNP	O	England	nn	17	SENT_524	[p26l1066t1326r1177b1357],
17	Journal	NNP	O	Journal	dep	3	SENT_524	[p26l1186t1326r1283b1350],
18	of	IN	O	of	_	0	SENT_524	[p26l1293t1326r1322b1350],
19	Medicine	NNP	O	Medicine	prep_of	17	SENT_524	[p26l1329t1326r1454b1350],

1	Downloaded	VBN	O	download	_	0	SENT_525	[p26l377t1367r547b1390],
2	from	IN	O	from	_	0	SENT_525	[p26l556t1367r621b1390],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_525	[p26l629t1367r748b1397],
4	at	IN	O	at	_	0	SENT_525	[p26l758t1371r781b1390],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_525	[p26l789t1367r972b1390],
6	on	IN	O	on	_	0	SENT_525	[p26l981t1374r1014b1390],
7	January	NNP	DATE	January	prep_on	1	SENT_525	[p26l1022t1367r1125b1397],
8	5	CD	DATE	5	num	7	SENT_525	[p26l1135t1367r1158b1394],
9	,	,	DATE	,	_	0	SENT_525	[p26l1135t1367r1158b1394],
10	2014	CD	DATE	2014	num	7	SENT_525	[p26l1168t1367r1240b1390],
11	.	.	O	.	_	0	SENT_525	[p26l1168t1367r1240b1390],

1	For	IN	O	for	_	0	SENT_526	[p26l1251t1367r1298b1390],
2	personal	JJ	O	personal	amod	3	SENT_526	[p26l1306t1367r1418b1397],
3	use	NN	O	use	pobj	1	SENT_526	[p26l1427t1374r1471b1390],
4	only	RB	O	only	advmod	3	SENT_526	[p26l1480t1367r1545b1397],
5	.	.	O	.	_	0	SENT_526	[p26l1480t1367r1545b1397],

1	No	DT	O	no	det	3	SENT_527	[p26l1556t1367r1595b1390],
2	other	JJ	O	other	amod	3	SENT_527	[p26l1605t1367r1673b1390],
3	uses	NNS	O	use	_	0	SENT_527	[p26l1682t1374r1738b1390],
4	without	IN	O	without	_	0	SENT_527	[p26l1748t1367r1849b1390],
5	permission	NN	O	permission	prep_without	3	SENT_527	[p26l1857t1367r2010b1397],
6	.	.	O	.	_	0	SENT_527	[p26l1857t1367r2010b1397],

1	Copyright	NN	O	copyright	_	0	SENT_528	[p26l728t1408r862b1439],
2	©	CD	NUMBER	©	num	6	SENT_528	[p26l871t1408r895b1432],
3	2011	CD	DATE	2011	num	6	SENT_528	[p26l905t1408r967b1432],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_528	[p26l979t1408r1170b1432],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_528	[p26l1180t1408r1288b1432],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_528	[p26l1299t1408r1404b1439],
7	.	.	O	.	_	0	SENT_528	[p26l1299t1408r1404b1439],

1	All	DT	O	all	det	2	SENT_529	[p26l1415t1408r1456b1432],
2	rights	NNS	O	rights	nsubj	3	SENT_529	[p26l1465t1408r1540b1439],
3	reserved	VBN	O	reserve	_	0	SENT_529	[p26l1550t1408r1668b1432],
4	.	.	O	.	_	0	SENT_529	[p26l1550t1408r1668b1432],

1	al.	FW	O	al.	_	0	SENT_530	[p26l14t1760r68b1803],
2	.	.	O	.	_	0	SENT_530	[p26l14t1760r68b1803],

1	Risk	NN	O	risk	nn	2	SENT_531	[p26l101t1760r210b1806],
2	factors	NNS	O	factor	nsubj	7	SENT_531	[p26l238t1760r402b1803],
3	for	IN	O	for	_	0	SENT_531	[p26l433t1760r502b1804],
4	development	NN	O	development	prep_for	2	SENT_531	[p26l531t1760r841b1815],
5	of	IN	O	of	_	0	SENT_531	[p26l869t1760r924b1803],
6	flucloxacillin	NN	O	flucloxacillin	prep_of	4	SENT_531	[p26l945t1760r1029b1804, p26l14t1830r264b1873],
7	associated	VBN	O	associate	_	0	SENT_531	[p26l282t1830r533b1873],
8	jaundice	NN	O	jaundice	dobj	7	SENT_531	[p26l543t1830r765b1885],
9	.	.	O	.	_	0	SENT_531	[p26l543t1830r765b1885],

1	BM	NN	O	bm	_	0	SENT_532	[p26l785t1834r884b1880],
2	]	CD	NUMBER	]	num	3	SENT_532	[p26l785t1834r884b1880],
3	1993	CD	DATE	1993	dep	1	SENT_532	[p26l903t1833r1028b1882],
4	;	:	O	;	_	0	SENT_532	[p26l903t1833r1028b1882],
5	306:233	CD	NUMBER	306:233	num	6	SENT_532	[p26l14t1903r263b1944],
6	-5	CD	NUMBER	-5	dep	1	SENT_532	[p26l14t1903r263b1944],
7	.	.	O	.	_	0	SENT_532	[p26l14t1903r263b1944],

1	[	NN	O	[	_	0	SENT_533	[p26l289t1904r520b1953],
2	Erratum	NN	O	erratum	dep	1	SENT_533	[p26l289t1904r520b1953],
3	,	,	O	,	_	0	SENT_533	[p26l289t1904r520b1953],
4	BMJ	NNP	O	BMJ	appos	2	SENT_533	[p26l540t1904r639b1950],
5	1993	CD	DATE	1993	rcmod	4	SENT_533	[p26l657t1903r1025b1953],
6	;	:	O	;	_	0	SENT_533	[p26l657t1903r1025b1953],
7	307:1179	CD	NUMBER	307:1179	dep	5	SENT_533	[p26l657t1903r1025b1953],
8	.	.	O	.	_	0	SENT_533	[p26l657t1903r1025b1953],
9	]	SYM	O	]	dep	5	SENT_533	[p26l657t1903r1025b1953],

1	43	CD	NUMBER	43	_	0	SENT_534	[p26l13t1975r78b2013],
2	.	.	O	.	_	0	SENT_534	[p26l13t1975r78b2013],

1	Russmann	NNP	PERSON	Russmann	nn	2	SENT_535	[p26l108t1974r366b2016],
2	S	NNP	PERSON	S	_	0	SENT_535	[p26l388t1973r426b2023],
3	,	,	O	,	_	0	SENT_535	[p26l388t1973r426b2023],
4	Kaye	NNP	ORGANIZATION	Kaye	nn	5	SENT_535	[p26l450t1974r562b2025],
5	IA	NNP	ORGANIZATION	IA	appos	2	SENT_535	[p26l578t1974r646b2023],
6	,	,	O	,	_	0	SENT_535	[p26l578t1974r646b2023],
7	Jick	NNP	PERSON	Jick	nn	8	SENT_535	[p26l665t1970r758b2020],
8	SS	NNP	O	SS	appos	2	SENT_535	[p26l777t1973r844b2023],
9	,	,	O	,	_	0	SENT_535	[p26l777t1973r844b2023],
10	Jick	NNP	PERSON	Jick	nn	12	SENT_535	[p26l862t1970r956b2020],
11	H.	NNP	PERSON	H.	nn	12	SENT_535	[p26l973t1974r1027b2013],
12	Risk	NN	PERSON	risk	appos	2	SENT_535	[p26l13t2040r122b2086],
13	of	IN	O	of	_	0	SENT_535	[p26l136t2040r191b2083],
14	cholestatic	JJ	O	cholestatic	amod	16	SENT_535	[p26l197t2040r456b2084],
15	liver	NN	O	liver	nn	16	SENT_535	[p26l471t2040r575b2084],
16	disease	NN	O	disease	prep_of	12	SENT_535	[p26l589t2040r764b2083],
17	associated	VBN	O	associate	partmod	2	SENT_535	[p26l779t2040r1030b2084],
18	with	IN	O	with	_	0	SENT_535	[p26l12t2110r121b2154],
19	flucloxacillin	NN	O	flucloxacillin	nn	23	SENT_535	[p26l142t2110r462b2154],
20	and	CC	O	and	_	0	SENT_535	[p26l484t2110r572b2153],
21	flucloxacillin	NN	O	flucloxacillin	nn	23	SENT_535	[p26l593t2110r913b2154],
22	prescribing	NN	O	prescribing	nn	23	SENT_535	[p26l934t2124r1029b2165, p26l15t2180r211b2236],
23	habits	NNS	O	habit	prep_with	17	SENT_535	[p26l239t2180r385b2223],
24	in	IN	O	in	_	0	SENT_535	[p26l415t2181r462b2223],
25	the	DT	O	the	det	26	SENT_535	[p26l491t2180r566b2223],
26	UK	NNP	LOCATION	UK	prep_in	17	SENT_535	[p26l596t2184r685b2225],
27	:	:	O	:	_	0	SENT_535	[p26l596t2184r685b2225],
28	cohort	NN	O	cohort	nn	29	SENT_535	[p26l718t2180r876b2224],
29	study	NN	O	study	nsubj	30	SENT_535	[p26l904t2180r1033b2235],
30	using	VBG	O	use	dep	2	SENT_535	[p26l14t2251r147b2306],
31	data	NNS	O	datum	dobj	30	SENT_535	[p26l168t2250r271b2293],
32	from	IN	O	from	_	0	SENT_535	[p26l292t2250r410b2294],
33	the	DT	O	the	det	38	SENT_535	[p26l433t2250r508b2293],
34	UK	NNP	LOCATION	UK	nn	38	SENT_535	[p26l529t2254r607b2295],
35	General	NNP	O	General	nn	38	SENT_535	[p26l628t2250r818b2294],
36	Practice	NNP	O	Practice	nn	38	SENT_535	[p26l839t2251r1030b2293],
37	Research	NNP	O	Research	nn	38	SENT_535	[p26l13t2320r233b2366],
38	Database	NNP	O	Database	prep_from	30	SENT_535	[p26l260t2320r495b2363],
39	.	.	O	.	_	0	SENT_535	[p26l260t2320r495b2363],

1	Br	NN	O	br	nn	4	SENT_536	[p26l524t2324r619b2370],
2	]	CD	NUMBER	]	num	4	SENT_536	[p26l524t2324r619b2370],
3	Clin	NNP	O	Clin	nn	4	SENT_536	[p26l645t2320r745b2363],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_536	[p26l771t2320r1030b2363],
5	2005	CD	DATE	2005	dep	4	SENT_536	[p26l14t2393r368b2442],
6	;	:	O	;	_	0	SENT_536	[p26l14t2393r368b2442],
7	60:76	CD	NUMBER	60:76	number	8	SENT_536	[p26l14t2393r368b2442],
8	—	CD	NUMBER	—	dep	4	SENT_536	[p26l14t2393r368b2442],
9	82	CD	NUMBER	82	dep	8	SENT_536	[p26l14t2393r368b2442],
10	.	.	O	.	_	0	SENT_536	[p26l14t2393r368b2442],

1	44	CD	NUMBER	44	_	0	SENT_537	[p26l13t2466r81b2503],
2	.	.	O	.	_	0	SENT_537	[p26l13t2466r81b2503],

1	Pachkoria	NN	LOCATION	pachkorium	nn	2	SENT_538	[p26l108t2460r349b2504],
2	K	NN	LOCATION	k	_	0	SENT_538	[p26l369t2464r417b2513],
3	,	,	O	,	_	0	SENT_538	[p26l369t2464r417b2513],
4	Lucena	NNP	ORGANIZATION	Lucena	nn	5	SENT_538	[p26l440t2464r611b2504],
5	MI	NNP	ORGANIZATION	MI	appos	2	SENT_538	[p26l630t2464r710b2513],
6	,	,	O	,	_	0	SENT_538	[p26l630t2464r710b2513],
7	Crespo	NNP	PERSON	Crespo	nn	8	SENT_538	[p26l734t2463r900b2515],
8	E	NNP	O	E	appos	2	SENT_538	[p26l922t2464r965b2513],
9	,	,	O	,	_	0	SENT_538	[p26l922t2464r965b2513],
10	et	FW	O	et	nn	11	SENT_538	[p26l990t2469r1033b2503],
11	al.	FW	O	al.	appos	2	SENT_538	[p26l14t2530r68b2573],
12	.	.	O	.	_	0	SENT_538	[p26l14t2530r68b2573],

1	Analysis	NN	O	analysis	_	0	SENT_539	[p26l92t2530r295b2585],
2	of	IN	O	of	_	0	SENT_539	[p26l319t2530r374b2573],
3	IL-10	NN	O	il-10	nn	8	SENT_539	[p26l385t2533r518b2583],
4	,	,	O	,	_	0	SENT_539	[p26l385t2533r518b2583],
5	IL-4	NN	O	il-4	nn	8	SENT_539	[p26l543t2533r641b2573],
6	and	CC	O	and	_	0	SENT_539	[p26l662t2530r751b2573],
7	TNF-alpha	NN	O	tnf-alpha	nn	8	SENT_539	[p26l771t2530r1031b2585],
8	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_539	[p26l13t2600r395b2655],
9	in	IN	O	in	_	0	SENT_539	[p26l419t2601r466b2643],
10	drug-induced	JJ	O	drug-induced	amod	12	SENT_539	[p26l491t2600r815b2656],
11	liver	NN	O	liver	nn	12	SENT_539	[p26l839t2600r943b2644],
12	injury	NN	O	injury	prep_in	8	SENT_539	[p26l965t2601r1029b2643, p26l6t2671r109b2725],
13	(	CD	NUMBER	(	num	14	SENT_539	[p26l141t2674r285b2720],
14	DILI	NNP	LOCATION	DILI	dep	1	SENT_539	[p26l141t2674r285b2720],
15	)	CD	NUMBER	)	num	14	SENT_539	[p26l141t2674r285b2720],
16	and	CC	O	and	_	0	SENT_539	[p26l320t2670r409b2713],
17	its	PRP$	O	its	poss	18	SENT_539	[p26l441t2671r498b2713],
18	outcome	NN	O	outcome	dep	1	SENT_539	[p26l532t2679r756b2714],
19	.	.	O	.	_	0	SENT_539	[p26l532t2679r756b2714],

1	J	NNP	O	J	nn	2	SENT_540	[p26l786t2674r807b2720],
2	Hepatol	NNP	O	Hepatol	_	0	SENT_540	[p26l837t2670r1031b2725],
3	2008	CD	DATE	2008	num	2	SENT_540	[p26l14t2743r377b2792],
4	;	:	O	;	_	0	SENT_540	[p26l14t2743r377b2792],
5	49:107	CD	NUMBER	49:107	number	6	SENT_540	[p26l14t2743r377b2792],
6	-14	CD	NUMBER	-14	dep	2	SENT_540	[p26l14t2743r377b2792],
7	.	.	O	.	_	0	SENT_540	[p26l14t2743r377b2792],

1	[	NNP	O	[	_	0	SENT_541	[p26l406t2744r632b2793],
2	Erratum	NNP	O	Erratum	nn	5	SENT_541	[p26l406t2744r632b2793],
3	,	,	O	,	_	0	SENT_541	[p26l406t2744r632b2793],
4	J	NNP	O	J	appos	5	SENT_541	[p26l652t2744r672b2790],
5	Hepatol	NNP	O	Hepatol	dep	1	SENT_541	[p26l692t2740r879b2795],
6	2009	CD	DATE	2009	rcmod	5	SENT_541	[p26l900t2743r1028b2792],
7	;	:	O	;	_	0	SENT_541	[p26l900t2743r1028b2792],
8	50:636	CD	NUMBER	50:636	dep	6	SENT_541	[p26l15t2813r203b2860],
9	.	.	O	.	_	0	SENT_541	[p26l15t2813r203b2860],
10	]	SYM	O	]	dep	6	SENT_541	[p26l15t2813r203b2860],

1	45	CD	NUMBER	45	_	0	SENT_542	[p26l13t2886r78b2923],
2	.	.	O	.	_	0	SENT_542	[p26l13t2886r78b2923],

1	Daly	NNP	PERSON	Daly	nn	2	SENT_543	[p26l108t2880r218b2935],
2	AK	NNP	PERSON	AK	_	0	SENT_543	[p26l232t2884r320b2933],
3	,	,	O	,	_	0	SENT_543	[p26l232t2884r320b2933],
4	Donaldson	NNP	ORGANIZATION	Donaldson	nn	5	SENT_543	[p26l342t2880r607b2924],
5	PT	NN	ORGANIZATION	pt	appos	2	SENT_543	[p26l625t2883r699b2933],
6	,	,	O	,	_	0	SENT_543	[p26l625t2883r699b2933],
7	Bhatnagar	NNP	PERSON	Bhatnagar	nn	8	SENT_543	[p26l721t2880r973b2936],
8	P	NN	O	p	appos	2	SENT_543	[p26l990t2884r1027b2933],
9	,	,	O	,	_	0	SENT_543	[p26l990t2884r1027b2933],
10	et	FW	O	et	nn	11	SENT_543	[p26l14t2959r58b2993],
11	al.	FW	O	al.	appos	2	SENT_543	[p26l85t2950r141b2993],
12	.	.	O	.	_	0	SENT_543	[p26l85t2950r141b2993],

1	HLA-B	NN	O	hla-b	nsubj	8	SENT_544	[p26l174t2950r481b2994],
2	*	CD	NUMBER	*	num	1	SENT_544	[p26l174t2950r481b2994],
3	5701	CD	NUMBER	5701	num	4	SENT_544	[p26l174t2950r481b2994],
4	genotype	NN	O	genotype	dep	1	SENT_544	[p26l511t2959r737b3006],
5	is	VBZ	O	be	cop	8	SENT_544	[p26l767t2951r805b2993],
6	a	DT	O	a	det	8	SENT_544	[p26l835t2964r860b2993],
7	major	JJ	O	major	amod	8	SENT_544	[p26l889t2951r1032b3005],
8	determinant	NN	O	determinant	_	0	SENT_544	[p26l14t3020r318b3063],
9	of	IN	O	of	_	0	SENT_544	[p26l341t3020r397b3064],
10	drug-induced	JJ	O	drug-induced	amod	12	SENT_544	[p26l413t3020r737b3076],
11	liver	NN	O	liver	nn	12	SENT_544	[p26l762t3020r866b3064],
12	injury	NN	O	injury	prep_of	8	SENT_544	[p26l890t3021r1033b3075],
13	due	JJ	O	due	_	0	SENT_544	[p26l14t3090r98b3134],
14	to	TO	O	to	_	0	SENT_544	[p26l122t3099r168b3133],
15	flucloxacillin	NN	O	flucloxacillin	prep_due_to	12	SENT_544	[p26l193t3090r526b3134],
16	.	.	O	.	_	0	SENT_544	[p26l193t3090r526b3134],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_545	[p26l552t3094r639b3134],
2	Genet	NNP	PERSON	Genet	_	0	SENT_545	[p26l660t3093r805b3134],
3	2009	CD	DATE	2009	num	2	SENT_545	[p26l826t3093r1028b3142],
4	;	:	O	;	_	0	SENT_545	[p26l826t3093r1028b3142],
5	41	CD	NUMBER	41	num	7	SENT_545	[p26l826t3093r1028b3142],
6	:	:	O	:	_	0	SENT_545	[p26l826t3093r1028b3142],
7	816-9	CD	NUMBER	816-9	dep	2	SENT_545	[p26l14t3163r158b3203],
8	.	.	O	.	_	0	SENT_545	[p26l14t3163r158b3203],

1	46	CD	NUMBER	46	_	0	SENT_546	[p26l13t3235r81b3273],
2	.	.	O	.	_	0	SENT_546	[p26l13t3235r81b3273],

1	Hetherington	NNP	PERSON	Hetherington	nn	2	SENT_547	[p26l108t3230r438b3286],
2	S	NNP	O	S	_	0	SENT_547	[p26l455t3233r494b3283],
3	,	,	O	,	_	0	SENT_547	[p26l455t3233r494b3283],
4	McGuirl	NNP	PERSON	McGuirl	appos	2	SENT_547	[p26l511t3230r729b3274],
5	<	JJR	O	<	amod	6	SENT_547	[p26l511t3230r729b3274],
6	S	NN	O	s	dep	4	SENT_547	[p26l744t3233r782b3283],
7	,	,	O	,	_	0	SENT_547	[p26l744t3233r782b3283],
8	Powell	NNP	PERSON	Powell	nn	9	SENT_547	[p26l800t3230r959b3274],
9	G	NNP	PERSON	G	appos	2	SENT_547	[p26l975t3233r1027b3283],
10	,	,	O	,	_	0	SENT_547	[p26l975t3233r1027b3283],
11	et	FW	O	et	nn	12	SENT_547	[p26l14t3309r58b3343],
12	al.	FW	O	al.	appos	2	SENT_547	[p26l90t3300r145b3343],
13	.	.	O	.	_	0	SENT_547	[p26l90t3300r145b3343],

1	Hypersensitivity	NN	O	hypersensitivity	nn	2	SENT_548	[p26l184t3301r579b3355],
2	reactions	NNS	O	reaction	_	0	SENT_548	[p26l612t3301r832b3343],
3	during	IN	O	during	_	0	SENT_548	[p26l870t3300r1032b3356],
4	therapy	NN	O	therapy	prep_during	2	SENT_548	[p26l14t3370r196b3425],
5	with	IN	O	with	_	0	SENT_548	[p26l213t3370r323b3414],
6	the	DT	O	the	det	11	SENT_548	[p26l346t3370r421b3413],
7	nucleoside	JJ	O	nucleoside	amod	11	SENT_548	[p26l443t3370r698b3414],
8	reverse	JJ	O	reverse	amod	11	SENT_548	[p26l721t3384r889b3414],
9	transcriptase	NN	O	transcriptase	nn	11	SENT_548	[p26l913t3379r1029b3413, p26l15t3441r233b3495],
10	inhibitor	NN	O	inhibitor	nn	11	SENT_548	[p26l270t3440r490b3483],
11	abacavir	NN	O	abacavir	prep_with	2	SENT_548	[p26l525t3440r741b3484],
12	.	.	O	.	_	0	SENT_548	[p26l525t3440r741b3484],

1	Clin	NNP	O	Clin	nn	2	SENT_549	[p26l781t3440r882b3483],
2	Ther	NNP	O	Ther	_	0	SENT_549	[p26l917t3440r1032b3483],
3	2001	CD	DATE	2001	num	2	SENT_549	[p26l14t3513r421b3562],
4	;	:	O	;	_	0	SENT_549	[p26l14t3513r421b3562],
5	23:1603	CD	NUMBER	23:1603	number	6	SENT_549	[p26l14t3513r421b3562],
6	-14	CD	NUMBER	-14	dep	2	SENT_549	[p26l14t3513r421b3562],
7	.	.	O	.	_	0	SENT_549	[p26l14t3513r421b3562],

1	47	CD	NUMBER	47	_	0	SENT_550	[p26l13t3585r74b3623],
2	.	.	O	.	_	0	SENT_550	[p26l13t3585r74b3623],

1	Mallal	JJ	O	mallal	amod	2	SENT_551	[p26l107t3580r262b3623],
2	S	NN	O	s	_	0	SENT_551	[p26l288t3583r326b3633],
3	,	,	O	,	_	0	SENT_551	[p26l288t3583r326b3633],
4	Nolan	NNP	PERSON	Nolan	nn	5	SENT_551	[p26l353t3580r500b3623],
5	D	NNP	PERSON	D	appos	2	SENT_551	[p26l524t3584r574b3632],
6	,	,	O	,	_	0	SENT_551	[p26l524t3584r574b3632],
7	Witt	NNP	PERSON	Witt	nn	8	SENT_551	[p26l600t3581r708b3623],
8	C	NNP	O	C	appos	2	SENT_551	[p26l730t3583r776b3632],
9	,	,	O	,	_	0	SENT_551	[p26l730t3583r776b3632],
10	et	FW	O	et	nn	11	SENT_551	[p26l805t3589r848b3623],
11	al.	FW	O	al.	appos	2	SENT_551	[p26l870t3580r925b3623],
12	.	.	O	.	_	0	SENT_551	[p26l870t3580r925b3623],

1	Association	NNP	O	Association	_	0	SENT_552	[p26l951t3584r1029b3623, p26l15t3651r235b3693],
2	between	IN	O	between	_	0	SENT_552	[p26l288t3650r489b3694],
3	presence	NN	O	presence	prep_between	1	SENT_552	[p26l541t3664r752b3705],
4	of	IN	O	of	_	0	SENT_552	[p26l805t3650r861b3693],
5	HLAB	NN	O	hlab	prep_of	3	SENT_552	[p26l903t3654r1029b3693, p26l13t3720r204b3772],
6	*	CD	NUMBER	*	num	5	SENT_552	[p26l903t3654r1029b3693, p26l13t3720r204b3772],
7	5701	CD	NUMBER	5701	dep	1	SENT_552	[p26l903t3654r1029b3693, p26l13t3720r204b3772],
8	,	,	O	,	_	0	SENT_552	[p26l903t3654r1029b3693, p26l13t3720r204b3772],
9	HLA-DR7	NN	O	hla-dr7	dep	1	SENT_552	[p26l247t3724r490b3773],
10	,	,	O	,	_	0	SENT_552	[p26l247t3724r490b3773],
11	and	CC	O	and	_	0	SENT_552	[p26l533t3720r623b3763],
12	HLA-DQ3	NN	O	hla-dq3	dep	1	SENT_552	[p26l662t3723r899b3774],
13	and	CC	O	and	advmod	7	SENT_552	[p26l941t3720r1030b3763],

1	GENOMIC	JJ	O	genomic	amod	2	SENT_553	[p26l1288t1581r1587b1617],
2	MEDICINE	NNP	O	MEDICINE	_	0	SENT_553	[p26l1613t1582r1937b1617],

1	B	NN	O	b	_	0	SENT_554	[p26l1104t1760r1280b1803],
2	*	CD	NUMBER	*	number	3	SENT_554	[p26l1104t1760r1280b1803],
3	1502	CD	DATE	1502	num	4	SENT_554	[p26l1104t1760r1280b1803],
4	screening	NN	O	screening	dep	1	SENT_554	[p26l1306t1761r1541b1816],
5	to	TO	O	to	aux	6	SENT_554	[p26l1564t1769r1610b1803],
6	prevent	VB	O	prevent	infmod	1	SENT_554	[p26l1635t1769r1815b1815],
7	carbamazepine-induced	JJ	O	carbamazepine-induced	amod	8	SENT_554	[p26l1837t1760r2120b1803, p26l1104t1830r1420b1885],
8	Stevens	NNP	PERSON	Stevens	nsubj	12	SENT_554	[p26l1440t1830r1848b1880],
9	—	CD	NUMBER	—	number	10	SENT_554	[p26l1440t1830r1848b1880],
10	]	CD	NUMBER	]	num	12	SENT_554	[p26l1440t1830r1848b1880],
11	ohnson	NN	O	ohnson	nn	12	SENT_554	[p26l1440t1830r1848b1880],
12	syndrome	NN	O	syndrome	xcomp	6	SENT_554	[p26l1867t1830r2118b1885],
13	.	.	O	.	_	0	SENT_554	[p26l1867t1830r2118b1885],

1	N	NN	O	n	nn	3	SENT_555	[p26l1103t1904r1145b1944],
2	Engl	NNP	O	Engl	nn	3	SENT_555	[p26l1162t1900r1305b1956],
3	]	NNP	O	]	nsubj	4	SENT_555	[p26l1162t1900r1305b1956],
4	Med	VBD	O	med	_	0	SENT_555	[p26l1321t1900r1426b1943],
5	2011	CD	DATE	2011	dobj	4	SENT_555	[p26l1444t1903r1884b1952],
6	;	:	O	;	_	0	SENT_555	[p26l1444t1903r1884b1952],
7	364:1126	CD	NUMBER	364:1126	num	8	SENT_555	[p26l1444t1903r1884b1952],
8	-33	CD	NUMBER	-33	dep	5	SENT_555	[p26l1444t1903r1884b1952],
9	.	.	O	.	_	0	SENT_555	[p26l1444t1903r1884b1952],

1	52	CD	NUMBER	52	_	0	SENT_556	[p26l1105t1975r1171b2013],
2	.	.	O	.	_	0	SENT_556	[p26l1105t1975r1171b2013],

1	Chung	NNP	PERSON	Chung	nn	2	SENT_557	[p26l1200t1970r1359b2026],
2	WH	NNP	PERSON	WH	_	0	SENT_557	[p26l1376t1974r1485b2023],
3	,	,	O	,	_	0	SENT_557	[p26l1376t1974r1485b2023],
4	Hung	NNP	O	Hung	nn	5	SENT_557	[p26l1508t1974r1644b2026],
5	SI	NNP	O	SI	appos	2	SENT_557	[p26l1663t1973r1720b2023],
6	,	,	O	,	_	0	SENT_557	[p26l1663t1973r1720b2023],
7	Hong	NNP	LOCATION	Hong	nn	8	SENT_557	[p26l1743t1974r1877b2026],
8	HS	NN	LOCATION	h	appos	2	SENT_557	[p26l1896t1973r1978b2023],
9	,	,	O	,	_	0	SENT_557	[p26l1896t1973r1978b2023],
10	et	FW	O	et	nn	11	SENT_557	[p26l2002t1979r2045b2013],
11	al.	FW	O	al.	appos	2	SENT_557	[p26l2063t1970r2118b2013],
12	.	.	O	.	_	0	SENT_557	[p26l2063t1970r2118b2013],

1	Medical	JJ	O	medical	amod	2	SENT_558	[p26l1103t2040r1295b2083],
2	genetics	NNS	O	genetics	_	0	SENT_558	[p26l1325t2041r1537b2096],
3	:	:	O	:	_	0	SENT_558	[p26l1325t2041r1537b2096],
4	a	DT	O	a	det	5	SENT_558	[p26l1569t2054r1593b2083],
5	marker	NN	O	marker	dep	2	SENT_558	[p26l1622t2040r1797b2084],
6	for	IN	O	for	_	0	SENT_558	[p26l1825t2040r1894b2084],
7	StevensJohnson	NN	O	stevensjohnson	nn	8	SENT_558	[p26l1924t2043r2120b2084, p26l1099t2110r1302b2160],
8	syndrome	NN	O	syndrome	prep_for	5	SENT_558	[p26l1321t2110r1572b2165],
9	.	.	O	.	_	0	SENT_558	[p26l1321t2110r1572b2165],

1	Nature	NNP	O	Nature	_	0	SENT_559	[p26l1593t2114r1759b2154],
2	2004	CD	DATE	2004	num	1	SENT_559	[p26l1778t2113r2115b2162],
3	;	:	O	;	_	0	SENT_559	[p26l1778t2113r2115b2162],
4	428:486	CD	NUMBER	428:486	dep	1	SENT_559	[p26l1778t2113r2115b2162],
5	.	.	O	.	_	0	SENT_559	[p26l1778t2113r2115b2162],

1	53	CD	NUMBER	53	_	0	SENT_560	[p26l1105t2185r1167b2223],
2	.	.	O	.	_	0	SENT_560	[p26l1105t2185r1167b2223],

1	NIH	NNP	ORGANIZATION	NIH	nn	3	SENT_561	[p26l1198t2184r1302b2224],
2	consensus	NN	O	consensus	nn	3	SENT_561	[p26l1321t2194r1564b2224],
3	statement	NN	O	statement	_	0	SENT_561	[p26l1585t2189r1820b2223],
4	on	IN	O	on	_	0	SENT_561	[p26l1836t2194r1894b2223],
5	management	NN	O	management	prep_on	3	SENT_561	[p26l1913t2194r2120b2236, p26l1105t2259r1229b2293],
6	of	IN	O	of	_	0	SENT_561	[p26l1253t2250r1309b2293],
7	hepatitis	NNP	O	hepatitis	nn	13	SENT_561	[p26l1326t2250r1536b2305],
8	C.	NNP	O	C.	nn	13	SENT_561	[p26l1564t2253r1611b2294],
9	NIH	NNP	O	NIH	nn	13	SENT_561	[p26l1640t2254r1744b2294],
10	Consens	NNPS	O	Consens	nn	13	SENT_561	[p26l1772t2253r1975b2294],
11	State	NNP	O	State	nn	13	SENT_561	[p26l2005t2253r2121b2294],
12	Sci	NNP	O	Sci	nn	13	SENT_561	[p26l1106t2321r1173b2363],
13	Statements	NNP	O	Statements	prep_of	5	SENT_561	[p26l1192t2323r1458b2363],
14	2002	CD	DATE	2002	dep	13	SENT_561	[p26l1478t2323r1866b2372],
15	;	:	O	;	_	0	SENT_561	[p26l1478t2323r1866b2372],
16	19	CD	NUMBER	19	number	17	SENT_561	[p26l1478t2323r1866b2372],
17	(	CD	NUMBER	(	dep	3	SENT_561	[p26l1478t2323r1866b2372],
18	3	CD	NUMBER	3	num	19	SENT_561	[p26l1478t2323r1866b2372],
19	)	NN	O	)	dep	17	SENT_561	[p26l1478t2323r1866b2372],
20	:1	CD	NUMBER	:1	num	21	SENT_561	[p26l1478t2323r1866b2372],
21	-46	CD	NUMBER	-46	dep	17	SENT_561	[p26l1478t2323r1866b2372],
22	.	.	O	.	_	0	SENT_561	[p26l1478t2323r1866b2372],

1	54	CD	NUMBER	54	_	0	SENT_562	[p26l1105t2395r1169b2433],
2	.	.	O	.	_	0	SENT_562	[p26l1105t2395r1169b2433],

1	Shepard	NNP	ORGANIZATION	Shepard	nn	2	SENT_563	[p26l1201t2390r1392b2445],
2	CW	NNP	ORGANIZATION	CW	_	0	SENT_563	[p26l1407t2393r1501b2443],
3	,	,	O	,	_	0	SENT_563	[p26l1407t2393r1501b2443],
4	Finelli	NNP	PERSON	Finelli	nn	5	SENT_563	[p26l1518t2390r1668b2433],
5	L	NNP	O	L	appos	2	SENT_563	[p26l1682t2394r1723b2442],
6	,	,	O	,	_	0	SENT_563	[p26l1682t2394r1723b2442],
7	Alter	NNP	O	Alter	nn	8	SENT_563	[p26l1740t2390r1857b2433],
8	MI	NNP	O	MI	appos	5	SENT_563	[p26l1869t2394r1945b2440],
9	.	.	O	.	_	0	SENT_563	[p26l1869t2394r1945b2440],

1	Global	JJ	O	global	amod	2	SENT_564	[p26l1964t2390r2121b2433],
2	epidemiology	NN	O	epidemiology	_	0	SENT_564	[p26l1105t2460r1433b2516],
3	of	IN	O	of	_	0	SENT_564	[p26l1460t2460r1516b2503],
4	hepatitis	NN	O	hepatitis	nn	7	SENT_564	[p26l1535t2460r1744b2515],
5	C	NN	O	c	nn	7	SENT_564	[p26l1774t2463r1806b2504],
6	virus	NN	O	virus	nn	7	SENT_564	[p26l1833t2461r1953b2504],
7	infection	NN	O	infection	prep_of	2	SENT_564	[p26l1982t2460r2120b2503, p26l1105t2531r1213b2573],
8	.	.	O	.	_	0	SENT_564	[p26l1982t2460r2120b2503, p26l1105t2531r1213b2573],

1	Lancet	NNP	O	Lancet	nn	3	SENT_565	[p26l1235t2534r1396b2573],
2	Infect	NNP	O	Infect	nn	3	SENT_565	[p26l1412t2530r1555b2573],
3	Dis	NNP	O	Dis	_	0	SENT_565	[p26l1570t2531r1648b2573],
4	2005	CD	DATE	2005	num	3	SENT_565	[p26l1668t2533r2015b2582],
5	;	:	O	;	_	0	SENT_565	[p26l1668t2533r2015b2582],
6	5:558	CD	NUMBER	5:558	number	7	SENT_565	[p26l1668t2533r2015b2582],
7	-67	CD	NUMBER	-67	dep	3	SENT_565	[p26l1668t2533r2015b2582],
8	.	.	O	.	_	0	SENT_565	[p26l1668t2533r2015b2582],

1	55	CD	NUMBER	55	_	0	SENT_566	[p26l1105t2606r1168b2643],
2	.	.	O	.	_	0	SENT_566	[p26l1105t2606r1168b2643],

1	Suppiah	NNP	O	Suppiah	nn	2	SENT_567	[p26l1201t2600r1395b2655],
2	V	NNP	O	V	_	0	SENT_567	[p26l1410t2604r1451b2653],
3	,	,	O	,	_	0	SENT_567	[p26l1410t2604r1451b2653],
4	Moldovan	NNP	MISC	Moldovan	nn	5	SENT_567	[p26l1469t2600r1708b2644],
5	M	NNP	O	M	appos	2	SENT_567	[p26l1723t2604r1784b2653],
6	,	,	O	,	_	0	SENT_567	[p26l1723t2604r1784b2653],
7	Ahlenstiel	NNP	O	Ahlenstiel	nn	8	SENT_567	[p26l1802t2600r2050b2643],
8	G	NNP	O	G	appos	2	SENT_567	[p26l2066t2603r2118b2653],
9	,	,	O	,	_	0	SENT_567	[p26l2066t2603r2118b2653],
10	et	FW	O	et	nn	11	SENT_567	[p26l1105t2679r1148b2713],
11	al.	FW	O	al.	appos	2	SENT_567	[p26l1163t2670r1217b2713],
12	.	.	O	.	_	0	SENT_567	[p26l1163t2670r1217b2713],

1	IL28B	NN	O	il28b	nsubjpass	3	SENT_568	[p26l1237t2673r1377b2713],
2	is	VBZ	O	be	auxpass	3	SENT_568	[p26l1394t2671r1432b2713],
3	associated	VBN	O	associate	_	0	SENT_568	[p26l1450t2670r1701b2713],
4	with	IN	O	with	_	0	SENT_568	[p26l1716t2670r1825b2714],
5	response	NN	O	response	prep_with	3	SENT_568	[p26l1842t2684r2057b2725],
6	to	TO	O	to	_	0	SENT_568	[p26l2074t2679r2120b2713],
7	chronic	JJ	O	chronic	amod	10	SENT_568	[p26l1105t2740r1287b2783],
8	hepatitis	NN	O	hepatitis	nn	10	SENT_568	[p26l1313t2740r1523b2795],
9	C	NN	O	c	nn	10	SENT_568	[p26l1550t2743r1582b2783],
10	interferon-alpha	NN	O	interferon-alpha	prep_to	3	SENT_568	[p26l1610t2740r2007b2795],
11	and	CC	O	and	_	0	SENT_568	[p26l2033t2740r2121b2783],
12	ribavirin	NNP	O	ribavirin	nn	13	SENT_568	[p26l1105t2810r1317b2854],
13	therapy	NN	O	therapy	prep_to	3	SENT_568	[p26l1360t2810r1553b2865],
14	.	.	O	.	_	0	SENT_568	[p26l1360t2810r1553b2865],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_569	[p26l1598t2814r1686b2853],
2	Genet	NNP	PERSON	Genet	_	0	SENT_569	[p26l1725t2813r1872b2853],
3	2009	CD	DATE	2009	num	2	SENT_569	[p26l1912t2813r2118b2862],
4	;	:	O	;	_	0	SENT_569	[p26l1912t2813r2118b2862],
5	41	CD	NUMBER	41	num	7	SENT_569	[p26l1912t2813r2118b2862],
6	:	:	O	:	_	0	SENT_569	[p26l1912t2813r2118b2862],
7	1100-4	CD	NUMBER	1100-4	dep	2	SENT_569	[p26l1107t2883r1283b2923],
8	.	.	O	.	_	0	SENT_569	[p26l1107t2883r1283b2923],

1	56	CD	NUMBER	56	_	0	SENT_570	[p26l1105t2955r1168b2994],
2	.	.	O	.	_	0	SENT_570	[p26l1105t2955r1168b2994],

1	Tanaka	NNP	PERSON	Tanaka	nn	2	SENT_571	[p26l1198t2950r1370b2994],
2	Y	NN	PERSON	y	_	0	SENT_571	[p26l1381t2954r1420b3003],
3	,	,	O	,	_	0	SENT_571	[p26l1381t2954r1420b3003],
4	Nishida	NNP	PERSON	Nishida	nn	5	SENT_571	[p26l1436t2950r1618b2994],
5	N	NNP	O	N	appos	2	SENT_571	[p26l1630t2954r1681b3003],
6	,	,	O	,	_	0	SENT_571	[p26l1630t2954r1681b3003],
7	Sugiyama	NNP	PERSON	Sugiyama	nn	8	SENT_571	[p26l1699t2951r1924b3006],
8	M	NNP	O	M	appos	2	SENT_571	[p26l1935t2954r1995b3003],
9	,	,	O	,	_	0	SENT_571	[p26l1935t2954r1995b3003],
10	et	FW	O	et	nn	11	SENT_571	[p26l2012t2959r2054b2993],
11	al.	FW	O	al.	appos	2	SENT_571	[p26l2065t2950r2117b2993],
12	.	.	O	.	_	0	SENT_571	[p26l2065t2950r2117b2993],

1	Genome-wide	JJ	O	genome-wide	amod	2	SENT_572	[p26l1105t3020r1441b3064],
2	association	NN	O	association	_	0	SENT_572	[p26l1469t3021r1743b3063],
3	of	IN	O	of	_	0	SENT_572	[p26l1771t3020r1827b3064],
4	IL28B	NN	O	il28b	prep_of	2	SENT_572	[p26l1845t3023r1984b3063],
5	with	IN	O	with	_	0	SENT_572	[p26l2011t3020r2121b3064],
6	response	NN	O	response	prep_with	4	SENT_572	[p26l1105t3104r1315b3145],
7	to	TO	O	to	aux	8	SENT_572	[p26l1330t3099r1375b3133],
8	pegylated	VBN	O	pegylate	infmod	2	SENT_572	[p26l1389t3090r1618b3146],
9	interferon-alpha	NN	O	interferon-alpha	nn	12	SENT_572	[p26l1632t3090r2020b3145],
10	and	CC	O	and	_	0	SENT_572	[p26l2034t3090r2121b3133],
11	ribavirin	NNP	O	ribavirin	nn	12	SENT_572	[p26l1105t3160r1312b3204],
12	therapy	NN	O	therapy	dobj	8	SENT_572	[p26l1336t3160r1518b3215],
13	for	IN	O	for	_	0	SENT_572	[p26l1539t3160r1609b3203],
14	chronic	JJ	O	chronic	amod	18	SENT_572	[p26l1631t3160r1814b3203],
15	hepatitis	NN	O	hepatitis	nn	18	SENT_572	[p26l1837t3160r2046b3215],
16	C.	NNP	PERSON	C.	nn	18	SENT_572	[p26l2071t3163r2118b3203],
17	Nat	NNP	PERSON	Nat	nn	18	SENT_572	[p26l1103t3234r1190b3274],
18	Genet	NNP	PERSON	Genet	prep_for	8	SENT_572	[p26l1206t3233r1351b3273],
19	2009	CD	DATE	2009	num	18	SENT_572	[p26l1367t3233r1745b3282],
20	;	:	O	;	_	0	SENT_572	[p26l1367t3233r1745b3282],
21	41:1105	CD	NUMBER	41:1105	dep	2	SENT_572	[p26l1367t3233r1745b3282],
22	-9	CD	NUMBER	-9	dep	21	SENT_572	[p26l1367t3233r1745b3282],
23	.	.	O	.	_	0	SENT_572	[p26l1367t3233r1745b3282],

1	57	CD	NUMBER	57	_	0	SENT_573	[p26l1105t3306r1164b3343],
2	.	.	O	.	_	0	SENT_573	[p26l1105t3306r1164b3343],

1	Ge	NN	O	ge	nn	2	SENT_574	[p26l1199t3303r1265b3344],
2	D	NN	O	d	_	0	SENT_574	[p26l1280t3304r1330b3353],
3	,	,	O	,	_	0	SENT_574	[p26l1280t3304r1330b3353],
4	Fellay	NNP	PERSON	Fellay	nn	5	SENT_574	[p26l1348t3300r1489b3355],
5	J	NNP	PERSON	J	appos	2	SENT_574	[p26l1497t3304r1528b3353],
6	,	,	O	,	_	0	SENT_574	[p26l1497t3304r1528b3353],
7	Thompson	NNP	PERSON	Thompson	nn	9	SENT_574	[p26l1546t3300r1807b3355],
8	A	NNP	O	A	nn	9	SENT_574	[p26l1821t3304r1886b3353],
9	]	NN	O	]	appos	2	SENT_574	[p26l1821t3304r1886b3353],
10	,	,	O	,	_	0	SENT_574	[p26l1821t3304r1886b3353],
11	et	FW	O	et	nn	12	SENT_574	[p26l1905t3309r1949b3343],
12	al.	FW	O	al.	appos	2	SENT_574	[p26l1961t3300r2016b3343],
13	.	.	O	.	_	0	SENT_574	[p26l1961t3300r2016b3343],

1	Genetic	JJ	O	genetic	amod	2	SENT_575	[p26l2035t3303r2120b3344, p26l1105t3371r1221b3413],
2	variation	NN	O	variation	nsubj	5	SENT_575	[p26l1238t3371r1454b3414],
3	in	IN	O	in	_	0	SENT_575	[p26l1473t3371r1519b3413],
4	IL28B	NN	O	il28b	prep_in	2	SENT_575	[p26l1537t3373r1677b3413],
5	predicts	VBZ	O	predict	_	0	SENT_575	[p26l1697t3370r1890b3425],
6	hepatitis	NN	O	hepatitis	dobj	5	SENT_575	[p26l1911t3370r2120b3425],
7	C	NN	O	c	prep	6	SENT_575	[p26l1105t3443r1137b3483],
8	treatment-induced	JJ	O	treatment-induced	amod	10	SENT_575	[p26l1164t3440r1610b3484],
9	viral	JJ	O	viral	amod	10	SENT_575	[p26l1634t3440r1742b3484],
10	clearance	NN	O	clearance	dep	7	SENT_575	[p26l1768t3440r2008b3483],
11	.	.	O	.	_	0	SENT_575	[p26l1768t3440r2008b3483],

1	Nature	NNP	O	Nature	_	0	SENT_576	[p26l2036t3444r2120b3484, p26l1105t3519r1201b3554],

1	2009	CD	DATE	2009	_	0	SENT_577	[p26l1220t3513r1665b3562],
2	;	:	O	;	_	0	SENT_577	[p26l1220t3513r1665b3562],
3	461:399	CD	NUMBER	461:399	number	4	SENT_577	[p26l1220t3513r1665b3562],
4	-401	CD	NUMBER	-401	dep	1	SENT_577	[p26l1220t3513r1665b3562],
5	.	.	O	.	_	0	SENT_577	[p26l1220t3513r1665b3562],

1	58	CD	NUMBER	58	_	0	SENT_578	[p26l1105t3584r1168b3624],
2	.	.	O	.	_	0	SENT_578	[p26l1105t3584r1168b3624],

1	O’Brien	NNP	O	O’Brien	_	0	SENT_579	[p26l1199t3581r1375b3623],
2	TR	NN	O	tr	dep	1	SENT_579	[p26l1392t3583r1474b3626],
3	.	.	O	.	_	0	SENT_579	[p26l1392t3583r1474b3626],

1	Interferon-alfa	NN	O	interferon-alfa	_	0	SENT_580	[p26l1496t3580r1848b3632],
2	,	,	O	,	_	0	SENT_580	[p26l1496t3580r1848b3632],
3	interferonlambda	NN	O	interferonlambda	conj_and	1	SENT_580	[p26l1870t3580r2120b3623, p26l1104t3650r1286b3693],
4	and	CC	O	and	_	0	SENT_580	[p26l1307t3650r1395b3693],
5	hepatitis	NN	O	hepatitis	nn	8	SENT_580	[p26l1417t3650r1626b3705],
6	C.	NN	PERSON	c.	nn	8	SENT_580	[p26l1649t3653r1695b3693],
7	Nat	NNP	PERSON	Nat	nn	8	SENT_580	[p26l1719t3654r1806b3694],
8	Genet	NNP	PERSON	Genet	conj_and	1	SENT_580	[p26l1825t3653r1969b3693],
9	2009	CD	DATE	2009	num	8	SENT_580	[p26l1988t3653r2118b3702],
10	;	:	O	;	_	0	SENT_580	[p26l1988t3653r2118b3702],
11	41:1048	CD	NUMBER	41:1048	num	12	SENT_580	[p26l1104t3723r1379b3763],
12	-50	CD	NUMBER	-50	dep	1	SENT_580	[p26l1104t3723r1379b3763],
13	.	.	O	.	_	0	SENT_580	[p26l1104t3723r1379b3763],

1	hypersensitivity	NN	O	hypersensitivity	_	0	SENT_581	[p27l14t15r384b70],
2	to	TO	O	to	_	0	SENT_581	[p27l402t24r446b58],
3	HIV-1	NN	O	hiv-1	nn	6	SENT_581	[p27l466t18r599b58],
4	reversetranscriptase	NN	O	reversetranscriptase	nn	6	SENT_581	[p27l619t16r1029b70, p27l14t94r109b128],
5	inhibitor	NN	O	inhibitor	nn	6	SENT_581	[p27l135t85r350b129],
6	abacavir	NN	O	abacavir	prep_to	1	SENT_581	[p27l374t85r586b129],
7	.	.	O	.	_	0	SENT_581	[p27l374t85r586b129],

1	Lancet	NNP	O	Lancet	_	0	SENT_582	[p27l614t89r775b128],
2	2002	CD	DATE	2002	num	1	SENT_582	[p27l799t88r1028b137],
3	;	:	O	;	_	0	SENT_582	[p27l799t88r1028b137],
4	359	CD	NUMBER	359	num	6	SENT_582	[p27l799t88r1028b137],
5	:	:	O	:	_	0	SENT_582	[p27l799t88r1028b137],
6	727-32	CD	NUMBER	727-32	dep	1	SENT_582	[p27l14t158r183b199],
7	.	.	O	.	_	0	SENT_582	[p27l14t158r183b199],

1	48	CD	NUMBER	48	_	0	SENT_583	[p27l13t229r81b269],
2	.	.	O	.	_	0	SENT_583	[p27l13t229r81b269],

1	Mallal	JJ	O	mallal	amod	2	SENT_584	[p27l107t225r262b268],
2	S	NN	O	s	_	0	SENT_584	[p27l290t228r328b278],
3	,	,	O	,	_	0	SENT_584	[p27l290t228r328b278],
4	Phillips	NNP	PERSON	Phillips	nn	5	SENT_584	[p27l358t225r540b280],
5	E	NNP	O	E	appos	2	SENT_584	[p27l568t229r611b278],
6	,	,	O	,	_	0	SENT_584	[p27l568t229r611b278],
7	Carosi	NNP	PERSON	Carosi	nn	8	SENT_584	[p27l642t226r796b269],
8	G	NNP	PERSON	G	appos	2	SENT_584	[p27l823t228r875b278],
9	,	,	O	,	_	0	SENT_584	[p27l823t228r875b278],
10	et	FW	O	et	nn	11	SENT_584	[p27l905t234r949b268],
11	al.	FW	O	al.	appos	2	SENT_584	[p27l972t225r1027b268],
12	.	.	O	.	_	0	SENT_584	[p27l972t225r1027b268],

1	HLA-B	NN	O	hla-b	_	0	SENT_585	[p27l14t295r315b338],
2	*	CD	NUMBER	*	number	3	SENT_585	[p27l14t295r315b338],
3	5701	CD	NUMBER	5701	num	4	SENT_585	[p27l14t295r315b338],
4	screening	NN	O	screening	dep	1	SENT_585	[p27l342t296r576b351],
5	for	IN	O	for	_	0	SENT_585	[p27l599t295r669b338],
6	hypersensitivity	NN	O	hypersensitivity	prep_for	4	SENT_585	[p27l692t295r1029b350, p27l13t366r74b420],
7	to	TO	O	to	_	0	SENT_585	[p27l101t374r146b409],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_585	[p27l175t365r387b409],
9	.	.	O	.	_	0	SENT_585	[p27l175t365r387b409],

1	N	NN	O	n	nn	3	SENT_586	[p27l417t369r458b409],
2	Engl	NNP	O	Engl	nn	3	SENT_586	[p27l486t365r594b421],
3	J	NNP	O	J	nsubj	4	SENT_586	[p27l617t369r638b415],
4	Med	VBD	O	med	_	0	SENT_586	[p27l664t365r768b409],
5	2008	CD	DATE	2008	dobj	4	SENT_586	[p27l797t368r1028b417],
6	;	:	O	;	_	0	SENT_586	[p27l797t368r1028b417],
7	358	CD	NUMBER	358	num	9	SENT_586	[p27l797t368r1028b417],
8	:	:	O	:	_	0	SENT_586	[p27l797t368r1028b417],
9	568-79	CD	NUMBER	568-79	dep	5	SENT_586	[p27l15t438r185b479],
10	.	.	O	.	_	0	SENT_586	[p27l15t438r185b479],

1	49	CD	NUMBER	49	_	0	SENT_587	[p27l13t510r79b548],
2	.	.	O	.	_	0	SENT_587	[p27l13t510r79b548],

1	Information	NN	O	information	_	0	SENT_588	[p27l108t505r412b548],
2	for	IN	O	for	_	0	SENT_588	[p27l451t505r521b548],
3	healthcare	NN	O	healthcare	nn	4	SENT_588	[p27l559t505r818b548],
4	professionals	NNS	O	professional	prep_for	1	SENT_588	[p27l856t505r1029b560, p27l15t575r201b619],
5	:	:	O	:	_	0	SENT_588	[p27l856t505r1029b560, p27l15t575r201b619],
6	abacavir	NN	O	abacavir	nn	7	SENT_588	[p27l238t575r443b619],
7	(	NN	O	(	dep	1	SENT_588	[p27l479t575r728b625],
8	marketed	VBN	O	market	partmod	7	SENT_588	[p27l479t575r728b625],
9	as	IN	O	as	_	0	SENT_588	[p27l762t589r811b618],
10	Ziagen	NNP	PERSON	Ziagen	nn	11	SENT_588	[p27l846t576r1027b631],
11	)	NN	O	)	prep_as	8	SENT_588	[p27l846t576r1027b631],
12	and	CC	O	and	_	0	SENT_588	[p27l14t645r103b688],
13	abacavir-containing	JJ	O	abacavir-containing	amod	14	SENT_588	[p27l159t645r657b701],
14	medications	NNS	O	medication	prep_as	8	SENT_588	[p27l711t645r1027b688],
15	.	.	O	.	_	0	SENT_588	[p27l711t645r1027b688],

1	(	NN	O	(	nn	2	SENT_589	[p27l17t715r992b771],
2	http	NN	O	http	_	0	SENT_589	[p27l17t715r992b771],
3	:	:	O	:	_	0	SENT_589	[p27l17t715r992b771],
4	I/WWW	NN	O	i/www	dep	2	SENT_589	[p27l17t715r992b771],
5	.	.	O	.	_	0	SENT_589	[p27l17t715r992b771],

1	fda	NN	O	fda	_	0	SENT_590	[p27l17t715r992b771],
2	.	.	O	.	_	0	SENT_590	[p27l17t715r992b771],

1	gov/Drugs/DrugSafety	NN	O	gov/drugs/drugsafety	_	0	SENT_591	[p27l17t715r992b771],
2	/	:	O	/	punct	1	SENT_591	[p27l17t715r992b771],
3	PostmarketDrugSafetylnformationfor	NNP	O	PostmarketDrugSafetylnformationfor	dep	1	SENT_591	[p27l13t785r957b841],
4	PatientsandProviders/ucm123927	NN	O	patientsandproviders/ucm123927	dep	3	SENT_591	[p27l13t855r963b905],
5	.	.	O	.	_	0	SENT_591	[p27l13t855r963b905],

1	htm	NN	O	htm	_	0	SENT_592	[p27l13t855r963b905],
2	.	.	O	.	_	0	SENT_592	[p27l13t855r963b905],
3	)	SYM	O	)	dep	1	SENT_592	[p27l13t855r963b905],

1	50	CD	NUMBER	50	_	0	SENT_593	[p27l14t929r79b968],
2	.	.	O	.	_	0	SENT_593	[p27l14t929r79b968],

1	Ferrell	NNP	O	Ferrell	nn	3	SENT_594	[p27l108t925r265b968],
2	PB	NN	O	pb	nn	3	SENT_594	[p27l281t929r340b968],
3	Jr	NNP	O	Jr	_	0	SENT_594	[p27l353t929r405b978],
4	,	,	O	,	_	0	SENT_594	[p27l353t929r405b978],
5	McLeod	NNP	PERSON	McLeod	nn	6	SENT_594	[p27l423t925r615b969],
6	HL	NNS	O	hl	appos	3	SENT_594	[p27l631t929r717b968],
7	.	.	O	.	_	0	SENT_594	[p27l631t929r717b968],

1	Carbamazepine	NNP	O	Carbamazepine	_	0	SENT_595	[p27l737t925r1029b969, p27l13t996r130b1050],
2	,	,	O	,	_	0	SENT_595	[p27l737t925r1029b969, p27l13t996r130b1050],
3	HLA-B	NN	O	hla-b	conj_and	1	SENT_595	[p27l167t995r471b1038],
4	*	CD	NUMBER	*	number	5	SENT_595	[p27l167t995r471b1038],
5	1502	CD	DATE	1502	dep	3	SENT_595	[p27l167t995r471b1038],
6	and	CC	O	and	_	0	SENT_595	[p27l505t995r593b1038],
7	risk	NN	O	risk	conj_and	1	SENT_595	[p27l628t995r720b1039],
8	of	IN	O	of	_	0	SENT_595	[p27l752t995r808b1038],
9	StevensJohnson	NN	O	stevensjohnson	nn	10	SENT_595	[p27l833t998r1029b1039, p27l9t1065r211b1115],
10	syndrome	NN	O	syndrome	prep_of	7	SENT_595	[p27l245t1065r483b1120],
11	and	CC	O	and	_	0	SENT_595	[p27l516t1065r604b1109],
12	toxic	JJ	O	toxic	amod	14	SENT_595	[p27l638t1066r754b1108],
13	epidermal	JJ	O	epidermal	amod	14	SENT_595	[p27l787t1065r1030b1120],
14	necrolysis	NN	O	necrolysis	conj_and	1	SENT_595	[p27l14t1135r266b1190],
15	:	:	O	:	_	0	SENT_595	[p27l14t1135r266b1190],
16	US	NNP	LOCATION	US	nn	17	SENT_595	[p27l315t1138r379b1179],
17	FDA	NNP	ORGANIZATION	FDA	dep	1	SENT_595	[p27l426t1139r529b1178],
18	recommendations	NNS	O	recommendation	dep	17	SENT_595	[p27l574t1135r1027b1179],
19	.	.	O	.	_	0	SENT_595	[p27l574t1135r1027b1179],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_596	[p27l13t1205r491b1261],
2	2008	CD	DATE	2008	num	1	SENT_596	[p27l511t1208r868b1257],
3	;	:	O	;	_	0	SENT_596	[p27l511t1208r868b1257],
4	9:1543	CD	NUMBER	9:1543	number	5	SENT_596	[p27l511t1208r868b1257],
5	—	CD	NUMBER	—	dep	1	SENT_596	[p27l511t1208r868b1257],
6	6	CD	NUMBER	6	dep	5	SENT_596	[p27l511t1208r868b1257],
7	.	.	O	.	_	0	SENT_596	[p27l511t1208r868b1257],

1	51	CD	NUMBER	51	_	0	SENT_597	[p27l14t1280r77b1318],
2	.	.	O	.	_	0	SENT_597	[p27l14t1280r77b1318],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_598	[p27l109t1275r232b1319],
2	P	NN	PERSON	p	_	0	SENT_598	[p27l261t1279r298b1328],
3	,	,	O	,	_	0	SENT_598	[p27l261t1279r298b1328],
4	Lin	NNP	PERSON	Lin	nn	5	SENT_598	[p27l330t1276r407b1318],
5	J-J	NNP	PERSON	J-J	appos	2	SENT_598	[p27l432t1279r499b1328],
6	,	,	O	,	_	0	SENT_598	[p27l432t1279r499b1328],
7	Lu	NNP	PERSON	Lu	nn	8	SENT_598	[p27l531t1279r589b1319],
8	C-S	NNP	O	C-S	appos	2	SENT_598	[p27l619t1278r713b1328],
9	,	,	O	,	_	0	SENT_598	[p27l619t1278r713b1328],
10	et	FW	O	et	nn	11	SENT_598	[p27l746t1284r789b1318],
11	al.	FW	O	al.	appos	2	SENT_598	[p27l816t1275r871b1318],
12	.	.	O	.	_	0	SENT_598	[p27l816t1275r871b1318],

1	HLA59	NN	O	hla59	_	0	SENT_599	[p27l903t1279r1029b1318, p27l1105t20r1168b58],
2	.	.	O	.	_	0	SENT_599	[p27l903t1279r1029b1318, p27l1105t20r1168b58],

1	Eisenhauer	NNP	PERSON	Eisenhauer	_	0	SENT_600	[p27l1199t15r1468b59],
2	EA	NN	O	ea	dep	1	SENT_600	[p27l1487t19r1567b58],
3	.	.	O	.	_	0	SENT_600	[p27l1487t19r1567b58],

1	From	IN	O	from	_	0	SENT_601	[p27l1591t19r1718b58],
2	the	DT	O	the	det	3	SENT_601	[p27l1739t15r1814b58],
3	molecule	NN	O	molecule	pobj	1	SENT_601	[p27l1835t15r2053b59],
4	to	TO	O	to	_	0	SENT_601	[p27l2075t24r2120b58],
5	the	DT	O	the	det	7	SENT_601	[p27l1105t85r1179b128],
6	clinic	NN	O	clinic	nn	7	SENT_601	[p27l1216t85r1347b128],
7	—	NN	O	—	prep_to	3	SENT_601	[p27l1381t110r1440b114],
8	inhibiting	VBG	O	inhibit	partmod	7	SENT_601	[p27l1474t85r1718b141],
9	HER2	NN	O	her2	dobj	8	SENT_601	[p27l1752t88r1892b131],
10	to	TO	O	to	aux	11	SENT_601	[p27l1929t94r1974b129],
11	treat	VB	O	treat	xcomp	8	SENT_601	[p27l2011t94r2124b128],
12	breast	NN	O	breast	nn	13	SENT_601	[p27l1105t155r1256b199],
13	cancer	NN	O	cancer	dobj	11	SENT_601	[p27l1284t169r1456b198],
14	.	.	O	.	_	0	SENT_601	[p27l1284t169r1456b198],

1	N	NN	O	n	nn	3	SENT_602	[p27l1489t159r1530b199],
2	Engl	NNP	O	Engl	nn	3	SENT_602	[p27l1559t155r1670b211],
3	J	NNP	O	J	nsubj	4	SENT_602	[p27l1695t159r1716b205],
4	Med	VBD	O	med	_	0	SENT_602	[p27l1743t155r1849b199],
5	2001	CD	DATE	2001	dobj	4	SENT_602	[p27l1880t158r2119b207],
6	;	:	O	;	_	0	SENT_602	[p27l1880t158r2119b207],
7	344	CD	NUMBER	344	num	9	SENT_602	[p27l1880t158r2119b207],
8	:	:	O	:	_	0	SENT_602	[p27l1880t158r2119b207],
9	841-2	CD	NUMBER	841-2	dep	5	SENT_602	[p27l1105t228r1246b268],
10	.	.	O	.	_	0	SENT_602	[p27l1105t228r1246b268],

1	60	CD	NUMBER	60	_	0	SENT_603	[p27l1105t299r1171b339],
2	.	.	O	.	_	0	SENT_603	[p27l1105t299r1171b339],

1	Slamon	NNP	PERSON	Slamon	nn	2	SENT_604	[p27l1201t295r1381b339],
2	DJ	NNP	O	DJ	_	0	SENT_604	[p27l1406t299r1473b348],
3	,	,	O	,	_	0	SENT_604	[p27l1406t299r1473b348],
4	Leyland-Jones	NNP	PERSON	Leyland-Jones	nn	5	SENT_604	[p27l1501t295r1836b350],
5	B	NNP	PERSON	B	appos	2	SENT_604	[p27l1862t299r1907b348],
6	,	,	O	,	_	0	SENT_604	[p27l1862t299r1907b348],
7	Shak	NNP	PERSON	Shak	nn	8	SENT_604	[p27l1937t295r2055b339],
8	S	NNP	O	S	appos	2	SENT_604	[p27l2080t298r2118b348],
9	,	,	O	,	_	0	SENT_604	[p27l2080t298r2118b348],
10	et	FW	O	et	nn	11	SENT_604	[p27l1105t374r1148b408],
11	al.	FW	O	al.	appos	2	SENT_604	[p27l1168t365r1223b408],
12	.	.	O	.	_	0	SENT_604	[p27l1168t365r1223b408],

1	Use	NN	O	use	_	0	SENT_605	[p27l1249t369r1336b409],
2	of	IN	O	of	_	0	SENT_605	[p27l1360t365r1415b409],
3	chemotherapy	NN	O	chemotherapy	prep_of	1	SENT_605	[p27l1429t365r1773b420],
4	plus	CC	O	plus	prep	1	SENT_605	[p27l1792t365r1891b420],
5	a	DT	O	a	det	7	SENT_605	[p27l1915t379r1940b408],
6	monoclonal	JJ	O	monoclonal	amod	7	SENT_605	[p27l1962t379r2120b409, p27l1105t435r1251b478],
7	antibody	NN	O	antibody	dep	4	SENT_605	[p27l1278t435r1492b490],
8	against	IN	O	against	_	0	SENT_605	[p27l1517t436r1695b491],
9	HER2	NN	O	her2	prep_against	1	SENT_605	[p27l1720t438r1860b481],
10	for	IN	O	for	_	0	SENT_605	[p27l1888t435r1958b479],
11	metastatic	JJ	O	metastatic	amod	13	SENT_605	[p27l1984t444r2120b478, p27l1105t506r1234b548],
12	breast	NN	O	breast	nn	13	SENT_605	[p27l1273t505r1422b548],
13	cancer	NN	O	cancer	prep_for	1	SENT_605	[p27l1458t519r1616b548],
14	that	WDT	O	that	nsubj	15	SENT_605	[p27l1654t505r1751b548],
15	overexpresses	VBZ	O	overexpress	rcmod	13	SENT_605	[p27l1788t519r2120b560],
16	HER2	NN	O	her2	dobj	15	SENT_605	[p27l1104t578r1258b621],
17	.	.	O	.	_	0	SENT_605	[p27l1104t578r1258b621],

1	N	NN	O	n	nn	2	SENT_606	[p27l1279t579r1320b619],
2	EnglJ	NN	O	englj	nsubj	3	SENT_606	[p27l1338t575r1481b631],
3	Med	VBD	O	med	_	0	SENT_606	[p27l1497t575r1601b618],
4	2001	CD	DATE	2001	dobj	3	SENT_606	[p27l1620t578r2032b627],
5	;	:	O	;	_	0	SENT_606	[p27l1620t578r2032b627],
6	344:783	CD	NUMBER	344:783	num	7	SENT_606	[p27l1620t578r2032b627],
7	-92	CD	NUMBER	-92	dep	4	SENT_606	[p27l1620t578r2032b627],
8	.	.	O	.	_	0	SENT_606	[p27l1620t578r2032b627],

1	61	CD	NUMBER	61	_	0	SENT_607	[p27l1105t650r1169b689],
2	.	.	O	.	_	0	SENT_607	[p27l1105t650r1169b689],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_608	[p27l1199t645r1341b700],
2	T	NN	O	t	nn	3	SENT_608	[p27l1365t648r1428b698],
3	]	NN	O	]	_	0	SENT_608	[p27l1365t648r1428b698],
4	,	,	O	,	_	0	SENT_608	[p27l1365t648r1428b698],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_608	[p27l1456t645r1548b688],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_608	[p27l1572t649r1670b698],
7	,	,	O	,	_	0	SENT_608	[p27l1572t649r1670b698],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_608	[p27l1700t645r1896b689],
9	R	NNP	PERSON	R	appos	3	SENT_608	[p27l1920t649r1968b698],
10	,	,	O	,	_	0	SENT_608	[p27l1920t649r1968b698],
11	et	FW	O	et	nn	12	SENT_608	[p27l1997t654r2040b688],
12	al.	FW	O	al.	appos	3	SENT_608	[p27l2063t645r2118b688],
13	.	.	O	.	_	0	SENT_608	[p27l2063t645r2118b688],

1	Activating	VBG	O	activate	amod	2	SENT_609	[p27l1103t716r1352b771],
2	mutations	NNS	O	mutation	_	0	SENT_609	[p27l1390t716r1635b759],
3	in	IN	O	in	_	0	SENT_609	[p27l1676t716r1722b758],
4	the	DT	O	the	det	7	SENT_609	[p27l1763t715r1837b758],
5	epidermal	JJ	O	epidermal	amod	7	SENT_609	[p27l1878t715r2121b770],
6	growth	NN	O	growth	nn	7	SENT_609	[p27l1104t785r1278b841],
7	factor	NN	O	factor	prep_in	2	SENT_609	[p27l1297t785r1435b828],
8	receptor	NN	O	receptor	nn	10	SENT_609	[p27l1453t794r1650b840],
9	underlying	VBG	O	underlie	amod	10	SENT_609	[p27l1667t785r1925b841],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_609	[p27l1942t799r2120b840, p27l1105t856r1298b899],
11	of	IN	O	of	_	0	SENT_609	[p27l1321t855r1376b898],
12	non	JJ	O	non	amod	16	SENT_609	[p27l1387t855r1749b898],
13	—	JJ	O	—	amod	16	SENT_609	[p27l1387t855r1749b898],
14	small-cell	NN	O	small-cell	nn	16	SENT_609	[p27l1387t855r1749b898],
15	lung	NN	O	lung	nn	16	SENT_609	[p27l1769t855r1878b911],
16	cancer	NN	O	cancer	prep_of	10	SENT_609	[p27l1897t869r2055b898],
17	to	TO	O	to	_	0	SENT_609	[p27l2074t864r2120b899],
18	gefitinib	NN	O	gefitinib	prep_to	10	SENT_609	[p27l1104t925r1327b981],
19	.	.	O	.	_	0	SENT_609	[p27l1104t925r1327b981],

1	N	NN	O	n	nn	2	SENT_610	[p27l1346t929r1387b968],
2	EnglJ	NN	O	englj	nsubj	3	SENT_610	[p27l1402t925r1542b981],
3	Med	VBD	O	med	_	0	SENT_610	[p27l1556t925r1660b969],
4	2004	CD	DATE	2004	dobj	3	SENT_610	[p27l1677t928r2118b977],
5	;	:	O	;	_	0	SENT_610	[p27l1677t928r2118b977],
6	350:2129	CD	NUMBER	350:2129	num	7	SENT_610	[p27l1677t928r2118b977],
7	-39	CD	NUMBER	-39	dep	4	SENT_610	[p27l1677t928r2118b977],
8	.	.	O	.	_	0	SENT_610	[p27l1677t928r2118b977],

1	62	CD	NUMBER	62	_	0	SENT_611	[p27l1105t1000r1172b1038],
2	.	.	O	.	_	0	SENT_611	[p27l1105t1000r1172b1038],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_612	[p27l1199t999r1307b1038],
2	JG	NNP	O	JG	_	0	SENT_612	[p27l1320t998r1394b1047],
3	,	,	O	,	_	0	SENT_612	[p27l1320t998r1394b1047],
4	Jéinne	NNP	ORGANIZATION	Jéinne	nn	5	SENT_612	[p27l1411t998r1549b1045],
5	PA	NN	ORGANIZATION	pa	appos	2	SENT_612	[p27l1567t999r1642b1048],
6	,	,	O	,	_	0	SENT_612	[p27l1567t999r1642b1048],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_612	[p27l1663t999r1744b1038],
8	JC	NNP	PERSON	JC	appos	2	SENT_612	[p27l1758t998r1826b1048],
9	,	,	O	,	_	0	SENT_612	[p27l1758t998r1826b1048],
10	et	FW	O	et	nn	11	SENT_612	[p27l1849t1004r1892b1038],
11	al.	FW	O	al.	appos	2	SENT_612	[p27l1908t995r1963b1038],
12	.	.	O	.	_	0	SENT_612	[p27l1908t995r1963b1038],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_613	[p27l1984t998r2127b1041],
2	mutations	NNS	O	mutation	_	0	SENT_613	[p27l1105t1066r1344b1109],
3	in	IN	O	in	_	0	SENT_613	[p27l1363t1066r1410b1108],
4	lung	NN	O	lung	nn	5	SENT_613	[p27l1427t1065r1534b1121],
5	cancer	NN	O	cancer	prep_in	2	SENT_613	[p27l1551t1079r1717b1108],
6	:	:	O	:	_	0	SENT_613	[p27l1551t1079r1717b1108],
7	correlation	NN	O	correlation	dep	2	SENT_613	[p27l1738t1065r1998b1109],
8	with	IN	O	with	_	0	SENT_613	[p27l2013t1065r2121b1109],
9	clinical	JJ	O	clinical	amod	10	SENT_613	[p27l1105t1135r1282b1178],
10	response	NN	O	response	prep_with	7	SENT_613	[p27l1299t1149r1514b1190],
11	to	TO	O	to	_	0	SENT_613	[p27l1532t1144r1578b1178],
12	gefitinib	NN	O	gefitinib	nn	13	SENT_613	[p27l1596t1135r1806b1191],
13	therapy	NN	O	therapy	prep_to	10	SENT_613	[p27l1824t1135r2013b1190],
14	.	.	O	.	_	0	SENT_613	[p27l1824t1135r2013b1190],

1	Science	NNP	O	Science	_	0	SENT_614	[p27l2035t1136r2120b1178, p27l1105t1219r1211b1248],
2	2004	CD	DATE	2004	num	1	SENT_614	[p27l1230t1208r1697b1257],
3	;	:	O	;	_	0	SENT_614	[p27l1230t1208r1697b1257],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_614	[p27l1230t1208r1697b1257],
5	-500	CD	NUMBER	-500	dep	1	SENT_614	[p27l1230t1208r1697b1257],
6	.	.	O	.	_	0	SENT_614	[p27l1230t1208r1697b1257],

1	63	CD	NUMBER	63	_	0	SENT_615	[p27l1105t1280r1169b1319],
2	.	.	O	.	_	0	SENT_615	[p27l1105t1280r1169b1319],

1	Davies	NNP	PERSON	Davies	nn	2	SENT_616	[p27l1199t1276r1355b1319],
2	H	NNP	PERSON	H	_	0	SENT_616	[p27l1386t1279r1439b1328],
3	,	,	O	,	_	0	SENT_616	[p27l1386t1279r1439b1328],
4	Bignell	NNP	PERSON	Bignell	nn	5	SENT_616	[p27l1472t1275r1642b1331],
5	GR	NN	O	gr	appos	2	SENT_616	[p27l1671t1278r1761b1328],
6	,	,	O	,	_	0	SENT_616	[p27l1671t1278r1761b1328],
7	Cox	NN	ORGANIZATION	cox	nn	8	SENT_616	[p27l1793t1278r1885b1319],
8	C	NN	ORGANIZATION	c	appos	2	SENT_616	[p27l1913t1278r1960b1328],
9	,	,	O	,	_	0	SENT_616	[p27l1913t1278r1960b1328],
10	et	FW	O	et	nn	11	SENT_616	[p27l1993t1284r2037b1318],
11	al.	FW	O	al.	appos	2	SENT_616	[p27l2063t1275r2118b1318],
12	.	.	O	.	_	0	SENT_616	[p27l2063t1275r2118b1318],

1	Mutations	NNS	O	mutation	_	0	SENT_617	[p27l88t1764r586b1850],
2	of	IN	O	of	_	0	SENT_617	[p27l651t1762r764b1850],
3	the	DT	O	the	det	5	SENT_617	[p27l806t1762r958b1850],
4	BRAF	NN	O	braf	nn	5	SENT_617	[p27l1019t1769r1294b1854],
5	gene	NN	O	gene	prep_of	1	SENT_617	[p27l1358t1791r1583b1875],
6	in	IN	O	in	_	0	SENT_617	[p27l1646t1764r1741b1848],
7	human	JJ	O	human	amod	8	SENT_617	[p27l1802t1762r2147b1850],
8	cancer	NN	O	cancer	prep_in	1	SENT_617	[p27l92t1934r432b1994],
9	.	.	O	.	_	0	SENT_617	[p27l92t1934r432b1994],

1	Nature	NNP	O	Nature	_	0	SENT_618	[p27l476t1913r810b1994],
2	2002	CD	DATE	2002	num	1	SENT_618	[p27l848t1911r1668b2011],
3	;	:	O	;	_	0	SENT_618	[p27l848t1911r1668b2011],
4	417:949	CD	NUMBER	417:949	number	5	SENT_618	[p27l848t1911r1668b2011],
5	-54	CD	NUMBER	-54	dep	1	SENT_618	[p27l848t1911r1668b2011],
6	.	.	O	.	_	0	SENT_618	[p27l848t1911r1668b2011],

1	64	CD	NUMBER	64	_	0	SENT_619	[p27l92t2060r227b2138],
2	.	.	O	.	_	0	SENT_619	[p27l92t2060r227b2138],

1	Flaherty	NNP	ORGANIZATION	Flaherty	nn	2	SENT_620	[p27l282t2050r687b2161],
2	KT	NNP	ORGANIZATION	KT	_	0	SENT_620	[p27l714t2057r877b2156],
3	,	,	O	,	_	0	SENT_620	[p27l714t2057r877b2156],
4	Puzanov	NNP	O	Puzanov	appos	2	SENT_620	[p27l915t2057r1334b2138],
5	1	CD	NUMBER	1	num	4	SENT_620	[p27l1362t2058r1422b2157],
6	,	,	O	,	_	0	SENT_620	[p27l1362t2058r1422b2157],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_620	[p27l1462t2052r1670b2140],
8	KB	NN	PERSON	kb	appos	2	SENT_620	[p27l1702t2057r1873b2157],
9	,	,	O	,	_	0	SENT_620	[p27l1702t2057r1873b2157],
10	et	FW	O	et	nn	11	SENT_620	[p27l1915t2069r2002b2136],
11	al.	FW	O	al.	appos	2	SENT_620	[p27l2030t2050r2141b2138],
12	.	.	O	.	_	0	SENT_620	[p27l2030t2050r2141b2138],

1	Inhibition	NN	O	inhibition	_	0	SENT_621	[p27l90t2193r586b2281],
2	of	IN	O	of	_	0	SENT_621	[p27l633t2193r747b2281],
3	mutated	VBN	O	mutate	dep	6	SENT_621	[p27l772t2193r1201b2298],
4	,	,	O	,	_	0	SENT_621	[p27l772t2193r1201b2298],
5	activated	VBN	O	activate	amod	6	SENT_621	[p27l1253t2193r1685b2281],
6	BRAF	NN	O	braf	prep_of	1	SENT_621	[p27l1729t2200r2005b2285],
7	in	IN	O	in	_	0	SENT_621	[p27l2053t2195r2147b2279],
8	metastatic	JJ	O	metastatic	amod	9	SENT_621	[p27l92t2339r601b2425],
9	melanoma	NN	O	melanoma	prep_in	6	SENT_621	[p27l633t2337r1178b2425],
10	.	.	O	.	_	0	SENT_621	[p27l633t2337r1178b2425],

1	N	NN	O	n	nn	2	SENT_622	[p27l1216t2345r1299b2425],
2	EnglJ	NN	O	englj	nsubj	3	SENT_622	[p27l1330t2337r1614b2450],
3	Med	VBD	O	med	_	0	SENT_622	[p27l1642t2337r1854b2425],
4	2010	CD	DATE	2010	dobj	3	SENT_622	[p27l1886t2343r2143b2443],
5	;	:	O	;	_	0	SENT_622	[p27l1886t2343r2143b2443],

1	65	CD	NUMBER	65	_	0	SENT_623	[p27l92t2636r221b2714],
2	.	.	O	.	_	0	SENT_623	[p27l92t2636r221b2714],

1	Iyer	NNP	O	Iyer	nn	2	SENT_624	[p27l282t2634r461b2737],
2	L	NNP	O	L	_	0	SENT_624	[p27l497t2634r582b2732],
3	,	,	O	,	_	0	SENT_624	[p27l497t2634r582b2732],
4	King	NNP	O	King	nn	5	SENT_624	[p27l626t2628r866b2739],
5	CD	NNP	O	CD	appos	2	SENT_624	[p27l902t2632r1073b2733],
6	,	,	O	,	_	0	SENT_624	[p27l902t2632r1073b2733],
7	Whitington	NNP	PERSON	Whitington	nn	8	SENT_624	[p27l1115t2626r1689b2739],
8	PF	NNP	O	PF	appos	2	SENT_624	[p27l1727t2633r1862b2733],
9	,	,	O	,	_	0	SENT_624	[p27l1727t2633r1862b2733],
10	et	FW	O	et	nn	11	SENT_624	[p27l1909t2645r1996b2713],
11	al.	FW	O	al.	appos	2	SENT_624	[p27l2030t2626r2141b2714],
12	.	.	O	.	_	0	SENT_624	[p27l2030t2626r2141b2714],

1	Genetic	JJ	O	genetic	amod	2	SENT_625	[p27l92t2772r467b2858],
2	predisposition	NN	O	predisposition	_	0	SENT_625	[p27l501t2770r1211b2881],
3	to	TO	O	to	_	0	SENT_625	[p27l1249t2789r1341b2858],
4	the	DT	O	the	det	5	SENT_625	[p27l1380t2770r1530b2858],
5	metabolism	NN	O	metabolism	prep_to	2	SENT_625	[p27l1566t2770r2147b2858],
6	of	IN	O	of	_	0	SENT_625	[p27l92t2913r205b3001],
7	irinotecan	NN	O	irinotecan	nn	9	SENT_625	[p27l227t2915r731b3001],
8	(	CD	NUMBER	(	num	9	SENT_625	[p27l781t2919r1209b3015],
9	CPT-11	NN	O	cpt-11	prep_of	5	SENT_625	[p27l781t2919r1209b3015],
10	)	CD	NUMBER	)	num	9	SENT_625	[p27l781t2919r1209b3015],
11	:	:	O	:	_	0	SENT_625	[p27l781t2919r1209b3015],
12	role	NN	O	role	dep	2	SENT_625	[p27l1259t2913r1441b3001],
13	of	IN	O	of	_	0	SENT_625	[p27l1485t2913r1599b3001],
14	uridine	NN	O	uridine	nn	15	SENT_625	[p27l1621t2913r1975b3002],
15	diphosphate	NN	O	diphosphate	prep_of	12	SENT_625	[p27l2019t2913r2146b3001, p27l90t3058r608b3169],

1	glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	3	SENT_626	[p27l681t3058r1890b3171],
2	isoform	NN	O	isoform	nn	3	SENT_626	[p27l1963t3060r2146b3146, p27l92t3202r332b3290],
3	1A1	NN	O	1a1	_	0	SENT_626	[p27l401t3208r587b3288],
4	in	IN	O	in	_	0	SENT_626	[p27l650t3204r745b3288],
5	the	DT	O	the	det	6	SENT_626	[p27l808t3202r960b3290],
6	glucuronidation	NN	O	glucuronidation	prep_in	3	SENT_626	[p27l1023t3202r1814b3315],
7	of	IN	O	of	_	0	SENT_626	[p27l1878t3202r1990b3290],
8	its	PRP$	O	its	poss	13	SENT_626	[p27l2032t3204r2145b3288],
9	active	JJ	O	active	amod	13	SENT_626	[p27l90t3347r365b3434],
10	metabolite	NN	O	metabolite	nn	13	SENT_626	[p27l416t3345r939b3433],
11	(	CD	NUMBER	(	num	13	SENT_626	[p27l994t3351r1345b3447],
12	SN-38	NN	O	sn-38	nn	13	SENT_626	[p27l994t3351r1345b3447],
13	)	NN	O	)	prep_of	3	SENT_626	[p27l994t3351r1345b3447],
14	in	IN	O	in	_	0	SENT_626	[p27l1401t3347r1497b3432],
15	human	JJ	O	human	amod	17	SENT_626	[p27l1546t3345r1890b3434],
16	liver	NN	O	liver	nn	17	SENT_626	[p27l1940t3345r2151b3434],
17	microsomes	NNS	O	microsome	prep_in	13	SENT_626	[p27l91t3492r703b3579],
18	.	.	O	.	_	0	SENT_626	[p27l91t3492r703b3579],

1	I	PRP	O	I	nsubj	2	SENT_627	[p27l729t3498r772b3592],
2	Clin	VBP	O	clin	_	0	SENT_627	[p27l800t3490r998b3579],
3	Invest	VB	O	invest	xcomp	2	SENT_627	[p27l1027t3498r1315b3579],
4	1998	CD	DATE	1998	dobj	3	SENT_627	[p27l1345t3496r2141b3596],
5	;	:	O	;	_	0	SENT_627	[p27l1345t3496r2141b3596],
6	101:847	CD	NUMBER	101:847	num	7	SENT_627	[p27l1345t3496r2141b3596],
7	-54	CD	NUMBER	-54	dep	4	SENT_627	[p27l1345t3496r2141b3596],
8	.	.	O	.	_	0	SENT_627	[p27l1345t3496r2141b3596],

1	66	CD	NUMBER	66	_	0	SENT_628	[p27l92t3645r227b3723],
2	.	.	O	.	_	0	SENT_628	[p27l92t3645r227b3723],

1	Freedman	NNP	PERSON	Freedman	nn	2	SENT_629	[p27l282t3635r774b3723],
2	RA	NN	O	ra	_	0	SENT_629	[p27l854t3642r1029b3742],
3	,	,	O	,	_	0	SENT_629	[p27l854t3642r1029b3742],
4	Winer	NNP	PERSON	Winer	nn	5	SENT_629	[p27l1113t3637r1416b3721],
5	EP	NNP	O	EP	appos	2	SENT_629	[p27l1493t3642r1633b3723],
6	.	.	O	.	_	0	SENT_629	[p27l1493t3642r1633b3723],

1	Adjuvant	JJ	O	adjuvant	amod	2	SENT_630	[p27l1717t3635r2153b3746],
2	therapy	NN	O	therapy	_	0	SENT_630	[p28l92t24r459b135],
3	for	IN	O	for	_	0	SENT_630	[p28l499t22r639b112],
4	postmenopausal	JJ	O	postmenopausal	amod	5	SENT_630	[p28l677t24r1489b135],
5	women	NNS	O	woman	prep_for	2	SENT_630	[p28l1528t52r1886b112],
6	With	IN	O	with	_	0	SENT_630	[p28l1926t24r2147b112],
7	endocrine-sensitive	JJ	O	endocrine-sensitive	amod	9	SENT_630	[p28l92t167r1042b255],
8	breast	NN	O	breast	nn	9	SENT_630	[p28l1096t167r1397b255],
9	cancer	NN	O	cancer	prep_with	2	SENT_630	[p28l1447t196r1787b255],
10	.	.	O	.	_	0	SENT_630	[p28l1447t196r1787b255],

1	Breast	NN	O	breast	_	0	SENT_631	[p28l1846t174r2153b253],

1	2010	CD	DATE	2010	_	0	SENT_632	[p28l92t316r793b416],
2	;	:	O	;	_	0	SENT_632	[p28l92t316r793b416],
3	19:69	CD	NUMBER	19:69	number	4	SENT_632	[p28l92t316r793b416],
4	-75	CD	NUMBER	-75	dep	1	SENT_632	[p28l92t316r793b416],
5	.	.	O	.	_	0	SENT_632	[p28l92t316r793b416],

1	67	CD	NUMBER	67	_	0	SENT_633	[p28l92t466r213b543],
2	.	.	O	.	_	0	SENT_633	[p28l92t466r213b543],

1	Janni	NNP	PERSON	Janni	nn	2	SENT_634	[p28l272t457r536b557],
2	W	NNP	PERSON	W	_	0	SENT_634	[p28l574t463r695b562],
3	,	,	O	,	_	0	SENT_634	[p28l574t463r695b562],
4	Hepp	NNP	PERSON	Hepp	nn	5	SENT_634	[p28l744t463r1002b566],
5	P.	NNP	PERSON	P.	appos	2	SENT_634	[p28l1046t462r1121b543],
6	Adjuvant	JJ	PERSON	adjuvant	amod	9	SENT_634	[p28l1165t455r1602b566],
7	aromatase	NN	O	aromatase	nn	9	SENT_634	[p28l1639t474r2147b543],
8	inhibitor	NN	O	inhibitor	nn	9	SENT_634	[p28l90t599r526b687],
9	therapy	NN	O	therapy	dep	5	SENT_634	[p28l591t599r979b710],
10	:	:	O	:	_	0	SENT_634	[p28l591t599r979b710],
11	outcomes	NNS	O	outcome	dep	2	SENT_634	[p28l1052t618r1520b687],
12	and	CC	O	and	_	0	SENT_634	[p28l1589t599r1768b687],
13	safety	NN	O	safety	conj_and	11	SENT_634	[p28l1836t599r2141b710],
14	.	.	O	.	_	0	SENT_634	[p28l1836t599r2141b710],

1	Cancer	NNP	O	Cancer	nn	3	SENT_635	[p28l92t748r430b831],
2	Treat	NNP	O	Treat	nn	3	SENT_635	[p28l462t750r718b829],
3	Rev	NN	O	rev	_	0	SENT_635	[p28l749t750r927b835],
4	2010	CD	DATE	2010	num	3	SENT_635	[p28l961t748r1731b848],
5	;	:	O	;	_	0	SENT_635	[p28l961t748r1731b848],
6	36:249	CD	NUMBER	36:249	number	7	SENT_635	[p28l961t748r1731b848],
7	-61	CD	NUMBER	-61	dep	3	SENT_635	[p28l961t748r1731b848],
8	.	.	O	.	_	0	SENT_635	[p28l961t748r1731b848],

1	68	CD	NUMBER	68	_	0	SENT_636	[p28l92t896r227b975],
2	.	.	O	.	_	0	SENT_636	[p28l92t896r227b975],

1	Early	RB	O	early	advmod	5	SENT_637	[p28l282t887r528b998],
2	Breast	NN	O	breast	nn	4	SENT_637	[p28l572t894r879b973],
3	Cancer	NN	O	cancer	nn	4	SENT_637	[p28l923t893r1263b975],
4	Trialists	NNS	O	trialist	nsubj	5	SENT_637	[p28l1307t887r1737b973],
5	’	VBP	O	’	_	0	SENT_637	[p28l1307t887r1737b973],
6	Collaborative	NNP	O	Collaborative	nn	7	SENT_637	[p28l1792t887r2146b975, p28l92t1033r419b1119],
7	Group	NNP	O	Group	nsubj	10	SENT_637	[p28l470t1037r776b1142],
8	(	CD	NUMBER	(	num	10	SENT_637	[p28l835t1037r1355b1133],
9	EBCTCG	NN	O	ebctcg	nn	10	SENT_637	[p28l835t1037r1355b1133],
10	)	NN	O	)	xcomp	5	SENT_637	[p28l835t1037r1355b1133],
11	.	.	O	.	_	0	SENT_637	[p28l835t1037r1355b1133],

1	Effects	NNS	O	effect	_	0	SENT_638	[p28l1412t1031r1746b1117],
2	of	IN	O	of	_	0	SENT_638	[p28l1802t1031r1913b1119],
3	chemotherapy	NN	O	chemotherapy	nn	6	SENT_638	[p28l1946t1031r2146b1117, p28l92t1175r618b1286],
4	and	CC	O	and	_	0	SENT_638	[p28l706t1175r885b1263],
5	hormonal	JJ	O	hormonal	conj_and	3	SENT_638	[p28l979t1175r1462b1263],
6	therapy	NN	O	therapy	prep_of	1	SENT_638	[p28l1556t1175r1921b1286],
7	for	IN	O	for	_	0	SENT_638	[p28l2011t1175r2151b1263],
8	early	JJ	O	early	amod	10	SENT_638	[p28l92t1319r327b1430],
9	breast	NN	O	breast	nn	10	SENT_638	[p28l363t1319r662b1407],
10	cancer	NN	O	cancer	prep_for	6	SENT_638	[p28l698t1348r1017b1407],
11	on	IN	O	on	_	0	SENT_638	[p28l1055t1348r1175b1407],
12	recurrence	NN	O	recurrence	nn	15	SENT_638	[p28l1215t1348r1735b1407],
13	and	CC	O	and	_	0	SENT_638	[p28l1775t1319r1953b1407],
14	15year	JJ	O	15year	nn	15	SENT_638	[p28l1997t1326r2145b1407, p28l86t1492r290b1574],
15	survival	NN	O	survival	prep_on	10	SENT_638	[p28l367t1463r772b1551],
16	:	:	O	:	_	0	SENT_638	[p28l367t1463r772b1551],
17	an	DT	O	a	det	18	SENT_638	[p28l852t1492r969b1549],
18	overview	NN	O	overview	dep	1	SENT_638	[p28l1047t1465r1478b1551],
19	of	IN	O	of	_	0	SENT_638	[p28l1552t1463r1664b1551],
20	the	DT	O	the	det	22	SENT_638	[p28l1721t1463r1871b1551],
21	randomised	JJ	O	randomised	amod	22	SENT_638	[p28l1949t1492r2146b1549, p28l92t1607r509b1696],
22	trials	NNS	O	trial	prep_of	18	SENT_638	[p28l547t1607r826b1696],
23	.	.	O	.	_	0	SENT_638	[p28l547t1607r826b1696],

1	Lancet	NNP	O	Lancet	_	0	SENT_639	[p28l867t1615r1194b1694],
2	2005	CD	DATE	2005	num	1	SENT_639	[p28l1224t1613r2142b1713],
3	;	:	O	;	_	0	SENT_639	[p28l1224t1613r2142b1713],
4	365:1687	CD	NUMBER	365:1687	number	5	SENT_639	[p28l1224t1613r2142b1713],
5	-717	CD	NUMBER	-717	dep	1	SENT_639	[p28l1224t1613r2142b1713],
6	.	.	O	.	_	0	SENT_639	[p28l1224t1613r2142b1713],

1	69	CD	NUMBER	69	_	0	SENT_640	[p28l92t1762r221b1840],
2	.	.	O	.	_	0	SENT_640	[p28l92t1762r221b1840],

1	Ingle	NNP	ORGANIZATION	Ingle	nn	2	SENT_641	[p28l282t1752r528b1865],
2	JN	NN	ORGANIZATION	jn	_	0	SENT_641	[p28l577t1760r729b1859],
3	,	,	O	,	_	0	SENT_641	[p28l577t1760r729b1859],
4	Schaid	NNP	O	Schaid	nn	5	SENT_641	[p28l798t1752r1119b1840],
5	DJ	NNP	O	DJ	appos	2	SENT_641	[p28l1176t1759r1311b1859],
6	,	,	O	,	_	0	SENT_641	[p28l1176t1759r1311b1859],
7	Goss	NNP	PERSON	Goss	nn	8	SENT_641	[p28l1376t1758r1616b1840],
8	PE	NNP	O	PE	appos	2	SENT_641	[p28l1677t1759r1823b1859],
9	,	,	O	,	_	0	SENT_641	[p28l1677t1759r1823b1859],
10	et	FW	O	et	nn	11	SENT_641	[p28l1890t1771r1977b1840],
11	al.	FW	O	al.	appos	2	SENT_641	[p28l2030t1752r2141b1840],
12	.	.	O	.	_	0	SENT_641	[p28l2030t1752r2141b1840],

1	Genome-wide	JJ	O	genome-wide	amod	2	SENT_642	[p28l92t1895r760b1983],
2	associations	NNS	O	association	_	0	SENT_642	[p28l802t1897r1388b1983],
3	and	CC	O	and	_	0	SENT_642	[p28l1431t1895r1608b1983],
4	functional	JJ	O	functional	amod	5	SENT_642	[p28l1648t1895r2148b1983],
5	genomic	JJ	O	genomic	amod	6	SENT_642	[p28l90t2041r511b2152],
6	studies	NNS	O	study	conj_and	2	SENT_642	[p28l576t2039r918b2127],
7	of	IN	O	of	_	0	SENT_642	[p28l985t2039r1098b2127],
8	musculoskeletal	JJ	O	musculoskeletal	amod	10	SENT_642	[p28l1142t2039r1936b2127],
9	adverse	JJ	O	adverse	amod	10	SENT_642	[p28l1999t2039r2146b2127, p28l86t2212r332b2271],
10	events	NNS	O	event	prep_of	6	SENT_642	[p28l389t2202r689b2271],
11	in	IN	O	in	_	0	SENT_642	[p28l746t2185r841b2269],
12	Women	NNS	O	woman	prep_in	10	SENT_642	[p28l890t2212r1249b2271],
13	receiving	VBG	O	receive	partmod	2	SENT_642	[p28l1305t2185r1750b2296],
14	aromatase	NN	O	aromatase	nn	15	SENT_642	[p28l1800t2212r2146b2271, p28l92t2346r283b2414],
15	inhibitors	NNS	O	inhibitor	dobj	13	SENT_642	[p28l367t2327r877b2416],
16	.	.	O	.	_	0	SENT_642	[p28l367t2327r877b2416],

1	J	NNP	O	J	nn	3	SENT_643	[p28l956t2335r998b2429],
2	Clin	NNP	O	Clin	nn	3	SENT_643	[p28l1080t2327r1280b2416],
3	Oncol	NNP	O	Oncol	_	0	SENT_643	[p28l1364t2327r1653b2416],
4	2010	CD	DATE	2010	num	3	SENT_643	[p28l1736t2333r2143b2433],
5	;	:	O	;	_	0	SENT_643	[p28l1736t2333r2143b2433],
6	28	CD	NUMBER	28	num	8	SENT_643	[p28l1736t2333r2143b2433],
7	:	:	O	:	_	0	SENT_643	[p28l1736t2333r2143b2433],
8	4674-82	CD	NUMBER	4674-82	dep	3	SENT_643	[p28l90t2478r503b2561],
9	.	.	O	.	_	0	SENT_643	[p28l90t2478r503b2561],

1	70	CD	NUMBER	70	_	0	SENT_644	[p28l94t2626r221b2706],
2	.	.	O	.	_	0	SENT_644	[p28l94t2626r221b2706],

1	Miossec	JJ	ORGANIZATION	miossec	amod	2	SENT_645	[p28l280t2619r678b2706],
2	P	NN	ORGANIZATION	p	_	0	SENT_645	[p28l708t2625r783b2723],
3	,	,	O	,	_	0	SENT_645	[p28l708t2625r783b2723],
4	Korn	NNP	ORGANIZATION	Korn	nn	5	SENT_645	[p28l821t2625r1063b2708],
5	T	NN	ORGANIZATION	t	appos	2	SENT_645	[p28l1092t2624r1180b2723],
6	,	,	O	,	_	0	SENT_645	[p28l1092t2624r1180b2723],
7	Kuchroo	NNP	ORGANIZATION	Kuchroo	nn	8	SENT_645	[p28l1218t2617r1635b2708],
8	VK	NNP	ORGANIZATION	VK	appos	5	SENT_645	[p28l1665t2625r1838b2708],
9	.	.	O	.	_	0	SENT_645	[p28l1665t2625r1838b2708],

1	Interleukin-17	NN	O	interleukin-17	_	0	SENT_646	[p28l1875t2625r2146b2704, p28l90t2762r530b2850],
2	and	CC	O	and	_	0	SENT_646	[p28l560t2762r735b2850],
3	type	NN	O	type	conj_and	1	SENT_646	[p28l766t2781r966b2873],
4	17	CD	NUMBER	17	num	7	SENT_646	[p28l1000t2768r1104b2850],
5	helper	NN	O	helper	nn	7	SENT_646	[p28l1134t2762r1432b2873],
6	T	NN	O	t	nn	7	SENT_646	[p28l1454t2769r1524b2848],
7	cells	NNS	O	cell	dep	1	SENT_646	[p28l1550t2762r1785b2850],
8	.	.	O	.	_	0	SENT_646	[p28l1550t2762r1785b2850],

1	N	NN	O	n	nn	3	SENT_647	[p28l1817t2770r1902b2850],
2	Engl	NNP	O	Engl	nn	3	SENT_647	[p28l1928t2762r2147b2875],
3	J	NNP	O	J	nsubj	4	SENT_647	[p28l81t2914r123b3008],
4	Med	VBD	O	med	_	0	SENT_647	[p28l155t2906r365b2995],
5	2009	CD	DATE	2009	dobj	4	SENT_647	[p28l405t2912r1242b3012],
6	;	:	O	;	_	0	SENT_647	[p28l405t2912r1242b3012],
7	361:888	CD	NUMBER	361:888	num	8	SENT_647	[p28l405t2912r1242b3012],
8	-98	CD	NUMBER	-98	dep	5	SENT_647	[p28l405t2912r1242b3012],
9	.	.	O	.	_	0	SENT_647	[p28l405t2912r1242b3012],

1	71	CD	NUMBER	71	_	0	SENT_648	[p28l94t3062r221b3139],
2	.	.	O	.	_	0	SENT_648	[p28l94t3062r221b3139],

1	The	DT	O	the	det	3	SENT_649	[p28l279t3051r461b3138],
2	human	JJ	O	human	amod	3	SENT_649	[p28l532t3051r877b3139],
3	genome	NN	O	genome	_	0	SENT_649	[p28l948t3080r1334b3164],
4	at	IN	O	at	_	0	SENT_649	[p28l1405t3070r1495b3138],
5	ten	CD	NUMBER	ten	prep_at	3	SENT_649	[p28l1560t3070r1737b3139],
6	.	.	O	.	_	0	SENT_649	[p28l1560t3070r1737b3139],

1	Nature	NNP	O	Nature	_	0	SENT_650	[p28l1813t3059r2147b3139],
2	2010	CD	DATE	2010	num	1	SENT_650	[p28l92t3200r927b3300],
3	;	:	O	;	_	0	SENT_650	[p28l92t3200r927b3300],
4	464:649	CD	NUMBER	464:649	number	5	SENT_650	[p28l92t3200r927b3300],
5	-50	CD	NUMBER	-50	dep	1	SENT_650	[p28l92t3200r927b3300],
6	.	.	O	.	_	0	SENT_650	[p28l92t3200r927b3300],

1	72	CD	NUMBER	72	_	0	SENT_651	[p28l94t3350r227b3427],
2	.	.	O	.	_	0	SENT_651	[p28l94t3350r227b3427],

1	Collins	NNP	PERSON	Collins	nn	2	SENT_652	[p28l284t3339r630b3427],
2	F.	NNP	O	F.	nsubj	3	SENT_652	[p28l674t3347r751b3427],
3	Has	VBZ	O	have	_	0	SENT_652	[p28l800t3347r985b3425],
4	the	DT	O	the	det	5	SENT_652	[p28l1032t3339r1182b3425],
5	revolution	NN	O	revolution	dobj	3	SENT_652	[p28l1226t3339r1721b3427],
6	arrived	VBN	O	arrive	partmod	5	SENT_652	[p28l1763t3337r2147b3427],
7	?	.	O	?	_	0	SENT_652	[p28l1763t3337r2147b3427],

1	Nature	NNP	O	Nature	_	0	SENT_653	[p28l89t3490r423b3571],
2	2010	CD	DATE	2010	num	1	SENT_653	[p28l462t3488r1228b3588],
3	;	:	O	;	_	0	SENT_653	[p28l462t3488r1228b3588],
4	464:674	CD	NUMBER	464:674	number	5	SENT_653	[p28l462t3488r1228b3588],
5	-5	CD	NUMBER	-5	dep	1	SENT_653	[p28l462t3488r1228b3588],
6	.	.	O	.	_	0	SENT_653	[p28l462t3488r1228b3588],

1	73	CD	NUMBER	73	_	0	SENT_654	[p28l94t3638r221b3715],
2	.	.	O	.	_	0	SENT_654	[p28l94t3638r221b3715],

1	Venter	NNP	O	Venter	nn	2	SENT_655	[p28l279t3635r593b3715],
2	JC	NNP	O	JC	_	0	SENT_655	[p28l618t3633r758b3729],
3	.	.	O	.	_	0	SENT_655	[p28l618t3633r758b3729],

1	Multiple	JJ	O	multiple	amod	3	SENT_656	[p28l800t3627r1209b3738],
2	personal	JJ	O	personal	amod	3	SENT_656	[p28l1247t3627r1673b3738],
3	genomes	NNS	O	genome	nsubj	4	SENT_656	[p28l1711t3656r2145b3740],
4	await	VBP	O	await	_	0	SENT_656	[p29l90t23r376b110],
5	.	.	O	.	_	0	SENT_656	[p29l90t23r376b110],

1	Nature	NNP	O	Nature	_	0	SENT_657	[p29l419t29r753b110],
2	2010	CD	DATE	2010	num	1	SENT_657	[p29l792t27r1547b127],
3	;	:	O	;	_	0	SENT_657	[p29l792t27r1547b127],
4	464:676	CD	NUMBER	464:676	num	5	SENT_657	[p29l792t27r1547b127],
5	—	NN	O	—	dep	1	SENT_657	[p29l792t27r1547b127],
6	7	CD	NUMBER	7	dep	5	SENT_657	[p29l792t27r1547b127],
7	.	.	O	.	_	0	SENT_657	[p29l792t27r1547b127],

1	74	CD	NUMBER	74	_	0	SENT_658	[p29l94t177r217b254],
2	.	.	O	.	_	0	SENT_658	[p29l94t177r217b254],

1	Varmus	NNP	PERSON	Varmus	nn	2	SENT_659	[p29l279t174r649b254],
2	H.	NNP	O	H.	_	0	SENT_659	[p29l685t174r793b254],
3	Ten	CD	DURATION	ten	num	4	SENT_659	[p29l829t173r1006b252],
4	years	NNS	NUMBER	year	dep	2	SENT_659	[p29l1034t195r1284b277],
5	on	IN	O	on	_	0	SENT_659	[p29l1320t195r1439b254],
6	—	NN	O	—	prep_on	4	SENT_659	[p29l1470t216r1589b225],
7	the	DT	O	the	det	9	SENT_659	[p29l1618t166r1769b254],
8	human	JJ	O	human	amod	9	SENT_659	[p29l1802t166r2147b254],
9	genome	NN	O	genome	dep	2	SENT_659	[p29l91t339r476b423],
10	and	CC	O	and	_	0	SENT_659	[p29l556t310r735b398],
11	medicine	NN	O	medicine	conj_and	9	SENT_659	[p29l814t310r1288b398],
12	.	.	O	.	_	0	SENT_659	[p29l814t310r1288b398],

1	N	NN	O	n	nn	3	SENT_660	[p29l1372t318r1456b398],
2	Engl	NNP	O	Engl	nn	3	SENT_660	[p29l1533t310r1752b423],
3	J	NNP	O	J	nsubj	4	SENT_660	[p29l1821t318r1863b412],
4	Med	VBD	O	med	_	0	SENT_660	[p29l1938t310r2147b398],
5	2010	CD	DATE	2010	dobj	4	SENT_660	[p29l92t459r916b559],
6	;	:	O	;	_	0	SENT_660	[p29l92t459r916b559],
7	362:2028	CD	NUMBER	362:2028	number	8	SENT_660	[p29l92t459r916b559],
8	—	CD	NUMBER	—	dep	5	SENT_660	[p29l92t459r916b559],
9	9	CD	NUMBER	9	dep	8	SENT_660	[p29l92t459r916b559],
10	.	.	O	.	_	0	SENT_660	[p29l92t459r916b559],

1	75	CD	NUMBER	75	_	0	SENT_661	[p29l94t609r219b686],
2	.	.	O	.	_	0	SENT_661	[p29l94t609r219b686],

1	Wade	NNP	PERSON	Wade	nn	3	SENT_662	[p29l279t598r545b686],
2	N.	NNP	PERSON	N.	nn	3	SENT_662	[p29l591t606r697b686],
3	A	NNP	DATE	A	_	0	SENT_662	[p29l747t606r820b684],
4	decade	NN	DATE	decade	dep	3	SENT_662	[p29l865t598r1197b686],
5	later	RB	DATE	later	advmod	4	SENT_662	[p29l1243t598r1485b704],
6	,	,	O	,	_	0	SENT_662	[p29l1243t598r1485b704],
7	genetic	JJ	O	genetic	amod	9	SENT_662	[p29l1539t600r1890b711],
8	map	NN	O	map	nn	9	SENT_662	[p29l1936t627r2146b709],
9	yields	NNS	O	yield	appos	4	SENT_662	[p29l86t742r365b853],
10	few	JJ	O	few	amod	12	SENT_662	[p29l428t742r603b830],
11	new	JJ	O	new	amod	12	SENT_662	[p29l658t771r860b830],
12	cures	NNS	O	cure	dep	9	SENT_662	[p29l917t771r1200b830],
13	.	.	O	.	_	0	SENT_662	[p29l917t771r1200b830],

1	New	NNP	ORGANIZATION	New	nn	3	SENT_663	[p29l1265t750r1487b830],
2	York	NNP	ORGANIZATION	York	nn	3	SENT_663	[p29l1539t742r1763b830],
3	Times	NNP	ORGANIZATION	Times	_	0	SENT_663	[p29l1814t744r2142b830],
4	.	.	O	.	_	0	SENT_663	[p29l1814t744r2142b830],

1	June	NNP	DATE	June	_	0	SENT_664	[p29l81t893r300b987],
2	12	CD	DATE	12	num	1	SENT_664	[p29l342t891r480b993],
3	,	,	DATE	,	_	0	SENT_664	[p29l342t891r480b993],
4	2010	CD	DATE	2010	dep	1	SENT_664	[p29l526t891r778b974],
5	.	.	O	.	_	0	SENT_664	[p29l526t891r778b974],

1	Copyright	NN	O	copyright	_	0	SENT_665	[p29l94t1045r451b1141],
2	©	CD	NUMBER	©	num	6	SENT_665	[p29l487t1052r567b1132],
3	2011	CD	DATE	2011	num	6	SENT_665	[p29l606t1049r785b1118],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_665	[p29l829t1045r1366b1116],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_665	[p29l1401t1045r1696b1118],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_665	[p29l1725t1047r2003b1139],
7	.	.	O	.	_	0	SENT_665	[p29l1725t1047r2003b1139],

1	SPECIALTIES	NNS	O	specialty	_	0	SENT_666	[p29l660t1482r794b1498],
2	AND	CC	O	and	_	0	SENT_666	[p29l806t1482r855b1498],
3	TOPICS	NNS	O	topic	conj_and	1	SENT_666	[p29l866t1482r945b1498],
4	AT	IN	O	at	dep	1	SENT_666	[p29l957t1482r984b1498],
5	NEJM.oRG	NN	O	nejm.org	pobj	4	SENT_666	[p29l996t1482r1111b1503],

1	Specialty	NNP	O	Specialty	_	0	SENT_667	[p29l374t1517r485b1546],
2	pages	NNS	O	page	dep	1	SENT_667	[p29l492t1524r563b1546],
3	at	IN	O	at	_	0	SENT_667	[p29l572t1522r596b1540],
4	the	DT	O	the	det	5	SENT_667	[p29l603t1517r752b1546],
5	]	NN	O	]	poss	11	SENT_667	[p29l603t1517r752b1546],
6	oumal	JJ	O	oumal	amod	5	SENT_667	[p29l603t1517r752b1546],
7	’s	POS	O	’s	_	0	SENT_667	[p29l603t1517r752b1546],
8	Web	NN	O	web	nn	11	SENT_667	[p29l760t1517r817b1540],
9	site	NN	O	site	nn	11	SENT_667	[p29l826t1517r869b1540],
10	(	CD	NUMBER	(	num	11	SENT_667	[p29l879t1519r1023b1546],
11	NEJM.org	NN	O	nejm.org	prep_at	2	SENT_667	[p29l879t1519r1023b1546],
12	)	CD	NUMBER	)	num	14	SENT_667	[p29l879t1519r1023b1546],
13	feature	NN	O	feature	nn	14	SENT_667	[p29l1033t1517r1119b1540],
14	articles	NNS	O	article	dep	1	SENT_667	[p29l1128t1517r1217b1540],
15	in	IN	O	in	_	0	SENT_667	[p29l1226t1517r1250b1539],
16	cardiology	NN	O	cardiology	prep_in	14	SENT_667	[p29l1259t1517r1397b1546],
17	,	,	O	,	_	0	SENT_667	[p29l1259t1517r1397b1546],
18	endocrinology	NN	O	endocrinology	appos	1	SENT_667	[p29l358t1554r546b1584],
19	,	,	O	,	_	0	SENT_667	[p29l358t1554r546b1584],
20	genetics	NNS	O	genetics	appos	1	SENT_667	[p29l556t1555r666b1584],
21	,	,	O	,	_	0	SENT_667	[p29l556t1555r666b1584],
22	infectious	JJ	O	infectious	appos	20	SENT_667	[p29l676t1554r800b1578],
23	dis	FW	O	dis	nn	24	SENT_667	[p29l809t1554r845b1577],
24	se	FW	O	se	nn	22	SENT_667	[p29l875t1562r907b1582],
25	,	,	O	,	_	0	SENT_667	[p29l875t1562r907b1582],
26	nephro	FW	O	nephro	dep	22	SENT_667	[p29l917t1554r1007b1584],
27	o	NN	O	o	dep	1	SENT_667	[p29l1017t1562r1031b1577],
28	,	,	O	,	_	0	SENT_667	[p29l1063t1573r1068b1582],
29	pediatrics	NNS	O	pediatrics	dep	1	SENT_667	[p29l1077t1554r1208b1584],
30	,	,	O	,	_	0	SENT_667	[p29l1077t1554r1208b1584],
31	and	CC	O	and	_	0	SENT_667	[p29l1218t1554r1264b1577],
32	many	JJ	O	many	amod	35	SENT_667	[p29l1272t1562r1341b1584],
33	other	JJ	O	other	amod	35	SENT_667	[p29l1349t1554r1415b1577],
34	medical	JJ	O	medical	amod	35	SENT_667	[p29l372t1592r470b1615],
35	specialties	NNS	O	specialty	dep	1	SENT_667	[p29l479t1592r616b1621],
36	.	.	O	.	_	0	SENT_667	[p29l479t1592r616b1621],

1	These	DT	O	these	predet	3	SENT_668	[p29l626t1592r700b1615],
2	a	DT	O	a	det	3	SENT_668	[p29l725t1599r738b1615],
3	es	NNS	O	e	nsubj	19	SENT_668	[p29l755t1599r787b1620],
4	,	,	O	,	_	0	SENT_668	[p29l755t1599r787b1620],
5	along	IN	O	along	_	0	SENT_668	[p29l797t1592r869b1621],
6	with	IN	O	with	_	0	SENT_668	[p29l875t1592r931b1615],
7	collec	NN	O	collec	prep_along_with	3	SENT_668	[p29l940t1592r1012b1615],
8	‘	CD	NUMBER	‘	num	9	SENT_668	[p29l1024t1592r1075b1615],
9	ons	NNS	O	on	dep	3	SENT_668	[p29l1024t1592r1075b1615],
10	of	IN	O	of	_	0	SENT_668	[p29l1084t1592r1114b1615],
11	articles	NNS	O	article	prep_of	9	SENT_668	[p29l1117t1592r1206b1615],
12	on	IN	O	on	_	0	SENT_668	[p29l1216t1599r1247b1615],
13	clinical	JJ	O	clinical	amod	17	SENT_668	[p29l1256t1592r1346b1615],
14	and	CC	O	and	_	0	SENT_668	[p29l1354t1592r1400b1615],
15	nonclinical	JJ	O	nonclinical	conj_and	13	SENT_668	[p29l385t1629r525b1652],
16	o	NN	O	o	nn	17	SENT_668	[p29l543t1637r557b1652],
17	ics	NNS	O	ic	prep_on	11	SENT_668	[p29l576t1630r616b1657],
18	,	,	O	,	_	0	SENT_668	[p29l576t1630r616b1657],
19	offer	VBP	O	offer	_	0	SENT_668	[p29l627t1629r687b1652],
20	lin	NN	O	lin	nn	21	SENT_668	[p29l694t1629r727b1652],
21	s	NNS	O	s	dobj	19	SENT_668	[p29l745t1637r755b1652],
22	o	NN	O	o	nsubj	30	SENT_668	[p29l774t1637r788b1652],
23	interactive	JJ	O	interactive	amod	22	SENT_668	[p29l797t1630r926b1652],
24	and	CC	O	and	_	0	SENT_668	[p29l935t1629r981b1652],
25	multimedia	NNS	O	multimedia	nn	26	SENT_668	[p29l989t1629r1135b1652],
26	content	NN	O	content	nsubj	30	SENT_668	[p29l1143t1634r1239b1652],
27	and	CC	O	and	_	0	SENT_668	[p29l1246t1629r1292b1652],
28	feature	NN	O	feature	conj_and	22	SENT_668	[p29l1300t1629r1387b1652],
29	recently	RB	DATE	recently	advmod	30	SENT_668	[p29l365t1667r464b1696],
30	publis	VBZ	O	publi	rcmod	21	SENT_668	[p29l471t1667r548b1696],
31	e	SYM	O	e	dep	32	SENT_668	[p29l568t1674r580b1690],
32	articles	NNS	O	article	dep	30	SENT_668	[p29l605t1667r694b1690],
33	as	RB	O	as	advmod	32	SENT_668	[p29l703t1674r728b1690],
34	well	RB	O	well	advmod	32	SENT_668	[p29l736t1667r788b1690],
35	as	IN	O	as	_	0	SENT_668	[p29l796t1674r821b1690],
36	material	NN	O	material	prep_as	32	SENT_668	[p29l830t1667r934b1690],
37	from	IN	O	from	_	0	SENT_668	[p29l942t1667r1003b1690],
38	the	DT	O	the	det	40	SENT_668	[p29l1012t1667r1051b1690],
39	NEIM	NN	O	neim	nn	40	SENT_668	[p29l1059t1669r1131b1693],
40	archive	NN	O	archive	prep_from	30	SENT_668	[p29l1140t1667r1229b1690],
41	(	CD	NUMBER	(	num	43	SENT_668	[p29l1239t1669r1405b1693],
42	1812-1989	CD	DATE	1812-1989	num	43	SENT_668	[p29l1239t1669r1405b1693],
43	)	NN	O	)	dep	40	SENT_668	[p29l1239t1669r1405b1693],
44	.	.	O	.	_	0	SENT_668	[p29l1239t1669r1405b1693],

1	N	NN	O	n	nn	3	SENT_669	[p29l558t1829r572b1844],
2	ENGLJ	NN	O	englj	nn	3	SENT_669	[p29l587t1829r665b1851],
3	MED	NN	O	med	_	0	SENT_669	[p29l679t1829r731b1844],
4	364	CD	NUMBER	364	dep	3	SENT_669	[p29l741t1823r820b1851],
5	;	:	O	;	_	0	SENT_669	[p29l741t1823r820b1851],
6	12	CD	NUMBER	12	num	8	SENT_669	[p29l741t1823r820b1851],
7	NEjM.ORG	NN	O	nejm.org	nn	8	SENT_669	[p29l856t1829r980b1851],
8	MARCH2	NN	O	march2	dep	4	SENT_669	[p29l1017t1829r1127b1844],
9	,2	CD	NUMBER	,2	num	10	SENT_669	[p29l1146t1829r1213b1849],
10	o11	NN	O	o11	dep	8	SENT_669	[p29l1146t1829r1213b1849],
11	1153	CD	DATE	1153	dep	3	SENT_669	[p29l1940t1819r2015b1842],

1	The	DT	O	the	det	5	SENT_670	[p29l702t1862r753b1886],
2	New	NNP	LOCATION	New	nn	5	SENT_670	[p29l762t1863r824b1886],
3	England	NNP	LOCATION	England	nn	5	SENT_670	[p29l833t1862r944b1893],
4	J	NNP	O	J	nn	5	SENT_670	[p29l952t1863r965b1886],
5	oumal	NN	O	oumal	_	0	SENT_670	[p29l966t1862r1050b1886],
6	of	IN	O	of	prep	5	SENT_670	[p29l1059t1862r1088b1886],
7	e	SYM	O	e	dep	6	SENT_670	[p29l1125t1870r1139b1886],
8	icine	FW	O	icine	dep	5	SENT_670	[p29l1156t1862r1220b1886],

1	Downloaded	VBN	O	download	_	0	SENT_671	[p29l144t1903r314b1926],
2	from	IN	O	from	_	0	SENT_671	[p29l323t1903r387b1926],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_671	[p29l396t1903r514b1933],
4	at	IN	O	at	_	0	SENT_671	[p29l524t1907r547b1926],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_671	[p29l556t1903r738b1926],
6	on	IN	O	on	_	0	SENT_671	[p29l748t1910r780b1926],
7	January	NNP	DATE	January	prep_on	1	SENT_671	[p29l789t1903r892b1933],
8	5	CD	DATE	5	num	7	SENT_671	[p29l902t1903r924b1931],
9	,	,	DATE	,	_	0	SENT_671	[p29l902t1903r924b1931],
10	2014	CD	DATE	2014	num	7	SENT_671	[p29l935t1903r1007b1926],
11	.	.	O	.	_	0	SENT_671	[p29l935t1903r1007b1926],

1	or	CC	O	or	dep	4	SENT_672	[p29l1037t1910r1064b1926],
2	ersonal	JJ	O	ersonal	amod	3	SENT_672	[p29l1089t1903r1185b1926],
3	use	NN	O	use	npadvmod	4	SENT_672	[p29l1194t1910r1237b1926],
4	only	RB	O	only	_	0	SENT_672	[p29l1247t1903r1312b1933],
5	.	.	O	.	_	0	SENT_672	[p29l1247t1903r1312b1933],

1	No	DT	O	no	det	3	SENT_673	[p29l1322t1903r1362b1926],
2	other	JJ	O	other	amod	3	SENT_673	[p29l1372t1903r1440b1926],
3	uses	NNS	O	use	_	0	SENT_673	[p29l1448t1910r1504b1926],
4	without	IN	O	without	_	0	SENT_673	[p29l1514t1903r1616b1926],
5	permission	NN	O	permission	prep_without	3	SENT_673	[p29l1624t1903r1776b1933],
6	.	.	O	.	_	0	SENT_673	[p29l1624t1903r1776b1933],

1	Copyright	NN	O	copyright	nn	5	SENT_674	[p29l494t1944r629b1975],
2	©	CD	NUMBER	©	num	5	SENT_674	[p29l638t1944r661b1968],
3	2011	CD	DATE	2011	num	5	SENT_674	[p29l671t1944r734b1968],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	5	SENT_674	[p29l746t1944r937b1968],
5	Medica	NNP	ORGANIZATION	Medica	_	0	SENT_674	[p29l947t1944r1047b1968],
6	ociety	NN	O	ociety	dep	5	SENT_674	[p29l1083t1944r1170b1975],
7	.	.	O	.	_	0	SENT_674	[p29l1083t1944r1170b1975],

1	All	DT	O	all	det	2	SENT_675	[p29l1181t1944r1223b1968],
2	rights	NNS	O	rights	nsubj	3	SENT_675	[p29l1232t1944r1306b1975],
3	reserved	VBN	O	reserve	_	0	SENT_675	[p29l1316t1944r1435b1968],
4	.	.	O	.	_	0	SENT_675	[p29l1316t1944r1435b1968],

